data_2alj_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2alj _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 121.052 0.453 . . . . 0.0 110.978 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 81.6 m95 -77.29 168.51 19.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.976 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.8 ttm-85 -102.4 134.19 46.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.607 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.9 mtm180 -70.42 106.8 3.53 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.887 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.405 ' CD1' ' HA ' ' A' ' 135' ' ' GLU . 44.5 pt -96.61 -7.06 9.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.448 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -159.38 175.94 12.73 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 120.606 0.241 . . . . 0.0 110.916 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.469 ' CD1' ' CG ' ' A' ' 149' ' ' PRO . 29.0 m-85 -143.65 126.23 15.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.253 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.8 t -93.86 123.28 45.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.512 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.501 ' CE1' ' CZ ' ' A' ' 130' ' ' PHE . 9.4 t80 -85.0 96.21 9.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.734 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -147.84 155.98 42.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.632 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.03 31.22 21.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.846 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.67 34.69 14.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.034 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 57.0 m -154.66 161.52 41.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.034 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.501 ' CZ ' ' CE1' ' A' ' 125' ' ' TYR . 96.2 m-85 -103.82 90.49 3.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.166 0.508 . . . . 0.0 110.712 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.446 ' CG ' ' HA ' ' A' ' 141' ' ' LYS . 22.9 m-85 -67.69 127.4 93.38 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.561 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -71.62 118.16 5.51 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 122.37 2.047 . . . . 0.0 112.369 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.426 ' HG ' HG22 ' A' ' 168' ' ' THR . 38.0 tp -97.52 123.6 41.44 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.123 0.487 . . . . 0.0 110.595 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 52.4 mt -71.46 173.0 8.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.578 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.405 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.3 pt-20 -63.71 -29.27 70.52 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.114 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -89.92 11.36 20.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.16 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.43 ' HA2' HG22 ' A' ' 168' ' ' THR . . . 75.5 18.67 79.76 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.831 -0.7 . . . . 0.0 113.162 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 13.4 tpp180 -76.78 95.7 4.1 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.41 ' CD2' ' CB ' ' A' ' 131' ' ' PHE . 0.4 OUTLIER -71.44 113.58 8.62 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.494 -179.054 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 22.8 mt -88.11 71.76 9.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.292 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.446 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 30.8 mttt -56.87 -20.62 23.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.922 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -87.04 -18.73 29.91 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -104.93 30.85 5.2 Favored 'General case' 0 N--CA 1.461 0.121 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . -63.89 162.38 35.06 Favored Glycine 0 CA--C 1.51 -0.237 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.786 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 10.6 t -136.03 151.39 49.82 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.543 -0.329 . . . . 0.0 110.658 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 4.7 mmpt? -89.32 50.37 1.92 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.953 0.406 . . . . 0.0 110.671 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -171.04 151.4 3.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.554 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.414 ' HB3' ' CE2' ' A' ' 130' ' ' PHE . . . -96.88 125.87 44.84 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.23 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.469 ' CG ' ' CD1' ' A' ' 123' ' ' TYR . 74.3 Cg_endo -82.82 112.75 2.12 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.396 2.064 . . . . 0.0 112.474 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 30.6 t -69.92 -7.65 42.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.121 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -76.53 -23.44 53.64 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 120.828 0.346 . . . . 0.0 110.417 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -139.83 167.89 16.9 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.723 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -74.79 158.24 43.11 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.351 2.034 . . . . 0.0 112.114 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 10.7 t -118.83 110.83 31.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.051 0.453 . . . . 0.0 111.081 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.434 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 0.9 OUTLIER -72.83 96.01 2.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.579 179.022 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 54.3 t -93.1 136.52 24.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.961 0.41 . . . . 0.0 111.103 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 50.06 55.28 15.79 Favored Glycine 0 CA--C 1.52 0.375 0 CA-C-N 115.906 -0.588 . . . . 0.0 113.287 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.434 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 3.5 m95 -99.59 151.25 21.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.169 0.509 . . . . 0.0 111.649 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.89 -172.19 0.26 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.457 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -42.69 154.32 0.07 Allowed 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -57.18 -25.29 53.91 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.181 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -59.62 -39.43 84.27 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 120.957 0.408 . . . . 0.0 110.036 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.1 -40.06 53.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.94 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 6.6 mt -59.68 -42.13 87.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.898 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.63 -30.63 43.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.139 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -67.22 -53.14 32.94 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 121.528 0.68 . . . . 0.0 110.098 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.38 -43.46 96.58 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.06 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.43 HG22 ' HA2' ' A' ' 137' ' ' GLY . 0.2 OUTLIER -58.77 -38.0 77.5 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.525 179.356 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.56 -37.65 92.51 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 178.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -72.03 -46.39 57.26 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.353 -0.423 . . . . 0.0 111.025 178.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.421 HD11 ' CE1' ' A' ' 214' ' ' PHE . 10.9 mp -66.14 -27.71 68.24 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.665 0.269 . . . . 0.0 111.417 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.69 -18.93 62.81 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.438 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -111.74 -27.37 8.54 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.6 0.238 . . . . 0.0 111.413 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.93 167.3 1.55 Allowed Pre-proline 0 CA--C 1.539 0.535 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.929 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -70.39 128.01 14.86 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.177 1.918 . . . . 0.0 112.858 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.96 -25.41 8.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.606 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.93 -49.15 77.76 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.814 0.34 . . . . 0.0 110.896 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.401 ' CG1' ' CE ' ' A' ' 182' ' ' MET . 37.6 t -73.96 -35.22 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.445 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 5.7 tp -56.04 -35.52 66.98 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.183 0.515 . . . . 0.0 109.988 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -78.33 -40.19 20.36 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.336 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -86.06 103.01 14.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.894 0.378 . . . . 0.0 110.625 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' MET . . . . . 0.401 ' CE ' ' CG1' ' A' ' 178' ' ' VAL . 2.9 mtm 178.43 165.84 0.8 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.128 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.47 -54.53 1.97 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.797 0.332 . . . . 0.0 111.253 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -163.31 142.94 8.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.92 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.41 HD12 HG23 ' A' ' 185' ' ' ILE . 16.8 mt -106.26 114.71 46.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.722 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . 0.454 ' CE1' ' CE1' ' A' ' 200' ' ' TYR . 11.4 m170 -104.68 131.03 52.61 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.988 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -83.24 104.79 13.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.515 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.649 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.53 0.191 0 CA-C-O 120.684 0.278 . . . . 0.0 111.297 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -102.18 35.13 2.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.774 0.321 . . . . 0.0 110.708 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -89.45 113.08 24.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.178 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 29.1 m -108.57 168.07 3.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.847 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 20.7 mm -134.79 108.06 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.826 0.345 . . . . 0.0 111.383 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.413 HG11 ' CZ ' ' A' ' 214' ' ' PHE . 8.1 m -96.42 124.06 48.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.895 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.454 ' CE1' ' CE1' ' A' ' 186' ' ' HIS . 5.2 m-85 -82.58 146.0 29.41 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.796 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.83 156.23 17.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.04 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -64.26 -23.81 67.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.532 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -90.25 15.4 10.49 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 79.59 14.29 81.41 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.079 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -84.43 167.32 16.55 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.929 0.364 . . . . 0.0 110.71 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -133.72 111.66 10.75 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.2 t -112.73 124.35 69.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.19 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 80.0 p -101.42 116.47 32.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.695 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -127.0 158.41 36.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.96 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.13 154.38 17.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.724 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 36.8 mt -66.39 -35.17 74.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.999 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.49 -35.31 80.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.384 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -129.8 40.91 3.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.891 0.377 . . . . 0.0 111.055 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.421 ' CE1' HD11 ' A' ' 171' ' ' LEU . 11.9 t80 -65.54 -50.62 64.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.707 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.9 -41.26 91.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.093 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.06 -49.38 65.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.997 0.427 . . . . 0.0 110.46 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 2.1 mmpt? -54.65 -45.09 73.75 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.07 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -80.95 -27.5 36.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.978 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 14.3 t -60.76 -31.55 70.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.964 0.411 . . . . 0.0 110.372 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.245 179.471 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 121.146 0.498 . . . . 0.0 111.174 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.414 ' HB2' ' HB3' ' A' ' 134' ' ' LEU . 79.4 m95 -68.67 168.27 13.5 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.092 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -102.8 136.37 42.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.476 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 41.7 mtt85 -71.95 106.11 4.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.936 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.401 ' CD1' HG22 ' A' ' 168' ' ' THR . 45.9 pt -94.1 -7.84 10.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.476 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -159.47 176.44 12.08 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 121.017 -0.273 . . . . 0.0 110.89 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.432 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 32.1 m-85 -142.85 126.14 16.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.322 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 4.1 t -93.43 122.74 45.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.963 0.411 . . . . 0.0 111.226 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.492 ' CD1' ' CE1' ' A' ' 130' ' ' PHE . 17.9 t80 -80.99 106.51 13.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.698 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -163.36 156.59 19.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.595 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.427 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 1.2 mmm180 60.18 30.22 19.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.884 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 63.12 32.24 15.31 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.366 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 91.1 m -156.92 161.25 39.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.878 0.371 . . . . 0.0 111.026 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.492 ' CE1' ' CD1' ' A' ' 125' ' ' TYR . 58.5 m-85 -99.85 90.3 4.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.626 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.474 ' HA ' ' HA2' ' A' ' 144' ' ' GLY . 22.6 m-85 -65.48 125.5 89.7 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.787 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.406 ' HB3' ' CE2' ' A' ' 123' ' ' TYR . 58.3 Cg_endo -73.57 118.82 5.64 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.044 1.829 . . . . 0.0 112.411 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.418 ' HG ' HG21 ' A' ' 168' ' ' THR . 28.4 tp -96.22 123.85 40.01 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.396 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.414 ' HB3' ' HB2' ' A' ' 118' ' ' TRP . 39.9 mt -69.64 173.62 5.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.45 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -64.68 -28.02 69.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.948 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 48.8 p-10 -90.93 13.91 15.26 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.285 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.436 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 72.63 21.78 79.39 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.731 -0.747 . . . . 0.0 113.119 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 9.7 tpp180 -80.82 94.25 6.4 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.13 113.6 9.33 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.48 -179.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 25.1 mt -88.39 80.43 7.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.414 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.433 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 15.4 mtpt -71.45 -5.77 35.34 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -91.11 -24.28 20.04 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 122.304 -0.248 . . . . 0.0 111.432 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -89.46 -79.12 0.34 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.779 0.323 . . . . 0.0 111.403 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . 58.11 161.1 0.04 OUTLIER Glycine 0 CA--C 1.505 -0.57 0 CA-C-N 116.279 -0.419 . . . . 0.0 112.753 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.8 t -140.01 148.61 42.11 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.872 0.368 . . . . 0.0 110.939 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 4.2 mmtt -91.1 51.97 2.04 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.157 0.503 . . . . 0.0 110.216 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.59 148.48 3.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.773 -179.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -81.89 135.14 48.89 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.703 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.441 ' HD2' ' CG2' ' A' ' 154' ' ' VAL . 68.4 Cg_endo -84.08 97.96 0.75 Allowed 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.052 2.501 . . . . 0.0 112.549 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 26.2 t -67.5 -9.3 41.0 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.825 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -90.0 -21.92 22.15 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.566 0.222 . . . . 0.0 111.588 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -139.79 167.4 18.63 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.65 162.89 38.7 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.408 2.072 . . . . 0.0 112.518 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.441 ' CG2' ' HD2' ' A' ' 149' ' ' PRO . 18.3 t -123.82 110.14 24.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.572 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.426 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.85 95.91 2.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.747 179.112 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 59.0 t -93.01 136.87 23.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.927 0.394 . . . . 0.0 111.094 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 48.85 55.42 11.47 Favored Glycine 0 CA--C 1.52 0.369 0 CA-C-N 115.966 -0.561 . . . . 0.0 113.174 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.426 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 3.4 m95 -99.07 151.18 21.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.156 0.503 . . . . 0.0 111.735 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.43 -172.27 0.15 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.604 179.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -43.21 154.39 0.08 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.332 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -56.94 -24.66 50.94 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.218 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.72 -40.09 86.85 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.967 0.413 . . . . 0.0 110.05 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.12 -39.78 54.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.009 178.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 6.1 mt -59.67 -41.23 84.55 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.9 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.0 -30.58 47.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.214 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -67.64 -52.9 32.73 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.385 0.612 . . . . 0.0 110.107 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.44 -45.27 92.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.971 178.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.436 HG21 ' HA2' ' A' ' 137' ' ' GLY . 0.2 OUTLIER -57.65 -38.38 74.96 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.549 179.207 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.83 -36.46 90.02 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 110.701 -0.959 . . . . 0.0 110.701 178.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -74.17 -46.36 42.65 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.451 -0.374 . . . . 0.0 111.06 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.426 HD11 ' CE1' ' A' ' 214' ' ' PHE . 11.3 mp -65.43 -29.6 70.31 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.689 0.28 . . . . 0.0 111.319 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.49 -19.18 63.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.345 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -111.01 -27.85 8.58 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.635 0.255 . . . . 0.0 111.433 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.89 166.58 1.32 Allowed Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.161 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.54 127.44 14.77 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.243 1.962 . . . . 0.0 112.744 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.71 -26.01 5.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.784 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.56 -50.76 72.05 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.925 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 33.8 t -74.16 -32.42 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.414 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.2 -34.2 70.12 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -79.48 -39.61 17.88 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -86.77 103.03 14.82 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.952 0.405 . . . . 0.0 110.6 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 2.8 mtm 178.49 160.48 0.6 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.994 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.1 m -120.56 -52.31 2.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.682 0.277 . . . . 0.0 111.379 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -163.27 142.64 8.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.926 0.394 . . . . 0.0 111.283 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.416 HD12 HG22 ' A' ' 185' ' ' ILE . 17.6 mt -106.71 114.19 45.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.344 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -104.39 119.87 39.94 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.135 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -75.8 104.57 6.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.544 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.572 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 . . . . . 0 CA--C 1.529 0.153 0 CA-C-O 120.599 0.238 . . . . 0.0 111.589 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -109.27 37.84 2.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.765 0.317 . . . . 0.0 111.082 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.83 115.59 27.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.947 0.403 . . . . 0.0 111.229 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.419 HG11 ' CZ2' ' A' ' 158' ' ' TRP . 28.1 m -112.51 166.14 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.808 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 22.3 mm -133.03 107.85 12.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.81 0.338 . . . . 0.0 111.401 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 11.3 m -96.73 120.9 46.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.934 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -81.84 152.29 26.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.562 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 3.6 mmt -108.53 150.03 28.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.809 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -58.74 -25.61 63.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.261 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -88.63 12.94 13.34 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 81.98 14.36 77.42 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.378 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -86.13 153.41 22.1 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 117.103 0.451 . . . . 0.0 110.807 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -123.27 111.42 16.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.86 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.6 t -115.01 123.25 70.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.154 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 9.8 t -98.84 115.49 28.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.742 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -123.91 162.93 22.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.8 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.73 153.99 18.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.727 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 33.1 mt -65.98 -36.64 77.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.803 0.335 . . . . 0.0 110.763 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -64.82 -36.51 84.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.124 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -128.31 43.51 3.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.916 0.389 . . . . 0.0 110.929 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.426 ' CE1' HD11 ' A' ' 171' ' ' LEU . 11.4 t80 -68.46 -54.61 15.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.786 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.5 -39.15 79.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.904 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -67.24 -50.04 62.16 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.117 0.484 . . . . 0.0 110.29 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.29 -45.35 72.5 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.057 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -80.18 -27.52 38.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.873 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 1.1 m -61.04 -29.85 69.97 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.403 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 7.1 m170 . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.282 179.831 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 121.047 0.451 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.412 ' HB2' ' HB3' ' A' ' 134' ' ' LEU . 80.9 m95 -68.7 168.31 13.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.015 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.14 135.72 43.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.548 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.9 mtm180 -71.5 105.29 3.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.721 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.401 ' CD1' HG21 ' A' ' 168' ' ' THR . 47.1 pt -94.18 -8.24 9.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.406 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -158.47 176.88 11.86 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.467 0.175 . . . . 0.0 110.575 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.454 ' CD1' ' CG ' ' A' ' 149' ' ' PRO . 31.3 m-85 -144.35 125.84 14.93 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.7 t -93.58 122.85 45.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.058 0.456 . . . . 0.0 111.557 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -83.49 94.31 8.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.681 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -145.01 155.13 43.2 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.603 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.93 30.82 20.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.712 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 63.29 33.85 13.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.863 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.4 ' CG2' ' N ' ' A' ' 145' ' ' THR . 58.6 m -155.9 159.7 39.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.057 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -99.77 91.23 4.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.217 0.532 . . . . 0.0 110.863 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.432 ' CG ' ' HA ' ' A' ' 141' ' ' LYS . 26.1 m-85 -70.37 114.13 23.53 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.722 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.4 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 31.8 Cg_exo -58.72 123.35 13.35 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 122.414 2.076 . . . . 0.0 112.659 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.416 ' HG ' HG23 ' A' ' 168' ' ' THR . 28.9 tp -102.39 123.94 47.06 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.346 179.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.412 ' HB3' ' HB2' ' A' ' 118' ' ' TRP . 40.3 mt -70.32 173.21 7.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.634 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -64.11 -28.3 69.68 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.037 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -90.79 13.72 15.53 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.209 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.43 ' HA2' HG23 ' A' ' 168' ' ' THR . . . 72.84 21.7 79.57 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.75 -0.738 . . . . 0.0 113.01 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -80.8 92.67 6.11 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.401 ' CD2' ' CB ' ' A' ' 131' ' ' PHE . 0.4 OUTLIER -66.21 113.56 4.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.322 -179.125 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 43.4 mt -83.66 67.68 9.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.707 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.432 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 2.3 mttp -57.58 -21.49 39.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.451 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -95.56 21.07 8.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.433 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -147.31 28.47 0.99 Allowed 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.787 0.327 . . . . 0.0 111.238 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.4 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -60.83 162.83 21.01 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.897 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.4 ' N ' ' CG2' ' A' ' 129' ' ' THR . 9.0 t -132.96 150.86 52.13 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.814 0.34 . . . . 0.0 110.611 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.4 mmtt -90.34 50.02 1.78 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.531 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -171.09 150.24 3.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.516 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -94.55 125.76 50.46 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.219 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.454 ' CG ' ' CD1' ' A' ' 123' ' ' TYR . 73.6 Cg_endo -83.65 111.97 1.8 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.428 2.085 . . . . 0.0 112.605 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 46.6 t -69.84 -7.89 43.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.038 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -77.27 -22.55 51.94 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 120.798 0.333 . . . . 0.0 110.572 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -142.15 167.06 17.72 Favored Pre-proline 0 N--CA 1.453 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.702 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -74.58 157.68 44.33 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.37 2.046 . . . . 0.0 112.315 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 12.8 t -118.28 111.0 32.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.346 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.434 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.65 96.05 1.94 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.762 179.016 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.1 t -93.56 135.44 28.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.995 0.426 . . . . 0.0 110.945 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 49.62 58.08 8.73 Favored Glycine 0 CA--C 1.521 0.42 0 CA-C-N 115.874 -0.603 . . . . 0.0 113.158 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.434 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 3.0 m95 -100.59 151.35 21.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.201 0.524 . . . . 0.0 111.744 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.412 ' HD3' ' CE2' ' A' ' 187' ' ' TYR . 2.6 tptt -64.76 -172.47 0.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.523 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -44.35 154.89 0.1 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.122 0.487 . . . . 0.0 112.212 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -57.29 -25.37 54.38 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.225 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.34 -38.25 83.21 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.979 0.419 . . . . 0.0 110.165 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.82 -40.61 47.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.116 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 5.9 mt -58.45 -41.38 81.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.973 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.12 -30.34 48.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.144 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -68.1 -53.04 28.34 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-O 121.368 0.604 . . . . 0.0 110.196 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.66 -43.6 93.89 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.03 179.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.43 HG23 ' HA2' ' A' ' 137' ' ' GLY . 0.2 OUTLIER -59.2 -37.24 76.95 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.466 179.009 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.05 -37.01 92.11 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -73.06 -46.87 49.21 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.359 -0.421 . . . . 0.0 111.163 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.422 HD13 ' CE1' ' A' ' 214' ' ' PHE . 11.1 mp -65.3 -29.28 70.02 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.7 0.286 . . . . 0.0 111.345 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.79 -20.89 64.36 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.317 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -110.56 -26.3 9.54 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.599 0.238 . . . . 0.0 111.52 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.42 166.62 1.58 Allowed Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.083 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -68.8 127.14 14.9 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.308 2.005 . . . . 0.0 112.698 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.07 -25.96 5.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.643 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -58.23 -49.89 75.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.907 0.384 . . . . 0.0 110.986 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.405 ' CG1' ' CE ' ' A' ' 182' ' ' MET . 32.0 t -74.0 -34.87 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.704 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.61 -33.91 68.73 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.119 0.485 . . . . 0.0 109.838 178.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -78.62 -39.79 20.37 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -87.74 103.18 15.37 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.884 0.373 . . . . 0.0 110.684 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' MET . . . . . 0.405 ' CE ' ' CG1' ' A' ' 178' ' ' VAL . 2.8 mtm 178.79 163.4 0.78 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.202 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -120.39 -57.1 1.94 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.742 0.306 . . . . 0.0 111.206 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -159.97 142.52 13.47 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.992 0.425 . . . . 0.0 111.124 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 17.8 mt -105.12 114.84 45.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.279 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 23.5 m170 -104.24 120.38 41.02 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.117 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.412 ' CE2' ' HD3' ' A' ' 159' ' ' LYS . 83.7 t80 -75.03 104.45 5.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.474 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.529 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 . . . . . 0 CA--C 1.529 0.167 0 CA-C-O 120.729 0.3 . . . . 0.0 111.333 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -106.55 40.39 1.63 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.036 0.446 . . . . 0.0 110.308 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.18 116.45 27.44 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.959 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 29.2 m -109.96 168.05 4.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.082 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 21.8 mm -135.37 108.24 8.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.196 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 15.4 m -97.61 139.72 19.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.998 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -101.51 152.72 20.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.778 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 6.0 mmt -105.28 159.7 15.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.88 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -60.13 -27.07 66.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.256 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -86.92 9.96 17.74 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 84.54 14.34 71.01 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.565 -0.826 . . . . 0.0 113.266 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -81.05 158.38 25.11 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 117.228 0.514 . . . . 0.0 110.739 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -128.15 111.25 13.25 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.814 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.2 t -111.21 133.58 56.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.951 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.63 117.25 33.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.938 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -129.49 156.84 43.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.681 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -99.16 149.33 23.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.78 0.324 . . . . 0.0 110.764 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.456 HG23 HD12 ' A' ' 211' ' ' ILE . 64.1 mt -59.55 -38.25 74.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.955 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -61.84 -32.9 73.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.301 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -134.87 46.41 2.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.904 0.383 . . . . 0.0 111.075 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.422 ' CE1' HD13 ' A' ' 171' ' ' LEU . 11.4 t80 -70.26 -51.36 31.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.795 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.93 -39.65 86.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.014 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.85 -50.34 62.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.144 0.497 . . . . 0.0 110.454 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.99 -45.11 71.36 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.169 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -81.33 -26.33 35.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.95 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.31 -30.56 70.57 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.871 0.367 . . . . 0.0 110.301 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 13.8 m170 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.189 179.767 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.898 0.38 . . . . 0.0 110.955 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -80.66 168.41 18.9 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.143 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -101.06 132.34 46.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.761 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 12.1 mtm-85 -69.94 106.12 3.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.667 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 43.4 pt -94.5 -7.82 9.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.409 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -160.46 176.81 11.22 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 121.158 -0.217 . . . . 0.0 110.669 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.453 ' O ' ' HA ' ' A' ' 154' ' ' VAL . 30.4 m-85 -142.34 126.96 17.96 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.11 -0.329 . . . . 0.0 110.11 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.9 t -93.22 122.49 44.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.345 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -80.42 94.39 6.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.632 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -146.92 156.5 43.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.375 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.34 29.79 19.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.86 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 62.76 34.92 14.24 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.108 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 86.7 m -158.06 161.76 38.05 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.194 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -98.2 90.9 5.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.142 0.496 . . . . 0.0 111.041 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.436 ' CG ' ' HA ' ' A' ' 141' ' ' LYS . 23.9 m-85 -69.67 120.35 76.85 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.248 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.425 ' HA ' ' CD2' ' A' ' 123' ' ' TYR . 23.5 Cg_exo -64.2 117.63 4.64 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.341 2.027 . . . . 0.0 112.798 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.423 ' HG ' HG21 ' A' ' 168' ' ' THR . 35.9 tp -96.84 123.65 40.6 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.144 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 55.9 mt -70.75 171.39 10.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.666 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -62.82 -29.36 70.67 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.938 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -89.29 10.3 22.8 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.156 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.437 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 76.57 18.05 79.38 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.159 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -76.97 94.04 3.9 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.14 110.03 3.8 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.675 -178.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 37.5 mt -81.74 73.62 8.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.676 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.436 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 13.1 mtpt -60.72 -17.86 50.89 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.575 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -101.32 25.01 8.75 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.535 0.207 . . . . 0.0 111.219 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -145.83 26.7 1.23 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.707 0.289 . . . . 0.0 111.353 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -59.21 164.16 10.66 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.719 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.8 t -135.24 148.55 49.63 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.925 0.393 . . . . 0.0 110.784 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 3.6 mmtt -90.04 53.24 2.47 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.491 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.72 153.56 4.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.361 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -88.62 133.8 35.37 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.83 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.439 ' HG3' ' CD1' ' A' ' 123' ' ' TYR . 73.7 Cg_endo -81.63 98.86 1.01 Allowed 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.905 2.404 . . . . 0.0 112.505 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.0 t -67.23 -9.62 42.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.877 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -89.65 -22.23 22.39 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 111.666 0.247 . . . . 0.0 111.666 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -139.03 168.07 16.88 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -74.12 165.81 31.09 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.352 2.035 . . . . 0.0 112.278 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 25.6 t -125.12 107.83 18.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.035 0.445 . . . . 0.0 111.744 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.444 HD22 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.43 96.19 1.87 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.023 179.336 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.435 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 61.9 t -94.17 138.02 21.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.085 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 48.01 56.05 9.36 Favored Glycine 0 CA--C 1.52 0.39 0 CA-C-N 115.964 -0.562 . . . . 0.0 113.261 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.444 ' CE2' HD22 ' A' ' 155' ' ' LEU . 3.4 m95 -99.16 151.16 21.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.187 0.518 . . . . 0.0 111.659 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.47 -172.37 0.16 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.519 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -43.06 154.22 0.08 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -57.06 -24.89 52.53 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.267 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -60.26 -39.27 86.17 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.998 0.427 . . . . 0.0 110.162 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.7 -39.51 51.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.18 179.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 7.1 mt -60.07 -42.13 88.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.126 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.48 -30.83 54.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.285 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -65.95 -53.27 41.19 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.409 0.623 . . . . 0.0 110.01 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.48 -43.05 99.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.087 179.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.437 HG21 ' HA2' ' A' ' 137' ' ' GLY . 0.2 OUTLIER -59.19 -37.28 77.02 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.38 179.281 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.52 -38.37 94.79 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 110.456 -1.057 . . . . 0.0 110.456 178.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 33.6 mm-40 -71.31 -44.15 65.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.384 -0.408 . . . . 0.0 110.801 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.428 HD13 ' CE1' ' A' ' 214' ' ' PHE . 10.5 mp -66.92 -28.41 68.27 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.7 0.286 . . . . 0.0 111.384 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.83 -16.18 62.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.377 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -114.7 -29.25 6.84 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 111.561 0.208 . . . . 0.0 111.561 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.85 167.16 1.12 Allowed Pre-proline 0 CA--C 1.538 0.5 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.121 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -69.99 126.94 13.73 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.153 1.902 . . . . 0.0 113.043 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.35 -25.31 5.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.696 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -56.08 -50.72 70.21 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.907 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.417 ' CG1' ' CE ' ' A' ' 182' ' ' MET . 42.8 t -74.74 -34.74 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.54 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 11.6 tp -54.92 -35.32 64.04 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.181 0.515 . . . . 0.0 110.13 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -79.99 -41.83 11.8 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 111.169 -0.773 . . . . 0.0 111.169 178.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -82.3 103.14 11.66 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.843 0.354 . . . . 0.0 110.469 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' MET . . . . . 0.417 ' CE ' ' CG1' ' A' ' 178' ' ' VAL . 2.9 mtm 177.81 171.6 0.64 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.129 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.3 m -127.54 -54.59 1.34 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.811 0.338 . . . . 0.0 110.877 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -163.49 142.32 8.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.029 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 18.6 mt -105.51 114.32 44.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.137 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . 0.435 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 19.2 m170 -105.88 114.92 29.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.424 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.408 ' HB2' ' CD2' ' A' ' 158' ' ' TRP . 83.8 t80 -66.09 104.43 1.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 12.2 mttt . . . . . 0 C--N 1.327 -0.396 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.939 -179.314 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 . . . . . 0 CA--C 1.529 0.139 0 CA-C-O 120.815 0.341 . . . . 0.0 111.166 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 6.9 p30 -102.15 37.27 1.91 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.556 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 2.0 tpm_? -89.5 114.23 25.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.134 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 28.7 m -110.48 166.0 5.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.622 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 19.1 mm -131.43 106.14 11.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.805 0.336 . . . . 0.0 111.43 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.419 HG13 ' CE2' ' A' ' 214' ' ' PHE . 9.5 m -96.11 118.36 42.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.919 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -81.63 152.92 26.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.547 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.17 148.15 28.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.863 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 36.1 m-20 -58.24 -28.85 65.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.017 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -76.86 -4.68 44.93 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.765 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 97.41 14.46 41.26 Favored Glycine 0 C--N 1.335 0.517 0 C-N-CA 120.533 -0.841 . . . . 0.0 113.106 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -87.61 170.99 10.8 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.957 0.408 . . . . 0.0 111.103 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -135.04 111.12 9.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.623 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 28.9 t -113.94 124.82 70.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.881 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 2.8 m -102.17 115.64 30.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.781 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -123.49 171.01 9.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.82 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -107.42 155.09 20.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.474 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 38.5 mt -68.13 -35.95 73.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.807 0.336 . . . . 0.0 110.76 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -62.85 -36.87 84.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.258 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -130.64 40.99 3.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.953 0.406 . . . . 0.0 111.068 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.428 ' CE1' HD13 ' A' ' 171' ' ' LEU . 10.6 t80 -64.06 -55.04 25.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.553 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.04 -42.73 85.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.271 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -66.67 -48.21 70.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.015 0.436 . . . . 0.0 110.496 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 1.2 mmpt? -55.1 -44.4 74.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.279 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.402 ' HB3' ' CG1' ' A' ' 178' ' ' VAL . 3.7 mm? -83.99 -25.69 29.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.074 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 14.9 t -60.74 -32.81 72.08 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.973 0.416 . . . . 0.0 110.157 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 24.5 m170 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.181 179.293 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.991 0.424 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 81.0 m95 -73.56 168.48 19.21 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.185 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -102.88 132.24 49.22 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.808 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.31 107.03 3.11 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.777 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.404 ' CD1' HG22 ' A' ' 168' ' ' THR . 44.2 pt -96.21 -7.8 9.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.498 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -159.94 176.78 11.47 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.003 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.442 ' O ' ' HA ' ' A' ' 154' ' ' VAL . 33.1 m-85 -143.41 127.2 17.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.284 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.6 t -93.44 122.71 45.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.098 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -82.52 94.11 7.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.36 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -145.22 155.68 43.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.255 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 59.31 29.45 19.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.855 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 62.88 35.03 13.82 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.142 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 53.3 m -157.13 156.76 33.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.836 0.351 . . . . 0.0 111.17 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -94.75 91.39 6.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.888 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.433 ' CG ' ' HA ' ' A' ' 141' ' ' LYS . 23.3 m-85 -70.81 121.75 84.77 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.303 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.421 ' HA ' ' CD2' ' A' ' 123' ' ' TYR . 22.3 Cg_exo -64.81 121.66 9.26 Favored 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 122.414 2.076 . . . . 0.0 112.757 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.428 ' HG ' HG21 ' A' ' 168' ' ' THR . 31.1 tp -102.09 123.36 45.82 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-O 121.128 0.49 . . . . 0.0 110.087 178.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 51.5 mt -70.72 171.81 9.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.652 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -62.94 -28.32 69.99 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.979 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 50.8 p-10 -90.46 11.97 20.0 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.225 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.435 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 75.15 18.79 80.05 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.237 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -77.6 92.43 4.09 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.41 113.78 4.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.418 -179.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 30.1 mt -84.01 70.07 10.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.69 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.433 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 5.4 mtpt -58.26 -20.3 41.18 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.56 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -99.38 25.24 7.15 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.739 -0.21 . . . . 0.0 111.27 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -147.16 24.83 1.14 Allowed 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.582 0.23 . . . . 0.0 111.493 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -59.41 161.71 15.21 Favored Glycine 0 CA--C 1.509 -0.335 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.747 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 9.0 t -131.27 154.51 48.42 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.041 0.448 . . . . 0.0 110.7 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -92.95 53.92 2.08 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.766 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.74 170.81 6.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.256 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -104.26 135.85 19.27 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.537 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.441 ' HG3' ' CD1' ' A' ' 123' ' ' TYR . 68.3 Cg_endo -82.77 99.67 0.93 Allowed 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.95 2.433 . . . . 0.0 112.443 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.4 t -67.01 -10.1 46.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.844 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.92 -22.08 22.16 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -138.67 166.69 23.4 Favored Pre-proline 0 C--N 1.328 -0.356 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -178.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.87 164.2 35.19 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 122.487 2.125 . . . . 0.0 112.3 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 24.3 t -123.4 109.68 24.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.666 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.43 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.58 96.77 2.02 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.947 179.344 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 59.5 t -94.68 136.87 24.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.983 0.421 . . . . 0.0 111.124 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 49.7 51.33 28.71 Favored Glycine 0 CA--C 1.52 0.375 0 CA-C-N 115.811 -0.631 . . . . 0.0 113.259 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.43 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 2.9 m95 -94.75 151.01 19.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.054 0.454 . . . . 0.0 111.574 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -66.0 -172.43 0.14 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.421 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -43.67 154.7 0.09 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.073 0.463 . . . . 0.0 112.217 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -56.45 -25.24 48.91 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.269 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.33 -39.17 86.12 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 120.912 0.387 . . . . 0.0 110.058 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.19 -40.22 52.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.102 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 6.1 mt -59.13 -41.58 84.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.909 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.44 -30.74 53.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.2 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -67.21 -53.17 32.67 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-O 121.439 0.638 . . . . 0.0 110.072 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.72 -45.53 91.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.989 178.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.435 HG21 ' HA2' ' A' ' 137' ' ' GLY . 0.2 OUTLIER -57.28 -36.77 71.45 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.565 179.037 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.13 -38.21 94.04 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 178.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -71.24 -48.17 52.83 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.329 -0.436 . . . . 0.0 110.939 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.427 HD11 ' CE1' ' A' ' 214' ' ' PHE . 10.9 mp -64.51 -28.6 69.76 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.742 0.306 . . . . 0.0 111.275 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.87 -18.37 63.41 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.37 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -112.15 -28.32 8.02 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.645 0.26 . . . . 0.0 111.421 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.55 166.9 1.51 Allowed Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.998 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -70.04 128.78 16.26 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.263 1.975 . . . . 0.0 112.898 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.94 -25.8 9.01 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.64 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -58.05 -48.79 79.04 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.881 0.372 . . . . 0.0 110.935 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.406 ' CG1' ' HB3' ' A' ' 218' ' ' LEU . 24.6 t -73.66 -35.31 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.504 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 11.5 tp -55.26 -34.61 64.19 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.234 0.54 . . . . 0.0 109.987 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -78.71 -42.73 12.86 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.314 178.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -82.16 103.19 11.59 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.899 0.381 . . . . 0.0 110.404 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 2.9 mtm 177.65 173.48 0.54 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.956 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 3.2 t -133.09 -51.65 0.89 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.705 0.288 . . . . 0.0 111.229 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . 0.408 ' HG2' ' CD1' ' A' ' 200' ' ' TYR . 1.3 pm0 -163.13 142.85 8.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.035 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 19.9 mt -106.66 114.24 45.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.442 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -104.6 124.04 48.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.16 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -80.47 104.82 11.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.368 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.54 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 . . . . . 0 CA--C 1.53 0.211 0 CA-C-O 120.658 0.266 . . . . 0.0 111.43 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -107.13 38.33 2.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.772 0.32 . . . . 0.0 110.616 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -91.1 115.75 28.27 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.985 0.421 . . . . 0.0 111.379 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 27.7 m -112.55 166.6 6.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.655 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 21.5 mm -131.68 109.85 16.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.732 0.301 . . . . 0.0 111.29 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.417 HG12 ' CE2' ' A' ' 214' ' ' PHE . 8.5 m -100.08 124.92 53.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.912 0.387 . . . . 0.0 111.021 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.408 ' CD1' ' HG2' ' A' ' 184' ' ' GLU . 44.8 m-85 -86.6 152.53 22.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.571 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 5.5 mmt -104.07 165.4 11.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.937 0.399 . . . . 0.0 110.936 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -67.4 -26.15 66.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.062 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -89.94 13.87 13.59 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 80.99 14.44 79.42 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 120.556 -0.831 . . . . 0.0 113.321 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -77.0 168.09 20.69 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 117.119 0.46 . . . . 0.0 110.729 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -134.51 111.57 10.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.851 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 17.9 t -119.38 123.91 72.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.165 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 27.1 t -101.29 114.84 29.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.751 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.91 161.75 23.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.862 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.83 154.94 17.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.624 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 36.8 mt -67.18 -30.14 48.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.713 0.292 . . . . 0.0 110.986 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -72.07 -38.26 69.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.289 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -121.99 34.69 5.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.038 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.427 ' CE1' HD11 ' A' ' 171' ' ' LEU . 12.0 t80 -62.0 -56.05 23.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.926 0.393 . . . . 0.0 110.7 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.63 -40.64 83.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.138 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -67.42 -49.19 64.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.952 0.406 . . . . 0.0 110.365 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.42 -45.02 72.91 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.057 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.406 ' HB3' ' CG1' ' A' ' 178' ' ' VAL . 3.8 mm? -80.89 -27.67 36.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.785 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 13.5 t -60.64 -30.34 69.81 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.846 0.355 . . . . 0.0 110.529 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 65.6 m-70 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.21 179.646 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 . . . . . 0 C--O 1.231 0.088 0 CA-C-O 121.031 0.443 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.407 ' HB2' ' HB3' ' A' ' 134' ' ' LEU . 81.9 m95 -74.15 168.4 19.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.143 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 6.9 ptt180 -101.7 134.49 44.78 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.845 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -71.2 106.89 3.96 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.858 0.361 . . . . 0.0 110.75 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.403 ' CD1' HG21 ' A' ' 168' ' ' THR . 46.0 pt -95.93 -9.45 9.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.315 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -157.75 176.14 12.97 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 120.586 0.231 . . . . 0.0 110.691 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.459 ' CD1' ' CG ' ' A' ' 149' ' ' PRO . 29.9 m-85 -143.92 126.7 16.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.16 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 4.3 t -93.12 122.42 44.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.279 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.497 ' CE1' ' CE1' ' A' ' 130' ' ' PHE . 7.3 t80 -81.92 97.13 7.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.935 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -149.14 151.62 34.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.44 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 61.17 30.88 19.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.804 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 61.81 31.29 18.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.034 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 70.4 m -151.2 151.13 31.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.941 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.497 ' CE1' ' CE1' ' A' ' 125' ' ' TYR . 12.1 m-85 -93.07 91.05 7.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.701 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.432 ' CD1' ' HA ' ' A' ' 141' ' ' LYS . 23.5 m-85 -66.57 123.38 85.56 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.665 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.416 ' HA ' ' CD2' ' A' ' 123' ' ' TYR . 44.8 Cg_endo -70.65 113.32 3.48 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 122.107 1.872 . . . . 0.0 112.727 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.414 ' HG ' HG23 ' A' ' 168' ' ' THR . 32.2 tp -92.44 124.02 36.18 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.706 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.407 ' HB3' ' HB2' ' A' ' 118' ' ' TRP . 48.1 mt -69.86 174.25 5.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.503 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -65.73 -28.31 68.95 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.029 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -89.74 11.84 18.82 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.156 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.444 ' HA2' HG23 ' A' ' 168' ' ' THR . . . 74.1 22.8 77.37 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.937 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 18.2 tpp180 -81.92 93.62 6.95 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.69 109.34 3.76 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.151 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 15.7 mt -85.14 71.64 10.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.87 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.432 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 12.8 mttt -57.77 -21.14 39.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.469 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -94.28 20.05 8.67 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.419 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -145.15 26.95 1.31 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.846 0.355 . . . . 0.0 111.045 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.77 163.89 39.76 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.96 -0.638 . . . . 0.0 113.199 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 6.7 t -130.69 157.01 43.94 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.328 -0.436 . . . . 0.0 110.563 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.3 mmmt -94.3 50.09 1.35 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.548 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.15 150.35 3.0 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.695 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.453 ' CB ' ' CE2' ' A' ' 130' ' ' PHE . . . -93.05 125.64 54.16 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.242 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.459 ' CG ' ' CD1' ' A' ' 123' ' ' TYR . 71.9 Cg_endo -84.1 111.32 1.62 Allowed 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.433 2.089 . . . . 0.0 112.599 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 45.5 t -69.62 -8.19 45.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.013 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -77.25 -23.51 51.24 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 120.865 0.364 . . . . 0.0 110.54 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.17 166.62 22.25 Favored Pre-proline 0 N--CA 1.453 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.562 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -74.99 158.03 42.49 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.342 2.028 . . . . 0.0 112.331 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 14.3 t -118.24 110.67 31.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.251 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.433 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.52 96.25 1.92 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.726 179.206 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.412 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 61.7 t -93.35 137.22 23.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.007 0.432 . . . . 0.0 111.149 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 49.0 54.13 15.77 Favored Glycine 0 CA--C 1.52 0.363 0 CA-C-N 115.859 -0.609 . . . . 0.0 113.327 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.433 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 2.7 m95 -97.32 151.13 20.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.118 0.485 . . . . 0.0 111.55 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.22 -172.41 0.15 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.322 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -43.21 154.99 0.07 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -56.51 -24.51 46.93 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.154 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -60.33 -40.27 90.02 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.969 0.414 . . . . 0.0 109.911 179.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -74.39 -41.43 60.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.972 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 6.6 mt -58.28 -42.21 83.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.009 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.77 -29.89 42.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.192 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -68.19 -53.2 26.6 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.435 0.636 . . . . 0.0 110.107 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.08 -45.97 89.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.099 178.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.444 HG23 ' HA2' ' A' ' 137' ' ' GLY . 0.2 OUTLIER -56.98 -37.52 71.75 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.709 179.258 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.14 -37.86 93.52 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 47.9 mm-40 -72.89 -46.32 53.43 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.419 -0.39 . . . . 0.0 111.135 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.421 HD12 ' CE1' ' A' ' 214' ' ' PHE . 11.1 mp -65.86 -28.57 69.06 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.658 0.266 . . . . 0.0 111.406 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.52 -17.67 62.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.379 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -112.51 -28.79 7.72 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 120.697 0.284 . . . . 0.0 111.453 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.94 167.28 1.11 Allowed Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.188 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -69.24 127.15 14.58 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.21 1.94 . . . . 0.0 112.861 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.11 -25.51 9.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.592 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -58.46 -48.99 78.92 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.959 0.409 . . . . 0.0 110.889 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.405 ' CG1' ' HB3' ' A' ' 218' ' ' LEU . 27.2 t -73.75 -33.8 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.438 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 13.8 tp -56.46 -35.26 67.72 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.141 0.496 . . . . 0.0 109.815 179.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -78.02 -40.84 19.73 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.188 178.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -84.6 102.84 13.22 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.977 0.418 . . . . 0.0 110.57 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' MET . . . . . 0.403 ' CE ' ' CG1' ' A' ' 178' ' ' VAL . 2.9 mtm 177.63 173.55 0.54 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.007 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 4.7 t -133.68 -50.27 0.84 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.752 0.31 . . . . 0.0 111.225 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -163.45 145.25 9.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.025 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 20.2 mt -110.87 115.99 51.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.539 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . 0.412 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 20.3 m170 -106.64 137.82 43.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.208 -179.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.403 ' CZ ' HD13 ' A' ' 211' ' ' ILE . 0.2 OUTLIER -87.86 104.54 16.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.472 179.596 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.87 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.857 0.36 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 6.8 p30 -102.94 37.09 2.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.752 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -87.59 115.39 24.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.938 0.399 . . . . 0.0 111.093 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 30.5 m -112.14 168.19 5.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.686 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 25.7 mm -132.61 109.77 15.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.785 0.326 . . . . 0.0 111.318 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.424 HG13 ' CZ ' ' A' ' 214' ' ' PHE . 6.9 m -99.0 121.04 49.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.901 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -81.94 152.52 26.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.835 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.04 146.44 35.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.863 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -57.32 -22.61 43.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.504 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -89.7 15.22 9.99 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 79.62 14.41 81.22 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.241 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -90.59 149.92 21.94 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 117.137 0.468 . . . . 0.0 110.801 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -119.38 111.33 18.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.765 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 20.8 t -111.68 126.23 69.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.964 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 11.0 m -103.08 116.36 32.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.934 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -121.84 -177.58 3.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.569 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.66 153.7 35.15 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.494 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.403 HD13 ' CZ ' ' A' ' 187' ' ' TYR . 43.7 mt -66.63 -34.93 73.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.811 0.339 . . . . 0.0 110.775 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.4 -36.42 81.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.207 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -129.92 45.27 2.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.978 0.418 . . . . 0.0 110.903 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.424 ' CZ ' HG13 ' A' ' 199' ' ' VAL . 11.6 t80 -68.53 -52.24 34.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.768 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.9 -39.7 86.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.132 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.71 -49.99 64.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.146 0.498 . . . . 0.0 110.603 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -53.99 -44.08 70.52 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.41 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.405 ' HB3' ' CG1' ' A' ' 178' ' ' VAL . 3.9 mm? -84.85 -23.77 28.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.266 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.31 -33.59 73.83 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.003 0.43 . . . . 0.0 109.934 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 38.2 m170 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.236 179.306 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.936 0.398 . . . . 0.0 110.995 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.402 ' HB2' ' HB3' ' A' ' 134' ' ' LEU . 80.7 m95 -77.13 168.36 20.21 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.053 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.32 133.77 46.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.818 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.4 mtt85 -70.4 106.78 3.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.869 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 44.6 pt -95.47 -8.44 9.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.412 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -159.38 176.28 12.32 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 120.588 0.232 . . . . 0.0 110.894 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.436 ' CD1' ' HG3' ' A' ' 149' ' ' PRO . 32.2 m-85 -143.5 126.96 16.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.332 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 5.0 t -93.36 122.63 45.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.083 0.468 . . . . 0.0 111.12 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.5 ' CD1' ' CE1' ' A' ' 130' ' ' PHE . 7.9 t80 -82.52 103.84 12.35 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.857 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -158.44 154.22 26.5 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.592 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.62 30.65 19.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.803 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 62.99 31.48 16.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.274 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 88.1 m -153.79 156.77 38.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.89 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.5 ' CE1' ' CD1' ' A' ' 125' ' ' TYR . 81.2 m-85 -98.42 90.88 4.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.602 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.443 ' CG ' ' HA ' ' A' ' 141' ' ' LYS . 23.4 m-85 -65.35 123.79 85.26 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.117 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.422 ' HA ' ' CD2' ' A' ' 123' ' ' TYR . 56.1 Cg_endo -71.57 115.22 4.21 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.255 1.97 . . . . 0.0 112.793 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.418 ' HG ' HG22 ' A' ' 168' ' ' THR . 29.2 tp -94.09 124.06 37.86 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.665 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.402 ' HB3' ' HB2' ' A' ' 118' ' ' TRP . 52.8 mt -70.69 173.29 7.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.517 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -64.3 -28.66 69.87 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.969 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -89.8 11.72 19.28 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.251 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.438 ' HA2' HG22 ' A' ' 168' ' ' THR . . . 74.38 22.72 77.11 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.726 -0.75 . . . . 0.0 113.048 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -81.43 94.53 6.84 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.96 107.88 4.28 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.211 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 16.7 mt -86.17 72.85 10.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.547 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.443 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 23.8 mttp -56.86 -20.95 25.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.77 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -85.24 -14.87 45.39 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -112.03 30.82 6.7 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . -60.5 166.24 12.12 Favored Glycine 0 CA--C 1.511 -0.185 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.453 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 9.0 t -135.3 148.27 49.45 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.992 0.425 . . . . 0.0 111.029 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 3.0 mmtt -90.86 52.82 2.24 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.356 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.68 152.22 3.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.549 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -86.99 135.95 34.61 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.833 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.437 ' HD2' ' CG2' ' A' ' 154' ' ' VAL . 60.6 Cg_endo -84.46 98.42 0.72 Allowed 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.028 2.485 . . . . 0.0 112.641 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.2 t -67.46 -9.13 39.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.714 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -90.35 -22.06 21.7 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 111.533 0.197 . . . . 0.0 111.533 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -138.7 167.43 19.52 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.36 161.85 41.7 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.533 2.156 . . . . 0.0 112.382 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.437 ' CG2' ' HD2' ' A' ' 149' ' ' PRO . 24.2 t -123.07 110.03 25.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.044 0.45 . . . . 0.0 111.712 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.434 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.62 95.92 1.91 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.74 179.156 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 59.6 t -91.37 137.06 22.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.99 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 46.72 56.59 7.33 Favored Glycine 0 CA--C 1.52 0.399 0 CA-C-N 115.882 -0.599 . . . . 0.0 113.374 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.434 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 2.7 m95 -98.25 151.2 20.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.26 0.552 . . . . 0.0 111.707 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 8.1 mmtm -65.23 -172.44 0.1 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.59 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -43.62 154.02 0.1 Allowed 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -57.21 -24.85 52.89 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.224 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.01 -38.53 82.9 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.984 0.421 . . . . 0.0 110.056 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.01 -40.24 47.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.003 178.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 6.2 mt -58.87 -41.46 82.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.874 178.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.09 -29.68 45.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.276 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -69.08 -53.03 22.47 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.31 0.576 . . . . 0.0 110.256 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.1 -44.52 91.97 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.041 178.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.438 HG22 ' HA2' ' A' ' 137' ' ' GLY . 0.2 OUTLIER -58.49 -38.22 77.19 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.397 179.214 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.19 -36.16 87.49 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 178.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -73.92 -47.59 36.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.264 -0.468 . . . . 0.0 110.988 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.421 HD13 ' CE1' ' A' ' 214' ' ' PHE . 11.0 mp -65.07 -27.93 69.11 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.754 0.311 . . . . 0.0 111.477 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.74 -18.6 62.78 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.297 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -113.4 -27.01 8.08 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.596 0.236 . . . . 0.0 111.626 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.09 167.5 1.12 Allowed Pre-proline 0 CA--C 1.537 0.481 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.079 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.52 128.22 15.92 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.2 1.933 . . . . 0.0 112.84 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.22 -25.38 9.1 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.631 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.74 -48.95 78.18 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.944 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.409 ' CG1' ' CE ' ' A' ' 182' ' ' MET . 38.9 t -74.16 -35.48 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.439 179.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 13.8 tp -56.82 -39.4 74.12 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.095 0.474 . . . . 0.0 109.969 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -73.6 -40.05 47.69 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 178.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -88.14 102.87 15.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.948 0.404 . . . . 0.0 110.577 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' MET . . . . . 0.409 ' CE ' ' CG1' ' A' ' 178' ' ' VAL . 2.8 mtm 177.69 164.19 0.62 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.146 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.53 -59.85 1.59 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.725 0.298 . . . . 0.0 111.091 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -155.24 142.58 19.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.034 0.445 . . . . 0.0 111.29 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 20.4 mt -104.69 114.86 45.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.317 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 23.6 m170 -103.12 117.46 34.59 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.256 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.4 ' HB2' ' CD2' ' A' ' 158' ' ' TRP . 71.2 t80 -76.4 104.48 6.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.432 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.647 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 . . . . . 0 CA--C 1.53 0.175 0 N-CA-C 111.577 0.214 . . . . 0.0 111.577 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -110.32 36.21 3.15 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.691 0.281 . . . . 0.0 111.062 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 9.4 ttt180 -89.53 115.17 26.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.121 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.414 HG13 ' CZ2' ' A' ' 158' ' ' TRP . 22.5 m -111.91 166.91 5.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.955 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 19.8 mm -133.9 107.72 10.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.8 0.333 . . . . 0.0 111.314 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.422 HG11 ' CE2' ' A' ' 214' ' ' PHE . 13.2 m -99.05 131.26 46.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.081 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -95.37 152.44 18.39 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.534 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.52 157.97 16.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.895 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -57.81 -24.8 59.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.343 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -90.42 15.45 10.65 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 79.53 14.32 81.45 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.565 -0.826 . . . . 0.0 113.243 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -75.75 164.98 25.7 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.994 0.397 . . . . 0.0 110.791 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -134.56 111.45 10.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.86 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.6 t -117.87 128.92 74.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.081 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 4.2 m -103.13 115.2 30.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.768 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -127.11 158.58 36.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.893 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.06 153.27 18.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.503 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 36.7 mt -65.07 -37.18 79.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.882 0.372 . . . . 0.0 110.867 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.48 -33.17 72.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.198 -179.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -134.89 42.27 2.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.86 0.362 . . . . 0.0 111.104 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.422 ' CE2' HG11 ' A' ' 199' ' ' VAL . 11.4 t80 -64.64 -52.24 58.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.625 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.69 -42.16 87.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.192 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.65 -48.78 63.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.063 0.458 . . . . 0.0 110.338 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 1.3 mmpt? -53.84 -41.63 67.62 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.06 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -87.0 -24.01 24.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.97 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 12.6 t -62.63 -30.47 71.38 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.81 0.338 . . . . 0.0 110.42 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 38.7 m170 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.265 179.784 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 121.028 0.442 . . . . 0.0 110.972 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -73.4 168.34 19.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.069 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.82 136.64 41.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.489 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.64 105.38 4.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.683 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.402 ' CD1' HG21 ' A' ' 168' ' ' THR . 47.8 pt -95.13 -7.68 9.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.574 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -159.34 177.06 11.4 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 120.481 0.181 . . . . 0.0 110.589 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.456 ' CD1' ' CG ' ' A' ' 149' ' ' PRO . 30.3 m-85 -144.69 126.0 14.79 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 4.2 t -93.27 122.27 44.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.165 0.507 . . . . 0.0 111.416 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.49 ' CE1' ' CE1' ' A' ' 130' ' ' PHE . 11.1 t80 -84.07 94.22 8.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.79 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -142.56 152.55 42.71 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.408 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 58.77 30.31 19.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.99 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 64.11 34.31 11.26 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.357 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.4 ' CG2' ' N ' ' A' ' 145' ' ' THR . 52.9 m -153.92 152.87 31.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.825 0.345 . . . . 0.0 111.135 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.49 ' CE1' ' CE1' ' A' ' 125' ' ' TYR . 11.1 m-85 -94.41 90.92 6.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.836 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.448 ' CD1' ' HA ' ' A' ' 141' ' ' LYS . 27.2 m-85 -71.17 110.83 8.12 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.794 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.418 ' HA ' ' CD2' ' A' ' 123' ' ' TYR . 49.5 Cg_exo -55.41 121.34 9.75 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 122.39 2.06 . . . . 0.0 112.73 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.423 ' HG ' HG23 ' A' ' 168' ' ' THR . 30.3 tp -101.42 123.82 46.1 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.43 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 46.4 mt -70.72 174.13 6.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.577 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.4 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.3 pt-20 -64.63 -29.28 70.28 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.079 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -90.07 12.62 17.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.192 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.434 ' HA2' HG23 ' A' ' 168' ' ' THR . . . 74.96 16.73 80.39 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.111 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -74.85 93.53 2.65 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.401 ' CD2' ' CB ' ' A' ' 131' ' ' PHE . 0.4 OUTLIER -68.35 121.29 15.98 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.631 -178.906 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -90.97 73.48 6.44 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.696 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.448 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 7.7 mttt -61.46 -16.11 43.85 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.995 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -94.7 -24.18 17.25 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -101.32 27.62 6.07 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -61.59 159.39 30.62 Favored Glycine 0 CA--C 1.508 -0.358 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.711 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.4 ' N ' ' CG2' ' A' ' 129' ' ' THR . 8.0 t -130.65 157.53 42.52 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.971 0.415 . . . . 0.0 110.877 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -94.69 50.34 1.32 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.577 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.98 149.81 3.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.583 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.452 ' CB ' ' CE2' ' A' ' 130' ' ' PHE . . . -93.66 125.77 52.32 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.387 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.456 ' CG ' ' CD1' ' A' ' 123' ' ' TYR . 60.6 Cg_endo -82.12 111.78 2.2 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.243 1.962 . . . . 0.0 112.339 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 11.6 t -69.5 -7.96 42.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.12 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -78.36 -23.32 46.94 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 120.717 0.294 . . . . 0.0 110.507 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.23 166.84 20.66 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.765 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -74.85 156.11 43.67 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.384 2.056 . . . . 0.0 112.304 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 9.3 t -116.68 110.44 31.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.192 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.431 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.41 95.93 1.83 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.577 179.0 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 46.6 t -92.58 137.15 22.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.98 0.419 . . . . 0.0 111.162 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 48.73 57.78 8.2 Favored Glycine 0 CA--C 1.52 0.382 0 CA-C-N 115.893 -0.594 . . . . 0.0 113.304 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.431 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 2.9 m95 -100.69 151.17 21.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.198 0.523 . . . . 0.0 111.536 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -65.34 -172.43 0.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.459 179.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -43.74 154.69 0.09 Allowed 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -56.79 -25.15 51.46 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.327 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.22 -38.84 84.61 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 120.951 0.405 . . . . 0.0 110.087 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.62 -40.31 49.71 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.081 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 6.5 mt -59.17 -41.67 84.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.035 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.34 -30.9 53.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.23 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -67.83 -53.23 28.53 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.4 0.619 . . . . 0.0 109.968 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.53 -45.45 91.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.936 178.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.434 HG23 ' HA2' ' A' ' 137' ' ' GLY . 0.3 OUTLIER -56.75 -37.95 71.74 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.555 179.172 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.9 -37.38 92.51 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 178.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -70.94 -48.24 54.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.41 -0.395 . . . . 0.0 110.785 178.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.444 ' CD1' ' CE1' ' A' ' 214' ' ' PHE . 11.2 mp -64.89 -28.76 69.76 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.797 0.332 . . . . 0.0 111.23 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.31 -18.94 63.87 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.229 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -111.49 -28.64 8.09 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.669 0.271 . . . . 0.0 111.372 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.85 166.86 1.21 Allowed Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.135 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.28 128.0 15.82 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.225 1.95 . . . . 0.0 112.918 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.34 -26.29 11.86 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.541 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -58.42 -48.63 80.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.923 0.392 . . . . 0.0 110.88 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.408 ' CG1' ' CE ' ' A' ' 182' ' ' MET . 33.7 t -73.7 -33.52 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.406 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 6.4 tp -57.44 -36.21 71.1 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 121.122 0.487 . . . . 0.0 109.818 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -76.42 -42.04 23.79 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.296 178.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -84.36 103.12 13.26 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.977 0.418 . . . . 0.0 110.584 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' MET . . . . . 0.408 ' CE ' ' CG1' ' A' ' 178' ' ' VAL . 3.0 mtm 178.74 169.57 0.87 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.008 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.13 -55.32 1.47 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.733 0.301 . . . . 0.0 111.082 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -163.23 142.32 8.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.928 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.437 HD12 HG21 ' A' ' 185' ' ' ILE . 12.4 mt -104.78 114.38 44.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.229 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 23.3 m170 -103.81 126.32 50.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.191 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -79.21 104.09 9.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.2 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.764 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 . . . . . 0 N--CA 1.462 0.171 0 CA-C-O 120.669 0.271 . . . . 0.0 111.351 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -106.57 38.52 2.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.754 0.311 . . . . 0.0 110.71 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 4.0 tpt180 -90.26 118.7 29.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.065 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 25.5 m -117.51 165.94 12.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.915 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 21.1 mm -134.56 107.45 9.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.149 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 8.4 m -96.12 123.84 48.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.985 0.421 . . . . 0.0 110.997 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -83.54 152.62 24.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.748 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 4.3 mmt -108.55 152.39 24.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.895 0.379 . . . . 0.0 110.947 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 39.2 m-20 -60.11 -26.35 66.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.196 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -89.77 14.54 11.6 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.89 0.329 . . . . 0.0 111.89 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 81.13 14.41 79.18 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.373 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.42 154.59 22.7 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 117.028 0.414 . . . . 0.0 110.78 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -125.1 111.36 15.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.841 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 26.2 t -112.79 123.76 68.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.004 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 58.2 m -97.7 114.7 26.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.676 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -127.28 162.23 26.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.955 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.91 156.18 17.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.555 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.469 HG22 HD11 ' A' ' 211' ' ' ILE . 48.9 mt -63.49 -29.73 48.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.784 0.326 . . . . 0.0 110.953 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -74.63 -39.74 61.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.343 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -118.86 36.74 4.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.86 0.362 . . . . 0.0 111.016 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.444 ' CE1' ' CD1' ' A' ' 171' ' ' LEU . 11.6 t80 -66.69 -53.3 35.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.738 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.55 -37.22 86.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.757 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.9 -51.76 44.29 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.205 0.526 . . . . 0.0 110.463 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 8.4 mmmt -54.23 -43.35 70.8 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.094 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.402 ' HB3' ' CG1' ' A' ' 178' ' ' VAL . 4.2 mm? -83.59 -23.67 31.84 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.114 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.41 -34.14 74.87 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.056 0.455 . . . . 0.0 109.834 178.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 . . . . . 0 CA--C 1.533 0.299 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.087 179.139 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.995 0.426 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -70.34 168.3 16.27 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.044 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.78 138.08 40.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.517 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.33 105.71 4.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.858 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.404 ' CD1' HG22 ' A' ' 168' ' ' THR . 49.4 pt -95.36 -6.64 9.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.604 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -159.75 176.83 11.49 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 120.553 0.216 . . . . 0.0 110.571 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.464 ' CD1' ' CG ' ' A' ' 149' ' ' PRO . 34.6 m-85 -144.64 126.11 14.94 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.7 t -93.16 122.28 44.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.101 0.477 . . . . 0.0 111.41 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.482 ' CE1' ' CE1' ' A' ' 130' ' ' PHE . 15.8 t80 -83.05 93.96 7.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.669 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -144.73 153.06 41.29 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.352 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 60.2 29.35 18.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.758 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 62.36 34.51 15.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.863 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.4 ' CG2' ' N ' ' A' ' 145' ' ' THR . 45.2 m -152.47 156.23 39.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.059 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.482 ' CE1' ' CE1' ' A' ' 125' ' ' TYR . 19.0 m-85 -97.93 91.43 5.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.225 0.536 . . . . 0.0 110.866 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.429 ' CG ' ' HA ' ' A' ' 141' ' ' LYS . 27.8 m-85 -72.0 115.04 34.33 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.613 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.422 ' HA ' ' CD2' ' A' ' 123' ' ' TYR . 33.3 Cg_exo -61.16 117.07 3.82 Favored 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 122.422 2.082 . . . . 0.0 112.672 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.416 ' HG ' HG21 ' A' ' 168' ' ' THR . 30.6 tp -96.77 124.01 40.63 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.414 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 52.1 mt -70.5 174.45 5.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.645 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -65.11 -29.26 70.11 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.099 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 51.3 p-10 -89.68 11.88 18.56 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.254 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.433 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 75.08 19.02 80.08 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.856 -0.688 . . . . 0.0 113.007 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -77.36 93.2 4.01 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.32 121.48 16.36 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.806 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -90.29 73.4 7.08 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.394 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.429 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 6.0 mttp -61.58 -15.61 40.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.302 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -98.52 -21.57 16.45 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -101.06 27.7 5.88 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -62.09 160.36 31.03 Favored Glycine 0 CA--C 1.51 -0.267 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.824 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.4 ' N ' ' CG2' ' A' ' 129' ' ' THR . 9.7 t -131.28 156.36 45.58 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.987 0.422 . . . . 0.0 110.729 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -93.11 51.0 1.6 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.735 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.1 151.23 3.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.573 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.457 ' CB ' ' CE2' ' A' ' 130' ' ' PHE . . . -95.14 125.64 49.59 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.39 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.464 ' CG ' ' CD1' ' A' ' 123' ' ' TYR . 73.9 Cg_endo -83.13 111.02 1.84 Allowed 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.355 2.037 . . . . 0.0 112.299 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 22.3 t -69.28 -8.12 43.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.163 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -77.85 -23.61 48.85 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 120.861 0.362 . . . . 0.0 110.607 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -138.11 166.71 23.89 Favored Pre-proline 0 N--CA 1.453 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.845 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -74.67 157.93 43.79 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.444 2.096 . . . . 0.0 112.105 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.424 HG12 ' CE2' ' A' ' 130' ' ' PHE . 12.5 t -118.47 110.09 29.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.0 0.428 . . . . 0.0 111.369 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.43 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.61 95.95 1.91 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.644 179.054 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.422 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 61.6 t -92.54 136.66 24.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.09 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 48.59 57.07 8.74 Favored Glycine 0 CA--C 1.521 0.41 0 CA-C-N 115.891 -0.595 . . . . 0.0 113.319 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.43 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 3.5 m95 -99.91 151.14 21.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.175 0.512 . . . . 0.0 111.65 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.37 -172.22 0.15 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.553 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -43.4 154.27 0.09 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.268 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -57.16 -24.94 53.07 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.238 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -59.98 -40.72 90.09 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.871 0.367 . . . . 0.0 110.124 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -75.12 -40.34 59.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.982 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 6.8 mt -58.89 -41.99 84.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.971 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.71 -31.54 48.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.087 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -67.23 -52.96 34.58 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.575 0.702 . . . . 0.0 109.885 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.26 -44.42 95.32 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.013 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.433 HG21 ' HA2' ' A' ' 137' ' ' GLY . 0.3 OUTLIER -57.02 -38.11 72.66 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.484 179.171 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.18 -37.78 93.44 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 46.9 mm-40 -69.45 -48.69 60.07 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.408 -0.396 . . . . 0.0 110.92 178.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.451 ' CD1' ' CE1' ' A' ' 214' ' ' PHE . 9.9 mp -64.61 -29.35 70.36 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.758 0.313 . . . . 0.0 111.191 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.44 -20.28 64.63 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.368 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -110.91 -26.58 9.23 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.601 0.238 . . . . 0.0 111.414 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.85 166.32 1.99 Allowed Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.898 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.52 128.29 16.03 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.26 1.973 . . . . 0.0 112.94 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.24 -25.95 10.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.53 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -58.63 -48.65 80.3 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.877 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.405 ' CG1' ' CE ' ' A' ' 182' ' ' MET . 32.3 t -73.81 -33.31 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.417 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 10.2 tp -56.71 -35.29 68.35 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 121.126 0.489 . . . . 0.0 110.047 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -79.5 -40.1 16.45 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.232 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -85.65 103.14 14.19 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 120.93 0.395 . . . . 0.0 110.556 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' MET . . . . . 0.405 ' CE ' ' CG1' ' A' ' 178' ' ' VAL . 2.8 mtm 177.35 170.8 0.58 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.158 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.48 -56.81 1.49 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.721 0.296 . . . . 0.0 111.063 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -163.16 142.7 8.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.047 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.42 HG21 HD11 ' A' ' 185' ' ' ILE . 13.8 mt -103.03 115.11 44.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.484 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . 0.422 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 21.6 m170 -105.75 125.43 50.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.205 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -78.48 104.73 9.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.335 179.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.424 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.722 0.296 . . . . 0.0 111.419 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -105.14 36.88 2.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.777 0.322 . . . . 0.0 110.782 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 4.6 tpt180 -90.5 115.61 27.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.108 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 25.0 m -112.97 167.34 6.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.717 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 20.6 mm -135.22 106.75 7.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.457 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.416 HG11 ' CE2' ' A' ' 214' ' ' PHE . 7.7 m -95.86 125.72 48.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.924 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -86.12 152.2 23.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.698 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.52 152.8 23.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.858 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -58.41 -23.84 58.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.418 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -89.99 15.35 10.2 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 78.16 14.41 82.28 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.508 -0.853 . . . . 0.0 113.13 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -82.83 166.47 18.95 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 117.07 0.435 . . . . 0.0 110.749 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -133.54 114.54 13.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.973 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.3 t -115.96 126.07 73.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.087 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 2.8 p -99.14 115.68 29.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.767 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -126.37 159.26 33.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.73 154.8 18.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.569 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.427 HG21 HD11 ' A' ' 211' ' ' ILE . 32.6 mt -64.02 -34.08 66.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.018 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -67.62 -40.51 84.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.4 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -125.28 43.53 3.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.88 0.372 . . . . 0.0 110.967 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.451 ' CE1' ' CD1' ' A' ' 171' ' ' LEU . 12.5 t80 -67.93 -53.34 27.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.836 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.72 -38.13 77.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.211 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.92 -48.45 65.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.99 0.424 . . . . 0.0 110.559 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.16 -43.77 70.89 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.094 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -84.53 -25.24 28.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.982 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 11.8 t -61.21 -31.36 71.14 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 120.822 0.344 . . . . 0.0 110.454 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 1.5 m170 . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.095 179.674 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 121.076 0.465 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -70.73 168.31 16.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.143 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -101.94 134.8 44.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.561 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 26.5 mtt180 -71.3 106.61 3.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.837 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.407 ' CD1' HG23 ' A' ' 168' ' ' THR . 47.5 pt -96.92 -6.38 9.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.494 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -160.64 176.25 11.76 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 121.08 -0.248 . . . . 0.0 110.88 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.468 ' CD1' ' CG ' ' A' ' 149' ' ' PRO . 37.5 m-85 -145.91 127.57 15.2 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 4.0 t -92.82 122.47 44.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.075 0.464 . . . . 0.0 111.445 -179.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.492 ' CE1' ' CZ ' ' A' ' 130' ' ' PHE . 9.5 t80 -85.12 100.93 12.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.925 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -154.16 154.22 33.17 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.489 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 8.1 tpp180 60.69 31.47 20.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.721 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 62.27 32.08 17.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.945 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 50.1 m -151.03 161.74 42.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.234 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.492 ' CZ ' ' CE1' ' A' ' 125' ' ' TYR . 87.0 m-85 -106.87 90.67 3.38 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.235 0.54 . . . . 0.0 110.841 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.444 ' CG ' ' HA ' ' A' ' 141' ' ' LYS . 20.7 m-85 -66.77 124.65 89.08 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.508 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.422 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 13.7 Cg_exo -68.6 123.29 10.31 Favored 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 122.327 2.018 . . . . 0.0 112.343 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.442 ' HG ' HG22 ' A' ' 168' ' ' THR . 36.9 tp -104.2 123.57 47.55 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.565 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 50.6 mt -72.69 173.07 9.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.733 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.402 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.5 pt-20 -63.02 -29.69 71.02 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.001 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 39.6 p-10 -89.84 11.91 18.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.143 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.426 ' HA2' HG22 ' A' ' 168' ' ' THR . . . 74.93 19.27 80.02 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.183 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 13.8 tpp180 -76.69 95.68 4.04 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.41 ' CD2' ' CB ' ' A' ' 131' ' ' PHE . 0.4 OUTLIER -70.71 122.46 19.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.913 -178.8 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -95.31 71.34 3.23 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.599 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.444 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 27.8 mttt -58.59 -19.76 41.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.78 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -89.46 -23.69 22.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.742 -0.208 . . . . 0.0 111.434 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -99.22 25.06 7.2 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.422 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -57.58 161.87 9.1 Favored Glycine 0 CA--C 1.51 -0.265 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.597 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 10.7 t -135.78 150.46 49.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.503 -0.348 . . . . 0.0 110.717 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 3.5 mmtt -89.81 52.05 2.22 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.017 0.437 . . . . 0.0 110.62 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.92 149.05 2.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.678 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.418 ' HB3' ' CE2' ' A' ' 130' ' ' PHE . . . -93.91 125.52 52.75 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.153 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.468 ' CG ' ' CD1' ' A' ' 123' ' ' TYR . 72.0 Cg_endo -84.22 109.72 1.45 Allowed 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.486 2.124 . . . . 0.0 112.567 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.2 t -69.77 -7.73 42.1 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.101 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -78.16 -22.95 47.95 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.79 0.329 . . . . 0.0 110.551 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -139.59 166.9 20.91 Favored Pre-proline 0 N--CA 1.453 -0.282 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.758 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -74.37 153.8 45.33 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.4 2.067 . . . . 0.0 112.194 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 12.2 t -115.67 109.51 28.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.222 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.431 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.55 95.74 1.86 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.534 178.881 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 55.3 t -92.33 136.99 23.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.956 0.407 . . . . 0.0 111.014 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 47.9 58.67 6.74 Favored Glycine 0 CA--C 1.521 0.416 0 CA-C-N 115.954 -0.567 . . . . 0.0 113.24 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.431 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 2.4 m95 -100.83 151.2 22.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.102 0.477 . . . . 0.0 111.828 -179.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -172.58 0.06 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.448 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -44.74 155.15 0.11 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.084 0.468 . . . . 0.0 112.173 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -57.42 -25.54 55.07 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.261 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.95 -39.42 85.52 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 120.991 0.424 . . . . 0.0 110.213 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -75.93 -40.75 53.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.184 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 6.2 mt -58.34 -41.48 81.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.045 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.14 -31.78 53.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.255 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -67.83 -53.08 29.74 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-O 121.517 0.675 . . . . 0.0 110.05 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.17 -45.74 90.22 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.002 178.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.442 HG22 ' HG ' ' A' ' 133' ' ' LEU . 0.5 OUTLIER -56.26 -38.63 71.41 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.643 179.075 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -58.77 -38.45 92.09 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 178.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 45.1 mm-40 -69.56 -48.37 60.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.315 -0.442 . . . . 0.0 110.902 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.45 ' CD1' ' CE1' ' A' ' 214' ' ' PHE . 10.8 mp -64.08 -29.85 70.96 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.724 0.297 . . . . 0.0 111.113 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -67.68 -19.96 65.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.259 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -111.22 -26.0 9.41 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.609 0.242 . . . . 0.0 111.424 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.4 166.6 1.58 Allowed Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.079 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.83 129.03 15.83 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.358 2.039 . . . . 0.0 112.707 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.19 -25.79 5.96 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.666 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.95 -49.82 75.48 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.953 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.409 ' CG1' ' CE ' ' A' ' 182' ' ' MET . 34.8 t -74.07 -34.65 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.502 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.47 -37.78 70.79 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.093 0.473 . . . . 0.0 110.063 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -78.92 -36.17 29.16 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.356 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -90.17 103.18 15.88 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.931 0.396 . . . . 0.0 110.846 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' MET . . . . . 0.409 ' CE ' ' CG1' ' A' ' 178' ' ' VAL . 2.7 mtm 177.66 173.99 0.53 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.034 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.97 -54.8 1.21 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.665 0.269 . . . . 0.0 111.168 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -163.14 142.83 8.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.959 0.409 . . . . 0.0 111.11 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.431 HD12 HG22 ' A' ' 185' ' ' ILE . 13.3 mt -104.8 114.98 45.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.454 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -103.32 123.66 47.2 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.155 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.426 ' HB2' ' CD2' ' A' ' 158' ' ' TRP . 65.9 t80 -81.58 104.33 11.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.375 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.667 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.165 0 CA-C-O 120.654 0.264 . . . . 0.0 111.646 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 11.3 p30 -109.47 38.98 2.19 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.861 0.362 . . . . 0.0 110.734 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 11.8 ttt-85 -91.47 117.16 29.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.18 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 28.9 m -113.48 167.13 6.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.676 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 17.0 mm -134.81 107.34 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.726 0.298 . . . . 0.0 111.363 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 11.9 m -98.04 134.87 34.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.927 0.394 . . . . 0.0 110.886 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -96.46 152.64 18.42 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.803 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 24.3 tpp -107.17 152.92 23.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.556 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -54.99 -24.45 24.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.784 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -90.44 15.55 10.5 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 79.24 14.54 81.55 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.544 -0.836 . . . . 0.0 113.047 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -77.99 157.8 29.52 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.929 0.395 . . . . 0.0 110.771 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -129.59 111.2 12.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.837 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.41 136.42 51.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.161 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 50.0 m -106.15 111.92 24.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.674 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -118.86 175.58 5.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.935 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.77 154.54 32.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.389 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.417 HD11 HG23 ' A' ' 211' ' ' ILE . 35.8 mt -66.61 -30.26 49.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.724 0.297 . . . . 0.0 110.859 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.61 -31.41 63.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.322 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -132.81 42.27 3.09 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.907 0.384 . . . . 0.0 110.96 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.45 ' CE1' ' CD1' ' A' ' 171' ' ' LEU . 11.7 t80 -68.3 -52.64 31.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.739 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.36 -39.44 87.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.892 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.18 -51.63 43.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.218 0.533 . . . . 0.0 110.243 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.91 -41.67 67.9 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.237 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -85.8 -23.13 27.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.061 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.03 -33.54 74.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.976 0.417 . . . . 0.0 110.144 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 21.1 m170 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.421 179.823 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 121.076 0.465 . . . . 0.0 111.048 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.421 ' HB2' ' HB3' ' A' ' 134' ' ' LEU . 84.9 m95 -66.18 168.31 8.75 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.007 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -100.72 136.33 40.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.391 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 5.9 mtm180 -72.35 107.33 4.89 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.762 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.402 ' CD1' HG22 ' A' ' 168' ' ' THR . 47.1 pt -96.89 -8.61 9.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.339 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -158.25 175.8 13.29 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 120.572 0.225 . . . . 0.0 110.672 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.478 ' CD1' ' CG ' ' A' ' 149' ' ' PRO . 30.4 m-85 -144.59 126.37 15.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.26 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 4.2 t -93.53 123.1 45.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.986 0.422 . . . . 0.0 111.294 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.491 ' CE1' ' CE1' ' A' ' 130' ' ' PHE . 7.0 t80 -84.61 105.38 15.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.842 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -159.77 154.44 24.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.673 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 60.57 30.96 20.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.914 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 62.05 31.87 17.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.136 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 89.3 m -153.72 150.16 28.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.987 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.491 ' CE1' ' CE1' ' A' ' 125' ' ' TYR . 54.1 m-85 -93.94 90.95 6.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.103 0.478 . . . . 0.0 110.705 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.424 ' CD1' ' HA ' ' A' ' 141' ' ' LYS . 22.3 m-85 -65.55 126.02 90.77 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.324 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.85 117.3 5.06 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 122.189 1.926 . . . . 0.0 112.441 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.411 ' HG ' HG21 ' A' ' 168' ' ' THR . 32.0 tp -96.59 124.02 40.45 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.731 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.421 ' HB3' ' HB2' ' A' ' 118' ' ' TRP . 54.0 mt -71.35 174.12 6.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.632 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.402 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.3 pt-20 -64.59 -29.45 70.47 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.091 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 48.4 p-10 -88.91 11.15 18.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.215 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.435 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 74.58 22.53 77.12 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.847 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 15.5 tpp85 -80.49 95.95 6.62 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.414 ' CD2' ' CB ' ' A' ' 131' ' ' PHE . 0.4 OUTLIER -73.28 106.1 4.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.232 -179.215 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 13.3 mt -85.51 72.41 10.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.335 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.424 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 33.6 mttt -56.2 -21.23 21.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.896 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -82.87 -22.62 33.96 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -103.11 28.58 6.17 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.16 163.84 33.67 Favored Glycine 0 CA--C 1.511 -0.169 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.699 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 9.2 t -132.09 157.03 45.24 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.504 -0.348 . . . . 0.0 110.529 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.6 mmtp -92.21 48.55 1.42 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.091 0.472 . . . . 0.0 110.554 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -171.26 154.55 4.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.438 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.447 ' CB ' ' CE2' ' A' ' 130' ' ' PHE . . . -99.31 126.52 37.5 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.076 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.478 ' CG ' ' CD1' ' A' ' 123' ' ' TYR . 72.2 Cg_endo -82.39 112.38 2.2 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.36 2.04 . . . . 0.0 112.702 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 28.0 t -69.82 -7.71 42.22 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.518 -0.764 . . . . 0.0 112.0 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -76.1 -22.82 55.11 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 120.779 0.323 . . . . 0.0 110.447 179.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -139.77 167.7 17.59 Favored Pre-proline 0 N--CA 1.452 -0.334 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.721 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.98 154.36 47.73 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.364 2.042 . . . . 0.0 112.332 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 10.1 t -116.66 110.44 31.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.971 0.415 . . . . 0.0 111.088 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.435 HD22 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.55 95.94 1.89 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.584 179.058 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.411 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 51.3 t -91.24 136.74 23.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.028 0.442 . . . . 0.0 111.106 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 48.56 58.59 7.29 Favored Glycine 0 CA--C 1.52 0.392 0 CA-C-N 115.816 -0.629 . . . . 0.0 113.259 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.435 ' CE2' HD22 ' A' ' 155' ' ' LEU . 3.2 m95 -102.13 151.12 22.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.186 0.517 . . . . 0.0 111.721 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.89 -172.07 0.17 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.548 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -42.71 154.22 0.07 Allowed 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -57.08 -24.89 52.62 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.163 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.56 -39.65 84.74 Favored 'General case' 0 C--O 1.23 0.074 0 CA-C-O 120.916 0.388 . . . . 0.0 110.007 179.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.05 -40.03 54.21 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.917 178.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 6.3 mt -59.73 -41.68 86.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.873 179.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.13 -30.97 50.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.228 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -66.97 -53.01 35.77 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-O 121.491 0.662 . . . . 0.0 110.05 179.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.94 -44.78 94.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.905 178.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.435 HG21 ' HA2' ' A' ' 137' ' ' GLY . 0.2 OUTLIER -58.34 -37.17 74.63 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.454 179.223 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.88 -37.68 92.93 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 178.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 35.0 mm-40 -72.87 -46.47 52.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.401 -0.399 . . . . 0.0 111.029 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.416 HD13 ' CE1' ' A' ' 214' ' ' PHE . 10.9 mp -65.92 -28.71 69.13 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.622 0.248 . . . . 0.0 111.323 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.88 -21.07 64.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.336 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -110.45 -26.19 9.65 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.588 0.232 . . . . 0.0 111.496 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.55 166.51 1.71 Allowed Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.107 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -70.09 128.08 15.22 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.305 2.003 . . . . 0.0 112.798 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.07 -25.78 5.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.726 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.71 -50.08 74.41 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.898 0.38 . . . . 0.0 111.012 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.404 ' CG1' ' CE ' ' A' ' 182' ' ' MET . 41.5 t -74.25 -34.9 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.495 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.19 -34.49 68.54 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.156 0.503 . . . . 0.0 109.842 179.096 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -79.47 -38.54 20.86 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 178.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -87.92 103.06 15.32 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.865 0.364 . . . . 0.0 110.75 179.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' MET . . . . . 0.404 ' CE ' ' CG1' ' A' ' 178' ' ' VAL . 2.8 mtm 178.25 172.04 0.7 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.055 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -130.45 -52.61 1.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.677 0.275 . . . . 0.0 111.466 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -163.17 143.69 9.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.881 0.372 . . . . 0.0 111.135 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.419 HG21 HD13 ' A' ' 185' ' ' ILE . 15.7 mt -108.29 114.78 47.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.653 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . 0.411 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 23.5 m170 -105.77 129.33 53.98 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.057 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.413 ' CZ ' HD13 ' A' ' 211' ' ' ILE . 0.3 OUTLIER -79.33 104.81 10.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.444 179.585 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.584 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 . . . . . 0 CA--C 1.53 0.202 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -113.27 35.71 3.86 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.693 0.283 . . . . 0.0 111.13 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 2.0 ttt-85 -89.64 113.48 24.96 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.894 0.378 . . . . 0.0 111.318 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.405 HG11 ' CZ2' ' A' ' 158' ' ' TRP . 31.3 m -109.76 167.9 4.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.858 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 22.4 mm -134.4 108.39 10.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.754 0.312 . . . . 0.0 111.278 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 11.2 m -97.51 137.52 24.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.989 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -98.26 152.82 19.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.79 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 27.9 tpp -110.77 153.65 25.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.831 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -55.92 -22.51 26.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.747 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -90.18 15.43 10.33 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 76.75 14.4 82.57 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.594 -0.813 . . . . 0.0 113.112 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -83.77 157.32 22.14 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 117.023 0.412 . . . . 0.0 110.729 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -127.69 111.47 13.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 20.6 t -111.44 130.54 64.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.942 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 16.7 m -102.62 116.66 33.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.798 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -128.19 160.25 32.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.861 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.69 155.68 16.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.561 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.413 HD13 ' CZ ' ' A' ' 187' ' ' TYR . 32.0 mt -67.18 -31.06 51.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.02 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.93 -32.06 65.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.357 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -126.53 33.95 4.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.06 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.416 ' CE1' HD13 ' A' ' 171' ' ' LEU . 11.4 t80 -62.99 -53.91 46.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.708 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.78 -39.95 86.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.832 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.29 -51.27 46.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.098 0.475 . . . . 0.0 110.236 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.86 -44.03 73.63 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.859 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.403 ' HB3' ' CG1' ' A' ' 178' ' ' VAL . 4.1 mm? -80.69 -25.75 37.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.942 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.9 -33.15 72.67 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.045 0.45 . . . . 0.0 110.123 179.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 3.6 m170 . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.445 179.675 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 121.134 0.492 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.405 ' HB2' ' HB3' ' A' ' 134' ' ' LEU . 79.3 m95 -66.11 168.25 8.72 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.015 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -101.36 141.09 34.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.631 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.55 106.14 5.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.748 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.404 ' CD1' ' HA ' ' A' ' 135' ' ' GLU . 50.9 pt -97.41 -7.04 9.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.299 179.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -162.42 175.29 11.68 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 120.597 0.237 . . . . 0.0 110.779 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.46 ' CD1' ' CG ' ' A' ' 149' ' ' PRO . 25.9 m-85 -144.12 127.11 16.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.097 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 4.9 t -93.14 122.36 44.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.119 0.485 . . . . 0.0 111.292 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.493 ' CE1' ' CE1' ' A' ' 130' ' ' PHE . 14.8 t80 -83.38 105.34 14.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.812 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -159.68 153.6 23.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.59 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.67 30.79 20.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.973 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 63.12 32.65 15.08 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.317 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 90.3 m -154.41 150.49 27.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.982 0.42 . . . . 0.0 111.087 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.493 ' CE1' ' CE1' ' A' ' 125' ' ' TYR . 22.6 m-85 -93.77 90.85 6.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.52 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.429 ' CD1' ' HA ' ' A' ' 141' ' ' LYS . 21.3 m-85 -65.35 121.03 72.58 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.329 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.419 ' HA ' ' CD2' ' A' ' 123' ' ' TYR . 37.5 Cg_endo -67.62 118.11 5.35 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.215 1.943 . . . . 0.0 112.544 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.413 ' HG ' HG21 ' A' ' 168' ' ' THR . 48.6 tp -99.66 124.69 45.13 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.953 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.405 ' HB3' ' HB2' ' A' ' 118' ' ' TRP . 52.7 mt -72.91 177.14 5.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.727 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.404 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.4 pt-20 -67.12 -28.77 68.43 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.118 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -89.71 12.45 16.95 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.167 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.434 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 72.25 23.95 77.15 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.741 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -81.14 97.66 7.68 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 178.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.405 ' CD2' ' CB ' ' A' ' 131' ' ' PHE . 0.4 OUTLIER -75.89 112.44 12.3 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.232 -179.031 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 12.7 mt -92.69 72.16 4.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.179 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.429 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 39.4 mttt -55.21 -22.25 17.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.814 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -82.34 -24.06 34.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.191 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -100.2 27.05 5.91 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -63.68 163.62 32.15 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.752 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 10.0 t -132.34 155.3 48.64 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.83 0.348 . . . . 0.0 110.714 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.8 mmtp -92.58 49.74 1.51 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.089 0.471 . . . . 0.0 110.494 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -171.13 153.73 3.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.613 -179.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.442 ' CB ' ' CE2' ' A' ' 130' ' ' PHE . . . -97.06 125.75 44.88 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.328 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.46 ' CG ' ' CD1' ' A' ' 123' ' ' TYR . 74.3 Cg_endo -83.2 111.76 1.9 Allowed 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.392 2.062 . . . . 0.0 112.533 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 29.1 t -69.87 -7.77 43.0 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.958 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -77.14 -23.22 51.72 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 120.763 0.316 . . . . 0.0 110.423 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.07 166.82 21.02 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.682 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -75.05 154.27 42.12 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.348 2.032 . . . . 0.0 112.34 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 9.0 t -114.56 110.91 33.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.139 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.433 HD22 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.61 95.96 1.91 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.536 179.069 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 50.1 t -91.48 137.18 22.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.053 0.454 . . . . 0.0 111.194 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 48.06 57.85 7.56 Favored Glycine 0 CA--C 1.521 0.459 0 CA-C-N 115.858 -0.61 . . . . 0.0 113.325 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.433 ' CE2' HD22 ' A' ' 155' ' ' LEU . 3.0 m95 -100.58 151.15 21.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.107 0.48 . . . . 0.0 111.782 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.32 -172.36 0.1 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.596 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -43.92 153.79 0.12 Allowed 'General case' 0 C--O 1.235 0.337 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -56.73 -25.16 50.97 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.261 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -60.29 -38.35 83.33 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.884 0.374 . . . . 0.0 110.109 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.96 -40.33 47.32 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.956 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 6.1 mt -58.53 -42.06 83.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.983 179.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.71 -30.19 42.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.299 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -68.26 -52.86 29.19 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.391 0.615 . . . . 0.0 110.016 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.7 -43.86 97.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.998 178.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.434 HG21 ' HA2' ' A' ' 137' ' ' GLY . 0.2 OUTLIER -58.2 -36.54 73.26 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.291 179.206 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.66 -39.4 96.52 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 110.509 -1.037 . . . . 0.0 110.509 178.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 54.6 mm-40 -69.62 -46.33 66.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.407 -0.396 . . . . 0.0 110.839 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.425 HD13 ' CE1' ' A' ' 214' ' ' PHE . 10.9 mp -66.01 -28.29 68.76 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.693 0.283 . . . . 0.0 111.363 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.1 -18.65 63.26 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.345 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -112.79 -27.29 8.2 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.622 0.249 . . . . 0.0 111.576 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.13 167.01 1.25 Allowed Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.072 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.29 127.81 15.53 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.198 1.932 . . . . 0.0 112.831 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.61 -25.77 7.6 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.652 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.97 -49.46 76.74 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.871 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.404 ' CG1' ' CE ' ' A' ' 182' ' ' MET . 24.5 t -74.01 -32.98 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.469 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 11.7 tp -57.24 -36.35 70.82 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 121.194 0.521 . . . . 0.0 109.865 179.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -77.35 -40.86 22.56 Favored Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.301 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -84.94 103.07 13.66 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.877 0.37 . . . . 0.0 110.658 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' MET . . . . . 0.404 ' CE ' ' CG1' ' A' ' 178' ' ' VAL . 2.8 mtm 177.31 162.63 0.5 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.033 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -120.9 -54.24 2.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.752 0.311 . . . . 0.0 111.267 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -162.38 142.94 10.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.814 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.401 HD12 HG22 ' A' ' 185' ' ' ILE . 16.2 mt -106.9 114.51 46.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.55 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 21.4 m170 -103.6 119.39 38.81 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.245 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.408 ' HB2' ' CD2' ' A' ' 158' ' ' TRP . 33.1 t80 -75.97 104.49 6.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.46 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.722 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 . . . . . 0 CA--C 1.529 0.163 0 CA-C-O 120.606 0.241 . . . . 0.0 111.596 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -108.95 38.47 2.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.802 0.334 . . . . 0.0 110.93 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -91.27 118.47 30.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.089 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.406 HG13 ' CZ2' ' A' ' 158' ' ' TRP . 21.2 m -115.63 167.81 7.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.863 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 19.1 mm -135.31 109.49 10.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.799 0.333 . . . . 0.0 111.059 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.408 HG13 ' CZ ' ' A' ' 214' ' ' PHE . 7.0 m -97.62 120.88 47.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.038 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -82.05 152.73 26.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.769 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.99 149.81 28.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.727 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -58.86 -29.12 66.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.168 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -80.87 1.76 29.43 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.983 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 92.1 14.43 56.14 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.466 -0.873 . . . . 0.0 113.184 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -86.69 162.32 17.96 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 117.067 0.434 . . . . 0.0 110.952 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -130.75 111.52 12.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.812 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.7 t -111.32 131.42 62.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.115 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 35.8 m -103.34 116.29 32.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.78 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -129.69 159.53 36.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.86 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.37 157.08 17.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.572 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 48.9 mt -67.44 -33.47 62.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.875 0.369 . . . . 0.0 110.848 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.73 -33.99 77.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.41 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -132.92 38.73 3.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.834 0.349 . . . . 0.0 111.148 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.425 ' CE1' HD13 ' A' ' 171' ' ' LEU . 11.0 t80 -62.52 -49.73 74.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.926 0.393 . . . . 0.0 110.637 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.97 -38.59 91.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.187 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -68.69 -50.56 49.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.022 0.439 . . . . 0.0 110.556 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 10.9 mmmt -53.43 -42.75 67.39 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.184 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.402 ' HB3' ' CG1' ' A' ' 178' ' ' VAL . 4.0 mm? -85.73 -23.46 27.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.968 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 9.0 t -60.13 -34.43 73.51 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.102 0.477 . . . . 0.0 109.964 179.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.968 179.015 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 . . . . . 0 C--O 1.23 0.058 0 CA-C-O 121.051 0.453 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.457 ' CD1' ' ND2' ' A' ' 136' ' ' ASN . 85.6 m95 -66.04 168.33 8.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.287 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.29 133.61 45.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.762 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 59.5 mtt180 -71.25 107.72 4.38 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.833 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.402 ' CD1' HG21 ' A' ' 168' ' ' THR . 42.9 pt -96.08 -9.15 9.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.414 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -156.33 175.97 13.3 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.659 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.458 ' CD1' ' CG ' ' A' ' 149' ' ' PRO . 37.9 m-85 -145.02 126.05 14.56 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.353 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.4 t -93.69 122.9 45.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.101 0.477 . . . . 0.0 111.13 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -82.4 97.46 8.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.776 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -151.09 156.01 40.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.44 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 6.3 tpp180 60.39 30.54 19.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.838 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.2 33.4 16.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.913 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 85.5 m -157.14 153.74 28.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.912 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -93.54 91.18 6.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.694 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.433 ' CG ' ' HA ' ' A' ' 141' ' ' LYS . 22.6 m-85 -66.06 125.02 89.33 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.874 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.412 ' HA ' ' CD2' ' A' ' 123' ' ' TYR . 57.0 Cg_endo -72.61 115.84 4.49 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.008 1.806 . . . . 0.0 112.725 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.403 ' HG ' HG23 ' A' ' 168' ' ' THR . 25.1 tp -93.64 123.8 37.2 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.656 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 39.9 mt -69.55 171.86 8.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.48 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.15 -31.76 72.98 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.987 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . 0.457 ' ND2' ' CD1' ' A' ' 118' ' ' TRP . 2.9 p30 -84.68 3.81 35.46 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.278 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.444 ' HA2' HG23 ' A' ' 168' ' ' THR . . . 82.71 21.24 60.07 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.766 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -79.9 94.29 5.82 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.79 107.41 3.5 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.95 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 15.3 mt -83.45 72.54 10.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.979 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.433 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 9.2 mttp -57.79 -20.73 37.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.481 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -96.9 23.79 6.81 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.289 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -147.94 27.49 0.96 Allowed 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.747 0.308 . . . . 0.0 111.122 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -63.52 166.66 25.84 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.913 -0.66 . . . . 0.0 113.183 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 9.6 t -132.58 151.72 51.84 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.867 0.365 . . . . 0.0 110.442 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.06 50.77 1.7 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.118 0.485 . . . . 0.0 110.598 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.71 147.04 2.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.644 -179.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -90.2 125.32 60.6 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.327 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.458 ' CG ' ' CD1' ' A' ' 123' ' ' TYR . 77.8 Cg_endo -84.83 107.27 1.1 Allowed 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.534 2.156 . . . . 0.0 112.605 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 15.0 t -69.83 -7.8 42.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.008 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -78.26 -23.64 47.19 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 120.841 0.353 . . . . 0.0 110.503 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -138.35 167.28 20.42 Favored Pre-proline 0 N--CA 1.453 -0.302 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.629 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -74.62 156.36 44.75 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.452 2.101 . . . . 0.0 112.539 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 18.3 t -118.96 109.22 26.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.236 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.43 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 1.1 mp -72.54 96.14 1.91 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.699 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.7 t -91.37 136.23 24.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.082 0.467 . . . . 0.0 111.046 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 47.9 57.71 7.54 Favored Glycine 0 CA--C 1.522 0.471 0 CA-C-N 115.701 -0.681 . . . . 0.0 113.237 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.43 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 2.5 m95 -99.81 151.36 21.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.193 0.52 . . . . 0.0 111.831 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.52 -172.42 0.08 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.627 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -44.37 154.24 0.13 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.284 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -57.65 -24.93 54.61 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.159 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -59.56 -39.49 84.21 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.887 0.375 . . . . 0.0 110.125 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.28 -40.32 51.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.962 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 5.9 mt -58.72 -41.08 81.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.922 178.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.72 -29.48 39.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.138 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -70.1 -53.01 19.26 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 121.512 0.672 . . . . 0.0 110.137 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.95 -43.98 91.36 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.042 178.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.444 HG23 ' HA2' ' A' ' 137' ' ' GLY . 0.2 OUTLIER -58.65 -36.43 74.12 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.395 179.08 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.26 -37.19 92.62 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 178.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 93.3 mm-40 -73.72 -45.58 51.27 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.339 -0.43 . . . . 0.0 111.083 178.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.423 HD11 ' CE1' ' A' ' 214' ' ' PHE . 11.3 mp -66.36 -28.47 68.67 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.697 0.284 . . . . 0.0 111.374 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.9 -16.18 62.66 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.34 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -115.2 -28.03 7.07 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.88 167.29 0.86 Allowed Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 116.754 -0.203 . . . . 0.0 111.3 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -69.92 128.15 15.47 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.269 1.979 . . . . 0.0 112.92 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.47 -25.64 6.8 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.718 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.51 -49.68 75.52 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.847 0.356 . . . . 0.0 110.947 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.408 ' CG1' ' CE ' ' A' ' 182' ' ' MET . 32.4 t -74.34 -36.05 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.608 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 10.7 tp -55.1 -34.08 63.37 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.162 0.506 . . . . 0.0 110.155 179.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -80.29 -41.59 11.58 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.405 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -85.53 103.02 14.01 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.912 0.386 . . . . 0.0 110.665 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' MET . . . . . 0.408 ' CE ' ' CG1' ' A' ' 178' ' ' VAL . 2.8 mtm 178.52 166.18 0.83 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.228 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.85 -56.96 1.91 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.836 0.35 . . . . 0.0 111.001 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -162.96 142.56 8.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.771 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.417 HD12 HG23 ' A' ' 185' ' ' ILE . 11.7 mt -101.91 115.55 43.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.475 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 22.9 m170 -105.21 121.62 44.21 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.98 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -78.53 104.69 9.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.509 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.547 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 . . . . . 0 CA--C 1.529 0.146 0 CA-C-O 120.754 0.311 . . . . 0.0 111.415 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 9.8 p30 -105.12 38.54 1.92 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.765 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -90.77 116.85 28.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.105 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 22.1 m -114.24 164.35 10.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.725 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 20.3 mm -133.3 105.95 8.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.785 0.326 . . . . 0.0 111.17 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.419 HG13 ' CE2' ' A' ' 214' ' ' PHE . 6.7 m -94.75 124.72 47.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.028 0.442 . . . . 0.0 111.011 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -84.26 152.82 23.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.809 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.8 149.02 29.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.729 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -58.77 -28.8 66.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.157 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -80.67 1.5 29.78 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.325 -0.398 . . . . 0.0 112.06 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 91.99 14.41 56.34 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.571 -0.823 . . . . 0.0 113.149 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -87.1 160.19 18.65 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.992 0.396 . . . . 0.0 110.732 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -128.67 111.47 13.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.919 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 23.1 t -110.88 137.46 43.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.044 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 3.8 m -110.83 112.07 23.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.755 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -121.86 170.76 9.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.938 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.92 157.56 19.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.402 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 33.0 mt -69.54 -31.48 49.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.794 0.331 . . . . 0.0 110.838 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.48 -30.15 65.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.345 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -133.12 37.31 3.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.809 0.338 . . . . 0.0 111.051 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.423 ' CE1' HD11 ' A' ' 171' ' ' LEU . 11.2 t80 -63.08 -55.46 25.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.837 0.351 . . . . 0.0 110.458 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.75 -42.38 79.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.146 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -68.91 -47.72 65.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.041 0.448 . . . . 0.0 110.232 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -54.95 -43.63 73.6 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.905 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -83.09 -26.44 31.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.779 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 13.2 t -61.19 -30.53 70.47 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.955 0.407 . . . . 0.0 110.528 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.107 179.612 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.993 0.425 . . . . 0.0 110.97 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.462 ' CD1' ' ND2' ' A' ' 136' ' ' ASN . 81.5 m95 -73.16 167.95 20.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.057 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.7 ttm-85 -102.64 135.57 44.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.401 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 -71.74 105.92 3.92 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.491 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.428 HG23 HD11 ' A' ' 121' ' ' ILE . 42.9 pt -93.54 -9.06 9.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.492 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -158.99 176.57 12.14 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 120.99 -0.284 . . . . 0.0 110.795 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.446 ' CD1' ' HG3' ' A' ' 149' ' ' PRO . 30.8 m-85 -142.77 128.3 19.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.268 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.9 t -93.28 122.41 44.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.072 0.463 . . . . 0.0 111.239 -179.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.479 ' CE1' ' CE1' ' A' ' 130' ' ' PHE . 7.6 t80 -82.75 94.45 7.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.735 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -144.46 153.04 41.47 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.433 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 59.44 30.66 20.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.858 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 61.81 34.71 17.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.036 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 65.7 m -152.2 162.21 41.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.07 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.479 ' CE1' ' CE1' ' A' ' 125' ' ' TYR . 18.5 m-85 -103.27 90.71 3.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.191 0.52 . . . . 0.0 111.194 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.438 ' CG ' ' HA ' ' A' ' 141' ' ' LYS . 23.8 m-85 -69.82 118.33 62.08 Favored Pre-proline 0 CA--C 1.536 0.437 0 CA-C-N 115.437 -0.802 . . . . 0.0 111.499 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.424 ' HA ' ' CD2' ' A' ' 123' ' ' TYR . 25.0 Cg_exo -63.16 119.86 7.09 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 122.423 2.082 . . . . 0.0 112.61 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.437 ' HG ' HG22 ' A' ' 168' ' ' THR . 29.6 tp -100.25 123.17 44.16 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.285 179.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 46.5 mt -70.13 171.4 9.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.701 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.401 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.5 pt-20 -61.67 -33.33 73.79 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.098 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . 0.462 ' ND2' ' CD1' ' A' ' 118' ' ' TRP . 4.2 p30 -82.34 -4.36 57.13 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.107 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.441 ' HA2' HG22 ' A' ' 168' ' ' THR . . . 91.34 15.84 54.56 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.804 -179.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 15.1 tpp85 -73.62 97.21 2.6 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.98 109.18 4.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.565 -178.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 27.6 mt -84.22 71.16 10.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.487 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.438 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 18.6 mttt -56.79 -21.5 29.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.738 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -84.54 -17.39 39.05 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -106.67 29.48 6.91 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . -60.55 161.62 21.7 Favored Glycine 0 CA--C 1.509 -0.316 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.359 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 11.1 t -136.28 148.81 48.17 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.999 0.428 . . . . 0.0 110.927 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 6.7 mmtt -89.92 55.86 3.28 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.343 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.405 ' O ' ' CG ' ' A' ' 130' ' ' PHE . 0.0 OUTLIER -170.41 167.32 8.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.255 -179.327 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -102.67 136.62 19.29 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.928 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.446 ' HG3' ' CD1' ' A' ' 123' ' ' TYR . 59.7 Cg_endo -84.7 99.98 0.74 Allowed 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 123.174 2.582 . . . . 0.0 112.491 179.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 16.8 t -67.24 -9.52 41.32 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.793 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -89.58 -22.24 22.46 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 111.562 0.208 . . . . 0.0 111.562 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -139.33 166.92 21.03 Favored Pre-proline 0 C--N 1.328 -0.334 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -178.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.46 164.24 35.56 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.495 2.13 . . . . 0.0 112.275 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 22.1 t -122.92 109.12 22.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 121.065 0.46 . . . . 0.0 111.655 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.437 HD22 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.72 95.95 1.96 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.687 179.068 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 54.9 t -92.99 137.87 21.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.164 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 47.69 56.06 8.93 Favored Glycine 0 CA--C 1.521 0.421 0 CA-C-N 115.913 -0.585 . . . . 0.0 113.227 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.437 ' CE2' HD22 ' A' ' 155' ' ' LEU . 3.2 m95 -98.9 151.26 21.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.181 0.515 . . . . 0.0 111.62 -179.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.98 -172.4 0.14 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.423 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -43.58 154.69 0.08 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.095 0.474 . . . . 0.0 112.184 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -57.29 -25.05 53.78 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.275 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.97 -38.75 83.44 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.001 0.429 . . . . 0.0 110.125 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.18 -40.23 46.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.053 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 6.5 mt -59.4 -42.25 86.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.081 179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.38 -29.49 48.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.366 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -67.84 -53.28 28.06 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.4 0.619 . . . . 0.0 110.162 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.89 -43.51 98.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.995 178.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.441 HG22 ' HA2' ' A' ' 137' ' ' GLY . 0.2 OUTLIER -58.88 -37.82 77.42 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.361 179.181 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.62 -37.54 92.42 Favored Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 178.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -72.04 -46.5 56.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.366 -0.417 . . . . 0.0 110.848 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.424 HD12 ' CE1' ' A' ' 214' ' ' PHE . 10.4 mp -64.22 -30.45 71.51 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.789 0.328 . . . . 0.0 111.219 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -67.67 -21.91 65.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.552 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -109.61 -26.49 9.88 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 120.595 0.236 . . . . 0.0 111.498 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.99 166.37 1.43 Allowed Pre-proline 0 CA--C 1.538 0.491 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.096 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -69.32 128.95 17.19 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.364 2.043 . . . . 0.0 112.702 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.89 -25.89 5.13 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.75 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.87 -50.05 74.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.971 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.408 ' CG1' ' CE ' ' A' ' 182' ' ' MET . 24.4 t -74.21 -35.44 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.705 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.56 -35.04 67.7 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.131 0.491 . . . . 0.0 109.956 179.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -79.5 -39.21 18.92 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.269 -0.733 . . . . 0.0 111.269 178.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -86.85 103.16 14.99 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.935 0.398 . . . . 0.0 110.654 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' MET . . . . . 0.408 ' CE ' ' CG1' ' A' ' 178' ' ' VAL . 2.9 mtm 178.35 161.18 0.61 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.027 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 6.6 t -118.93 -58.52 1.94 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.767 0.318 . . . . 0.0 110.881 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.8 pm0 -157.62 142.58 16.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.001 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 17.0 mt -107.01 115.0 47.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.341 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 21.8 m170 -106.01 123.46 48.03 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.207 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -75.67 104.55 6.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.167 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 4.3 mttm . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.908 -179.629 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.257 0 CA-C-O 120.719 0.295 . . . . 0.0 111.332 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -106.9 37.86 2.24 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.746 0.308 . . . . 0.0 110.802 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 7.2 ttt180 -88.86 116.22 26.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.838 0.352 . . . . 0.0 111.439 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 23.6 m -112.81 166.41 6.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.66 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 19.2 mm -132.01 108.77 14.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.793 0.33 . . . . 0.0 111.287 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.418 HG11 ' CZ ' ' A' ' 214' ' ' PHE . 10.2 m -100.98 120.78 50.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.028 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -85.81 152.62 22.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.631 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 9.7 mmt -102.67 161.24 13.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.034 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -62.56 -25.89 68.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.153 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -87.15 10.62 16.22 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 83.77 14.4 72.97 Favored Glycine 0 C--N 1.335 0.496 0 C-N-CA 120.451 -0.881 . . . . 0.0 113.282 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -80.15 170.41 16.47 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 117.014 0.407 . . . . 0.0 110.767 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -136.43 111.48 8.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.928 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.77 122.59 69.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.089 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -99.31 114.64 27.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.671 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -126.12 161.32 27.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.802 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.76 152.73 19.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.673 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.407 HG23 HD13 ' A' ' 211' ' ' ILE . 48.4 mt -63.88 -36.49 76.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.838 0.351 . . . . 0.0 110.724 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.23 -34.66 76.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.158 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -132.64 44.28 2.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.919 0.39 . . . . 0.0 111.02 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.424 ' CE1' HD12 ' A' ' 171' ' ' LEU . 11.3 t80 -66.94 -52.58 41.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.564 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.01 -40.02 91.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.911 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.37 -51.15 55.66 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.158 0.504 . . . . 0.0 110.399 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.25 -43.78 71.22 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.163 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.401 ' HB3' ' CG1' ' A' ' 178' ' ' VAL . 4.1 mm? -83.52 -23.15 32.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.097 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.49 -34.3 75.26 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.045 0.45 . . . . 0.0 109.799 179.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 . . . . . 0 CA--C 1.533 0.298 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.151 179.446 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 121.025 0.44 . . . . 0.0 110.939 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.461 ' CD1' ' ND2' ' A' ' 136' ' ' ASN . 87.3 m95 -70.11 168.37 15.73 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.093 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 2.0 ptt180 -99.57 133.39 43.97 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.696 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 32.4 mtm180 -71.33 106.68 3.96 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.628 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.43 HG23 HD13 ' A' ' 121' ' ' ILE . 44.1 pt -95.86 -8.25 9.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.436 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -158.41 176.53 12.33 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 120.647 0.26 . . . . 0.0 110.882 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.462 ' CD1' ' CG ' ' A' ' 149' ' ' PRO . 38.2 m-85 -144.91 126.59 15.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.188 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 4.1 t -93.45 122.65 45.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.124 0.487 . . . . 0.0 111.013 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -83.69 95.07 8.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.48 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -145.52 155.16 42.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.42 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 4.0 tpp180 59.58 30.2 19.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.787 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 62.27 34.83 15.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.997 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 57.8 m -153.54 161.46 42.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.826 0.346 . . . . 0.0 111.278 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.448 ' CE2' ' CB ' ' A' ' 148' ' ' ALA . 31.8 m-85 -101.75 91.12 4.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.132 0.491 . . . . 0.0 110.914 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.424 ' CG ' ' HA ' ' A' ' 141' ' ' LYS . 24.3 m-85 -70.19 122.96 87.9 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.336 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.42 ' HA ' ' CD2' ' A' ' 123' ' ' TYR . 15.1 Cg_exo -67.94 118.17 5.42 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 122.31 2.007 . . . . 0.0 112.636 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.42 ' HG ' HG23 ' A' ' 168' ' ' THR . 30.4 tp -98.02 123.32 41.98 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.086 0.469 . . . . 0.0 110.362 179.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 44.6 mt -70.4 171.97 9.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.511 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.85 -32.33 73.53 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.857 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . 0.461 ' ND2' ' CD1' ' A' ' 118' ' ' TRP . 3.1 p30 -84.07 2.45 39.22 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.161 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.454 ' HA2' HG23 ' A' ' 168' ' ' THR . . . 83.89 20.27 59.83 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.827 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 13.8 tpp180 -78.4 94.08 4.82 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.2 105.1 1.99 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.438 -179.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 17.3 mt -78.58 69.34 4.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.746 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.424 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 2.3 mttt -57.2 -21.31 32.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.564 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -91.96 11.94 23.44 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -134.74 26.5 3.67 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.762 0.315 . . . . 0.0 111.17 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -61.23 163.02 22.63 Favored Glycine 0 CA--C 1.509 -0.323 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.844 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.9 t -136.3 151.84 50.05 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.526 -0.337 . . . . 0.0 110.428 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 4.2 mmtt -89.03 51.84 2.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.014 0.435 . . . . 0.0 110.705 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.18 148.97 2.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.638 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.448 ' CB ' ' CE2' ' A' ' 130' ' ' PHE . . . -93.73 125.81 52.0 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.474 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.462 ' CG ' ' CD1' ' A' ' 123' ' ' TYR . 89.1 Cg_endo -84.39 109.97 1.43 Allowed 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.528 2.152 . . . . 0.0 112.508 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.3 t -70.2 -6.86 37.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.081 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.73 -23.04 53.06 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 120.836 0.351 . . . . 0.0 110.507 178.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.72 167.2 18.42 Favored Pre-proline 0 N--CA 1.453 -0.306 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.794 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -74.04 154.44 47.48 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.412 2.074 . . . . 0.0 112.306 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 14.2 t -115.81 111.5 35.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.115 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.43 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.71 96.45 2.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.858 179.207 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.423 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 59.0 t -93.07 136.03 26.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.975 0.417 . . . . 0.0 110.981 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 48.97 56.32 10.25 Favored Glycine 0 CA--C 1.521 0.423 0 CA-C-N 115.903 -0.589 . . . . 0.0 113.17 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.43 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 3.2 m95 -99.52 151.31 21.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.195 0.521 . . . . 0.0 111.799 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -65.79 -172.43 0.13 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.529 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -44.33 154.43 0.12 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.118 0.485 . . . . 0.0 112.203 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -57.27 -25.07 53.78 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.239 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -60.12 -38.3 82.59 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 120.967 0.413 . . . . 0.0 110.113 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.79 -41.36 44.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.0 178.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 6.5 mt -57.73 -42.35 81.56 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.11 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.22 -29.78 34.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.166 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -68.64 -53.43 22.53 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-O 121.503 0.668 . . . . 0.0 110.054 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.84 -43.81 94.39 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.701 -0.682 . . . . 0.0 109.88 178.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.454 HG23 ' HA2' ' A' ' 137' ' ' GLY . 0.2 OUTLIER -58.62 -36.35 73.92 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.329 179.018 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.84 -38.47 94.06 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 178.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -71.93 -45.45 61.1 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.269 -0.465 . . . . 0.0 110.727 178.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.427 HD13 ' CE1' ' A' ' 214' ' ' PHE . 10.7 mp -67.83 -21.32 65.21 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.72 0.295 . . . . 0.0 111.691 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -77.12 -16.69 59.09 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.114 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -114.9 -26.5 7.75 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.75 166.35 1.91 Allowed Pre-proline 0 CA--C 1.536 0.412 0 CA-C-O 120.513 0.197 . . . . 0.0 111.051 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -69.48 128.88 16.94 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.31 2.007 . . . . 0.0 112.707 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.86 -25.25 7.52 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.67 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.42 -49.39 76.36 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.904 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.406 ' CG1' ' CE ' ' A' ' 182' ' ' MET . 23.5 t -74.32 -39.97 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.57 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 12.4 tp -54.52 -32.63 58.5 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.059 0.457 . . . . 0.0 110.22 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -82.41 -36.18 17.95 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 178.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -90.48 103.2 15.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.898 0.38 . . . . 0.0 110.614 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' MET . . . . . 0.406 ' CE ' ' CG1' ' A' ' 178' ' ' VAL . 2.9 mtm 178.92 179.79 0.39 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.023 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -136.72 -52.16 0.69 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.732 0.301 . . . . 0.0 111.198 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -163.43 142.69 8.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.124 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.406 HD12 HG21 ' A' ' 185' ' ' ILE . 19.2 mt -106.25 114.95 46.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.316 179.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . 0.423 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 20.1 m170 -106.24 123.61 48.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.25 -179.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -75.31 104.85 6.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.474 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 9.0 mmtt . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.5 179.867 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 . . . . . 0 CA--C 1.528 0.121 0 CA-C-O 120.695 0.283 . . . . 0.0 111.282 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -104.19 36.01 2.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.795 0.331 . . . . 0.0 110.779 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 24.0 ttt85 -90.57 113.43 25.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.988 0.423 . . . . 0.0 111.182 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 23.1 m -109.2 167.82 4.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.751 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 22.5 mm -134.33 105.75 7.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.684 0.278 . . . . 0.0 111.34 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.42 HG13 ' CE2' ' A' ' 214' ' ' PHE . 12.5 m -94.53 134.87 30.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.868 0.366 . . . . 0.0 110.921 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -97.54 153.08 18.4 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.667 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 33.5 tpp -112.24 149.35 32.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.448 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 16.9 m-20 -55.27 -28.96 57.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.513 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -75.38 -5.89 47.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.817 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 94.78 14.62 49.02 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.499 -0.857 . . . . 0.0 112.988 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -86.28 158.2 19.75 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 117.005 0.403 . . . . 0.0 110.915 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -124.85 111.18 15.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.676 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 25.5 t -113.04 135.64 51.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.938 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 93.7 p -109.26 116.36 31.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.74 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -125.27 169.36 12.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.797 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -108.2 154.25 22.03 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.706 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 34.5 mt -66.08 -34.05 67.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.782 0.325 . . . . 0.0 110.832 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.46 -35.61 80.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.334 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -131.65 43.34 3.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.983 0.42 . . . . 0.0 110.961 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.427 ' CE1' HD13 ' A' ' 171' ' ' LEU . 11.1 t80 -66.73 -50.77 61.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.722 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.27 -42.22 90.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.347 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -67.31 -49.55 63.7 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.052 0.454 . . . . 0.0 110.458 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.93 -43.4 69.76 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.174 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.4 ' HB3' ' CG1' ' A' ' 178' ' ' VAL . 4.0 mm? -84.11 -25.5 29.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.004 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 12.6 t -61.15 -31.45 71.18 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.892 0.377 . . . . 0.0 110.396 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 . . . . . 0 CA--C 1.531 0.248 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.402 179.665 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 121.041 0.448 . . . . 0.0 110.977 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.41 ' HB2' ' HB3' ' A' ' 134' ' ' LEU . 81.3 m95 -73.89 168.55 19.22 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.204 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.2 ptt180 -101.05 135.22 42.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.841 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 8.4 mtm180 -71.87 106.68 4.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.867 0.365 . . . . 0.0 110.731 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.405 ' CD1' HG21 ' A' ' 168' ' ' THR . 49.3 pt -97.09 -7.65 9.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.366 179.268 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -159.39 176.17 12.44 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 121.111 -0.236 . . . . 0.0 110.71 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.465 ' CD1' ' CG ' ' A' ' 149' ' ' PRO . 29.1 m-85 -144.48 126.26 15.24 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.088 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 8.6 t -93.64 122.77 45.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.108 0.48 . . . . 0.0 111.471 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.476 ' CD1' ' CE1' ' A' ' 130' ' ' PHE . 28.5 t80 -82.7 110.7 17.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.729 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -165.08 152.41 10.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.651 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? 60.37 31.6 20.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.015 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 62.2 31.49 17.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.264 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 84.7 m -153.43 150.13 28.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.874 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.476 ' CE1' ' CD1' ' A' ' 125' ' ' TYR . 98.7 m-85 -95.55 91.52 6.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.793 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.44 ' CD1' ' HA ' ' A' ' 141' ' ' LYS . 23.8 m-85 -65.19 126.15 90.77 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.313 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -72.58 116.67 4.8 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.176 1.917 . . . . 0.0 112.434 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.418 ' HG ' HG23 ' A' ' 168' ' ' THR . 42.8 tp -96.02 124.38 40.01 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.864 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.41 ' HB3' ' HB2' ' A' ' 118' ' ' TRP . 55.0 mt -71.65 174.73 6.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.65 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -65.46 -28.73 69.43 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.076 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 46.7 p-10 -89.82 11.68 19.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.143 179.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.446 ' HA2' HG23 ' A' ' 168' ' ' THR . . . 73.41 23.49 77.1 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.932 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 18.4 tpp180 -81.11 95.95 7.02 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.68 107.33 5.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.326 -179.005 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 13.5 mt -85.03 72.13 10.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.321 179.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.44 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 7.5 mtpt -56.2 -21.38 22.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.993 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -85.54 -16.22 40.17 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -108.88 29.69 7.23 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.52 163.08 36.42 Favored Glycine 0 CA--C 1.51 -0.228 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.88 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 9.1 t -131.31 155.95 46.31 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.41 -0.395 . . . . 0.0 110.619 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.39 48.52 1.31 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.127 0.489 . . . . 0.0 110.319 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -170.97 150.73 3.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.533 -179.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -95.02 125.93 48.76 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.21 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.465 ' CG ' ' CD1' ' A' ' 123' ' ' TYR . 72.8 Cg_endo -83.02 111.83 1.96 Allowed 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.349 2.032 . . . . 0.0 112.619 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 33.3 t -69.81 -7.6 41.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.062 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.82 -23.44 52.76 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 120.821 0.343 . . . . 0.0 110.456 178.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -139.44 166.9 21.05 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.653 -179.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.81 154.54 48.7 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.348 2.032 . . . . 0.0 112.265 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 13.4 t -116.91 109.98 29.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.063 0.458 . . . . 0.0 111.207 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.443 HD22 ' CD2' ' A' ' 158' ' ' TRP . 1.2 mp -72.33 96.12 1.82 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.611 179.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.408 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 60.8 t -92.41 137.16 22.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.129 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 48.97 57.85 8.33 Favored Glycine 0 CA--C 1.52 0.374 0 CA-C-N 115.921 -0.581 . . . . 0.0 113.223 179.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.443 ' CD2' HD22 ' A' ' 155' ' ' LEU . 2.7 m95 -101.13 151.07 22.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.162 0.506 . . . . 0.0 111.679 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.7 tttp -66.76 -172.18 0.16 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.374 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -42.26 154.42 0.06 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -56.87 -24.96 51.63 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.267 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.04 -38.69 83.51 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.996 0.427 . . . . 0.0 109.978 179.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -75.91 -40.6 53.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.913 178.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 6.2 mt -59.11 -44.0 90.58 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.878 179.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -52.92 -25.9 13.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.617 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -71.39 -54.43 10.73 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 121.072 0.463 . . . . 0.0 110.923 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.14 -37.19 84.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.217 179.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.446 HG23 ' HA2' ' A' ' 137' ' ' GLY . 0.2 OUTLIER -60.5 -38.11 83.26 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.911 178.881 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -61.59 -35.68 91.49 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 177.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -71.6 -49.02 44.27 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.181 -0.51 . . . . 0.0 110.669 178.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.428 HD12 ' CE1' ' A' ' 214' ' ' PHE . 10.8 mp -65.2 -27.42 68.67 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.548 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.13 -18.2 61.91 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.273 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -113.27 -27.75 7.86 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.0 167.23 1.14 Allowed Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.154 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.19 127.78 17.32 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.192 1.928 . . . . 0.0 112.728 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.45 -26.43 12.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.525 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -58.93 -48.09 82.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.924 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.412 ' CG1' ' CE ' ' A' ' 182' ' ' MET . 22.1 t -73.0 -35.82 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.696 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 13.0 tp -56.13 -36.36 68.15 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.129 0.49 . . . . 0.0 110.032 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -76.92 -40.11 26.46 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 178.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -87.7 103.09 15.27 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.879 0.371 . . . . 0.0 110.718 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' MET . . . . . 0.412 ' CE ' ' CG1' ' A' ' 178' ' ' VAL . 2.8 mtm 178.02 167.73 0.75 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.127 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.92 -56.75 1.55 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.63 0.252 . . . . 0.0 111.268 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 6.3 pm0 -160.39 142.79 13.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.894 0.378 . . . . 0.0 111.307 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 13.3 mt -104.33 115.96 47.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.455 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . 0.408 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 20.2 m170 -106.45 124.05 49.01 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.113 -179.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -79.46 104.7 10.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.709 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.517 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.53 0.209 0 CA-C-O 120.748 0.308 . . . . 0.0 111.245 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -106.0 38.37 2.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.608 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.08 114.72 25.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.322 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 32.8 m -110.59 169.37 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.724 179.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 22.0 mm -134.95 110.29 12.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.72 0.295 . . . . 0.0 111.285 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.401 HG11 ' CE2' ' A' ' 214' ' ' PHE . 12.3 m -102.81 127.18 56.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.987 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -88.64 152.56 21.75 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.675 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.11 157.62 16.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.812 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -57.78 -23.84 54.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.527 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -89.89 15.36 10.03 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 79.64 14.19 81.47 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.57 -0.824 . . . . 0.0 113.081 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -78.39 175.05 10.64 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 117.094 0.447 . . . . 0.0 110.836 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -140.53 111.46 7.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.082 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 20.1 t -114.22 135.63 53.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.911 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 1.5 m -107.64 118.36 36.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.928 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -131.12 161.94 30.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.66 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -99.28 156.75 16.82 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.737 0.303 . . . . 0.0 110.788 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.416 HG21 HD11 ' A' ' 211' ' ' ILE . 45.9 mt -68.46 -33.1 58.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.771 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 -67.38 -38.06 84.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.091 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -126.53 41.14 3.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.974 0.416 . . . . 0.0 110.866 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.428 ' CE1' HD12 ' A' ' 171' ' ' LEU . 11.5 t80 -65.02 -52.57 55.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.869 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.29 -37.74 81.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.048 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -69.25 -49.62 54.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.063 0.458 . . . . 0.0 110.372 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 1.2 mmpt? -53.25 -41.72 65.76 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.058 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.402 ' HB3' ' CG1' ' A' ' 178' ' ' VAL . 4.3 mm? -87.06 -23.16 25.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.9 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 11.0 t -60.95 -32.64 72.17 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.921 0.391 . . . . 0.0 110.157 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 24.9 m170 . . . . . 0 CA--C 1.533 0.29 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.195 179.398 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 121.011 0.434 . . . . 0.0 110.942 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.404 ' HB2' ' HB3' ' A' ' 134' ' ' LEU . 82.8 m95 -70.91 168.44 16.91 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.219 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.85 132.2 47.76 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.799 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -69.17 108.4 3.6 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.926 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.407 ' CD1' HG23 ' A' ' 168' ' ' THR . 44.2 pt -98.01 -7.93 9.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.323 179.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -159.97 174.45 14.36 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 121.134 -0.226 . . . . 0.0 110.649 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.47 ' CD1' ' CG ' ' A' ' 149' ' ' PRO . 28.0 m-85 -143.03 126.75 17.04 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.277 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.5 t -93.35 123.65 45.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.018 0.437 . . . . 0.0 111.643 -179.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.481 ' CE1' ' CE1' ' A' ' 130' ' ' PHE . 7.5 t80 -84.51 105.11 15.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.754 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -159.66 154.92 25.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.681 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 60.46 30.56 19.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.945 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 62.38 32.16 16.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.166 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 75.3 m -153.1 151.39 30.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.085 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.481 ' CE1' ' CE1' ' A' ' 125' ' ' TYR . 36.4 m-85 -94.52 90.91 6.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.537 179.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.437 ' CD1' ' HA ' ' A' ' 141' ' ' LYS . 21.4 m-85 -65.47 138.17 96.82 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.739 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.418 ' HA ' ' CD2' ' A' ' 123' ' ' TYR . 57.9 Cg_endo -85.16 116.06 1.73 Allowed 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.311 2.008 . . . . 0.0 112.083 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.428 ' HG ' HG22 ' A' ' 168' ' ' THR . 37.9 tp -95.29 123.65 38.91 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.882 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.418 ' CD1' ' HB3' ' A' ' 138' ' ' ARG . 58.2 mt -72.15 172.69 9.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.485 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -63.19 -28.75 70.26 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.854 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -90.5 12.39 18.81 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.209 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.438 ' HA2' HG22 ' A' ' 168' ' ' THR . . . 74.07 28.34 64.63 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.717 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.418 ' HB3' ' CD1' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -81.62 92.36 6.55 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.723 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.41 ' CD2' ' CB ' ' A' ' 131' ' ' PHE . 0.4 OUTLIER -74.17 105.03 5.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.957 0.408 . . . . 0.0 110.972 -179.533 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 88.6 mt -85.84 70.87 10.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.701 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.437 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 29.5 mttt -52.87 -23.24 6.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.983 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -84.09 -20.54 32.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.596 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -102.54 27.86 6.51 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 111.703 0.26 . . . . 0.0 111.703 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . -65.22 163.88 37.74 Favored Glycine 0 CA--C 1.511 -0.215 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.144 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 7.8 t -133.07 158.3 43.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.955 0.407 . . . . 0.0 110.648 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 6.2 mmmm -93.98 48.86 1.28 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.36 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.33 151.53 3.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.593 -179.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.452 ' CB ' ' CE2' ' A' ' 130' ' ' PHE . . . -96.93 126.73 41.51 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.178 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.47 ' CG ' ' CD1' ' A' ' 123' ' ' TYR . 73.2 Cg_endo -82.24 111.95 2.19 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.335 2.023 . . . . 0.0 112.552 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 28.2 t -69.82 -7.47 40.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.112 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -76.47 -23.33 53.82 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 120.859 0.362 . . . . 0.0 110.451 179.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -139.74 167.88 17.01 Favored Pre-proline 0 N--CA 1.454 -0.265 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.697 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -74.22 158.0 45.52 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.389 2.059 . . . . 0.0 112.236 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 11.1 t -118.47 111.04 32.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.049 0.452 . . . . 0.0 111.16 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.436 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.52 95.98 1.88 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.535 179.122 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.418 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 61.2 t -93.22 136.45 25.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.977 0.418 . . . . 0.0 111.014 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 49.05 55.98 10.96 Favored Glycine 0 CA--C 1.521 0.411 0 CA-C-N 115.808 -0.633 . . . . 0.0 113.264 179.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.436 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 2.7 m95 -98.34 151.11 20.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.128 0.489 . . . . 0.0 111.652 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.97 -172.65 0.07 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.349 179.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -44.46 155.5 0.09 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.134 0.492 . . . . 0.0 112.143 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -56.54 -25.14 49.45 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.25 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -60.89 -39.03 87.71 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 120.938 0.399 . . . . 0.0 110.038 179.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -75.36 -40.16 58.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.128 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 6.3 mt -59.0 -43.1 88.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.102 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.34 -29.69 35.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.35 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -68.14 -53.12 27.51 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.424 0.63 . . . . 0.0 110.189 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.39 -42.3 95.6 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.027 179.064 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.438 HG22 ' HA2' ' A' ' 137' ' ' GLY . 0.2 OUTLIER -59.51 -37.47 78.42 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.306 179.252 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.78 -36.67 92.3 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 178.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -72.92 -46.86 50.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.424 -0.388 . . . . 0.0 110.945 178.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.424 HD13 ' CE1' ' A' ' 214' ' ' PHE . 10.6 mp -65.69 -28.49 69.11 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.75 0.31 . . . . 0.0 111.34 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.31 -17.98 63.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.335 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -112.72 -27.36 8.19 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.65 0.262 . . . . 0.0 111.529 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.88 167.0 1.16 Allowed Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.183 -179.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -69.2 127.82 15.61 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.249 1.966 . . . . 0.0 112.721 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.02 -25.85 5.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.81 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.65 -50.0 74.61 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.007 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.403 ' CG1' ' CE ' ' A' ' 182' ' ' MET . 22.3 t -74.19 -35.33 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.667 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.37 -34.78 66.98 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.105 0.479 . . . . 0.0 110.091 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -79.56 -40.27 15.81 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.35 178.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -87.32 103.15 15.2 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.931 0.396 . . . . 0.0 110.745 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' MET . . . . . 0.403 ' CE ' ' CG1' ' A' ' 178' ' ' VAL . 2.8 mtm 178.95 164.66 0.86 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.24 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.33 -60.28 1.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.755 0.312 . . . . 0.0 111.195 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -155.64 142.89 19.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.029 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 16.7 mt -107.35 115.12 47.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.434 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . 0.418 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 20.7 m170 -106.39 135.07 48.53 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.186 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.403 ' CZ ' HD11 ' A' ' 211' ' ' ILE . 0.3 OUTLIER -86.65 104.35 15.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.269 179.417 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.8 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 . . . . . 0 CA--C 1.53 0.208 0 CA-C-O 120.598 0.237 . . . . 0.0 111.61 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 9.3 p30 -110.09 38.26 2.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.743 0.306 . . . . 0.0 111.047 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.34 117.04 28.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.912 0.387 . . . . 0.0 111.121 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 22.0 m -114.45 168.47 6.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.747 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 22.7 mm -134.64 113.58 16.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.732 0.301 . . . . 0.0 111.221 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 10.4 m -104.8 125.91 59.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.09 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -88.72 152.52 21.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.787 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.02 154.88 18.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.761 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -58.03 -27.82 63.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.249 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -82.98 4.24 26.72 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 89.98 14.4 59.32 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 120.476 -0.869 . . . . 0.0 113.244 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -80.1 173.58 12.45 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 117.059 0.429 . . . . 0.0 110.902 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -139.3 111.34 7.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.904 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 19.6 t -115.79 137.36 49.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.924 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 97.7 p -110.77 119.66 39.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.942 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -130.36 164.21 25.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.71 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.86 153.71 20.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.76 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.403 HD11 ' CZ ' ' A' ' 187' ' ' TYR . 33.9 mt -64.3 -36.81 78.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.837 0.351 . . . . 0.0 110.693 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.14 -36.39 81.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.159 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -132.0 46.12 2.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.007 0.432 . . . . 0.0 110.889 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.424 ' CE1' HD13 ' A' ' 171' ' ' LEU . 11.5 t80 -67.53 -51.71 47.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.785 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.15 -41.05 87.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.146 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -68.25 -49.85 57.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.148 0.499 . . . . 0.0 110.268 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 1.5 mmpt? -52.28 -41.81 63.19 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.102 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -86.85 -24.66 24.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.008 179.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 13.5 t -60.87 -30.76 70.34 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.829 0.347 . . . . 0.0 110.531 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 58.7 m170 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.25 179.777 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 121.049 0.452 . . . . 0.0 111.071 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.459 ' CD1' ' ND2' ' A' ' 136' ' ' ASN . 82.1 m95 -68.79 168.0 14.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.106 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -102.68 138.01 40.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.403 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 10.3 mtt180 -73.4 105.59 4.84 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.729 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 45.6 pt -93.49 -9.26 9.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.366 179.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -157.36 176.44 12.68 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 120.599 0.237 . . . . 0.0 110.537 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.448 ' CD1' ' CG ' ' A' ' 149' ' ' PRO . 34.0 m-85 -143.9 126.14 15.62 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.9 t -93.67 122.91 45.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.058 0.456 . . . . 0.0 111.417 -179.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -80.69 94.21 6.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.556 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -145.26 154.13 42.03 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.327 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.2 mmt-85 60.0 29.94 19.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.699 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 61.51 34.75 17.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.968 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 83.6 m -154.87 162.04 41.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.818 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.413 ' CE2' ' HB2' ' A' ' 148' ' ' ALA . 10.7 m-85 -100.47 90.71 4.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.141 0.496 . . . . 0.0 111.201 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.434 ' CG ' ' HA ' ' A' ' 141' ' ' LYS . 23.1 m-85 -68.9 118.09 57.74 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.391 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -64.3 115.35 3.11 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 122.359 2.039 . . . . 0.0 112.594 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.425 ' HG ' HG22 ' A' ' 168' ' ' THR . 30.3 tp -94.17 123.41 37.54 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.358 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 45.5 mt -69.02 173.6 5.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.557 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -64.72 -29.7 70.69 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.14 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . 0.459 ' ND2' ' CD1' ' A' ' 118' ' ' TRP . 2.7 p30 -88.14 9.84 21.38 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.19 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.445 ' HA2' HG22 ' A' ' 168' ' ' THR . . . 77.01 20.99 75.03 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.817 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -79.85 92.39 5.48 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.81 119.89 12.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.501 -178.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 33.1 mt -88.17 76.49 8.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.306 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.434 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 15.7 mtpt -71.49 -5.86 36.22 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.002 -0.544 . . . . 0.0 112.454 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -94.97 -25.08 16.66 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.606 0.241 . . . . 0.0 111.078 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -87.16 -82.19 0.22 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.294 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . 59.52 153.84 0.02 OUTLIER Glycine 0 CA--C 1.506 -0.506 0 C-N-CA 121.337 -0.459 . . . . 0.0 112.8 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 10.1 t -137.77 152.35 49.08 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.127 -0.536 . . . . 0.0 110.61 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.31 51.34 1.89 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.566 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.12 147.43 2.57 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.741 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.413 ' HB2' ' CE2' ' A' ' 130' ' ' PHE . . . -90.9 125.11 60.08 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.332 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.448 ' CG ' ' CD1' ' A' ' 123' ' ' TYR . 71.6 Cg_endo -84.74 107.88 1.17 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.613 2.209 . . . . 0.0 112.659 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 25.8 t -69.52 -8.03 43.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.017 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -77.83 -24.49 48.68 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 120.879 0.371 . . . . 0.0 110.377 179.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -138.85 167.04 20.8 Favored Pre-proline 0 N--CA 1.452 -0.339 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.616 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -75.03 157.99 42.32 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.404 2.069 . . . . 0.0 112.572 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 13.6 t -118.97 110.72 30.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.095 0.474 . . . . 0.0 111.028 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.429 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.64 96.05 1.94 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.868 179.439 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.405 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 61.3 t -94.18 137.14 23.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.989 0.423 . . . . 0.0 111.048 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 48.83 57.02 9.03 Favored Glycine 0 C--N 1.332 0.345 0 CA-C-N 115.921 -0.581 . . . . 0.0 113.175 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.429 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 3.2 m95 -100.04 151.14 21.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.153 0.501 . . . . 0.0 111.843 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.407 ' HB2' ' CD2' ' A' ' 187' ' ' TYR . 0.0 OUTLIER -66.56 -172.27 0.16 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.438 179.288 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -43.6 154.39 0.09 Allowed 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -57.07 -25.63 54.2 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.262 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -60.22 -37.66 80.99 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.984 0.421 . . . . 0.0 110.027 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.14 -40.51 45.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.039 179.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 6.2 mt -58.73 -41.42 82.4 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.051 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.24 -29.92 48.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.067 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -68.26 -53.0 27.63 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 121.387 0.613 . . . . 0.0 110.117 179.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.12 -46.3 88.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.036 178.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.445 HG22 ' HA2' ' A' ' 137' ' ' GLY . 0.2 OUTLIER -57.01 -36.78 70.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.549 179.231 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.75 -37.37 93.47 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 178.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -73.64 -45.78 50.71 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.315 -0.443 . . . . 0.0 111.077 179.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.429 HD12 ' CE1' ' A' ' 214' ' ' PHE . 11.0 mp -65.0 -29.69 70.62 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.828 0.347 . . . . 0.0 111.338 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.6 -16.99 63.5 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.365 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -114.23 -27.28 7.68 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.658 0.266 . . . . 0.0 111.633 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.05 167.17 1.18 Allowed Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.269 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -70.68 127.79 14.32 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.226 1.95 . . . . 0.0 112.938 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.04 -25.64 5.12 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.723 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.4 -50.17 73.86 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.968 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.41 ' CG1' ' CE ' ' A' ' 182' ' ' MET . 34.7 t -74.18 -33.5 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.49 179.446 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 11.4 tp -56.46 -36.88 69.55 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.096 0.474 . . . . 0.0 109.935 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -77.36 -41.65 20.49 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.284 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -84.32 103.0 13.13 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.896 0.379 . . . . 0.0 110.558 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' MET . . . . . 0.41 ' CE ' ' CG1' ' A' ' 178' ' ' VAL . 2.8 mtm 177.02 166.11 0.53 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.142 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 27.3 t -124.82 -53.99 1.64 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.732 0.301 . . . . 0.0 111.147 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -162.14 142.63 10.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.977 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.406 HD12 HG22 ' A' ' 185' ' ' ILE . 19.1 mt -104.89 115.44 46.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.472 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . 0.405 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 21.9 m170 -105.37 123.36 47.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.159 -179.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.407 ' CD2' ' HB2' ' A' ' 159' ' ' LYS . 14.0 t80 -78.82 104.35 9.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.438 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.406 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.584 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 . . . . . 0 CA--C 1.529 0.153 0 CA-C-O 120.617 0.246 . . . . 0.0 111.499 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 5.8 p30 -108.17 37.71 2.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.731 0.301 . . . . 0.0 110.819 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 9.5 ttt-85 -89.76 114.32 26.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.911 0.386 . . . . 0.0 111.2 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 25.1 m -111.61 167.85 5.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.9 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 22.7 mm -134.24 111.34 14.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.844 0.354 . . . . 0.0 110.974 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 6.7 m -100.31 120.15 49.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.21 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -81.88 152.46 26.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.661 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 7.6 mmt -105.6 157.89 17.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.99 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 39.5 m-20 -59.82 -27.03 66.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.142 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.02 13.27 13.33 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 89.1 -14.07 61.64 Favored Glycine 0 CA--C 1.52 0.397 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.247 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -58.13 156.03 10.24 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 117.133 0.467 . . . . 0.0 110.96 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -131.3 111.31 11.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.919 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 20.8 t -107.03 141.92 21.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.04 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 5.6 m -112.41 116.87 31.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.883 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -128.58 162.48 27.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.804 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.7 154.91 17.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.584 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 40.5 mt -67.3 -35.7 74.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.804 0.335 . . . . 0.0 110.96 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -38.4 91.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.24 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -128.09 40.64 3.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.914 0.388 . . . . 0.0 110.892 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.429 ' CE1' HD12 ' A' ' 171' ' ' LEU . 11.1 t80 -62.56 -54.35 41.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.768 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.1 -41.38 78.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.276 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.62 -46.58 68.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.075 0.464 . . . . 0.0 110.421 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.6 -44.75 77.29 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.883 179.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -83.31 -25.05 31.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.037 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 13.0 t -60.97 -33.14 72.76 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.062 0.458 . . . . 0.0 110.131 179.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 9.6 m170 . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.268 179.181 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 121.005 0.431 . . . . 0.0 111.047 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.404 ' HB2' ' HB3' ' A' ' 134' ' ' LEU . 80.6 m95 -68.42 168.3 12.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.237 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 11.4 ttt180 -102.49 137.66 40.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.348 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 24.8 mtt85 -72.91 106.48 4.84 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.861 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.401 ' CD1' HG23 ' A' ' 168' ' ' THR . 46.6 pt -95.61 -8.1 9.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.361 179.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -158.75 176.45 12.34 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 120.578 0.228 . . . . 0.0 110.708 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.465 ' CD1' ' CG ' ' A' ' 149' ' ' PRO . 29.8 m-85 -144.94 126.45 15.01 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 4.3 t -93.08 122.61 44.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.091 0.472 . . . . 0.0 111.267 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.472 ' CE1' ' CE1' ' A' ' 130' ' ' PHE . 9.3 t80 -83.96 100.01 10.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.842 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -151.76 151.8 31.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.601 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 60.0 30.88 20.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 63.4 32.41 14.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.2 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 87.8 m -152.89 149.02 27.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.828 0.347 . . . . 0.0 110.988 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.472 ' CE1' ' CE1' ' A' ' 125' ' ' TYR . 24.2 m-85 -93.69 91.0 6.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.713 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.448 ' CD1' ' HA ' ' A' ' 141' ' ' LYS . 24.7 m-85 -66.05 120.79 72.27 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.141 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.408 ' HA ' ' CD2' ' A' ' 123' ' ' TYR . 37.2 Cg_endo -68.12 115.5 3.86 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.045 1.83 . . . . 0.0 112.539 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.414 ' HG ' HG22 ' A' ' 168' ' ' THR . 34.1 tp -95.0 124.2 38.91 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.787 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.404 ' HB3' ' HB2' ' A' ' 118' ' ' TRP . 42.5 mt -69.89 175.47 4.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.5 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -66.52 -28.41 68.53 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.125 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 32.7 p-10 -90.47 13.21 16.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.235 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.436 ' HA2' HG22 ' A' ' 168' ' ' THR . . . 73.79 20.15 79.76 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.978 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -79.04 94.14 5.25 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.326 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.405 ' CD2' ' CB ' ' A' ' 131' ' ' PHE . 0.4 OUTLIER -70.45 116.37 10.7 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.652 -178.875 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.4 mp -90.35 76.25 6.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.343 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.448 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 4.5 mttt -61.46 -15.46 37.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.241 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -94.38 -24.11 17.5 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -99.81 26.82 5.91 Favored 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -62.95 163.66 29.13 Favored Glycine 0 CA--C 1.51 -0.222 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.885 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 7.1 t -130.79 158.2 40.8 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.877 0.37 . . . . 0.0 110.712 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -94.42 49.32 1.27 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.513 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.3 154.64 4.0 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.609 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.451 ' CB ' ' CE2' ' A' ' 130' ' ' PHE . . . -97.64 125.53 44.43 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.24 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.465 ' CG ' ' CD1' ' A' ' 123' ' ' TYR . 73.7 Cg_endo -83.06 111.9 1.96 Allowed 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.4 2.066 . . . . 0.0 112.573 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 11.0 t -69.48 -8.14 44.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.175 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -77.11 -23.54 51.81 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 120.88 0.372 . . . . 0.0 110.507 179.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -138.97 166.92 21.43 Favored Pre-proline 0 N--CA 1.452 -0.336 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.669 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -74.83 154.33 43.32 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.401 2.067 . . . . 0.0 112.308 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 10.6 t -116.04 110.48 31.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.93 0.395 . . . . 0.0 111.293 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.429 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.36 95.94 1.81 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.552 179.025 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.406 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 60.1 t -91.98 136.12 25.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.946 0.403 . . . . 0.0 111.116 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 48.83 58.75 7.34 Favored Glycine 0 CA--C 1.521 0.468 0 CA-C-N 115.837 -0.619 . . . . 0.0 113.189 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.429 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 3.1 m95 -101.31 151.17 22.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.198 0.523 . . . . 0.0 111.834 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.42 -172.24 0.15 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.412 179.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -42.92 154.49 0.07 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -57.51 -25.84 55.86 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.157 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.97 -38.85 80.05 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.967 0.413 . . . . 0.0 109.943 179.191 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.64 -39.98 50.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.009 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 5.8 mt -59.28 -41.39 83.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.903 178.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.9 -31.06 48.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.129 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -67.8 -53.02 30.37 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.386 0.613 . . . . 0.0 110.138 179.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.24 -44.56 92.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.01 179.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.436 HG22 ' HA2' ' A' ' 137' ' ' GLY . 0.2 OUTLIER -58.42 -37.55 75.61 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.545 179.106 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.89 -36.86 91.48 Favored Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 178.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -73.83 -46.33 45.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.342 -0.429 . . . . 0.0 111.008 178.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.422 HD11 ' CE1' ' A' ' 214' ' ' PHE . 11.3 mp -66.22 -28.01 68.41 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.683 0.278 . . . . 0.0 111.349 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.87 -17.22 62.73 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.682 -0.236 . . . . 0.0 111.291 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -112.62 -29.85 7.31 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.653 0.263 . . . . 0.0 111.345 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.44 167.32 0.76 Allowed Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.216 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -69.63 128.78 16.63 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.208 1.939 . . . . 0.0 112.921 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.28 -25.63 9.95 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.535 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -58.82 -48.59 80.78 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.894 0.378 . . . . 0.0 110.927 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.409 ' CG1' ' CE ' ' A' ' 182' ' ' MET . 23.0 t -73.51 -35.69 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.649 179.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.8 tp -55.85 -34.31 65.33 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.128 0.49 . . . . 0.0 110.075 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -78.77 -41.9 14.25 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.295 178.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -84.99 102.86 13.52 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.884 0.373 . . . . 0.0 110.632 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' MET . . . . . 0.409 ' CE ' ' CG1' ' A' ' 178' ' ' VAL . 2.8 mtm 177.22 161.81 0.47 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.146 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 12.3 t -117.18 -57.63 2.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.749 0.309 . . . . 0.0 110.908 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -160.91 142.31 11.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.001 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.409 HD11 HG22 ' A' ' 185' ' ' ILE . 16.3 mt -102.1 114.51 41.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.316 179.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . 0.406 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 21.6 m170 -104.34 122.58 45.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.237 -179.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -74.5 104.25 5.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.275 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 11.8 mmtt . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.692 -179.748 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.623 0.249 . . . . 0.0 111.484 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -107.01 36.52 2.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.75 0.31 . . . . 0.0 110.976 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 6.4 ttt85 -89.58 115.03 26.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.979 0.419 . . . . 0.0 111.15 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 27.2 m -111.67 166.68 5.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.729 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 22.7 mm -133.52 108.9 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.821 0.343 . . . . 0.0 111.222 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.414 HG12 ' CE2' ' A' ' 214' ' ' PHE . 9.1 m -99.08 122.65 51.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.088 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -85.14 152.48 23.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.761 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 4.7 mmt -104.97 158.88 16.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.017 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -63.22 -26.64 68.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.13 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -87.09 11.16 14.5 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 83.65 14.51 73.06 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.539 -0.838 . . . . 0.0 113.281 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -82.14 166.83 19.33 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 117.073 0.437 . . . . 0.0 110.845 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -133.72 111.67 10.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.879 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.4 t -114.63 125.26 71.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.131 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 2.0 p -101.18 116.1 32.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.76 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -126.87 159.89 32.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.872 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.47 152.52 19.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.687 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 35.2 mt -64.37 -38.29 82.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.95 0.405 . . . . 0.0 110.642 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 2.2 ptt85 -60.01 -34.61 73.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.205 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -134.77 45.5 2.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.933 0.397 . . . . 0.0 111.034 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.422 ' CE1' HD11 ' A' ' 171' ' ' LEU . 10.9 t80 -67.75 -53.9 23.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.712 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.2 -39.81 76.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.264 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.99 -48.84 62.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.101 0.477 . . . . 0.0 110.284 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.27 -42.51 66.59 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.14 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.407 ' HB3' ' CG1' ' A' ' 178' ' ' VAL . 3.9 mm? -86.95 -23.48 25.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.042 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 11.2 t -60.99 -33.15 72.79 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.901 0.381 . . . . 0.0 110.22 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 30.2 m170 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.204 179.394 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 121.066 0.46 . . . . 0.0 110.997 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 78.8 m95 -67.3 168.09 11.18 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.06 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? -103.05 138.77 39.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.287 179.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.26 105.73 4.79 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 120.822 0.344 . . . . 0.0 110.669 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.409 ' CD1' ' HA ' ' A' ' 135' ' ' GLU . 46.6 pt -95.04 -7.55 9.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.501 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -160.15 176.36 11.86 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 120.766 0.317 . . . . 0.0 110.946 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.463 ' CD1' ' CG ' ' A' ' 149' ' ' PRO . 35.7 m-85 -144.98 126.93 15.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.821 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 6.1 t -93.21 122.91 45.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.155 0.503 . . . . 0.0 111.587 -179.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.437 ' CE1' ' CE1' ' A' ' 130' ' ' PHE . 34.7 t80 -83.11 94.38 7.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.916 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -144.76 152.97 41.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.437 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.86 30.32 19.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.812 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 62.13 34.25 16.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.934 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 58.5 m -151.04 161.93 41.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.993 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.45 ' CE2' ' CB ' ' A' ' 148' ' ' ALA . 16.8 m-85 -104.61 91.14 3.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.256 0.551 . . . . 0.0 110.897 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.447 ' CG ' ' HA ' ' A' ' 141' ' ' LYS . 23.8 m-85 -69.62 121.55 82.81 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.547 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.405 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 21.1 Cg_exo -65.2 122.16 9.82 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 122.374 2.05 . . . . 0.0 112.549 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.428 ' HG ' HG23 ' A' ' 168' ' ' THR . 31.0 tp -104.12 123.48 47.34 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.296 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.417 ' CD1' ' HB3' ' A' ' 138' ' ' ARG . 53.6 mt -71.58 174.92 6.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.582 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.409 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.3 pt-20 -64.93 -29.06 69.97 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.915 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 14.9 p-10 -91.17 13.66 16.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.152 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.438 ' HA2' HG23 ' A' ' 168' ' ' THR . . . 74.95 22.52 76.7 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.059 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.417 ' HB3' ' CD1' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -76.0 92.76 3.18 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.412 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.64 119.86 15.41 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.023 0.439 . . . . 0.0 111.607 -179.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -92.24 72.91 5.38 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.711 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.447 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 0.4 OUTLIER -61.05 -16.84 48.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.012 -179.753 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -95.52 -20.0 19.37 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -102.23 25.7 8.57 Favored 'General case' 0 N--CA 1.461 0.111 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.405 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -58.43 162.6 10.29 Favored Glycine 0 CA--C 1.509 -0.337 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.708 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 11.1 t -136.33 150.83 49.04 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.767 0.317 . . . . 0.0 110.67 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 3.9 mmtt -88.99 52.19 2.35 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.005 0.431 . . . . 0.0 110.705 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.23 149.46 2.81 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.658 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.45 ' CB ' ' CE2' ' A' ' 130' ' ' PHE . . . -94.6 125.66 50.7 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.324 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.463 ' CG ' ' CD1' ' A' ' 123' ' ' TYR . 75.2 Cg_endo -84.24 111.26 1.58 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.49 2.126 . . . . 0.0 112.638 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.3 t -69.91 -7.53 41.16 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.035 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -77.09 -23.2 51.9 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 120.806 0.336 . . . . 0.0 110.58 179.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.47 167.11 18.96 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.944 -179.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -74.48 154.33 45.1 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.351 2.034 . . . . 0.0 112.133 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.421 HG11 ' CE2' ' A' ' 130' ' ' PHE . 14.3 t -115.47 111.12 34.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.019 0.437 . . . . 0.0 111.286 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.428 HD21 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.36 96.11 1.83 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.747 179.052 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.427 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 62.6 t -92.74 135.78 26.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.901 0.382 . . . . 0.0 110.936 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 48.77 58.28 7.75 Favored Glycine 0 CA--C 1.521 0.443 0 CA-C-N 115.963 -0.562 . . . . 0.0 113.209 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.428 ' CE2' HD21 ' A' ' 155' ' ' LEU . 3.0 m95 -101.13 151.3 22.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.206 0.526 . . . . 0.0 111.787 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -65.49 -173.34 0.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.319 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -43.81 154.88 0.09 Allowed 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -57.26 -25.13 53.86 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.134 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -59.95 -38.52 82.69 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.921 0.391 . . . . 0.0 110.107 179.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.89 -41.02 45.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.056 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 6.1 mt -58.08 -41.89 81.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.016 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.87 -30.54 46.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.228 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -68.74 -53.02 24.48 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 121.548 0.689 . . . . 0.0 110.026 179.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.11 -42.94 95.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.947 178.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.438 HG23 ' HA2' ' A' ' 137' ' ' GLY . 0.3 OUTLIER -59.51 -37.01 77.16 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.296 179.22 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.17 -39.52 94.59 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 110.556 -1.017 . . . . 0.0 110.556 178.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 48.1 mm-40 -69.72 -45.73 67.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.427 -0.387 . . . . 0.0 110.782 178.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.423 HD13 ' CE1' ' A' ' 214' ' ' PHE . 11.0 mp -66.58 -26.94 67.35 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.695 0.284 . . . . 0.0 111.462 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.98 -19.12 62.57 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.223 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -112.63 -26.67 8.52 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.573 0.225 . . . . 0.0 111.505 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.55 167.4 1.34 Allowed Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.089 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -70.66 127.9 14.48 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.201 1.934 . . . . 0.0 112.943 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.08 -25.28 8.34 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.597 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.44 -49.33 76.6 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.856 0.36 . . . . 0.0 110.944 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.408 ' CG1' ' CE ' ' A' ' 182' ' ' MET . 39.9 t -74.24 -36.11 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.451 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 12.7 tp -55.13 -37.01 66.37 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.09 0.472 . . . . 0.0 110.11 179.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -78.39 -39.09 23.44 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.393 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -87.29 103.04 15.08 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.9 0.381 . . . . 0.0 110.73 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' MET . . . . . 0.408 ' CE ' ' CG1' ' A' ' 178' ' ' VAL . 2.8 mtm 178.05 176.61 0.44 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.053 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 9.1 t -132.07 -54.77 0.98 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.783 0.325 . . . . 0.0 111.129 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -162.17 142.52 10.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.021 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.401 HD11 HG22 ' A' ' 185' ' ' ILE . 19.7 mt -104.76 114.69 45.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.34 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . 0.427 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 20.0 m170 -106.21 126.28 52.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.079 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -77.39 104.83 8.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.517 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 11.8 mmtp . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.351 179.733 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 . . . . . 0 CA--C 1.53 0.197 0 CA-C-O 120.571 0.224 . . . . 0.0 111.376 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -104.11 35.88 2.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.749 0.309 . . . . 0.0 110.881 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -89.95 113.15 24.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.044 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 19.7 m -109.8 168.31 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.88 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 22.8 mm -135.14 110.54 12.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.708 0.29 . . . . 0.0 111.242 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.418 HG12 ' CE2' ' A' ' 214' ' ' PHE . 10.6 m -99.09 133.97 39.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.963 0.411 . . . . 0.0 110.878 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -95.98 152.5 18.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.765 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 25.2 tpp -112.28 150.61 30.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.745 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 21.1 p30 -57.47 -28.93 63.81 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.28 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -72.69 -8.78 57.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.768 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 96.73 14.55 43.07 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 120.473 -0.87 . . . . 0.0 113.1 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -90.82 162.55 14.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 117.026 0.413 . . . . 0.0 111.018 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -126.85 111.26 13.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.809 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 20.6 t -109.36 137.52 41.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.067 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 10.7 p -109.58 118.66 37.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.967 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -127.07 172.54 10.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.679 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.33 154.5 27.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.609 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 31.9 mt -66.01 -35.45 75.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.812 0.339 . . . . 0.0 110.938 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.7 -35.63 81.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.194 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -134.83 47.53 2.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.016 0.436 . . . . 0.0 111.005 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.423 ' CE1' HD13 ' A' ' 171' ' ' LEU . 10.5 t80 -69.35 -50.81 42.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.613 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.97 -42.22 84.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.256 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -67.37 -47.68 69.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.986 0.422 . . . . 0.0 110.397 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.9 -45.34 74.69 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.09 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -82.12 -26.25 33.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.979 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 13.5 t -60.38 -32.46 71.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.002 0.429 . . . . 0.0 110.217 179.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.9 m170 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.118 179.255 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 121.107 0.479 . . . . 0.0 110.935 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.412 ' HB2' ' HB3' ' A' ' 134' ' ' LEU . 79.5 m95 -67.11 168.27 10.5 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.068 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -102.79 135.41 44.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.466 179.449 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 15.0 mtt180 -71.42 105.49 3.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.743 -179.906 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 45.3 pt -93.53 -8.31 10.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.503 179.455 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -159.16 176.53 12.12 Favored 'General case' 0 C--O 1.226 -0.178 0 C-N-CA 121.037 -0.265 . . . . 0.0 111.0 179.885 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.444 ' O ' ' HA ' ' A' ' 154' ' ' VAL . 32.3 m-85 -143.28 126.8 16.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.455 179.78 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 4.5 t -93.47 123.01 45.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.05 0.453 . . . . 0.0 111.133 -179.607 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.428 ' CD1' ' CE1' ' A' ' 130' ' ' PHE . 37.3 t80 -80.19 103.02 9.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.748 -179.889 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -159.18 155.44 27.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.559 -179.808 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.19 31.61 19.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.849 -179.851 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 60.41 31.38 20.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.0 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 86.3 m -154.05 161.87 41.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.846 179.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.428 ' CE1' ' CD1' ' A' ' 125' ' ' TYR . 8.9 m-85 -100.65 90.4 4.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.669 179.625 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.459 ' HA ' ' HA2' ' A' ' 144' ' ' GLY . 22.3 m-85 -65.41 125.44 89.52 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.811 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.41 ' HB3' ' CE2' ' A' ' 123' ' ' TYR . 60.9 Cg_endo -73.66 120.17 6.3 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.219 1.946 . . . . 0.0 112.372 -179.773 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.42 ' HG ' HG21 ' A' ' 168' ' ' THR . 27.4 tp -98.04 123.58 42.13 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.489 179.636 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.412 ' HB3' ' HB2' ' A' ' 118' ' ' TRP . 37.0 mt -69.63 172.68 7.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.464 -179.747 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -63.81 -28.32 69.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.998 179.706 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 50.5 p-10 -90.59 13.43 15.93 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.281 179.781 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.438 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 73.1 22.36 79.07 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.227 179.797 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.01 94.44 6.56 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.519 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.42 112.49 9.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.362 -179.04 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 34.3 mt -88.84 81.25 6.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.405 179.418 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.443 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 9.6 mtpt -71.13 -5.61 33.03 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -179.388 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -90.41 -27.14 19.51 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.635 0.255 . . . . 0.0 111.183 179.885 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -85.81 -79.98 0.23 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.76 0.314 . . . . 0.0 111.322 -179.707 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . 57.83 161.13 0.04 OUTLIER Glycine 0 CA--C 1.506 -0.514 0 CA-C-N 116.29 -0.413 . . . . 0.0 112.708 -179.572 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.9 t -140.07 148.67 42.11 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.357 -0.422 . . . . 0.0 110.842 -179.548 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 4.0 mmtt -89.85 52.56 2.32 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.381 179.807 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.98 154.48 4.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.093 0.473 . . . . 0.0 110.613 -179.358 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.33 135.41 34.63 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.597 -179.493 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.436 ' HG3' ' CD1' ' A' ' 123' ' ' TYR . 67.1 Cg_endo -83.81 98.73 0.79 Allowed 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 122.993 2.462 . . . . 0.0 112.535 179.689 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 43.9 t -67.23 -9.57 41.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.786 179.468 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -90.15 -22.2 21.85 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 120.615 0.245 . . . . 0.0 111.572 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -138.9 167.75 18.16 Favored Pre-proline 0 C--N 1.329 -0.287 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -178.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -74.22 163.97 35.29 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 122.469 2.113 . . . . 0.0 112.511 -179.863 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 20.1 t -123.73 109.05 22.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.517 -179.755 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.426 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 1.1 mp -72.8 95.97 1.99 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.694 179.107 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 53.5 t -92.57 136.46 24.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.983 0.421 . . . . 0.0 111.231 -179.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 49.21 49.17 31.55 Favored Glycine 0 CA--C 1.519 0.299 0 CA-C-N 115.783 -0.644 . . . . 0.0 113.381 179.16 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.426 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 2.7 m95 -92.2 151.1 20.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.102 0.477 . . . . 0.0 111.371 -179.622 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -172.55 0.08 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.539 179.542 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -43.99 154.34 0.11 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.088 -0.506 . . . . 0.0 112.21 -179.846 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -57.41 -24.75 53.19 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.147 179.448 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.8 -39.23 84.31 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-O 120.959 0.409 . . . . 0.0 110.137 179.219 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.65 -40.84 47.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.054 178.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 6.2 mt -58.13 -41.68 81.28 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.093 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.991 179.104 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.21 -28.69 28.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.151 179.494 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -69.15 -53.23 21.19 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-O 121.474 0.654 . . . . 0.0 110.172 179.348 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.84 -45.11 93.45 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.11 179.051 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.438 HG21 ' HA2' ' A' ' 137' ' ' GLY . 0.2 OUTLIER -56.84 -38.82 73.19 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.592 179.344 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.14 -37.73 92.12 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 178.26 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -72.03 -46.47 56.97 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.375 -0.412 . . . . 0.0 111.073 178.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.422 HD13 ' CZ ' ' A' ' 214' ' ' PHE . 10.9 mp -65.88 -28.73 69.17 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.724 0.297 . . . . 0.0 111.414 179.785 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.82 -18.12 63.43 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.363 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -113.8 -26.79 8.03 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 111.661 0.245 . . . . 0.0 111.661 -179.73 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.32 167.27 1.28 Allowed Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 116.682 -0.236 . . . . 0.0 111.22 -179.561 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -67.68 126.32 14.56 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.215 1.943 . . . . 0.0 112.796 179.74 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.92 -26.07 9.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.676 179.805 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -58.5 -48.83 79.52 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.873 0.368 . . . . 0.0 110.891 179.683 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.403 ' CG1' ' CE ' ' A' ' 182' ' ' MET . 25.3 t -73.7 -33.7 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.531 179.515 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 11.4 tp -56.87 -35.78 69.3 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.135 0.493 . . . . 0.0 109.816 178.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -77.05 -42.39 19.83 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.276 178.74 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -84.13 103.02 13.0 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.829 0.347 . . . . 0.0 110.656 179.232 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 182' ' ' MET . . . . . 0.403 ' CE ' ' CG1' ' A' ' 178' ' ' VAL . 2.9 mtm 178.85 159.76 0.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.123 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -118.36 -54.53 2.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.814 0.34 . . . . 0.0 111.122 -179.743 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -162.66 142.63 9.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.999 -179.834 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 17.7 mt -105.23 115.04 46.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.422 179.4 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 23.2 m170 -105.69 129.37 53.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.164 -179.499 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -82.2 104.54 12.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.521 179.663 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.65 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.529 0.149 0 CA-C-O 120.861 0.362 . . . . 0.0 111.101 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -99.86 34.03 2.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.612 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.48 111.64 22.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.422 -179.491 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 33.3 m -107.78 169.46 2.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.495 179.384 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 15.1 mm -136.03 109.67 9.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.785 0.326 . . . . 0.0 111.2 179.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 9.9 m -97.85 120.9 47.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.081 179.727 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -81.76 152.65 26.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.788 -179.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 4.6 mmt -109.44 146.93 33.7 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.604 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -58.13 -29.07 65.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.073 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -78.21 -2.17 36.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.836 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 95.3 14.49 47.91 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 120.478 -0.867 . . . . 0.0 113.142 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -89.51 157.14 18.21 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.972 0.386 . . . . 0.0 111.04 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -125.84 111.54 14.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.724 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 22.8 t -110.77 139.59 33.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.139 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 14.5 m -110.36 118.33 36.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.737 179.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -128.42 164.57 22.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.888 0.375 . . . . 0.0 111.067 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.67 155.38 18.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.507 179.842 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 25.7 mt -62.91 -27.48 43.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.008 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . 0.403 ' CZ ' ' HB3' ' A' ' 212' ' ' ARG . 0.0 OUTLIER -82.48 -41.9 19.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.742 0.306 . . . . 0.0 111.009 179.877 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -108.78 32.12 5.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.121 -179.931 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.422 ' CZ ' HD13 ' A' ' 171' ' ' LEU . 11.3 t80 -64.25 -54.59 30.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.94 0.4 . . . . 0.0 110.284 179.737 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.71 -38.36 90.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.611 179.685 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -68.32 -51.95 39.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.436 179.53 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 1.8 mmmm -54.33 -43.02 70.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.951 179.819 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -82.32 -24.96 34.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.769 179.3 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 10.2 t -61.75 -31.74 71.94 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.851 0.357 . . . . 0.0 110.191 179.26 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.068 179.596 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 121.176 0.512 . . . . 0.0 111.103 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.405 ' HB2' ' HB3' ' A' ' 134' ' ' LEU . 78.8 m95 -72.21 168.2 18.75 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.955 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -102.75 136.1 43.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.542 179.559 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 73.4 mtt180 -71.69 105.87 3.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.833 0.349 . . . . 0.0 110.669 -179.875 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 45.9 pt -94.06 -8.82 9.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.472 179.31 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -158.62 176.36 12.49 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 120.629 0.252 . . . . 0.0 110.76 179.926 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.438 ' CD1' ' HG3' ' A' ' 149' ' ' PRO . 32.2 m-85 -143.07 127.0 17.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.378 179.771 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 5.3 t -93.51 122.79 45.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.32 -179.464 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.432 ' CD1' ' CE1' ' A' ' 130' ' ' PHE . 42.4 t80 -80.67 107.1 13.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.844 -179.943 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -163.47 154.24 16.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.521 -179.866 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.54 30.59 19.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.865 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 61.82 32.28 18.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.15 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 73.3 m -154.98 155.29 33.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.036 179.841 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.432 ' CE1' ' CD1' ' A' ' 125' ' ' TYR . 7.0 m-85 -96.26 91.11 5.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.463 179.567 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.426 ' CD1' ' HA ' ' A' ' 141' ' ' LYS . 24.2 m-85 -65.52 123.98 85.98 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.964 -179.626 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.419 ' HA ' ' CD2' ' A' ' 123' ' ' TYR . 55.4 Cg_endo -71.53 114.62 4.0 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 122.171 1.914 . . . . 0.0 112.743 -179.552 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.417 ' HG ' HG22 ' A' ' 168' ' ' THR . 29.0 tp -93.36 123.83 36.93 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.632 179.453 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.405 ' HB3' ' HB2' ' A' ' 118' ' ' TRP . 45.0 mt -69.51 173.66 5.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.47 -179.851 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -64.71 -28.35 69.53 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.118 179.751 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 42.7 p-10 -90.33 12.58 17.85 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.301 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.432 ' HA2' HG22 ' A' ' 168' ' ' THR . . . 74.08 22.74 77.48 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.987 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 15.1 tpp85 -82.14 93.42 7.04 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.539 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.51 108.76 3.92 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.155 -179.212 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 15.8 mt -85.53 72.03 10.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.821 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.426 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 19.7 mttt -57.96 -20.85 40.97 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.45 179.873 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -94.09 19.74 8.82 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.42 179.578 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -144.49 25.32 1.51 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.655 0.264 . . . . 0.0 111.151 179.781 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.98 166.69 7.59 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.88 -179.683 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 10.2 t -132.41 150.44 52.16 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.873 0.368 . . . . 0.0 110.751 -179.878 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.02 52.1 2.08 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.436 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.72 158.47 6.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.094 0.473 . . . . 0.0 110.678 -179.399 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -91.2 136.13 27.55 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.61 -179.504 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.438 ' HG3' ' CD1' ' A' ' 123' ' ' TYR . 62.9 Cg_endo -84.09 98.57 0.76 Allowed 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.11 2.54 . . . . 0.0 112.621 179.78 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 4.9 t -67.36 -9.66 43.51 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.713 179.363 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -90.21 -21.8 21.98 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -138.78 167.09 20.7 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.019 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.76 163.55 36.91 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 122.5 2.134 . . . . 0.0 112.382 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 25.2 t -124.09 109.89 24.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.051 0.453 . . . . 0.0 111.591 -179.798 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.431 HD22 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.6 96.18 1.94 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.836 179.228 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.419 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 57.4 t -92.33 137.31 22.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.055 -179.928 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 47.5 56.96 7.76 Favored Glycine 0 CA--C 1.52 0.393 0 CA-C-N 115.855 -0.611 . . . . 0.0 113.231 179.371 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.431 ' CE2' HD22 ' A' ' 155' ' ' LEU . 2.9 m95 -99.44 151.16 21.42 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.185 0.516 . . . . 0.0 111.756 -179.386 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.66 -172.1 0.16 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.509 179.377 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -42.58 154.29 0.06 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.68 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -57.15 -24.68 52.04 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.232 179.491 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.05 -40.54 89.8 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-O 120.975 0.417 . . . . 0.0 110.041 179.193 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -74.25 -40.66 62.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.935 178.88 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 6.1 mt -58.92 -41.06 81.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.931 178.885 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.73 -31.0 57.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.25 179.881 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -67.63 -52.97 31.95 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-O 121.434 0.635 . . . . 0.0 110.245 179.571 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.45 -44.28 92.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.175 179.151 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.432 HG22 ' HA2' ' A' ' 137' ' ' GLY . 0.2 OUTLIER -58.85 -38.16 78.11 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.534 179.271 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.37 -37.35 91.84 Favored Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 178.493 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 40.8 mm-40 -73.4 -45.71 53.06 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.403 -0.399 . . . . 0.0 111.199 179.035 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.415 HD11 ' CE1' ' A' ' 214' ' ' PHE . 11.0 mp -65.8 -29.55 70.05 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.688 0.28 . . . . 0.0 111.295 179.836 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.4 -19.98 64.64 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.335 -179.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -111.61 -26.75 8.87 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.613 0.244 . . . . 0.0 111.511 -179.834 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.72 166.53 1.29 Allowed Pre-proline 0 CA--C 1.538 0.516 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.06 -179.665 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -69.7 128.07 15.55 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.269 1.979 . . . . 0.0 112.692 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.97 -25.9 5.29 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.676 179.802 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.76 -50.06 74.51 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.844 0.354 . . . . 0.0 111.037 179.701 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.405 ' CG1' ' CE ' ' A' ' 182' ' ' MET . 30.1 t -74.11 -35.61 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.582 179.638 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.98 -34.35 68.01 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.108 0.48 . . . . 0.0 109.772 179.002 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -78.48 -38.86 23.73 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 178.578 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -88.35 103.17 15.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.947 0.403 . . . . 0.0 110.774 179.229 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 182' ' ' MET . . . . . 0.405 ' CE ' ' CG1' ' A' ' 178' ' ' VAL . 2.9 mtm 178.73 166.72 0.88 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.987 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.4 t -127.04 -51.48 1.43 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.706 0.289 . . . . 0.0 111.51 -179.613 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -163.06 142.83 8.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.934 0.397 . . . . 0.0 111.082 -179.668 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 19.0 mt -108.7 115.14 48.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.54 179.516 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . 0.419 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 22.2 m170 -106.14 123.4 47.95 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.952 -179.684 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -76.35 105.38 7.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.617 179.75 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.643 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 CA--C 1.529 0.168 0 N-CA-C 111.641 0.237 . . . . 0.0 111.641 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -110.3 37.45 2.72 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.624 0.249 . . . . 0.0 111.07 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.19 117.34 28.87 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.04 0.448 . . . . 0.0 111.255 -179.795 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 31.7 m -112.73 169.84 4.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.73 179.655 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 22.7 mm -134.61 111.12 13.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.774 0.321 . . . . 0.0 111.356 179.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.406 HG12 ' CZ ' ' A' ' 214' ' ' PHE . 10.7 m -100.23 133.58 42.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.877 179.601 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -95.11 152.51 18.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.799 179.954 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 6.5 mmt -105.12 166.74 10.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.937 0.398 . . . . 0.0 111.051 -179.904 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 19.5 p30 -69.37 -26.39 64.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.195 179.884 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -88.48 12.57 14.04 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -179.856 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 83.05 14.34 75.16 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.554 -0.831 . . . . 0.0 113.311 179.718 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -82.98 150.94 26.08 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 117.127 0.463 . . . . 0.0 110.626 179.886 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -121.75 111.43 17.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.889 -179.922 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.6 t -113.03 140.24 34.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.142 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 26.6 t -113.69 119.43 37.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.783 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -130.21 159.29 37.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.857 179.803 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -92.36 156.56 17.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.68 179.747 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.409 HG23 HD11 ' A' ' 211' ' ' ILE . 33.9 mt -70.41 -34.82 59.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.764 0.316 . . . . 0.0 110.749 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.5 -30.89 70.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.215 -179.467 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -130.62 35.85 3.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.898 179.984 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.415 ' CE1' HD11 ' A' ' 171' ' ' LEU . 11.8 t80 -63.08 -52.7 61.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.801 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.43 -40.22 86.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.062 -179.918 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.21 -49.77 58.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.077 0.465 . . . . 0.0 110.439 179.589 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.23 -43.79 71.16 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.027 179.701 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -82.7 -26.32 32.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.97 179.517 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 12.2 t -60.81 -31.61 71.01 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.996 0.427 . . . . 0.0 110.386 179.463 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.27 179.532 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 121.101 0.477 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.41 ' HB2' ' HB3' ' A' ' 134' ' ' LEU . 81.0 m95 -65.71 168.35 7.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.142 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -102.25 135.23 44.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.53 179.536 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 6.6 mtm-85 -71.29 105.28 3.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.673 -179.923 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.404 ' CD1' HG22 ' A' ' 168' ' ' THR . 46.7 pt -94.19 -6.7 10.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.654 179.518 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -161.14 176.71 11.0 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 121.002 -0.279 . . . . 0.0 111.065 179.823 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.447 ' CD1' ' HG3' ' A' ' 149' ' ' PRO . 32.5 m-85 -143.35 127.19 17.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.19 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 5.1 t -93.26 122.81 45.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.041 0.448 . . . . 0.0 111.344 -179.386 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -80.43 109.48 14.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.712 -179.945 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.401 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 4.9 t70 -164.77 148.93 9.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.538 -179.788 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.68 31.69 18.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.895 -179.659 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 61.43 30.27 18.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.972 -179.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 84.7 m -151.09 149.73 29.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.801 179.861 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -94.2 91.75 6.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.53 179.65 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.444 ' CG ' ' HA ' ' A' ' 141' ' ' LYS . 20.6 m-85 -64.82 117.0 34.28 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.289 -179.41 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.416 ' HA ' ' CD2' ' A' ' 123' ' ' TYR . 27.8 Cg_endo -64.12 119.03 5.96 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.172 1.915 . . . . 0.0 112.435 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.414 ' HG ' HG21 ' A' ' 168' ' ' THR . 38.3 tp -99.79 124.18 44.8 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.802 179.672 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.41 ' HB3' ' HB2' ' A' ' 118' ' ' TRP . 41.3 mt -70.5 173.39 7.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.647 -179.827 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -64.59 -28.46 69.65 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.03 179.604 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -90.17 12.78 16.92 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.213 179.61 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.438 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 72.5 23.8 77.32 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.755 -0.736 . . . . 0.0 113.048 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.76 96.88 7.71 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.385 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.412 ' CD2' ' CB ' ' A' ' 131' ' ' PHE . 0.4 OUTLIER -72.48 121.26 19.31 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.664 -178.93 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -98.39 72.24 2.08 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.678 179.385 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.444 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 21.6 mttt -57.83 -20.16 33.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.69 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -88.24 -24.43 23.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.564 -180.0 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -102.07 25.61 8.58 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.846 0.314 . . . . 0.0 111.846 -179.566 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.95 164.91 8.92 Favored Glycine 0 CA--C 1.509 -0.292 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.757 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 9.0 t -130.03 155.29 46.37 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.073 0.463 . . . . 0.0 110.907 179.969 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -97.1 54.24 1.23 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.433 -179.703 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.69 170.95 6.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.265 -179.294 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -103.87 138.19 19.46 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.776 -179.355 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.447 ' HG3' ' CD1' ' A' ' 123' ' ' TYR . 58.8 Cg_endo -84.9 100.27 0.73 Allowed 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.219 2.613 . . . . 0.0 112.645 179.799 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 18.1 t -65.82 -11.21 44.54 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.72 179.334 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.93 -21.77 20.4 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.783 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -136.7 166.4 27.79 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -178.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -75.15 164.57 32.83 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.487 2.125 . . . . 0.0 112.335 179.924 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 20.1 t -122.61 108.87 22.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.95 0.405 . . . . 0.0 111.677 -179.763 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.445 HD23 ' CD2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.52 95.99 1.88 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.728 179.065 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 50.3 t -92.78 137.65 21.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.918 0.389 . . . . 0.0 111.181 -179.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 47.78 57.61 7.51 Favored Glycine 0 CA--C 1.521 0.431 0 CA-C-N 115.987 -0.551 . . . . 0.0 113.27 179.363 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.445 ' CD2' HD23 ' A' ' 155' ' ' LEU . 3.1 m95 -100.11 151.27 21.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.167 0.508 . . . . 0.0 111.705 -179.452 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -66.51 -172.39 0.16 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.569 179.276 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -43.08 154.17 0.08 Allowed 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -179.75 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -57.0 -24.76 51.82 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.239 179.477 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.15 -39.55 86.76 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.959 0.409 . . . . 0.0 110.066 179.199 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -75.86 -40.97 53.63 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.108 178.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 6.2 mt -58.55 -42.34 84.38 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.884 179.048 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.65 -25.93 20.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.477 179.648 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -71.49 -54.38 10.76 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.056 0.455 . . . . 0.0 110.854 -179.901 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -37.33 85.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.244 179.547 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.438 HG21 ' HA2' ' A' ' 137' ' ' GLY . 0.2 OUTLIER -60.51 -38.3 83.9 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.909 179.027 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -61.3 -36.06 91.88 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 177.62 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 55.3 mm-40 -70.65 -48.94 52.32 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.118 -0.541 . . . . 0.0 110.6 178.478 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.42 HD12 ' CE1' ' A' ' 214' ' ' PHE . 10.8 mp -65.06 -27.86 69.08 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.396 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.67 -18.46 62.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.373 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -112.19 -28.66 7.87 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 120.658 0.266 . . . . 0.0 111.519 -179.706 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.61 167.2 1.43 Allowed Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.041 -179.612 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -70.34 129.19 16.58 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.248 1.965 . . . . 0.0 112.893 179.946 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.33 -25.34 9.38 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.65 179.667 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.97 -48.63 79.41 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.944 0.402 . . . . 0.0 110.869 179.664 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.407 ' CG1' ' CE ' ' A' ' 182' ' ' MET . 39.3 t -74.12 -35.53 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.424 179.399 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 8.7 tp -56.8 -36.26 69.69 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.118 0.485 . . . . 0.0 109.949 179.019 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -76.67 -39.96 28.06 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.328 178.759 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -88.09 103.14 15.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.906 0.384 . . . . 0.0 110.669 179.268 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 182' ' ' MET . . . . . 0.407 ' CE ' ' CG1' ' A' ' 178' ' ' VAL . 3.0 mtm 179.42 162.34 0.86 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.194 179.992 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.42 -56.22 2.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.742 0.306 . . . . 0.0 111.038 -179.838 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -163.11 142.69 8.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.832 -179.945 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 14.3 mt -103.11 115.15 44.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.539 179.484 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 24.2 m170 -104.19 127.32 51.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.03 -179.548 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -82.52 104.66 12.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.576 179.719 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.714 -179.929 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 . . . . . 0 CA--C 1.529 0.15 0 CA-C-O 120.664 0.269 . . . . 0.0 111.427 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.68 40.87 1.8 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.017 0.437 . . . . 0.0 110.295 179.748 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 2.1 tpm_? -87.68 112.86 22.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.857 -179.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 31.9 m -108.23 168.23 3.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.027 179.941 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 19.3 mm -134.4 108.45 10.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.372 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.413 HG12 ' CE2' ' A' ' 214' ' ' PHE . 6.8 m -98.08 122.37 49.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.903 0.382 . . . . 0.0 110.873 179.462 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -82.4 152.27 26.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.834 -179.869 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.56 144.67 31.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.554 179.887 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 44.3 m-20 -57.43 -29.28 64.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.017 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -74.78 -7.44 53.4 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.633 179.676 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 101.54 14.47 29.87 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 120.484 -0.865 . . . . 0.0 113.123 -179.929 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -92.24 166.11 12.77 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.98 0.39 . . . . 0.0 111.049 -179.844 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -132.16 111.43 11.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.827 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.5 t -109.86 138.56 36.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.103 179.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 52.5 p -112.08 116.78 31.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.981 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -127.75 158.14 38.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.653 179.775 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -97.62 148.43 23.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.778 0.323 . . . . 0.0 110.653 179.891 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 59.5 mt -59.96 -36.59 67.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.825 179.927 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.25 -33.88 74.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.289 -179.524 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -134.92 44.17 2.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.984 0.421 . . . . 0.0 111.015 -179.885 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.42 ' CE1' HD12 ' A' ' 171' ' ' LEU . 10.8 t80 -66.91 -52.64 40.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.779 179.801 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.35 -41.51 89.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.232 -179.724 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -67.13 -49.76 63.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.102 0.477 . . . . 0.0 110.476 179.655 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.95 -44.56 74.43 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.015 179.782 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -81.22 -26.86 35.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.061 179.635 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 13.6 t -61.14 -31.7 71.41 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.93 0.395 . . . . 0.0 110.28 179.346 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.232 179.556 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 121.094 0.473 . . . . 0.0 110.944 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.419 ' HB2' ' HB3' ' A' ' 134' ' ' LEU . 82.7 m95 -70.42 168.29 16.42 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.967 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.94 135.02 44.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.503 179.594 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 12.8 mtt180 -71.39 106.45 3.91 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.915 -179.815 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.405 ' CD1' HG21 ' A' ' 168' ' ' THR . 46.0 pt -95.8 -7.81 9.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.496 179.278 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -157.94 176.1 12.99 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 120.619 0.247 . . . . 0.0 110.713 179.768 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.468 ' CD1' ' CG ' ' A' ' 149' ' ' PRO . 39.1 m-85 -145.58 126.0 14.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.348 -179.895 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 4.2 t -94.05 123.21 46.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.016 0.436 . . . . 0.0 111.269 -179.458 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.465 ' CD1' ' CE1' ' A' ' 130' ' ' PHE . 7.0 t80 -82.59 101.85 11.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.892 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -156.31 155.35 32.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.704 -179.912 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 60.85 32.95 20.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.878 -179.783 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 60.28 31.26 20.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.91 179.961 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 70.6 m -152.94 161.49 42.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.883 179.766 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.465 ' CE1' ' CD1' ' A' ' 125' ' ' TYR . 97.2 m-85 -102.54 90.41 3.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.696 179.668 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.447 ' HA ' ' HA2' ' A' ' 144' ' ' GLY . 22.8 m-85 -65.45 124.79 88.12 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.088 -179.923 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.413 ' HA ' ' CD2' ' A' ' 123' ' ' TYR . 59.5 Cg_endo -73.63 119.17 5.79 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 121.986 1.791 . . . . 0.0 112.367 179.964 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.411 ' HG ' HG23 ' A' ' 168' ' ' THR . 32.2 tp -96.1 123.81 39.86 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.657 179.793 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.419 ' HB3' ' HB2' ' A' ' 118' ' ' TRP . 41.6 mt -70.79 172.77 8.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.563 -179.713 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -63.27 -29.05 70.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.992 179.692 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -89.9 12.52 17.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.131 179.577 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.454 ' HA2' HG23 ' A' ' 168' ' ' THR . . . 72.72 25.09 74.87 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.997 179.874 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -82.61 95.11 7.68 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.433 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.69 107.21 5.03 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.301 -179.221 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 30.5 mt -84.48 76.8 10.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.271 179.375 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.428 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 24.6 mtpt -67.84 -8.77 38.99 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.407 -179.603 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -84.77 -28.53 26.13 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.707 0.289 . . . . 0.0 110.915 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -85.65 -79.95 0.23 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.072 -179.848 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.447 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . 57.28 160.71 0.02 OUTLIER Glycine 0 CA--C 1.507 -0.462 0 CA-C-N 116.283 -0.417 . . . . 0.0 112.837 -179.625 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 9.6 t -140.63 150.78 43.99 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.356 -0.422 . . . . 0.0 110.68 -179.647 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -89.26 50.87 2.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.96 0.41 . . . . 0.0 110.625 179.839 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -171.33 155.49 4.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.956 0.408 . . . . 0.0 110.611 -179.286 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -98.74 125.26 43.05 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.148 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.468 ' CG ' ' CD1' ' A' ' 123' ' ' TYR . 96.5 Cg_endo -84.93 109.26 1.25 Allowed 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 122.494 2.13 . . . . 0.0 112.779 -179.767 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 17.0 t -69.86 -7.86 43.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.958 179.743 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -77.28 -23.41 51.13 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 120.808 0.337 . . . . 0.0 110.451 179.006 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -139.47 166.23 25.82 Favored Pre-proline 0 N--CA 1.453 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.546 -179.493 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.57 151.08 36.6 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.426 2.084 . . . . 0.0 112.662 -179.821 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 9.4 t -113.2 111.59 36.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.902 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.43 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.44 96.02 1.85 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.619 179.22 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 62.1 t -90.75 137.0 22.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.956 0.408 . . . . 0.0 111.18 179.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 47.76 60.78 5.19 Favored Glycine 0 CA--C 1.521 0.434 0 CA-C-N 115.938 -0.573 . . . . 0.0 113.147 179.377 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.43 ' CE2' HD23 ' A' ' 155' ' ' LEU . 3.0 m95 -104.35 151.27 23.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.228 0.537 . . . . 0.0 111.823 -179.344 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.25 -172.17 0.2 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.393 179.386 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -42.15 153.66 0.06 Allowed 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.733 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -56.94 -24.85 51.74 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.215 179.446 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -59.87 -40.49 88.84 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.916 0.388 . . . . 0.0 109.987 179.213 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -75.17 -38.95 60.67 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.988 178.907 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 5.4 mt -59.88 -43.69 92.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.808 178.866 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.54 -26.11 19.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.717 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -70.34 -54.57 12.01 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.1 0.476 . . . . 0.0 110.781 -179.9 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 167' ' ' MET . . . . . 0.419 ' HG3' ' N ' ' A' ' 168' ' ' THR . 0.0 OUTLIER -61.75 -35.85 79.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.291 179.518 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.454 HG23 ' HA2' ' A' ' 137' ' ' GLY . 0.2 OUTLIER -60.88 -40.88 94.69 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.938 178.89 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.94 -35.36 86.74 Favored Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 177.903 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -72.46 -46.85 53.0 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.236 -0.482 . . . . 0.0 110.66 178.656 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.418 HD13 ' CE1' ' A' ' 214' ' ' PHE . 10.8 mp -66.25 -27.57 68.05 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.773 0.321 . . . . 0.0 111.592 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.46 -17.54 62.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.257 179.868 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -114.38 -26.89 7.78 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -179.681 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.77 167.63 1.37 Allowed Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.037 -179.58 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -69.1 127.74 15.57 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.138 1.892 . . . . 0.0 112.829 179.812 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.45 -25.88 11.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.611 179.713 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.81 -48.45 79.69 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.866 0.365 . . . . 0.0 110.967 179.658 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.407 ' CG1' ' CE ' ' A' ' 182' ' ' MET . 22.3 t -74.06 -37.13 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.571 179.584 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 6.6 tp -55.59 -36.1 66.52 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.237 0.541 . . . . 0.0 110.072 179.058 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -76.54 -40.96 26.09 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.268 178.864 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -87.58 102.87 15.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.979 0.419 . . . . 0.0 110.596 179.225 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 182' ' ' MET . . . . . 0.407 ' CE ' ' CG1' ' A' ' 178' ' ' VAL . 2.9 mtm 177.89 162.47 0.59 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.084 -179.916 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 7.5 t -118.26 -56.9 2.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.819 0.343 . . . . 0.0 110.92 -179.859 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -161.28 142.44 11.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.957 -179.848 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 16.8 mt -100.4 115.91 42.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.403 179.483 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 19.9 m170 -105.04 115.25 29.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.965 -179.526 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.422 ' HB2' ' CE2' ' A' ' 158' ' ' TRP . 14.5 t80 -74.79 104.62 5.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.688 179.817 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.448 179.85 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 . . . . . 0 CA--C 1.529 0.172 0 CA-C-O 120.548 0.213 . . . . 0.0 111.271 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -107.8 36.75 2.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.742 0.306 . . . . 0.0 110.591 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 3.3 ttt180 -89.42 115.87 27.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.306 -179.673 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 34.0 m -112.78 165.27 7.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.684 179.563 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 23.8 mm -131.32 105.76 11.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.775 0.321 . . . . 0.0 111.279 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 6.9 m -95.85 121.48 46.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.941 179.652 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -81.82 146.47 29.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.646 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -95.06 167.15 11.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.033 -179.655 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.27 -27.69 65.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.059 -179.919 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -90.43 15.31 10.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.884 -179.845 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 87.69 -7.14 82.1 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.474 -0.869 . . . . 0.0 113.315 179.947 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.09 170.2 0.93 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 117.235 0.518 . . . . 0.0 110.928 -179.966 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -141.33 111.45 6.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.694 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.4 t -112.4 125.27 69.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.262 -179.774 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 4.6 m -100.98 112.04 24.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.661 179.721 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -124.1 160.87 26.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.88 -179.899 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.66 155.85 17.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.499 179.841 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 30.8 mt -67.08 -32.07 56.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.897 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.45 -40.52 70.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.355 -179.469 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -116.86 31.8 6.53 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.796 0.331 . . . . 0.0 110.95 -179.912 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.418 ' CE1' HD13 ' A' ' 171' ' ' LEU . 11.6 t80 -59.4 -54.92 41.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.997 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.43 -40.12 81.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.138 -179.922 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.38 -49.73 52.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.075 0.464 . . . . 0.0 110.333 179.553 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.14 -41.99 69.03 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.012 179.654 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.402 ' HB3' ' CG1' ' A' ' 178' ' ' VAL . 4.1 mm? -85.97 -23.54 26.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.825 179.462 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 9.4 t -60.69 -33.87 73.5 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.006 0.431 . . . . 0.0 110.119 179.232 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 32.7 m170 . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.117 179.183 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 . . . . . 0 CA--C 1.522 -0.129 0 CA-C-O 121.133 0.492 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.414 ' HB2' ' HB3' ' A' ' 134' ' ' LEU . 78.9 m95 -66.89 168.21 10.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.988 179.915 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 -102.82 136.67 42.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.467 179.588 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.7 mtm-85 -71.75 105.54 3.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.874 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 46.8 pt -94.34 -8.71 9.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.38 179.205 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -158.16 176.19 12.81 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 120.601 0.238 . . . . 0.0 110.609 179.749 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.464 ' CD1' ' CG ' ' A' ' 149' ' ' PRO . 34.2 m-85 -144.99 125.91 14.44 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 4.8 t -93.69 123.3 45.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.044 0.45 . . . . 0.0 111.509 -179.292 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.478 ' CD1' ' CE1' ' A' ' 130' ' ' PHE . 30.2 t80 -81.35 101.77 10.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.758 179.965 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -155.58 153.74 30.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.645 -179.887 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 60.87 31.17 20.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.952 -179.672 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 61.87 30.86 18.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.188 179.811 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 87.1 m -151.46 161.73 42.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.768 179.773 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.478 ' CE1' ' CD1' ' A' ' 125' ' ' TYR . 9.1 m-85 -101.39 90.27 4.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.866 179.666 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.438 ' CG ' ' HA ' ' A' ' 141' ' ' LYS . 22.1 m-85 -65.79 123.99 86.31 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.766 179.809 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.3 118.34 5.47 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.114 1.876 . . . . 0.0 112.338 -179.936 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.41 ' HG ' HG23 ' A' ' 168' ' ' THR . 25.8 tp -95.96 123.54 39.6 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.521 179.684 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.414 ' HB3' ' HB2' ' A' ' 118' ' ' TRP . 50.7 mt -70.67 173.73 6.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.344 -0.843 . . . . 0.0 111.449 -179.748 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -63.89 -28.33 69.76 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.995 179.588 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -91.29 14.23 15.05 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.199 179.791 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.448 ' HA2' HG23 ' A' ' 168' ' ' THR . . . 72.85 28.06 67.68 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.57 -179.976 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.403 ' HB3' ' CD1' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -81.65 90.1 6.29 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 178.721 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.31 102.01 3.01 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.802 -179.485 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 31.7 mt -83.06 79.39 9.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.824 -179.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.438 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 37.8 mttt -69.69 -8.51 48.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.207 -179.912 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -82.92 -29.63 29.02 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.83 0.348 . . . . 0.0 110.695 179.69 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -85.27 -80.4 0.21 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.957 179.98 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.431 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . 56.92 160.76 0.02 OUTLIER Glycine 0 CA--C 1.506 -0.475 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.949 -179.777 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 10.2 t -142.07 150.38 41.15 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.437 -0.382 . . . . 0.0 110.753 -179.738 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 3.7 mmtt -89.53 51.8 2.19 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.018 0.437 . . . . 0.0 110.596 179.995 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -171.26 149.99 2.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.735 -179.34 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.421 ' CB ' ' CE2' ' A' ' 130' ' ' PHE . . . -93.94 125.01 54.65 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.201 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.464 ' CG ' ' CD1' ' A' ' 123' ' ' TYR . 89.9 Cg_endo -85.04 109.89 1.27 Allowed 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.57 2.18 . . . . 0.0 112.796 -179.861 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 21.5 t -69.93 -7.74 43.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.935 179.79 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -77.61 -23.07 49.93 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 120.809 0.338 . . . . 0.0 110.515 179.096 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -139.92 166.22 25.35 Favored Pre-proline 0 N--CA 1.453 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.628 -179.41 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -74.68 152.24 42.21 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.424 2.082 . . . . 0.0 112.346 -179.926 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 9.8 t -113.99 109.46 28.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.065 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.429 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.33 96.03 1.81 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.705 179.231 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.411 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 53.5 t -93.68 136.21 26.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.91 0.386 . . . . 0.0 111.012 179.944 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 50.81 57.5 10.79 Favored Glycine 0 CA--C 1.519 0.306 0 CA-C-N 115.886 -0.597 . . . . 0.0 113.089 179.443 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.434 ' CZ2' ' CG1' ' A' ' 197' ' ' VAL . 3.2 m95 -102.16 151.2 22.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.08 0.467 . . . . 0.0 111.634 -179.572 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.73 -172.41 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.608 179.523 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -43.59 154.26 0.1 Allowed 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.775 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -57.58 -25.11 54.79 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.239 179.544 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.2 -38.42 83.24 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.948 0.404 . . . . 0.0 110.112 179.278 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.34 -39.2 48.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.03 179.034 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 5.9 mt -59.96 -41.46 86.15 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.857 179.046 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.8 -30.51 45.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.168 179.682 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -67.19 -53.0 34.41 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-O 121.417 0.627 . . . . 0.0 110.14 179.391 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.78 -43.22 98.38 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.088 179.025 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.448 HG23 ' HA2' ' A' ' 137' ' ' GLY . 0.2 OUTLIER -58.5 -38.66 78.11 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.51 179.214 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.09 -37.43 92.8 Favored Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 178.378 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 63.2 mm-40 -72.29 -45.85 58.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.462 -0.369 . . . . 0.0 110.892 178.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.425 HD11 ' CE1' ' A' ' 214' ' ' PHE . 11.1 mp -65.48 -30.05 70.78 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.694 0.283 . . . . 0.0 111.202 179.685 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.0 -18.57 64.07 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.344 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -112.28 -26.71 8.63 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.632 0.254 . . . . 0.0 111.66 -179.696 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.86 166.67 1.28 Allowed Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.169 -179.517 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -69.29 128.66 16.79 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.163 1.908 . . . . 0.0 112.69 179.832 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.09 -25.66 5.36 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.69 179.715 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.18 -49.97 74.32 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.033 179.76 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.413 ' CG1' ' HB3' ' A' ' 218' ' ' LEU . 23.9 t -74.18 -39.81 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.715 179.609 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.15 -33.38 52.24 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.103 0.478 . . . . 0.0 110.169 179.385 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -81.86 -38.92 12.55 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.591 178.802 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -88.92 103.43 16.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.828 0.347 . . . . 0.0 110.852 179.528 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 182' ' ' MET . . . . . 0.411 ' CE ' ' CG1' ' A' ' 178' ' ' VAL . 2.6 mtm 177.87 169.08 0.71 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.304 179.817 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 7.7 t -124.24 -59.61 1.47 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.752 0.311 . . . . 0.0 111.127 -179.901 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -157.02 142.73 17.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.121 -179.784 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.443 HD13 HG23 ' A' ' 185' ' ' ILE . 14.9 mt -106.23 114.53 45.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.269 179.359 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . 0.411 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 22.5 m170 -104.7 121.56 43.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.153 -179.431 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -72.67 104.95 4.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.58 179.769 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.78 -179.921 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 . . . . . 0 N--CA 1.462 0.137 0 CA-C-O 120.647 0.26 . . . . 0.0 111.51 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.5 40.04 1.7 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.967 0.413 . . . . 0.0 110.373 179.785 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 31.7 ttt85 -93.0 119.94 32.78 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.969 179.974 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.434 ' CG1' ' CZ2' ' A' ' 158' ' ' TRP . 23.2 m -113.03 167.77 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.09 -179.931 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 24.7 mm -134.09 105.9 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.139 179.783 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.422 HG13 ' CE2' ' A' ' 214' ' ' PHE . 15.8 m -97.63 138.81 21.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.992 0.425 . . . . 0.0 111.02 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.42 ' CE2' ' HG3' ' A' ' 206' ' ' GLU . 50.7 m-85 -102.46 152.48 21.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.587 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 21.3 tpp -104.06 158.21 16.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.833 0.349 . . . . 0.0 110.914 -179.902 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -56.27 -22.37 29.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.584 -179.825 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -90.4 15.34 10.8 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 111.825 0.305 . . . . 0.0 111.825 -179.913 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 77.05 14.58 82.48 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.583 -0.818 . . . . 0.0 113.147 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -77.55 167.7 21.19 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.99 0.395 . . . . 0.0 110.884 179.994 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . 0.42 ' HG3' ' CE2' ' A' ' 200' ' ' TYR . 7.2 tt0 -134.31 111.47 10.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.854 -179.964 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 17.7 t -116.56 131.14 70.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.976 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 59.5 m -104.03 116.9 33.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.054 -179.858 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -127.62 159.24 35.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.736 179.712 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.2 153.1 19.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.811 0.339 . . . . 0.0 110.751 -179.95 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 64.2 mt -63.31 -36.71 77.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.803 179.763 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.92 -35.9 79.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.548 -179.452 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -132.67 42.76 3.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.925 0.393 . . . . 0.0 111.115 -179.835 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.425 ' CE1' HD11 ' A' ' 171' ' ' LEU . 11.3 t80 -65.49 -52.57 51.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.525 179.815 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.89 -43.38 86.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.293 -179.716 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.38 -49.39 60.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.102 0.477 . . . . 0.0 110.205 179.461 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.73 -42.76 65.18 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.181 179.683 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.413 ' HB3' ' CG1' ' A' ' 178' ' ' VAL . 4.0 mm? -87.16 -23.43 24.82 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.181 179.614 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 10.9 t -60.35 -33.88 73.05 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.025 0.44 . . . . 0.0 110.299 179.542 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.534 0.347 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.109 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.187 0 N-CA-C 112.556 -0.218 . . . . 0.0 112.556 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 13.3 p -115.64 153.64 30.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.807 0.337 . . . . 0.0 110.871 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 61.07 154.79 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.052 0.453 . . . . 0.0 110.978 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 81.6 m95 -77.29 168.51 19.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.976 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.8 ttm-85 -102.4 134.19 46.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.607 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.9 mtm180 -70.42 106.8 3.53 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.887 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.405 ' CD1' ' HA ' ' A' ' 135' ' ' GLU . 44.5 pt -96.61 -7.06 9.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.448 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -159.38 175.94 12.73 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 120.606 0.241 . . . . 0.0 110.916 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.469 ' CD1' ' CG ' ' A' ' 149' ' ' PRO . 29.0 m-85 -143.65 126.23 15.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.253 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.8 t -93.86 123.28 45.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.512 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.501 ' CE1' ' CZ ' ' A' ' 130' ' ' PHE . 9.4 t80 -85.0 96.21 9.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.734 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -147.84 155.98 42.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.632 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.03 31.22 21.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.846 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.67 34.69 14.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.034 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 57.0 m -154.66 161.52 41.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.034 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.501 ' CZ ' ' CE1' ' A' ' 125' ' ' TYR . 96.2 m-85 -103.82 90.49 3.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.166 0.508 . . . . 0.0 110.712 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.446 ' CG ' ' HA ' ' A' ' 141' ' ' LYS . 22.9 m-85 -67.69 127.4 93.38 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.561 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -71.62 118.16 5.51 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 122.37 2.047 . . . . 0.0 112.369 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.426 ' HG ' HG22 ' A' ' 168' ' ' THR . 38.0 tp -97.52 123.6 41.44 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.123 0.487 . . . . 0.0 110.595 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 52.4 mt -71.46 173.0 8.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.578 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.405 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.3 pt-20 -63.71 -29.27 70.52 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.114 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -89.92 11.36 20.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.16 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.43 ' HA2' HG22 ' A' ' 168' ' ' THR . . . 75.5 18.67 79.76 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.831 -0.7 . . . . 0.0 113.162 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 13.4 tpp180 -76.78 95.7 4.1 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.41 ' CD2' ' CB ' ' A' ' 131' ' ' PHE . 0.4 OUTLIER -71.44 113.58 8.62 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.494 -179.054 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 22.8 mt -88.11 71.76 9.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.292 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.446 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 30.8 mttt -56.87 -20.62 23.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.922 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -87.04 -18.73 29.91 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -104.93 30.85 5.2 Favored 'General case' 0 N--CA 1.461 0.121 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . -63.89 162.38 35.06 Favored Glycine 0 CA--C 1.51 -0.237 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.786 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 10.6 t -136.03 151.39 49.82 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.543 -0.329 . . . . 0.0 110.658 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 4.7 mmpt? -89.32 50.37 1.92 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.953 0.406 . . . . 0.0 110.671 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -171.04 151.4 3.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.554 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.414 ' HB3' ' CE2' ' A' ' 130' ' ' PHE . . . -96.88 125.87 44.84 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.23 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.469 ' CG ' ' CD1' ' A' ' 123' ' ' TYR . 74.3 Cg_endo -82.82 112.75 2.12 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.396 2.064 . . . . 0.0 112.474 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 30.6 t -69.92 -7.65 42.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.121 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -76.53 -23.44 53.64 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 120.828 0.346 . . . . 0.0 110.417 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -139.83 167.89 16.9 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.723 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -74.79 158.24 43.11 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.351 2.034 . . . . 0.0 112.114 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 10.7 t -118.83 110.83 31.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.051 0.453 . . . . 0.0 111.081 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.434 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 0.9 OUTLIER -72.83 96.01 2.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.579 179.022 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 54.3 t -93.1 136.52 24.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.961 0.41 . . . . 0.0 111.103 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 50.06 55.28 15.79 Favored Glycine 0 CA--C 1.52 0.375 0 CA-C-N 115.906 -0.588 . . . . 0.0 113.287 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.434 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 3.5 m95 -99.59 151.25 21.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.169 0.509 . . . . 0.0 111.649 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.89 -172.19 0.26 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.457 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -42.69 154.32 0.07 Allowed 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -57.18 -25.29 53.91 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.181 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -59.62 -39.43 84.27 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 120.957 0.408 . . . . 0.0 110.036 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.1 -40.06 53.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.94 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 6.6 mt -59.68 -42.13 87.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.898 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.63 -30.63 43.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.139 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -67.22 -53.14 32.94 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 121.528 0.68 . . . . 0.0 110.098 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.38 -43.46 96.58 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.06 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.43 HG22 ' HA2' ' A' ' 137' ' ' GLY . 0.2 OUTLIER -58.77 -38.0 77.5 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.525 179.356 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.56 -37.65 92.51 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 178.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -72.03 -46.39 57.26 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.353 -0.423 . . . . 0.0 111.025 178.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.421 HD11 ' CE1' ' A' ' 214' ' ' PHE . 10.9 mp -66.14 -27.71 68.24 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.665 0.269 . . . . 0.0 111.417 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.69 -18.93 62.81 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.438 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -111.74 -27.37 8.54 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.6 0.238 . . . . 0.0 111.413 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.93 167.3 1.55 Allowed Pre-proline 0 CA--C 1.539 0.535 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.929 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -70.39 128.01 14.86 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.177 1.918 . . . . 0.0 112.858 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.96 -25.41 8.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.606 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.93 -49.15 77.76 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.814 0.34 . . . . 0.0 110.896 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.401 ' CG1' ' CE ' ' A' ' 182' ' ' MET . 37.6 t -73.96 -35.22 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.445 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 5.7 tp -56.04 -35.52 66.98 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.183 0.515 . . . . 0.0 109.988 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -78.33 -40.19 20.36 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.336 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -86.06 103.01 14.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.894 0.378 . . . . 0.0 110.625 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' MET . . . . . 0.401 ' CE ' ' CG1' ' A' ' 178' ' ' VAL . 2.9 mtm 178.43 165.84 0.8 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.128 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.47 -54.53 1.97 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.797 0.332 . . . . 0.0 111.253 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -163.31 142.94 8.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.92 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.41 HD12 HG23 ' A' ' 185' ' ' ILE . 16.8 mt -106.26 114.71 46.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.722 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . 0.454 ' CE1' ' CE1' ' A' ' 200' ' ' TYR . 11.4 m170 -104.68 131.03 52.61 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.988 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -83.24 104.79 13.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.515 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.36 89.64 52.19 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.649 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.67 149.18 60.67 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.312 2.008 . . . . 0.0 112.578 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 21.9 p -121.53 161.05 23.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.548 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 9.5 ptt85 -54.7 -23.05 15.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.651 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -113.75 -10.78 13.0 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -143.49 79.95 1.65 Allowed 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.9 0.381 . . . . 0.0 111.554 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.58 -21.4 38.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.297 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -102.18 35.13 2.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.774 0.321 . . . . 0.0 110.708 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -89.45 113.08 24.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.178 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 29.1 m -108.57 168.07 3.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.847 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 20.7 mm -134.79 108.06 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.826 0.345 . . . . 0.0 111.383 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.413 HG11 ' CZ ' ' A' ' 214' ' ' PHE . 8.1 m -96.42 124.06 48.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.895 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.454 ' CE1' ' CE1' ' A' ' 186' ' ' HIS . 5.2 m-85 -82.58 146.0 29.41 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.796 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.83 156.23 17.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.04 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -64.26 -23.81 67.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.532 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -90.25 15.4 10.49 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 79.59 14.29 81.41 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.079 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -84.43 167.32 16.55 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.929 0.364 . . . . 0.0 110.71 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -133.72 111.66 10.75 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.2 t -112.73 124.35 69.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.19 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 80.0 p -101.42 116.47 32.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.695 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -127.0 158.41 36.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.96 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.13 154.38 17.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.724 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 36.8 mt -66.39 -35.17 74.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.999 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.49 -35.31 80.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.384 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -129.8 40.91 3.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.891 0.377 . . . . 0.0 111.055 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.421 ' CE1' HD11 ' A' ' 171' ' ' LEU . 11.9 t80 -65.54 -50.62 64.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.707 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.9 -41.26 91.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.093 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.06 -49.38 65.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.997 0.427 . . . . 0.0 110.46 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 2.1 mmpt? -54.65 -45.09 73.75 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.07 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -80.95 -27.5 36.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.978 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 14.3 t -60.76 -31.55 70.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.964 0.411 . . . . 0.0 110.372 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 -69.97 -16.68 63.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.245 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -67.06 130.16 93.87 Favored Pre-proline 0 CA--C 1.535 0.381 0 C-N-CA 121.289 -0.164 . . . . 0.0 110.9 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -86.72 108.03 1.03 Allowed 'Cis proline' 0 C--N 1.358 1.062 0 C-N-CA 124.586 -1.006 . . . . 0.0 112.663 0.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . 174.15 42.13 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.166 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 4.6 pt -121.02 -178.79 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.248 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 76.05 93.23 0.07 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.944 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -110.0 -161.77 0.77 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.9 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -93.65 21.13 6.67 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 1.7 tt -97.24 24.34 6.54 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.725 0.298 . . . . 0.0 110.831 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -135.68 30.86 3.11 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.813 0.34 . . . . 0.0 110.9 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 3.3 ptt85 -110.91 -33.5 6.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.859 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 25.7 p30 -98.19 36.75 1.53 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.881 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 13.6 m -150.88 33.92 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.072 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 7.8 mtpt . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.935 -179.986 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.175 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.14 93.86 9.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.717 0.294 . . . . 0.0 110.94 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 61.89 148.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.174 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.414 ' HB2' ' HB3' ' A' ' 134' ' ' LEU . 79.4 m95 -68.67 168.27 13.5 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.092 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -102.8 136.37 42.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.476 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 41.7 mtt85 -71.95 106.11 4.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.936 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.401 ' CD1' HG22 ' A' ' 168' ' ' THR . 45.9 pt -94.1 -7.84 10.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.476 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -159.47 176.44 12.08 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 121.017 -0.273 . . . . 0.0 110.89 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.432 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 32.1 m-85 -142.85 126.14 16.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.322 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 4.1 t -93.43 122.74 45.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.963 0.411 . . . . 0.0 111.226 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.492 ' CD1' ' CE1' ' A' ' 130' ' ' PHE . 17.9 t80 -80.99 106.51 13.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.698 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -163.36 156.59 19.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.595 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.427 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 1.2 mmm180 60.18 30.22 19.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.884 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 63.12 32.24 15.31 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.366 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 91.1 m -156.92 161.25 39.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.878 0.371 . . . . 0.0 111.026 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.492 ' CE1' ' CD1' ' A' ' 125' ' ' TYR . 58.5 m-85 -99.85 90.3 4.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.626 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.474 ' HA ' ' HA2' ' A' ' 144' ' ' GLY . 22.6 m-85 -65.48 125.5 89.7 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.787 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.406 ' HB3' ' CE2' ' A' ' 123' ' ' TYR . 58.3 Cg_endo -73.57 118.82 5.64 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.044 1.829 . . . . 0.0 112.411 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.418 ' HG ' HG21 ' A' ' 168' ' ' THR . 28.4 tp -96.22 123.85 40.01 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.396 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.414 ' HB3' ' HB2' ' A' ' 118' ' ' TRP . 39.9 mt -69.64 173.62 5.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.45 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -64.68 -28.02 69.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.948 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 48.8 p-10 -90.93 13.91 15.26 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.285 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.436 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 72.63 21.78 79.39 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.731 -0.747 . . . . 0.0 113.119 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 9.7 tpp180 -80.82 94.25 6.4 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.13 113.6 9.33 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.48 -179.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 25.1 mt -88.39 80.43 7.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.414 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.433 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 15.4 mtpt -71.45 -5.77 35.34 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -91.11 -24.28 20.04 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 122.304 -0.248 . . . . 0.0 111.432 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -89.46 -79.12 0.34 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.779 0.323 . . . . 0.0 111.403 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . 58.11 161.1 0.04 OUTLIER Glycine 0 CA--C 1.505 -0.57 0 CA-C-N 116.279 -0.419 . . . . 0.0 112.753 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.8 t -140.01 148.61 42.11 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.872 0.368 . . . . 0.0 110.939 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 4.2 mmtt -91.1 51.97 2.04 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.157 0.503 . . . . 0.0 110.216 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.59 148.48 3.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.773 -179.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -81.89 135.14 48.89 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.703 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.441 ' HD2' ' CG2' ' A' ' 154' ' ' VAL . 68.4 Cg_endo -84.08 97.96 0.75 Allowed 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.052 2.501 . . . . 0.0 112.549 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 26.2 t -67.5 -9.3 41.0 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.825 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -90.0 -21.92 22.15 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.566 0.222 . . . . 0.0 111.588 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -139.79 167.4 18.63 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.65 162.89 38.7 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.408 2.072 . . . . 0.0 112.518 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.441 ' CG2' ' HD2' ' A' ' 149' ' ' PRO . 18.3 t -123.82 110.14 24.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.572 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.426 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.85 95.91 2.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.747 179.112 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 59.0 t -93.01 136.87 23.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.927 0.394 . . . . 0.0 111.094 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 48.85 55.42 11.47 Favored Glycine 0 CA--C 1.52 0.369 0 CA-C-N 115.966 -0.561 . . . . 0.0 113.174 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.426 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 3.4 m95 -99.07 151.18 21.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.156 0.503 . . . . 0.0 111.735 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.43 -172.27 0.15 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.604 179.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -43.21 154.39 0.08 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.332 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -56.94 -24.66 50.94 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.218 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.72 -40.09 86.85 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.967 0.413 . . . . 0.0 110.05 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.12 -39.78 54.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.009 178.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 6.1 mt -59.67 -41.23 84.55 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.9 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.0 -30.58 47.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.214 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -67.64 -52.9 32.73 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.385 0.612 . . . . 0.0 110.107 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.44 -45.27 92.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.971 178.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.436 HG21 ' HA2' ' A' ' 137' ' ' GLY . 0.2 OUTLIER -57.65 -38.38 74.96 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.549 179.207 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.83 -36.46 90.02 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 110.701 -0.959 . . . . 0.0 110.701 178.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -74.17 -46.36 42.65 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.451 -0.374 . . . . 0.0 111.06 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.426 HD11 ' CE1' ' A' ' 214' ' ' PHE . 11.3 mp -65.43 -29.6 70.31 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.689 0.28 . . . . 0.0 111.319 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.49 -19.18 63.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.345 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -111.01 -27.85 8.58 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.635 0.255 . . . . 0.0 111.433 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.89 166.58 1.32 Allowed Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.161 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.54 127.44 14.77 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.243 1.962 . . . . 0.0 112.744 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.71 -26.01 5.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.784 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.56 -50.76 72.05 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.925 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 33.8 t -74.16 -32.42 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.414 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.2 -34.2 70.12 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -79.48 -39.61 17.88 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -86.77 103.03 14.82 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.952 0.405 . . . . 0.0 110.6 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 2.8 mtm 178.49 160.48 0.6 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.994 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.1 m -120.56 -52.31 2.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.682 0.277 . . . . 0.0 111.379 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -163.27 142.64 8.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.926 0.394 . . . . 0.0 111.283 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.416 HD12 HG22 ' A' ' 185' ' ' ILE . 17.6 mt -106.71 114.19 45.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.344 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -104.39 119.87 39.94 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.135 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -75.8 104.57 6.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.544 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.33 82.0 52.6 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.572 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.73 140.5 42.95 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.35 2.033 . . . . 0.0 112.487 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 17.4 p -116.71 160.11 21.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.703 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -53.4 -25.41 15.63 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.464 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -107.69 -16.85 14.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.687 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -134.27 76.83 1.67 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.906 0.384 . . . . 0.0 111.227 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -56.57 -22.25 32.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.589 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -109.27 37.84 2.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.765 0.317 . . . . 0.0 111.082 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.83 115.59 27.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.947 0.403 . . . . 0.0 111.229 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.419 HG11 ' CZ2' ' A' ' 158' ' ' TRP . 28.1 m -112.51 166.14 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.808 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 22.3 mm -133.03 107.85 12.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.81 0.338 . . . . 0.0 111.401 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 11.3 m -96.73 120.9 46.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.934 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -81.84 152.29 26.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.562 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 3.6 mmt -108.53 150.03 28.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.809 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -58.74 -25.61 63.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.261 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -88.63 12.94 13.34 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 81.98 14.36 77.42 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.378 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -86.13 153.41 22.1 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 117.103 0.451 . . . . 0.0 110.807 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -123.27 111.42 16.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.86 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.6 t -115.01 123.25 70.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.154 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 9.8 t -98.84 115.49 28.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.742 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -123.91 162.93 22.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.8 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.73 153.99 18.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.727 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 33.1 mt -65.98 -36.64 77.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.803 0.335 . . . . 0.0 110.763 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -64.82 -36.51 84.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.124 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -128.31 43.51 3.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.916 0.389 . . . . 0.0 110.929 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.426 ' CE1' HD11 ' A' ' 171' ' ' LEU . 11.4 t80 -68.46 -54.61 15.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.786 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.5 -39.15 79.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.904 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -67.24 -50.04 62.16 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.117 0.484 . . . . 0.0 110.29 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.29 -45.35 72.5 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.057 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -80.18 -27.52 38.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.873 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 1.1 m -61.04 -29.85 69.97 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.403 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 7.1 m170 -68.94 -17.58 63.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.282 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -64.84 137.05 97.02 Favored Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.06 154.57 96.74 Favored 'Cis proline' 0 C--N 1.356 0.937 0 C-N-CA 124.714 -0.952 . . . . 0.0 112.822 0.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . 83.12 76.4 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.42 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.496 HD12 HG23 ' A' ' 224' ' ' ILE . 7.4 pt -124.7 -178.88 2.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.2 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 67.99 139.12 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.085 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -115.91 -164.1 0.94 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.106 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -100.45 31.43 3.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.889 0.376 . . . . 0.0 110.938 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 9.9 mt -90.9 15.52 11.2 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.44 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -110.6 56.47 0.63 Allowed 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 121.046 0.451 . . . . 0.0 110.874 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 7.3 mtt85 -148.33 -55.31 0.2 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.911 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 25.0 p30 -60.84 92.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.872 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 12.1 p -108.29 137.73 38.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.073 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 16.9 mmmt . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.942 179.934 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.078 0 N-CA-C 112.522 -0.231 . . . . 0.0 112.522 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 7.5 t 68.31 -68.03 0.18 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.747 0.308 . . . . 0.0 111.001 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -63.81 148.67 48.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.047 0.451 . . . . 0.0 111.013 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.412 ' HB2' ' HB3' ' A' ' 134' ' ' LEU . 80.9 m95 -68.7 168.31 13.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.015 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.14 135.72 43.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.548 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.9 mtm180 -71.5 105.29 3.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.721 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.401 ' CD1' HG21 ' A' ' 168' ' ' THR . 47.1 pt -94.18 -8.24 9.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.406 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -158.47 176.88 11.86 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.467 0.175 . . . . 0.0 110.575 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.454 ' CD1' ' CG ' ' A' ' 149' ' ' PRO . 31.3 m-85 -144.35 125.84 14.93 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.7 t -93.58 122.85 45.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.058 0.456 . . . . 0.0 111.557 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -83.49 94.31 8.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.681 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -145.01 155.13 43.2 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.603 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.93 30.82 20.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.712 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 63.29 33.85 13.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.863 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.4 ' CG2' ' N ' ' A' ' 145' ' ' THR . 58.6 m -155.9 159.7 39.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.057 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -99.77 91.23 4.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.217 0.532 . . . . 0.0 110.863 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.432 ' CG ' ' HA ' ' A' ' 141' ' ' LYS . 26.1 m-85 -70.37 114.13 23.53 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.722 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.4 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 31.8 Cg_exo -58.72 123.35 13.35 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 122.414 2.076 . . . . 0.0 112.659 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.416 ' HG ' HG23 ' A' ' 168' ' ' THR . 28.9 tp -102.39 123.94 47.06 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.346 179.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.412 ' HB3' ' HB2' ' A' ' 118' ' ' TRP . 40.3 mt -70.32 173.21 7.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.634 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -64.11 -28.3 69.68 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.037 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -90.79 13.72 15.53 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.209 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.43 ' HA2' HG23 ' A' ' 168' ' ' THR . . . 72.84 21.7 79.57 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.75 -0.738 . . . . 0.0 113.01 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -80.8 92.67 6.11 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.401 ' CD2' ' CB ' ' A' ' 131' ' ' PHE . 0.4 OUTLIER -66.21 113.56 4.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.322 -179.125 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 43.4 mt -83.66 67.68 9.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.707 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.432 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 2.3 mttp -57.58 -21.49 39.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.451 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -95.56 21.07 8.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.433 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -147.31 28.47 0.99 Allowed 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.787 0.327 . . . . 0.0 111.238 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.4 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -60.83 162.83 21.01 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.897 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.4 ' N ' ' CG2' ' A' ' 129' ' ' THR . 9.0 t -132.96 150.86 52.13 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.814 0.34 . . . . 0.0 110.611 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.4 mmtt -90.34 50.02 1.78 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.531 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -171.09 150.24 3.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.516 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -94.55 125.76 50.46 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.219 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.454 ' CG ' ' CD1' ' A' ' 123' ' ' TYR . 73.6 Cg_endo -83.65 111.97 1.8 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.428 2.085 . . . . 0.0 112.605 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 46.6 t -69.84 -7.89 43.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.038 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -77.27 -22.55 51.94 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 120.798 0.333 . . . . 0.0 110.572 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -142.15 167.06 17.72 Favored Pre-proline 0 N--CA 1.453 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.702 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -74.58 157.68 44.33 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.37 2.046 . . . . 0.0 112.315 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 12.8 t -118.28 111.0 32.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.346 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.434 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.65 96.05 1.94 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.762 179.016 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.1 t -93.56 135.44 28.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.995 0.426 . . . . 0.0 110.945 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 49.62 58.08 8.73 Favored Glycine 0 CA--C 1.521 0.42 0 CA-C-N 115.874 -0.603 . . . . 0.0 113.158 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.434 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 3.0 m95 -100.59 151.35 21.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.201 0.524 . . . . 0.0 111.744 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.412 ' HD3' ' CE2' ' A' ' 187' ' ' TYR . 2.6 tptt -64.76 -172.47 0.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.523 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -44.35 154.89 0.1 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.122 0.487 . . . . 0.0 112.212 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -57.29 -25.37 54.38 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.225 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.34 -38.25 83.21 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.979 0.419 . . . . 0.0 110.165 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.82 -40.61 47.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.116 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 5.9 mt -58.45 -41.38 81.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.973 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.12 -30.34 48.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.144 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -68.1 -53.04 28.34 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-O 121.368 0.604 . . . . 0.0 110.196 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.66 -43.6 93.89 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.03 179.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.43 HG23 ' HA2' ' A' ' 137' ' ' GLY . 0.2 OUTLIER -59.2 -37.24 76.95 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.466 179.009 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.05 -37.01 92.11 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -73.06 -46.87 49.21 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.359 -0.421 . . . . 0.0 111.163 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.422 HD13 ' CE1' ' A' ' 214' ' ' PHE . 11.1 mp -65.3 -29.28 70.02 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.7 0.286 . . . . 0.0 111.345 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.79 -20.89 64.36 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.317 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -110.56 -26.3 9.54 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.599 0.238 . . . . 0.0 111.52 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.42 166.62 1.58 Allowed Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.083 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -68.8 127.14 14.9 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.308 2.005 . . . . 0.0 112.698 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.07 -25.96 5.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.643 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -58.23 -49.89 75.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.907 0.384 . . . . 0.0 110.986 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.405 ' CG1' ' CE ' ' A' ' 182' ' ' MET . 32.0 t -74.0 -34.87 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.704 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.61 -33.91 68.73 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.119 0.485 . . . . 0.0 109.838 178.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -78.62 -39.79 20.37 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -87.74 103.18 15.37 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.884 0.373 . . . . 0.0 110.684 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' MET . . . . . 0.405 ' CE ' ' CG1' ' A' ' 178' ' ' VAL . 2.8 mtm 178.79 163.4 0.78 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.202 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -120.39 -57.1 1.94 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.742 0.306 . . . . 0.0 111.206 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -159.97 142.52 13.47 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.992 0.425 . . . . 0.0 111.124 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 17.8 mt -105.12 114.84 45.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.279 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 23.5 m170 -104.24 120.38 41.02 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.117 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.412 ' CE2' ' HD3' ' A' ' 159' ' ' LYS . 83.7 t80 -75.03 104.45 5.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.474 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.23 89.24 52.11 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.529 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.402 ' HD3' ' CD2' ' A' ' 187' ' ' TYR . 49.2 Cg_endo -68.42 142.12 53.34 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.258 1.972 . . . . 0.0 112.386 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 18.3 p -119.77 159.1 25.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.678 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -54.96 -24.73 25.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.51 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -104.15 -17.83 14.75 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.828 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -141.45 85.41 1.96 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.93 0.395 . . . . 0.0 111.498 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -55.68 -24.23 32.98 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.333 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -106.55 40.39 1.63 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.036 0.446 . . . . 0.0 110.308 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.18 116.45 27.44 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.959 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 29.2 m -109.96 168.05 4.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.082 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 21.8 mm -135.37 108.24 8.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.196 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 15.4 m -97.61 139.72 19.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.998 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -101.51 152.72 20.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.778 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 6.0 mmt -105.28 159.7 15.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.88 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -60.13 -27.07 66.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.256 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -86.92 9.96 17.74 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 84.54 14.34 71.01 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.565 -0.826 . . . . 0.0 113.266 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -81.05 158.38 25.11 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 117.228 0.514 . . . . 0.0 110.739 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -128.15 111.25 13.25 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.814 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.2 t -111.21 133.58 56.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.951 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.63 117.25 33.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.938 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -129.49 156.84 43.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.681 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -99.16 149.33 23.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.78 0.324 . . . . 0.0 110.764 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.456 HD12 HG23 ' A' ' 211' ' ' ILE . 64.1 mt -59.55 -38.25 74.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.955 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -61.84 -32.9 73.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.301 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -134.87 46.41 2.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.904 0.383 . . . . 0.0 111.075 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.422 ' CE1' HD13 ' A' ' 171' ' ' LEU . 11.4 t80 -70.26 -51.36 31.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.795 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.93 -39.65 86.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.014 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.85 -50.34 62.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.144 0.497 . . . . 0.0 110.454 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.99 -45.11 71.36 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.169 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -81.33 -26.33 35.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.95 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.31 -30.56 70.57 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.871 0.367 . . . . 0.0 110.301 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 13.8 m170 -68.72 -17.51 64.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.189 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -67.78 137.3 92.66 Favored Pre-proline 0 CA--C 1.533 0.301 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.31 155.0 97.3 Favored 'Cis proline' 0 C--N 1.355 0.88 0 C-N-CA 124.728 -0.947 . . . . 0.0 112.799 0.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . 85.18 74.49 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.714 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.452 HG23 HD11 ' A' ' 224' ' ' ILE . 7.5 pt -125.38 -179.42 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.027 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 64.44 164.66 0.14 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.081 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -143.64 -165.11 2.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.179 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -106.43 34.11 3.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.929 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 5.1 tt -86.28 8.54 20.9 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.829 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.45 40.5 1.3 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.944 0.402 . . . . 0.0 110.952 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 31.3 mtp180 -94.28 -34.61 12.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.875 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -61.14 -37.05 81.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.963 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 21.1 t 63.71 151.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.206 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.794 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.207 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.6 m -70.01 -32.15 70.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.821 0.343 . . . . 0.0 110.88 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -82.71 157.96 23.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.955 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -80.66 168.41 18.9 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.143 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -101.06 132.34 46.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.761 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 12.1 mtm-85 -69.94 106.12 3.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.667 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 43.4 pt -94.5 -7.82 9.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.409 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -160.46 176.81 11.22 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 121.158 -0.217 . . . . 0.0 110.669 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.453 ' O ' ' HA ' ' A' ' 154' ' ' VAL . 30.4 m-85 -142.34 126.96 17.96 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.11 -0.329 . . . . 0.0 110.11 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.9 t -93.22 122.49 44.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.345 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -80.42 94.39 6.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.632 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -146.92 156.5 43.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.375 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.34 29.79 19.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.86 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 62.76 34.92 14.24 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.108 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 86.7 m -158.06 161.76 38.05 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.194 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -98.2 90.9 5.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.142 0.496 . . . . 0.0 111.041 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.436 ' CG ' ' HA ' ' A' ' 141' ' ' LYS . 23.9 m-85 -69.67 120.35 76.85 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.248 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.425 ' HA ' ' CD2' ' A' ' 123' ' ' TYR . 23.5 Cg_exo -64.2 117.63 4.64 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.341 2.027 . . . . 0.0 112.798 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.423 ' HG ' HG21 ' A' ' 168' ' ' THR . 35.9 tp -96.84 123.65 40.6 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.144 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 55.9 mt -70.75 171.39 10.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.666 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -62.82 -29.36 70.67 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.938 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -89.29 10.3 22.8 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.156 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.437 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 76.57 18.05 79.38 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.159 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -76.97 94.04 3.9 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.14 110.03 3.8 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.675 -178.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 37.5 mt -81.74 73.62 8.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.676 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.436 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 13.1 mtpt -60.72 -17.86 50.89 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.575 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -101.32 25.01 8.75 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.535 0.207 . . . . 0.0 111.219 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -145.83 26.7 1.23 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.707 0.289 . . . . 0.0 111.353 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -59.21 164.16 10.66 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.719 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.8 t -135.24 148.55 49.63 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.925 0.393 . . . . 0.0 110.784 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 3.6 mmtt -90.04 53.24 2.47 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.491 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.72 153.56 4.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.361 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -88.62 133.8 35.37 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.83 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.439 ' HG3' ' CD1' ' A' ' 123' ' ' TYR . 73.7 Cg_endo -81.63 98.86 1.01 Allowed 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.905 2.404 . . . . 0.0 112.505 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.0 t -67.23 -9.62 42.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.877 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -89.65 -22.23 22.39 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 111.666 0.247 . . . . 0.0 111.666 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -139.03 168.07 16.88 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -74.12 165.81 31.09 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.352 2.035 . . . . 0.0 112.278 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 25.6 t -125.12 107.83 18.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.035 0.445 . . . . 0.0 111.744 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.444 HD22 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.43 96.19 1.87 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.023 179.336 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.435 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 61.9 t -94.17 138.02 21.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.085 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 48.01 56.05 9.36 Favored Glycine 0 CA--C 1.52 0.39 0 CA-C-N 115.964 -0.562 . . . . 0.0 113.261 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.444 ' CE2' HD22 ' A' ' 155' ' ' LEU . 3.4 m95 -99.16 151.16 21.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.187 0.518 . . . . 0.0 111.659 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.47 -172.37 0.16 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.519 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -43.06 154.22 0.08 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -57.06 -24.89 52.53 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.267 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -60.26 -39.27 86.17 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.998 0.427 . . . . 0.0 110.162 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.7 -39.51 51.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.18 179.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 7.1 mt -60.07 -42.13 88.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.126 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.48 -30.83 54.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.285 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -65.95 -53.27 41.19 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.409 0.623 . . . . 0.0 110.01 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.48 -43.05 99.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.087 179.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.437 HG21 ' HA2' ' A' ' 137' ' ' GLY . 0.2 OUTLIER -59.19 -37.28 77.02 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.38 179.281 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.52 -38.37 94.79 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 110.456 -1.057 . . . . 0.0 110.456 178.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 33.6 mm-40 -71.31 -44.15 65.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.384 -0.408 . . . . 0.0 110.801 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.428 HD13 ' CE1' ' A' ' 214' ' ' PHE . 10.5 mp -66.92 -28.41 68.27 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.7 0.286 . . . . 0.0 111.384 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.83 -16.18 62.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.377 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -114.7 -29.25 6.84 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 111.561 0.208 . . . . 0.0 111.561 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.85 167.16 1.12 Allowed Pre-proline 0 CA--C 1.538 0.5 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.121 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -69.99 126.94 13.73 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.153 1.902 . . . . 0.0 113.043 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.35 -25.31 5.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.696 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -56.08 -50.72 70.21 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.907 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.417 ' CG1' ' CE ' ' A' ' 182' ' ' MET . 42.8 t -74.74 -34.74 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.54 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 11.6 tp -54.92 -35.32 64.04 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.181 0.515 . . . . 0.0 110.13 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -79.99 -41.83 11.8 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 111.169 -0.773 . . . . 0.0 111.169 178.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -82.3 103.14 11.66 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.843 0.354 . . . . 0.0 110.469 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' MET . . . . . 0.417 ' CE ' ' CG1' ' A' ' 178' ' ' VAL . 2.9 mtm 177.81 171.6 0.64 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.129 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.3 m -127.54 -54.59 1.34 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.811 0.338 . . . . 0.0 110.877 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -163.49 142.32 8.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.029 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 18.6 mt -105.51 114.32 44.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.137 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . 0.435 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 19.2 m170 -105.88 114.92 29.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.424 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.408 ' HB2' ' CD2' ' A' ' 158' ' ' TRP . 83.8 t80 -66.09 104.43 1.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -126.78 87.65 56.09 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.939 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.25 159.61 52.47 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.432 2.088 . . . . 0.0 112.288 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 5.5 p -134.14 169.29 17.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.61 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -59.88 -26.97 66.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.096 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . 0.404 ' O ' ' CD1' ' A' ' 193' ' ' TYR . 0.5 OUTLIER -118.18 11.21 13.16 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.594 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 192' ' ' GLU . 58.0 m-85 -157.73 75.25 0.77 Allowed 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 120.987 0.422 . . . . 0.0 111.131 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -56.91 -25.85 58.01 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.166 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 6.9 p30 -102.15 37.27 1.91 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.556 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 2.0 tpm_? -89.5 114.23 25.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.134 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 28.7 m -110.48 166.0 5.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.622 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 19.1 mm -131.43 106.14 11.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.805 0.336 . . . . 0.0 111.43 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.419 HG13 ' CE2' ' A' ' 214' ' ' PHE . 9.5 m -96.11 118.36 42.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.919 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -81.63 152.92 26.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.547 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.17 148.15 28.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.863 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 36.1 m-20 -58.24 -28.85 65.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.017 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -76.86 -4.68 44.93 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.765 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 97.41 14.46 41.26 Favored Glycine 0 C--N 1.335 0.517 0 C-N-CA 120.533 -0.841 . . . . 0.0 113.106 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -87.61 170.99 10.8 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.957 0.408 . . . . 0.0 111.103 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -135.04 111.12 9.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.623 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 28.9 t -113.94 124.82 70.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.881 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 2.8 m -102.17 115.64 30.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.781 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -123.49 171.01 9.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.82 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -107.42 155.09 20.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.474 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 38.5 mt -68.13 -35.95 73.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.807 0.336 . . . . 0.0 110.76 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -62.85 -36.87 84.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.258 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -130.64 40.99 3.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.953 0.406 . . . . 0.0 111.068 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.428 ' CE1' HD13 ' A' ' 171' ' ' LEU . 10.6 t80 -64.06 -55.04 25.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.553 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.04 -42.73 85.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.271 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -66.67 -48.21 70.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.015 0.436 . . . . 0.0 110.496 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 1.2 mmpt? -55.1 -44.4 74.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.279 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.402 ' HB3' ' CG1' ' A' ' 178' ' ' VAL . 3.7 mm? -83.99 -25.69 29.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.074 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 14.9 t -60.74 -32.81 72.08 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.973 0.416 . . . . 0.0 110.157 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 24.5 m170 -71.17 -16.72 62.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.181 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.435 ' CD1' ' HA ' ' A' ' 222' ' ' PRO . 3.5 t80 -56.96 135.52 79.92 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.877 -0.147 . . . . 0.0 110.986 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . 0.435 ' HA ' ' CD1' ' A' ' 221' ' ' TYR . 57.1 Cg_endo -90.51 107.91 0.79 Allowed 'Cis proline' 0 C--N 1.357 0.983 0 C-N-CA 124.681 -0.966 . . . . 0.0 112.631 0.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . 178.84 42.56 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.096 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.01 160.51 11.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.078 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 176.81 40.33 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.083 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . 59.99 -176.25 0.1 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.075 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -138.41 31.49 2.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.048 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 10.8 mp -118.84 32.61 6.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.854 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -112.69 44.64 1.44 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.812 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 48.3 mtp85 -136.45 -53.39 0.72 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.983 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 43.7 m-20 -90.93 81.59 5.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.879 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 10.2 m -75.09 177.46 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.061 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 6.8 ttmm . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.188 -0.911 . . . . 0.0 110.88 179.959 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.15 0 N-CA-C 112.469 -0.252 . . . . 0.0 112.469 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.8 m -96.69 80.12 3.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.804 0.335 . . . . 0.0 110.931 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -133.69 151.39 51.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.876 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 81.0 m95 -73.56 168.48 19.21 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.185 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -102.88 132.24 49.22 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.808 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.31 107.03 3.11 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.777 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.404 ' CD1' HG22 ' A' ' 168' ' ' THR . 44.2 pt -96.21 -7.8 9.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.498 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -159.94 176.78 11.47 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.003 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.442 ' O ' ' HA ' ' A' ' 154' ' ' VAL . 33.1 m-85 -143.41 127.2 17.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.284 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.6 t -93.44 122.71 45.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.098 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -82.52 94.11 7.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.36 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -145.22 155.68 43.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.255 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 59.31 29.45 19.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.855 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 62.88 35.03 13.82 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.142 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 53.3 m -157.13 156.76 33.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.836 0.351 . . . . 0.0 111.17 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -94.75 91.39 6.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.888 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.433 ' CG ' ' HA ' ' A' ' 141' ' ' LYS . 23.3 m-85 -70.81 121.75 84.77 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.303 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.421 ' HA ' ' CD2' ' A' ' 123' ' ' TYR . 22.3 Cg_exo -64.81 121.66 9.26 Favored 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 122.414 2.076 . . . . 0.0 112.757 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.428 ' HG ' HG21 ' A' ' 168' ' ' THR . 31.1 tp -102.09 123.36 45.82 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-O 121.128 0.49 . . . . 0.0 110.087 178.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 51.5 mt -70.72 171.81 9.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.652 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -62.94 -28.32 69.99 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.979 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 50.8 p-10 -90.46 11.97 20.0 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.225 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.435 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 75.15 18.79 80.05 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.237 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -77.6 92.43 4.09 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.41 113.78 4.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.418 -179.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 30.1 mt -84.01 70.07 10.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.69 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.433 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 5.4 mtpt -58.26 -20.3 41.18 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.56 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -99.38 25.24 7.15 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.739 -0.21 . . . . 0.0 111.27 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -147.16 24.83 1.14 Allowed 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.582 0.23 . . . . 0.0 111.493 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -59.41 161.71 15.21 Favored Glycine 0 CA--C 1.509 -0.335 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.747 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 9.0 t -131.27 154.51 48.42 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.041 0.448 . . . . 0.0 110.7 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -92.95 53.92 2.08 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.766 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.74 170.81 6.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.256 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -104.26 135.85 19.27 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.537 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.441 ' HG3' ' CD1' ' A' ' 123' ' ' TYR . 68.3 Cg_endo -82.77 99.67 0.93 Allowed 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.95 2.433 . . . . 0.0 112.443 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.4 t -67.01 -10.1 46.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.844 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.92 -22.08 22.16 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -138.67 166.69 23.4 Favored Pre-proline 0 C--N 1.328 -0.356 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -178.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.87 164.2 35.19 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 122.487 2.125 . . . . 0.0 112.3 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 24.3 t -123.4 109.68 24.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.666 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.43 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.58 96.77 2.02 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.947 179.344 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 59.5 t -94.68 136.87 24.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.983 0.421 . . . . 0.0 111.124 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 49.7 51.33 28.71 Favored Glycine 0 CA--C 1.52 0.375 0 CA-C-N 115.811 -0.631 . . . . 0.0 113.259 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.43 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 2.9 m95 -94.75 151.01 19.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.054 0.454 . . . . 0.0 111.574 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -66.0 -172.43 0.14 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.421 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -43.67 154.7 0.09 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.073 0.463 . . . . 0.0 112.217 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -56.45 -25.24 48.91 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.269 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.33 -39.17 86.12 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 120.912 0.387 . . . . 0.0 110.058 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.19 -40.22 52.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.102 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 6.1 mt -59.13 -41.58 84.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.909 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.44 -30.74 53.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.2 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -67.21 -53.17 32.67 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-O 121.439 0.638 . . . . 0.0 110.072 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.72 -45.53 91.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.989 178.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.435 HG21 ' HA2' ' A' ' 137' ' ' GLY . 0.2 OUTLIER -57.28 -36.77 71.45 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.565 179.037 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.13 -38.21 94.04 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 178.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -71.24 -48.17 52.83 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.329 -0.436 . . . . 0.0 110.939 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.427 HD11 ' CE1' ' A' ' 214' ' ' PHE . 10.9 mp -64.51 -28.6 69.76 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.742 0.306 . . . . 0.0 111.275 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.87 -18.37 63.41 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.37 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -112.15 -28.32 8.02 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.645 0.26 . . . . 0.0 111.421 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.55 166.9 1.51 Allowed Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.998 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -70.04 128.78 16.26 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.263 1.975 . . . . 0.0 112.898 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.94 -25.8 9.01 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.64 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -58.05 -48.79 79.04 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.881 0.372 . . . . 0.0 110.935 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.406 ' CG1' ' HB3' ' A' ' 218' ' ' LEU . 24.6 t -73.66 -35.31 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.504 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 11.5 tp -55.26 -34.61 64.19 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.234 0.54 . . . . 0.0 109.987 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -78.71 -42.73 12.86 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.314 178.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -82.16 103.19 11.59 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.899 0.381 . . . . 0.0 110.404 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 2.9 mtm 177.65 173.48 0.54 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.956 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 3.2 t -133.09 -51.65 0.89 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.705 0.288 . . . . 0.0 111.229 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . 0.408 ' HG2' ' CD1' ' A' ' 200' ' ' TYR . 1.3 pm0 -163.13 142.85 8.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.035 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 19.9 mt -106.66 114.24 45.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.442 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -104.6 124.04 48.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.16 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -80.47 104.82 11.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.368 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.71 85.91 56.37 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.54 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.27 140.29 44.14 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.258 1.972 . . . . 0.0 112.419 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 17.2 p -117.9 160.54 21.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.76 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -54.7 -28.65 49.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.335 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -102.41 -15.9 16.37 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.841 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -141.05 80.21 1.73 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.924 0.392 . . . . 0.0 111.464 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -56.66 -22.01 31.47 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.43 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -107.13 38.33 2.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.772 0.32 . . . . 0.0 110.616 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -91.1 115.75 28.27 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.985 0.421 . . . . 0.0 111.379 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 27.7 m -112.55 166.6 6.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.655 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 21.5 mm -131.68 109.85 16.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.732 0.301 . . . . 0.0 111.29 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.417 HG12 ' CE2' ' A' ' 214' ' ' PHE . 8.5 m -100.08 124.92 53.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.912 0.387 . . . . 0.0 111.021 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.408 ' CD1' ' HG2' ' A' ' 184' ' ' GLU . 44.8 m-85 -86.6 152.53 22.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.571 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 5.5 mmt -104.07 165.4 11.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.937 0.399 . . . . 0.0 110.936 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -67.4 -26.15 66.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.062 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -89.94 13.87 13.59 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 80.99 14.44 79.42 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 120.556 -0.831 . . . . 0.0 113.321 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -77.0 168.09 20.69 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 117.119 0.46 . . . . 0.0 110.729 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -134.51 111.57 10.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.851 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 17.9 t -119.38 123.91 72.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.165 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 27.1 t -101.29 114.84 29.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.751 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.91 161.75 23.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.862 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.83 154.94 17.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.624 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 36.8 mt -67.18 -30.14 48.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.713 0.292 . . . . 0.0 110.986 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -72.07 -38.26 69.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.289 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -121.99 34.69 5.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.038 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.427 ' CE1' HD11 ' A' ' 171' ' ' LEU . 12.0 t80 -62.0 -56.05 23.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.926 0.393 . . . . 0.0 110.7 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.63 -40.64 83.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.138 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -67.42 -49.19 64.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.952 0.406 . . . . 0.0 110.365 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.42 -45.02 72.91 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.057 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.406 ' HB3' ' CG1' ' A' ' 178' ' ' VAL . 3.8 mm? -80.89 -27.67 36.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.785 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 13.5 t -60.64 -30.34 69.81 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.846 0.355 . . . . 0.0 110.529 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 65.6 m-70 -69.25 -16.9 63.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.21 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.412 ' CG ' ' HA ' ' A' ' 222' ' ' PRO . 60.6 t80 -64.66 139.46 97.76 Favored Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 121.285 -0.166 . . . . 0.0 110.844 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . 0.412 ' HA ' ' CG ' ' A' ' 221' ' ' TYR . 70.5 Cg_endo -86.64 110.47 1.64 Allowed 'Cis proline' 0 C--N 1.357 0.976 0 C-N-CA 124.532 -1.029 . . . . 0.0 112.609 0.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . 169.27 43.94 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.216 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 9.9 pt -120.76 -178.48 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.273 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 77.19 68.61 0.05 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.043 0.449 . . . . 0.0 110.99 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -89.91 -157.0 0.44 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.576 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -92.1 20.49 5.84 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.9 26.54 10.08 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.793 0.33 . . . . 0.0 110.666 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -135.12 73.87 1.5 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.047 0.451 . . . . 0.0 110.877 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -153.26 -48.74 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.87 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 64.0 -79.27 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.004 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 5.0 m -157.84 178.53 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.833 0.349 . . . . 0.0 111.065 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 22.0 pttt . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.83 -179.958 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.185 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 59.1 p -72.27 149.23 44.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.744 0.307 . . . . 0.0 110.916 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -157.98 154.18 27.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.959 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.407 ' HB2' ' HB3' ' A' ' 134' ' ' LEU . 81.9 m95 -74.15 168.4 19.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.143 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 6.9 ptt180 -101.7 134.49 44.78 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.845 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -71.2 106.89 3.96 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.858 0.361 . . . . 0.0 110.75 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.403 ' CD1' HG21 ' A' ' 168' ' ' THR . 46.0 pt -95.93 -9.45 9.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.315 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -157.75 176.14 12.97 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 120.586 0.231 . . . . 0.0 110.691 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.459 ' CD1' ' CG ' ' A' ' 149' ' ' PRO . 29.9 m-85 -143.92 126.7 16.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.16 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 4.3 t -93.12 122.42 44.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.279 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.497 ' CE1' ' CE1' ' A' ' 130' ' ' PHE . 7.3 t80 -81.92 97.13 7.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.935 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -149.14 151.62 34.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.44 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 61.17 30.88 19.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.804 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 61.81 31.29 18.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.034 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 70.4 m -151.2 151.13 31.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.941 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.497 ' CE1' ' CE1' ' A' ' 125' ' ' TYR . 12.1 m-85 -93.07 91.05 7.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.701 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.432 ' CD1' ' HA ' ' A' ' 141' ' ' LYS . 23.5 m-85 -66.57 123.38 85.56 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.665 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.416 ' HA ' ' CD2' ' A' ' 123' ' ' TYR . 44.8 Cg_endo -70.65 113.32 3.48 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 122.107 1.872 . . . . 0.0 112.727 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.414 ' HG ' HG23 ' A' ' 168' ' ' THR . 32.2 tp -92.44 124.02 36.18 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.706 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.407 ' HB3' ' HB2' ' A' ' 118' ' ' TRP . 48.1 mt -69.86 174.25 5.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.503 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -65.73 -28.31 68.95 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.029 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -89.74 11.84 18.82 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.156 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.444 ' HA2' HG23 ' A' ' 168' ' ' THR . . . 74.1 22.8 77.37 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.937 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 18.2 tpp180 -81.92 93.62 6.95 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.69 109.34 3.76 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.151 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 15.7 mt -85.14 71.64 10.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.87 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.432 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 12.8 mttt -57.77 -21.14 39.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.469 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -94.28 20.05 8.67 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.419 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -145.15 26.95 1.31 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.846 0.355 . . . . 0.0 111.045 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.77 163.89 39.76 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.96 -0.638 . . . . 0.0 113.199 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 6.7 t -130.69 157.01 43.94 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.328 -0.436 . . . . 0.0 110.563 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.3 mmmt -94.3 50.09 1.35 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.548 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.15 150.35 3.0 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.695 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.453 ' CB ' ' CE2' ' A' ' 130' ' ' PHE . . . -93.05 125.64 54.16 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.242 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.459 ' CG ' ' CD1' ' A' ' 123' ' ' TYR . 71.9 Cg_endo -84.1 111.32 1.62 Allowed 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.433 2.089 . . . . 0.0 112.599 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 45.5 t -69.62 -8.19 45.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.013 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -77.25 -23.51 51.24 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 120.865 0.364 . . . . 0.0 110.54 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.17 166.62 22.25 Favored Pre-proline 0 N--CA 1.453 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.562 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -74.99 158.03 42.49 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.342 2.028 . . . . 0.0 112.331 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 14.3 t -118.24 110.67 31.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.251 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.433 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.52 96.25 1.92 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.726 179.206 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.412 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 61.7 t -93.35 137.22 23.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.007 0.432 . . . . 0.0 111.149 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 49.0 54.13 15.77 Favored Glycine 0 CA--C 1.52 0.363 0 CA-C-N 115.859 -0.609 . . . . 0.0 113.327 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.433 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 2.7 m95 -97.32 151.13 20.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.118 0.485 . . . . 0.0 111.55 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.22 -172.41 0.15 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.322 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -43.21 154.99 0.07 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -56.51 -24.51 46.93 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.154 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -60.33 -40.27 90.02 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.969 0.414 . . . . 0.0 109.911 179.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -74.39 -41.43 60.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.972 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 6.6 mt -58.28 -42.21 83.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.009 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.77 -29.89 42.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.192 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -68.19 -53.2 26.6 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.435 0.636 . . . . 0.0 110.107 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.08 -45.97 89.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.099 178.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.444 HG23 ' HA2' ' A' ' 137' ' ' GLY . 0.2 OUTLIER -56.98 -37.52 71.75 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.709 179.258 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.14 -37.86 93.52 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 47.9 mm-40 -72.89 -46.32 53.43 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.419 -0.39 . . . . 0.0 111.135 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.421 HD12 ' CE1' ' A' ' 214' ' ' PHE . 11.1 mp -65.86 -28.57 69.06 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.658 0.266 . . . . 0.0 111.406 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.52 -17.67 62.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.379 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -112.51 -28.79 7.72 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 120.697 0.284 . . . . 0.0 111.453 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.94 167.28 1.11 Allowed Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.188 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -69.24 127.15 14.58 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.21 1.94 . . . . 0.0 112.861 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.11 -25.51 9.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.592 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -58.46 -48.99 78.92 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.959 0.409 . . . . 0.0 110.889 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.405 ' CG1' ' HB3' ' A' ' 218' ' ' LEU . 27.2 t -73.75 -33.8 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.438 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 13.8 tp -56.46 -35.26 67.72 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.141 0.496 . . . . 0.0 109.815 179.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -78.02 -40.84 19.73 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.188 178.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -84.6 102.84 13.22 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.977 0.418 . . . . 0.0 110.57 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' MET . . . . . 0.403 ' CE ' ' CG1' ' A' ' 178' ' ' VAL . 2.9 mtm 177.63 173.55 0.54 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.007 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 4.7 t -133.68 -50.27 0.84 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.752 0.31 . . . . 0.0 111.225 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -163.45 145.25 9.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.025 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 20.2 mt -110.87 115.99 51.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.539 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . 0.412 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 20.3 m170 -106.64 137.82 43.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.208 -179.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.403 ' CZ ' HD13 ' A' ' 211' ' ' ILE . 0.2 OUTLIER -87.86 104.54 16.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.472 179.596 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.35 89.27 50.26 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.87 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.78 158.76 55.83 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.314 2.009 . . . . 0.0 112.486 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 6.9 p -133.59 170.0 16.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.75 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 7.4 ptt180 -60.23 -27.42 67.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.151 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . 0.403 ' O ' ' CG ' ' A' ' 193' ' ' TYR . 1.7 mm-40 -117.3 10.6 13.76 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.403 ' CG ' ' O ' ' A' ' 192' ' ' GLU . 73.7 m-85 -156.96 75.5 0.83 Allowed 'General case' 0 C--O 1.231 0.108 0 CA-C-O 120.949 0.404 . . . . 0.0 111.208 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -57.21 -26.36 60.57 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.215 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 6.8 p30 -102.94 37.09 2.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.752 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -87.59 115.39 24.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.938 0.399 . . . . 0.0 111.093 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 30.5 m -112.14 168.19 5.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.686 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 25.7 mm -132.61 109.77 15.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.785 0.326 . . . . 0.0 111.318 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.424 HG13 ' CZ ' ' A' ' 214' ' ' PHE . 6.9 m -99.0 121.04 49.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.901 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -81.94 152.52 26.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.835 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.04 146.44 35.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.863 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -57.32 -22.61 43.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.504 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -89.7 15.22 9.99 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 79.62 14.41 81.22 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.241 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -90.59 149.92 21.94 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 117.137 0.468 . . . . 0.0 110.801 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -119.38 111.33 18.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.765 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 20.8 t -111.68 126.23 69.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.964 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 11.0 m -103.08 116.36 32.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.934 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -121.84 -177.58 3.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.569 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.66 153.7 35.15 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.494 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.403 HD13 ' CZ ' ' A' ' 187' ' ' TYR . 43.7 mt -66.63 -34.93 73.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.811 0.339 . . . . 0.0 110.775 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.4 -36.42 81.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.207 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -129.92 45.27 2.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.978 0.418 . . . . 0.0 110.903 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.424 ' CZ ' HG13 ' A' ' 199' ' ' VAL . 11.6 t80 -68.53 -52.24 34.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.768 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.9 -39.7 86.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.132 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.71 -49.99 64.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.146 0.498 . . . . 0.0 110.603 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -53.99 -44.08 70.52 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.41 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.405 ' HB3' ' CG1' ' A' ' 178' ' ' VAL . 3.9 mm? -84.85 -23.77 28.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.266 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.31 -33.59 73.83 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.003 0.43 . . . . 0.0 109.934 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 38.2 m170 -70.06 -16.16 63.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.236 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.42 ' CE1' ' HB3' ' A' ' 222' ' ' PRO . 12.6 t80 -56.82 137.62 78.59 Favored Pre-proline 0 CA--C 1.535 0.367 0 O-C-N 122.535 -0.103 . . . . 0.0 111.134 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . 0.42 ' HB3' ' CE1' ' A' ' 221' ' ' TYR . 51.9 Cg_endo -91.81 105.43 0.45 Allowed 'Cis proline' 0 C--N 1.357 0.995 0 C-N-CA 124.702 -0.958 . . . . 0.0 112.539 0.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . 176.47 42.85 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.969 0.414 . . . . 0.0 111.124 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -117.65 -178.63 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.136 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 70.34 86.49 0.12 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.971 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -76.79 -163.8 0.37 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.096 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -98.82 33.06 2.41 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.882 0.372 . . . . 0.0 110.906 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 1.3 tp -83.65 5.5 24.25 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.75 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -118.69 31.7 6.52 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.861 0.363 . . . . 0.0 110.888 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -176.79 37.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.947 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -168.97 -60.13 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.85 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 21.5 t -108.38 106.79 21.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.078 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 2.3 mttm . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.878 179.98 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.152 0 N-CA-C 112.535 -0.226 . . . . 0.0 112.535 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.51 88.75 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.852 0.358 . . . . 0.0 110.941 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -77.66 153.08 33.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.995 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.402 ' HB2' ' HB3' ' A' ' 134' ' ' LEU . 80.7 m95 -77.13 168.36 20.21 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.053 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.32 133.77 46.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.818 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.4 mtt85 -70.4 106.78 3.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.869 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 44.6 pt -95.47 -8.44 9.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.412 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -159.38 176.28 12.32 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 120.588 0.232 . . . . 0.0 110.894 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.436 ' CD1' ' HG3' ' A' ' 149' ' ' PRO . 32.2 m-85 -143.5 126.96 16.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.332 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 5.0 t -93.36 122.63 45.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.083 0.468 . . . . 0.0 111.12 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.5 ' CD1' ' CE1' ' A' ' 130' ' ' PHE . 7.9 t80 -82.52 103.84 12.35 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.857 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -158.44 154.22 26.5 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.592 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.62 30.65 19.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.803 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 62.99 31.48 16.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.274 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 88.1 m -153.79 156.77 38.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.89 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.5 ' CE1' ' CD1' ' A' ' 125' ' ' TYR . 81.2 m-85 -98.42 90.88 4.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.602 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.443 ' CG ' ' HA ' ' A' ' 141' ' ' LYS . 23.4 m-85 -65.35 123.79 85.26 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.117 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.422 ' HA ' ' CD2' ' A' ' 123' ' ' TYR . 56.1 Cg_endo -71.57 115.22 4.21 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.255 1.97 . . . . 0.0 112.793 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.418 ' HG ' HG22 ' A' ' 168' ' ' THR . 29.2 tp -94.09 124.06 37.86 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.665 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.402 ' HB3' ' HB2' ' A' ' 118' ' ' TRP . 52.8 mt -70.69 173.29 7.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.517 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -64.3 -28.66 69.87 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.969 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -89.8 11.72 19.28 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.251 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.438 ' HA2' HG22 ' A' ' 168' ' ' THR . . . 74.38 22.72 77.11 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.726 -0.75 . . . . 0.0 113.048 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -81.43 94.53 6.84 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.96 107.88 4.28 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.211 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 16.7 mt -86.17 72.85 10.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.547 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.443 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 23.8 mttp -56.86 -20.95 25.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.77 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -85.24 -14.87 45.39 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -112.03 30.82 6.7 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . -60.5 166.24 12.12 Favored Glycine 0 CA--C 1.511 -0.185 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.453 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 9.0 t -135.3 148.27 49.45 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.992 0.425 . . . . 0.0 111.029 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 3.0 mmtt -90.86 52.82 2.24 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.356 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.68 152.22 3.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.549 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -86.99 135.95 34.61 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.833 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.437 ' HD2' ' CG2' ' A' ' 154' ' ' VAL . 60.6 Cg_endo -84.46 98.42 0.72 Allowed 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.028 2.485 . . . . 0.0 112.641 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.2 t -67.46 -9.13 39.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.714 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -90.35 -22.06 21.7 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 111.533 0.197 . . . . 0.0 111.533 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -138.7 167.43 19.52 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.36 161.85 41.7 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.533 2.156 . . . . 0.0 112.382 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.437 ' CG2' ' HD2' ' A' ' 149' ' ' PRO . 24.2 t -123.07 110.03 25.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.044 0.45 . . . . 0.0 111.712 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.434 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.62 95.92 1.91 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.74 179.156 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 59.6 t -91.37 137.06 22.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.99 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 46.72 56.59 7.33 Favored Glycine 0 CA--C 1.52 0.399 0 CA-C-N 115.882 -0.599 . . . . 0.0 113.374 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.434 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 2.7 m95 -98.25 151.2 20.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.26 0.552 . . . . 0.0 111.707 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 8.1 mmtm -65.23 -172.44 0.1 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.59 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -43.62 154.02 0.1 Allowed 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -57.21 -24.85 52.89 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.224 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.01 -38.53 82.9 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.984 0.421 . . . . 0.0 110.056 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.01 -40.24 47.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.003 178.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 6.2 mt -58.87 -41.46 82.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.874 178.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.09 -29.68 45.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.276 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -69.08 -53.03 22.47 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.31 0.576 . . . . 0.0 110.256 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.1 -44.52 91.97 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.041 178.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.438 HG22 ' HA2' ' A' ' 137' ' ' GLY . 0.2 OUTLIER -58.49 -38.22 77.19 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.397 179.214 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.19 -36.16 87.49 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 178.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -73.92 -47.59 36.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.264 -0.468 . . . . 0.0 110.988 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.421 HD13 ' CE1' ' A' ' 214' ' ' PHE . 11.0 mp -65.07 -27.93 69.11 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.754 0.311 . . . . 0.0 111.477 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.74 -18.6 62.78 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.297 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -113.4 -27.01 8.08 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.596 0.236 . . . . 0.0 111.626 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.09 167.5 1.12 Allowed Pre-proline 0 CA--C 1.537 0.481 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.079 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.52 128.22 15.92 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.2 1.933 . . . . 0.0 112.84 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.22 -25.38 9.1 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.631 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.74 -48.95 78.18 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.944 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.409 ' CG1' ' CE ' ' A' ' 182' ' ' MET . 38.9 t -74.16 -35.48 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.439 179.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 13.8 tp -56.82 -39.4 74.12 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.095 0.474 . . . . 0.0 109.969 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -73.6 -40.05 47.69 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 178.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -88.14 102.87 15.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.948 0.404 . . . . 0.0 110.577 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' MET . . . . . 0.409 ' CE ' ' CG1' ' A' ' 178' ' ' VAL . 2.8 mtm 177.69 164.19 0.62 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.146 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.53 -59.85 1.59 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.725 0.298 . . . . 0.0 111.091 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -155.24 142.58 19.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.034 0.445 . . . . 0.0 111.29 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 20.4 mt -104.69 114.86 45.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.317 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 23.6 m170 -103.12 117.46 34.59 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.256 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.4 ' HB2' ' CD2' ' A' ' 158' ' ' TRP . 71.2 t80 -76.4 104.48 6.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.432 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.94 82.44 43.21 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.647 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -71.99 147.53 49.32 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.383 2.056 . . . . 0.0 112.559 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 19.5 p -128.52 160.35 32.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.699 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 6.0 ptp85 -52.52 -24.98 9.1 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.661 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -106.62 -19.22 13.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.685 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -136.37 75.57 1.55 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.912 0.387 . . . . 0.0 111.274 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -58.37 -20.1 41.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.577 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -110.32 36.21 3.15 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.691 0.281 . . . . 0.0 111.062 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 9.4 ttt180 -89.53 115.17 26.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.121 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.414 HG13 ' CZ2' ' A' ' 158' ' ' TRP . 22.5 m -111.91 166.91 5.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.955 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 19.8 mm -133.9 107.72 10.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.8 0.333 . . . . 0.0 111.314 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.422 HG11 ' CE2' ' A' ' 214' ' ' PHE . 13.2 m -99.05 131.26 46.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.081 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -95.37 152.44 18.39 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.534 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.52 157.97 16.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.895 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -57.81 -24.8 59.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.343 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -90.42 15.45 10.65 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 79.53 14.32 81.45 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.565 -0.826 . . . . 0.0 113.243 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -75.75 164.98 25.7 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.994 0.397 . . . . 0.0 110.791 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -134.56 111.45 10.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.86 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.6 t -117.87 128.92 74.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.081 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 4.2 m -103.13 115.2 30.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.768 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -127.11 158.58 36.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.893 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.06 153.27 18.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.503 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 36.7 mt -65.07 -37.18 79.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.882 0.372 . . . . 0.0 110.867 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.48 -33.17 72.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.198 -179.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -134.89 42.27 2.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.86 0.362 . . . . 0.0 111.104 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.422 ' CE2' HG11 ' A' ' 199' ' ' VAL . 11.4 t80 -64.64 -52.24 58.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.625 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.69 -42.16 87.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.192 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.65 -48.78 63.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.063 0.458 . . . . 0.0 110.338 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 1.3 mmpt? -53.84 -41.63 67.62 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.06 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -87.0 -24.01 24.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.97 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 12.6 t -62.63 -30.47 71.38 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.81 0.338 . . . . 0.0 110.42 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 38.7 m170 -69.03 -16.79 63.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.265 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.408 ' N ' ' CG2' ' A' ' 224' ' ' ILE . 71.5 t80 -66.11 136.49 95.43 Favored Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 110.259 -0.275 . . . . 0.0 110.259 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -72.77 154.92 99.41 Favored 'Cis proline' 0 C--N 1.355 0.887 0 C-N-CA 124.585 -1.006 . . . . 0.0 112.795 0.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . 81.99 77.57 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.921 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.408 ' CG2' ' N ' ' A' ' 221' ' ' TYR . 12.3 pt -127.74 -178.51 2.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.414 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 68.01 122.47 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.046 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -107.59 -164.99 1.01 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.173 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -105.08 36.24 2.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.86 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 6.7 tt -80.03 0.9 29.81 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.986 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -89.95 53.03 2.42 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.081 0.467 . . . . 0.0 110.744 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.9 -28.66 20.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.166 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -57.81 -74.56 0.06 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.081 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 17.5 m 46.19 -173.52 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.295 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.883 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.104 0 N-CA-C 112.522 -0.231 . . . . 0.0 112.522 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 59.98 109.36 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.759 0.314 . . . . 0.0 110.987 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -111.68 148.51 33.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.028 0.442 . . . . 0.0 110.972 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -73.4 168.34 19.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.069 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.82 136.64 41.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.489 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.64 105.38 4.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.683 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.402 ' CD1' HG21 ' A' ' 168' ' ' THR . 47.8 pt -95.13 -7.68 9.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.574 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -159.34 177.06 11.4 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 120.481 0.181 . . . . 0.0 110.589 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.456 ' CD1' ' CG ' ' A' ' 149' ' ' PRO . 30.3 m-85 -144.69 126.0 14.79 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 4.2 t -93.27 122.27 44.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.165 0.507 . . . . 0.0 111.416 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.49 ' CE1' ' CE1' ' A' ' 130' ' ' PHE . 11.1 t80 -84.07 94.22 8.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.79 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -142.56 152.55 42.71 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.408 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 58.77 30.31 19.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.99 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 64.11 34.31 11.26 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.357 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.4 ' CG2' ' N ' ' A' ' 145' ' ' THR . 52.9 m -153.92 152.87 31.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.825 0.345 . . . . 0.0 111.135 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.49 ' CE1' ' CE1' ' A' ' 125' ' ' TYR . 11.1 m-85 -94.41 90.92 6.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.836 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.448 ' CD1' ' HA ' ' A' ' 141' ' ' LYS . 27.2 m-85 -71.17 110.83 8.12 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.794 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.418 ' HA ' ' CD2' ' A' ' 123' ' ' TYR . 49.5 Cg_exo -55.41 121.34 9.75 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 122.39 2.06 . . . . 0.0 112.73 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.423 ' HG ' HG23 ' A' ' 168' ' ' THR . 30.3 tp -101.42 123.82 46.1 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.43 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 46.4 mt -70.72 174.13 6.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.577 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.4 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.3 pt-20 -64.63 -29.28 70.28 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.079 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -90.07 12.62 17.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.192 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.434 ' HA2' HG23 ' A' ' 168' ' ' THR . . . 74.96 16.73 80.39 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.111 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -74.85 93.53 2.65 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.401 ' CD2' ' CB ' ' A' ' 131' ' ' PHE . 0.4 OUTLIER -68.35 121.29 15.98 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.631 -178.906 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -90.97 73.48 6.44 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.696 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.448 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 7.7 mttt -61.46 -16.11 43.85 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.995 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -94.7 -24.18 17.25 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -101.32 27.62 6.07 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -61.59 159.39 30.62 Favored Glycine 0 CA--C 1.508 -0.358 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.711 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.4 ' N ' ' CG2' ' A' ' 129' ' ' THR . 8.0 t -130.65 157.53 42.52 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.971 0.415 . . . . 0.0 110.877 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -94.69 50.34 1.32 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.577 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.98 149.81 3.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.583 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.452 ' CB ' ' CE2' ' A' ' 130' ' ' PHE . . . -93.66 125.77 52.32 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.387 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.456 ' CG ' ' CD1' ' A' ' 123' ' ' TYR . 60.6 Cg_endo -82.12 111.78 2.2 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.243 1.962 . . . . 0.0 112.339 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 11.6 t -69.5 -7.96 42.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.12 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -78.36 -23.32 46.94 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 120.717 0.294 . . . . 0.0 110.507 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.23 166.84 20.66 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.765 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -74.85 156.11 43.67 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.384 2.056 . . . . 0.0 112.304 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 9.3 t -116.68 110.44 31.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.192 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.431 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.41 95.93 1.83 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.577 179.0 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 46.6 t -92.58 137.15 22.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.98 0.419 . . . . 0.0 111.162 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 48.73 57.78 8.2 Favored Glycine 0 CA--C 1.52 0.382 0 CA-C-N 115.893 -0.594 . . . . 0.0 113.304 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.431 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 2.9 m95 -100.69 151.17 21.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.198 0.523 . . . . 0.0 111.536 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -65.34 -172.43 0.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.459 179.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -43.74 154.69 0.09 Allowed 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -56.79 -25.15 51.46 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.327 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.22 -38.84 84.61 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 120.951 0.405 . . . . 0.0 110.087 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.62 -40.31 49.71 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.081 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 6.5 mt -59.17 -41.67 84.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.035 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.34 -30.9 53.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.23 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -67.83 -53.23 28.53 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.4 0.619 . . . . 0.0 109.968 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.53 -45.45 91.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.936 178.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.434 HG23 ' HA2' ' A' ' 137' ' ' GLY . 0.3 OUTLIER -56.75 -37.95 71.74 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.555 179.172 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.9 -37.38 92.51 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 178.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -70.94 -48.24 54.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.41 -0.395 . . . . 0.0 110.785 178.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.444 ' CD1' ' CE1' ' A' ' 214' ' ' PHE . 11.2 mp -64.89 -28.76 69.76 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.797 0.332 . . . . 0.0 111.23 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.31 -18.94 63.87 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.229 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -111.49 -28.64 8.09 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.669 0.271 . . . . 0.0 111.372 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.85 166.86 1.21 Allowed Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.135 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.28 128.0 15.82 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.225 1.95 . . . . 0.0 112.918 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.34 -26.29 11.86 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.541 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -58.42 -48.63 80.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.923 0.392 . . . . 0.0 110.88 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.408 ' CG1' ' CE ' ' A' ' 182' ' ' MET . 33.7 t -73.7 -33.52 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.406 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 6.4 tp -57.44 -36.21 71.1 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 121.122 0.487 . . . . 0.0 109.818 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -76.42 -42.04 23.79 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.296 178.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -84.36 103.12 13.26 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.977 0.418 . . . . 0.0 110.584 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' MET . . . . . 0.408 ' CE ' ' CG1' ' A' ' 178' ' ' VAL . 3.0 mtm 178.74 169.57 0.87 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.008 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.13 -55.32 1.47 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.733 0.301 . . . . 0.0 111.082 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -163.23 142.32 8.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.928 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.437 HD12 HG21 ' A' ' 185' ' ' ILE . 12.4 mt -104.78 114.38 44.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.229 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 23.3 m170 -103.81 126.32 50.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.191 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.419 ' CD2' ' HD3' ' A' ' 189' ' ' PRO . 46.0 t80 -79.21 104.09 9.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.2 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.75 78.41 39.3 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.764 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.419 ' HD3' ' CD2' ' A' ' 187' ' ' TYR . 50.6 Cg_endo -68.2 143.03 57.53 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.418 2.079 . . . . 0.0 112.365 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 18.6 p -122.47 160.47 25.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.786 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 57.8 mtt-85 -53.4 -26.91 21.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.403 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -105.96 -16.66 14.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.784 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -137.06 76.75 1.6 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.898 0.38 . . . . 0.0 111.367 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -56.5 -23.8 41.95 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.351 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -106.57 38.52 2.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.754 0.311 . . . . 0.0 110.71 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 4.0 tpt180 -90.26 118.7 29.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.065 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 25.5 m -117.51 165.94 12.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.915 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 21.1 mm -134.56 107.45 9.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.149 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 8.4 m -96.12 123.84 48.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.985 0.421 . . . . 0.0 110.997 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -83.54 152.62 24.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.748 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 4.3 mmt -108.55 152.39 24.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.895 0.379 . . . . 0.0 110.947 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 39.2 m-20 -60.11 -26.35 66.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.196 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -89.77 14.54 11.6 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.89 0.329 . . . . 0.0 111.89 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 81.13 14.41 79.18 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.373 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.42 154.59 22.7 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 117.028 0.414 . . . . 0.0 110.78 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -125.1 111.36 15.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.841 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 26.2 t -112.79 123.76 68.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.004 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 58.2 m -97.7 114.7 26.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.676 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -127.28 162.23 26.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.955 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.91 156.18 17.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.555 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.469 HG22 HD11 ' A' ' 211' ' ' ILE . 48.9 mt -63.49 -29.73 48.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.784 0.326 . . . . 0.0 110.953 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -74.63 -39.74 61.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.343 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -118.86 36.74 4.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.86 0.362 . . . . 0.0 111.016 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.444 ' CE1' ' CD1' ' A' ' 171' ' ' LEU . 11.6 t80 -66.69 -53.3 35.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.738 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.55 -37.22 86.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.757 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.9 -51.76 44.29 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.205 0.526 . . . . 0.0 110.463 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 8.4 mmmt -54.23 -43.35 70.8 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.094 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.402 ' HB3' ' CG1' ' A' ' 178' ' ' VAL . 4.2 mm? -83.59 -23.67 31.84 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.114 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.41 -34.14 74.87 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.056 0.455 . . . . 0.0 109.834 178.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -74.12 -16.85 61.0 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.087 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.442 ' CD1' ' HA ' ' A' ' 222' ' ' PRO . 1.5 t80 -55.58 130.64 71.04 Favored Pre-proline 0 CA--C 1.536 0.437 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.213 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . 0.442 ' HA ' ' CD1' ' A' ' 221' ' ' TYR . 55.4 Cg_endo -91.07 104.93 0.43 Allowed 'Cis proline' 0 C--N 1.356 0.968 0 C-N-CA 124.931 -0.862 . . . . 0.0 112.519 0.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -178.74 38.36 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.15 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.439 HD13 ' CD2' ' A' ' 221' ' ' TYR . 0.1 OUTLIER -141.78 157.98 20.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.99 179.588 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -179.82 174.53 0.91 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.167 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -85.87 148.53 25.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.194 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -144.51 34.26 1.17 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.054 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 3.3 tp -97.51 38.13 1.3 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.868 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 2.9 t70 59.0 90.51 0.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.853 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.42 87.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.029 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -177.03 -39.66 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.985 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 21.7 t 66.66 98.6 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.022 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 8.2 tppt? . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.931 -179.984 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.18 0 N-CA-C 112.452 -0.259 . . . . 0.0 112.452 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.2 m -111.24 170.65 7.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.857 0.361 . . . . 0.0 110.859 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -68.19 147.53 52.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.034 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -70.34 168.3 16.27 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.044 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.78 138.08 40.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.517 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.33 105.71 4.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.858 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.404 ' CD1' HG22 ' A' ' 168' ' ' THR . 49.4 pt -95.36 -6.64 9.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.604 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -159.75 176.83 11.49 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 120.553 0.216 . . . . 0.0 110.571 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.464 ' CD1' ' CG ' ' A' ' 149' ' ' PRO . 34.6 m-85 -144.64 126.11 14.94 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.7 t -93.16 122.28 44.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.101 0.477 . . . . 0.0 111.41 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.482 ' CE1' ' CE1' ' A' ' 130' ' ' PHE . 15.8 t80 -83.05 93.96 7.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.669 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -144.73 153.06 41.29 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.352 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 60.2 29.35 18.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.758 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 62.36 34.51 15.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.863 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.4 ' CG2' ' N ' ' A' ' 145' ' ' THR . 45.2 m -152.47 156.23 39.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.059 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.482 ' CE1' ' CE1' ' A' ' 125' ' ' TYR . 19.0 m-85 -97.93 91.43 5.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.225 0.536 . . . . 0.0 110.866 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.429 ' CG ' ' HA ' ' A' ' 141' ' ' LYS . 27.8 m-85 -72.0 115.04 34.33 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.613 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.422 ' HA ' ' CD2' ' A' ' 123' ' ' TYR . 33.3 Cg_exo -61.16 117.07 3.82 Favored 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 122.422 2.082 . . . . 0.0 112.672 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.416 ' HG ' HG21 ' A' ' 168' ' ' THR . 30.6 tp -96.77 124.01 40.63 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.414 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 52.1 mt -70.5 174.45 5.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.645 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -65.11 -29.26 70.11 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.099 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 51.3 p-10 -89.68 11.88 18.56 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.254 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.433 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 75.08 19.02 80.08 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.856 -0.688 . . . . 0.0 113.007 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -77.36 93.2 4.01 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.32 121.48 16.36 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.806 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -90.29 73.4 7.08 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.394 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.429 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 6.0 mttp -61.58 -15.61 40.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.302 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -98.52 -21.57 16.45 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -101.06 27.7 5.88 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -62.09 160.36 31.03 Favored Glycine 0 CA--C 1.51 -0.267 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.824 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.4 ' N ' ' CG2' ' A' ' 129' ' ' THR . 9.7 t -131.28 156.36 45.58 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.987 0.422 . . . . 0.0 110.729 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -93.11 51.0 1.6 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.735 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.1 151.23 3.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.573 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.457 ' CB ' ' CE2' ' A' ' 130' ' ' PHE . . . -95.14 125.64 49.59 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.39 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.464 ' CG ' ' CD1' ' A' ' 123' ' ' TYR . 73.9 Cg_endo -83.13 111.02 1.84 Allowed 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.355 2.037 . . . . 0.0 112.299 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 22.3 t -69.28 -8.12 43.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.163 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -77.85 -23.61 48.85 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 120.861 0.362 . . . . 0.0 110.607 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -138.11 166.71 23.89 Favored Pre-proline 0 N--CA 1.453 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.845 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -74.67 157.93 43.79 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.444 2.096 . . . . 0.0 112.105 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.424 HG12 ' CE2' ' A' ' 130' ' ' PHE . 12.5 t -118.47 110.09 29.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.0 0.428 . . . . 0.0 111.369 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.43 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.61 95.95 1.91 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.644 179.054 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.422 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 61.6 t -92.54 136.66 24.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.09 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 48.59 57.07 8.74 Favored Glycine 0 CA--C 1.521 0.41 0 CA-C-N 115.891 -0.595 . . . . 0.0 113.319 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.43 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 3.5 m95 -99.91 151.14 21.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.175 0.512 . . . . 0.0 111.65 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.37 -172.22 0.15 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.553 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -43.4 154.27 0.09 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.268 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -57.16 -24.94 53.07 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.238 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -59.98 -40.72 90.09 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.871 0.367 . . . . 0.0 110.124 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -75.12 -40.34 59.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.982 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 6.8 mt -58.89 -41.99 84.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.971 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.71 -31.54 48.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.087 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -67.23 -52.96 34.58 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.575 0.702 . . . . 0.0 109.885 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.26 -44.42 95.32 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.013 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.433 HG21 ' HA2' ' A' ' 137' ' ' GLY . 0.3 OUTLIER -57.02 -38.11 72.66 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.484 179.171 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.18 -37.78 93.44 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 46.9 mm-40 -69.45 -48.69 60.07 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.408 -0.396 . . . . 0.0 110.92 178.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.451 ' CD1' ' CE1' ' A' ' 214' ' ' PHE . 9.9 mp -64.61 -29.35 70.36 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.758 0.313 . . . . 0.0 111.191 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.44 -20.28 64.63 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.368 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -110.91 -26.58 9.23 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.601 0.238 . . . . 0.0 111.414 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.85 166.32 1.99 Allowed Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.898 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.52 128.29 16.03 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.26 1.973 . . . . 0.0 112.94 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.24 -25.95 10.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.53 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -58.63 -48.65 80.3 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.877 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.405 ' CG1' ' CE ' ' A' ' 182' ' ' MET . 32.3 t -73.81 -33.31 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.417 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 10.2 tp -56.71 -35.29 68.35 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 121.126 0.489 . . . . 0.0 110.047 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -79.5 -40.1 16.45 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.232 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -85.65 103.14 14.19 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 120.93 0.395 . . . . 0.0 110.556 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' MET . . . . . 0.405 ' CE ' ' CG1' ' A' ' 178' ' ' VAL . 2.8 mtm 177.35 170.8 0.58 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.158 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.48 -56.81 1.49 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.721 0.296 . . . . 0.0 111.063 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -163.16 142.7 8.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.047 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.42 HG21 HD11 ' A' ' 185' ' ' ILE . 13.8 mt -103.03 115.11 44.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.484 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . 0.422 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 21.6 m170 -105.75 125.43 50.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.205 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -78.48 104.73 9.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.335 179.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.5 78.53 37.09 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.424 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -66.54 147.87 82.75 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.442 2.095 . . . . 0.0 112.647 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 24.9 p -126.49 158.46 36.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.624 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 25.4 mtt180 -52.64 -26.59 14.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.507 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -105.63 -18.31 14.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.691 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -137.22 77.01 1.61 Allowed 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.955 0.407 . . . . 0.0 111.414 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -57.14 -22.15 37.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.419 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -105.14 36.88 2.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.777 0.322 . . . . 0.0 110.782 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 4.6 tpt180 -90.5 115.61 27.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.108 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 25.0 m -112.97 167.34 6.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.717 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 20.6 mm -135.22 106.75 7.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.457 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.416 HG11 ' CE2' ' A' ' 214' ' ' PHE . 7.7 m -95.86 125.72 48.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.924 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -86.12 152.2 23.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.698 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.52 152.8 23.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.858 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -58.41 -23.84 58.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.418 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -89.99 15.35 10.2 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 78.16 14.41 82.28 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.508 -0.853 . . . . 0.0 113.13 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -82.83 166.47 18.95 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 117.07 0.435 . . . . 0.0 110.749 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -133.54 114.54 13.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.973 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.3 t -115.96 126.07 73.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.087 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 2.8 p -99.14 115.68 29.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.767 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -126.37 159.26 33.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.73 154.8 18.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.569 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.427 HG21 HD11 ' A' ' 211' ' ' ILE . 32.6 mt -64.02 -34.08 66.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.018 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -67.62 -40.51 84.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.4 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -125.28 43.53 3.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.88 0.372 . . . . 0.0 110.967 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.451 ' CE1' ' CD1' ' A' ' 171' ' ' LEU . 12.5 t80 -67.93 -53.34 27.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.836 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.72 -38.13 77.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.211 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.92 -48.45 65.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.99 0.424 . . . . 0.0 110.559 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.16 -43.77 70.89 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.094 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -84.53 -25.24 28.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.982 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 11.8 t -61.21 -31.36 71.14 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 120.822 0.344 . . . . 0.0 110.454 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 1.5 m170 -69.12 -17.07 63.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.095 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.408 ' CD1' ' HA ' ' A' ' 222' ' ' PRO . 78.2 t80 -63.79 135.9 96.49 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . 0.408 ' HA ' ' CD1' ' A' ' 221' ' ' TYR . 60.8 Cg_endo -72.0 153.9 97.82 Favored 'Cis proline' 0 C--N 1.356 0.961 0 C-N-CA 124.512 -1.037 . . . . 0.0 112.444 0.032 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . 82.44 77.62 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.508 -179.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.407 HG21 HD11 ' A' ' 224' ' ' ILE . 5.5 pt -123.01 -179.18 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.096 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 66.53 123.2 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.076 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -115.28 -164.55 0.95 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.099 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -98.16 30.89 2.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.041 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 5.3 tt -86.44 8.6 21.13 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.662 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -88.75 53.87 2.84 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.047 0.451 . . . . 0.0 110.903 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 12.8 mtt180 -142.35 54.96 1.44 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.551 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 19.4 t30 64.11 132.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.773 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 11.1 p -57.26 144.23 9.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.254 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.297 -0.859 . . . . 0.0 110.887 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.168 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 79.6 p -88.39 148.25 24.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.763 0.316 . . . . 0.0 110.925 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 61.67 148.99 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.139 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -70.73 168.31 16.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.143 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -101.94 134.8 44.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.561 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 26.5 mtt180 -71.3 106.61 3.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.837 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.407 ' CD1' HG23 ' A' ' 168' ' ' THR . 47.5 pt -96.92 -6.38 9.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.494 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -160.64 176.25 11.76 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 121.08 -0.248 . . . . 0.0 110.88 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.468 ' CD1' ' CG ' ' A' ' 149' ' ' PRO . 37.5 m-85 -145.91 127.57 15.2 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 4.0 t -92.82 122.47 44.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.075 0.464 . . . . 0.0 111.445 -179.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.492 ' CE1' ' CZ ' ' A' ' 130' ' ' PHE . 9.5 t80 -85.12 100.93 12.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.925 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -154.16 154.22 33.17 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.489 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 8.1 tpp180 60.69 31.47 20.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.721 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 62.27 32.08 17.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.945 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 50.1 m -151.03 161.74 42.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.234 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.492 ' CZ ' ' CE1' ' A' ' 125' ' ' TYR . 87.0 m-85 -106.87 90.67 3.38 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.235 0.54 . . . . 0.0 110.841 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.444 ' CG ' ' HA ' ' A' ' 141' ' ' LYS . 20.7 m-85 -66.77 124.65 89.08 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.508 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.422 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 13.7 Cg_exo -68.6 123.29 10.31 Favored 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 122.327 2.018 . . . . 0.0 112.343 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.442 ' HG ' HG22 ' A' ' 168' ' ' THR . 36.9 tp -104.2 123.57 47.55 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.565 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 50.6 mt -72.69 173.07 9.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.733 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.402 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.5 pt-20 -63.02 -29.69 71.02 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.001 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 39.6 p-10 -89.84 11.91 18.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.143 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.426 ' HA2' HG22 ' A' ' 168' ' ' THR . . . 74.93 19.27 80.02 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.183 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 13.8 tpp180 -76.69 95.68 4.04 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.41 ' CD2' ' CB ' ' A' ' 131' ' ' PHE . 0.4 OUTLIER -70.71 122.46 19.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.913 -178.8 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -95.31 71.34 3.23 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.599 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.444 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 27.8 mttt -58.59 -19.76 41.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.78 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -89.46 -23.69 22.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.742 -0.208 . . . . 0.0 111.434 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -99.22 25.06 7.2 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.422 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -57.58 161.87 9.1 Favored Glycine 0 CA--C 1.51 -0.265 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.597 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 10.7 t -135.78 150.46 49.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.503 -0.348 . . . . 0.0 110.717 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 3.5 mmtt -89.81 52.05 2.22 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.017 0.437 . . . . 0.0 110.62 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.92 149.05 2.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.678 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.418 ' HB3' ' CE2' ' A' ' 130' ' ' PHE . . . -93.91 125.52 52.75 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.153 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.468 ' CG ' ' CD1' ' A' ' 123' ' ' TYR . 72.0 Cg_endo -84.22 109.72 1.45 Allowed 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.486 2.124 . . . . 0.0 112.567 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.2 t -69.77 -7.73 42.1 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.101 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -78.16 -22.95 47.95 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.79 0.329 . . . . 0.0 110.551 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -139.59 166.9 20.91 Favored Pre-proline 0 N--CA 1.453 -0.282 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.758 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -74.37 153.8 45.33 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.4 2.067 . . . . 0.0 112.194 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 12.2 t -115.67 109.51 28.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.222 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.431 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.55 95.74 1.86 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.534 178.881 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 55.3 t -92.33 136.99 23.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.956 0.407 . . . . 0.0 111.014 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 47.9 58.67 6.74 Favored Glycine 0 CA--C 1.521 0.416 0 CA-C-N 115.954 -0.567 . . . . 0.0 113.24 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.431 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 2.4 m95 -100.83 151.2 22.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.102 0.477 . . . . 0.0 111.828 -179.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -172.58 0.06 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.448 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -44.74 155.15 0.11 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.084 0.468 . . . . 0.0 112.173 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -57.42 -25.54 55.07 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.261 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.95 -39.42 85.52 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 120.991 0.424 . . . . 0.0 110.213 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -75.93 -40.75 53.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.184 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 6.2 mt -58.34 -41.48 81.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.045 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.14 -31.78 53.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.255 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -67.83 -53.08 29.74 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-O 121.517 0.675 . . . . 0.0 110.05 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.17 -45.74 90.22 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.002 178.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.442 HG22 ' HG ' ' A' ' 133' ' ' LEU . 0.5 OUTLIER -56.26 -38.63 71.41 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.643 179.075 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -58.77 -38.45 92.09 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 178.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 45.1 mm-40 -69.56 -48.37 60.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.315 -0.442 . . . . 0.0 110.902 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.45 ' CD1' ' CE1' ' A' ' 214' ' ' PHE . 10.8 mp -64.08 -29.85 70.96 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.724 0.297 . . . . 0.0 111.113 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -67.68 -19.96 65.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.259 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -111.22 -26.0 9.41 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.609 0.242 . . . . 0.0 111.424 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.4 166.6 1.58 Allowed Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.079 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.83 129.03 15.83 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.358 2.039 . . . . 0.0 112.707 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.19 -25.79 5.96 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.666 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.95 -49.82 75.48 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.953 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.409 ' CG1' ' CE ' ' A' ' 182' ' ' MET . 34.8 t -74.07 -34.65 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.502 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.47 -37.78 70.79 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.093 0.473 . . . . 0.0 110.063 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -78.92 -36.17 29.16 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.356 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -90.17 103.18 15.88 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.931 0.396 . . . . 0.0 110.846 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' MET . . . . . 0.409 ' CE ' ' CG1' ' A' ' 178' ' ' VAL . 2.7 mtm 177.66 173.99 0.53 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.034 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.97 -54.8 1.21 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.665 0.269 . . . . 0.0 111.168 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -163.14 142.83 8.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.959 0.409 . . . . 0.0 111.11 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.431 HD12 HG22 ' A' ' 185' ' ' ILE . 13.3 mt -104.8 114.98 45.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.454 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -103.32 123.66 47.2 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.155 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.426 ' HB2' ' CD2' ' A' ' 158' ' ' TRP . 65.9 t80 -81.58 104.33 11.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.375 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.37 80.87 45.79 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.667 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -67.96 146.69 72.25 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.324 2.016 . . . . 0.0 112.46 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 22.3 p -127.11 158.36 37.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.771 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 7.5 ptt-85 -52.18 -26.32 11.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.571 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -106.37 -18.89 13.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.506 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -134.99 73.82 1.5 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.007 0.432 . . . . 0.0 111.106 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.62 -21.58 28.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.646 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 11.3 p30 -109.47 38.98 2.19 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.861 0.362 . . . . 0.0 110.734 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 11.8 ttt-85 -91.47 117.16 29.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.18 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 28.9 m -113.48 167.13 6.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.676 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 17.0 mm -134.81 107.34 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.726 0.298 . . . . 0.0 111.363 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 11.9 m -98.04 134.87 34.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.927 0.394 . . . . 0.0 110.886 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -96.46 152.64 18.42 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.803 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 24.3 tpp -107.17 152.92 23.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.556 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -54.99 -24.45 24.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.784 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -90.44 15.55 10.5 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 79.24 14.54 81.55 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.544 -0.836 . . . . 0.0 113.047 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -77.99 157.8 29.52 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.929 0.395 . . . . 0.0 110.771 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -129.59 111.2 12.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.837 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.41 136.42 51.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.161 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 50.0 m -106.15 111.92 24.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.674 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -118.86 175.58 5.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.935 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.77 154.54 32.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.389 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.417 HD11 HG23 ' A' ' 211' ' ' ILE . 35.8 mt -66.61 -30.26 49.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.724 0.297 . . . . 0.0 110.859 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.61 -31.41 63.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.322 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -132.81 42.27 3.09 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.907 0.384 . . . . 0.0 110.96 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.45 ' CE1' ' CD1' ' A' ' 171' ' ' LEU . 11.7 t80 -68.3 -52.64 31.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.739 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.36 -39.44 87.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.892 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.18 -51.63 43.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.218 0.533 . . . . 0.0 110.243 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.91 -41.67 67.9 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.237 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -85.8 -23.13 27.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.061 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.03 -33.54 74.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.976 0.417 . . . . 0.0 110.144 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 21.1 m170 -70.7 -16.77 62.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.421 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.425 ' CD2' ' HA ' ' A' ' 222' ' ' PRO . 48.3 t80 -54.32 139.65 56.44 Favored Pre-proline 0 CA--C 1.537 0.473 0 O-C-N 122.42 -0.175 . . . . 0.0 110.557 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . 0.425 ' HA ' ' CD2' ' A' ' 221' ' ' TYR . 69.2 Cg_endo -73.37 154.06 99.41 Favored 'Cis proline' 0 C--N 1.354 0.852 0 C-N-CA 124.307 -1.122 . . . . 0.0 112.751 0.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . 84.63 76.59 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.099 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.406 ' CD1' ' N ' ' A' ' 224' ' ' ILE . 0.1 OUTLIER -146.09 143.57 21.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.032 0.444 . . . . 0.0 111.498 178.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 179.13 -169.93 0.11 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.029 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -109.66 144.95 37.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.943 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -129.81 33.37 4.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.242 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 13.8 mt -100.94 31.69 3.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.847 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -118.79 35.56 4.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.932 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 25.4 mtt85 -147.35 -47.46 0.17 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.835 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -122.7 111.78 17.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.782 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 21.3 t -59.26 139.05 19.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.193 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.903 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.142 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 62.21 149.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.755 0.312 . . . . 0.0 111.005 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 60.97 159.38 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.076 0.465 . . . . 0.0 111.048 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.421 ' HB2' ' HB3' ' A' ' 134' ' ' LEU . 84.9 m95 -66.18 168.31 8.75 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.007 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -100.72 136.33 40.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.391 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 5.9 mtm180 -72.35 107.33 4.89 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.762 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.402 ' CD1' HG22 ' A' ' 168' ' ' THR . 47.1 pt -96.89 -8.61 9.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.339 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -158.25 175.8 13.29 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 120.572 0.225 . . . . 0.0 110.672 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.478 ' CD1' ' CG ' ' A' ' 149' ' ' PRO . 30.4 m-85 -144.59 126.37 15.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.26 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 4.2 t -93.53 123.1 45.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.986 0.422 . . . . 0.0 111.294 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.491 ' CE1' ' CE1' ' A' ' 130' ' ' PHE . 7.0 t80 -84.61 105.38 15.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.842 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -159.77 154.44 24.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.673 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 60.57 30.96 20.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.914 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 62.05 31.87 17.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.136 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 89.3 m -153.72 150.16 28.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.987 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.491 ' CE1' ' CE1' ' A' ' 125' ' ' TYR . 54.1 m-85 -93.94 90.95 6.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.103 0.478 . . . . 0.0 110.705 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.424 ' CD1' ' HA ' ' A' ' 141' ' ' LYS . 22.3 m-85 -65.55 126.02 90.77 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.324 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.85 117.3 5.06 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 122.189 1.926 . . . . 0.0 112.441 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.411 ' HG ' HG21 ' A' ' 168' ' ' THR . 32.0 tp -96.59 124.02 40.45 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.731 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.421 ' HB3' ' HB2' ' A' ' 118' ' ' TRP . 54.0 mt -71.35 174.12 6.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.632 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.402 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.3 pt-20 -64.59 -29.45 70.47 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.091 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 48.4 p-10 -88.91 11.15 18.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.215 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.435 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 74.58 22.53 77.12 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.847 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 15.5 tpp85 -80.49 95.95 6.62 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.414 ' CD2' ' CB ' ' A' ' 131' ' ' PHE . 0.4 OUTLIER -73.28 106.1 4.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.232 -179.215 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 13.3 mt -85.51 72.41 10.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.335 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.424 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 33.6 mttt -56.2 -21.23 21.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.896 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -82.87 -22.62 33.96 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -103.11 28.58 6.17 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.16 163.84 33.67 Favored Glycine 0 CA--C 1.511 -0.169 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.699 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 9.2 t -132.09 157.03 45.24 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.504 -0.348 . . . . 0.0 110.529 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.6 mmtp -92.21 48.55 1.42 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.091 0.472 . . . . 0.0 110.554 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -171.26 154.55 4.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.438 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.447 ' CB ' ' CE2' ' A' ' 130' ' ' PHE . . . -99.31 126.52 37.5 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.076 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.478 ' CG ' ' CD1' ' A' ' 123' ' ' TYR . 72.2 Cg_endo -82.39 112.38 2.2 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.36 2.04 . . . . 0.0 112.702 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 28.0 t -69.82 -7.71 42.22 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.518 -0.764 . . . . 0.0 112.0 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -76.1 -22.82 55.11 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 120.779 0.323 . . . . 0.0 110.447 179.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -139.77 167.7 17.59 Favored Pre-proline 0 N--CA 1.452 -0.334 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.721 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.98 154.36 47.73 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.364 2.042 . . . . 0.0 112.332 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 10.1 t -116.66 110.44 31.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.971 0.415 . . . . 0.0 111.088 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.435 HD22 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.55 95.94 1.89 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.584 179.058 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.411 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 51.3 t -91.24 136.74 23.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.028 0.442 . . . . 0.0 111.106 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 48.56 58.59 7.29 Favored Glycine 0 CA--C 1.52 0.392 0 CA-C-N 115.816 -0.629 . . . . 0.0 113.259 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.435 ' CE2' HD22 ' A' ' 155' ' ' LEU . 3.2 m95 -102.13 151.12 22.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.186 0.517 . . . . 0.0 111.721 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.89 -172.07 0.17 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.548 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -42.71 154.22 0.07 Allowed 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -57.08 -24.89 52.62 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.163 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.56 -39.65 84.74 Favored 'General case' 0 C--O 1.23 0.074 0 CA-C-O 120.916 0.388 . . . . 0.0 110.007 179.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.05 -40.03 54.21 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.917 178.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 6.3 mt -59.73 -41.68 86.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.873 179.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.13 -30.97 50.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.228 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -66.97 -53.01 35.77 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-O 121.491 0.662 . . . . 0.0 110.05 179.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.94 -44.78 94.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.905 178.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.435 HG21 ' HA2' ' A' ' 137' ' ' GLY . 0.2 OUTLIER -58.34 -37.17 74.63 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.454 179.223 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.88 -37.68 92.93 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 178.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 35.0 mm-40 -72.87 -46.47 52.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.401 -0.399 . . . . 0.0 111.029 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.416 HD13 ' CE1' ' A' ' 214' ' ' PHE . 10.9 mp -65.92 -28.71 69.13 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.622 0.248 . . . . 0.0 111.323 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.88 -21.07 64.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.336 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -110.45 -26.19 9.65 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.588 0.232 . . . . 0.0 111.496 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.55 166.51 1.71 Allowed Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.107 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -70.09 128.08 15.22 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.305 2.003 . . . . 0.0 112.798 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.07 -25.78 5.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.726 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.71 -50.08 74.41 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.898 0.38 . . . . 0.0 111.012 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.404 ' CG1' ' CE ' ' A' ' 182' ' ' MET . 41.5 t -74.25 -34.9 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.495 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.19 -34.49 68.54 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.156 0.503 . . . . 0.0 109.842 179.096 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -79.47 -38.54 20.86 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 178.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -87.92 103.06 15.32 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.865 0.364 . . . . 0.0 110.75 179.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' MET . . . . . 0.404 ' CE ' ' CG1' ' A' ' 178' ' ' VAL . 2.8 mtm 178.25 172.04 0.7 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.055 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -130.45 -52.61 1.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.677 0.275 . . . . 0.0 111.466 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -163.17 143.69 9.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.881 0.372 . . . . 0.0 111.135 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.419 HG21 HD13 ' A' ' 185' ' ' ILE . 15.7 mt -108.29 114.78 47.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.653 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . 0.411 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 23.5 m170 -105.77 129.33 53.98 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.057 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.413 ' CZ ' HD13 ' A' ' 211' ' ' ILE . 0.3 OUTLIER -79.33 104.81 10.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.444 179.585 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -127.68 78.07 75.37 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.584 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -81.19 160.22 20.38 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.475 2.117 . . . . 0.0 112.709 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 19.2 p -128.17 169.62 13.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.531 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.38 -24.1 11.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.611 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -110.39 -15.2 13.99 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.941 0.348 . . . . 0.0 111.941 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -130.73 73.08 1.52 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.045 0.45 . . . . 0.0 111.255 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -58.88 -18.65 34.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.895 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -113.27 35.71 3.86 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.693 0.283 . . . . 0.0 111.13 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 2.0 ttt-85 -89.64 113.48 24.96 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.894 0.378 . . . . 0.0 111.318 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.405 HG11 ' CZ2' ' A' ' 158' ' ' TRP . 31.3 m -109.76 167.9 4.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.858 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 22.4 mm -134.4 108.39 10.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.754 0.312 . . . . 0.0 111.278 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 11.2 m -97.51 137.52 24.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.989 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -98.26 152.82 19.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.79 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 27.9 tpp -110.77 153.65 25.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.831 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -55.92 -22.51 26.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.747 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -90.18 15.43 10.33 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 76.75 14.4 82.57 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.594 -0.813 . . . . 0.0 113.112 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -83.77 157.32 22.14 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 117.023 0.412 . . . . 0.0 110.729 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -127.69 111.47 13.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 20.6 t -111.44 130.54 64.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.942 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 16.7 m -102.62 116.66 33.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.798 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -128.19 160.25 32.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.861 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.69 155.68 16.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.561 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.413 HD13 ' CZ ' ' A' ' 187' ' ' TYR . 32.0 mt -67.18 -31.06 51.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.02 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.93 -32.06 65.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.357 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -126.53 33.95 4.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.06 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.416 ' CE1' HD13 ' A' ' 171' ' ' LEU . 11.4 t80 -62.99 -53.91 46.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.708 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.78 -39.95 86.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.832 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.29 -51.27 46.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.098 0.475 . . . . 0.0 110.236 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.86 -44.03 73.63 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.859 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.403 ' HB3' ' CG1' ' A' ' 178' ' ' VAL . 4.1 mm? -80.69 -25.75 37.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.942 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.9 -33.15 72.67 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.045 0.45 . . . . 0.0 110.123 179.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 3.6 m170 -74.33 -17.19 60.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.445 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -64.33 136.28 96.69 Favored Pre-proline 0 CA--C 1.533 0.293 0 C-N-CA 121.359 -0.136 . . . . 0.0 110.978 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -89.89 107.34 0.75 Allowed 'Cis proline' 0 C--N 1.357 1.0 0 C-N-CA 124.595 -1.002 . . . . 0.0 112.596 0.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . 171.01 43.38 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.073 0.463 . . . . 0.0 110.356 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 10.2 pt -125.25 -178.57 2.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.206 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 76.31 96.3 0.07 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.964 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -95.46 -158.59 0.66 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.901 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -96.83 35.87 1.48 Allowed 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.786 0.327 . . . . 0.0 111.017 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.19 3.51 27.01 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.54 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -88.5 53.79 2.84 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.021 0.439 . . . . 0.0 110.929 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 31.1 mtt85 -142.85 -77.33 0.25 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.773 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 43.16 60.07 2.68 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.995 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 21.8 m -73.4 168.49 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.323 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 7.4 mtmt . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.849 -179.928 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.158 0 N-CA-C 112.563 -0.215 . . . . 0.0 112.563 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.2 m -105.54 -39.69 6.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.856 0.36 . . . . 0.0 110.939 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -89.97 150.6 22.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.134 0.492 . . . . 0.0 110.911 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.405 ' HB2' ' HB3' ' A' ' 134' ' ' LEU . 79.3 m95 -66.11 168.25 8.72 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.015 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -101.36 141.09 34.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.631 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.55 106.14 5.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.748 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.404 ' CD1' ' HA ' ' A' ' 135' ' ' GLU . 50.9 pt -97.41 -7.04 9.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.299 179.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -162.42 175.29 11.68 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 120.597 0.237 . . . . 0.0 110.779 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.46 ' CD1' ' CG ' ' A' ' 149' ' ' PRO . 25.9 m-85 -144.12 127.11 16.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.097 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 4.9 t -93.14 122.36 44.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.119 0.485 . . . . 0.0 111.292 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.493 ' CE1' ' CE1' ' A' ' 130' ' ' PHE . 14.8 t80 -83.38 105.34 14.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.812 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -159.68 153.6 23.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.59 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.67 30.79 20.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.973 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 63.12 32.65 15.08 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.317 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 90.3 m -154.41 150.49 27.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.982 0.42 . . . . 0.0 111.087 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.493 ' CE1' ' CE1' ' A' ' 125' ' ' TYR . 22.6 m-85 -93.77 90.85 6.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.52 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.429 ' CD1' ' HA ' ' A' ' 141' ' ' LYS . 21.3 m-85 -65.35 121.03 72.58 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.329 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.419 ' HA ' ' CD2' ' A' ' 123' ' ' TYR . 37.5 Cg_endo -67.62 118.11 5.35 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.215 1.943 . . . . 0.0 112.544 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.413 ' HG ' HG21 ' A' ' 168' ' ' THR . 48.6 tp -99.66 124.69 45.13 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.953 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.405 ' HB3' ' HB2' ' A' ' 118' ' ' TRP . 52.7 mt -72.91 177.14 5.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.727 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.404 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.4 pt-20 -67.12 -28.77 68.43 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.118 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -89.71 12.45 16.95 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.167 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.434 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 72.25 23.95 77.15 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.741 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -81.14 97.66 7.68 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 178.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.405 ' CD2' ' CB ' ' A' ' 131' ' ' PHE . 0.4 OUTLIER -75.89 112.44 12.3 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.232 -179.031 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 12.7 mt -92.69 72.16 4.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.179 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.429 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 39.4 mttt -55.21 -22.25 17.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.814 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -82.34 -24.06 34.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.191 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -100.2 27.05 5.91 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -63.68 163.62 32.15 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.752 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 10.0 t -132.34 155.3 48.64 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.83 0.348 . . . . 0.0 110.714 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.8 mmtp -92.58 49.74 1.51 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.089 0.471 . . . . 0.0 110.494 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -171.13 153.73 3.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.613 -179.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.442 ' CB ' ' CE2' ' A' ' 130' ' ' PHE . . . -97.06 125.75 44.88 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.328 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.46 ' CG ' ' CD1' ' A' ' 123' ' ' TYR . 74.3 Cg_endo -83.2 111.76 1.9 Allowed 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.392 2.062 . . . . 0.0 112.533 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 29.1 t -69.87 -7.77 43.0 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.958 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -77.14 -23.22 51.72 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 120.763 0.316 . . . . 0.0 110.423 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.07 166.82 21.02 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.682 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -75.05 154.27 42.12 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.348 2.032 . . . . 0.0 112.34 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 9.0 t -114.56 110.91 33.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.139 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.433 HD22 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.61 95.96 1.91 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.536 179.069 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 50.1 t -91.48 137.18 22.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.053 0.454 . . . . 0.0 111.194 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 48.06 57.85 7.56 Favored Glycine 0 CA--C 1.521 0.459 0 CA-C-N 115.858 -0.61 . . . . 0.0 113.325 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.433 ' CE2' HD22 ' A' ' 155' ' ' LEU . 3.0 m95 -100.58 151.15 21.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.107 0.48 . . . . 0.0 111.782 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.32 -172.36 0.1 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.596 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -43.92 153.79 0.12 Allowed 'General case' 0 C--O 1.235 0.337 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -56.73 -25.16 50.97 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.261 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -60.29 -38.35 83.33 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.884 0.374 . . . . 0.0 110.109 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.96 -40.33 47.32 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.956 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 6.1 mt -58.53 -42.06 83.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.983 179.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.71 -30.19 42.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.299 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -68.26 -52.86 29.19 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.391 0.615 . . . . 0.0 110.016 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.7 -43.86 97.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.998 178.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.434 HG21 ' HA2' ' A' ' 137' ' ' GLY . 0.2 OUTLIER -58.2 -36.54 73.26 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.291 179.206 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.66 -39.4 96.52 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 110.509 -1.037 . . . . 0.0 110.509 178.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 54.6 mm-40 -69.62 -46.33 66.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.407 -0.396 . . . . 0.0 110.839 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.425 HD13 ' CE1' ' A' ' 214' ' ' PHE . 10.9 mp -66.01 -28.29 68.76 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.693 0.283 . . . . 0.0 111.363 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.1 -18.65 63.26 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.345 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -112.79 -27.29 8.2 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.622 0.249 . . . . 0.0 111.576 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.13 167.01 1.25 Allowed Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.072 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.29 127.81 15.53 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.198 1.932 . . . . 0.0 112.831 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.61 -25.77 7.6 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.652 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.97 -49.46 76.74 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.871 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.404 ' CG1' ' CE ' ' A' ' 182' ' ' MET . 24.5 t -74.01 -32.98 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.469 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 11.7 tp -57.24 -36.35 70.82 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 121.194 0.521 . . . . 0.0 109.865 179.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -77.35 -40.86 22.56 Favored Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.301 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -84.94 103.07 13.66 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.877 0.37 . . . . 0.0 110.658 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' MET . . . . . 0.404 ' CE ' ' CG1' ' A' ' 178' ' ' VAL . 2.8 mtm 177.31 162.63 0.5 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.033 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -120.9 -54.24 2.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.752 0.311 . . . . 0.0 111.267 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -162.38 142.94 10.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.814 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.401 HD12 HG22 ' A' ' 185' ' ' ILE . 16.2 mt -106.9 114.51 46.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.55 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 21.4 m170 -103.6 119.39 38.81 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.245 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.408 ' HB2' ' CD2' ' A' ' 158' ' ' TRP . 33.1 t80 -75.97 104.49 6.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.46 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.87 79.56 24.5 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.722 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.1 145.9 62.52 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.319 2.013 . . . . 0.0 112.479 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 19.5 p -128.17 159.24 35.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.815 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 8.1 ptt180 -52.54 -25.35 10.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.615 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -105.53 -19.9 13.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.627 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -136.04 74.81 1.52 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.871 0.367 . . . . 0.0 111.198 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -56.47 -22.04 29.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.596 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -108.95 38.47 2.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.802 0.334 . . . . 0.0 110.93 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -91.27 118.47 30.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.089 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.406 HG13 ' CZ2' ' A' ' 158' ' ' TRP . 21.2 m -115.63 167.81 7.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.863 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 19.1 mm -135.31 109.49 10.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.799 0.333 . . . . 0.0 111.059 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.408 HG13 ' CZ ' ' A' ' 214' ' ' PHE . 7.0 m -97.62 120.88 47.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.038 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -82.05 152.73 26.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.769 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.99 149.81 28.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.727 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -58.86 -29.12 66.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.168 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -80.87 1.76 29.43 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.983 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 92.1 14.43 56.14 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.466 -0.873 . . . . 0.0 113.184 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -86.69 162.32 17.96 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 117.067 0.434 . . . . 0.0 110.952 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -130.75 111.52 12.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.812 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.7 t -111.32 131.42 62.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.115 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 35.8 m -103.34 116.29 32.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.78 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -129.69 159.53 36.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.86 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.37 157.08 17.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.572 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 48.9 mt -67.44 -33.47 62.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.875 0.369 . . . . 0.0 110.848 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.73 -33.99 77.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.41 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -132.92 38.73 3.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.834 0.349 . . . . 0.0 111.148 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.425 ' CE1' HD13 ' A' ' 171' ' ' LEU . 11.0 t80 -62.52 -49.73 74.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.926 0.393 . . . . 0.0 110.637 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.97 -38.59 91.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.187 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -68.69 -50.56 49.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.022 0.439 . . . . 0.0 110.556 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 10.9 mmmt -53.43 -42.75 67.39 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.184 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.402 ' HB3' ' CG1' ' A' ' 178' ' ' VAL . 4.0 mm? -85.73 -23.46 27.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.968 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 9.0 t -60.13 -34.43 73.51 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.102 0.477 . . . . 0.0 109.964 179.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -74.18 -16.23 60.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.968 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.423 ' CE1' ' HB3' ' A' ' 222' ' ' PRO . 14.6 t80 -60.76 139.78 93.28 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 116.867 -0.151 . . . . 0.0 111.104 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . 0.423 ' HB3' ' CE1' ' A' ' 221' ' ' TYR . 62.2 Cg_endo -89.84 107.57 0.79 Allowed 'Cis proline' 0 C--N 1.356 0.923 0 C-N-CA 124.543 -1.024 . . . . 0.0 112.425 0.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . 171.95 41.94 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.864 0.364 . . . . 0.0 110.992 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.4 HD13 HG22 ' A' ' 224' ' ' ILE . 0.1 OUTLIER -134.51 157.88 41.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.92 0.39 . . . . 0.0 111.143 179.747 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 176.78 76.67 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.114 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . 60.14 158.11 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.233 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -145.2 31.43 1.11 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.732 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 19.0 mt -94.5 46.02 1.14 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.622 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 71.27 22.6 4.28 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.321 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 50.75 27.25 2.94 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.743 0.306 . . . . 0.0 111.759 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -91.49 93.37 8.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.973 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 20.3 t -143.13 67.98 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.103 0.477 . . . . 0.0 111.043 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 4.9 ptmm? . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.235 -0.888 . . . . 0.0 112.009 -179.869 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 18.9 m -65.1 81.85 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.873 0.368 . . . . 0.0 110.885 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -100.5 151.96 20.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.915 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.457 ' CD1' ' ND2' ' A' ' 136' ' ' ASN . 85.6 m95 -66.04 168.33 8.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.287 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.29 133.61 45.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.762 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 59.5 mtt180 -71.25 107.72 4.38 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.833 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.402 ' CD1' HG21 ' A' ' 168' ' ' THR . 42.9 pt -96.08 -9.15 9.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.414 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -156.33 175.97 13.3 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.659 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.458 ' CD1' ' CG ' ' A' ' 149' ' ' PRO . 37.9 m-85 -145.02 126.05 14.56 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.353 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.4 t -93.69 122.9 45.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.101 0.477 . . . . 0.0 111.13 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -82.4 97.46 8.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.776 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -151.09 156.01 40.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.44 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 6.3 tpp180 60.39 30.54 19.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.838 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.2 33.4 16.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.913 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 85.5 m -157.14 153.74 28.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.912 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -93.54 91.18 6.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.694 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.433 ' CG ' ' HA ' ' A' ' 141' ' ' LYS . 22.6 m-85 -66.06 125.02 89.33 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.874 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.412 ' HA ' ' CD2' ' A' ' 123' ' ' TYR . 57.0 Cg_endo -72.61 115.84 4.49 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.008 1.806 . . . . 0.0 112.725 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.403 ' HG ' HG23 ' A' ' 168' ' ' THR . 25.1 tp -93.64 123.8 37.2 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.656 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 39.9 mt -69.55 171.86 8.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.48 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.15 -31.76 72.98 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.987 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . 0.457 ' ND2' ' CD1' ' A' ' 118' ' ' TRP . 2.9 p30 -84.68 3.81 35.46 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.278 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.444 ' HA2' HG23 ' A' ' 168' ' ' THR . . . 82.71 21.24 60.07 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.766 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -79.9 94.29 5.82 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.79 107.41 3.5 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.95 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 15.3 mt -83.45 72.54 10.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.979 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.433 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 9.2 mttp -57.79 -20.73 37.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.481 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -96.9 23.79 6.81 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.289 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -147.94 27.49 0.96 Allowed 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.747 0.308 . . . . 0.0 111.122 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -63.52 166.66 25.84 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.913 -0.66 . . . . 0.0 113.183 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 9.6 t -132.58 151.72 51.84 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.867 0.365 . . . . 0.0 110.442 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.06 50.77 1.7 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.118 0.485 . . . . 0.0 110.598 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.71 147.04 2.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.644 -179.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -90.2 125.32 60.6 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.327 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.458 ' CG ' ' CD1' ' A' ' 123' ' ' TYR . 77.8 Cg_endo -84.83 107.27 1.1 Allowed 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.534 2.156 . . . . 0.0 112.605 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 15.0 t -69.83 -7.8 42.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.008 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -78.26 -23.64 47.19 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 120.841 0.353 . . . . 0.0 110.503 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -138.35 167.28 20.42 Favored Pre-proline 0 N--CA 1.453 -0.302 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.629 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -74.62 156.36 44.75 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.452 2.101 . . . . 0.0 112.539 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 18.3 t -118.96 109.22 26.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.236 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.43 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 1.1 mp -72.54 96.14 1.91 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.699 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.7 t -91.37 136.23 24.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.082 0.467 . . . . 0.0 111.046 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 47.9 57.71 7.54 Favored Glycine 0 CA--C 1.522 0.471 0 CA-C-N 115.701 -0.681 . . . . 0.0 113.237 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.43 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 2.5 m95 -99.81 151.36 21.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.193 0.52 . . . . 0.0 111.831 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.52 -172.42 0.08 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.627 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -44.37 154.24 0.13 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.284 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -57.65 -24.93 54.61 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.159 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -59.56 -39.49 84.21 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.887 0.375 . . . . 0.0 110.125 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.28 -40.32 51.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.962 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 5.9 mt -58.72 -41.08 81.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.922 178.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.72 -29.48 39.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.138 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -70.1 -53.01 19.26 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 121.512 0.672 . . . . 0.0 110.137 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.95 -43.98 91.36 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.042 178.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.444 HG23 ' HA2' ' A' ' 137' ' ' GLY . 0.2 OUTLIER -58.65 -36.43 74.12 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.395 179.08 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.26 -37.19 92.62 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 178.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 93.3 mm-40 -73.72 -45.58 51.27 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.339 -0.43 . . . . 0.0 111.083 178.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.423 HD11 ' CE1' ' A' ' 214' ' ' PHE . 11.3 mp -66.36 -28.47 68.67 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.697 0.284 . . . . 0.0 111.374 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.9 -16.18 62.66 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.34 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -115.2 -28.03 7.07 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.88 167.29 0.86 Allowed Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 116.754 -0.203 . . . . 0.0 111.3 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -69.92 128.15 15.47 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.269 1.979 . . . . 0.0 112.92 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.47 -25.64 6.8 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.718 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.51 -49.68 75.52 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.847 0.356 . . . . 0.0 110.947 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.408 ' CG1' ' CE ' ' A' ' 182' ' ' MET . 32.4 t -74.34 -36.05 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.608 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 10.7 tp -55.1 -34.08 63.37 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.162 0.506 . . . . 0.0 110.155 179.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -80.29 -41.59 11.58 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.405 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -85.53 103.02 14.01 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.912 0.386 . . . . 0.0 110.665 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' MET . . . . . 0.408 ' CE ' ' CG1' ' A' ' 178' ' ' VAL . 2.8 mtm 178.52 166.18 0.83 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.228 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.85 -56.96 1.91 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.836 0.35 . . . . 0.0 111.001 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -162.96 142.56 8.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.771 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.417 HD12 HG23 ' A' ' 185' ' ' ILE . 11.7 mt -101.91 115.55 43.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.475 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 22.9 m170 -105.21 121.62 44.21 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.98 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -78.53 104.69 9.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.509 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.93 82.55 43.18 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.547 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -67.77 147.73 75.87 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.409 2.073 . . . . 0.0 112.593 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 22.0 p -126.17 160.01 31.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.695 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 12.5 mtt180 -51.88 -28.83 17.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.608 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -107.48 -15.08 14.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.875 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -135.29 74.41 1.52 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.996 0.427 . . . . 0.0 111.293 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -56.18 -24.96 44.8 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.415 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 9.8 p30 -105.12 38.54 1.92 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.765 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -90.77 116.85 28.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.105 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 22.1 m -114.24 164.35 10.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.725 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 20.3 mm -133.3 105.95 8.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.785 0.326 . . . . 0.0 111.17 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.419 HG13 ' CE2' ' A' ' 214' ' ' PHE . 6.7 m -94.75 124.72 47.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.028 0.442 . . . . 0.0 111.011 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -84.26 152.82 23.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.809 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.8 149.02 29.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.729 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -58.77 -28.8 66.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.157 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -80.67 1.5 29.78 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.325 -0.398 . . . . 0.0 112.06 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 91.99 14.41 56.34 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.571 -0.823 . . . . 0.0 113.149 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -87.1 160.19 18.65 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.992 0.396 . . . . 0.0 110.732 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -128.67 111.47 13.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.919 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 23.1 t -110.88 137.46 43.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.044 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 3.8 m -110.83 112.07 23.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.755 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -121.86 170.76 9.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.938 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.92 157.56 19.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.402 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 33.0 mt -69.54 -31.48 49.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.794 0.331 . . . . 0.0 110.838 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.48 -30.15 65.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.345 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -133.12 37.31 3.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.809 0.338 . . . . 0.0 111.051 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.423 ' CE1' HD11 ' A' ' 171' ' ' LEU . 11.2 t80 -63.08 -55.46 25.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.837 0.351 . . . . 0.0 110.458 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.75 -42.38 79.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.146 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -68.91 -47.72 65.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.041 0.448 . . . . 0.0 110.232 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -54.95 -43.63 73.6 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.905 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -83.09 -26.44 31.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.779 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 13.2 t -61.19 -30.53 70.47 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.955 0.407 . . . . 0.0 110.528 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -69.37 -16.81 63.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.107 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -59.06 138.4 87.85 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 110.477 -0.194 . . . . 0.0 110.477 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -70.48 154.82 95.35 Favored 'Cis proline' 0 C--N 1.355 0.893 0 C-N-CA 124.875 -0.885 . . . . 0.0 112.707 0.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . 83.96 75.89 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.912 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.414 HD13 HG22 ' A' ' 224' ' ' ILE . 26.2 pt -136.77 -178.65 2.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.059 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 72.57 -179.03 0.21 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.095 0.474 . . . . 0.0 111.367 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . 62.89 94.4 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.286 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -117.76 30.88 7.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.621 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 22.3 mt -123.1 30.2 6.45 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.097 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.86 36.26 2.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.903 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.88 -62.0 0.42 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.898 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -91.61 101.35 13.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.865 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 20.0 t -101.98 121.39 52.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.108 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.882 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.144 0 N-CA-C 112.534 -0.226 . . . . 0.0 112.534 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.5 p -103.38 -74.2 0.65 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.816 0.341 . . . . 0.0 110.946 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -60.82 148.53 38.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.97 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.462 ' CD1' ' ND2' ' A' ' 136' ' ' ASN . 81.5 m95 -73.16 167.95 20.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.057 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.7 ttm-85 -102.64 135.57 44.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.401 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 -71.74 105.92 3.92 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.491 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.428 HG23 HD11 ' A' ' 121' ' ' ILE . 42.9 pt -93.54 -9.06 9.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.492 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -158.99 176.57 12.14 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 120.99 -0.284 . . . . 0.0 110.795 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.446 ' CD1' ' HG3' ' A' ' 149' ' ' PRO . 30.8 m-85 -142.77 128.3 19.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.268 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.9 t -93.28 122.41 44.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.072 0.463 . . . . 0.0 111.239 -179.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.479 ' CE1' ' CE1' ' A' ' 130' ' ' PHE . 7.6 t80 -82.75 94.45 7.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.735 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -144.46 153.04 41.47 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.433 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 59.44 30.66 20.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.858 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 61.81 34.71 17.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.036 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 65.7 m -152.2 162.21 41.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.07 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.479 ' CE1' ' CE1' ' A' ' 125' ' ' TYR . 18.5 m-85 -103.27 90.71 3.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.191 0.52 . . . . 0.0 111.194 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.438 ' CG ' ' HA ' ' A' ' 141' ' ' LYS . 23.8 m-85 -69.82 118.33 62.08 Favored Pre-proline 0 CA--C 1.536 0.437 0 CA-C-N 115.437 -0.802 . . . . 0.0 111.499 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.424 ' HA ' ' CD2' ' A' ' 123' ' ' TYR . 25.0 Cg_exo -63.16 119.86 7.09 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 122.423 2.082 . . . . 0.0 112.61 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.437 ' HG ' HG22 ' A' ' 168' ' ' THR . 29.6 tp -100.25 123.17 44.16 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.285 179.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 46.5 mt -70.13 171.4 9.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.701 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.401 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.5 pt-20 -61.67 -33.33 73.79 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.098 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . 0.462 ' ND2' ' CD1' ' A' ' 118' ' ' TRP . 4.2 p30 -82.34 -4.36 57.13 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.107 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.441 ' HA2' HG22 ' A' ' 168' ' ' THR . . . 91.34 15.84 54.56 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.804 -179.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 15.1 tpp85 -73.62 97.21 2.6 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.98 109.18 4.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.565 -178.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 27.6 mt -84.22 71.16 10.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.487 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.438 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 18.6 mttt -56.79 -21.5 29.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.738 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -84.54 -17.39 39.05 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -106.67 29.48 6.91 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . -60.55 161.62 21.7 Favored Glycine 0 CA--C 1.509 -0.316 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.359 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 11.1 t -136.28 148.81 48.17 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.999 0.428 . . . . 0.0 110.927 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 6.7 mmtt -89.92 55.86 3.28 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.343 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.405 ' O ' ' CG ' ' A' ' 130' ' ' PHE . 0.0 OUTLIER -170.41 167.32 8.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.255 -179.327 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -102.67 136.62 19.29 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.928 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.446 ' HG3' ' CD1' ' A' ' 123' ' ' TYR . 59.7 Cg_endo -84.7 99.98 0.74 Allowed 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 123.174 2.582 . . . . 0.0 112.491 179.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 16.8 t -67.24 -9.52 41.32 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.793 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -89.58 -22.24 22.46 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 111.562 0.208 . . . . 0.0 111.562 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -139.33 166.92 21.03 Favored Pre-proline 0 C--N 1.328 -0.334 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -178.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.46 164.24 35.56 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.495 2.13 . . . . 0.0 112.275 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 22.1 t -122.92 109.12 22.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 121.065 0.46 . . . . 0.0 111.655 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.437 HD22 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.72 95.95 1.96 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.687 179.068 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 54.9 t -92.99 137.87 21.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.164 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 47.69 56.06 8.93 Favored Glycine 0 CA--C 1.521 0.421 0 CA-C-N 115.913 -0.585 . . . . 0.0 113.227 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.437 ' CE2' HD22 ' A' ' 155' ' ' LEU . 3.2 m95 -98.9 151.26 21.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.181 0.515 . . . . 0.0 111.62 -179.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.98 -172.4 0.14 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.423 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -43.58 154.69 0.08 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.095 0.474 . . . . 0.0 112.184 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -57.29 -25.05 53.78 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.275 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.97 -38.75 83.44 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.001 0.429 . . . . 0.0 110.125 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.18 -40.23 46.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.053 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 6.5 mt -59.4 -42.25 86.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.081 179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.38 -29.49 48.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.366 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -67.84 -53.28 28.06 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.4 0.619 . . . . 0.0 110.162 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.89 -43.51 98.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.995 178.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.441 HG22 ' HA2' ' A' ' 137' ' ' GLY . 0.2 OUTLIER -58.88 -37.82 77.42 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.361 179.181 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.62 -37.54 92.42 Favored Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 178.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -72.04 -46.5 56.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.366 -0.417 . . . . 0.0 110.848 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.424 HD12 ' CE1' ' A' ' 214' ' ' PHE . 10.4 mp -64.22 -30.45 71.51 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.789 0.328 . . . . 0.0 111.219 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -67.67 -21.91 65.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.552 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -109.61 -26.49 9.88 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 120.595 0.236 . . . . 0.0 111.498 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.99 166.37 1.43 Allowed Pre-proline 0 CA--C 1.538 0.491 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.096 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -69.32 128.95 17.19 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.364 2.043 . . . . 0.0 112.702 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.89 -25.89 5.13 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.75 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.87 -50.05 74.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.971 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.408 ' CG1' ' CE ' ' A' ' 182' ' ' MET . 24.4 t -74.21 -35.44 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.705 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.56 -35.04 67.7 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.131 0.491 . . . . 0.0 109.956 179.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -79.5 -39.21 18.92 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.269 -0.733 . . . . 0.0 111.269 178.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -86.85 103.16 14.99 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.935 0.398 . . . . 0.0 110.654 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' MET . . . . . 0.408 ' CE ' ' CG1' ' A' ' 178' ' ' VAL . 2.9 mtm 178.35 161.18 0.61 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.027 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 6.6 t -118.93 -58.52 1.94 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.767 0.318 . . . . 0.0 110.881 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.8 pm0 -157.62 142.58 16.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.001 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 17.0 mt -107.01 115.0 47.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.341 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 21.8 m170 -106.01 123.46 48.03 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.207 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.42 ' CE2' ' HG3' ' A' ' 189' ' ' PRO . 59.1 t80 -75.67 104.55 6.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.167 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 4.3 mttm -129.7 88.79 48.48 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.908 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.42 ' HG3' ' CE2' ' A' ' 187' ' ' TYR . 13.0 Cg_exo -69.58 161.64 45.13 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.477 2.118 . . . . 0.0 112.073 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 9.1 p -133.6 169.48 16.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.764 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.1 -23.5 62.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.193 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -120.3 8.78 10.89 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -155.46 75.94 0.94 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.994 0.426 . . . . 0.0 111.272 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.61 -22.46 34.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.332 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -106.9 37.86 2.24 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.746 0.308 . . . . 0.0 110.802 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 7.2 ttt180 -88.86 116.22 26.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.838 0.352 . . . . 0.0 111.439 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 23.6 m -112.81 166.41 6.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.66 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 19.2 mm -132.01 108.77 14.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.793 0.33 . . . . 0.0 111.287 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.418 HG11 ' CZ ' ' A' ' 214' ' ' PHE . 10.2 m -100.98 120.78 50.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.028 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -85.81 152.62 22.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.631 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 9.7 mmt -102.67 161.24 13.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.034 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -62.56 -25.89 68.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.153 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -87.15 10.62 16.22 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 83.77 14.4 72.97 Favored Glycine 0 C--N 1.335 0.496 0 C-N-CA 120.451 -0.881 . . . . 0.0 113.282 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -80.15 170.41 16.47 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 117.014 0.407 . . . . 0.0 110.767 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -136.43 111.48 8.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.928 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.77 122.59 69.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.089 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -99.31 114.64 27.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.671 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -126.12 161.32 27.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.802 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.76 152.73 19.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.673 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.407 HG23 HD13 ' A' ' 211' ' ' ILE . 48.4 mt -63.88 -36.49 76.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.838 0.351 . . . . 0.0 110.724 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.23 -34.66 76.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.158 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -132.64 44.28 2.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.919 0.39 . . . . 0.0 111.02 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.424 ' CE1' HD12 ' A' ' 171' ' ' LEU . 11.3 t80 -66.94 -52.58 41.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.564 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.01 -40.02 91.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.911 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.37 -51.15 55.66 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.158 0.504 . . . . 0.0 110.399 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.25 -43.78 71.22 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.163 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.401 ' HB3' ' CG1' ' A' ' 178' ' ' VAL . 4.1 mm? -83.52 -23.15 32.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.097 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.49 -34.3 75.26 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.045 0.45 . . . . 0.0 109.799 179.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -70.5 -16.93 62.95 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.151 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.422 ' CD2' ' HA ' ' A' ' 222' ' ' PRO . 55.2 t80 -56.43 141.76 70.57 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 116.866 -0.152 . . . . 0.0 111.187 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . 0.422 ' HA ' ' CD2' ' A' ' 221' ' ' TYR . 56.1 Cg_endo -91.04 106.71 0.6 Allowed 'Cis proline' 0 C--N 1.356 0.972 0 C-N-CA 124.557 -1.018 . . . . 0.0 112.624 0.143 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . 168.43 42.61 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.773 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.2 152.7 33.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.927 0.394 . . . . 0.0 111.232 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 173.76 -178.15 0.08 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.887 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -63.67 157.32 24.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.187 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -145.07 29.07 1.2 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.129 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 5.5 mp -95.27 46.38 1.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.139 0.495 . . . . 0.0 110.487 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 65.51 26.8 11.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.994 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 55.71 99.26 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.224 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 -154.85 133.04 11.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.919 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 11.0 p -151.93 110.89 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.952 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.892 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.176 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.4 m -94.55 -37.5 11.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.809 0.338 . . . . 0.0 110.978 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -126.99 161.07 29.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.939 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.461 ' CD1' ' ND2' ' A' ' 136' ' ' ASN . 87.3 m95 -70.11 168.37 15.73 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.093 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 2.0 ptt180 -99.57 133.39 43.97 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.696 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 32.4 mtm180 -71.33 106.68 3.96 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.628 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.43 HG23 HD13 ' A' ' 121' ' ' ILE . 44.1 pt -95.86 -8.25 9.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.436 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -158.41 176.53 12.33 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 120.647 0.26 . . . . 0.0 110.882 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.462 ' CD1' ' CG ' ' A' ' 149' ' ' PRO . 38.2 m-85 -144.91 126.59 15.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.188 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 4.1 t -93.45 122.65 45.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.124 0.487 . . . . 0.0 111.013 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -83.69 95.07 8.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.48 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -145.52 155.16 42.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.42 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 4.0 tpp180 59.58 30.2 19.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.787 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 62.27 34.83 15.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.997 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 57.8 m -153.54 161.46 42.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.826 0.346 . . . . 0.0 111.278 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.448 ' CE2' ' CB ' ' A' ' 148' ' ' ALA . 31.8 m-85 -101.75 91.12 4.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.132 0.491 . . . . 0.0 110.914 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.424 ' CG ' ' HA ' ' A' ' 141' ' ' LYS . 24.3 m-85 -70.19 122.96 87.9 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.336 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.42 ' HA ' ' CD2' ' A' ' 123' ' ' TYR . 15.1 Cg_exo -67.94 118.17 5.42 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 122.31 2.007 . . . . 0.0 112.636 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.42 ' HG ' HG23 ' A' ' 168' ' ' THR . 30.4 tp -98.02 123.32 41.98 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.086 0.469 . . . . 0.0 110.362 179.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 44.6 mt -70.4 171.97 9.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.511 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.85 -32.33 73.53 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.857 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . 0.461 ' ND2' ' CD1' ' A' ' 118' ' ' TRP . 3.1 p30 -84.07 2.45 39.22 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.161 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.454 ' HA2' HG23 ' A' ' 168' ' ' THR . . . 83.89 20.27 59.83 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.827 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 13.8 tpp180 -78.4 94.08 4.82 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.2 105.1 1.99 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.438 -179.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 17.3 mt -78.58 69.34 4.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.746 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.424 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 2.3 mttt -57.2 -21.31 32.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.564 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -91.96 11.94 23.44 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -134.74 26.5 3.67 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.762 0.315 . . . . 0.0 111.17 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -61.23 163.02 22.63 Favored Glycine 0 CA--C 1.509 -0.323 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.844 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.9 t -136.3 151.84 50.05 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.526 -0.337 . . . . 0.0 110.428 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 4.2 mmtt -89.03 51.84 2.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.014 0.435 . . . . 0.0 110.705 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.18 148.97 2.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.638 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.448 ' CB ' ' CE2' ' A' ' 130' ' ' PHE . . . -93.73 125.81 52.0 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.474 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.462 ' CG ' ' CD1' ' A' ' 123' ' ' TYR . 89.1 Cg_endo -84.39 109.97 1.43 Allowed 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.528 2.152 . . . . 0.0 112.508 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.3 t -70.2 -6.86 37.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.081 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.73 -23.04 53.06 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 120.836 0.351 . . . . 0.0 110.507 178.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.72 167.2 18.42 Favored Pre-proline 0 N--CA 1.453 -0.306 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.794 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -74.04 154.44 47.48 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.412 2.074 . . . . 0.0 112.306 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 14.2 t -115.81 111.5 35.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.115 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.43 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.71 96.45 2.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.858 179.207 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.423 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 59.0 t -93.07 136.03 26.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.975 0.417 . . . . 0.0 110.981 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 48.97 56.32 10.25 Favored Glycine 0 CA--C 1.521 0.423 0 CA-C-N 115.903 -0.589 . . . . 0.0 113.17 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.43 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 3.2 m95 -99.52 151.31 21.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.195 0.521 . . . . 0.0 111.799 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -65.79 -172.43 0.13 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.529 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -44.33 154.43 0.12 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.118 0.485 . . . . 0.0 112.203 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -57.27 -25.07 53.78 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.239 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -60.12 -38.3 82.59 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 120.967 0.413 . . . . 0.0 110.113 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.79 -41.36 44.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.0 178.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 6.5 mt -57.73 -42.35 81.56 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.11 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.22 -29.78 34.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.166 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -68.64 -53.43 22.53 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-O 121.503 0.668 . . . . 0.0 110.054 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.84 -43.81 94.39 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.701 -0.682 . . . . 0.0 109.88 178.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.454 HG23 ' HA2' ' A' ' 137' ' ' GLY . 0.2 OUTLIER -58.62 -36.35 73.92 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.329 179.018 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.84 -38.47 94.06 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 178.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -71.93 -45.45 61.1 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.269 -0.465 . . . . 0.0 110.727 178.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.427 HD13 ' CE1' ' A' ' 214' ' ' PHE . 10.7 mp -67.83 -21.32 65.21 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.72 0.295 . . . . 0.0 111.691 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -77.12 -16.69 59.09 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.114 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -114.9 -26.5 7.75 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.75 166.35 1.91 Allowed Pre-proline 0 CA--C 1.536 0.412 0 CA-C-O 120.513 0.197 . . . . 0.0 111.051 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -69.48 128.88 16.94 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.31 2.007 . . . . 0.0 112.707 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.86 -25.25 7.52 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.67 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.42 -49.39 76.36 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.904 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.406 ' CG1' ' CE ' ' A' ' 182' ' ' MET . 23.5 t -74.32 -39.97 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.57 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 12.4 tp -54.52 -32.63 58.5 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.059 0.457 . . . . 0.0 110.22 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -82.41 -36.18 17.95 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 178.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -90.48 103.2 15.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.898 0.38 . . . . 0.0 110.614 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' MET . . . . . 0.406 ' CE ' ' CG1' ' A' ' 178' ' ' VAL . 2.9 mtm 178.92 179.79 0.39 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.023 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -136.72 -52.16 0.69 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.732 0.301 . . . . 0.0 111.198 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -163.43 142.69 8.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.124 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.406 HD12 HG21 ' A' ' 185' ' ' ILE . 19.2 mt -106.25 114.95 46.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.316 179.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . 0.423 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 20.1 m170 -106.24 123.61 48.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.25 -179.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.42 ' CD1' ' HD3' ' A' ' 189' ' ' PRO . 0.5 OUTLIER -75.31 104.85 6.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.474 179.558 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 9.0 mmtt -118.05 75.86 11.24 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.5 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.42 ' HD3' ' CD1' ' A' ' 187' ' ' TYR . 43.9 Cg_endo -67.4 145.17 70.44 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.392 2.061 . . . . 0.0 112.595 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 20.5 p -127.92 158.61 37.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.726 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.04 -24.82 10.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.612 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -103.3 -21.63 13.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.51 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -137.41 79.67 1.76 Allowed 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.844 0.354 . . . . 0.0 111.28 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -57.99 -24.29 57.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.282 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -104.19 36.01 2.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.795 0.331 . . . . 0.0 110.779 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 24.0 ttt85 -90.57 113.43 25.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.988 0.423 . . . . 0.0 111.182 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 23.1 m -109.2 167.82 4.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.751 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 22.5 mm -134.33 105.75 7.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.684 0.278 . . . . 0.0 111.34 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.42 HG13 ' CE2' ' A' ' 214' ' ' PHE . 12.5 m -94.53 134.87 30.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.868 0.366 . . . . 0.0 110.921 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -97.54 153.08 18.4 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.667 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 33.5 tpp -112.24 149.35 32.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.448 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 16.9 m-20 -55.27 -28.96 57.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.513 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -75.38 -5.89 47.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.817 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 94.78 14.62 49.02 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.499 -0.857 . . . . 0.0 112.988 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -86.28 158.2 19.75 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 117.005 0.403 . . . . 0.0 110.915 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -124.85 111.18 15.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.676 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 25.5 t -113.04 135.64 51.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.938 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 93.7 p -109.26 116.36 31.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.74 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -125.27 169.36 12.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.797 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -108.2 154.25 22.03 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.706 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 34.5 mt -66.08 -34.05 67.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.782 0.325 . . . . 0.0 110.832 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.46 -35.61 80.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.334 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -131.65 43.34 3.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.983 0.42 . . . . 0.0 110.961 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.427 ' CE1' HD13 ' A' ' 171' ' ' LEU . 11.1 t80 -66.73 -50.77 61.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.722 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.27 -42.22 90.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.347 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -67.31 -49.55 63.7 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.052 0.454 . . . . 0.0 110.458 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.93 -43.4 69.76 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.174 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.4 ' HB3' ' CG1' ' A' ' 178' ' ' VAL . 4.0 mm? -84.11 -25.5 29.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.004 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 12.6 t -61.15 -31.45 71.18 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.892 0.377 . . . . 0.0 110.396 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -69.66 -15.74 63.23 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.402 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.411 ' N ' ' CG2' ' A' ' 224' ' ' ILE . 68.8 t80 -59.33 137.79 88.75 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 110.399 -0.223 . . . . 0.0 110.399 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.6 154.71 97.59 Favored 'Cis proline' 0 C--N 1.355 0.906 0 C-N-CA 124.569 -1.013 . . . . 0.0 112.743 0.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . 82.26 77.39 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.821 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.411 ' CG2' ' N ' ' A' ' 221' ' ' TYR . 18.7 pt -130.11 176.59 8.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.296 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 59.02 165.13 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.202 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -110.26 -165.04 0.97 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.93 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -100.3 24.71 8.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.24 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.14 25.31 6.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.741 0.305 . . . . 0.0 110.835 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 25.1 p30 -107.22 31.3 5.48 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.865 0.364 . . . . 0.0 110.859 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 15.9 mtp180 -105.61 -74.88 0.64 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.76 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 63.98 -78.96 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.014 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 10.6 p -113.88 128.42 70.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.814 0.34 . . . . 0.0 111.064 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 16.9 mttp . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.892 179.967 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.176 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 68.4 m -65.03 -68.66 0.34 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.81 0.338 . . . . 0.0 110.93 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 61.7 155.37 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.041 0.448 . . . . 0.0 110.977 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.41 ' HB2' ' HB3' ' A' ' 134' ' ' LEU . 81.3 m95 -73.89 168.55 19.22 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.204 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.2 ptt180 -101.05 135.22 42.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.841 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 8.4 mtm180 -71.87 106.68 4.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.867 0.365 . . . . 0.0 110.731 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.405 ' CD1' HG21 ' A' ' 168' ' ' THR . 49.3 pt -97.09 -7.65 9.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.366 179.268 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -159.39 176.17 12.44 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 121.111 -0.236 . . . . 0.0 110.71 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.465 ' CD1' ' CG ' ' A' ' 149' ' ' PRO . 29.1 m-85 -144.48 126.26 15.24 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.088 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 8.6 t -93.64 122.77 45.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.108 0.48 . . . . 0.0 111.471 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.476 ' CD1' ' CE1' ' A' ' 130' ' ' PHE . 28.5 t80 -82.7 110.7 17.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.729 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -165.08 152.41 10.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.651 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? 60.37 31.6 20.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.015 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 62.2 31.49 17.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.264 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 84.7 m -153.43 150.13 28.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.874 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.476 ' CE1' ' CD1' ' A' ' 125' ' ' TYR . 98.7 m-85 -95.55 91.52 6.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.793 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.44 ' CD1' ' HA ' ' A' ' 141' ' ' LYS . 23.8 m-85 -65.19 126.15 90.77 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.313 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -72.58 116.67 4.8 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.176 1.917 . . . . 0.0 112.434 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.418 ' HG ' HG23 ' A' ' 168' ' ' THR . 42.8 tp -96.02 124.38 40.01 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.864 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.41 ' HB3' ' HB2' ' A' ' 118' ' ' TRP . 55.0 mt -71.65 174.73 6.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.65 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -65.46 -28.73 69.43 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.076 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 46.7 p-10 -89.82 11.68 19.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.143 179.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.446 ' HA2' HG23 ' A' ' 168' ' ' THR . . . 73.41 23.49 77.1 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.932 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 18.4 tpp180 -81.11 95.95 7.02 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.68 107.33 5.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.326 -179.005 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 13.5 mt -85.03 72.13 10.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.321 179.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.44 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 7.5 mtpt -56.2 -21.38 22.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.993 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -85.54 -16.22 40.17 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -108.88 29.69 7.23 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.52 163.08 36.42 Favored Glycine 0 CA--C 1.51 -0.228 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.88 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 9.1 t -131.31 155.95 46.31 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.41 -0.395 . . . . 0.0 110.619 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.39 48.52 1.31 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.127 0.489 . . . . 0.0 110.319 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -170.97 150.73 3.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.533 -179.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -95.02 125.93 48.76 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.21 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.465 ' CG ' ' CD1' ' A' ' 123' ' ' TYR . 72.8 Cg_endo -83.02 111.83 1.96 Allowed 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.349 2.032 . . . . 0.0 112.619 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 33.3 t -69.81 -7.6 41.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.062 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.82 -23.44 52.76 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 120.821 0.343 . . . . 0.0 110.456 178.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -139.44 166.9 21.05 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.653 -179.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.81 154.54 48.7 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.348 2.032 . . . . 0.0 112.265 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 13.4 t -116.91 109.98 29.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.063 0.458 . . . . 0.0 111.207 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.443 HD22 ' CD2' ' A' ' 158' ' ' TRP . 1.2 mp -72.33 96.12 1.82 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.611 179.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.408 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 60.8 t -92.41 137.16 22.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.129 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 48.97 57.85 8.33 Favored Glycine 0 CA--C 1.52 0.374 0 CA-C-N 115.921 -0.581 . . . . 0.0 113.223 179.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.443 ' CD2' HD22 ' A' ' 155' ' ' LEU . 2.7 m95 -101.13 151.07 22.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.162 0.506 . . . . 0.0 111.679 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.7 tttp -66.76 -172.18 0.16 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.374 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -42.26 154.42 0.06 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -56.87 -24.96 51.63 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.267 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.04 -38.69 83.51 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.996 0.427 . . . . 0.0 109.978 179.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -75.91 -40.6 53.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.913 178.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 6.2 mt -59.11 -44.0 90.58 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.878 179.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -52.92 -25.9 13.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.617 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -71.39 -54.43 10.73 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 121.072 0.463 . . . . 0.0 110.923 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.14 -37.19 84.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.217 179.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.446 HG23 ' HA2' ' A' ' 137' ' ' GLY . 0.2 OUTLIER -60.5 -38.11 83.26 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.911 178.881 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -61.59 -35.68 91.49 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 177.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -71.6 -49.02 44.27 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.181 -0.51 . . . . 0.0 110.669 178.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.428 HD12 ' CE1' ' A' ' 214' ' ' PHE . 10.8 mp -65.2 -27.42 68.67 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.548 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.13 -18.2 61.91 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.273 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -113.27 -27.75 7.86 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.0 167.23 1.14 Allowed Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.154 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.19 127.78 17.32 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.192 1.928 . . . . 0.0 112.728 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.45 -26.43 12.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.525 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -58.93 -48.09 82.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.924 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.412 ' CG1' ' CE ' ' A' ' 182' ' ' MET . 22.1 t -73.0 -35.82 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.696 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 13.0 tp -56.13 -36.36 68.15 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.129 0.49 . . . . 0.0 110.032 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -76.92 -40.11 26.46 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 178.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -87.7 103.09 15.27 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.879 0.371 . . . . 0.0 110.718 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' MET . . . . . 0.412 ' CE ' ' CG1' ' A' ' 178' ' ' VAL . 2.8 mtm 178.02 167.73 0.75 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.127 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.92 -56.75 1.55 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.63 0.252 . . . . 0.0 111.268 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 6.3 pm0 -160.39 142.79 13.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.894 0.378 . . . . 0.0 111.307 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 13.3 mt -104.33 115.96 47.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.455 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . 0.408 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 20.2 m170 -106.45 124.05 49.01 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.113 -179.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -79.46 104.7 10.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.709 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.75 86.86 55.51 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.517 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.33 146.9 57.94 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.312 2.008 . . . . 0.0 112.535 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 18.6 p -128.28 159.66 34.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.677 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 4.2 mtt180 -54.51 -26.83 34.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.459 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -100.99 -19.32 15.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.652 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -141.46 82.18 1.81 Allowed 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.767 0.318 . . . . 0.0 111.439 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.1 -24.15 52.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.245 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -106.0 38.37 2.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.608 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.08 114.72 25.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.322 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 32.8 m -110.59 169.37 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.724 179.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 22.0 mm -134.95 110.29 12.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.72 0.295 . . . . 0.0 111.285 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.401 HG11 ' CE2' ' A' ' 214' ' ' PHE . 12.3 m -102.81 127.18 56.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.987 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -88.64 152.56 21.75 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.675 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.11 157.62 16.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.812 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -57.78 -23.84 54.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.527 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -89.89 15.36 10.03 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 79.64 14.19 81.47 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.57 -0.824 . . . . 0.0 113.081 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -78.39 175.05 10.64 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 117.094 0.447 . . . . 0.0 110.836 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -140.53 111.46 7.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.082 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 20.1 t -114.22 135.63 53.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.911 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 1.5 m -107.64 118.36 36.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.928 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -131.12 161.94 30.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.66 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -99.28 156.75 16.82 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.737 0.303 . . . . 0.0 110.788 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.416 HG21 HD11 ' A' ' 211' ' ' ILE . 45.9 mt -68.46 -33.1 58.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.771 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 -67.38 -38.06 84.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.091 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -126.53 41.14 3.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.974 0.416 . . . . 0.0 110.866 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.428 ' CE1' HD12 ' A' ' 171' ' ' LEU . 11.5 t80 -65.02 -52.57 55.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.869 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.29 -37.74 81.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.048 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -69.25 -49.62 54.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.063 0.458 . . . . 0.0 110.372 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 1.2 mmpt? -53.25 -41.72 65.76 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.058 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.402 ' HB3' ' CG1' ' A' ' 178' ' ' VAL . 4.3 mm? -87.06 -23.16 25.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.9 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 11.0 t -60.95 -32.64 72.17 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.921 0.391 . . . . 0.0 110.157 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -69.53 -15.84 63.32 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.195 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.42 ' CD2' ' HA ' ' A' ' 222' ' ' PRO . 48.1 t80 -55.76 139.87 68.66 Favored Pre-proline 0 CA--C 1.537 0.444 0 N-CA-C 110.492 -0.188 . . . . 0.0 110.492 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . 0.42 ' HA ' ' CD2' ' A' ' 221' ' ' TYR . 68.8 Cg_endo -73.33 154.14 99.45 Favored 'Cis proline' 0 C--N 1.354 0.86 0 C-N-CA 124.344 -1.107 . . . . 0.0 112.714 0.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . 85.43 75.63 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.22 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.97 135.95 22.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.044 0.45 . . . . 0.0 111.358 178.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 176.5 -175.5 0.12 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.045 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -105.5 -166.42 1.21 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.878 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -128.02 33.81 4.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.79 0.329 . . . . 0.0 111.102 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 60.1 mt -107.54 30.21 6.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.964 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -111.93 57.37 0.64 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.995 0.426 . . . . 0.0 110.787 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 -132.69 -47.31 0.88 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.982 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -67.31 88.9 0.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.808 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 11.1 p -88.25 154.48 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.04 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 16.7 mttm . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.922 -179.951 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.216 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.98 137.03 19.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.867 0.365 . . . . 0.0 110.945 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -65.28 154.93 36.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.942 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.404 ' HB2' ' HB3' ' A' ' 134' ' ' LEU . 82.8 m95 -70.91 168.44 16.91 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.219 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.85 132.2 47.76 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.799 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -69.17 108.4 3.6 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.926 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.407 ' CD1' HG23 ' A' ' 168' ' ' THR . 44.2 pt -98.01 -7.93 9.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.323 179.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -159.97 174.45 14.36 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 121.134 -0.226 . . . . 0.0 110.649 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.47 ' CD1' ' CG ' ' A' ' 149' ' ' PRO . 28.0 m-85 -143.03 126.75 17.04 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.277 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.5 t -93.35 123.65 45.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.018 0.437 . . . . 0.0 111.643 -179.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.481 ' CE1' ' CE1' ' A' ' 130' ' ' PHE . 7.5 t80 -84.51 105.11 15.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.754 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -159.66 154.92 25.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.681 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 60.46 30.56 19.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.945 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 62.38 32.16 16.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.166 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 75.3 m -153.1 151.39 30.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.085 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.481 ' CE1' ' CE1' ' A' ' 125' ' ' TYR . 36.4 m-85 -94.52 90.91 6.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.537 179.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.437 ' CD1' ' HA ' ' A' ' 141' ' ' LYS . 21.4 m-85 -65.47 138.17 96.82 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.739 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.418 ' HA ' ' CD2' ' A' ' 123' ' ' TYR . 57.9 Cg_endo -85.16 116.06 1.73 Allowed 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.311 2.008 . . . . 0.0 112.083 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.428 ' HG ' HG22 ' A' ' 168' ' ' THR . 37.9 tp -95.29 123.65 38.91 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.882 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.418 ' CD1' ' HB3' ' A' ' 138' ' ' ARG . 58.2 mt -72.15 172.69 9.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.485 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -63.19 -28.75 70.26 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.854 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -90.5 12.39 18.81 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.209 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.438 ' HA2' HG22 ' A' ' 168' ' ' THR . . . 74.07 28.34 64.63 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.717 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.418 ' HB3' ' CD1' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -81.62 92.36 6.55 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.723 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.41 ' CD2' ' CB ' ' A' ' 131' ' ' PHE . 0.4 OUTLIER -74.17 105.03 5.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.957 0.408 . . . . 0.0 110.972 -179.533 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 88.6 mt -85.84 70.87 10.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.701 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.437 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 29.5 mttt -52.87 -23.24 6.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.983 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -84.09 -20.54 32.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.596 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -102.54 27.86 6.51 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 111.703 0.26 . . . . 0.0 111.703 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . -65.22 163.88 37.74 Favored Glycine 0 CA--C 1.511 -0.215 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.144 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 7.8 t -133.07 158.3 43.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.955 0.407 . . . . 0.0 110.648 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 6.2 mmmm -93.98 48.86 1.28 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.36 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.33 151.53 3.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.593 -179.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.452 ' CB ' ' CE2' ' A' ' 130' ' ' PHE . . . -96.93 126.73 41.51 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.178 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.47 ' CG ' ' CD1' ' A' ' 123' ' ' TYR . 73.2 Cg_endo -82.24 111.95 2.19 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.335 2.023 . . . . 0.0 112.552 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 28.2 t -69.82 -7.47 40.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.112 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -76.47 -23.33 53.82 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 120.859 0.362 . . . . 0.0 110.451 179.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -139.74 167.88 17.01 Favored Pre-proline 0 N--CA 1.454 -0.265 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.697 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -74.22 158.0 45.52 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.389 2.059 . . . . 0.0 112.236 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 11.1 t -118.47 111.04 32.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.049 0.452 . . . . 0.0 111.16 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.436 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.52 95.98 1.88 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.535 179.122 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.418 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 61.2 t -93.22 136.45 25.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.977 0.418 . . . . 0.0 111.014 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 49.05 55.98 10.96 Favored Glycine 0 CA--C 1.521 0.411 0 CA-C-N 115.808 -0.633 . . . . 0.0 113.264 179.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.436 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 2.7 m95 -98.34 151.11 20.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.128 0.489 . . . . 0.0 111.652 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.97 -172.65 0.07 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.349 179.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -44.46 155.5 0.09 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.134 0.492 . . . . 0.0 112.143 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -56.54 -25.14 49.45 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.25 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -60.89 -39.03 87.71 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 120.938 0.399 . . . . 0.0 110.038 179.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -75.36 -40.16 58.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.128 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 6.3 mt -59.0 -43.1 88.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.102 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.34 -29.69 35.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.35 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -68.14 -53.12 27.51 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.424 0.63 . . . . 0.0 110.189 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.39 -42.3 95.6 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.027 179.064 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.438 HG22 ' HA2' ' A' ' 137' ' ' GLY . 0.2 OUTLIER -59.51 -37.47 78.42 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.306 179.252 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.78 -36.67 92.3 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 178.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -72.92 -46.86 50.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.424 -0.388 . . . . 0.0 110.945 178.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.424 HD13 ' CE1' ' A' ' 214' ' ' PHE . 10.6 mp -65.69 -28.49 69.11 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.75 0.31 . . . . 0.0 111.34 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.31 -17.98 63.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.335 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -112.72 -27.36 8.19 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.65 0.262 . . . . 0.0 111.529 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.88 167.0 1.16 Allowed Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.183 -179.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -69.2 127.82 15.61 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.249 1.966 . . . . 0.0 112.721 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.02 -25.85 5.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.81 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.65 -50.0 74.61 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.007 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.403 ' CG1' ' CE ' ' A' ' 182' ' ' MET . 22.3 t -74.19 -35.33 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.667 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.37 -34.78 66.98 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.105 0.479 . . . . 0.0 110.091 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -79.56 -40.27 15.81 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.35 178.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -87.32 103.15 15.2 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.931 0.396 . . . . 0.0 110.745 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' MET . . . . . 0.403 ' CE ' ' CG1' ' A' ' 178' ' ' VAL . 2.8 mtm 178.95 164.66 0.86 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.24 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.33 -60.28 1.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.755 0.312 . . . . 0.0 111.195 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -155.64 142.89 19.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.029 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 16.7 mt -107.35 115.12 47.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.434 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . 0.418 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 20.7 m170 -106.39 135.07 48.53 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.186 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.403 ' CZ ' HD11 ' A' ' 211' ' ' ILE . 0.3 OUTLIER -86.65 104.35 15.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.269 179.417 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.12 81.66 57.27 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.8 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.3 151.91 60.69 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.44 2.094 . . . . 0.0 112.371 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 18.2 p -123.46 174.11 7.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.809 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 42.4 mtt180 -57.35 -29.5 64.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.341 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . 0.402 ' O ' ' CD1' ' A' ' 193' ' ' TYR . 6.0 pm0 -118.74 7.87 11.73 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.402 ' CD1' ' O ' ' A' ' 192' ' ' GLU . 39.5 m-85 -144.51 69.57 1.27 Allowed 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.977 0.418 . . . . 0.0 111.064 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -56.58 -22.0 30.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.61 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 9.3 p30 -110.09 38.26 2.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.743 0.306 . . . . 0.0 111.047 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.34 117.04 28.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.912 0.387 . . . . 0.0 111.121 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 22.0 m -114.45 168.47 6.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.747 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 22.7 mm -134.64 113.58 16.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.732 0.301 . . . . 0.0 111.221 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 10.4 m -104.8 125.91 59.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.09 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -88.72 152.52 21.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.787 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.02 154.88 18.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.761 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -58.03 -27.82 63.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.249 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -82.98 4.24 26.72 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 89.98 14.4 59.32 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 120.476 -0.869 . . . . 0.0 113.244 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -80.1 173.58 12.45 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 117.059 0.429 . . . . 0.0 110.902 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -139.3 111.34 7.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.904 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 19.6 t -115.79 137.36 49.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.924 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 97.7 p -110.77 119.66 39.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.942 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -130.36 164.21 25.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.71 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.86 153.71 20.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.76 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.403 HD11 ' CZ ' ' A' ' 187' ' ' TYR . 33.9 mt -64.3 -36.81 78.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.837 0.351 . . . . 0.0 110.693 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.14 -36.39 81.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.159 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -132.0 46.12 2.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.007 0.432 . . . . 0.0 110.889 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.424 ' CE1' HD13 ' A' ' 171' ' ' LEU . 11.5 t80 -67.53 -51.71 47.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.785 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.15 -41.05 87.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.146 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -68.25 -49.85 57.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.148 0.499 . . . . 0.0 110.268 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 1.5 mmpt? -52.28 -41.81 63.19 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.102 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -86.85 -24.66 24.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.008 179.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 13.5 t -60.87 -30.76 70.34 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.829 0.347 . . . . 0.0 110.531 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 58.7 m170 -68.83 -16.96 63.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.25 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.406 ' N ' ' CG2' ' A' ' 224' ' ' ILE . 70.1 t80 -65.04 137.4 97.09 Favored Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 110.408 -0.219 . . . . 0.0 110.408 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -72.48 154.86 98.96 Favored 'Cis proline' 0 C--N 1.355 0.891 0 C-N-CA 124.845 -0.898 . . . . 0.0 112.532 0.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . 82.02 77.75 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.079 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.406 ' CG2' ' N ' ' A' ' 221' ' ' TYR . 15.5 pt -129.25 -178.64 2.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.387 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 65.19 132.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.226 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -65.49 -165.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.083 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -102.03 31.42 3.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.883 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -90.56 14.98 11.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.562 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -88.39 -32.0 18.58 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.856 0.36 . . . . 0.0 110.83 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -68.19 -31.96 71.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.898 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -90.84 51.99 2.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.852 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 11.2 p -59.34 148.7 6.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.087 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 20.3 pttm . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.161 -0.923 . . . . 0.0 110.846 179.972 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.212 0 N-CA-C 112.469 -0.252 . . . . 0.0 112.469 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 26.5 t 60.38 66.25 0.97 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.069 0.461 . . . . 0.0 110.877 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -148.96 151.77 35.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.071 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.459 ' CD1' ' ND2' ' A' ' 136' ' ' ASN . 82.1 m95 -68.79 168.0 14.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.106 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -102.68 138.01 40.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.403 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 10.3 mtt180 -73.4 105.59 4.84 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.729 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 45.6 pt -93.49 -9.26 9.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.366 179.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -157.36 176.44 12.68 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 120.599 0.237 . . . . 0.0 110.537 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.448 ' CD1' ' CG ' ' A' ' 149' ' ' PRO . 34.0 m-85 -143.9 126.14 15.62 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.9 t -93.67 122.91 45.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.058 0.456 . . . . 0.0 111.417 -179.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -80.69 94.21 6.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.556 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -145.26 154.13 42.03 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.327 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.2 mmt-85 60.0 29.94 19.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.699 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 61.51 34.75 17.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.968 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 83.6 m -154.87 162.04 41.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.818 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.413 ' CE2' ' HB2' ' A' ' 148' ' ' ALA . 10.7 m-85 -100.47 90.71 4.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.141 0.496 . . . . 0.0 111.201 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.434 ' CG ' ' HA ' ' A' ' 141' ' ' LYS . 23.1 m-85 -68.9 118.09 57.74 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.391 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -64.3 115.35 3.11 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 122.359 2.039 . . . . 0.0 112.594 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.425 ' HG ' HG22 ' A' ' 168' ' ' THR . 30.3 tp -94.17 123.41 37.54 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.358 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 45.5 mt -69.02 173.6 5.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.557 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -64.72 -29.7 70.69 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.14 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . 0.459 ' ND2' ' CD1' ' A' ' 118' ' ' TRP . 2.7 p30 -88.14 9.84 21.38 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.19 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.445 ' HA2' HG22 ' A' ' 168' ' ' THR . . . 77.01 20.99 75.03 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.817 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -79.85 92.39 5.48 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.81 119.89 12.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.501 -178.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 33.1 mt -88.17 76.49 8.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.306 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.434 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 15.7 mtpt -71.49 -5.86 36.22 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.002 -0.544 . . . . 0.0 112.454 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -94.97 -25.08 16.66 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.606 0.241 . . . . 0.0 111.078 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -87.16 -82.19 0.22 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.294 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . 59.52 153.84 0.02 OUTLIER Glycine 0 CA--C 1.506 -0.506 0 C-N-CA 121.337 -0.459 . . . . 0.0 112.8 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 10.1 t -137.77 152.35 49.08 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.127 -0.536 . . . . 0.0 110.61 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.31 51.34 1.89 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.566 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.12 147.43 2.57 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.741 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.413 ' HB2' ' CE2' ' A' ' 130' ' ' PHE . . . -90.9 125.11 60.08 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.332 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.448 ' CG ' ' CD1' ' A' ' 123' ' ' TYR . 71.6 Cg_endo -84.74 107.88 1.17 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.613 2.209 . . . . 0.0 112.659 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 25.8 t -69.52 -8.03 43.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.017 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -77.83 -24.49 48.68 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 120.879 0.371 . . . . 0.0 110.377 179.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -138.85 167.04 20.8 Favored Pre-proline 0 N--CA 1.452 -0.339 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.616 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -75.03 157.99 42.32 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.404 2.069 . . . . 0.0 112.572 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 13.6 t -118.97 110.72 30.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.095 0.474 . . . . 0.0 111.028 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.429 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.64 96.05 1.94 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.868 179.439 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.405 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 61.3 t -94.18 137.14 23.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.989 0.423 . . . . 0.0 111.048 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 48.83 57.02 9.03 Favored Glycine 0 C--N 1.332 0.345 0 CA-C-N 115.921 -0.581 . . . . 0.0 113.175 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.429 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 3.2 m95 -100.04 151.14 21.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.153 0.501 . . . . 0.0 111.843 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.407 ' HB2' ' CD2' ' A' ' 187' ' ' TYR . 0.0 OUTLIER -66.56 -172.27 0.16 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.438 179.288 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -43.6 154.39 0.09 Allowed 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -57.07 -25.63 54.2 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.262 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -60.22 -37.66 80.99 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.984 0.421 . . . . 0.0 110.027 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.14 -40.51 45.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.039 179.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 6.2 mt -58.73 -41.42 82.4 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.051 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.24 -29.92 48.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.067 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -68.26 -53.0 27.63 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 121.387 0.613 . . . . 0.0 110.117 179.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.12 -46.3 88.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.036 178.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.445 HG22 ' HA2' ' A' ' 137' ' ' GLY . 0.2 OUTLIER -57.01 -36.78 70.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.549 179.231 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.75 -37.37 93.47 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 178.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -73.64 -45.78 50.71 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.315 -0.443 . . . . 0.0 111.077 179.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.429 HD12 ' CE1' ' A' ' 214' ' ' PHE . 11.0 mp -65.0 -29.69 70.62 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.828 0.347 . . . . 0.0 111.338 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.6 -16.99 63.5 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.365 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -114.23 -27.28 7.68 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.658 0.266 . . . . 0.0 111.633 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.05 167.17 1.18 Allowed Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.269 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -70.68 127.79 14.32 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.226 1.95 . . . . 0.0 112.938 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.04 -25.64 5.12 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.723 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.4 -50.17 73.86 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.968 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.41 ' CG1' ' CE ' ' A' ' 182' ' ' MET . 34.7 t -74.18 -33.5 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.49 179.446 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 11.4 tp -56.46 -36.88 69.55 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.096 0.474 . . . . 0.0 109.935 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -77.36 -41.65 20.49 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.284 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -84.32 103.0 13.13 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.896 0.379 . . . . 0.0 110.558 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' MET . . . . . 0.41 ' CE ' ' CG1' ' A' ' 178' ' ' VAL . 2.8 mtm 177.02 166.11 0.53 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.142 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 27.3 t -124.82 -53.99 1.64 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.732 0.301 . . . . 0.0 111.147 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -162.14 142.63 10.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.977 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.406 HD12 HG22 ' A' ' 185' ' ' ILE . 19.1 mt -104.89 115.44 46.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.472 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . 0.405 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 21.9 m170 -105.37 123.36 47.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.159 -179.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.407 ' CD2' ' HB2' ' A' ' 159' ' ' LYS . 14.0 t80 -78.82 104.35 9.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.438 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.65 81.56 40.46 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.584 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -67.26 145.8 73.5 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.311 2.007 . . . . 0.0 112.451 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 21.2 p -123.98 158.85 31.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.735 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.38 -25.16 9.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.664 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -108.61 -17.64 13.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.629 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -135.14 77.76 1.7 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.883 0.373 . . . . 0.0 111.209 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -57.09 -22.45 39.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.499 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 5.8 p30 -108.17 37.71 2.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.731 0.301 . . . . 0.0 110.819 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 9.5 ttt-85 -89.76 114.32 26.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.911 0.386 . . . . 0.0 111.2 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 25.1 m -111.61 167.85 5.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.9 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 22.7 mm -134.24 111.34 14.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.844 0.354 . . . . 0.0 110.974 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 6.7 m -100.31 120.15 49.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.21 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -81.88 152.46 26.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.661 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' MET . . . . . 0.41 ' HE2' ' CE2' ' A' ' 221' ' ' TYR . 7.6 mmt -105.6 157.89 17.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.99 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 39.5 m-20 -59.82 -27.03 66.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.142 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.02 13.27 13.33 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 89.1 -14.07 61.64 Favored Glycine 0 CA--C 1.52 0.397 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.247 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -58.13 156.03 10.24 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 117.133 0.467 . . . . 0.0 110.96 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -131.3 111.31 11.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.919 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 20.8 t -107.03 141.92 21.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.04 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 5.6 m -112.41 116.87 31.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.883 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -128.58 162.48 27.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.804 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.7 154.91 17.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.584 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 40.5 mt -67.3 -35.7 74.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.804 0.335 . . . . 0.0 110.96 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -38.4 91.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.24 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -128.09 40.64 3.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.914 0.388 . . . . 0.0 110.892 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.429 ' CE1' HD12 ' A' ' 171' ' ' LEU . 11.1 t80 -62.56 -54.35 41.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.768 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.1 -41.38 78.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.276 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.62 -46.58 68.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.075 0.464 . . . . 0.0 110.421 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.6 -44.75 77.29 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.883 179.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -83.31 -25.05 31.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.037 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 13.0 t -60.97 -33.14 72.76 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.062 0.458 . . . . 0.0 110.131 179.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 9.6 m170 -71.66 -15.84 62.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.268 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.446 ' CD1' ' HA ' ' A' ' 222' ' ' PRO . 2.1 t80 -55.05 133.47 68.1 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 116.726 -0.215 . . . . 0.0 111.165 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . 0.446 ' HA ' ' CD1' ' A' ' 221' ' ' TYR . 50.6 Cg_endo -91.72 105.68 0.48 Allowed 'Cis proline' 0 C--N 1.356 0.953 0 C-N-CA 124.824 -0.907 . . . . 0.0 112.677 0.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -179.02 38.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.118 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.442 HD13 ' CD2' ' A' ' 221' ' ' TYR . 0.1 OUTLIER -139.84 156.83 25.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.029 179.666 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 179.6 172.05 0.97 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.098 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -123.67 154.88 38.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.165 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -143.2 42.56 1.53 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.076 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 4.5 tp -98.64 30.9 3.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.012 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -113.78 32.52 5.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.808 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 46.7 mtm180 -147.34 54.6 1.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.794 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -167.33 152.55 7.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.665 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 21.0 t 67.08 116.29 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.11 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.874 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.166 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 26.1 m -132.98 178.43 6.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.795 0.331 . . . . 0.0 110.902 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -68.53 147.18 52.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.047 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.404 ' HB2' ' HB3' ' A' ' 134' ' ' LEU . 80.6 m95 -68.42 168.3 12.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.237 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 11.4 ttt180 -102.49 137.66 40.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.348 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 24.8 mtt85 -72.91 106.48 4.84 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.861 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.401 ' CD1' HG23 ' A' ' 168' ' ' THR . 46.6 pt -95.61 -8.1 9.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.361 179.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -158.75 176.45 12.34 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 120.578 0.228 . . . . 0.0 110.708 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.465 ' CD1' ' CG ' ' A' ' 149' ' ' PRO . 29.8 m-85 -144.94 126.45 15.01 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 4.3 t -93.08 122.61 44.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.091 0.472 . . . . 0.0 111.267 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.472 ' CE1' ' CE1' ' A' ' 130' ' ' PHE . 9.3 t80 -83.96 100.01 10.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.842 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -151.76 151.8 31.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.601 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 60.0 30.88 20.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 63.4 32.41 14.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.2 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 87.8 m -152.89 149.02 27.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.828 0.347 . . . . 0.0 110.988 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.472 ' CE1' ' CE1' ' A' ' 125' ' ' TYR . 24.2 m-85 -93.69 91.0 6.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.713 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.448 ' CD1' ' HA ' ' A' ' 141' ' ' LYS . 24.7 m-85 -66.05 120.79 72.27 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.141 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.408 ' HA ' ' CD2' ' A' ' 123' ' ' TYR . 37.2 Cg_endo -68.12 115.5 3.86 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.045 1.83 . . . . 0.0 112.539 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.414 ' HG ' HG22 ' A' ' 168' ' ' THR . 34.1 tp -95.0 124.2 38.91 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.787 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.404 ' HB3' ' HB2' ' A' ' 118' ' ' TRP . 42.5 mt -69.89 175.47 4.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.5 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -66.52 -28.41 68.53 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.125 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 32.7 p-10 -90.47 13.21 16.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.235 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.436 ' HA2' HG22 ' A' ' 168' ' ' THR . . . 73.79 20.15 79.76 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.978 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -79.04 94.14 5.25 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.326 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.405 ' CD2' ' CB ' ' A' ' 131' ' ' PHE . 0.4 OUTLIER -70.45 116.37 10.7 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.652 -178.875 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.4 mp -90.35 76.25 6.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.343 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.448 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 4.5 mttt -61.46 -15.46 37.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.241 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -94.38 -24.11 17.5 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -99.81 26.82 5.91 Favored 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -62.95 163.66 29.13 Favored Glycine 0 CA--C 1.51 -0.222 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.885 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 7.1 t -130.79 158.2 40.8 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.877 0.37 . . . . 0.0 110.712 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -94.42 49.32 1.27 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.513 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.3 154.64 4.0 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.609 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.451 ' CB ' ' CE2' ' A' ' 130' ' ' PHE . . . -97.64 125.53 44.43 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.24 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.465 ' CG ' ' CD1' ' A' ' 123' ' ' TYR . 73.7 Cg_endo -83.06 111.9 1.96 Allowed 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.4 2.066 . . . . 0.0 112.573 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 11.0 t -69.48 -8.14 44.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.175 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -77.11 -23.54 51.81 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 120.88 0.372 . . . . 0.0 110.507 179.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -138.97 166.92 21.43 Favored Pre-proline 0 N--CA 1.452 -0.336 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.669 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -74.83 154.33 43.32 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.401 2.067 . . . . 0.0 112.308 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 10.6 t -116.04 110.48 31.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.93 0.395 . . . . 0.0 111.293 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.429 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.36 95.94 1.81 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.552 179.025 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.406 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 60.1 t -91.98 136.12 25.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.946 0.403 . . . . 0.0 111.116 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 48.83 58.75 7.34 Favored Glycine 0 CA--C 1.521 0.468 0 CA-C-N 115.837 -0.619 . . . . 0.0 113.189 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.429 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 3.1 m95 -101.31 151.17 22.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.198 0.523 . . . . 0.0 111.834 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.42 -172.24 0.15 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.412 179.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -42.92 154.49 0.07 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -57.51 -25.84 55.86 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.157 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.97 -38.85 80.05 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.967 0.413 . . . . 0.0 109.943 179.191 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.64 -39.98 50.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.009 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 5.8 mt -59.28 -41.39 83.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.903 178.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.9 -31.06 48.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.129 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -67.8 -53.02 30.37 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.386 0.613 . . . . 0.0 110.138 179.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.24 -44.56 92.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.01 179.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.436 HG22 ' HA2' ' A' ' 137' ' ' GLY . 0.2 OUTLIER -58.42 -37.55 75.61 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.545 179.106 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.89 -36.86 91.48 Favored Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 178.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -73.83 -46.33 45.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.342 -0.429 . . . . 0.0 111.008 178.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.422 HD11 ' CE1' ' A' ' 214' ' ' PHE . 11.3 mp -66.22 -28.01 68.41 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.683 0.278 . . . . 0.0 111.349 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.87 -17.22 62.73 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.682 -0.236 . . . . 0.0 111.291 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -112.62 -29.85 7.31 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.653 0.263 . . . . 0.0 111.345 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.44 167.32 0.76 Allowed Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.216 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -69.63 128.78 16.63 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.208 1.939 . . . . 0.0 112.921 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.28 -25.63 9.95 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.535 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -58.82 -48.59 80.78 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.894 0.378 . . . . 0.0 110.927 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.409 ' CG1' ' CE ' ' A' ' 182' ' ' MET . 23.0 t -73.51 -35.69 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.649 179.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.8 tp -55.85 -34.31 65.33 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.128 0.49 . . . . 0.0 110.075 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -78.77 -41.9 14.25 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.295 178.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -84.99 102.86 13.52 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.884 0.373 . . . . 0.0 110.632 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' MET . . . . . 0.409 ' CE ' ' CG1' ' A' ' 178' ' ' VAL . 2.8 mtm 177.22 161.81 0.47 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.146 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 12.3 t -117.18 -57.63 2.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.749 0.309 . . . . 0.0 110.908 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -160.91 142.31 11.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.001 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.409 HD11 HG22 ' A' ' 185' ' ' ILE . 16.3 mt -102.1 114.51 41.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.316 179.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . 0.406 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 21.6 m170 -104.34 122.58 45.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.237 -179.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.42 ' CE2' ' HG3' ' A' ' 189' ' ' PRO . 51.9 t80 -74.5 104.25 5.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.275 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 11.8 mmtt -119.78 76.37 20.72 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.692 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.42 ' HG3' ' CE2' ' A' ' 187' ' ' TYR . 56.0 Cg_endo -70.2 144.69 52.44 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.21 1.94 . . . . 0.0 112.443 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 18.6 p -127.18 159.77 33.27 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.671 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 37.8 mtt-85 -53.52 -24.91 14.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.45 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -103.12 -21.14 13.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.597 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -137.16 79.2 1.74 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.975 0.417 . . . . 0.0 111.282 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.68 -23.23 50.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.484 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -107.01 36.52 2.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.75 0.31 . . . . 0.0 110.976 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 6.4 ttt85 -89.58 115.03 26.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.979 0.419 . . . . 0.0 111.15 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 27.2 m -111.67 166.68 5.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.729 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 22.7 mm -133.52 108.9 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.821 0.343 . . . . 0.0 111.222 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.414 HG12 ' CE2' ' A' ' 214' ' ' PHE . 9.1 m -99.08 122.65 51.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.088 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -85.14 152.48 23.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.761 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 4.7 mmt -104.97 158.88 16.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.017 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -63.22 -26.64 68.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.13 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -87.09 11.16 14.5 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 83.65 14.51 73.06 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.539 -0.838 . . . . 0.0 113.281 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -82.14 166.83 19.33 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 117.073 0.437 . . . . 0.0 110.845 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -133.72 111.67 10.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.879 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.4 t -114.63 125.26 71.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.131 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 2.0 p -101.18 116.1 32.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.76 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -126.87 159.89 32.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.872 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.47 152.52 19.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.687 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 35.2 mt -64.37 -38.29 82.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.95 0.405 . . . . 0.0 110.642 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 2.2 ptt85 -60.01 -34.61 73.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.205 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -134.77 45.5 2.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.933 0.397 . . . . 0.0 111.034 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.422 ' CE1' HD11 ' A' ' 171' ' ' LEU . 10.9 t80 -67.75 -53.9 23.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.712 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.2 -39.81 76.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.264 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.99 -48.84 62.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.101 0.477 . . . . 0.0 110.284 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.27 -42.51 66.59 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.14 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.407 ' HB3' ' CG1' ' A' ' 178' ' ' VAL . 3.9 mm? -86.95 -23.48 25.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.042 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 11.2 t -60.99 -33.15 72.79 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.901 0.381 . . . . 0.0 110.22 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -69.83 -16.44 63.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.204 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.434 ' CG ' ' HA ' ' A' ' 222' ' ' PRO . 38.0 t80 -57.79 142.58 78.3 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.734 -0.212 . . . . 0.0 111.057 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . 0.434 ' HA ' ' CG ' ' A' ' 221' ' ' TYR . 46.1 Cg_endo -92.71 105.74 0.45 Allowed 'Cis proline' 0 C--N 1.356 0.953 0 C-N-CA 124.733 -0.944 . . . . 0.0 112.698 0.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . 172.7 42.3 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.441 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.02 165.23 32.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.858 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 179.74 -170.16 0.13 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.12 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -79.3 151.64 30.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.158 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -145.24 25.63 1.37 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.134 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 1.4 tt -110.1 50.26 0.81 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.176 0.512 . . . . 0.0 110.381 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 76.13 -60.49 0.48 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.952 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 65.39 47.67 2.26 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.991 0.424 . . . . 0.0 110.865 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -116.6 86.18 2.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.722 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 11.5 p -73.59 127.94 35.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.065 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.993 179.995 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.183 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.8 m 64.01 -78.33 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.698 0.285 . . . . 0.0 111.138 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -105.2 144.97 31.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.066 0.46 . . . . 0.0 110.997 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 78.8 m95 -67.3 168.09 11.18 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.06 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? -103.05 138.77 39.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.287 179.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.26 105.73 4.79 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 120.822 0.344 . . . . 0.0 110.669 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.409 ' CD1' ' HA ' ' A' ' 135' ' ' GLU . 46.6 pt -95.04 -7.55 9.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.501 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -160.15 176.36 11.86 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 120.766 0.317 . . . . 0.0 110.946 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.463 ' CD1' ' CG ' ' A' ' 149' ' ' PRO . 35.7 m-85 -144.98 126.93 15.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.821 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 6.1 t -93.21 122.91 45.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.155 0.503 . . . . 0.0 111.587 -179.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.437 ' CE1' ' CE1' ' A' ' 130' ' ' PHE . 34.7 t80 -83.11 94.38 7.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.916 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -144.76 152.97 41.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.437 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.86 30.32 19.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.812 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 62.13 34.25 16.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.934 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 58.5 m -151.04 161.93 41.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.993 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.45 ' CE2' ' CB ' ' A' ' 148' ' ' ALA . 16.8 m-85 -104.61 91.14 3.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.256 0.551 . . . . 0.0 110.897 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.447 ' CG ' ' HA ' ' A' ' 141' ' ' LYS . 23.8 m-85 -69.62 121.55 82.81 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.547 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.405 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 21.1 Cg_exo -65.2 122.16 9.82 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 122.374 2.05 . . . . 0.0 112.549 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.428 ' HG ' HG23 ' A' ' 168' ' ' THR . 31.0 tp -104.12 123.48 47.34 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.296 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.417 ' CD1' ' HB3' ' A' ' 138' ' ' ARG . 53.6 mt -71.58 174.92 6.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.582 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.409 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.3 pt-20 -64.93 -29.06 69.97 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.915 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 14.9 p-10 -91.17 13.66 16.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.152 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.438 ' HA2' HG23 ' A' ' 168' ' ' THR . . . 74.95 22.52 76.7 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.059 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.417 ' HB3' ' CD1' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -76.0 92.76 3.18 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.412 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.64 119.86 15.41 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.023 0.439 . . . . 0.0 111.607 -179.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -92.24 72.91 5.38 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.711 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.447 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 0.4 OUTLIER -61.05 -16.84 48.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.012 -179.753 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -95.52 -20.0 19.37 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -102.23 25.7 8.57 Favored 'General case' 0 N--CA 1.461 0.111 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.405 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -58.43 162.6 10.29 Favored Glycine 0 CA--C 1.509 -0.337 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.708 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 11.1 t -136.33 150.83 49.04 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.767 0.317 . . . . 0.0 110.67 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 3.9 mmtt -88.99 52.19 2.35 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.005 0.431 . . . . 0.0 110.705 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.23 149.46 2.81 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.658 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.45 ' CB ' ' CE2' ' A' ' 130' ' ' PHE . . . -94.6 125.66 50.7 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.324 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.463 ' CG ' ' CD1' ' A' ' 123' ' ' TYR . 75.2 Cg_endo -84.24 111.26 1.58 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.49 2.126 . . . . 0.0 112.638 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.3 t -69.91 -7.53 41.16 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.035 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -77.09 -23.2 51.9 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 120.806 0.336 . . . . 0.0 110.58 179.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.47 167.11 18.96 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.944 -179.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -74.48 154.33 45.1 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.351 2.034 . . . . 0.0 112.133 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.421 HG11 ' CE2' ' A' ' 130' ' ' PHE . 14.3 t -115.47 111.12 34.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.019 0.437 . . . . 0.0 111.286 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.428 HD21 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.36 96.11 1.83 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.747 179.052 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.427 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 62.6 t -92.74 135.78 26.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.901 0.382 . . . . 0.0 110.936 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 48.77 58.28 7.75 Favored Glycine 0 CA--C 1.521 0.443 0 CA-C-N 115.963 -0.562 . . . . 0.0 113.209 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.428 ' CE2' HD21 ' A' ' 155' ' ' LEU . 3.0 m95 -101.13 151.3 22.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.206 0.526 . . . . 0.0 111.787 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -65.49 -173.34 0.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.319 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -43.81 154.88 0.09 Allowed 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -57.26 -25.13 53.86 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.134 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -59.95 -38.52 82.69 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.921 0.391 . . . . 0.0 110.107 179.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.89 -41.02 45.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.056 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 6.1 mt -58.08 -41.89 81.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.016 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.87 -30.54 46.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.228 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -68.74 -53.02 24.48 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 121.548 0.689 . . . . 0.0 110.026 179.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.11 -42.94 95.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.947 178.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.438 HG23 ' HA2' ' A' ' 137' ' ' GLY . 0.3 OUTLIER -59.51 -37.01 77.16 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.296 179.22 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.17 -39.52 94.59 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 110.556 -1.017 . . . . 0.0 110.556 178.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 48.1 mm-40 -69.72 -45.73 67.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.427 -0.387 . . . . 0.0 110.782 178.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.423 HD13 ' CE1' ' A' ' 214' ' ' PHE . 11.0 mp -66.58 -26.94 67.35 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.695 0.284 . . . . 0.0 111.462 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.98 -19.12 62.57 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.223 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -112.63 -26.67 8.52 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.573 0.225 . . . . 0.0 111.505 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.55 167.4 1.34 Allowed Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.089 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -70.66 127.9 14.48 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.201 1.934 . . . . 0.0 112.943 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.08 -25.28 8.34 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.597 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.44 -49.33 76.6 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.856 0.36 . . . . 0.0 110.944 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.408 ' CG1' ' CE ' ' A' ' 182' ' ' MET . 39.9 t -74.24 -36.11 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.451 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 12.7 tp -55.13 -37.01 66.37 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.09 0.472 . . . . 0.0 110.11 179.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -78.39 -39.09 23.44 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.393 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -87.29 103.04 15.08 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.9 0.381 . . . . 0.0 110.73 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' MET . . . . . 0.408 ' CE ' ' CG1' ' A' ' 178' ' ' VAL . 2.8 mtm 178.05 176.61 0.44 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.053 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 9.1 t -132.07 -54.77 0.98 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.783 0.325 . . . . 0.0 111.129 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -162.17 142.52 10.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.021 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.401 HD11 HG22 ' A' ' 185' ' ' ILE . 19.7 mt -104.76 114.69 45.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.34 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . 0.427 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 20.0 m170 -106.21 126.28 52.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.079 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.417 ' CD1' ' HD3' ' A' ' 189' ' ' PRO . 0.4 OUTLIER -77.39 104.83 8.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.517 179.57 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 11.8 mmtp -117.24 76.03 8.73 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.351 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.417 ' HD3' ' CD1' ' A' ' 187' ' ' TYR . 39.7 Cg_endo -66.67 145.43 75.73 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.374 2.05 . . . . 0.0 112.631 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 20.8 p -127.06 157.23 40.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.699 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 3.9 ptp85 -54.14 -24.2 16.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.4 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -101.41 -22.81 14.47 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.353 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -139.67 81.61 1.83 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.936 0.398 . . . . 0.0 111.216 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -57.54 -22.45 44.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.376 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -104.11 35.88 2.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.749 0.309 . . . . 0.0 110.881 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -89.95 113.15 24.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.044 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 19.7 m -109.8 168.31 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.88 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 22.8 mm -135.14 110.54 12.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.708 0.29 . . . . 0.0 111.242 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.418 HG12 ' CE2' ' A' ' 214' ' ' PHE . 10.6 m -99.09 133.97 39.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.963 0.411 . . . . 0.0 110.878 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -95.98 152.5 18.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.765 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 25.2 tpp -112.28 150.61 30.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.745 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 21.1 p30 -57.47 -28.93 63.81 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.28 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -72.69 -8.78 57.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.768 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 96.73 14.55 43.07 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 120.473 -0.87 . . . . 0.0 113.1 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -90.82 162.55 14.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 117.026 0.413 . . . . 0.0 111.018 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -126.85 111.26 13.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.809 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 20.6 t -109.36 137.52 41.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.067 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 10.7 p -109.58 118.66 37.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.967 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -127.07 172.54 10.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.679 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.33 154.5 27.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.609 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 31.9 mt -66.01 -35.45 75.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.812 0.339 . . . . 0.0 110.938 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.7 -35.63 81.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.194 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -134.83 47.53 2.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.016 0.436 . . . . 0.0 111.005 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.423 ' CE1' HD13 ' A' ' 171' ' ' LEU . 10.5 t80 -69.35 -50.81 42.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.613 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.97 -42.22 84.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.256 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -67.37 -47.68 69.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.986 0.422 . . . . 0.0 110.397 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.9 -45.34 74.69 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.09 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -82.12 -26.25 33.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.979 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 13.5 t -60.38 -32.46 71.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.002 0.429 . . . . 0.0 110.217 179.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.9 m170 -70.14 -17.11 63.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.118 179.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.406 ' CG ' ' HA ' ' A' ' 222' ' ' PRO . 50.5 t80 -71.26 139.6 84.72 Favored Pre-proline 0 CA--C 1.533 0.316 0 C-N-CA 121.359 -0.136 . . . . 0.0 110.939 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . 0.406 ' HA ' ' CG ' ' A' ' 221' ' ' TYR . 67.0 Cg_endo -87.26 109.97 1.44 Allowed 'Cis proline' 0 C--N 1.357 0.981 0 C-N-CA 124.505 -1.04 . . . . 0.0 112.56 0.169 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . 168.09 44.63 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.007 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 4.3 pt -115.81 -178.8 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.249 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 74.78 75.68 0.11 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.042 0.448 . . . . 0.0 110.842 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -112.21 -158.78 0.66 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.809 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -97.09 35.91 1.51 Allowed 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 120.845 0.355 . . . . 0.0 110.933 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 7.5 tt -76.26 -3.08 34.61 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.794 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -98.32 32.47 2.47 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.765 0.317 . . . . 0.0 110.933 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 2.3 mtt85 -105.09 -52.26 2.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.88 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -63.53 89.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.885 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 19.6 t -127.25 143.29 41.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.117 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.278 -0.867 . . . . 0.0 110.874 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.113 0 N-CA-C 112.534 -0.226 . . . . 0.0 112.534 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 51.9 p -105.84 -176.97 3.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.857 0.36 . . . . 0.0 110.936 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -112.95 146.48 38.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.107 0.479 . . . . 0.0 110.935 179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.412 ' HB2' ' HB3' ' A' ' 134' ' ' LEU . 79.5 m95 -67.11 168.27 10.5 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.068 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -102.79 135.41 44.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.466 179.449 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 15.0 mtt180 -71.42 105.49 3.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.743 -179.906 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 45.3 pt -93.53 -8.31 10.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.503 179.455 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -159.16 176.53 12.12 Favored 'General case' 0 C--O 1.226 -0.178 0 C-N-CA 121.037 -0.265 . . . . 0.0 111.0 179.885 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.444 ' O ' ' HA ' ' A' ' 154' ' ' VAL . 32.3 m-85 -143.28 126.8 16.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.455 179.78 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 4.5 t -93.47 123.01 45.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.05 0.453 . . . . 0.0 111.133 -179.607 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.428 ' CD1' ' CE1' ' A' ' 130' ' ' PHE . 37.3 t80 -80.19 103.02 9.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.748 -179.889 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -159.18 155.44 27.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.559 -179.808 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.19 31.61 19.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.849 -179.851 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 60.41 31.38 20.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.0 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 86.3 m -154.05 161.87 41.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.846 179.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.428 ' CE1' ' CD1' ' A' ' 125' ' ' TYR . 8.9 m-85 -100.65 90.4 4.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.669 179.625 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.459 ' HA ' ' HA2' ' A' ' 144' ' ' GLY . 22.3 m-85 -65.41 125.44 89.52 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.811 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.41 ' HB3' ' CE2' ' A' ' 123' ' ' TYR . 60.9 Cg_endo -73.66 120.17 6.3 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.219 1.946 . . . . 0.0 112.372 -179.773 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.42 ' HG ' HG21 ' A' ' 168' ' ' THR . 27.4 tp -98.04 123.58 42.13 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.489 179.636 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.412 ' HB3' ' HB2' ' A' ' 118' ' ' TRP . 37.0 mt -69.63 172.68 7.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.464 -179.747 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -63.81 -28.32 69.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.998 179.706 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 50.5 p-10 -90.59 13.43 15.93 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.281 179.781 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.438 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 73.1 22.36 79.07 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.227 179.797 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.01 94.44 6.56 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.519 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.42 112.49 9.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.362 -179.04 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 34.3 mt -88.84 81.25 6.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.405 179.418 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.443 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 9.6 mtpt -71.13 -5.61 33.03 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -179.388 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -90.41 -27.14 19.51 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.635 0.255 . . . . 0.0 111.183 179.885 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -85.81 -79.98 0.23 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.76 0.314 . . . . 0.0 111.322 -179.707 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . 57.83 161.13 0.04 OUTLIER Glycine 0 CA--C 1.506 -0.514 0 CA-C-N 116.29 -0.413 . . . . 0.0 112.708 -179.572 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.9 t -140.07 148.67 42.11 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.357 -0.422 . . . . 0.0 110.842 -179.548 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 4.0 mmtt -89.85 52.56 2.32 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.381 179.807 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.98 154.48 4.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.093 0.473 . . . . 0.0 110.613 -179.358 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.33 135.41 34.63 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.597 -179.493 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.436 ' HG3' ' CD1' ' A' ' 123' ' ' TYR . 67.1 Cg_endo -83.81 98.73 0.79 Allowed 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 122.993 2.462 . . . . 0.0 112.535 179.689 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 43.9 t -67.23 -9.57 41.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.786 179.468 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -90.15 -22.2 21.85 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 120.615 0.245 . . . . 0.0 111.572 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -138.9 167.75 18.16 Favored Pre-proline 0 C--N 1.329 -0.287 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -178.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -74.22 163.97 35.29 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 122.469 2.113 . . . . 0.0 112.511 -179.863 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 20.1 t -123.73 109.05 22.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.517 -179.755 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.426 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 1.1 mp -72.8 95.97 1.99 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.694 179.107 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 53.5 t -92.57 136.46 24.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.983 0.421 . . . . 0.0 111.231 -179.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 49.21 49.17 31.55 Favored Glycine 0 CA--C 1.519 0.299 0 CA-C-N 115.783 -0.644 . . . . 0.0 113.381 179.16 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.426 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 2.7 m95 -92.2 151.1 20.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.102 0.477 . . . . 0.0 111.371 -179.622 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -172.55 0.08 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.539 179.542 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -43.99 154.34 0.11 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.088 -0.506 . . . . 0.0 112.21 -179.846 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -57.41 -24.75 53.19 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.147 179.448 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.8 -39.23 84.31 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-O 120.959 0.409 . . . . 0.0 110.137 179.219 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.65 -40.84 47.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.054 178.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 6.2 mt -58.13 -41.68 81.28 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.093 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.991 179.104 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.21 -28.69 28.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.151 179.494 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -69.15 -53.23 21.19 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-O 121.474 0.654 . . . . 0.0 110.172 179.348 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.84 -45.11 93.45 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.11 179.051 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.438 HG21 ' HA2' ' A' ' 137' ' ' GLY . 0.2 OUTLIER -56.84 -38.82 73.19 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.592 179.344 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.14 -37.73 92.12 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 178.26 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -72.03 -46.47 56.97 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.375 -0.412 . . . . 0.0 111.073 178.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.422 HD13 ' CZ ' ' A' ' 214' ' ' PHE . 10.9 mp -65.88 -28.73 69.17 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.724 0.297 . . . . 0.0 111.414 179.785 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.82 -18.12 63.43 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.363 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -113.8 -26.79 8.03 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 111.661 0.245 . . . . 0.0 111.661 -179.73 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.32 167.27 1.28 Allowed Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 116.682 -0.236 . . . . 0.0 111.22 -179.561 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -67.68 126.32 14.56 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.215 1.943 . . . . 0.0 112.796 179.74 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.92 -26.07 9.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.676 179.805 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -58.5 -48.83 79.52 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.873 0.368 . . . . 0.0 110.891 179.683 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.403 ' CG1' ' CE ' ' A' ' 182' ' ' MET . 25.3 t -73.7 -33.7 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.531 179.515 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 11.4 tp -56.87 -35.78 69.3 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.135 0.493 . . . . 0.0 109.816 178.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -77.05 -42.39 19.83 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.276 178.74 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -84.13 103.02 13.0 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.829 0.347 . . . . 0.0 110.656 179.232 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 182' ' ' MET . . . . . 0.403 ' CE ' ' CG1' ' A' ' 178' ' ' VAL . 2.9 mtm 178.85 159.76 0.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.123 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -118.36 -54.53 2.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.814 0.34 . . . . 0.0 111.122 -179.743 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -162.66 142.63 9.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.999 -179.834 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 17.7 mt -105.23 115.04 46.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.422 179.4 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 23.2 m170 -105.69 129.37 53.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.164 -179.499 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -82.2 104.54 12.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.521 179.663 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.19 90.01 51.05 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.65 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.21 149.65 58.04 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.309 2.006 . . . . 0.0 112.49 -179.721 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 6.9 p -122.09 169.94 10.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.557 179.728 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -60.2 -28.4 67.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.942 179.886 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . 0.406 ' O ' ' CG ' ' A' ' 193' ' ' TYR . 3.0 mm-40 -115.61 9.78 15.4 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -179.54 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.406 ' CG ' ' O ' ' A' ' 192' ' ' GLU . 53.1 m-85 -157.96 76.29 0.78 Allowed 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.919 0.39 . . . . 0.0 111.327 179.872 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.54 -24.3 60.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.101 179.481 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -99.86 34.03 2.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.612 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.48 111.64 22.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.422 -179.491 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 33.3 m -107.78 169.46 2.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.495 179.384 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 15.1 mm -136.03 109.67 9.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.785 0.326 . . . . 0.0 111.2 179.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 9.9 m -97.85 120.9 47.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.081 179.727 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -81.76 152.65 26.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.788 -179.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 4.6 mmt -109.44 146.93 33.7 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.604 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -58.13 -29.07 65.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.073 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -78.21 -2.17 36.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.836 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 95.3 14.49 47.91 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 120.478 -0.867 . . . . 0.0 113.142 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -89.51 157.14 18.21 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.972 0.386 . . . . 0.0 111.04 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -125.84 111.54 14.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.724 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 22.8 t -110.77 139.59 33.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.139 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 14.5 m -110.36 118.33 36.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.737 179.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -128.42 164.57 22.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.888 0.375 . . . . 0.0 111.067 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.67 155.38 18.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.507 179.842 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 25.7 mt -62.91 -27.48 43.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.008 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . 0.403 ' CZ ' ' HB3' ' A' ' 212' ' ' ARG . 0.0 OUTLIER -82.48 -41.9 19.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.742 0.306 . . . . 0.0 111.009 179.877 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -108.78 32.12 5.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.121 -179.931 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.422 ' CZ ' HD13 ' A' ' 171' ' ' LEU . 11.3 t80 -64.25 -54.59 30.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.94 0.4 . . . . 0.0 110.284 179.737 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.71 -38.36 90.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.611 179.685 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -68.32 -51.95 39.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.436 179.53 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 1.8 mmmm -54.33 -43.02 70.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.951 179.819 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -82.32 -24.96 34.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.769 179.3 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 10.2 t -61.75 -31.74 71.94 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.851 0.357 . . . . 0.0 110.191 179.26 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -69.3 -17.1 63.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.068 179.596 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.421 ' CD1' ' HA ' ' A' ' 222' ' ' PRO . 60.1 t80 -63.74 136.41 96.71 Favored Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.469 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . 0.421 ' HA ' ' CD1' ' A' ' 221' ' ' TYR . 59.6 Cg_endo -71.38 154.42 97.14 Favored 'Cis proline' 0 C--N 1.355 0.878 0 C-N-CA 124.619 -0.992 . . . . 0.0 112.711 0.277 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . 83.43 76.54 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.736 -179.479 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 8.3 pt -125.9 -179.95 2.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.065 -179.84 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 61.56 154.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.034 -179.808 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -115.34 -164.82 0.97 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.076 -179.841 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -106.83 31.19 5.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.898 0.38 . . . . 0.0 110.838 179.84 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -95.23 23.3 5.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.167 179.783 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -128.51 31.73 4.95 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.793 0.33 . . . . 0.0 110.929 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -95.46 -33.38 12.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.042 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -82.34 -63.05 1.46 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.937 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 33.8 m 43.15 34.37 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 179.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.807 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.155 0 N-CA-C 112.451 -0.26 . . . . 0.0 112.451 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.3 t 60.71 -172.0 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.781 0.324 . . . . 0.0 110.855 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 61.57 150.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.176 0.512 . . . . 0.0 111.103 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.405 ' HB2' ' HB3' ' A' ' 134' ' ' LEU . 78.8 m95 -72.21 168.2 18.75 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.955 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -102.75 136.1 43.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.542 179.559 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 73.4 mtt180 -71.69 105.87 3.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.833 0.349 . . . . 0.0 110.669 -179.875 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 45.9 pt -94.06 -8.82 9.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.472 179.31 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -158.62 176.36 12.49 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 120.629 0.252 . . . . 0.0 110.76 179.926 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.438 ' CD1' ' HG3' ' A' ' 149' ' ' PRO . 32.2 m-85 -143.07 127.0 17.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.378 179.771 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 5.3 t -93.51 122.79 45.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.32 -179.464 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.432 ' CD1' ' CE1' ' A' ' 130' ' ' PHE . 42.4 t80 -80.67 107.1 13.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.844 -179.943 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -163.47 154.24 16.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.521 -179.866 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.54 30.59 19.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.865 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 61.82 32.28 18.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.15 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 73.3 m -154.98 155.29 33.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.036 179.841 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.432 ' CE1' ' CD1' ' A' ' 125' ' ' TYR . 7.0 m-85 -96.26 91.11 5.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.463 179.567 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.426 ' CD1' ' HA ' ' A' ' 141' ' ' LYS . 24.2 m-85 -65.52 123.98 85.98 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.964 -179.626 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.419 ' HA ' ' CD2' ' A' ' 123' ' ' TYR . 55.4 Cg_endo -71.53 114.62 4.0 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 122.171 1.914 . . . . 0.0 112.743 -179.552 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.417 ' HG ' HG22 ' A' ' 168' ' ' THR . 29.0 tp -93.36 123.83 36.93 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.632 179.453 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.405 ' HB3' ' HB2' ' A' ' 118' ' ' TRP . 45.0 mt -69.51 173.66 5.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.47 -179.851 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -64.71 -28.35 69.53 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.118 179.751 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 42.7 p-10 -90.33 12.58 17.85 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.301 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.432 ' HA2' HG22 ' A' ' 168' ' ' THR . . . 74.08 22.74 77.48 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.987 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 15.1 tpp85 -82.14 93.42 7.04 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.539 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.51 108.76 3.92 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.155 -179.212 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 15.8 mt -85.53 72.03 10.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.821 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.426 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 19.7 mttt -57.96 -20.85 40.97 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.45 179.873 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -94.09 19.74 8.82 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.42 179.578 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -144.49 25.32 1.51 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.655 0.264 . . . . 0.0 111.151 179.781 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.98 166.69 7.59 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.88 -179.683 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 10.2 t -132.41 150.44 52.16 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.873 0.368 . . . . 0.0 110.751 -179.878 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.02 52.1 2.08 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.436 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.72 158.47 6.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.094 0.473 . . . . 0.0 110.678 -179.399 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -91.2 136.13 27.55 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.61 -179.504 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.438 ' HG3' ' CD1' ' A' ' 123' ' ' TYR . 62.9 Cg_endo -84.09 98.57 0.76 Allowed 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.11 2.54 . . . . 0.0 112.621 179.78 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 4.9 t -67.36 -9.66 43.51 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.713 179.363 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -90.21 -21.8 21.98 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -138.78 167.09 20.7 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.019 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.76 163.55 36.91 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 122.5 2.134 . . . . 0.0 112.382 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 25.2 t -124.09 109.89 24.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.051 0.453 . . . . 0.0 111.591 -179.798 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.431 HD22 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.6 96.18 1.94 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.836 179.228 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.419 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 57.4 t -92.33 137.31 22.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.055 -179.928 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 47.5 56.96 7.76 Favored Glycine 0 CA--C 1.52 0.393 0 CA-C-N 115.855 -0.611 . . . . 0.0 113.231 179.371 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.431 ' CE2' HD22 ' A' ' 155' ' ' LEU . 2.9 m95 -99.44 151.16 21.42 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.185 0.516 . . . . 0.0 111.756 -179.386 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.66 -172.1 0.16 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.509 179.377 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -42.58 154.29 0.06 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.68 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -57.15 -24.68 52.04 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.232 179.491 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.05 -40.54 89.8 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-O 120.975 0.417 . . . . 0.0 110.041 179.193 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -74.25 -40.66 62.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.935 178.88 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 6.1 mt -58.92 -41.06 81.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.931 178.885 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.73 -31.0 57.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.25 179.881 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -67.63 -52.97 31.95 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-O 121.434 0.635 . . . . 0.0 110.245 179.571 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.45 -44.28 92.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.175 179.151 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.432 HG22 ' HA2' ' A' ' 137' ' ' GLY . 0.2 OUTLIER -58.85 -38.16 78.11 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.534 179.271 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.37 -37.35 91.84 Favored Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 178.493 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 40.8 mm-40 -73.4 -45.71 53.06 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.403 -0.399 . . . . 0.0 111.199 179.035 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.415 HD11 ' CE1' ' A' ' 214' ' ' PHE . 11.0 mp -65.8 -29.55 70.05 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.688 0.28 . . . . 0.0 111.295 179.836 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.4 -19.98 64.64 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.335 -179.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -111.61 -26.75 8.87 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.613 0.244 . . . . 0.0 111.511 -179.834 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.72 166.53 1.29 Allowed Pre-proline 0 CA--C 1.538 0.516 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.06 -179.665 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -69.7 128.07 15.55 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.269 1.979 . . . . 0.0 112.692 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.97 -25.9 5.29 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.676 179.802 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.76 -50.06 74.51 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.844 0.354 . . . . 0.0 111.037 179.701 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.405 ' CG1' ' CE ' ' A' ' 182' ' ' MET . 30.1 t -74.11 -35.61 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.582 179.638 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.98 -34.35 68.01 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.108 0.48 . . . . 0.0 109.772 179.002 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -78.48 -38.86 23.73 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 178.578 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -88.35 103.17 15.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.947 0.403 . . . . 0.0 110.774 179.229 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 182' ' ' MET . . . . . 0.405 ' CE ' ' CG1' ' A' ' 178' ' ' VAL . 2.9 mtm 178.73 166.72 0.88 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.987 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.4 t -127.04 -51.48 1.43 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.706 0.289 . . . . 0.0 111.51 -179.613 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -163.06 142.83 8.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.934 0.397 . . . . 0.0 111.082 -179.668 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 19.0 mt -108.7 115.14 48.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.54 179.516 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . 0.419 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 22.2 m170 -106.14 123.4 47.95 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.952 -179.684 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -76.35 105.38 7.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.617 179.75 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.04 83.2 60.65 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.643 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.78 151.58 63.36 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.406 2.071 . . . . 0.0 112.653 -179.699 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 22.8 p -127.85 159.8 33.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.637 179.721 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -52.4 -24.96 8.67 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.727 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -107.32 -18.77 13.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.646 -179.954 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -133.67 77.7 1.73 Allowed 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.922 0.392 . . . . 0.0 111.159 -179.694 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -57.18 -21.11 30.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.641 179.819 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -110.3 37.45 2.72 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.624 0.249 . . . . 0.0 111.07 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.19 117.34 28.87 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.04 0.448 . . . . 0.0 111.255 -179.795 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 31.7 m -112.73 169.84 4.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.73 179.655 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 22.7 mm -134.61 111.12 13.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.774 0.321 . . . . 0.0 111.356 179.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.406 HG12 ' CZ ' ' A' ' 214' ' ' PHE . 10.7 m -100.23 133.58 42.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.877 179.601 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -95.11 152.51 18.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.799 179.954 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 6.5 mmt -105.12 166.74 10.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.937 0.398 . . . . 0.0 111.051 -179.904 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 19.5 p30 -69.37 -26.39 64.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.195 179.884 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -88.48 12.57 14.04 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -179.856 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 83.05 14.34 75.16 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.554 -0.831 . . . . 0.0 113.311 179.718 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -82.98 150.94 26.08 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 117.127 0.463 . . . . 0.0 110.626 179.886 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -121.75 111.43 17.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.889 -179.922 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.6 t -113.03 140.24 34.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.142 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 26.6 t -113.69 119.43 37.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.783 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -130.21 159.29 37.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.857 179.803 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -92.36 156.56 17.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.68 179.747 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.409 HG23 HD11 ' A' ' 211' ' ' ILE . 33.9 mt -70.41 -34.82 59.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.764 0.316 . . . . 0.0 110.749 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.5 -30.89 70.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.215 -179.467 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -130.62 35.85 3.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.898 179.984 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.415 ' CE1' HD11 ' A' ' 171' ' ' LEU . 11.8 t80 -63.08 -52.7 61.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.801 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.43 -40.22 86.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.062 -179.918 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.21 -49.77 58.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.077 0.465 . . . . 0.0 110.439 179.589 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.23 -43.79 71.16 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.027 179.701 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -82.7 -26.32 32.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.97 179.517 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 12.2 t -60.81 -31.61 71.01 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.996 0.427 . . . . 0.0 110.386 179.463 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -69.78 -16.47 63.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.27 179.532 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -65.83 137.79 96.24 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 121.328 -0.149 . . . . 0.0 110.901 180.0 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -86.51 109.9 1.47 Allowed 'Cis proline' 0 C--N 1.358 1.053 0 C-N-CA 124.513 -1.036 . . . . 0.0 112.601 0.145 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . 166.85 44.74 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.034 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 4.3 pt -115.16 -178.92 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.077 -179.433 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 69.87 73.85 0.23 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.113 0.482 . . . . 0.0 110.655 -179.485 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -90.74 -166.3 1.55 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.416 -179.659 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -110.04 46.31 1.04 Allowed 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.746 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 1.7 tt -64.76 52.72 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.671 -178.766 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 56.22 -178.01 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.849 0.357 . . . . 0.0 111.438 179.674 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.43 33.45 3.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.662 179.935 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -61.52 87.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.806 -179.864 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 12.3 p -154.27 47.44 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.133 0.492 . . . . 0.0 110.962 179.921 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 25.0 tttt . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.893 -179.951 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 112.543 -0.223 . . . . 0.0 112.543 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 8.5 t 61.03 112.05 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.725 0.297 . . . . 0.0 110.864 -179.9 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 62.34 146.46 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.101 0.477 . . . . 0.0 110.885 -179.853 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.41 ' HB2' ' HB3' ' A' ' 134' ' ' LEU . 81.0 m95 -65.71 168.35 7.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.142 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -102.25 135.23 44.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.53 179.536 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 6.6 mtm-85 -71.29 105.28 3.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.673 -179.923 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.404 ' CD1' HG22 ' A' ' 168' ' ' THR . 46.7 pt -94.19 -6.7 10.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.654 179.518 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -161.14 176.71 11.0 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 121.002 -0.279 . . . . 0.0 111.065 179.823 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.447 ' CD1' ' HG3' ' A' ' 149' ' ' PRO . 32.5 m-85 -143.35 127.19 17.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.19 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 5.1 t -93.26 122.81 45.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.041 0.448 . . . . 0.0 111.344 -179.386 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -80.43 109.48 14.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.712 -179.945 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.401 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 4.9 t70 -164.77 148.93 9.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.538 -179.788 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.68 31.69 18.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.895 -179.659 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 61.43 30.27 18.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.972 -179.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 84.7 m -151.09 149.73 29.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.801 179.861 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -94.2 91.75 6.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.53 179.65 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.444 ' CG ' ' HA ' ' A' ' 141' ' ' LYS . 20.6 m-85 -64.82 117.0 34.28 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.289 -179.41 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.416 ' HA ' ' CD2' ' A' ' 123' ' ' TYR . 27.8 Cg_endo -64.12 119.03 5.96 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.172 1.915 . . . . 0.0 112.435 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.414 ' HG ' HG21 ' A' ' 168' ' ' THR . 38.3 tp -99.79 124.18 44.8 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.802 179.672 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.41 ' HB3' ' HB2' ' A' ' 118' ' ' TRP . 41.3 mt -70.5 173.39 7.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.647 -179.827 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -64.59 -28.46 69.65 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.03 179.604 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -90.17 12.78 16.92 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.213 179.61 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.438 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 72.5 23.8 77.32 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.755 -0.736 . . . . 0.0 113.048 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.76 96.88 7.71 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.385 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.412 ' CD2' ' CB ' ' A' ' 131' ' ' PHE . 0.4 OUTLIER -72.48 121.26 19.31 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.664 -178.93 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -98.39 72.24 2.08 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.678 179.385 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.444 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 21.6 mttt -57.83 -20.16 33.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.69 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -88.24 -24.43 23.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.564 -180.0 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -102.07 25.61 8.58 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.846 0.314 . . . . 0.0 111.846 -179.566 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.95 164.91 8.92 Favored Glycine 0 CA--C 1.509 -0.292 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.757 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 9.0 t -130.03 155.29 46.37 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.073 0.463 . . . . 0.0 110.907 179.969 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -97.1 54.24 1.23 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.433 -179.703 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.69 170.95 6.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.265 -179.294 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -103.87 138.19 19.46 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.776 -179.355 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.447 ' HG3' ' CD1' ' A' ' 123' ' ' TYR . 58.8 Cg_endo -84.9 100.27 0.73 Allowed 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.219 2.613 . . . . 0.0 112.645 179.799 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 18.1 t -65.82 -11.21 44.54 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.72 179.334 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.93 -21.77 20.4 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.783 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -136.7 166.4 27.79 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -178.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -75.15 164.57 32.83 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.487 2.125 . . . . 0.0 112.335 179.924 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 20.1 t -122.61 108.87 22.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.95 0.405 . . . . 0.0 111.677 -179.763 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.445 HD23 ' CD2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.52 95.99 1.88 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.728 179.065 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 50.3 t -92.78 137.65 21.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.918 0.389 . . . . 0.0 111.181 -179.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 47.78 57.61 7.51 Favored Glycine 0 CA--C 1.521 0.431 0 CA-C-N 115.987 -0.551 . . . . 0.0 113.27 179.363 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.445 ' CD2' HD23 ' A' ' 155' ' ' LEU . 3.1 m95 -100.11 151.27 21.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.167 0.508 . . . . 0.0 111.705 -179.452 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -66.51 -172.39 0.16 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.569 179.276 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -43.08 154.17 0.08 Allowed 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -179.75 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -57.0 -24.76 51.82 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.239 179.477 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.15 -39.55 86.76 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.959 0.409 . . . . 0.0 110.066 179.199 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -75.86 -40.97 53.63 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.108 178.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 6.2 mt -58.55 -42.34 84.38 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.884 179.048 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.65 -25.93 20.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.477 179.648 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -71.49 -54.38 10.76 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.056 0.455 . . . . 0.0 110.854 -179.901 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -37.33 85.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.244 179.547 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.438 HG21 ' HA2' ' A' ' 137' ' ' GLY . 0.2 OUTLIER -60.51 -38.3 83.9 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.909 179.027 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -61.3 -36.06 91.88 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 177.62 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 55.3 mm-40 -70.65 -48.94 52.32 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.118 -0.541 . . . . 0.0 110.6 178.478 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.42 HD12 ' CE1' ' A' ' 214' ' ' PHE . 10.8 mp -65.06 -27.86 69.08 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.396 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.67 -18.46 62.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.373 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -112.19 -28.66 7.87 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 120.658 0.266 . . . . 0.0 111.519 -179.706 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.61 167.2 1.43 Allowed Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.041 -179.612 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -70.34 129.19 16.58 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.248 1.965 . . . . 0.0 112.893 179.946 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.33 -25.34 9.38 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.65 179.667 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.97 -48.63 79.41 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.944 0.402 . . . . 0.0 110.869 179.664 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.407 ' CG1' ' CE ' ' A' ' 182' ' ' MET . 39.3 t -74.12 -35.53 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.424 179.399 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 8.7 tp -56.8 -36.26 69.69 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.118 0.485 . . . . 0.0 109.949 179.019 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -76.67 -39.96 28.06 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.328 178.759 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -88.09 103.14 15.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.906 0.384 . . . . 0.0 110.669 179.268 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 182' ' ' MET . . . . . 0.407 ' CE ' ' CG1' ' A' ' 178' ' ' VAL . 3.0 mtm 179.42 162.34 0.86 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.194 179.992 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.42 -56.22 2.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.742 0.306 . . . . 0.0 111.038 -179.838 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -163.11 142.69 8.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.832 -179.945 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 14.3 mt -103.11 115.15 44.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.539 179.484 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 24.2 m170 -104.19 127.32 51.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.03 -179.548 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -82.52 104.66 12.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.576 179.719 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -127.93 89.22 51.08 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.714 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -66.93 149.2 83.02 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.283 1.989 . . . . 0.0 112.532 -179.862 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 25.8 p -126.21 157.78 37.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.828 179.891 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -53.12 -25.31 12.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.595 -179.98 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -106.73 -17.92 14.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.785 -179.893 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -137.86 83.66 1.99 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.886 0.374 . . . . 0.0 111.315 -179.676 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -55.92 -22.7 27.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.427 179.623 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.68 40.87 1.8 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.017 0.437 . . . . 0.0 110.295 179.748 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 2.1 tpm_? -87.68 112.86 22.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.857 -179.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 31.9 m -108.23 168.23 3.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.027 179.941 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 19.3 mm -134.4 108.45 10.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.372 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.413 HG12 ' CE2' ' A' ' 214' ' ' PHE . 6.8 m -98.08 122.37 49.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.903 0.382 . . . . 0.0 110.873 179.462 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -82.4 152.27 26.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.834 -179.869 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.56 144.67 31.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.554 179.887 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 44.3 m-20 -57.43 -29.28 64.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.017 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -74.78 -7.44 53.4 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.633 179.676 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 101.54 14.47 29.87 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 120.484 -0.865 . . . . 0.0 113.123 -179.929 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -92.24 166.11 12.77 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.98 0.39 . . . . 0.0 111.049 -179.844 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -132.16 111.43 11.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.827 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.5 t -109.86 138.56 36.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.103 179.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 52.5 p -112.08 116.78 31.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.981 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -127.75 158.14 38.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.653 179.775 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -97.62 148.43 23.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.778 0.323 . . . . 0.0 110.653 179.891 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 59.5 mt -59.96 -36.59 67.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.825 179.927 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.25 -33.88 74.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.289 -179.524 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -134.92 44.17 2.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.984 0.421 . . . . 0.0 111.015 -179.885 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.42 ' CE1' HD12 ' A' ' 171' ' ' LEU . 10.8 t80 -66.91 -52.64 40.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.779 179.801 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.35 -41.51 89.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.232 -179.724 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -67.13 -49.76 63.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.102 0.477 . . . . 0.0 110.476 179.655 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.95 -44.56 74.43 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.015 179.782 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -81.22 -26.86 35.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.061 179.635 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 13.6 t -61.14 -31.7 71.41 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.93 0.395 . . . . 0.0 110.28 179.346 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 -69.77 -16.78 63.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.232 179.556 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.405 ' CD1' ' HA ' ' A' ' 222' ' ' PRO . 67.9 t80 -66.27 138.17 95.85 Favored Pre-proline 0 CA--C 1.534 0.33 0 C-N-CA 121.445 -0.102 . . . . 0.0 110.963 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . 0.405 ' HA ' ' CD1' ' A' ' 221' ' ' TYR . 68.9 Cg_endo -86.62 110.44 1.63 Allowed 'Cis proline' 0 C--N 1.356 0.961 0 C-N-CA 124.499 -1.042 . . . . 0.0 112.614 0.184 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . 167.72 44.27 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.147 179.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 5.5 pt -117.13 -178.71 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.22 -179.44 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 75.87 88.55 0.08 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.909 -179.589 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -85.35 -162.82 0.76 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.079 -179.92 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -98.22 30.11 3.27 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.807 0.337 . . . . 0.0 110.995 179.862 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -58.96 -20.32 51.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.436 179.643 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -82.98 63.88 7.3 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.046 0.451 . . . . 0.0 110.871 179.821 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 10.9 ttp180 -98.25 -27.93 13.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.08 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -58.07 -51.34 70.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.826 0.346 . . . . 0.0 111.116 -179.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 27.7 m -69.94 108.22 2.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.122 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.848 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.151 0 N-CA-C 112.575 -0.21 . . . . 0.0 112.575 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.25 177.8 4.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.838 0.351 . . . . 0.0 110.813 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 61.72 152.54 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.094 0.473 . . . . 0.0 110.944 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.419 ' HB2' ' HB3' ' A' ' 134' ' ' LEU . 82.7 m95 -70.42 168.29 16.42 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.967 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.94 135.02 44.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.503 179.594 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 12.8 mtt180 -71.39 106.45 3.91 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.915 -179.815 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.405 ' CD1' HG21 ' A' ' 168' ' ' THR . 46.0 pt -95.8 -7.81 9.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.496 179.278 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -157.94 176.1 12.99 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 120.619 0.247 . . . . 0.0 110.713 179.768 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.468 ' CD1' ' CG ' ' A' ' 149' ' ' PRO . 39.1 m-85 -145.58 126.0 14.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.348 -179.895 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 4.2 t -94.05 123.21 46.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.016 0.436 . . . . 0.0 111.269 -179.458 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.465 ' CD1' ' CE1' ' A' ' 130' ' ' PHE . 7.0 t80 -82.59 101.85 11.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.892 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -156.31 155.35 32.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.704 -179.912 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 60.85 32.95 20.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.878 -179.783 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 60.28 31.26 20.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.91 179.961 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 70.6 m -152.94 161.49 42.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.883 179.766 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.465 ' CE1' ' CD1' ' A' ' 125' ' ' TYR . 97.2 m-85 -102.54 90.41 3.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.696 179.668 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.447 ' HA ' ' HA2' ' A' ' 144' ' ' GLY . 22.8 m-85 -65.45 124.79 88.12 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.088 -179.923 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.413 ' HA ' ' CD2' ' A' ' 123' ' ' TYR . 59.5 Cg_endo -73.63 119.17 5.79 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 121.986 1.791 . . . . 0.0 112.367 179.964 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.411 ' HG ' HG23 ' A' ' 168' ' ' THR . 32.2 tp -96.1 123.81 39.86 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.657 179.793 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.419 ' HB3' ' HB2' ' A' ' 118' ' ' TRP . 41.6 mt -70.79 172.77 8.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.563 -179.713 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -63.27 -29.05 70.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.992 179.692 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -89.9 12.52 17.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.131 179.577 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.454 ' HA2' HG23 ' A' ' 168' ' ' THR . . . 72.72 25.09 74.87 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.997 179.874 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -82.61 95.11 7.68 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.433 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.69 107.21 5.03 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.301 -179.221 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 30.5 mt -84.48 76.8 10.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.271 179.375 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.428 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 24.6 mtpt -67.84 -8.77 38.99 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.407 -179.603 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -84.77 -28.53 26.13 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.707 0.289 . . . . 0.0 110.915 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -85.65 -79.95 0.23 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.072 -179.848 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.447 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . 57.28 160.71 0.02 OUTLIER Glycine 0 CA--C 1.507 -0.462 0 CA-C-N 116.283 -0.417 . . . . 0.0 112.837 -179.625 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 9.6 t -140.63 150.78 43.99 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.356 -0.422 . . . . 0.0 110.68 -179.647 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -89.26 50.87 2.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.96 0.41 . . . . 0.0 110.625 179.839 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -171.33 155.49 4.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.956 0.408 . . . . 0.0 110.611 -179.286 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -98.74 125.26 43.05 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.148 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.468 ' CG ' ' CD1' ' A' ' 123' ' ' TYR . 96.5 Cg_endo -84.93 109.26 1.25 Allowed 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 122.494 2.13 . . . . 0.0 112.779 -179.767 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 17.0 t -69.86 -7.86 43.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.958 179.743 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -77.28 -23.41 51.13 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 120.808 0.337 . . . . 0.0 110.451 179.006 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -139.47 166.23 25.82 Favored Pre-proline 0 N--CA 1.453 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.546 -179.493 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.57 151.08 36.6 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.426 2.084 . . . . 0.0 112.662 -179.821 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 9.4 t -113.2 111.59 36.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.902 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.43 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.44 96.02 1.85 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.619 179.22 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 62.1 t -90.75 137.0 22.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.956 0.408 . . . . 0.0 111.18 179.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 47.76 60.78 5.19 Favored Glycine 0 CA--C 1.521 0.434 0 CA-C-N 115.938 -0.573 . . . . 0.0 113.147 179.377 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.43 ' CE2' HD23 ' A' ' 155' ' ' LEU . 3.0 m95 -104.35 151.27 23.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.228 0.537 . . . . 0.0 111.823 -179.344 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.25 -172.17 0.2 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.393 179.386 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -42.15 153.66 0.06 Allowed 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.733 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -56.94 -24.85 51.74 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.215 179.446 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -59.87 -40.49 88.84 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.916 0.388 . . . . 0.0 109.987 179.213 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -75.17 -38.95 60.67 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.988 178.907 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 5.4 mt -59.88 -43.69 92.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.808 178.866 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.54 -26.11 19.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.717 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -70.34 -54.57 12.01 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.1 0.476 . . . . 0.0 110.781 -179.9 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 167' ' ' MET . . . . . 0.419 ' HG3' ' N ' ' A' ' 168' ' ' THR . 0.0 OUTLIER -61.75 -35.85 79.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.291 179.518 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.454 HG23 ' HA2' ' A' ' 137' ' ' GLY . 0.2 OUTLIER -60.88 -40.88 94.69 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.938 178.89 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.94 -35.36 86.74 Favored Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 177.903 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -72.46 -46.85 53.0 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.236 -0.482 . . . . 0.0 110.66 178.656 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.418 HD13 ' CE1' ' A' ' 214' ' ' PHE . 10.8 mp -66.25 -27.57 68.05 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.773 0.321 . . . . 0.0 111.592 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.46 -17.54 62.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.257 179.868 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -114.38 -26.89 7.78 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -179.681 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.77 167.63 1.37 Allowed Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.037 -179.58 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -69.1 127.74 15.57 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.138 1.892 . . . . 0.0 112.829 179.812 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.45 -25.88 11.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.611 179.713 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.81 -48.45 79.69 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.866 0.365 . . . . 0.0 110.967 179.658 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.407 ' CG1' ' CE ' ' A' ' 182' ' ' MET . 22.3 t -74.06 -37.13 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.571 179.584 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 6.6 tp -55.59 -36.1 66.52 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.237 0.541 . . . . 0.0 110.072 179.058 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -76.54 -40.96 26.09 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.268 178.864 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -87.58 102.87 15.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.979 0.419 . . . . 0.0 110.596 179.225 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 182' ' ' MET . . . . . 0.407 ' CE ' ' CG1' ' A' ' 178' ' ' VAL . 2.9 mtm 177.89 162.47 0.59 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.084 -179.916 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 7.5 t -118.26 -56.9 2.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.819 0.343 . . . . 0.0 110.92 -179.859 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -161.28 142.44 11.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.957 -179.848 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 16.8 mt -100.4 115.91 42.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.403 179.483 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 19.9 m170 -105.04 115.25 29.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.965 -179.526 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.422 ' HB2' ' CE2' ' A' ' 158' ' ' TRP . 14.5 t80 -74.79 104.62 5.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.688 179.817 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.91 84.8 44.79 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.448 179.85 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.83 148.78 58.9 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.395 2.063 . . . . 0.0 112.62 -179.668 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 8.3 p -133.74 162.11 32.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.58 179.681 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 17.7 mtt-85 -57.04 -26.38 60.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.149 179.721 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -97.48 -19.25 18.53 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.583 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -146.91 82.16 1.56 Allowed 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 120.87 0.367 . . . . 0.0 111.388 -179.881 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -58.29 -21.65 49.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.271 179.737 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -107.8 36.75 2.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.742 0.306 . . . . 0.0 110.591 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 3.3 ttt180 -89.42 115.87 27.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.306 -179.673 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 34.0 m -112.78 165.27 7.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.684 179.563 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 23.8 mm -131.32 105.76 11.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.775 0.321 . . . . 0.0 111.279 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 6.9 m -95.85 121.48 46.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.941 179.652 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -81.82 146.47 29.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.646 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -95.06 167.15 11.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.033 -179.655 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.27 -27.69 65.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.059 -179.919 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -90.43 15.31 10.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.884 -179.845 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 87.69 -7.14 82.1 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.474 -0.869 . . . . 0.0 113.315 179.947 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.09 170.2 0.93 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 117.235 0.518 . . . . 0.0 110.928 -179.966 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -141.33 111.45 6.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.694 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.4 t -112.4 125.27 69.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.262 -179.774 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 4.6 m -100.98 112.04 24.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.661 179.721 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -124.1 160.87 26.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.88 -179.899 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.66 155.85 17.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.499 179.841 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 30.8 mt -67.08 -32.07 56.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.897 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.45 -40.52 70.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.355 -179.469 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -116.86 31.8 6.53 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.796 0.331 . . . . 0.0 110.95 -179.912 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.418 ' CE1' HD13 ' A' ' 171' ' ' LEU . 11.6 t80 -59.4 -54.92 41.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.997 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.43 -40.12 81.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.138 -179.922 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.38 -49.73 52.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.075 0.464 . . . . 0.0 110.333 179.553 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.14 -41.99 69.03 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.012 179.654 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.402 ' HB3' ' CG1' ' A' ' 178' ' ' VAL . 4.1 mm? -85.97 -23.54 26.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.825 179.462 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 9.4 t -60.69 -33.87 73.5 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.006 0.431 . . . . 0.0 110.119 179.232 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -70.08 -16.95 63.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.117 179.183 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.426 ' CG ' ' HA ' ' A' ' 222' ' ' PRO . 22.5 t80 -58.16 141.06 82.5 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 116.772 -0.194 . . . . 0.0 111.132 -179.902 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . 0.426 ' HA ' ' CG ' ' A' ' 221' ' ' TYR . 60.2 Cg_endo -90.42 107.4 0.72 Allowed 'Cis proline' 0 C--N 1.357 1.011 0 C-N-CA 124.597 -1.001 . . . . 0.0 112.654 0.191 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . 172.77 41.58 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.913 179.822 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.424 HG22 HD13 ' A' ' 224' ' ' ILE . 0.1 OUTLIER -134.2 158.75 42.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.165 179.885 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 177.13 -179.68 0.21 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.982 179.718 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -79.58 118.23 21.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.023 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -130.86 35.45 3.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.148 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 4.9 tp -98.73 30.83 3.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.878 179.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -139.44 34.03 2.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.87 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 20.7 mtp85 -125.75 -45.49 1.76 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.75 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 24.5 m-20 60.82 102.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.933 -179.957 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 21.6 t -84.89 90.76 2.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.09 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 15.3 tttm . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.957 179.904 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.16 0 N-CA-C 112.549 -0.221 . . . . 0.0 112.549 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.13 76.82 9.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.92 0.39 . . . . 0.0 110.924 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -101.6 151.95 21.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.133 0.492 . . . . 0.0 110.968 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.414 ' HB2' ' HB3' ' A' ' 134' ' ' LEU . 78.9 m95 -66.89 168.21 10.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.988 179.915 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 -102.82 136.67 42.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.467 179.588 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.7 mtm-85 -71.75 105.54 3.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.874 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 46.8 pt -94.34 -8.71 9.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.38 179.205 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -158.16 176.19 12.81 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 120.601 0.238 . . . . 0.0 110.609 179.749 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.464 ' CD1' ' CG ' ' A' ' 149' ' ' PRO . 34.2 m-85 -144.99 125.91 14.44 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 4.8 t -93.69 123.3 45.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.044 0.45 . . . . 0.0 111.509 -179.292 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.478 ' CD1' ' CE1' ' A' ' 130' ' ' PHE . 30.2 t80 -81.35 101.77 10.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.758 179.965 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -155.58 153.74 30.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.645 -179.887 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 60.87 31.17 20.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.952 -179.672 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 61.87 30.86 18.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.188 179.811 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 87.1 m -151.46 161.73 42.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.768 179.773 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.478 ' CE1' ' CD1' ' A' ' 125' ' ' TYR . 9.1 m-85 -101.39 90.27 4.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.866 179.666 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.438 ' CG ' ' HA ' ' A' ' 141' ' ' LYS . 22.1 m-85 -65.79 123.99 86.31 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.766 179.809 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.3 118.34 5.47 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.114 1.876 . . . . 0.0 112.338 -179.936 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.41 ' HG ' HG23 ' A' ' 168' ' ' THR . 25.8 tp -95.96 123.54 39.6 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.521 179.684 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.414 ' HB3' ' HB2' ' A' ' 118' ' ' TRP . 50.7 mt -70.67 173.73 6.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.344 -0.843 . . . . 0.0 111.449 -179.748 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -63.89 -28.33 69.76 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.995 179.588 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -91.29 14.23 15.05 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.199 179.791 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.448 ' HA2' HG23 ' A' ' 168' ' ' THR . . . 72.85 28.06 67.68 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.57 -179.976 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.403 ' HB3' ' CD1' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -81.65 90.1 6.29 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 178.721 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.31 102.01 3.01 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.802 -179.485 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 31.7 mt -83.06 79.39 9.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.824 -179.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.438 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 37.8 mttt -69.69 -8.51 48.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.207 -179.912 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -82.92 -29.63 29.02 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.83 0.348 . . . . 0.0 110.695 179.69 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -85.27 -80.4 0.21 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.957 179.98 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.431 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . 56.92 160.76 0.02 OUTLIER Glycine 0 CA--C 1.506 -0.475 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.949 -179.777 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 10.2 t -142.07 150.38 41.15 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.437 -0.382 . . . . 0.0 110.753 -179.738 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 3.7 mmtt -89.53 51.8 2.19 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.018 0.437 . . . . 0.0 110.596 179.995 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -171.26 149.99 2.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.735 -179.34 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.421 ' CB ' ' CE2' ' A' ' 130' ' ' PHE . . . -93.94 125.01 54.65 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.201 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.464 ' CG ' ' CD1' ' A' ' 123' ' ' TYR . 89.9 Cg_endo -85.04 109.89 1.27 Allowed 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.57 2.18 . . . . 0.0 112.796 -179.861 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 21.5 t -69.93 -7.74 43.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.935 179.79 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -77.61 -23.07 49.93 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 120.809 0.338 . . . . 0.0 110.515 179.096 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -139.92 166.22 25.35 Favored Pre-proline 0 N--CA 1.453 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.628 -179.41 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -74.68 152.24 42.21 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.424 2.082 . . . . 0.0 112.346 -179.926 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 9.8 t -113.99 109.46 28.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.065 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.429 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.33 96.03 1.81 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.705 179.231 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.411 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 53.5 t -93.68 136.21 26.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.91 0.386 . . . . 0.0 111.012 179.944 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 50.81 57.5 10.79 Favored Glycine 0 CA--C 1.519 0.306 0 CA-C-N 115.886 -0.597 . . . . 0.0 113.089 179.443 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.434 ' CZ2' ' CG1' ' A' ' 197' ' ' VAL . 3.2 m95 -102.16 151.2 22.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.08 0.467 . . . . 0.0 111.634 -179.572 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.73 -172.41 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.608 179.523 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -43.59 154.26 0.1 Allowed 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.775 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -57.58 -25.11 54.79 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.239 179.544 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.2 -38.42 83.24 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.948 0.404 . . . . 0.0 110.112 179.278 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.34 -39.2 48.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.03 179.034 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 5.9 mt -59.96 -41.46 86.15 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.857 179.046 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.8 -30.51 45.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.168 179.682 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -67.19 -53.0 34.41 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-O 121.417 0.627 . . . . 0.0 110.14 179.391 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.78 -43.22 98.38 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.088 179.025 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.448 HG23 ' HA2' ' A' ' 137' ' ' GLY . 0.2 OUTLIER -58.5 -38.66 78.11 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.51 179.214 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.09 -37.43 92.8 Favored Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 178.378 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 63.2 mm-40 -72.29 -45.85 58.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.462 -0.369 . . . . 0.0 110.892 178.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.425 HD11 ' CE1' ' A' ' 214' ' ' PHE . 11.1 mp -65.48 -30.05 70.78 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.694 0.283 . . . . 0.0 111.202 179.685 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.0 -18.57 64.07 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.344 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -112.28 -26.71 8.63 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.632 0.254 . . . . 0.0 111.66 -179.696 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.86 166.67 1.28 Allowed Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.169 -179.517 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -69.29 128.66 16.79 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.163 1.908 . . . . 0.0 112.69 179.832 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.09 -25.66 5.36 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.69 179.715 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.18 -49.97 74.32 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.033 179.76 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.413 ' CG1' ' HB3' ' A' ' 218' ' ' LEU . 23.9 t -74.18 -39.81 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.715 179.609 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.15 -33.38 52.24 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.103 0.478 . . . . 0.0 110.169 179.385 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -81.86 -38.92 12.55 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.591 178.802 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -88.92 103.43 16.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.828 0.347 . . . . 0.0 110.852 179.528 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 182' ' ' MET . . . . . 0.411 ' CE ' ' CG1' ' A' ' 178' ' ' VAL . 2.6 mtm 177.87 169.08 0.71 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.304 179.817 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 7.7 t -124.24 -59.61 1.47 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.752 0.311 . . . . 0.0 111.127 -179.901 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -157.02 142.73 17.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.121 -179.784 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.443 HD13 HG23 ' A' ' 185' ' ' ILE . 14.9 mt -106.23 114.53 45.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.269 179.359 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . 0.411 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 22.5 m170 -104.7 121.56 43.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.153 -179.431 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -72.67 104.95 4.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.58 179.769 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp -119.51 80.43 22.5 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.78 -179.921 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.27 145.21 59.26 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.259 1.973 . . . . 0.0 112.296 -179.903 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 18.2 p -128.3 159.31 35.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.733 179.944 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.41 -23.51 16.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.518 179.87 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -104.19 -20.39 13.82 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.569 -179.921 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -140.19 78.5 1.66 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.901 0.381 . . . . 0.0 111.287 -179.656 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -55.71 -24.06 32.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.51 179.835 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.5 40.04 1.7 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.967 0.413 . . . . 0.0 110.373 179.785 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 31.7 ttt85 -93.0 119.94 32.78 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.969 179.974 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.434 ' CG1' ' CZ2' ' A' ' 158' ' ' TRP . 23.2 m -113.03 167.77 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.09 -179.931 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 24.7 mm -134.09 105.9 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.139 179.783 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.422 HG13 ' CE2' ' A' ' 214' ' ' PHE . 15.8 m -97.63 138.81 21.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.992 0.425 . . . . 0.0 111.02 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.42 ' CE2' ' HG3' ' A' ' 206' ' ' GLU . 50.7 m-85 -102.46 152.48 21.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.587 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 21.3 tpp -104.06 158.21 16.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.833 0.349 . . . . 0.0 110.914 -179.902 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -56.27 -22.37 29.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.584 -179.825 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -90.4 15.34 10.8 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 111.825 0.305 . . . . 0.0 111.825 -179.913 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 77.05 14.58 82.48 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.583 -0.818 . . . . 0.0 113.147 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -77.55 167.7 21.19 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.99 0.395 . . . . 0.0 110.884 179.994 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . 0.42 ' HG3' ' CE2' ' A' ' 200' ' ' TYR . 7.2 tt0 -134.31 111.47 10.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.854 -179.964 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 17.7 t -116.56 131.14 70.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.976 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 59.5 m -104.03 116.9 33.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.054 -179.858 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -127.62 159.24 35.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.736 179.712 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.2 153.1 19.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.811 0.339 . . . . 0.0 110.751 -179.95 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 64.2 mt -63.31 -36.71 77.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.803 179.763 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.92 -35.9 79.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.548 -179.452 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -132.67 42.76 3.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.925 0.393 . . . . 0.0 111.115 -179.835 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.425 ' CE1' HD11 ' A' ' 171' ' ' LEU . 11.3 t80 -65.49 -52.57 51.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.525 179.815 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.89 -43.38 86.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.293 -179.716 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.38 -49.39 60.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.102 0.477 . . . . 0.0 110.205 179.461 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.73 -42.76 65.18 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.181 179.683 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.413 ' HB3' ' CG1' ' A' ' 178' ' ' VAL . 4.0 mm? -87.16 -23.43 24.82 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.181 179.614 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 10.9 t -60.35 -33.88 73.05 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.025 0.44 . . . . 0.0 110.299 179.542 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -70.86 -16.88 62.73 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.109 179.3 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.443 ' CG ' ' HA ' ' A' ' 222' ' ' PRO . 21.9 t80 -58.13 142.16 80.78 Favored Pre-proline 0 CA--C 1.534 0.342 0 CA-C-N 116.798 -0.183 . . . . 0.0 110.901 179.925 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . 0.443 ' HA ' ' CG ' ' A' ' 221' ' ' TYR . 58.9 Cg_endo -89.98 108.66 0.93 Allowed 'Cis proline' 0 C--N 1.357 0.988 0 C-N-CA 124.649 -0.98 . . . . 0.0 112.705 0.264 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . 171.08 45.51 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.707 179.726 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.55 162.86 23.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.923 0.392 . . . . 0.0 111.366 -179.719 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 178.94 -169.16 0.09 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.798 179.724 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -60.05 113.0 2.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.139 179.939 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -127.94 40.96 3.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.031 -179.998 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 4.4 tt -88.84 11.72 17.11 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.749 179.885 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -108.59 172.45 6.83 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.887 0.375 . . . . 0.0 110.922 179.964 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 1.3 mtp180 62.57 20.77 12.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.452 -179.985 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 61.44 116.13 0.02 OUTLIER 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.898 0.38 . . . . 0.0 111.154 179.86 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 5.5 m -118.14 141.94 35.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.167 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 12.1 mttm . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.844 -179.988 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 121.052 0.453 . . . . 0.0 110.978 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.769 ' HB2' HD13 ' A' ' 134' ' ' LEU . 81.6 m95 -77.29 168.51 19.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.976 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.8 ttm-85 -102.4 134.19 46.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.607 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.9 mtm180 -70.42 106.8 3.53 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.887 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.875 HD11 HG22 ' A' ' 168' ' ' THR . 44.5 pt -96.61 -7.06 9.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.448 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.536 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -159.38 175.94 12.73 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 120.606 0.241 . . . . 0.0 110.916 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.472 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 29.0 m-85 -143.65 126.23 15.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.253 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.661 HG21 HD11 ' A' ' 139' ' ' LEU . 3.8 t -93.86 123.28 45.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.512 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.501 ' CE1' ' CZ ' ' A' ' 130' ' ' PHE . 9.4 t80 -85.0 96.21 9.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.734 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -147.84 155.98 42.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.632 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.03 31.22 21.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.846 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.67 34.69 14.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.034 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.451 HG22 ' N ' ' A' ' 130' ' ' PHE . 57.0 m -154.66 161.52 41.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.034 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.501 ' CZ ' ' CE1' ' A' ' 125' ' ' TYR . 96.2 m-85 -103.82 90.49 3.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.166 0.508 . . . . 0.0 110.712 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.565 ' HB2' HD21 ' A' ' 139' ' ' LEU . 22.9 m-85 -67.69 127.4 93.38 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.561 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.424 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 7.7 Cg_exo -71.62 118.16 5.51 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 122.37 2.047 . . . . 0.0 112.369 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.64 HD21 ' OG1' ' A' ' 168' ' ' THR . 38.0 tp -97.52 123.6 41.44 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.123 0.487 . . . . 0.0 110.595 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.769 HD13 ' HB2' ' A' ' 118' ' ' TRP . 52.4 mt -71.46 173.0 8.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.578 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.418 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.3 pt-20 -63.71 -29.27 70.52 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.114 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -89.92 11.36 20.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.16 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.64 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 75.5 18.67 79.76 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.831 -0.7 . . . . 0.0 113.162 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.701 ' HB3' HD12 ' A' ' 134' ' ' LEU . 13.4 tpp180 -76.78 95.7 4.1 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.661 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -71.44 113.58 8.62 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.494 -179.054 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 22.8 mt -88.11 71.76 9.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.292 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.463 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 30.8 mttt -56.87 -20.62 23.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.922 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -87.04 -18.73 29.91 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -104.93 30.85 5.2 Favored 'General case' 0 N--CA 1.461 0.121 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . -63.89 162.38 35.06 Favored Glycine 0 CA--C 1.51 -0.237 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.786 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 10.6 t -136.03 151.39 49.82 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.543 -0.329 . . . . 0.0 110.658 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.423 ' HE2' HG23 ' A' ' 129' ' ' THR . 4.7 mmpt? -89.32 50.37 1.92 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.953 0.406 . . . . 0.0 110.671 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -171.04 151.4 3.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.554 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -96.88 125.87 44.84 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.23 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.472 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 74.3 Cg_endo -82.82 112.75 2.12 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.396 2.064 . . . . 0.0 112.474 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 30.6 t -69.92 -7.65 42.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.121 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -76.53 -23.44 53.64 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 120.828 0.346 . . . . 0.0 110.417 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.697 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -139.83 167.89 16.9 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.723 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.697 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 67.3 Cg_endo -74.79 158.24 43.11 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.351 2.034 . . . . 0.0 112.114 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 10.7 t -118.83 110.83 31.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.051 0.453 . . . . 0.0 111.081 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.833 HD23 ' CE2' ' A' ' 158' ' ' TRP . 0.9 OUTLIER -72.83 96.01 2.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.579 179.022 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 54.3 t -93.1 136.52 24.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.961 0.41 . . . . 0.0 111.103 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 50.06 55.28 15.79 Favored Glycine 0 CA--C 1.52 0.375 0 CA-C-N 115.906 -0.588 . . . . 0.0 113.287 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.833 ' CE2' HD23 ' A' ' 155' ' ' LEU . 3.5 m95 -99.59 151.25 21.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.169 0.509 . . . . 0.0 111.649 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.89 -172.19 0.26 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.457 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -42.69 154.32 0.07 Allowed 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.541 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.18 -25.29 53.91 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.181 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -59.62 -39.43 84.27 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 120.957 0.408 . . . . 0.0 110.036 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.1 -40.06 53.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.94 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.541 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.6 mt -59.68 -42.13 87.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.898 179.087 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.63 -30.63 43.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.139 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.438 ' CB ' HG21 ' A' ' 211' ' ' ILE . 2.5 mm-40 -67.22 -53.14 32.94 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 121.528 0.68 . . . . 0.0 110.098 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.774 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -60.38 -43.46 96.58 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.06 179.019 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.875 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -58.77 -38.0 77.5 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.525 179.356 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.56 -37.65 92.51 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 178.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -72.03 -46.39 57.26 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.353 -0.423 . . . . 0.0 111.025 178.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.601 ' HA ' HD22 ' A' ' 174' ' ' LEU . 10.9 mp -66.14 -27.71 68.24 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.665 0.269 . . . . 0.0 111.417 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.69 -18.93 62.81 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.438 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -111.74 -27.37 8.54 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.6 0.238 . . . . 0.0 111.413 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.601 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.1 OUTLIER -57.93 167.3 1.55 Allowed Pre-proline 0 CA--C 1.539 0.535 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.929 -179.735 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -70.39 128.01 14.86 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.177 1.918 . . . . 0.0 112.858 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.96 -25.41 8.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.606 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.93 -49.15 77.76 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.814 0.34 . . . . 0.0 110.896 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.874 HG11 ' HB3' ' A' ' 218' ' ' LEU . 37.6 t -73.96 -35.22 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.445 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.537 HD13 ' CD2' ' A' ' 174' ' ' LEU . 5.7 tp -56.04 -35.52 66.98 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.183 0.515 . . . . 0.0 109.988 179.043 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -78.33 -40.19 20.36 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.336 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -86.06 103.01 14.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.894 0.378 . . . . 0.0 110.625 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' MET . . . . . 0.838 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.9 mtm 178.43 165.84 0.8 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.128 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.47 -54.53 1.97 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.797 0.332 . . . . 0.0 111.253 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -163.31 142.94 8.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.92 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.923 HG12 HG12 ' A' ' 199' ' ' VAL . 16.8 mt -106.26 114.71 46.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.722 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' HIS . . . . . 0.454 ' CE1' ' CE1' ' A' ' 200' ' ' TYR . 11.4 m170 -104.68 131.03 52.61 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.988 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -83.24 104.79 13.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.515 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.649 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.53 0.191 0 CA-C-O 120.684 0.278 . . . . 0.0 111.297 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ASP . . . . . 0.404 ' OD1' HG22 ' A' ' 210' ' ' THR . 1.5 p30 -102.18 35.13 2.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.774 0.321 . . . . 0.0 110.708 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -89.45 113.08 24.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.178 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.868 ' O ' HD13 ' A' ' 198' ' ' ILE . 29.1 m -108.57 168.07 3.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.847 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.868 HD13 ' O ' ' A' ' 197' ' ' VAL . 20.7 mm -134.79 108.06 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.826 0.345 . . . . 0.0 111.383 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.923 HG12 HG12 ' A' ' 185' ' ' ILE . 8.1 m -96.42 124.06 48.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.895 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.454 ' CE1' ' CE1' ' A' ' 186' ' ' HIS . 5.2 m-85 -82.58 146.0 29.41 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.796 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.83 156.23 17.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.04 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -64.26 -23.81 67.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.532 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -90.25 15.4 10.49 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 79.59 14.29 81.41 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.079 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -84.43 167.32 16.55 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.929 0.364 . . . . 0.0 110.71 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -133.72 111.66 10.75 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.405 ' HB ' HG23 ' A' ' 199' ' ' VAL . 21.2 t -112.73 124.35 69.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.19 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 80.0 p -101.42 116.47 32.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.695 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.671 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -127.0 158.41 36.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.96 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.404 HG22 ' OD1' ' A' ' 195' ' ' ASP . 0.6 OUTLIER -95.13 154.38 17.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.724 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.438 HG21 ' CB ' ' A' ' 166' ' ' GLU . 36.8 mt -66.39 -35.17 74.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.999 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.49 -35.31 80.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.384 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -129.8 40.91 3.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.891 0.377 . . . . 0.0 111.055 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.563 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 11.9 t80 -65.54 -50.62 64.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.707 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.9 -41.26 91.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.093 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.06 -49.38 65.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.997 0.427 . . . . 0.0 110.46 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 2.1 mmpt? -54.65 -45.09 73.75 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.07 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.874 ' HB3' HG11 ' A' ' 178' ' ' VAL . 4.2 mm? -80.95 -27.5 36.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.978 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 14.3 t -60.76 -31.55 70.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.964 0.411 . . . . 0.0 110.372 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.245 179.471 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 121.146 0.498 . . . . 0.0 111.174 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.746 ' HB2' HD13 ' A' ' 134' ' ' LEU . 79.4 m95 -68.67 168.27 13.5 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.092 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -102.8 136.37 42.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.476 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 41.7 mtt85 -71.95 106.11 4.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.936 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.912 HD11 HG22 ' A' ' 168' ' ' THR . 45.9 pt -94.1 -7.84 10.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.476 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -159.47 176.44 12.08 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 121.017 -0.273 . . . . 0.0 110.89 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.449 ' O ' ' HA ' ' A' ' 154' ' ' VAL . 32.1 m-85 -142.85 126.14 16.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.322 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.621 HG21 ' CD1' ' A' ' 139' ' ' LEU . 4.1 t -93.43 122.74 45.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.963 0.411 . . . . 0.0 111.226 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.492 ' CD1' ' CE1' ' A' ' 130' ' ' PHE . 17.9 t80 -80.99 106.51 13.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.698 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -163.36 156.59 19.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.595 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.448 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 1.2 mmm180 60.18 30.22 19.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.884 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 63.12 32.24 15.31 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.366 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.452 HG22 ' N ' ' A' ' 130' ' ' PHE . 91.1 m -156.92 161.25 39.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.878 0.371 . . . . 0.0 111.026 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.492 ' CE1' ' CD1' ' A' ' 125' ' ' TYR . 58.5 m-85 -99.85 90.3 4.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.626 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.513 ' HA ' ' HA2' ' A' ' 144' ' ' GLY . 22.6 m-85 -65.48 125.5 89.7 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.787 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.456 ' HG2' HD12 ' A' ' 140' ' ' LEU . 58.3 Cg_endo -73.57 118.82 5.64 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.044 1.829 . . . . 0.0 112.411 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.666 HD21 ' OG1' ' A' ' 168' ' ' THR . 28.4 tp -96.22 123.85 40.01 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.396 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.746 HD13 ' HB2' ' A' ' 118' ' ' TRP . 39.9 mt -69.64 173.62 5.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.45 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -64.68 -28.02 69.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.948 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 48.8 p-10 -90.93 13.91 15.26 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.285 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.602 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 72.63 21.78 79.39 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.731 -0.747 . . . . 0.0 113.119 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.687 ' HB3' HD12 ' A' ' 134' ' ' LEU . 9.7 tpp180 -80.82 94.25 6.4 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.461 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.621 ' CD1' HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -72.13 113.6 9.33 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.48 -179.024 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.569 HD11 HD21 ' A' ' 134' ' ' LEU . 25.1 mt -88.39 80.43 7.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.414 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.454 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 15.4 mtpt -71.45 -5.77 35.34 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -91.11 -24.28 20.04 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 122.304 -0.248 . . . . 0.0 111.432 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -89.46 -79.12 0.34 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.779 0.323 . . . . 0.0 111.403 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.513 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . 58.11 161.1 0.04 OUTLIER Glycine 0 CA--C 1.505 -0.57 0 CA-C-N 116.279 -0.419 . . . . 0.0 112.753 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.8 t -140.01 148.61 42.11 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.872 0.368 . . . . 0.0 110.939 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.45 ' HE2' HG23 ' A' ' 129' ' ' THR . 4.2 mmtt -91.1 51.97 2.04 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.157 0.503 . . . . 0.0 110.216 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.59 148.48 3.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.773 -179.041 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -81.89 135.14 48.89 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.703 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.458 ' HD2' ' CG2' ' A' ' 154' ' ' VAL . 68.4 Cg_endo -84.08 97.96 0.75 Allowed 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.052 2.501 . . . . 0.0 112.549 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 26.2 t -67.5 -9.3 41.0 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.825 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -90.0 -21.92 22.15 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.566 0.222 . . . . 0.0 111.588 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.71 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -139.79 167.4 18.63 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.71 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 60.3 Cg_endo -73.65 162.89 38.7 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.408 2.072 . . . . 0.0 112.518 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.458 ' CG2' ' HD2' ' A' ' 149' ' ' PRO . 18.3 t -123.82 110.14 24.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.572 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.84 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.85 95.91 2.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.747 179.112 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 59.0 t -93.01 136.87 23.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.927 0.394 . . . . 0.0 111.094 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 48.85 55.42 11.47 Favored Glycine 0 CA--C 1.52 0.369 0 CA-C-N 115.966 -0.561 . . . . 0.0 113.174 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.84 ' CE2' HD23 ' A' ' 155' ' ' LEU . 3.4 m95 -99.07 151.18 21.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.156 0.503 . . . . 0.0 111.735 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.43 -172.27 0.15 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.604 179.451 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -43.21 154.39 0.08 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.332 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.515 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -56.94 -24.66 50.94 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.218 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.72 -40.09 86.85 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.967 0.413 . . . . 0.0 110.05 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.12 -39.78 54.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.009 178.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.515 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.1 mt -59.67 -41.23 84.55 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.9 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.0 -30.58 47.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.214 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.403 ' CB ' HG21 ' A' ' 211' ' ' ILE . 15.4 mm-40 -67.64 -52.9 32.73 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.385 0.612 . . . . 0.0 110.107 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.82 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -59.44 -45.27 92.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.971 178.954 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.912 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -57.65 -38.38 74.96 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.549 179.207 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.83 -36.46 90.02 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 110.701 -0.959 . . . . 0.0 110.701 178.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -74.17 -46.36 42.65 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.451 -0.374 . . . . 0.0 111.06 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.565 ' HA ' HD22 ' A' ' 174' ' ' LEU . 11.3 mp -65.43 -29.6 70.31 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.689 0.28 . . . . 0.0 111.319 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.49 -19.18 63.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.345 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -111.01 -27.85 8.58 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.635 0.255 . . . . 0.0 111.433 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.565 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.1 OUTLIER -56.89 166.58 1.32 Allowed Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.161 -179.473 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.54 127.44 14.77 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.243 1.962 . . . . 0.0 112.744 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.71 -26.01 5.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.784 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.56 -50.76 72.05 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.925 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.854 HG11 ' HB3' ' A' ' 218' ' ' LEU . 33.8 t -74.16 -32.42 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.414 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.525 HD23 ' HD3' ' A' ' 153' ' ' PRO . 0.5 OUTLIER -58.2 -34.2 70.12 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.865 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -79.48 -39.61 17.88 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -86.77 103.03 14.82 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.952 0.405 . . . . 0.0 110.6 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' MET . . . . . 0.844 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.8 mtm 178.49 160.48 0.6 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.994 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.1 m -120.56 -52.31 2.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.682 0.277 . . . . 0.0 111.379 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -163.27 142.64 8.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.926 0.394 . . . . 0.0 111.283 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.922 HG12 HG12 ' A' ' 199' ' ' VAL . 17.6 mt -106.71 114.19 45.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.344 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -104.39 119.87 39.94 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.135 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.415 ' HD1' HG12 ' A' ' 197' ' ' VAL . 13.6 t80 -75.8 104.57 6.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.544 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.572 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 . . . . . 0 CA--C 1.529 0.153 0 CA-C-O 120.599 0.238 . . . . 0.0 111.589 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -109.27 37.84 2.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.765 0.317 . . . . 0.0 111.082 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.83 115.59 27.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.947 0.403 . . . . 0.0 111.229 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.825 ' O ' HD13 ' A' ' 198' ' ' ILE . 28.1 m -112.51 166.14 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.808 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.825 HD13 ' O ' ' A' ' 197' ' ' VAL . 22.3 mm -133.03 107.85 12.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.81 0.338 . . . . 0.0 111.401 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.922 HG12 HG12 ' A' ' 185' ' ' ILE . 11.3 m -96.73 120.9 46.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.934 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -81.84 152.29 26.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.562 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 3.6 mmt -108.53 150.03 28.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.809 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -58.74 -25.61 63.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.261 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -88.63 12.94 13.34 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 81.98 14.36 77.42 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.378 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -86.13 153.41 22.1 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 117.103 0.451 . . . . 0.0 110.807 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -123.27 111.42 16.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.86 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.6 t -115.01 123.25 70.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.154 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' SER . . . . . 0.557 ' HB2' HD12 ' A' ' 198' ' ' ILE . 9.8 t -98.84 115.49 28.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.742 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.626 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -123.91 162.93 22.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.8 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.73 153.99 18.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.727 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.403 HG21 ' CB ' ' A' ' 166' ' ' GLU . 33.1 mt -65.98 -36.64 77.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.803 0.335 . . . . 0.0 110.763 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -64.82 -36.51 84.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.124 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -128.31 43.51 3.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.916 0.389 . . . . 0.0 110.929 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.571 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 11.4 t80 -68.46 -54.61 15.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.786 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.5 -39.15 79.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.904 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -67.24 -50.04 62.16 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.117 0.484 . . . . 0.0 110.29 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.29 -45.35 72.5 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.057 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.854 ' HB3' HG11 ' A' ' 178' ' ' VAL . 3.9 mm? -80.18 -27.52 38.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.873 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 1.1 m -61.04 -29.85 69.97 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.403 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 7.1 m170 . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.282 179.831 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 121.047 0.451 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.75 ' HB2' HD13 ' A' ' 134' ' ' LEU . 80.9 m95 -68.7 168.31 13.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.015 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.14 135.72 43.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.548 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.9 mtm180 -71.5 105.29 3.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.721 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.892 HD11 HG22 ' A' ' 168' ' ' THR . 47.1 pt -94.18 -8.24 9.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.406 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.443 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -158.47 176.88 11.86 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.467 0.175 . . . . 0.0 110.575 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.467 ' CD1' ' HG3' ' A' ' 149' ' ' PRO . 31.3 m-85 -144.35 125.84 14.93 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.558 HG21 HD11 ' A' ' 139' ' ' LEU . 3.7 t -93.58 122.85 45.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.058 0.456 . . . . 0.0 111.557 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -83.49 94.31 8.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.681 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -145.01 155.13 43.2 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.603 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.93 30.82 20.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.712 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 63.29 33.85 13.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.863 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.41 HG22 ' N ' ' A' ' 130' ' ' PHE . 58.6 m -155.9 159.7 39.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.057 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.41 ' N ' HG22 ' A' ' 129' ' ' THR . 92.6 m-85 -99.77 91.23 4.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.217 0.532 . . . . 0.0 110.863 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.5 ' HB2' HD21 ' A' ' 139' ' ' LEU . 26.1 m-85 -70.37 114.13 23.53 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.722 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.431 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 31.8 Cg_exo -58.72 123.35 13.35 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 122.414 2.076 . . . . 0.0 112.659 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.692 HD21 ' OG1' ' A' ' 168' ' ' THR . 28.9 tp -102.39 123.94 47.06 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.346 179.138 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.75 HD13 ' HB2' ' A' ' 118' ' ' TRP . 40.3 mt -70.32 173.21 7.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.634 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.402 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 2.1 pt-20 -64.11 -28.3 69.68 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.037 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -90.79 13.72 15.53 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.209 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.604 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 72.84 21.7 79.57 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.75 -0.738 . . . . 0.0 113.01 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.686 ' HB3' HD12 ' A' ' 134' ' ' LEU . 1.3 tpt180 -80.8 92.67 6.11 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.558 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -66.21 113.56 4.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.322 -179.125 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 43.4 mt -83.66 67.68 9.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.707 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.446 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 2.3 mttp -57.58 -21.49 39.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.451 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -95.56 21.07 8.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.433 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -147.31 28.47 0.99 Allowed 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.787 0.327 . . . . 0.0 111.238 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.431 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -60.83 162.83 21.01 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.897 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.4 ' N ' ' CG2' ' A' ' 129' ' ' THR . 9.0 t -132.96 150.86 52.13 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.814 0.34 . . . . 0.0 110.611 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.4 mmtt -90.34 50.02 1.78 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.531 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -171.09 150.24 3.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.516 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -94.55 125.76 50.46 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.219 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.467 ' HG3' ' CD1' ' A' ' 123' ' ' TYR . 73.6 Cg_endo -83.65 111.97 1.8 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.428 2.085 . . . . 0.0 112.605 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 46.6 t -69.84 -7.89 43.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.038 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -77.27 -22.55 51.94 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 120.798 0.333 . . . . 0.0 110.572 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.673 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -142.15 167.06 17.72 Favored Pre-proline 0 N--CA 1.453 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.702 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.673 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 62.5 Cg_endo -74.58 157.68 44.33 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.37 2.046 . . . . 0.0 112.315 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 12.8 t -118.28 111.0 32.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.346 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.836 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.65 96.05 1.94 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.762 179.016 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.1 t -93.56 135.44 28.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.995 0.426 . . . . 0.0 110.945 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 49.62 58.08 8.73 Favored Glycine 0 CA--C 1.521 0.42 0 CA-C-N 115.874 -0.603 . . . . 0.0 113.158 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.836 ' CE2' HD23 ' A' ' 155' ' ' LEU . 3.0 m95 -100.59 151.35 21.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.201 0.524 . . . . 0.0 111.744 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.413 ' HD3' ' CE2' ' A' ' 187' ' ' TYR . 2.6 tptt -64.76 -172.47 0.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.523 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -44.35 154.89 0.1 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.122 0.487 . . . . 0.0 112.212 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.55 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.29 -25.37 54.38 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.225 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.34 -38.25 83.21 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.979 0.419 . . . . 0.0 110.165 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.82 -40.61 47.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.116 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.55 HD12 ' HA2' ' A' ' 161' ' ' GLY . 5.9 mt -58.45 -41.38 81.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.973 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.12 -30.34 48.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.144 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.406 ' CB ' HG21 ' A' ' 211' ' ' ILE . 3.8 mm-40 -68.1 -53.04 28.34 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-O 121.368 0.604 . . . . 0.0 110.196 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.817 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -59.66 -43.6 93.89 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.03 179.064 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.892 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -59.2 -37.24 76.95 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.466 179.009 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.05 -37.01 92.11 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -73.06 -46.87 49.21 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.359 -0.421 . . . . 0.0 111.163 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.574 ' HA ' HD22 ' A' ' 174' ' ' LEU . 11.1 mp -65.3 -29.28 70.02 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.7 0.286 . . . . 0.0 111.345 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.79 -20.89 64.36 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.317 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -110.56 -26.3 9.54 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.599 0.238 . . . . 0.0 111.52 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.574 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.1 OUTLIER -57.42 166.62 1.58 Allowed Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.083 -179.697 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -68.8 127.14 14.9 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.308 2.005 . . . . 0.0 112.698 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.07 -25.96 5.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.643 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -58.23 -49.89 75.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.907 0.384 . . . . 0.0 110.986 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.852 HG11 ' HB3' ' A' ' 218' ' ' LEU . 32.0 t -74.0 -34.87 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.704 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.567 HD21 ' O ' ' A' ' 121' ' ' ILE . 0.5 OUTLIER -57.61 -33.91 68.73 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.119 0.485 . . . . 0.0 109.838 178.99 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -78.62 -39.79 20.37 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -87.74 103.18 15.37 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.884 0.373 . . . . 0.0 110.684 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' MET . . . . . 0.842 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.8 mtm 178.79 163.4 0.78 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.202 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -120.39 -57.1 1.94 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.742 0.306 . . . . 0.0 111.206 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -159.97 142.52 13.47 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.992 0.425 . . . . 0.0 111.124 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.882 HG12 HG12 ' A' ' 199' ' ' VAL . 17.8 mt -105.12 114.84 45.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.279 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 23.5 m170 -104.24 120.38 41.02 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.117 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.413 ' CE2' ' HD3' ' A' ' 159' ' ' LYS . 83.7 t80 -75.03 104.45 5.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.474 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.529 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 . . . . . 0 CA--C 1.529 0.167 0 CA-C-O 120.729 0.3 . . . . 0.0 111.333 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ASP . . . . . 0.604 ' HB3' HD12 ' A' ' 211' ' ' ILE . 0.5 OUTLIER -106.55 40.39 1.63 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.036 0.446 . . . . 0.0 110.308 179.755 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.18 116.45 27.44 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.959 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.874 ' O ' HD13 ' A' ' 198' ' ' ILE . 29.2 m -109.96 168.05 4.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.082 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.874 HD13 ' O ' ' A' ' 197' ' ' VAL . 21.8 mm -135.37 108.24 8.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.196 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.882 HG12 HG12 ' A' ' 185' ' ' ILE . 15.4 m -97.61 139.72 19.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.998 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -101.51 152.72 20.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.778 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 6.0 mmt -105.28 159.7 15.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.88 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -60.13 -27.07 66.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.256 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -86.92 9.96 17.74 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 84.54 14.34 71.01 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.565 -0.826 . . . . 0.0 113.266 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -81.05 158.38 25.11 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 117.228 0.514 . . . . 0.0 110.739 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -128.15 111.25 13.25 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.814 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.2 t -111.21 133.58 56.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.951 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' SER . . . . . 0.489 ' HB3' HD12 ' A' ' 198' ' ' ILE . 0.3 OUTLIER -104.63 117.25 33.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.938 -179.919 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.661 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -129.49 156.84 43.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.681 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -99.16 149.33 23.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.78 0.324 . . . . 0.0 110.764 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.604 HD12 ' HB3' ' A' ' 195' ' ' ASP . 64.1 mt -59.55 -38.25 74.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.955 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -61.84 -32.9 73.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.301 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -134.87 46.41 2.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.904 0.383 . . . . 0.0 111.075 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.493 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 11.4 t80 -70.26 -51.36 31.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.795 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.93 -39.65 86.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.014 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.85 -50.34 62.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.144 0.497 . . . . 0.0 110.454 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.99 -45.11 71.36 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.169 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.852 ' HB3' HG11 ' A' ' 178' ' ' VAL . 3.9 mm? -81.33 -26.33 35.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.95 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.31 -30.56 70.57 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.871 0.367 . . . . 0.0 110.301 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 13.8 m170 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.189 179.767 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.898 0.38 . . . . 0.0 110.955 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.779 ' HB2' HD13 ' A' ' 134' ' ' LEU . 82.3 m95 -80.66 168.41 18.9 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.143 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -101.06 132.34 46.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.761 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 12.1 mtm-85 -69.94 106.12 3.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.667 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.891 HD11 HG22 ' A' ' 168' ' ' THR . 43.4 pt -94.5 -7.82 9.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.409 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -160.46 176.81 11.22 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 121.158 -0.217 . . . . 0.0 110.669 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.475 ' O ' ' HA ' ' A' ' 154' ' ' VAL . 30.4 m-85 -142.34 126.96 17.96 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.11 -0.329 . . . . 0.0 110.11 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.552 HG21 ' CD1' ' A' ' 139' ' ' LEU . 3.9 t -93.22 122.49 44.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.345 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -80.42 94.39 6.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.632 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -146.92 156.5 43.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.375 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.34 29.79 19.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.86 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 62.76 34.92 14.24 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.108 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.447 HG22 ' N ' ' A' ' 130' ' ' PHE . 86.7 m -158.06 161.76 38.05 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.194 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.447 ' N ' HG22 ' A' ' 129' ' ' THR . 6.3 m-85 -98.2 90.9 5.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.142 0.496 . . . . 0.0 111.041 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.479 ' HB2' HD21 ' A' ' 139' ' ' LEU . 23.9 m-85 -69.67 120.35 76.85 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.248 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.42 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 23.5 Cg_exo -64.2 117.63 4.64 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.341 2.027 . . . . 0.0 112.798 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.643 HD21 ' OG1' ' A' ' 168' ' ' THR . 35.9 tp -96.84 123.65 40.6 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.144 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.779 HD13 ' HB2' ' A' ' 118' ' ' TRP . 55.9 mt -70.75 171.39 10.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.666 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.412 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 2.1 pt-20 -62.82 -29.36 70.67 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.938 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -89.29 10.3 22.8 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.156 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.645 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 76.57 18.05 79.38 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.159 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.715 ' HB3' HD12 ' A' ' 134' ' ' LEU . 18.3 tpp85 -76.97 94.04 3.9 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.552 ' CD1' HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -68.14 110.03 3.8 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.675 -178.889 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 37.5 mt -81.74 73.62 8.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.676 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.452 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 13.1 mtpt -60.72 -17.86 50.89 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.575 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -101.32 25.01 8.75 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.535 0.207 . . . . 0.0 111.219 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -145.83 26.7 1.23 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.707 0.289 . . . . 0.0 111.353 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . -59.21 164.16 10.66 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.719 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.8 t -135.24 148.55 49.63 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.925 0.393 . . . . 0.0 110.784 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 3.6 mmtt -90.04 53.24 2.47 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.491 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.72 153.56 4.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.361 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -88.62 133.8 35.37 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.83 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.448 ' HG3' ' CD1' ' A' ' 123' ' ' TYR . 73.7 Cg_endo -81.63 98.86 1.01 Allowed 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.905 2.404 . . . . 0.0 112.505 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.0 t -67.23 -9.62 42.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.877 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -89.65 -22.23 22.39 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 111.666 0.247 . . . . 0.0 111.666 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.731 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -139.03 168.07 16.88 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.067 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.731 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 61.6 Cg_endo -74.12 165.81 31.09 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.352 2.035 . . . . 0.0 112.278 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 25.6 t -125.12 107.83 18.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.035 0.445 . . . . 0.0 111.744 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.882 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.43 96.19 1.87 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.023 179.336 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.444 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 61.9 t -94.17 138.02 21.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.085 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 48.01 56.05 9.36 Favored Glycine 0 CA--C 1.52 0.39 0 CA-C-N 115.964 -0.562 . . . . 0.0 113.261 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.882 ' CE2' HD23 ' A' ' 155' ' ' LEU . 3.4 m95 -99.16 151.16 21.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.187 0.518 . . . . 0.0 111.659 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.47 -172.37 0.16 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.519 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -43.06 154.22 0.08 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.567 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.06 -24.89 52.53 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.267 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -60.26 -39.27 86.17 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.998 0.427 . . . . 0.0 110.162 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.7 -39.51 51.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.18 179.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.567 HD12 ' HA2' ' A' ' 161' ' ' GLY . 7.1 mt -60.07 -42.13 88.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.126 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.48 -30.83 54.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.285 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.414 ' HB3' HG21 ' A' ' 211' ' ' ILE . 3.0 mm-40 -65.95 -53.27 41.19 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.409 0.623 . . . . 0.0 110.01 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.785 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -61.48 -43.05 99.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.087 179.06 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.891 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -59.19 -37.28 77.02 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.38 179.281 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.52 -38.37 94.79 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 110.456 -1.057 . . . . 0.0 110.456 178.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 33.6 mm-40 -71.31 -44.15 65.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.384 -0.408 . . . . 0.0 110.801 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.659 ' HA ' HD22 ' A' ' 174' ' ' LEU . 10.5 mp -66.92 -28.41 68.27 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.7 0.286 . . . . 0.0 111.384 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.83 -16.18 62.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.377 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -114.7 -29.25 6.84 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 111.561 0.208 . . . . 0.0 111.561 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.659 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER -56.85 167.16 1.12 Allowed Pre-proline 0 CA--C 1.538 0.5 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.121 -179.673 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -69.99 126.94 13.73 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.153 1.902 . . . . 0.0 113.043 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.35 -25.31 5.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.696 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -56.08 -50.72 70.21 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.907 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.886 HG11 ' HB3' ' A' ' 218' ' ' LEU . 42.8 t -74.74 -34.74 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.54 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.478 ' HB2' HD21 ' A' ' 174' ' ' LEU . 11.6 tp -54.92 -35.32 64.04 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.181 0.515 . . . . 0.0 110.13 179.069 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -79.99 -41.83 11.8 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 111.169 -0.773 . . . . 0.0 111.169 178.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -82.3 103.14 11.66 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.843 0.354 . . . . 0.0 110.469 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' MET . . . . . 0.844 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.9 mtm 177.81 171.6 0.64 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.129 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.3 m -127.54 -54.59 1.34 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.811 0.338 . . . . 0.0 110.877 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -163.49 142.32 8.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.029 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.925 HG12 HG12 ' A' ' 199' ' ' VAL . 18.6 mt -105.51 114.32 44.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.137 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' HIS . . . . . 0.444 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 19.2 m170 -105.88 114.92 29.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.424 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.419 ' HB2' ' CD2' ' A' ' 158' ' ' TRP . 83.8 t80 -66.09 104.43 1.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.136 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 12.2 mttt . . . . . 0 C--N 1.327 -0.396 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.939 -179.314 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 . . . . . 0 CA--C 1.529 0.139 0 CA-C-O 120.815 0.341 . . . . 0.0 111.166 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 6.9 p30 -102.15 37.27 1.91 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.556 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 2.0 tpm_? -89.5 114.23 25.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.134 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.686 ' O ' HD13 ' A' ' 198' ' ' ILE . 28.7 m -110.48 166.0 5.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.622 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.686 HD13 ' O ' ' A' ' 197' ' ' VAL . 19.1 mm -131.43 106.14 11.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.805 0.336 . . . . 0.0 111.43 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.925 HG12 HG12 ' A' ' 185' ' ' ILE . 9.5 m -96.11 118.36 42.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.919 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -81.63 152.92 26.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.547 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.17 148.15 28.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.863 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 36.1 m-20 -58.24 -28.85 65.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.017 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -76.86 -4.68 44.93 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.765 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 97.41 14.46 41.26 Favored Glycine 0 C--N 1.335 0.517 0 C-N-CA 120.533 -0.841 . . . . 0.0 113.106 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -87.61 170.99 10.8 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.957 0.408 . . . . 0.0 111.103 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -135.04 111.12 9.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.623 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.437 ' HB ' HG23 ' A' ' 199' ' ' VAL . 28.9 t -113.94 124.82 70.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.881 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 2.8 m -102.17 115.64 30.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.781 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -123.49 171.01 9.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.82 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -107.42 155.09 20.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.474 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.414 HG21 ' HB3' ' A' ' 166' ' ' GLU . 38.5 mt -68.13 -35.95 73.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.807 0.336 . . . . 0.0 110.76 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -62.85 -36.87 84.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.258 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -130.64 40.99 3.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.953 0.406 . . . . 0.0 111.068 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.542 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 10.6 t80 -64.06 -55.04 25.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.553 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.04 -42.73 85.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.271 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -66.67 -48.21 70.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.015 0.436 . . . . 0.0 110.496 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 1.2 mmpt? -55.1 -44.4 74.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.279 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.886 ' HB3' HG11 ' A' ' 178' ' ' VAL . 3.7 mm? -83.99 -25.69 29.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.074 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 14.9 t -60.74 -32.81 72.08 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.973 0.416 . . . . 0.0 110.157 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 24.5 m170 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.181 179.293 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.991 0.424 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.769 ' HB2' HD13 ' A' ' 134' ' ' LEU . 81.0 m95 -73.56 168.48 19.21 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.185 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -102.88 132.24 49.22 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.808 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.31 107.03 3.11 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.777 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.887 HD11 HG22 ' A' ' 168' ' ' THR . 44.2 pt -96.21 -7.8 9.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.498 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.435 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -159.94 176.78 11.47 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.003 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.463 ' O ' ' HA ' ' A' ' 154' ' ' VAL . 33.1 m-85 -143.41 127.2 17.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.284 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.577 HG21 ' CD1' ' A' ' 139' ' ' LEU . 3.6 t -93.44 122.71 45.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.098 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -82.52 94.11 7.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.36 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -145.22 155.68 43.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.255 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 59.31 29.45 19.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.855 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 62.88 35.03 13.82 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.142 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 53.3 m -157.13 156.76 33.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.836 0.351 . . . . 0.0 111.17 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -94.75 91.39 6.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.888 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.45 ' CG ' ' HA ' ' A' ' 141' ' ' LYS . 23.3 m-85 -70.81 121.75 84.77 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.303 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.409 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 22.3 Cg_exo -64.81 121.66 9.26 Favored 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 122.414 2.076 . . . . 0.0 112.757 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.658 HD21 ' OG1' ' A' ' 168' ' ' THR . 31.1 tp -102.09 123.36 45.82 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-O 121.128 0.49 . . . . 0.0 110.087 178.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.769 HD13 ' HB2' ' A' ' 118' ' ' TRP . 51.5 mt -70.72 171.81 9.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.652 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.407 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.6 pt-20 -62.94 -28.32 69.99 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.979 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 50.8 p-10 -90.46 11.97 20.0 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.225 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.628 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 75.15 18.79 80.05 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.237 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.69 ' HB3' HD12 ' A' ' 134' ' ' LEU . 1.5 tpt180 -77.6 92.43 4.09 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.577 ' CD1' HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -66.41 113.78 4.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.418 -179.053 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.503 HD13 ' HG3' ' A' ' 143' ' ' GLU . 30.1 mt -84.01 70.07 10.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.69 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.45 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 5.4 mtpt -58.26 -20.3 41.18 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.56 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -99.38 25.24 7.15 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.739 -0.21 . . . . 0.0 111.27 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.503 ' HG3' HD13 ' A' ' 140' ' ' LEU . 54.3 mm-40 -147.16 24.83 1.14 Allowed 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.582 0.23 . . . . 0.0 111.493 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . -59.41 161.71 15.21 Favored Glycine 0 CA--C 1.509 -0.335 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.747 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 9.0 t -131.27 154.51 48.42 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.041 0.448 . . . . 0.0 110.7 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -92.95 53.92 2.08 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.766 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.74 170.81 6.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.256 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -104.26 135.85 19.27 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.537 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.449 ' HG3' ' CD1' ' A' ' 123' ' ' TYR . 68.3 Cg_endo -82.77 99.67 0.93 Allowed 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.95 2.433 . . . . 0.0 112.443 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.4 t -67.01 -10.1 46.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.844 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.92 -22.08 22.16 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.692 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -138.67 166.69 23.4 Favored Pre-proline 0 C--N 1.328 -0.356 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -178.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.692 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 61.3 Cg_endo -73.87 164.2 35.19 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 122.487 2.125 . . . . 0.0 112.3 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 24.3 t -123.4 109.68 24.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.666 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.841 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.58 96.77 2.02 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.947 179.344 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 59.5 t -94.68 136.87 24.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.983 0.421 . . . . 0.0 111.124 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 49.7 51.33 28.71 Favored Glycine 0 CA--C 1.52 0.375 0 CA-C-N 115.811 -0.631 . . . . 0.0 113.259 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.841 ' CE2' HD23 ' A' ' 155' ' ' LEU . 2.9 m95 -94.75 151.01 19.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.054 0.454 . . . . 0.0 111.574 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -66.0 -172.43 0.14 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.421 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -43.67 154.7 0.09 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.073 0.463 . . . . 0.0 112.217 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.55 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -56.45 -25.24 48.91 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.269 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.33 -39.17 86.12 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 120.912 0.387 . . . . 0.0 110.058 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.19 -40.22 52.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.102 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.55 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.1 mt -59.13 -41.58 84.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.909 179.073 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.44 -30.74 53.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.2 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.4 ' CB ' HG21 ' A' ' 211' ' ' ILE . 3.2 mm-40 -67.21 -53.17 32.67 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-O 121.439 0.638 . . . . 0.0 110.072 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.802 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -59.72 -45.53 91.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.989 178.865 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.887 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -57.28 -36.77 71.45 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.565 179.037 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.13 -38.21 94.04 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 178.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -71.24 -48.17 52.83 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.329 -0.436 . . . . 0.0 110.939 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.612 ' HA ' HD22 ' A' ' 174' ' ' LEU . 10.9 mp -64.51 -28.6 69.76 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.742 0.306 . . . . 0.0 111.275 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.87 -18.37 63.41 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.37 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -112.15 -28.32 8.02 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.645 0.26 . . . . 0.0 111.421 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.612 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.1 OUTLIER -57.55 166.9 1.51 Allowed Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.998 -179.695 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -70.04 128.78 16.26 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.263 1.975 . . . . 0.0 112.898 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.94 -25.8 9.01 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.64 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -58.05 -48.79 79.04 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.881 0.372 . . . . 0.0 110.935 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.882 HG11 ' HB3' ' A' ' 218' ' ' LEU . 24.6 t -73.66 -35.31 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.504 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 11.5 tp -55.26 -34.61 64.19 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.234 0.54 . . . . 0.0 109.987 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -78.71 -42.73 12.86 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.314 178.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -82.16 103.19 11.59 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.899 0.381 . . . . 0.0 110.404 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' MET . . . . . 0.84 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.9 mtm 177.65 173.48 0.54 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.956 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 3.2 t -133.09 -51.65 0.89 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.705 0.288 . . . . 0.0 111.229 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' GLU . . . . . 0.428 ' HG2' ' CD1' ' A' ' 200' ' ' TYR . 1.3 pm0 -163.13 142.85 8.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.035 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.898 HG12 HG12 ' A' ' 199' ' ' VAL . 19.9 mt -106.66 114.24 45.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.442 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -104.6 124.04 48.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.16 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -80.47 104.82 11.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.368 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.54 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 . . . . . 0 CA--C 1.53 0.211 0 CA-C-O 120.658 0.266 . . . . 0.0 111.43 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -107.13 38.33 2.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.772 0.32 . . . . 0.0 110.616 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -91.1 115.75 28.27 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.985 0.421 . . . . 0.0 111.379 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.727 ' O ' HD13 ' A' ' 198' ' ' ILE . 27.7 m -112.55 166.6 6.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.655 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.727 HD13 ' O ' ' A' ' 197' ' ' VAL . 21.5 mm -131.68 109.85 16.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.732 0.301 . . . . 0.0 111.29 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.898 HG12 HG12 ' A' ' 185' ' ' ILE . 8.5 m -100.08 124.92 53.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.912 0.387 . . . . 0.0 111.021 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.428 ' CD1' ' HG2' ' A' ' 184' ' ' GLU . 44.8 m-85 -86.6 152.53 22.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.571 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 5.5 mmt -104.07 165.4 11.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.937 0.399 . . . . 0.0 110.936 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -67.4 -26.15 66.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.062 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -89.94 13.87 13.59 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 80.99 14.44 79.42 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 120.556 -0.831 . . . . 0.0 113.321 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -77.0 168.09 20.69 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 117.119 0.46 . . . . 0.0 110.729 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -134.51 111.57 10.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.851 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 17.9 t -119.38 123.91 72.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.165 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' SER . . . . . 0.544 ' HB2' HD12 ' A' ' 198' ' ' ILE . 27.1 t -101.29 114.84 29.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.751 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.625 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -122.91 161.75 23.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.862 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.83 154.94 17.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.624 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.4 HG21 ' CB ' ' A' ' 166' ' ' GLU . 36.8 mt -67.18 -30.14 48.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.713 0.292 . . . . 0.0 110.986 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -72.07 -38.26 69.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.289 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -121.99 34.69 5.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.038 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.602 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 12.0 t80 -62.0 -56.05 23.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.926 0.393 . . . . 0.0 110.7 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.63 -40.64 83.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.138 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -67.42 -49.19 64.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.952 0.406 . . . . 0.0 110.365 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.42 -45.02 72.91 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.057 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.882 ' HB3' HG11 ' A' ' 178' ' ' VAL . 3.8 mm? -80.89 -27.67 36.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.785 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 13.5 t -60.64 -30.34 69.81 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.846 0.355 . . . . 0.0 110.529 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 65.6 m-70 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.21 179.646 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 . . . . . 0 C--O 1.231 0.088 0 CA-C-O 121.031 0.443 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.767 ' HB2' HD13 ' A' ' 134' ' ' LEU . 81.9 m95 -74.15 168.4 19.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.143 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 6.9 ptt180 -101.7 134.49 44.78 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.845 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -71.2 106.89 3.96 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.858 0.361 . . . . 0.0 110.75 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.918 HD11 HG22 ' A' ' 168' ' ' THR . 46.0 pt -95.93 -9.45 9.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.315 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.467 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -157.75 176.14 12.97 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 120.586 0.231 . . . . 0.0 110.691 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.47 ' CD1' ' HG3' ' A' ' 149' ' ' PRO . 29.9 m-85 -143.92 126.7 16.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.16 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.646 HG21 HD11 ' A' ' 139' ' ' LEU . 4.3 t -93.12 122.42 44.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.279 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.497 ' CE1' ' CE1' ' A' ' 130' ' ' PHE . 7.3 t80 -81.92 97.13 7.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.935 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -149.14 151.62 34.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.44 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 61.17 30.88 19.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.804 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 61.81 31.29 18.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.034 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.501 HG23 ' O ' ' A' ' 145' ' ' THR . 70.4 m -151.2 151.13 31.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.941 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.639 ' CE2' ' HB2' ' A' ' 148' ' ' ALA . 12.1 m-85 -93.07 91.05 7.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.701 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.507 ' HB2' HD21 ' A' ' 139' ' ' LEU . 23.5 m-85 -66.57 123.38 85.56 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.665 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -70.65 113.32 3.48 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 122.107 1.872 . . . . 0.0 112.727 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.647 HD21 ' OG1' ' A' ' 168' ' ' THR . 32.2 tp -92.44 124.02 36.18 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.706 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.767 HD13 ' HB2' ' A' ' 118' ' ' TRP . 48.1 mt -69.86 174.25 5.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.503 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -65.73 -28.31 68.95 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.029 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -89.74 11.84 18.82 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.156 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.625 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 74.1 22.8 77.37 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.937 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.687 ' HB3' HD12 ' A' ' 134' ' ' LEU . 18.2 tpp180 -81.92 93.62 6.95 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.646 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -68.69 109.34 3.76 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.151 -179.155 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 15.7 mt -85.14 71.64 10.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.87 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.478 ' HE3' HD13 ' A' ' 139' ' ' LEU . 12.8 mttt -57.77 -21.14 39.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.469 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -94.28 20.05 8.67 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.419 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -145.15 26.95 1.31 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.846 0.355 . . . . 0.0 111.045 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.77 163.89 39.76 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.96 -0.638 . . . . 0.0 113.199 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.501 ' O ' HG23 ' A' ' 129' ' ' THR . 6.7 t -130.69 157.01 43.94 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.328 -0.436 . . . . 0.0 110.563 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.3 mmmt -94.3 50.09 1.35 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.548 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.15 150.35 3.0 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.695 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.639 ' HB2' ' CE2' ' A' ' 130' ' ' PHE . . . -93.05 125.64 54.16 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.242 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.47 ' HG3' ' CD1' ' A' ' 123' ' ' TYR . 71.9 Cg_endo -84.1 111.32 1.62 Allowed 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.433 2.089 . . . . 0.0 112.599 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 45.5 t -69.62 -8.19 45.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.013 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -77.25 -23.51 51.24 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 120.865 0.364 . . . . 0.0 110.54 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.665 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -140.17 166.62 22.25 Favored Pre-proline 0 N--CA 1.453 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.562 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.665 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 66.7 Cg_endo -74.99 158.03 42.49 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.342 2.028 . . . . 0.0 112.331 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 14.3 t -118.24 110.67 31.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.251 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.838 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.52 96.25 1.92 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.726 179.206 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.42 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 61.7 t -93.35 137.22 23.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.007 0.432 . . . . 0.0 111.149 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 49.0 54.13 15.77 Favored Glycine 0 CA--C 1.52 0.363 0 CA-C-N 115.859 -0.609 . . . . 0.0 113.327 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.838 ' CE2' HD23 ' A' ' 155' ' ' LEU . 2.7 m95 -97.32 151.13 20.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.118 0.485 . . . . 0.0 111.55 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.22 -172.41 0.15 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.322 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -43.21 154.99 0.07 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.543 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -56.51 -24.51 46.93 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.154 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -60.33 -40.27 90.02 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.969 0.414 . . . . 0.0 109.911 179.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.51 ' HB1' ' HE2' ' A' ' 187' ' ' TYR . . . -74.39 -41.43 60.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.972 178.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.543 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.6 mt -58.28 -42.21 83.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.009 179.06 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.77 -29.89 42.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.192 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.429 ' CB ' HG21 ' A' ' 211' ' ' ILE . 4.2 mm-40 -68.19 -53.2 26.6 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.435 0.636 . . . . 0.0 110.107 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.804 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -59.08 -45.97 89.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.099 178.981 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.918 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -56.98 -37.52 71.75 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.709 179.258 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.14 -37.86 93.52 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 47.9 mm-40 -72.89 -46.32 53.43 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.419 -0.39 . . . . 0.0 111.135 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.613 ' HA ' HD22 ' A' ' 174' ' ' LEU . 11.1 mp -65.86 -28.57 69.06 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.658 0.266 . . . . 0.0 111.406 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.52 -17.67 62.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.379 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -112.51 -28.79 7.72 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 120.697 0.284 . . . . 0.0 111.453 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.613 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.1 OUTLIER -56.94 167.28 1.11 Allowed Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.188 -179.564 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -69.24 127.15 14.58 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.21 1.94 . . . . 0.0 112.861 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.11 -25.51 9.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.592 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -58.46 -48.99 78.92 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.959 0.409 . . . . 0.0 110.889 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.854 HG11 ' HB3' ' A' ' 218' ' ' LEU . 27.2 t -73.75 -33.8 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.438 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.408 ' HB2' HD21 ' A' ' 174' ' ' LEU . 13.8 tp -56.46 -35.26 67.72 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.141 0.496 . . . . 0.0 109.815 179.009 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -78.02 -40.84 19.73 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.188 178.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -84.6 102.84 13.22 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.977 0.418 . . . . 0.0 110.57 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' MET . . . . . 0.842 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.9 mtm 177.63 173.55 0.54 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.007 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 4.7 t -133.68 -50.27 0.84 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.752 0.31 . . . . 0.0 111.225 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -163.45 145.25 9.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.025 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.905 HG12 HG12 ' A' ' 199' ' ' VAL . 20.2 mt -110.87 115.99 51.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.539 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' HIS . . . . . 0.42 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 20.3 m170 -106.64 137.82 43.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.208 -179.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.51 ' HE2' ' HB1' ' A' ' 163' ' ' ALA . 0.2 OUTLIER -87.86 104.54 16.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.472 179.596 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.87 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.857 0.36 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ASP . . . . . 0.4 ' HB2' ' HB ' ' A' ' 211' ' ' ILE . 6.8 p30 -102.94 37.09 2.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.752 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -87.59 115.39 24.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.938 0.399 . . . . 0.0 111.093 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.813 ' O ' HD13 ' A' ' 198' ' ' ILE . 30.5 m -112.14 168.19 5.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.686 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.813 HD13 ' O ' ' A' ' 197' ' ' VAL . 25.7 mm -132.61 109.77 15.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.785 0.326 . . . . 0.0 111.318 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.905 HG12 HG12 ' A' ' 185' ' ' ILE . 6.9 m -99.0 121.04 49.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.901 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -81.94 152.52 26.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.835 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.04 146.44 35.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.863 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -57.32 -22.61 43.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.504 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -89.7 15.22 9.99 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 79.62 14.41 81.22 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.241 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -90.59 149.92 21.94 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 117.137 0.468 . . . . 0.0 110.801 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -119.38 111.33 18.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.765 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 20.8 t -111.68 126.23 69.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.964 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' SER . . . . . 0.578 ' OG ' HD12 ' A' ' 198' ' ' ILE . 11.0 m -103.08 116.36 32.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.934 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -121.84 -177.58 3.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.569 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.66 153.7 35.15 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.494 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.429 HG21 ' CB ' ' A' ' 166' ' ' GLU . 43.7 mt -66.63 -34.93 73.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.811 0.339 . . . . 0.0 110.775 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.4 -36.42 81.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.207 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -129.92 45.27 2.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.978 0.418 . . . . 0.0 110.903 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.621 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 11.6 t80 -68.53 -52.24 34.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.768 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.9 -39.7 86.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.132 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.71 -49.99 64.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.146 0.498 . . . . 0.0 110.603 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -53.99 -44.08 70.52 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.41 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.854 ' HB3' HG11 ' A' ' 178' ' ' VAL . 3.9 mm? -84.85 -23.77 28.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.266 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.31 -33.59 73.83 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.003 0.43 . . . . 0.0 109.934 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 38.2 m170 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.236 179.306 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.936 0.398 . . . . 0.0 110.995 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.769 ' HB2' HD13 ' A' ' 134' ' ' LEU . 80.7 m95 -77.13 168.36 20.21 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.053 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.32 133.77 46.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.818 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.4 mtt85 -70.4 106.78 3.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.869 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.904 HD11 HG22 ' A' ' 168' ' ' THR . 44.6 pt -95.47 -8.44 9.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.412 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.406 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -159.38 176.28 12.32 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 120.588 0.232 . . . . 0.0 110.894 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.453 ' O ' ' HA ' ' A' ' 154' ' ' VAL . 32.2 m-85 -143.5 126.96 16.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.332 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.645 HG21 HD11 ' A' ' 139' ' ' LEU . 5.0 t -93.36 122.63 45.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.083 0.468 . . . . 0.0 111.12 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.5 ' CD1' ' CE1' ' A' ' 130' ' ' PHE . 7.9 t80 -82.52 103.84 12.35 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.857 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -158.44 154.22 26.5 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.592 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.62 30.65 19.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.803 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 62.99 31.48 16.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.274 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 88.1 m -153.79 156.77 38.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.89 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.5 ' CE1' ' CD1' ' A' ' 125' ' ' TYR . 81.2 m-85 -98.42 90.88 4.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.602 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.491 ' HB2' HD21 ' A' ' 139' ' ' LEU . 23.4 m-85 -65.35 123.79 85.26 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.117 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.402 ' HB3' ' CE2' ' A' ' 123' ' ' TYR . 56.1 Cg_endo -71.57 115.22 4.21 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.255 1.97 . . . . 0.0 112.793 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.687 HD21 ' OG1' ' A' ' 168' ' ' THR . 29.2 tp -94.09 124.06 37.86 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.665 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.769 HD13 ' HB2' ' A' ' 118' ' ' TRP . 52.8 mt -70.69 173.29 7.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.517 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.4 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.3 pt-20 -64.3 -28.66 69.87 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.969 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -89.8 11.72 19.28 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.251 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.602 ' HA2' HD11 ' A' ' 133' ' ' LEU . . . 74.38 22.72 77.11 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.726 -0.75 . . . . 0.0 113.048 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.693 ' HB3' HD12 ' A' ' 134' ' ' LEU . 1.4 tpt180 -81.43 94.53 6.84 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.645 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -70.96 107.88 4.28 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.211 -179.164 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 16.7 mt -86.17 72.85 10.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.547 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.46 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 23.8 mttp -56.86 -20.95 25.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.77 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -85.24 -14.87 45.39 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -112.03 30.82 6.7 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . -60.5 166.24 12.12 Favored Glycine 0 CA--C 1.511 -0.185 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.453 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 9.0 t -135.3 148.27 49.45 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.992 0.425 . . . . 0.0 111.029 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 3.0 mmtt -90.86 52.82 2.24 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.356 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.68 152.22 3.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.549 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -86.99 135.95 34.61 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.833 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.452 ' HD2' ' CG2' ' A' ' 154' ' ' VAL . 60.6 Cg_endo -84.46 98.42 0.72 Allowed 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.028 2.485 . . . . 0.0 112.641 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.2 t -67.46 -9.13 39.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.714 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -90.35 -22.06 21.7 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 111.533 0.197 . . . . 0.0 111.533 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.717 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -138.7 167.43 19.52 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.717 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 60.9 Cg_endo -73.36 161.85 41.7 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.533 2.156 . . . . 0.0 112.382 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 24.2 t -123.07 110.03 25.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.044 0.45 . . . . 0.0 111.712 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.827 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.62 95.92 1.91 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.74 179.156 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 59.6 t -91.37 137.06 22.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.99 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 46.72 56.59 7.33 Favored Glycine 0 CA--C 1.52 0.399 0 CA-C-N 115.882 -0.599 . . . . 0.0 113.374 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.827 ' CE2' HD23 ' A' ' 155' ' ' LEU . 2.7 m95 -98.25 151.2 20.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.26 0.552 . . . . 0.0 111.707 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 8.1 mmtm -65.23 -172.44 0.1 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.59 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -43.62 154.02 0.1 Allowed 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.54 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.21 -24.85 52.89 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.224 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.01 -38.53 82.9 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.984 0.421 . . . . 0.0 110.056 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.01 -40.24 47.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.003 178.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.54 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.2 mt -58.87 -41.46 82.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.874 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.09 -29.68 45.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.276 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.432 ' CB ' HG21 ' A' ' 211' ' ' ILE . 3.0 mm-40 -69.08 -53.03 22.47 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.31 0.576 . . . . 0.0 110.256 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.825 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -59.1 -44.52 91.97 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.041 178.965 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.904 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -58.49 -38.22 77.19 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.397 179.214 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.19 -36.16 87.49 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 178.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -73.92 -47.59 36.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.264 -0.468 . . . . 0.0 110.988 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.611 ' HA ' HD22 ' A' ' 174' ' ' LEU . 11.0 mp -65.07 -27.93 69.11 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.754 0.311 . . . . 0.0 111.477 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.74 -18.6 62.78 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.297 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -113.4 -27.01 8.08 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.596 0.236 . . . . 0.0 111.626 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.611 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER -57.09 167.5 1.12 Allowed Pre-proline 0 CA--C 1.537 0.481 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.079 -179.684 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.52 128.22 15.92 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.2 1.933 . . . . 0.0 112.84 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.22 -25.38 9.1 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.631 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.74 -48.95 78.18 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.944 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.904 HG11 ' HB3' ' A' ' 218' ' ' LEU . 38.9 t -74.16 -35.48 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.439 179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.487 ' HB2' HD21 ' A' ' 174' ' ' LEU . 13.8 tp -56.82 -39.4 74.12 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.095 0.474 . . . . 0.0 109.969 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -73.6 -40.05 47.69 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 178.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -88.14 102.87 15.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.948 0.404 . . . . 0.0 110.577 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' MET . . . . . 0.837 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.8 mtm 177.69 164.19 0.62 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.146 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.53 -59.85 1.59 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.725 0.298 . . . . 0.0 111.091 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -155.24 142.58 19.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.034 0.445 . . . . 0.0 111.29 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.907 HG12 HG12 ' A' ' 199' ' ' VAL . 20.4 mt -104.69 114.86 45.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.317 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 23.6 m170 -103.12 117.46 34.59 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.256 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.41 ' HB2' ' CD2' ' A' ' 158' ' ' TRP . 71.2 t80 -76.4 104.48 6.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.432 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.647 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 . . . . . 0 CA--C 1.53 0.175 0 N-CA-C 111.577 0.214 . . . . 0.0 111.577 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -110.32 36.21 3.15 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.691 0.281 . . . . 0.0 111.062 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 9.4 ttt180 -89.53 115.17 26.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.121 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.86 ' O ' HD13 ' A' ' 198' ' ' ILE . 22.5 m -111.91 166.91 5.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.955 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.86 HD13 ' O ' ' A' ' 197' ' ' VAL . 19.8 mm -133.9 107.72 10.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.8 0.333 . . . . 0.0 111.314 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.907 HG12 HG12 ' A' ' 185' ' ' ILE . 13.2 m -99.05 131.26 46.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.081 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -95.37 152.44 18.39 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.534 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.52 157.97 16.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.895 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -57.81 -24.8 59.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.343 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -90.42 15.45 10.65 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 79.53 14.32 81.45 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.565 -0.826 . . . . 0.0 113.243 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -75.75 164.98 25.7 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.994 0.397 . . . . 0.0 110.791 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -134.56 111.45 10.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.86 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.6 t -117.87 128.92 74.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.081 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 4.2 m -103.13 115.2 30.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.768 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.686 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -127.11 158.58 36.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.893 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.06 153.27 18.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.503 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.432 HG21 ' CB ' ' A' ' 166' ' ' GLU . 36.7 mt -65.07 -37.18 79.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.882 0.372 . . . . 0.0 110.867 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.48 -33.17 72.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.198 -179.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -134.89 42.27 2.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.86 0.362 . . . . 0.0 111.104 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.584 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 11.4 t80 -64.64 -52.24 58.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.625 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.69 -42.16 87.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.192 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.65 -48.78 63.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.063 0.458 . . . . 0.0 110.338 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 1.3 mmpt? -53.84 -41.63 67.62 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.06 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.904 ' HB3' HG11 ' A' ' 178' ' ' VAL . 3.8 mm? -87.0 -24.01 24.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.97 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 12.6 t -62.63 -30.47 71.38 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.81 0.338 . . . . 0.0 110.42 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 38.7 m170 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.265 179.784 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 121.028 0.442 . . . . 0.0 110.972 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.759 ' HB2' HD13 ' A' ' 134' ' ' LEU . 81.8 m95 -73.4 168.34 19.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.069 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.82 136.64 41.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.489 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.64 105.38 4.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.683 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.86 HD11 HG22 ' A' ' 168' ' ' THR . 47.8 pt -95.13 -7.68 9.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.574 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.519 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -159.34 177.06 11.4 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 120.481 0.181 . . . . 0.0 110.589 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.476 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 30.3 m-85 -144.69 126.0 14.79 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.566 HG21 HD11 ' A' ' 139' ' ' LEU . 4.2 t -93.27 122.27 44.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.165 0.507 . . . . 0.0 111.416 -179.379 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.49 ' CE1' ' CE1' ' A' ' 130' ' ' PHE . 11.1 t80 -84.07 94.22 8.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.79 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -142.56 152.55 42.71 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.408 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 58.77 30.31 19.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.99 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 64.11 34.31 11.26 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.357 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.464 HG23 ' O ' ' A' ' 145' ' ' THR . 52.9 m -153.92 152.87 31.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.825 0.345 . . . . 0.0 111.135 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.692 ' CE2' ' HB2' ' A' ' 148' ' ' ALA . 11.1 m-85 -94.41 90.92 6.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.836 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.529 ' HB2' HD21 ' A' ' 139' ' ' LEU . 27.2 m-85 -71.17 110.83 8.12 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.794 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.429 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 49.5 Cg_exo -55.41 121.34 9.75 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 122.39 2.06 . . . . 0.0 112.73 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.713 HD21 ' OG1' ' A' ' 168' ' ' THR . 30.3 tp -101.42 123.82 46.1 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.43 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.759 HD13 ' HB2' ' A' ' 118' ' ' TRP . 46.4 mt -70.72 174.13 6.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.577 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.414 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.3 pt-20 -64.63 -29.28 70.28 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.079 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -90.07 12.62 17.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.192 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.631 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 74.96 16.73 80.39 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.111 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.7 ' HB3' HD12 ' A' ' 134' ' ' LEU . 9.2 tpt180 -74.85 93.53 2.65 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.566 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -68.35 121.29 15.98 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.631 -178.906 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -90.97 73.48 6.44 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.696 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.476 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 7.7 mttt -61.46 -16.11 43.85 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.995 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -94.7 -24.18 17.25 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -101.32 27.62 6.07 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.429 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -61.59 159.39 30.62 Favored Glycine 0 CA--C 1.508 -0.358 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.711 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.464 ' O ' HG23 ' A' ' 129' ' ' THR . 8.0 t -130.65 157.53 42.52 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.971 0.415 . . . . 0.0 110.877 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -94.69 50.34 1.32 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.577 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.98 149.81 3.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.583 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.692 ' HB2' ' CE2' ' A' ' 130' ' ' PHE . . . -93.66 125.77 52.32 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.387 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.476 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 60.6 Cg_endo -82.12 111.78 2.2 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.243 1.962 . . . . 0.0 112.339 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 11.6 t -69.5 -7.96 42.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.12 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -78.36 -23.32 46.94 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 120.717 0.294 . . . . 0.0 110.507 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.664 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -140.23 166.84 20.66 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.765 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.664 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 65.2 Cg_endo -74.85 156.11 43.67 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.384 2.056 . . . . 0.0 112.304 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 9.3 t -116.68 110.44 31.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.192 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.868 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.41 95.93 1.83 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.577 179.0 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 46.6 t -92.58 137.15 22.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.98 0.419 . . . . 0.0 111.162 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 48.73 57.78 8.2 Favored Glycine 0 CA--C 1.52 0.382 0 CA-C-N 115.893 -0.594 . . . . 0.0 113.304 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.868 ' CE2' HD23 ' A' ' 155' ' ' LEU . 2.9 m95 -100.69 151.17 21.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.198 0.523 . . . . 0.0 111.536 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -65.34 -172.43 0.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.459 179.329 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -43.74 154.69 0.09 Allowed 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.558 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -56.79 -25.15 51.46 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.327 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.22 -38.84 84.61 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 120.951 0.405 . . . . 0.0 110.087 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.62 -40.31 49.71 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.081 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.558 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.5 mt -59.17 -41.67 84.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.035 179.189 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.34 -30.9 53.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.23 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.422 ' HB3' HG21 ' A' ' 211' ' ' ILE . 5.4 mm-40 -67.83 -53.23 28.53 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.4 0.619 . . . . 0.0 109.968 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.808 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -59.53 -45.45 91.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.936 178.939 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.86 HG22 HD11 ' A' ' 121' ' ' ILE . 0.3 OUTLIER -56.75 -37.95 71.74 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.555 179.172 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.9 -37.38 92.51 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 178.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -70.94 -48.24 54.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.41 -0.395 . . . . 0.0 110.785 178.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.629 HD11 ' CE1' ' A' ' 214' ' ' PHE . 11.2 mp -64.89 -28.76 69.76 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.797 0.332 . . . . 0.0 111.23 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.31 -18.94 63.87 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.229 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -111.49 -28.64 8.09 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.669 0.271 . . . . 0.0 111.372 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.61 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.1 OUTLIER -56.85 166.86 1.21 Allowed Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.135 -179.658 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.28 128.0 15.82 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.225 1.95 . . . . 0.0 112.918 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.34 -26.29 11.86 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.541 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -58.42 -48.63 80.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.923 0.392 . . . . 0.0 110.88 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.855 HG11 ' HB3' ' A' ' 218' ' ' LEU . 33.7 t -73.7 -33.52 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.406 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.57 HD13 ' CD2' ' A' ' 174' ' ' LEU . 6.4 tp -57.44 -36.21 71.1 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 121.122 0.487 . . . . 0.0 109.818 179.048 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -76.42 -42.04 23.79 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.296 178.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -84.36 103.12 13.26 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.977 0.418 . . . . 0.0 110.584 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' MET . . . . . 0.853 ' CE ' HG12 ' A' ' 178' ' ' VAL . 3.0 mtm 178.74 169.57 0.87 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.008 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.13 -55.32 1.47 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.733 0.301 . . . . 0.0 111.082 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -163.23 142.32 8.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.928 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.897 HG12 HG12 ' A' ' 199' ' ' VAL . 12.4 mt -104.78 114.38 44.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.229 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 23.3 m170 -103.81 126.32 50.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.191 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.423 ' HE1' HD11 ' A' ' 211' ' ' ILE . 46.0 t80 -79.21 104.09 9.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.2 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.764 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 . . . . . 0 N--CA 1.462 0.171 0 CA-C-O 120.669 0.271 . . . . 0.0 111.351 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -106.57 38.52 2.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.754 0.311 . . . . 0.0 110.71 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 4.0 tpt180 -90.26 118.7 29.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.065 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.854 ' O ' HD13 ' A' ' 198' ' ' ILE . 25.5 m -117.51 165.94 12.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.915 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.854 HD13 ' O ' ' A' ' 197' ' ' VAL . 21.1 mm -134.56 107.45 9.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.149 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.897 HG12 HG12 ' A' ' 185' ' ' ILE . 8.4 m -96.12 123.84 48.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.985 0.421 . . . . 0.0 110.997 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -83.54 152.62 24.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.748 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 4.3 mmt -108.55 152.39 24.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.895 0.379 . . . . 0.0 110.947 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 39.2 m-20 -60.11 -26.35 66.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.196 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -89.77 14.54 11.6 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.89 0.329 . . . . 0.0 111.89 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 81.13 14.41 79.18 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.373 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.42 154.59 22.7 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 117.028 0.414 . . . . 0.0 110.78 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -125.1 111.36 15.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.841 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 26.2 t -112.79 123.76 68.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.004 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' SER . . . . . 0.634 ' OG ' HD12 ' A' ' 198' ' ' ILE . 58.2 m -97.7 114.7 26.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.676 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.659 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -127.28 162.23 26.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.955 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.91 156.18 17.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.555 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.423 HD11 ' HE1' ' A' ' 187' ' ' TYR . 48.9 mt -63.49 -29.73 48.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.784 0.326 . . . . 0.0 110.953 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -74.63 -39.74 61.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.343 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -118.86 36.74 4.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.86 0.362 . . . . 0.0 111.016 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.629 ' CE1' HD11 ' A' ' 171' ' ' LEU . 11.6 t80 -66.69 -53.3 35.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.738 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.55 -37.22 86.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.757 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.9 -51.76 44.29 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.205 0.526 . . . . 0.0 110.463 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 8.4 mmmt -54.23 -43.35 70.8 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.094 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.855 ' HB3' HG11 ' A' ' 178' ' ' VAL . 4.2 mm? -83.59 -23.67 31.84 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.114 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.41 -34.14 74.87 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.056 0.455 . . . . 0.0 109.834 178.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 . . . . . 0 CA--C 1.533 0.299 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.087 179.139 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.995 0.426 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.754 ' HB2' HD13 ' A' ' 134' ' ' LEU . 79.3 m95 -70.34 168.3 16.27 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.044 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.78 138.08 40.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.517 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.33 105.71 4.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.858 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.87 HD11 HG22 ' A' ' 168' ' ' THR . 49.4 pt -95.36 -6.64 9.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.604 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.493 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -159.75 176.83 11.49 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 120.553 0.216 . . . . 0.0 110.571 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.473 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 34.6 m-85 -144.64 126.11 14.94 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.622 HG21 HD11 ' A' ' 139' ' ' LEU . 3.7 t -93.16 122.28 44.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.101 0.477 . . . . 0.0 111.41 -179.091 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.482 ' CE1' ' CE1' ' A' ' 130' ' ' PHE . 15.8 t80 -83.05 93.96 7.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.669 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -144.73 153.06 41.29 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.352 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 60.2 29.35 18.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.758 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 62.36 34.51 15.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.863 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.4 ' CG2' ' N ' ' A' ' 145' ' ' THR . 45.2 m -152.47 156.23 39.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.059 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.648 ' CE2' ' HB2' ' A' ' 148' ' ' ALA . 19.0 m-85 -97.93 91.43 5.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.225 0.536 . . . . 0.0 110.866 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.525 ' HB2' HD21 ' A' ' 139' ' ' LEU . 27.8 m-85 -72.0 115.04 34.33 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.613 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.419 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 33.3 Cg_exo -61.16 117.07 3.82 Favored 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 122.422 2.082 . . . . 0.0 112.672 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.677 HD21 ' OG1' ' A' ' 168' ' ' THR . 30.6 tp -96.77 124.01 40.63 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.414 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.754 HD13 ' HB2' ' A' ' 118' ' ' TRP . 52.1 mt -70.5 174.45 5.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.645 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.409 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 2.0 pt-20 -65.11 -29.26 70.11 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.099 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 51.3 p-10 -89.68 11.88 18.56 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.254 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.636 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 75.08 19.02 80.08 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.856 -0.688 . . . . 0.0 113.007 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.709 ' HB3' HD12 ' A' ' 134' ' ' LEU . 1.2 tpt180 -77.36 93.2 4.01 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.282 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.622 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -68.32 121.48 16.36 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.806 -178.791 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.492 HD12 ' HG2' ' A' ' 143' ' ' GLU . 3.8 mm? -90.29 73.4 7.08 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.394 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.456 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 6.0 mttp -61.58 -15.61 40.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.302 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -98.52 -21.57 16.45 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.492 ' HG2' HD12 ' A' ' 140' ' ' LEU . 39.0 mm-40 -101.06 27.7 5.88 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.419 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -62.09 160.36 31.03 Favored Glycine 0 CA--C 1.51 -0.267 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.824 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.4 ' N ' ' CG2' ' A' ' 129' ' ' THR . 9.7 t -131.28 156.36 45.58 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.987 0.422 . . . . 0.0 110.729 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -93.11 51.0 1.6 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.735 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.1 151.23 3.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.573 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.648 ' HB2' ' CE2' ' A' ' 130' ' ' PHE . . . -95.14 125.64 49.59 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.39 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.473 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 73.9 Cg_endo -83.13 111.02 1.84 Allowed 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.355 2.037 . . . . 0.0 112.299 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 22.3 t -69.28 -8.12 43.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.163 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -77.85 -23.61 48.85 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 120.861 0.362 . . . . 0.0 110.607 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.668 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -138.11 166.71 23.89 Favored Pre-proline 0 N--CA 1.453 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.845 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.668 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 65.5 Cg_endo -74.67 157.93 43.79 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.444 2.096 . . . . 0.0 112.105 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 12.5 t -118.47 110.09 29.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.0 0.428 . . . . 0.0 111.369 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.854 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.61 95.95 1.91 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.644 179.054 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.432 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 61.6 t -92.54 136.66 24.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.09 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 48.59 57.07 8.74 Favored Glycine 0 CA--C 1.521 0.41 0 CA-C-N 115.891 -0.595 . . . . 0.0 113.319 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.854 ' CE2' HD23 ' A' ' 155' ' ' LEU . 3.5 m95 -99.91 151.14 21.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.175 0.512 . . . . 0.0 111.65 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.37 -172.22 0.15 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.553 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -43.4 154.27 0.09 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.268 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.56 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.16 -24.94 53.07 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.238 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -59.98 -40.72 90.09 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.871 0.367 . . . . 0.0 110.124 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -75.12 -40.34 59.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.982 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.56 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.8 mt -58.89 -41.99 84.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.971 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.71 -31.54 48.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.087 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -67.23 -52.96 34.58 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.575 0.702 . . . . 0.0 109.885 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.802 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -60.26 -44.42 95.32 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.013 178.865 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.87 HG22 HD11 ' A' ' 121' ' ' ILE . 0.3 OUTLIER -57.02 -38.11 72.66 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.484 179.171 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.18 -37.78 93.44 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 46.9 mm-40 -69.45 -48.69 60.07 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.408 -0.396 . . . . 0.0 110.92 178.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.602 HD11 ' CE1' ' A' ' 214' ' ' PHE . 9.9 mp -64.61 -29.35 70.36 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.758 0.313 . . . . 0.0 111.191 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.44 -20.28 64.63 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.368 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -110.91 -26.58 9.23 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.601 0.238 . . . . 0.0 111.414 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.673 ' CD2' HD13 ' A' ' 179' ' ' LEU . 0.1 OUTLIER -57.85 166.32 1.99 Allowed Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.898 -179.754 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.52 128.29 16.03 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.26 1.973 . . . . 0.0 112.94 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.24 -25.95 10.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.53 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -58.63 -48.65 80.3 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.877 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.85 HG11 ' HB3' ' A' ' 218' ' ' LEU . 32.3 t -73.81 -33.31 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.417 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.673 HD13 ' CD2' ' A' ' 174' ' ' LEU . 10.2 tp -56.71 -35.29 68.35 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 121.126 0.489 . . . . 0.0 110.047 179.102 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -79.5 -40.1 16.45 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.232 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -85.65 103.14 14.19 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 120.93 0.395 . . . . 0.0 110.556 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' MET . . . . . 0.838 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.8 mtm 177.35 170.8 0.58 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.158 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.48 -56.81 1.49 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.721 0.296 . . . . 0.0 111.063 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -163.16 142.7 8.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.047 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.922 HG12 HG12 ' A' ' 199' ' ' VAL . 13.8 mt -103.03 115.11 44.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.484 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' HIS . . . . . 0.432 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 21.6 m170 -105.75 125.43 50.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.205 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -78.48 104.73 9.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.335 179.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.424 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.722 0.296 . . . . 0.0 111.419 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -105.14 36.88 2.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.777 0.322 . . . . 0.0 110.782 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 4.6 tpt180 -90.5 115.61 27.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.108 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.871 ' O ' HD13 ' A' ' 198' ' ' ILE . 25.0 m -112.97 167.34 6.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.717 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.871 HD13 ' O ' ' A' ' 197' ' ' VAL . 20.6 mm -135.22 106.75 7.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.457 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.922 HG12 HG12 ' A' ' 185' ' ' ILE . 7.7 m -95.86 125.72 48.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.924 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -86.12 152.2 23.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.698 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.52 152.8 23.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.858 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -58.41 -23.84 58.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.418 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -89.99 15.35 10.2 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 78.16 14.41 82.28 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.508 -0.853 . . . . 0.0 113.13 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -82.83 166.47 18.95 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 117.07 0.435 . . . . 0.0 110.749 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -133.54 114.54 13.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.973 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.3 t -115.96 126.07 73.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.087 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 2.8 p -99.14 115.68 29.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.767 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.67 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -126.37 159.26 33.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.73 154.8 18.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.569 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 32.6 mt -64.02 -34.08 66.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.018 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -67.62 -40.51 84.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.4 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -125.28 43.53 3.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.88 0.372 . . . . 0.0 110.967 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.602 ' CE1' HD11 ' A' ' 171' ' ' LEU . 12.5 t80 -67.93 -53.34 27.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.836 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.72 -38.13 77.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.211 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.92 -48.45 65.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.99 0.424 . . . . 0.0 110.559 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.16 -43.77 70.89 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.094 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.85 ' HB3' HG11 ' A' ' 178' ' ' VAL . 4.0 mm? -84.53 -25.24 28.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.982 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 11.8 t -61.21 -31.36 71.14 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 120.822 0.344 . . . . 0.0 110.454 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 1.5 m170 . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.095 179.674 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 121.076 0.465 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.755 ' HB2' HD13 ' A' ' 134' ' ' LEU . 80.6 m95 -70.73 168.31 16.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.143 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -101.94 134.8 44.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.561 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 26.5 mtt180 -71.3 106.61 3.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.837 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.873 HD11 HG22 ' A' ' 168' ' ' THR . 47.5 pt -96.92 -6.38 9.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.494 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.565 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -160.64 176.25 11.76 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 121.08 -0.248 . . . . 0.0 110.88 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.481 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 37.5 m-85 -145.91 127.57 15.2 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.674 HG21 HD11 ' A' ' 139' ' ' LEU . 4.0 t -92.82 122.47 44.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.075 0.464 . . . . 0.0 111.445 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.492 ' CE1' ' CZ ' ' A' ' 130' ' ' PHE . 9.5 t80 -85.12 100.93 12.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.925 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -154.16 154.22 33.17 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.489 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 8.1 tpp180 60.69 31.47 20.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.721 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 62.27 32.08 17.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.945 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.452 HG22 ' N ' ' A' ' 130' ' ' PHE . 50.1 m -151.03 161.74 42.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.234 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.492 ' CZ ' ' CE1' ' A' ' 125' ' ' TYR . 87.0 m-85 -106.87 90.67 3.38 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.235 0.54 . . . . 0.0 110.841 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.563 ' HB2' HD21 ' A' ' 139' ' ' LEU . 20.7 m-85 -66.77 124.65 89.08 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.508 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.45 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 13.7 Cg_exo -68.6 123.29 10.31 Favored 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 122.327 2.018 . . . . 0.0 112.343 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.7 HD21 ' OG1' ' A' ' 168' ' ' THR . 36.9 tp -104.2 123.57 47.55 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.565 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.755 HD13 ' HB2' ' A' ' 118' ' ' TRP . 50.6 mt -72.69 173.07 9.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.733 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.414 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.5 pt-20 -63.02 -29.69 71.02 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.001 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 39.6 p-10 -89.84 11.91 18.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.143 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.648 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 74.93 19.27 80.02 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.183 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.688 ' HB3' HD12 ' A' ' 134' ' ' LEU . 13.8 tpp180 -76.69 95.68 4.04 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.674 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -70.71 122.46 19.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.913 -178.8 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -95.31 71.34 3.23 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.599 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.459 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 27.8 mttt -58.59 -19.76 41.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.78 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -89.46 -23.69 22.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.742 -0.208 . . . . 0.0 111.434 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -99.22 25.06 7.2 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.45 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -57.58 161.87 9.1 Favored Glycine 0 CA--C 1.51 -0.265 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.597 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 10.7 t -135.78 150.46 49.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.503 -0.348 . . . . 0.0 110.717 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.444 ' HE2' HG23 ' A' ' 129' ' ' THR . 3.5 mmtt -89.81 52.05 2.22 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.017 0.437 . . . . 0.0 110.62 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.92 149.05 2.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.678 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -93.91 125.52 52.75 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.153 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.481 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 72.0 Cg_endo -84.22 109.72 1.45 Allowed 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.486 2.124 . . . . 0.0 112.567 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.2 t -69.77 -7.73 42.1 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.101 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -78.16 -22.95 47.95 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.79 0.329 . . . . 0.0 110.551 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.674 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -139.59 166.9 20.91 Favored Pre-proline 0 N--CA 1.453 -0.282 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.758 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.718 ' HD3' HD23 ' A' ' 179' ' ' LEU . 61.0 Cg_endo -74.37 153.8 45.33 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.4 2.067 . . . . 0.0 112.194 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 12.2 t -115.67 109.51 28.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.222 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.861 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.55 95.74 1.86 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.534 178.881 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 55.3 t -92.33 136.99 23.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.956 0.407 . . . . 0.0 111.014 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 47.9 58.67 6.74 Favored Glycine 0 CA--C 1.521 0.416 0 CA-C-N 115.954 -0.567 . . . . 0.0 113.24 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.861 ' CE2' HD23 ' A' ' 155' ' ' LEU . 2.4 m95 -100.83 151.2 22.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.102 0.477 . . . . 0.0 111.828 -179.254 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -172.58 0.06 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.448 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -44.74 155.15 0.11 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.084 0.468 . . . . 0.0 112.173 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.564 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.42 -25.54 55.07 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.261 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.95 -39.42 85.52 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 120.991 0.424 . . . . 0.0 110.213 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -75.93 -40.75 53.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.184 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.564 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.2 mt -58.34 -41.48 81.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.045 179.109 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.14 -31.78 53.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.255 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -67.83 -53.08 29.74 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-O 121.517 0.675 . . . . 0.0 110.05 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.798 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -59.17 -45.74 90.22 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.002 178.919 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.873 HG22 HD11 ' A' ' 121' ' ' ILE . 0.5 OUTLIER -56.26 -38.63 71.41 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.643 179.075 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -58.77 -38.45 92.09 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 178.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 45.1 mm-40 -69.56 -48.37 60.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.315 -0.442 . . . . 0.0 110.902 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.618 HD11 ' CE1' ' A' ' 214' ' ' PHE . 10.8 mp -64.08 -29.85 70.96 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.724 0.297 . . . . 0.0 111.113 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -67.68 -19.96 65.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.259 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -111.22 -26.0 9.41 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.609 0.242 . . . . 0.0 111.424 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.557 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.1 OUTLIER -57.4 166.6 1.58 Allowed Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.079 -179.607 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.83 129.03 15.83 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.358 2.039 . . . . 0.0 112.707 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.19 -25.79 5.96 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.666 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.95 -49.82 75.48 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.953 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.925 HG11 ' HB3' ' A' ' 218' ' ' LEU . 34.8 t -74.07 -34.65 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.502 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.718 HD23 ' HD3' ' A' ' 153' ' ' PRO . 0.7 OUTLIER -56.47 -37.78 70.79 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.093 0.473 . . . . 0.0 110.063 179.276 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -78.92 -36.17 29.16 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.356 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -90.17 103.18 15.88 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.931 0.396 . . . . 0.0 110.846 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' MET . . . . . 0.836 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.7 mtm 177.66 173.99 0.53 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.034 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.97 -54.8 1.21 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.665 0.269 . . . . 0.0 111.168 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -163.14 142.83 8.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.959 0.409 . . . . 0.0 111.11 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.888 HG12 HG12 ' A' ' 199' ' ' VAL . 13.3 mt -104.8 114.98 45.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.454 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -103.32 123.66 47.2 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.155 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.437 ' HB2' ' CD2' ' A' ' 158' ' ' TRP . 65.9 t80 -81.58 104.33 11.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.375 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.667 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.165 0 CA-C-O 120.654 0.264 . . . . 0.0 111.646 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 11.3 p30 -109.47 38.98 2.19 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.861 0.362 . . . . 0.0 110.734 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 11.8 ttt-85 -91.47 117.16 29.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.18 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.857 ' O ' HD13 ' A' ' 198' ' ' ILE . 28.9 m -113.48 167.13 6.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.676 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.857 HD13 ' O ' ' A' ' 197' ' ' VAL . 17.0 mm -134.81 107.34 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.726 0.298 . . . . 0.0 111.363 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.888 HG12 HG12 ' A' ' 185' ' ' ILE . 11.9 m -98.04 134.87 34.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.927 0.394 . . . . 0.0 110.886 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -96.46 152.64 18.42 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.803 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 24.3 tpp -107.17 152.92 23.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.556 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -54.99 -24.45 24.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.784 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -90.44 15.55 10.5 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 79.24 14.54 81.55 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.544 -0.836 . . . . 0.0 113.047 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -77.99 157.8 29.52 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.929 0.395 . . . . 0.0 110.771 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -129.59 111.2 12.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.837 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.41 136.42 51.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.161 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 50.0 m -106.15 111.92 24.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.674 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -118.86 175.58 5.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.935 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.77 154.54 32.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.389 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 35.8 mt -66.61 -30.26 49.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.724 0.297 . . . . 0.0 110.859 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.61 -31.41 63.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.322 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -132.81 42.27 3.09 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.907 0.384 . . . . 0.0 110.96 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.618 ' CE1' HD11 ' A' ' 171' ' ' LEU . 11.7 t80 -68.3 -52.64 31.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.739 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.36 -39.44 87.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.892 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.18 -51.63 43.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.218 0.533 . . . . 0.0 110.243 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.91 -41.67 67.9 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.237 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.925 ' HB3' HG11 ' A' ' 178' ' ' VAL . 4.1 mm? -85.8 -23.13 27.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.061 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.03 -33.54 74.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.976 0.417 . . . . 0.0 110.144 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 21.1 m170 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.421 179.823 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 121.076 0.465 . . . . 0.0 111.048 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.761 ' HB2' HD13 ' A' ' 134' ' ' LEU . 84.9 m95 -66.18 168.31 8.75 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.007 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -100.72 136.33 40.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.391 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 5.9 mtm180 -72.35 107.33 4.89 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.762 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.886 HD11 HG22 ' A' ' 168' ' ' THR . 47.1 pt -96.89 -8.61 9.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.339 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.564 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -158.25 175.8 13.29 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 120.572 0.225 . . . . 0.0 110.672 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.478 ' CD1' ' CG ' ' A' ' 149' ' ' PRO . 30.4 m-85 -144.59 126.37 15.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.26 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.703 HG21 HD11 ' A' ' 139' ' ' LEU . 4.2 t -93.53 123.1 45.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.986 0.422 . . . . 0.0 111.294 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.491 ' CE1' ' CE1' ' A' ' 130' ' ' PHE . 7.0 t80 -84.61 105.38 15.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.842 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -159.77 154.44 24.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.673 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 60.57 30.96 20.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.914 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 62.05 31.87 17.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.136 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.527 HG23 ' O ' ' A' ' 145' ' ' THR . 89.3 m -153.72 150.16 28.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.987 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.842 ' CE2' ' HB2' ' A' ' 148' ' ' ALA . 54.1 m-85 -93.94 90.95 6.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.103 0.478 . . . . 0.0 110.705 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.554 ' HB2' HD21 ' A' ' 139' ' ' LEU . 22.3 m-85 -65.55 126.02 90.77 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.324 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.85 117.3 5.06 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 122.189 1.926 . . . . 0.0 112.441 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.67 HD21 ' OG1' ' A' ' 168' ' ' THR . 32.0 tp -96.59 124.02 40.45 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.731 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.761 HD13 ' HB2' ' A' ' 118' ' ' TRP . 54.0 mt -71.35 174.12 6.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.632 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.413 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.3 pt-20 -64.59 -29.45 70.47 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.091 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 48.4 p-10 -88.91 11.15 18.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.215 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.637 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 74.58 22.53 77.12 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.847 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.69 ' HB3' HD12 ' A' ' 134' ' ' LEU . 15.5 tpp85 -80.49 95.95 6.62 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.51 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.703 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -73.28 106.1 4.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.232 -179.215 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 13.3 mt -85.51 72.41 10.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.335 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.448 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 33.6 mttt -56.2 -21.23 21.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.896 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -82.87 -22.62 33.96 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -103.11 28.58 6.17 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . -64.16 163.84 33.67 Favored Glycine 0 CA--C 1.511 -0.169 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.699 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.527 ' O ' HG23 ' A' ' 129' ' ' THR . 9.2 t -132.09 157.03 45.24 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.504 -0.348 . . . . 0.0 110.529 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.6 mmtp -92.21 48.55 1.42 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.091 0.472 . . . . 0.0 110.554 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -171.26 154.55 4.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.438 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.842 ' HB2' ' CE2' ' A' ' 130' ' ' PHE . . . -99.31 126.52 37.5 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.076 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.478 ' CG ' ' CD1' ' A' ' 123' ' ' TYR . 72.2 Cg_endo -82.39 112.38 2.2 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.36 2.04 . . . . 0.0 112.702 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 28.0 t -69.82 -7.71 42.22 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.518 -0.764 . . . . 0.0 112.0 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -76.1 -22.82 55.11 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 120.779 0.323 . . . . 0.0 110.447 179.004 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.699 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -139.77 167.7 17.59 Favored Pre-proline 0 N--CA 1.452 -0.334 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.721 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.699 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 61.5 Cg_endo -73.98 154.36 47.73 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.364 2.042 . . . . 0.0 112.332 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 10.1 t -116.66 110.44 31.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.971 0.415 . . . . 0.0 111.088 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.856 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.55 95.94 1.89 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.584 179.058 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.42 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 51.3 t -91.24 136.74 23.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.028 0.442 . . . . 0.0 111.106 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 48.56 58.59 7.29 Favored Glycine 0 CA--C 1.52 0.392 0 CA-C-N 115.816 -0.629 . . . . 0.0 113.259 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.856 ' CE2' HD23 ' A' ' 155' ' ' LEU . 3.2 m95 -102.13 151.12 22.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.186 0.517 . . . . 0.0 111.721 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.89 -172.07 0.17 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.548 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -42.71 154.22 0.07 Allowed 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.526 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.08 -24.89 52.62 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.163 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.56 -39.65 84.74 Favored 'General case' 0 C--O 1.23 0.074 0 CA-C-O 120.916 0.388 . . . . 0.0 110.007 179.219 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.05 -40.03 54.21 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.917 178.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.526 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.3 mt -59.73 -41.68 86.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.873 179.018 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.13 -30.97 50.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.228 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.406 ' CB ' HG21 ' A' ' 211' ' ' ILE . 17.5 mm-40 -66.97 -53.01 35.77 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-O 121.491 0.662 . . . . 0.0 110.05 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.822 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -59.94 -44.78 94.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.905 178.914 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.886 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -58.34 -37.17 74.63 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.454 179.223 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.88 -37.68 92.93 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 178.338 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 35.0 mm-40 -72.87 -46.47 52.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.401 -0.399 . . . . 0.0 111.029 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.584 ' HA ' HD22 ' A' ' 174' ' ' LEU . 10.9 mp -65.92 -28.71 69.13 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.622 0.248 . . . . 0.0 111.323 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.88 -21.07 64.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.336 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -110.45 -26.19 9.65 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.588 0.232 . . . . 0.0 111.496 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.584 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.1 OUTLIER -57.55 166.51 1.71 Allowed Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.107 -179.684 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -70.09 128.08 15.22 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.305 2.003 . . . . 0.0 112.798 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.07 -25.78 5.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.726 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.71 -50.08 74.41 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.898 0.38 . . . . 0.0 111.012 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.869 HG11 ' HB3' ' A' ' 218' ' ' LEU . 41.5 t -74.25 -34.9 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.495 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.646 HD21 ' O ' ' A' ' 121' ' ' ILE . 0.5 OUTLIER -57.19 -34.49 68.54 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.156 0.503 . . . . 0.0 109.842 179.096 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -79.47 -38.54 20.86 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 178.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -87.92 103.06 15.32 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.865 0.364 . . . . 0.0 110.75 179.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' MET . . . . . 0.836 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.8 mtm 178.25 172.04 0.7 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.055 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -130.45 -52.61 1.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.677 0.275 . . . . 0.0 111.466 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -163.17 143.69 9.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.881 0.372 . . . . 0.0 111.135 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.905 HG12 HG12 ' A' ' 199' ' ' VAL . 15.7 mt -108.29 114.78 47.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.653 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' HIS . . . . . 0.42 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 23.5 m170 -105.77 129.33 53.98 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.057 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -79.33 104.81 10.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.444 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.584 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 . . . . . 0 CA--C 1.53 0.202 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 195' ' ' ASP . . . . . 0.448 ' OD1' HG22 ' A' ' 210' ' ' THR . 3.5 p30 -113.27 35.71 3.86 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.693 0.283 . . . . 0.0 111.13 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 2.0 ttt-85 -89.64 113.48 24.96 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.894 0.378 . . . . 0.0 111.318 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.845 ' O ' HD13 ' A' ' 198' ' ' ILE . 31.3 m -109.76 167.9 4.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.858 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.845 HD13 ' O ' ' A' ' 197' ' ' VAL . 22.4 mm -134.4 108.39 10.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.754 0.312 . . . . 0.0 111.278 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.905 HG12 HG12 ' A' ' 185' ' ' ILE . 11.2 m -97.51 137.52 24.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.989 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -98.26 152.82 19.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.79 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 27.9 tpp -110.77 153.65 25.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.831 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -55.92 -22.51 26.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.747 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -90.18 15.43 10.33 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 76.75 14.4 82.57 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.594 -0.813 . . . . 0.0 113.112 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -83.77 157.32 22.14 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 117.023 0.412 . . . . 0.0 110.729 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -127.69 111.47 13.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 20.6 t -111.44 130.54 64.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.942 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' SER . . . . . 0.519 ' OG ' HD12 ' A' ' 198' ' ' ILE . 16.7 m -102.62 116.66 33.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.798 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.647 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -128.19 160.25 32.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.861 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.448 HG22 ' OD1' ' A' ' 195' ' ' ASP . 0.6 OUTLIER -96.69 155.68 16.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.561 179.84 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.406 HG21 ' CB ' ' A' ' 166' ' ' GLU . 32.0 mt -67.18 -31.06 51.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.02 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.93 -32.06 65.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.357 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -126.53 33.95 4.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.06 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.578 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 11.4 t80 -62.99 -53.91 46.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.708 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.78 -39.95 86.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.832 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.29 -51.27 46.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.098 0.475 . . . . 0.0 110.236 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.86 -44.03 73.63 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.859 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.869 ' HB3' HG11 ' A' ' 178' ' ' VAL . 4.1 mm? -80.69 -25.75 37.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.942 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.9 -33.15 72.67 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.045 0.45 . . . . 0.0 110.123 179.07 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 3.6 m170 . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.445 179.675 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 121.134 0.492 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.759 ' HB2' HD13 ' A' ' 134' ' ' LEU . 79.3 m95 -66.11 168.25 8.72 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.015 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -101.36 141.09 34.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.631 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.402 ' HG3' HD23 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -74.55 106.14 5.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.748 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.897 HD11 HG22 ' A' ' 168' ' ' THR . 50.9 pt -97.41 -7.04 9.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.299 179.086 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.471 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -162.42 175.29 11.68 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 120.597 0.237 . . . . 0.0 110.779 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.464 ' CD1' ' HG3' ' A' ' 149' ' ' PRO . 25.9 m-85 -144.12 127.11 16.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.097 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.709 HG21 HD11 ' A' ' 139' ' ' LEU . 4.9 t -93.14 122.36 44.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.119 0.485 . . . . 0.0 111.292 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.493 ' CE1' ' CE1' ' A' ' 130' ' ' PHE . 14.8 t80 -83.38 105.34 14.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.812 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -159.68 153.6 23.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.59 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.67 30.79 20.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.973 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 63.12 32.65 15.08 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.317 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 145' ' ' THR . 90.3 m -154.41 150.49 27.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.982 0.42 . . . . 0.0 111.087 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.711 ' CE2' ' HB2' ' A' ' 148' ' ' ALA . 22.6 m-85 -93.77 90.85 6.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.52 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.533 ' HB2' HD21 ' A' ' 139' ' ' LEU . 21.3 m-85 -65.35 121.03 72.58 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.329 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.402 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 37.5 Cg_endo -67.62 118.11 5.35 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.215 1.943 . . . . 0.0 112.544 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.645 HD11 ' HA2' ' A' ' 137' ' ' GLY . 48.6 tp -99.66 124.69 45.13 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.953 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.759 HD13 ' HB2' ' A' ' 118' ' ' TRP . 52.7 mt -72.91 177.14 5.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.727 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.416 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.4 pt-20 -67.12 -28.77 68.43 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.118 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -89.71 12.45 16.95 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.167 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.654 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 72.25 23.95 77.15 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.741 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.696 ' HB3' HD12 ' A' ' 134' ' ' LEU . 1.3 tpt180 -81.14 97.66 7.68 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 178.328 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.709 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -75.89 112.44 12.3 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.232 -179.031 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 12.7 mt -92.69 72.16 4.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.179 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.453 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 39.4 mttt -55.21 -22.25 17.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.814 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -82.34 -24.06 34.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.191 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -100.2 27.05 5.91 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.417 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . -63.68 163.62 32.15 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.752 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.49 ' O ' HG23 ' A' ' 129' ' ' THR . 10.0 t -132.34 155.3 48.64 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.83 0.348 . . . . 0.0 110.714 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.8 mmtp -92.58 49.74 1.51 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.089 0.471 . . . . 0.0 110.494 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -171.13 153.73 3.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.613 -179.373 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.711 ' HB2' ' CE2' ' A' ' 130' ' ' PHE . . . -97.06 125.75 44.88 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.328 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.464 ' HG3' ' CD1' ' A' ' 123' ' ' TYR . 74.3 Cg_endo -83.2 111.76 1.9 Allowed 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.392 2.062 . . . . 0.0 112.533 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 29.1 t -69.87 -7.77 43.0 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.958 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -77.14 -23.22 51.72 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 120.763 0.316 . . . . 0.0 110.423 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.665 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -140.07 166.82 21.02 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.682 -179.394 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.665 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 69.1 Cg_endo -75.05 154.27 42.12 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.348 2.032 . . . . 0.0 112.34 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 9.0 t -114.56 110.91 33.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.139 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.858 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.61 95.96 1.91 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.536 179.069 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 50.1 t -91.48 137.18 22.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.053 0.454 . . . . 0.0 111.194 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 48.06 57.85 7.56 Favored Glycine 0 CA--C 1.521 0.459 0 CA-C-N 115.858 -0.61 . . . . 0.0 113.325 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.858 ' CE2' HD23 ' A' ' 155' ' ' LEU . 3.0 m95 -100.58 151.15 21.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.107 0.48 . . . . 0.0 111.782 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.32 -172.36 0.1 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.596 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -43.92 153.79 0.12 Allowed 'General case' 0 C--O 1.235 0.337 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.552 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -56.73 -25.16 50.97 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.261 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -60.29 -38.35 83.33 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.884 0.374 . . . . 0.0 110.109 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.96 -40.33 47.32 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.956 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.552 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.1 mt -58.53 -42.06 83.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.983 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.71 -30.19 42.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.299 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.45 ' CB ' HG21 ' A' ' 211' ' ' ILE . 14.2 mm-40 -68.26 -52.86 29.19 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.391 0.615 . . . . 0.0 110.016 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.788 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -60.7 -43.86 97.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.998 178.999 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.897 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -58.2 -36.54 73.26 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.291 179.206 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.66 -39.4 96.52 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 110.509 -1.037 . . . . 0.0 110.509 178.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 54.6 mm-40 -69.62 -46.33 66.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.407 -0.396 . . . . 0.0 110.839 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.593 ' HA ' HD22 ' A' ' 174' ' ' LEU . 10.9 mp -66.01 -28.29 68.76 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.693 0.283 . . . . 0.0 111.363 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.1 -18.65 63.26 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.345 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -112.79 -27.29 8.2 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.622 0.249 . . . . 0.0 111.576 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.593 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER -57.13 167.01 1.25 Allowed Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.072 -179.745 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.29 127.81 15.53 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.198 1.932 . . . . 0.0 112.831 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.61 -25.77 7.6 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.652 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.97 -49.46 76.74 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.871 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.881 HG11 ' HB3' ' A' ' 218' ' ' LEU . 24.5 t -74.01 -32.98 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.469 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.445 HD12 ' HA ' ' A' ' 179' ' ' LEU . 11.7 tp -57.24 -36.35 70.82 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 121.194 0.521 . . . . 0.0 109.865 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -77.35 -40.86 22.56 Favored Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.301 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -84.94 103.07 13.66 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.877 0.37 . . . . 0.0 110.658 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' MET . . . . . 0.85 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.8 mtm 177.31 162.63 0.5 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.033 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -120.9 -54.24 2.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.752 0.311 . . . . 0.0 111.267 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -162.38 142.94 10.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.814 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.896 HG12 HG12 ' A' ' 199' ' ' VAL . 16.2 mt -106.9 114.51 46.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.55 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 21.4 m170 -103.6 119.39 38.81 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.245 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.422 ' HB2' ' CD2' ' A' ' 158' ' ' TRP . 33.1 t80 -75.97 104.49 6.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.46 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.722 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 . . . . . 0 CA--C 1.529 0.163 0 CA-C-O 120.606 0.241 . . . . 0.0 111.596 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -108.95 38.47 2.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.802 0.334 . . . . 0.0 110.93 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -91.27 118.47 30.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.089 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.88 ' O ' HD13 ' A' ' 198' ' ' ILE . 21.2 m -115.63 167.81 7.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.863 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.88 HD13 ' O ' ' A' ' 197' ' ' VAL . 19.1 mm -135.31 109.49 10.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.799 0.333 . . . . 0.0 111.059 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.896 HG12 HG12 ' A' ' 185' ' ' ILE . 7.0 m -97.62 120.88 47.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.038 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -82.05 152.73 26.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.769 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.99 149.81 28.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.727 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -58.86 -29.12 66.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.168 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -80.87 1.76 29.43 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.983 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 92.1 14.43 56.14 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.466 -0.873 . . . . 0.0 113.184 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -86.69 162.32 17.96 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 117.067 0.434 . . . . 0.0 110.952 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -130.75 111.52 12.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.812 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.427 ' HB ' HG23 ' A' ' 199' ' ' VAL . 21.7 t -111.32 131.42 62.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.115 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 208' ' ' SER . . . . . 0.545 ' OG ' HD12 ' A' ' 198' ' ' ILE . 35.8 m -103.34 116.29 32.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.78 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.685 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -129.69 159.53 36.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.86 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.37 157.08 17.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.572 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.45 HG21 ' CB ' ' A' ' 166' ' ' GLU . 48.9 mt -67.44 -33.47 62.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.875 0.369 . . . . 0.0 110.848 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.73 -33.99 77.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.41 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -132.92 38.73 3.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.834 0.349 . . . . 0.0 111.148 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.582 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 11.0 t80 -62.52 -49.73 74.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.926 0.393 . . . . 0.0 110.637 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.97 -38.59 91.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.187 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -68.69 -50.56 49.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.022 0.439 . . . . 0.0 110.556 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 10.9 mmmt -53.43 -42.75 67.39 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.184 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.881 ' HB3' HG11 ' A' ' 178' ' ' VAL . 4.0 mm? -85.73 -23.46 27.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.968 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 9.0 t -60.13 -34.43 73.51 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.102 0.477 . . . . 0.0 109.964 179.103 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.968 179.015 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 . . . . . 0 C--O 1.23 0.058 0 CA-C-O 121.051 0.453 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.767 ' HB2' HD13 ' A' ' 134' ' ' LEU . 85.6 m95 -66.04 168.33 8.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.287 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.29 133.61 45.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.762 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 59.5 mtt180 -71.25 107.72 4.38 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.833 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.909 HD11 HG22 ' A' ' 168' ' ' THR . 42.9 pt -96.08 -9.15 9.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.414 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.518 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -156.33 175.97 13.3 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.659 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.479 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 37.9 m-85 -145.02 126.05 14.56 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.353 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.614 HG21 HD11 ' A' ' 139' ' ' LEU . 3.4 t -93.69 122.9 45.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.101 0.477 . . . . 0.0 111.13 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -82.4 97.46 8.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.776 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -151.09 156.01 40.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.44 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 6.3 tpp180 60.39 30.54 19.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.838 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.2 33.4 16.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.913 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 145' ' ' THR . 85.5 m -157.14 153.74 28.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.912 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -93.54 91.18 6.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.694 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.493 ' HB2' HD21 ' A' ' 139' ' ' LEU . 22.6 m-85 -66.06 125.02 89.33 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.874 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.61 115.84 4.49 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.008 1.806 . . . . 0.0 112.725 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.694 HD21 ' OG1' ' A' ' 168' ' ' THR . 25.1 tp -93.64 123.8 37.2 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.656 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.767 HD13 ' HB2' ' A' ' 118' ' ' TRP . 39.9 mt -69.55 171.86 8.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.48 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.4 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 0.9 OUTLIER -63.15 -31.76 72.98 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.987 179.893 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -84.68 3.81 35.46 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.278 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.621 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 82.71 21.24 60.07 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.766 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.644 ' HB3' HD12 ' A' ' 134' ' ' LEU . 6.2 tpt180 -79.9 94.29 5.82 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.572 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.614 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -69.79 107.41 3.5 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.95 -179.502 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 15.3 mt -83.45 72.54 10.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.979 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.451 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 9.2 mttp -57.79 -20.73 37.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.481 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -96.9 23.79 6.81 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.289 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -147.94 27.49 0.96 Allowed 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.747 0.308 . . . . 0.0 111.122 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.422 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . -63.52 166.66 25.84 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.913 -0.66 . . . . 0.0 113.183 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.416 ' O ' HG23 ' A' ' 129' ' ' THR . 9.6 t -132.58 151.72 51.84 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.867 0.365 . . . . 0.0 110.442 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.06 50.77 1.7 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.118 0.485 . . . . 0.0 110.598 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.71 147.04 2.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.644 -179.404 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -90.2 125.32 60.6 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.327 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.479 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 77.8 Cg_endo -84.83 107.27 1.1 Allowed 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.534 2.156 . . . . 0.0 112.605 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 15.0 t -69.83 -7.8 42.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.008 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -78.26 -23.64 47.19 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 120.841 0.353 . . . . 0.0 110.503 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.689 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -138.35 167.28 20.42 Favored Pre-proline 0 N--CA 1.453 -0.302 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.629 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.689 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 68.0 Cg_endo -74.62 156.36 44.75 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.452 2.101 . . . . 0.0 112.539 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 18.3 t -118.96 109.22 26.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.236 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.853 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.1 mp -72.54 96.14 1.91 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.699 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.7 t -91.37 136.23 24.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.082 0.467 . . . . 0.0 111.046 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 47.9 57.71 7.54 Favored Glycine 0 CA--C 1.522 0.471 0 CA-C-N 115.701 -0.681 . . . . 0.0 113.237 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.853 ' CE2' HD23 ' A' ' 155' ' ' LEU . 2.5 m95 -99.81 151.36 21.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.193 0.52 . . . . 0.0 111.831 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.52 -172.42 0.08 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.627 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -44.37 154.24 0.13 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.284 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.533 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.65 -24.93 54.61 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.159 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -59.56 -39.49 84.21 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.887 0.375 . . . . 0.0 110.125 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.28 -40.32 51.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.962 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.533 HD12 ' HA2' ' A' ' 161' ' ' GLY . 5.9 mt -58.72 -41.08 81.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.922 178.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.72 -29.48 39.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.138 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -70.1 -53.01 19.26 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 121.512 0.672 . . . . 0.0 110.137 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.833 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -58.95 -43.98 91.36 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.042 178.996 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.909 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -58.65 -36.43 74.12 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.395 179.08 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.26 -37.19 92.62 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 178.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 93.3 mm-40 -73.72 -45.58 51.27 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.339 -0.43 . . . . 0.0 111.083 178.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.608 ' HA ' HD22 ' A' ' 174' ' ' LEU . 11.3 mp -66.36 -28.47 68.67 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.697 0.284 . . . . 0.0 111.374 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.9 -16.18 62.66 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.34 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -115.2 -28.03 7.07 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.669 HD21 HD13 ' A' ' 179' ' ' LEU . 0.2 OUTLIER -55.88 167.29 0.86 Allowed Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 116.754 -0.203 . . . . 0.0 111.3 -179.539 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -69.92 128.15 15.47 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.269 1.979 . . . . 0.0 112.92 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.47 -25.64 6.8 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.718 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.51 -49.68 75.52 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.847 0.356 . . . . 0.0 110.947 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.871 HG11 ' HB3' ' A' ' 218' ' ' LEU . 32.4 t -74.34 -36.05 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.608 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.669 HD13 HD21 ' A' ' 174' ' ' LEU . 10.7 tp -55.1 -34.08 63.37 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.162 0.506 . . . . 0.0 110.155 179.027 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -80.29 -41.59 11.58 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.405 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -85.53 103.02 14.01 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.912 0.386 . . . . 0.0 110.665 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' MET . . . . . 0.835 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.8 mtm 178.52 166.18 0.83 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.228 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.85 -56.96 1.91 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.836 0.35 . . . . 0.0 111.001 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -162.96 142.56 8.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.771 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.894 HG12 HG12 ' A' ' 199' ' ' VAL . 11.7 mt -101.91 115.55 43.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.475 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 186' ' ' HIS . . . . . 0.4 ' HB3' ' CE ' ' A' ' 188' ' ' LYS . 22.9 m170 -105.21 121.62 44.21 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.98 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -78.53 104.69 9.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.509 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' LYS . . . . . 0.4 ' CE ' ' HB3' ' A' ' 186' ' ' HIS . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.547 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 . . . . . 0 CA--C 1.529 0.146 0 CA-C-O 120.754 0.311 . . . . 0.0 111.415 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 9.8 p30 -105.12 38.54 1.92 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.765 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -90.77 116.85 28.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.105 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.798 ' O ' HD13 ' A' ' 198' ' ' ILE . 22.1 m -114.24 164.35 10.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.725 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.798 HD13 ' O ' ' A' ' 197' ' ' VAL . 20.3 mm -133.3 105.95 8.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.785 0.326 . . . . 0.0 111.17 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.894 HG12 HG12 ' A' ' 185' ' ' ILE . 6.7 m -94.75 124.72 47.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.028 0.442 . . . . 0.0 111.011 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -84.26 152.82 23.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.809 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.8 149.02 29.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.729 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -58.77 -28.8 66.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.157 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -80.67 1.5 29.78 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.325 -0.398 . . . . 0.0 112.06 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 91.99 14.41 56.34 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.571 -0.823 . . . . 0.0 113.149 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -87.1 160.19 18.65 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.992 0.396 . . . . 0.0 110.732 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -128.67 111.47 13.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.919 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 23.1 t -110.88 137.46 43.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.044 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 3.8 m -110.83 112.07 23.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.755 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.41 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -121.86 170.76 9.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.938 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.92 157.56 19.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.402 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 33.0 mt -69.54 -31.48 49.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.794 0.331 . . . . 0.0 110.838 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.48 -30.15 65.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.345 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -133.12 37.31 3.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.809 0.338 . . . . 0.0 111.051 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.577 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 11.2 t80 -63.08 -55.46 25.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.837 0.351 . . . . 0.0 110.458 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.75 -42.38 79.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.146 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -68.91 -47.72 65.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.041 0.448 . . . . 0.0 110.232 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -54.95 -43.63 73.6 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.905 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.871 ' HB3' HG11 ' A' ' 178' ' ' VAL . 3.9 mm? -83.09 -26.44 31.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.779 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 13.2 t -61.19 -30.53 70.47 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.955 0.407 . . . . 0.0 110.528 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.107 179.612 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.993 0.425 . . . . 0.0 110.97 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.773 ' HB2' HD13 ' A' ' 134' ' ' LEU . 81.5 m95 -73.16 167.95 20.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.057 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.7 ttm-85 -102.64 135.57 44.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.401 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 -71.74 105.92 3.92 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.491 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.87 HD11 HG22 ' A' ' 168' ' ' THR . 42.9 pt -93.54 -9.06 9.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.492 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.486 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -158.99 176.57 12.14 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 120.99 -0.284 . . . . 0.0 110.795 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.456 ' O ' ' HA ' ' A' ' 154' ' ' VAL . 30.8 m-85 -142.77 128.3 19.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.268 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.623 HG21 HD11 ' A' ' 139' ' ' LEU . 3.9 t -93.28 122.41 44.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.072 0.463 . . . . 0.0 111.239 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.479 ' CE1' ' CE1' ' A' ' 130' ' ' PHE . 7.6 t80 -82.75 94.45 7.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.735 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -144.46 153.04 41.47 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.433 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 59.44 30.66 20.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.858 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 61.81 34.71 17.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.036 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.472 HG23 ' HE2' ' A' ' 146' ' ' LYS . 65.7 m -152.2 162.21 41.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.07 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.479 ' CE1' ' CE1' ' A' ' 125' ' ' TYR . 18.5 m-85 -103.27 90.71 3.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.191 0.52 . . . . 0.0 111.194 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.514 ' HB2' HD21 ' A' ' 139' ' ' LEU . 23.8 m-85 -69.82 118.33 62.08 Favored Pre-proline 0 CA--C 1.536 0.437 0 CA-C-N 115.437 -0.802 . . . . 0.0 111.499 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.433 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 25.0 Cg_exo -63.16 119.86 7.09 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 122.423 2.082 . . . . 0.0 112.61 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.677 HD21 ' OG1' ' A' ' 168' ' ' THR . 29.6 tp -100.25 123.17 44.16 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.285 179.153 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.773 HD13 ' HB2' ' A' ' 118' ' ' TRP . 46.5 mt -70.13 171.4 9.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.701 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.415 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.5 pt-20 -61.67 -33.33 73.79 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.098 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ASN . . . . . 0.462 ' ND2' ' CD1' ' A' ' 118' ' ' TRP . 4.2 p30 -82.34 -4.36 57.13 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.107 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.663 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 91.34 15.84 54.56 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.804 -179.438 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.669 ' HB3' HD12 ' A' ' 134' ' ' LEU . 15.1 tpp85 -73.62 97.21 2.6 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.466 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.623 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -70.98 109.18 4.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.565 -178.978 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 27.6 mt -84.22 71.16 10.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.487 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.452 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 18.6 mttt -56.79 -21.5 29.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.738 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -84.54 -17.39 39.05 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -106.67 29.48 6.91 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . -60.55 161.62 21.7 Favored Glycine 0 CA--C 1.509 -0.316 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.359 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 11.1 t -136.28 148.81 48.17 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.999 0.428 . . . . 0.0 110.927 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.472 ' HE2' HG23 ' A' ' 129' ' ' THR . 6.7 mmtt -89.92 55.86 3.28 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.343 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.405 ' O ' ' CG ' ' A' ' 130' ' ' PHE . 0.0 OUTLIER -170.41 167.32 8.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.255 -179.327 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -102.67 136.62 19.29 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.928 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.455 ' HG3' ' CD1' ' A' ' 123' ' ' TYR . 59.7 Cg_endo -84.7 99.98 0.74 Allowed 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 123.174 2.582 . . . . 0.0 112.491 179.451 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 16.8 t -67.24 -9.52 41.32 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.793 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -89.58 -22.24 22.46 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 111.562 0.208 . . . . 0.0 111.562 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.692 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -139.33 166.92 21.03 Favored Pre-proline 0 C--N 1.328 -0.334 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -178.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.692 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 58.9 Cg_endo -73.46 164.24 35.56 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.495 2.13 . . . . 0.0 112.275 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 22.1 t -122.92 109.12 22.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 121.065 0.46 . . . . 0.0 111.655 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.873 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.72 95.95 1.96 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.687 179.068 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.405 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 54.9 t -92.99 137.87 21.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.164 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 47.69 56.06 8.93 Favored Glycine 0 CA--C 1.521 0.421 0 CA-C-N 115.913 -0.585 . . . . 0.0 113.227 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.873 ' CE2' HD23 ' A' ' 155' ' ' LEU . 3.2 m95 -98.9 151.26 21.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.181 0.515 . . . . 0.0 111.62 -179.464 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.98 -172.4 0.14 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.423 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -43.58 154.69 0.08 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.095 0.474 . . . . 0.0 112.184 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.552 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.29 -25.05 53.78 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.275 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.97 -38.75 83.44 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.001 0.429 . . . . 0.0 110.125 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.18 -40.23 46.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.053 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.552 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.5 mt -59.4 -42.25 86.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.081 179.257 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.38 -29.49 48.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.366 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.429 ' CB ' HG21 ' A' ' 211' ' ' ILE . 5.6 mm-40 -67.84 -53.28 28.06 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.4 0.619 . . . . 0.0 110.162 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.79 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -60.89 -43.51 98.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.995 178.92 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.87 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -58.88 -37.82 77.42 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.361 179.181 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.62 -37.54 92.42 Favored Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 178.291 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -72.04 -46.5 56.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.366 -0.417 . . . . 0.0 110.848 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.552 ' HA ' HD22 ' A' ' 174' ' ' LEU . 10.4 mp -64.22 -30.45 71.51 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.789 0.328 . . . . 0.0 111.219 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -67.67 -21.91 65.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.552 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -109.61 -26.49 9.88 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 120.595 0.236 . . . . 0.0 111.498 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.552 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.1 OUTLIER -56.99 166.37 1.43 Allowed Pre-proline 0 CA--C 1.538 0.491 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.096 -179.685 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -69.32 128.95 17.19 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.364 2.043 . . . . 0.0 112.702 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.89 -25.89 5.13 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.75 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.87 -50.05 74.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.971 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.905 HG11 ' HB3' ' A' ' 218' ' ' LEU . 24.4 t -74.21 -35.44 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.705 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.523 ' HG ' HD21 ' A' ' 174' ' ' LEU . 0.4 OUTLIER -56.56 -35.04 67.7 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.131 0.491 . . . . 0.0 109.956 179.29 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -79.5 -39.21 18.92 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.269 -0.733 . . . . 0.0 111.269 178.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -86.85 103.16 14.99 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.935 0.398 . . . . 0.0 110.654 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' MET . . . . . 0.841 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.9 mtm 178.35 161.18 0.61 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.027 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 6.6 t -118.93 -58.52 1.94 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.767 0.318 . . . . 0.0 110.881 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.8 pm0 -157.62 142.58 16.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.001 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.89 HG12 HG12 ' A' ' 199' ' ' VAL . 17.0 mt -107.01 115.0 47.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.341 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' HIS . . . . . 0.405 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 21.8 m170 -106.01 123.46 48.03 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.207 -179.39 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -75.67 104.55 6.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.167 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 4.3 mttm . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.908 -179.629 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.257 0 CA-C-O 120.719 0.295 . . . . 0.0 111.332 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' ASP . . . . . 0.442 ' OD1' HG22 ' A' ' 210' ' ' THR . 3.4 p30 -106.9 37.86 2.24 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.746 0.308 . . . . 0.0 110.802 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 7.2 ttt180 -88.86 116.22 26.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.838 0.352 . . . . 0.0 111.439 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.74 ' O ' HD13 ' A' ' 198' ' ' ILE . 23.6 m -112.81 166.41 6.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.66 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.74 HD13 ' O ' ' A' ' 197' ' ' VAL . 19.2 mm -132.01 108.77 14.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.793 0.33 . . . . 0.0 111.287 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.89 HG12 HG12 ' A' ' 185' ' ' ILE . 10.2 m -100.98 120.78 50.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.028 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -85.81 152.62 22.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.631 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 9.7 mmt -102.67 161.24 13.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.034 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -62.56 -25.89 68.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.153 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -87.15 10.62 16.22 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 83.77 14.4 72.97 Favored Glycine 0 C--N 1.335 0.496 0 C-N-CA 120.451 -0.881 . . . . 0.0 113.282 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -80.15 170.41 16.47 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 117.014 0.407 . . . . 0.0 110.767 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -136.43 111.48 8.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.928 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.444 ' HB ' HG23 ' A' ' 199' ' ' VAL . 21.7 t -114.77 122.59 69.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.089 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -99.31 114.64 27.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.671 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.626 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -126.12 161.32 27.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.802 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.442 HG22 ' OD1' ' A' ' 195' ' ' ASP . 0.6 OUTLIER -99.76 152.73 19.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.673 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.429 HG21 ' CB ' ' A' ' 166' ' ' GLU . 48.4 mt -63.88 -36.49 76.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.838 0.351 . . . . 0.0 110.724 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.23 -34.66 76.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.158 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -132.64 44.28 2.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.919 0.39 . . . . 0.0 111.02 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.623 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 11.3 t80 -66.94 -52.58 41.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.564 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.01 -40.02 91.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.911 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.37 -51.15 55.66 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.158 0.504 . . . . 0.0 110.399 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.25 -43.78 71.22 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.163 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.905 ' HB3' HG11 ' A' ' 178' ' ' VAL . 4.1 mm? -83.52 -23.15 32.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.097 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.49 -34.3 75.26 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.045 0.45 . . . . 0.0 109.799 179.069 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 . . . . . 0 CA--C 1.533 0.298 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.151 179.446 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 121.025 0.44 . . . . 0.0 110.939 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.774 ' HB2' HD13 ' A' ' 134' ' ' LEU . 87.3 m95 -70.11 168.37 15.73 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.093 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 2.0 ptt180 -99.57 133.39 43.97 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.696 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 32.4 mtm180 -71.33 106.68 3.96 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.628 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.892 HD11 HG22 ' A' ' 168' ' ' THR . 44.1 pt -95.86 -8.25 9.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.436 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.541 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -158.41 176.53 12.33 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 120.647 0.26 . . . . 0.0 110.882 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.469 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 38.2 m-85 -144.91 126.59 15.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.188 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.643 HG21 HD11 ' A' ' 139' ' ' LEU . 4.1 t -93.45 122.65 45.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.124 0.487 . . . . 0.0 111.013 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -83.69 95.07 8.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.48 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -145.52 155.16 42.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.42 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 4.0 tpp180 59.58 30.2 19.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.787 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 62.27 34.83 15.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.997 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.445 HG22 ' N ' ' A' ' 130' ' ' PHE . 57.8 m -153.54 161.46 42.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.826 0.346 . . . . 0.0 111.278 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.659 ' CZ ' ' HB2' ' A' ' 148' ' ' ALA . 31.8 m-85 -101.75 91.12 4.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.132 0.491 . . . . 0.0 110.914 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.471 ' HB2' HD21 ' A' ' 139' ' ' LEU . 24.3 m-85 -70.19 122.96 87.9 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.336 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.422 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 15.1 Cg_exo -67.94 118.17 5.42 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 122.31 2.007 . . . . 0.0 112.636 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.655 HD21 ' OG1' ' A' ' 168' ' ' THR . 30.4 tp -98.02 123.32 41.98 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.086 0.469 . . . . 0.0 110.362 179.167 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.774 HD13 ' HB2' ' A' ' 118' ' ' TRP . 44.6 mt -70.4 171.97 9.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.511 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.406 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 0.9 OUTLIER -62.85 -32.33 73.53 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.857 179.924 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -84.07 2.45 39.22 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.161 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.666 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 83.89 20.27 59.83 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.827 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.64 ' HB3' HD12 ' A' ' 134' ' ' LEU . 13.8 tpp180 -78.4 94.08 4.82 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.416 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.643 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -68.2 105.1 1.99 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.438 -179.025 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 17.3 mt -78.58 69.34 4.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.746 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.44 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 2.3 mttt -57.2 -21.31 32.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.564 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -91.96 11.94 23.44 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -134.74 26.5 3.67 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.762 0.315 . . . . 0.0 111.17 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.422 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -61.23 163.02 22.63 Favored Glycine 0 CA--C 1.509 -0.323 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.844 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.9 t -136.3 151.84 50.05 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.526 -0.337 . . . . 0.0 110.428 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.42 ' HE2' HG23 ' A' ' 129' ' ' THR . 4.2 mmtt -89.03 51.84 2.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.014 0.435 . . . . 0.0 110.705 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.18 148.97 2.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.638 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.659 ' HB2' ' CZ ' ' A' ' 130' ' ' PHE . . . -93.73 125.81 52.0 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.474 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.469 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 89.1 Cg_endo -84.39 109.97 1.43 Allowed 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.528 2.152 . . . . 0.0 112.508 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.3 t -70.2 -6.86 37.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.081 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.73 -23.04 53.06 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 120.836 0.351 . . . . 0.0 110.507 178.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.688 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -140.72 167.2 18.42 Favored Pre-proline 0 N--CA 1.453 -0.306 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.794 -179.401 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.688 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 61.5 Cg_endo -74.04 154.44 47.48 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.412 2.074 . . . . 0.0 112.306 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 14.2 t -115.81 111.5 35.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.115 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.823 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.71 96.45 2.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.858 179.207 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.434 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 59.0 t -93.07 136.03 26.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.975 0.417 . . . . 0.0 110.981 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 48.97 56.32 10.25 Favored Glycine 0 CA--C 1.521 0.423 0 CA-C-N 115.903 -0.589 . . . . 0.0 113.17 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.823 ' CE2' HD23 ' A' ' 155' ' ' LEU . 3.2 m95 -99.52 151.31 21.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.195 0.521 . . . . 0.0 111.799 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -65.79 -172.43 0.13 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.529 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -44.33 154.43 0.12 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.118 0.485 . . . . 0.0 112.203 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.564 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.27 -25.07 53.78 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.239 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -60.12 -38.3 82.59 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 120.967 0.413 . . . . 0.0 110.113 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.79 -41.36 44.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.0 178.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.564 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.5 mt -57.73 -42.35 81.56 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.11 179.173 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.22 -29.78 34.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.166 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.416 ' CB ' HG21 ' A' ' 211' ' ' ILE . 2.0 mt-10 -68.64 -53.43 22.53 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-O 121.503 0.668 . . . . 0.0 110.054 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.797 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -59.84 -43.81 94.39 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.701 -0.682 . . . . 0.0 109.88 178.989 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.892 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -58.62 -36.35 73.92 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.329 179.018 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.84 -38.47 94.06 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 178.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -71.93 -45.45 61.1 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.269 -0.465 . . . . 0.0 110.727 178.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.563 ' HA ' HD22 ' A' ' 174' ' ' LEU . 10.7 mp -67.83 -21.32 65.21 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.72 0.295 . . . . 0.0 111.691 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -77.12 -16.69 59.09 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.114 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -114.9 -26.5 7.75 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.75 HD21 ' HB2' ' A' ' 179' ' ' LEU . 0.1 OUTLIER -57.75 166.35 1.91 Allowed Pre-proline 0 CA--C 1.536 0.412 0 CA-C-O 120.513 0.197 . . . . 0.0 111.051 -179.497 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -69.48 128.88 16.94 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.31 2.007 . . . . 0.0 112.707 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.86 -25.25 7.52 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.67 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.42 -49.39 76.36 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.904 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.906 HG11 ' HB3' ' A' ' 218' ' ' LEU . 23.5 t -74.32 -39.97 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.57 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.75 ' HB2' HD21 ' A' ' 174' ' ' LEU . 12.4 tp -54.52 -32.63 58.5 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.059 0.457 . . . . 0.0 110.22 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -82.41 -36.18 17.95 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 178.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -90.48 103.2 15.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.898 0.38 . . . . 0.0 110.614 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' MET . . . . . 0.833 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.9 mtm 178.92 179.79 0.39 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.023 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -136.72 -52.16 0.69 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.732 0.301 . . . . 0.0 111.198 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -163.43 142.69 8.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.124 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.89 HG12 HG12 ' A' ' 199' ' ' VAL . 19.2 mt -106.25 114.95 46.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.316 179.215 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 186' ' ' HIS . . . . . 0.434 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 20.1 m170 -106.24 123.61 48.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.25 -179.372 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -75.31 104.85 6.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.474 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 9.0 mmtt . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.5 179.867 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 . . . . . 0 CA--C 1.528 0.121 0 CA-C-O 120.695 0.283 . . . . 0.0 111.282 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -104.19 36.01 2.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.795 0.331 . . . . 0.0 110.779 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 24.0 ttt85 -90.57 113.43 25.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.988 0.423 . . . . 0.0 111.182 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.854 ' O ' HD13 ' A' ' 198' ' ' ILE . 23.1 m -109.2 167.82 4.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.751 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.854 HD13 ' O ' ' A' ' 197' ' ' VAL . 22.5 mm -134.33 105.75 7.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.684 0.278 . . . . 0.0 111.34 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.89 HG12 HG12 ' A' ' 185' ' ' ILE . 12.5 m -94.53 134.87 30.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.868 0.366 . . . . 0.0 110.921 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -97.54 153.08 18.4 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.667 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 33.5 tpp -112.24 149.35 32.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.448 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 16.9 m-20 -55.27 -28.96 57.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.513 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -75.38 -5.89 47.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.817 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 94.78 14.62 49.02 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.499 -0.857 . . . . 0.0 112.988 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.439 ' CE2' HG22 ' A' ' 207' ' ' VAL . 11.2 t80 -86.28 158.2 19.75 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 117.005 0.403 . . . . 0.0 110.915 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -124.85 111.18 15.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.676 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.439 HG22 ' CE2' ' A' ' 205' ' ' TYR . 25.5 t -113.04 135.64 51.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.938 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 93.7 p -109.26 116.36 31.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.74 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.407 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -125.27 169.36 12.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.797 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -108.2 154.25 22.03 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.706 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.416 HG21 ' CB ' ' A' ' 166' ' ' GLU . 34.5 mt -66.08 -34.05 67.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.782 0.325 . . . . 0.0 110.832 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.46 -35.61 80.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.334 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -131.65 43.34 3.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.983 0.42 . . . . 0.0 110.961 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.568 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 11.1 t80 -66.73 -50.77 61.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.722 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.27 -42.22 90.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.347 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -67.31 -49.55 63.7 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.052 0.454 . . . . 0.0 110.458 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.93 -43.4 69.76 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.174 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.906 ' HB3' HG11 ' A' ' 178' ' ' VAL . 4.0 mm? -84.11 -25.5 29.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.004 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 12.6 t -61.15 -31.45 71.18 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.892 0.377 . . . . 0.0 110.396 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 . . . . . 0 CA--C 1.531 0.248 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.402 179.665 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 121.041 0.448 . . . . 0.0 110.977 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.762 ' HB2' HD13 ' A' ' 134' ' ' LEU . 81.3 m95 -73.89 168.55 19.22 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.204 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.2 ptt180 -101.05 135.22 42.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.841 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 8.4 mtm180 -71.87 106.68 4.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.867 0.365 . . . . 0.0 110.731 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.888 HD11 HG22 ' A' ' 168' ' ' THR . 49.3 pt -97.09 -7.65 9.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.366 179.268 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.478 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -159.39 176.17 12.44 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 121.111 -0.236 . . . . 0.0 110.71 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.47 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 29.1 m-85 -144.48 126.26 15.24 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.088 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.559 HG21 HD11 ' A' ' 139' ' ' LEU . 8.6 t -93.64 122.77 45.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.108 0.48 . . . . 0.0 111.471 -179.445 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.476 ' CD1' ' CE1' ' A' ' 130' ' ' PHE . 28.5 t80 -82.7 110.7 17.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.729 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -165.08 152.41 10.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.651 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? 60.37 31.6 20.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.015 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 62.2 31.49 17.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.264 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.521 HG23 ' O ' ' A' ' 145' ' ' THR . 84.7 m -153.43 150.13 28.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.874 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.476 ' CE1' ' CD1' ' A' ' 125' ' ' TYR . 98.7 m-85 -95.55 91.52 6.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.793 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.516 ' HB2' HD21 ' A' ' 139' ' ' LEU . 23.8 m-85 -65.19 126.15 90.77 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.313 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -72.58 116.67 4.8 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.176 1.917 . . . . 0.0 112.434 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.621 HD21 ' OG1' ' A' ' 168' ' ' THR . 42.8 tp -96.02 124.38 40.01 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.864 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.762 HD13 ' HB2' ' A' ' 118' ' ' TRP . 55.0 mt -71.65 174.73 6.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.65 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.406 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.5 pt-20 -65.46 -28.73 69.43 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.076 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 46.7 p-10 -89.82 11.68 19.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.143 179.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.666 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 73.41 23.49 77.1 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.932 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.703 ' HB3' HD12 ' A' ' 134' ' ' LEU . 18.4 tpp180 -81.11 95.95 7.02 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.368 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.559 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -72.68 107.33 5.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.326 -179.005 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 13.5 mt -85.03 72.13 10.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.321 179.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.465 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 7.5 mtpt -56.2 -21.38 22.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.993 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -85.54 -16.22 40.17 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -108.88 29.69 7.23 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . -64.52 163.08 36.42 Favored Glycine 0 CA--C 1.51 -0.228 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.88 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.521 ' O ' HG23 ' A' ' 129' ' ' THR . 9.1 t -131.31 155.95 46.31 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.41 -0.395 . . . . 0.0 110.619 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.39 48.52 1.31 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.127 0.489 . . . . 0.0 110.319 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -170.97 150.73 3.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.533 -179.314 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.455 ' HB2' ' CZ ' ' A' ' 130' ' ' PHE . . . -95.02 125.93 48.76 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.21 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.47 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 72.8 Cg_endo -83.02 111.83 1.96 Allowed 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.349 2.032 . . . . 0.0 112.619 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 33.3 t -69.81 -7.6 41.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.062 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.82 -23.44 52.76 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 120.821 0.343 . . . . 0.0 110.456 178.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.674 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -139.44 166.9 21.05 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.653 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.674 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 60.0 Cg_endo -73.81 154.54 48.7 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.348 2.032 . . . . 0.0 112.265 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 13.4 t -116.91 109.98 29.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.063 0.458 . . . . 0.0 111.207 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.891 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.2 mp -72.33 96.12 1.82 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.611 179.085 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.417 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 60.8 t -92.41 137.16 22.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.129 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 48.97 57.85 8.33 Favored Glycine 0 CA--C 1.52 0.374 0 CA-C-N 115.921 -0.581 . . . . 0.0 113.223 179.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.891 ' CE2' HD23 ' A' ' 155' ' ' LEU . 2.7 m95 -101.13 151.07 22.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.162 0.506 . . . . 0.0 111.679 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.7 tttp -66.76 -172.18 0.16 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.374 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -42.26 154.42 0.06 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.534 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -56.87 -24.96 51.63 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.267 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.04 -38.69 83.51 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.996 0.427 . . . . 0.0 109.978 179.068 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -75.91 -40.6 53.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.913 178.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.534 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.2 mt -59.11 -44.0 90.58 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.878 179.08 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -52.92 -25.9 13.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.617 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -71.39 -54.43 10.73 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 121.072 0.463 . . . . 0.0 110.923 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.813 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -62.14 -37.19 84.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.217 179.495 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.888 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -60.5 -38.11 83.26 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.911 178.881 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -61.59 -35.68 91.49 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 177.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -71.6 -49.02 44.27 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.181 -0.51 . . . . 0.0 110.669 178.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.637 ' HA ' HD22 ' A' ' 174' ' ' LEU . 10.8 mp -65.2 -27.42 68.67 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.548 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.13 -18.2 61.91 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.273 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -113.27 -27.75 7.86 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.637 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER -57.0 167.23 1.14 Allowed Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.154 -179.582 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.413 ' HG2' HG23 ' A' ' 178' ' ' VAL . 38.2 Cg_endo -67.19 127.78 17.32 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.192 1.928 . . . . 0.0 112.728 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.45 -26.43 12.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.525 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -58.93 -48.09 82.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.924 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.894 HG11 ' HB3' ' A' ' 218' ' ' LEU . 22.1 t -73.0 -35.82 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.696 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.484 ' HB2' HD21 ' A' ' 174' ' ' LEU . 13.0 tp -56.13 -36.36 68.15 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.129 0.49 . . . . 0.0 110.032 179.223 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -76.92 -40.11 26.46 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 178.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -87.7 103.09 15.27 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.879 0.371 . . . . 0.0 110.718 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' MET . . . . . 0.839 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.8 mtm 178.02 167.73 0.75 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.127 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.92 -56.75 1.55 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.63 0.252 . . . . 0.0 111.268 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 6.3 pm0 -160.39 142.79 13.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.894 0.378 . . . . 0.0 111.307 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.874 HG12 HG12 ' A' ' 199' ' ' VAL . 13.3 mt -104.33 115.96 47.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.455 179.424 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 186' ' ' HIS . . . . . 0.417 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 20.2 m170 -106.45 124.05 49.01 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.113 -179.628 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -79.46 104.7 10.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.709 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.517 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.53 0.209 0 CA-C-O 120.748 0.308 . . . . 0.0 111.245 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -106.0 38.37 2.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.608 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.08 114.72 25.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.322 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.874 ' O ' HD13 ' A' ' 198' ' ' ILE . 32.8 m -110.59 169.37 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.724 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.874 HD13 ' O ' ' A' ' 197' ' ' VAL . 22.0 mm -134.95 110.29 12.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.72 0.295 . . . . 0.0 111.285 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.874 HG12 HG12 ' A' ' 185' ' ' ILE . 12.3 m -102.81 127.18 56.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.987 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -88.64 152.56 21.75 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.675 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.11 157.62 16.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.812 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -57.78 -23.84 54.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.527 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -89.89 15.36 10.03 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 79.64 14.19 81.47 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.57 -0.824 . . . . 0.0 113.081 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -78.39 175.05 10.64 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 117.094 0.447 . . . . 0.0 110.836 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -140.53 111.46 7.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.082 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 20.1 t -114.22 135.63 53.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.911 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 1.5 m -107.64 118.36 36.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.928 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.645 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -131.12 161.94 30.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.66 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -99.28 156.75 16.82 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.737 0.303 . . . . 0.0 110.788 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 45.9 mt -68.46 -33.1 58.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.771 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 -67.38 -38.06 84.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.091 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -126.53 41.14 3.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.974 0.416 . . . . 0.0 110.866 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.597 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 11.5 t80 -65.02 -52.57 55.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.869 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.29 -37.74 81.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.048 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -69.25 -49.62 54.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.063 0.458 . . . . 0.0 110.372 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 1.2 mmpt? -53.25 -41.72 65.76 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.058 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.894 ' HB3' HG11 ' A' ' 178' ' ' VAL . 4.3 mm? -87.06 -23.16 25.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.9 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 11.0 t -60.95 -32.64 72.17 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.921 0.391 . . . . 0.0 110.157 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 24.9 m170 . . . . . 0 CA--C 1.533 0.29 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.195 179.398 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 121.011 0.434 . . . . 0.0 110.942 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.769 ' HB2' HD13 ' A' ' 134' ' ' LEU . 82.8 m95 -70.91 168.44 16.91 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.219 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.85 132.2 47.76 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.799 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -69.17 108.4 3.6 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.926 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.911 HD11 HG22 ' A' ' 168' ' ' THR . 44.2 pt -98.01 -7.93 9.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.323 179.151 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.471 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -159.97 174.45 14.36 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 121.134 -0.226 . . . . 0.0 110.649 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.476 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 28.0 m-85 -143.03 126.75 17.04 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.277 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.651 HG21 HD11 ' A' ' 139' ' ' LEU . 3.5 t -93.35 123.65 45.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.018 0.437 . . . . 0.0 111.643 -179.179 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.481 ' CE1' ' CE1' ' A' ' 130' ' ' PHE . 7.5 t80 -84.51 105.11 15.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.754 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -159.66 154.92 25.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.681 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 60.46 30.56 19.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.945 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 62.38 32.16 16.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.166 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.484 HG23 ' O ' ' A' ' 145' ' ' THR . 75.3 m -153.1 151.39 30.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.085 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.815 ' CE2' ' HB2' ' A' ' 148' ' ' ALA . 36.4 m-85 -94.52 90.91 6.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.537 179.573 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.564 ' HB2' HD21 ' A' ' 139' ' ' LEU . 21.4 m-85 -65.47 138.17 96.82 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.739 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -85.16 116.06 1.73 Allowed 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.311 2.008 . . . . 0.0 112.083 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.609 HD21 ' OG1' ' A' ' 168' ' ' THR . 37.9 tp -95.29 123.65 38.91 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.882 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.769 HD13 ' HB2' ' A' ' 118' ' ' TRP . 58.2 mt -72.15 172.69 9.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.485 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.41 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.5 pt-20 -63.19 -28.75 70.26 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.854 179.725 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -90.5 12.39 18.81 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.209 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.642 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 74.07 28.34 64.63 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.717 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.628 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -81.62 92.36 6.55 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.723 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.651 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -74.17 105.03 5.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.957 0.408 . . . . 0.0 110.972 -179.533 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 88.6 mt -85.84 70.87 10.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.701 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.462 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 29.5 mttt -52.87 -23.24 6.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.983 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -84.09 -20.54 32.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.596 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -102.54 27.86 6.51 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 111.703 0.26 . . . . 0.0 111.703 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . -65.22 163.88 37.74 Favored Glycine 0 CA--C 1.511 -0.215 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.144 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.484 ' O ' HG23 ' A' ' 129' ' ' THR . 7.8 t -133.07 158.3 43.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.955 0.407 . . . . 0.0 110.648 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 6.2 mmmm -93.98 48.86 1.28 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.36 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.33 151.53 3.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.593 -179.007 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.815 ' HB2' ' CE2' ' A' ' 130' ' ' PHE . . . -96.93 126.73 41.51 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.178 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.476 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 73.2 Cg_endo -82.24 111.95 2.19 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.335 2.023 . . . . 0.0 112.552 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 28.2 t -69.82 -7.47 40.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.112 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -76.47 -23.33 53.82 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 120.859 0.362 . . . . 0.0 110.451 179.021 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.697 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -139.74 167.88 17.01 Favored Pre-proline 0 N--CA 1.454 -0.265 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.697 -179.308 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.697 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 61.0 Cg_endo -74.22 158.0 45.52 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.389 2.059 . . . . 0.0 112.236 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 11.1 t -118.47 111.04 32.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.049 0.452 . . . . 0.0 111.16 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.829 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.52 95.98 1.88 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.535 179.122 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.426 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 61.2 t -93.22 136.45 25.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.977 0.418 . . . . 0.0 111.014 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 49.05 55.98 10.96 Favored Glycine 0 CA--C 1.521 0.411 0 CA-C-N 115.808 -0.633 . . . . 0.0 113.264 179.295 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.829 ' CE2' HD23 ' A' ' 155' ' ' LEU . 2.7 m95 -98.34 151.11 20.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.128 0.489 . . . . 0.0 111.652 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.97 -172.65 0.07 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.349 179.337 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -44.46 155.5 0.09 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.134 0.492 . . . . 0.0 112.143 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.567 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -56.54 -25.14 49.45 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.25 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -60.89 -39.03 87.71 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 120.938 0.399 . . . . 0.0 110.038 179.202 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.424 ' HB1' ' HE2' ' A' ' 187' ' ' TYR . . . -75.36 -40.16 58.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.128 179.045 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.567 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.3 mt -59.0 -43.1 88.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.102 179.157 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.34 -29.69 35.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.35 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -68.14 -53.12 27.51 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.424 0.63 . . . . 0.0 110.189 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.77 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -60.39 -42.3 95.6 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.027 179.064 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.911 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -59.51 -37.47 78.42 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.306 179.252 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.78 -36.67 92.3 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 178.224 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -72.92 -46.86 50.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.424 -0.388 . . . . 0.0 110.945 178.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.573 ' O ' HD22 ' A' ' 174' ' ' LEU . 10.6 mp -65.69 -28.49 69.11 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.75 0.31 . . . . 0.0 111.34 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.31 -17.98 63.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.335 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -112.72 -27.36 8.19 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.65 0.262 . . . . 0.0 111.529 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.573 HD22 ' O ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER -56.88 167.0 1.16 Allowed Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.183 -179.463 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -69.2 127.82 15.61 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.249 1.966 . . . . 0.0 112.721 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.02 -25.85 5.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.81 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.65 -50.0 74.61 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.007 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.855 HG11 ' HB3' ' A' ' 218' ' ' LEU . 22.3 t -74.19 -35.33 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.667 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.661 HD21 ' O ' ' A' ' 121' ' ' ILE . 0.8 OUTLIER -56.37 -34.78 66.98 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.105 0.479 . . . . 0.0 110.091 179.212 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -79.56 -40.27 15.81 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.35 178.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -87.32 103.15 15.2 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.931 0.396 . . . . 0.0 110.745 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' MET . . . . . 0.841 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.8 mtm 178.95 164.66 0.86 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.24 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.33 -60.28 1.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.755 0.312 . . . . 0.0 111.195 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -155.64 142.89 19.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.029 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.89 HG12 HG12 ' A' ' 199' ' ' VAL . 16.7 mt -107.35 115.12 47.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.434 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 186' ' ' HIS . . . . . 0.426 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 20.7 m170 -106.39 135.07 48.53 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.186 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.424 ' HE2' ' HB1' ' A' ' 163' ' ' ALA . 0.3 OUTLIER -86.65 104.35 15.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.269 179.417 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.8 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 . . . . . 0 CA--C 1.53 0.208 0 CA-C-O 120.598 0.237 . . . . 0.0 111.61 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 9.3 p30 -110.09 38.26 2.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.743 0.306 . . . . 0.0 111.047 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.34 117.04 28.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.912 0.387 . . . . 0.0 111.121 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.88 ' O ' HD13 ' A' ' 198' ' ' ILE . 22.0 m -114.45 168.47 6.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.747 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.88 HD13 ' O ' ' A' ' 197' ' ' VAL . 22.7 mm -134.64 113.58 16.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.732 0.301 . . . . 0.0 111.221 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.89 HG12 HG12 ' A' ' 185' ' ' ILE . 10.4 m -104.8 125.91 59.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.09 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -88.72 152.52 21.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.787 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.02 154.88 18.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.761 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -58.03 -27.82 63.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.249 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -82.98 4.24 26.72 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 89.98 14.4 59.32 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 120.476 -0.869 . . . . 0.0 113.244 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -80.1 173.58 12.45 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 117.059 0.429 . . . . 0.0 110.902 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -139.3 111.34 7.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.904 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 19.6 t -115.79 137.36 49.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.924 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 97.7 p -110.77 119.66 39.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.942 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.567 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -130.36 164.21 25.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.71 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.86 153.71 20.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.76 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 33.9 mt -64.3 -36.81 78.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.837 0.351 . . . . 0.0 110.693 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.14 -36.39 81.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.159 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -132.0 46.12 2.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.007 0.432 . . . . 0.0 110.889 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.574 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 11.5 t80 -67.53 -51.71 47.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.785 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.15 -41.05 87.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.146 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -68.25 -49.85 57.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.148 0.499 . . . . 0.0 110.268 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 1.5 mmpt? -52.28 -41.81 63.19 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.102 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.855 ' HB3' HG11 ' A' ' 178' ' ' VAL . 3.8 mm? -86.85 -24.66 24.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.008 179.35 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 13.5 t -60.87 -30.76 70.34 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.829 0.347 . . . . 0.0 110.531 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 58.7 m170 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.25 179.777 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 121.049 0.452 . . . . 0.0 111.071 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.773 ' HB2' HD13 ' A' ' 134' ' ' LEU . 82.1 m95 -68.79 168.0 14.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.106 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -102.68 138.01 40.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.403 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 10.3 mtt180 -73.4 105.59 4.84 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.729 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.922 HD11 HG22 ' A' ' 168' ' ' THR . 45.6 pt -93.49 -9.26 9.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.366 179.244 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.483 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -157.36 176.44 12.68 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 120.599 0.237 . . . . 0.0 110.537 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.467 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 34.0 m-85 -143.9 126.14 15.62 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.588 HG21 ' CD1' ' A' ' 139' ' ' LEU . 3.9 t -93.67 122.91 45.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.058 0.456 . . . . 0.0 111.417 -179.222 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -80.69 94.21 6.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.556 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -145.26 154.13 42.03 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.327 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.2 mmt-85 60.0 29.94 19.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.699 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 61.51 34.75 17.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.968 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.446 HG22 ' N ' ' A' ' 130' ' ' PHE . 83.6 m -154.87 162.04 41.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.818 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.446 ' N ' HG22 ' A' ' 129' ' ' THR . 10.7 m-85 -100.47 90.71 4.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.141 0.496 . . . . 0.0 111.201 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.464 ' HA ' ' HA2' ' A' ' 144' ' ' GLY . 23.1 m-85 -68.9 118.09 57.74 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.391 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.678 ' HB2' HD12 ' A' ' 140' ' ' LEU . 23.1 Cg_exo -64.3 115.35 3.11 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 122.359 2.039 . . . . 0.0 112.594 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.655 HD21 ' OG1' ' A' ' 168' ' ' THR . 30.3 tp -94.17 123.41 37.54 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.358 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.773 HD13 ' HB2' ' A' ' 118' ' ' TRP . 45.5 mt -69.02 173.6 5.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.557 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.404 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.6 pt-20 -64.72 -29.7 70.69 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.14 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -88.14 9.84 21.38 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.19 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.635 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 77.01 20.99 75.03 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.817 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.683 ' HB3' HD12 ' A' ' 134' ' ' LEU . 17.3 tpp180 -79.85 92.39 5.48 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.317 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.588 ' CD1' HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -66.81 119.89 12.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.501 -178.893 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.678 HD12 ' HB2' ' A' ' 132' ' ' PRO . 33.1 mt -88.17 76.49 8.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.306 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.453 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 15.7 mtpt -71.49 -5.86 36.22 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.002 -0.544 . . . . 0.0 112.454 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -94.97 -25.08 16.66 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.606 0.241 . . . . 0.0 111.078 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -87.16 -82.19 0.22 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.294 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.464 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . 59.52 153.84 0.02 OUTLIER Glycine 0 CA--C 1.506 -0.506 0 C-N-CA 121.337 -0.459 . . . . 0.0 112.8 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 10.1 t -137.77 152.35 49.08 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.127 -0.536 . . . . 0.0 110.61 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.31 51.34 1.89 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.566 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.12 147.43 2.57 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.741 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -90.9 125.11 60.08 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.332 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.467 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 71.6 Cg_endo -84.74 107.88 1.17 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.613 2.209 . . . . 0.0 112.659 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 25.8 t -69.52 -8.03 43.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.017 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -77.83 -24.49 48.68 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 120.879 0.371 . . . . 0.0 110.377 179.079 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.68 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -138.85 167.04 20.8 Favored Pre-proline 0 N--CA 1.452 -0.339 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.616 -179.488 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.68 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 70.2 Cg_endo -75.03 157.99 42.32 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.404 2.069 . . . . 0.0 112.572 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 13.6 t -118.97 110.72 30.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.095 0.474 . . . . 0.0 111.028 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.854 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.64 96.05 1.94 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.868 179.439 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.416 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 61.3 t -94.18 137.14 23.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.989 0.423 . . . . 0.0 111.048 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 48.83 57.02 9.03 Favored Glycine 0 C--N 1.332 0.345 0 CA-C-N 115.921 -0.581 . . . . 0.0 113.175 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.854 ' CE2' HD23 ' A' ' 155' ' ' LEU . 3.2 m95 -100.04 151.14 21.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.153 0.501 . . . . 0.0 111.843 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.411 ' HB2' ' CD2' ' A' ' 187' ' ' TYR . 0.0 OUTLIER -66.56 -172.27 0.16 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.438 179.288 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -43.6 154.39 0.09 Allowed 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.566 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.07 -25.63 54.2 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.262 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -60.22 -37.66 80.99 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.984 0.421 . . . . 0.0 110.027 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.14 -40.51 45.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.039 179.008 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.566 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.2 mt -58.73 -41.42 82.4 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.051 179.106 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.24 -29.92 48.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.067 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.462 ' CB ' HG21 ' A' ' 211' ' ' ILE . 5.0 mm-40 -68.26 -53.0 27.63 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 121.387 0.613 . . . . 0.0 110.117 179.378 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.811 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -59.12 -46.3 88.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.036 178.993 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.922 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -57.01 -36.78 70.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.549 179.231 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.75 -37.37 93.47 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 178.316 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -73.64 -45.78 50.71 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.315 -0.443 . . . . 0.0 111.077 179.058 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.574 ' HA ' HD22 ' A' ' 174' ' ' LEU . 11.0 mp -65.0 -29.69 70.62 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.828 0.347 . . . . 0.0 111.338 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.6 -16.99 63.5 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.365 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -114.23 -27.28 7.68 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.658 0.266 . . . . 0.0 111.633 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.574 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER -57.05 167.17 1.18 Allowed Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.269 -179.561 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -70.68 127.79 14.32 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.226 1.95 . . . . 0.0 112.938 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.04 -25.64 5.12 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.723 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.4 -50.17 73.86 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.968 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.867 HG11 ' HB3' ' A' ' 218' ' ' LEU . 34.7 t -74.18 -33.5 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.49 179.446 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.516 HD13 HD21 ' A' ' 174' ' ' LEU . 11.4 tp -56.46 -36.88 69.55 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.096 0.474 . . . . 0.0 109.935 179.076 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -77.36 -41.65 20.49 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.284 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -84.32 103.0 13.13 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.896 0.379 . . . . 0.0 110.558 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' MET . . . . . 0.84 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.8 mtm 177.02 166.11 0.53 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.142 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 27.3 t -124.82 -53.99 1.64 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.732 0.301 . . . . 0.0 111.147 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -162.14 142.63 10.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.977 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.925 HG12 HG12 ' A' ' 199' ' ' VAL . 19.1 mt -104.89 115.44 46.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.472 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 186' ' ' HIS . . . . . 0.416 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 21.9 m170 -105.37 123.36 47.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.159 -179.525 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.411 ' CD2' ' HB2' ' A' ' 159' ' ' LYS . 14.0 t80 -78.82 104.35 9.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.438 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.406 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.584 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 . . . . . 0 CA--C 1.529 0.153 0 CA-C-O 120.617 0.246 . . . . 0.0 111.499 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 5.8 p30 -108.17 37.71 2.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.731 0.301 . . . . 0.0 110.819 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 9.5 ttt-85 -89.76 114.32 26.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.911 0.386 . . . . 0.0 111.2 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.852 ' O ' HD13 ' A' ' 198' ' ' ILE . 25.1 m -111.61 167.85 5.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.9 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.852 HD13 ' O ' ' A' ' 197' ' ' VAL . 22.7 mm -134.24 111.34 14.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.844 0.354 . . . . 0.0 110.974 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.925 HG12 HG12 ' A' ' 185' ' ' ILE . 6.7 m -100.31 120.15 49.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.21 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -81.88 152.46 26.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.661 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 7.6 mmt -105.6 157.89 17.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.99 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 39.5 m-20 -59.82 -27.03 66.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.142 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.02 13.27 13.33 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 89.1 -14.07 61.64 Favored Glycine 0 CA--C 1.52 0.397 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.247 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -58.13 156.03 10.24 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 117.133 0.467 . . . . 0.0 110.96 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -131.3 111.31 11.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.919 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 20.8 t -107.03 141.92 21.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.04 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 5.6 m -112.41 116.87 31.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.883 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.607 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -128.58 162.48 27.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.804 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.7 154.91 17.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.584 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.462 HG21 ' CB ' ' A' ' 166' ' ' GLU . 40.5 mt -67.3 -35.7 74.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.804 0.335 . . . . 0.0 110.96 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -38.4 91.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.24 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -128.09 40.64 3.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.914 0.388 . . . . 0.0 110.892 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.572 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 11.1 t80 -62.56 -54.35 41.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.768 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.1 -41.38 78.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.276 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.62 -46.58 68.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.075 0.464 . . . . 0.0 110.421 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.6 -44.75 77.29 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.883 179.611 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.867 ' HB3' HG11 ' A' ' 178' ' ' VAL . 3.9 mm? -83.31 -25.05 31.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.037 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 13.0 t -60.97 -33.14 72.76 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.062 0.458 . . . . 0.0 110.131 179.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 9.6 m170 . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.268 179.181 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 121.005 0.431 . . . . 0.0 111.047 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.759 ' HB2' HD13 ' A' ' 134' ' ' LEU . 80.6 m95 -68.42 168.3 12.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.237 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 11.4 ttt180 -102.49 137.66 40.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.348 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 24.8 mtt85 -72.91 106.48 4.84 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.861 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.9 HD11 HG22 ' A' ' 168' ' ' THR . 46.6 pt -95.61 -8.1 9.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.361 179.278 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.475 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -158.75 176.45 12.34 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 120.578 0.228 . . . . 0.0 110.708 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.465 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 29.8 m-85 -144.94 126.45 15.01 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.688 HG21 HD11 ' A' ' 139' ' ' LEU . 4.3 t -93.08 122.61 44.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.091 0.472 . . . . 0.0 111.267 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.472 ' CE1' ' CE1' ' A' ' 130' ' ' PHE . 9.3 t80 -83.96 100.01 10.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.842 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -151.76 151.8 31.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.601 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 60.0 30.88 20.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 63.4 32.41 14.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.2 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.573 HG23 ' O ' ' A' ' 145' ' ' THR . 87.8 m -152.89 149.02 27.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.828 0.347 . . . . 0.0 110.988 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.755 ' CE2' ' HB2' ' A' ' 148' ' ' ALA . 24.2 m-85 -93.69 91.0 6.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.713 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.565 ' HB2' HD21 ' A' ' 139' ' ' LEU . 24.7 m-85 -66.05 120.79 72.27 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.141 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -68.12 115.5 3.86 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.045 1.83 . . . . 0.0 112.539 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.661 HD21 ' OG1' ' A' ' 168' ' ' THR . 34.1 tp -95.0 124.2 38.91 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.787 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.759 HD13 ' HB2' ' A' ' 118' ' ' TRP . 42.5 mt -69.89 175.47 4.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.5 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.41 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.3 pt-20 -66.52 -28.41 68.53 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.125 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 32.7 p-10 -90.47 13.21 16.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.235 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.615 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 73.79 20.15 79.76 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.978 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.69 ' HB3' HD12 ' A' ' 134' ' ' LEU . 0.7 OUTLIER -79.04 94.14 5.25 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.326 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.688 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -70.45 116.37 10.7 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.652 -178.875 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.474 HD23 ' HG3' ' A' ' 143' ' ' GLU . 10.4 mp -90.35 76.25 6.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.343 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.478 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 4.5 mttt -61.46 -15.46 37.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.241 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -94.38 -24.11 17.5 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.474 ' HG3' HD23 ' A' ' 140' ' ' LEU . 68.7 mm-40 -99.81 26.82 5.91 Favored 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.428 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . -62.95 163.66 29.13 Favored Glycine 0 CA--C 1.51 -0.222 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.885 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.573 ' O ' HG23 ' A' ' 129' ' ' THR . 7.1 t -130.79 158.2 40.8 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.877 0.37 . . . . 0.0 110.712 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -94.42 49.32 1.27 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.513 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.3 154.64 4.0 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.609 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.755 ' HB2' ' CE2' ' A' ' 130' ' ' PHE . . . -97.64 125.53 44.43 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.24 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.465 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 73.7 Cg_endo -83.06 111.9 1.96 Allowed 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.4 2.066 . . . . 0.0 112.573 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 11.0 t -69.48 -8.14 44.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.175 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -77.11 -23.54 51.81 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 120.88 0.372 . . . . 0.0 110.507 179.023 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.672 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -138.97 166.92 21.43 Favored Pre-proline 0 N--CA 1.452 -0.336 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.669 -179.328 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.672 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 67.7 Cg_endo -74.83 154.33 43.32 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.401 2.067 . . . . 0.0 112.308 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 10.6 t -116.04 110.48 31.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.93 0.395 . . . . 0.0 111.293 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.849 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.36 95.94 1.81 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.552 179.025 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.415 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 60.1 t -91.98 136.12 25.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.946 0.403 . . . . 0.0 111.116 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 48.83 58.75 7.34 Favored Glycine 0 CA--C 1.521 0.468 0 CA-C-N 115.837 -0.619 . . . . 0.0 113.189 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.849 ' CE2' HD23 ' A' ' 155' ' ' LEU . 3.1 m95 -101.31 151.17 22.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.198 0.523 . . . . 0.0 111.834 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.42 -172.24 0.15 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.412 179.394 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -42.92 154.49 0.07 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.532 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.51 -25.84 55.86 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.157 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.97 -38.85 80.05 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.967 0.413 . . . . 0.0 109.943 179.191 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.64 -39.98 50.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.009 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.532 HD12 ' HA2' ' A' ' 161' ' ' GLY . 5.8 mt -59.28 -41.39 83.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.903 178.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.9 -31.06 48.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.129 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.419 ' HB3' HG21 ' A' ' 211' ' ' ILE . 2.6 mm-40 -67.8 -53.02 30.37 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.386 0.613 . . . . 0.0 110.138 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.82 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -59.24 -44.56 92.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.01 179.095 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.9 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -58.42 -37.55 75.61 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.545 179.106 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.89 -36.86 91.48 Favored Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 178.298 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -73.83 -46.33 45.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.342 -0.429 . . . . 0.0 111.008 178.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.592 ' HA ' HD22 ' A' ' 174' ' ' LEU . 11.3 mp -66.22 -28.01 68.41 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.683 0.278 . . . . 0.0 111.349 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.87 -17.22 62.73 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.682 -0.236 . . . . 0.0 111.291 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -112.62 -29.85 7.31 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.653 0.263 . . . . 0.0 111.345 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.592 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER -55.44 167.32 0.76 Allowed Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.216 -179.651 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.416 ' HG2' HG23 ' A' ' 178' ' ' VAL . 47.9 Cg_endo -69.63 128.78 16.63 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.208 1.939 . . . . 0.0 112.921 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.28 -25.63 9.95 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.535 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -58.82 -48.59 80.78 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.894 0.378 . . . . 0.0 110.927 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.873 HG11 ' HB3' ' A' ' 218' ' ' LEU . 23.0 t -73.51 -35.69 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.649 179.58 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.432 ' HB2' HD21 ' A' ' 174' ' ' LEU . 4.8 tp -55.85 -34.31 65.33 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.128 0.49 . . . . 0.0 110.075 179.217 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -78.77 -41.9 14.25 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.295 178.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -84.99 102.86 13.52 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.884 0.373 . . . . 0.0 110.632 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' MET . . . . . 0.844 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.8 mtm 177.22 161.81 0.47 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.146 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 12.3 t -117.18 -57.63 2.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.749 0.309 . . . . 0.0 110.908 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -160.91 142.31 11.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.001 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.904 HG12 HG12 ' A' ' 199' ' ' VAL . 16.3 mt -102.1 114.51 41.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.316 179.329 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 186' ' ' HIS . . . . . 0.415 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 21.6 m170 -104.34 122.58 45.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.237 -179.408 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -74.5 104.25 5.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.275 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 11.8 mmtt . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.692 -179.748 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.623 0.249 . . . . 0.0 111.484 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -107.01 36.52 2.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.75 0.31 . . . . 0.0 110.976 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 6.4 ttt85 -89.58 115.03 26.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.979 0.419 . . . . 0.0 111.15 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.839 ' O ' HD13 ' A' ' 198' ' ' ILE . 27.2 m -111.67 166.68 5.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.729 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.839 HD13 ' O ' ' A' ' 197' ' ' VAL . 22.7 mm -133.52 108.9 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.821 0.343 . . . . 0.0 111.222 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.904 HG12 HG12 ' A' ' 185' ' ' ILE . 9.1 m -99.08 122.65 51.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.088 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -85.14 152.48 23.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.761 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 4.7 mmt -104.97 158.88 16.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.017 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -63.22 -26.64 68.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.13 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -87.09 11.16 14.5 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 83.65 14.51 73.06 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.539 -0.838 . . . . 0.0 113.281 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -82.14 166.83 19.33 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 117.073 0.437 . . . . 0.0 110.845 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -133.72 111.67 10.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.879 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.416 ' HB ' HG23 ' A' ' 199' ' ' VAL . 21.4 t -114.63 125.26 71.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.131 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 208' ' ' SER . . . . . 0.557 ' HB3' HD12 ' A' ' 198' ' ' ILE . 2.0 p -101.18 116.1 32.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.76 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.664 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -126.87 159.89 32.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.872 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.47 152.52 19.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.687 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.419 HG21 ' HB3' ' A' ' 166' ' ' GLU . 35.2 mt -64.37 -38.29 82.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.95 0.405 . . . . 0.0 110.642 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 2.2 ptt85 -60.01 -34.61 73.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.205 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -134.77 45.5 2.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.933 0.397 . . . . 0.0 111.034 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.6 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 10.9 t80 -67.75 -53.9 23.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.712 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.2 -39.81 76.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.264 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.99 -48.84 62.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.101 0.477 . . . . 0.0 110.284 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.27 -42.51 66.59 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.14 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.873 ' HB3' HG11 ' A' ' 178' ' ' VAL . 3.9 mm? -86.95 -23.48 25.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.042 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 11.2 t -60.99 -33.15 72.79 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.901 0.381 . . . . 0.0 110.22 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 30.2 m170 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.204 179.394 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 121.066 0.46 . . . . 0.0 110.997 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.763 ' HB2' HD13 ' A' ' 134' ' ' LEU . 78.8 m95 -67.3 168.09 11.18 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.06 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? -103.05 138.77 39.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.287 179.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.26 105.73 4.79 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 120.822 0.344 . . . . 0.0 110.669 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.867 HD11 HG22 ' A' ' 168' ' ' THR . 46.6 pt -95.04 -7.55 9.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.501 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.526 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -160.15 176.36 11.86 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 120.766 0.317 . . . . 0.0 110.946 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.471 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 35.7 m-85 -144.98 126.93 15.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.821 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.516 HG21 HD11 ' A' ' 139' ' ' LEU . 6.1 t -93.21 122.91 45.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.155 0.503 . . . . 0.0 111.587 -179.044 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.437 ' CE1' ' CE1' ' A' ' 130' ' ' PHE . 34.7 t80 -83.11 94.38 7.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.916 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -144.76 152.97 41.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.437 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.86 30.32 19.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.812 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 62.13 34.25 16.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.934 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.454 HG22 ' N ' ' A' ' 130' ' ' PHE . 58.5 m -151.04 161.93 41.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.993 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.641 ' CE2' ' HB2' ' A' ' 148' ' ' ALA . 16.8 m-85 -104.61 91.14 3.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.256 0.551 . . . . 0.0 110.897 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.489 ' HB2' HD21 ' A' ' 139' ' ' LEU . 23.8 m-85 -69.62 121.55 82.81 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.547 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.436 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 21.1 Cg_exo -65.2 122.16 9.82 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 122.374 2.05 . . . . 0.0 112.549 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.697 HD21 ' OG1' ' A' ' 168' ' ' THR . 31.0 tp -104.12 123.48 47.34 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.296 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.763 HD13 ' HB2' ' A' ' 118' ' ' TRP . 53.6 mt -71.58 174.92 6.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.582 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.421 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.3 pt-20 -64.93 -29.06 69.97 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.915 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 14.9 p-10 -91.17 13.66 16.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.152 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.638 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 74.95 22.52 76.7 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.059 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.674 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -76.0 92.76 3.18 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.412 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.516 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -70.64 119.86 15.41 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.023 0.439 . . . . 0.0 111.607 -179.083 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.421 HD12 ' HG2' ' A' ' 143' ' ' GLU . 4.0 mm? -92.24 72.91 5.38 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.711 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.467 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 0.4 OUTLIER -61.05 -16.84 48.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.012 -179.753 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -95.52 -20.0 19.37 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.421 ' HG2' HD12 ' A' ' 140' ' ' LEU . 39.9 mm-40 -102.23 25.7 8.57 Favored 'General case' 0 N--CA 1.461 0.111 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.436 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -58.43 162.6 10.29 Favored Glycine 0 CA--C 1.509 -0.337 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.708 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 11.1 t -136.33 150.83 49.04 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.767 0.317 . . . . 0.0 110.67 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.438 ' HE2' HG23 ' A' ' 129' ' ' THR . 3.9 mmtt -88.99 52.19 2.35 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.005 0.431 . . . . 0.0 110.705 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.23 149.46 2.81 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.658 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.641 ' HB2' ' CE2' ' A' ' 130' ' ' PHE . . . -94.6 125.66 50.7 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.324 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.471 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 75.2 Cg_endo -84.24 111.26 1.58 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.49 2.126 . . . . 0.0 112.638 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.3 t -69.91 -7.53 41.16 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.035 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -77.09 -23.2 51.9 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 120.806 0.336 . . . . 0.0 110.58 179.009 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.681 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -140.47 167.11 18.96 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.944 -179.246 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.681 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 62.7 Cg_endo -74.48 154.33 45.1 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.351 2.034 . . . . 0.0 112.133 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 14.3 t -115.47 111.12 34.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.019 0.437 . . . . 0.0 111.286 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.807 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.36 96.11 1.83 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.747 179.052 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.436 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 62.6 t -92.74 135.78 26.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.901 0.382 . . . . 0.0 110.936 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 48.77 58.28 7.75 Favored Glycine 0 CA--C 1.521 0.443 0 CA-C-N 115.963 -0.562 . . . . 0.0 113.209 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.807 ' CE2' HD23 ' A' ' 155' ' ' LEU . 3.0 m95 -101.13 151.3 22.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.206 0.526 . . . . 0.0 111.787 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -65.49 -173.34 0.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.319 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -43.81 154.88 0.09 Allowed 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.552 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.26 -25.13 53.86 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.134 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -59.95 -38.52 82.69 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.921 0.391 . . . . 0.0 110.107 179.297 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.89 -41.02 45.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.056 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.552 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.1 mt -58.08 -41.89 81.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.016 179.222 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.87 -30.54 46.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.228 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -68.74 -53.02 24.48 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 121.548 0.689 . . . . 0.0 110.026 179.386 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.766 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -60.11 -42.94 95.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.947 178.958 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.867 HG22 HD11 ' A' ' 121' ' ' ILE . 0.3 OUTLIER -59.51 -37.01 77.16 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.296 179.22 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.17 -39.52 94.59 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 110.556 -1.017 . . . . 0.0 110.556 178.338 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 48.1 mm-40 -69.72 -45.73 67.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.427 -0.387 . . . . 0.0 110.782 178.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.611 ' HA ' HD22 ' A' ' 174' ' ' LEU . 11.0 mp -66.58 -26.94 67.35 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.695 0.284 . . . . 0.0 111.462 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.98 -19.12 62.57 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.223 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -112.63 -26.67 8.52 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.573 0.225 . . . . 0.0 111.505 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.611 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER -57.55 167.4 1.34 Allowed Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.089 -179.754 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -70.66 127.9 14.48 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.201 1.934 . . . . 0.0 112.943 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.08 -25.28 8.34 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.597 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.44 -49.33 76.6 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.856 0.36 . . . . 0.0 110.944 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.866 HG11 ' HB3' ' A' ' 218' ' ' LEU . 39.9 t -74.24 -36.11 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.451 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.493 ' HB2' HD21 ' A' ' 174' ' ' LEU . 12.7 tp -55.13 -37.01 66.37 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.09 0.472 . . . . 0.0 110.11 179.209 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -78.39 -39.09 23.44 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.393 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -87.29 103.04 15.08 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.9 0.381 . . . . 0.0 110.73 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' MET . . . . . 0.834 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.8 mtm 178.05 176.61 0.44 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.053 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 9.1 t -132.07 -54.77 0.98 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.783 0.325 . . . . 0.0 111.129 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -162.17 142.52 10.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.021 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.89 HG12 HG12 ' A' ' 199' ' ' VAL . 19.7 mt -104.76 114.69 45.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.34 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 186' ' ' HIS . . . . . 0.436 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 20.0 m170 -106.21 126.28 52.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.079 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -77.39 104.83 8.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.517 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 11.8 mmtp . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.351 179.733 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 . . . . . 0 CA--C 1.53 0.197 0 CA-C-O 120.571 0.224 . . . . 0.0 111.376 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -104.11 35.88 2.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.749 0.309 . . . . 0.0 110.881 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -89.95 113.15 24.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.044 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.875 ' O ' HD13 ' A' ' 198' ' ' ILE . 19.7 m -109.8 168.31 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.88 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.875 HD13 ' O ' ' A' ' 197' ' ' VAL . 22.8 mm -135.14 110.54 12.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.708 0.29 . . . . 0.0 111.242 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.89 HG12 HG12 ' A' ' 185' ' ' ILE . 10.6 m -99.09 133.97 39.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.963 0.411 . . . . 0.0 110.878 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -95.98 152.5 18.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.765 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 25.2 tpp -112.28 150.61 30.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.745 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 21.1 p30 -57.47 -28.93 63.81 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.28 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -72.69 -8.78 57.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.768 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 96.73 14.55 43.07 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 120.473 -0.87 . . . . 0.0 113.1 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -90.82 162.55 14.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 117.026 0.413 . . . . 0.0 111.018 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -126.85 111.26 13.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.809 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 20.6 t -109.36 137.52 41.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.067 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 10.7 p -109.58 118.66 37.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.967 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -127.07 172.54 10.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.679 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.33 154.5 27.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.609 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 31.9 mt -66.01 -35.45 75.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.812 0.339 . . . . 0.0 110.938 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.7 -35.63 81.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.194 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -134.83 47.53 2.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.016 0.436 . . . . 0.0 111.005 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.583 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 10.5 t80 -69.35 -50.81 42.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.613 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.97 -42.22 84.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.256 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -67.37 -47.68 69.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.986 0.422 . . . . 0.0 110.397 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.9 -45.34 74.69 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.09 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.866 ' HB3' HG11 ' A' ' 178' ' ' VAL . 4.4 mm? -82.12 -26.25 33.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.979 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 13.5 t -60.38 -32.46 71.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.002 0.429 . . . . 0.0 110.217 179.288 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.9 m170 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.118 179.255 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 121.107 0.479 . . . . 0.0 110.935 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.731 ' HB2' HD13 ' A' ' 134' ' ' LEU . 79.5 m95 -67.11 168.27 10.5 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.068 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -102.79 135.41 44.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.466 179.449 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 15.0 mtt180 -71.42 105.49 3.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.743 -179.906 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.91 HD11 HG22 ' A' ' 168' ' ' THR . 45.3 pt -93.53 -8.31 10.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.503 179.455 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -159.16 176.53 12.12 Favored 'General case' 0 C--O 1.226 -0.178 0 C-N-CA 121.037 -0.265 . . . . 0.0 111.0 179.885 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.464 ' O ' ' HA ' ' A' ' 154' ' ' VAL . 32.3 m-85 -143.28 126.8 16.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.455 179.78 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.638 HG21 HD11 ' A' ' 139' ' ' LEU . 4.5 t -93.47 123.01 45.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.05 0.453 . . . . 0.0 111.133 -179.607 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.428 ' CD1' ' CE1' ' A' ' 130' ' ' PHE . 37.3 t80 -80.19 103.02 9.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.748 -179.889 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -159.18 155.44 27.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.559 -179.808 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.19 31.61 19.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.849 -179.851 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 60.41 31.38 20.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.0 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.45 HG23 ' HE2' ' A' ' 146' ' ' LYS . 86.3 m -154.05 161.87 41.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.846 179.929 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.446 ' N ' HG22 ' A' ' 129' ' ' THR . 8.9 m-85 -100.65 90.4 4.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.669 179.625 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.502 ' HA ' ' HA2' ' A' ' 144' ' ' GLY . 22.3 m-85 -65.41 125.44 89.52 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.811 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.4 ' HB3' ' CE2' ' A' ' 123' ' ' TYR . 60.9 Cg_endo -73.66 120.17 6.3 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.219 1.946 . . . . 0.0 112.372 -179.773 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.676 HD21 ' OG1' ' A' ' 168' ' ' THR . 27.4 tp -98.04 123.58 42.13 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.489 179.636 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.731 HD13 ' HB2' ' A' ' 118' ' ' TRP . 37.0 mt -69.63 172.68 7.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.464 -179.747 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -63.81 -28.32 69.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.998 179.706 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 50.5 p-10 -90.59 13.43 15.93 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.281 179.781 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.599 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 73.1 22.36 79.07 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.227 179.797 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.66 ' HB3' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -81.01 94.44 6.56 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.519 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.638 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -73.42 112.49 9.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.362 -179.04 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 34.3 mt -88.84 81.25 6.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.405 179.418 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.456 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 9.6 mtpt -71.13 -5.61 33.03 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -179.388 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -90.41 -27.14 19.51 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.635 0.255 . . . . 0.0 111.183 179.885 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -85.81 -79.98 0.23 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.76 0.314 . . . . 0.0 111.322 -179.707 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.502 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . 57.83 161.13 0.04 OUTLIER Glycine 0 CA--C 1.506 -0.514 0 CA-C-N 116.29 -0.413 . . . . 0.0 112.708 -179.572 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.9 t -140.07 148.67 42.11 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.357 -0.422 . . . . 0.0 110.842 -179.548 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.45 ' HE2' HG23 ' A' ' 129' ' ' THR . 4.0 mmtt -89.85 52.56 2.32 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.381 179.807 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.98 154.48 4.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.093 0.473 . . . . 0.0 110.613 -179.358 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.33 135.41 34.63 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.597 -179.493 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.45 ' HD2' ' CG2' ' A' ' 154' ' ' VAL . 67.1 Cg_endo -83.81 98.73 0.79 Allowed 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 122.993 2.462 . . . . 0.0 112.535 179.689 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 43.9 t -67.23 -9.57 41.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.786 179.468 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -90.15 -22.2 21.85 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 120.615 0.245 . . . . 0.0 111.572 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.723 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -138.9 167.75 18.16 Favored Pre-proline 0 C--N 1.329 -0.287 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -178.997 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.723 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 64.7 Cg_endo -74.22 163.97 35.29 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 122.469 2.113 . . . . 0.0 112.511 -179.863 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 20.1 t -123.73 109.05 22.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.517 -179.755 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.826 HD21 ' SD ' ' A' ' 167' ' ' MET . 1.1 mp -72.8 95.97 1.99 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.694 179.107 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 53.5 t -92.57 136.46 24.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.983 0.421 . . . . 0.0 111.231 -179.904 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 49.21 49.17 31.55 Favored Glycine 0 CA--C 1.519 0.299 0 CA-C-N 115.783 -0.644 . . . . 0.0 113.381 179.16 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.823 ' CE2' HD23 ' A' ' 155' ' ' LEU . 2.7 m95 -92.2 151.1 20.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.102 0.477 . . . . 0.0 111.371 -179.622 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -172.55 0.08 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.539 179.542 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -43.99 154.34 0.11 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.088 -0.506 . . . . 0.0 112.21 -179.846 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.534 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.41 -24.75 53.19 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.147 179.448 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.8 -39.23 84.31 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-O 120.959 0.409 . . . . 0.0 110.137 179.219 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.65 -40.84 47.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.054 178.996 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.534 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.2 mt -58.13 -41.68 81.28 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.093 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.991 179.104 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.21 -28.69 28.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.151 179.494 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -69.15 -53.23 21.19 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-O 121.474 0.654 . . . . 0.0 110.172 179.348 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.826 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -59.84 -45.11 93.45 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.11 179.051 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.91 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -56.84 -38.82 73.19 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.592 179.344 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.14 -37.73 92.12 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 178.26 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -72.03 -46.47 56.97 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.375 -0.412 . . . . 0.0 111.073 178.822 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.595 ' HA ' HD22 ' A' ' 174' ' ' LEU . 10.9 mp -65.88 -28.73 69.17 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.724 0.297 . . . . 0.0 111.414 179.785 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.82 -18.12 63.43 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.363 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -113.8 -26.79 8.03 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 111.661 0.245 . . . . 0.0 111.661 -179.73 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.595 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER -57.32 167.27 1.28 Allowed Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 116.682 -0.236 . . . . 0.0 111.22 -179.561 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -67.68 126.32 14.56 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.215 1.943 . . . . 0.0 112.796 179.74 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.92 -26.07 9.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.676 179.805 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -58.5 -48.83 79.52 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.873 0.368 . . . . 0.0 110.891 179.683 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.851 HG11 ' HB3' ' A' ' 218' ' ' LEU . 25.3 t -73.7 -33.7 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.531 179.515 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.401 ' HB2' HD21 ' A' ' 174' ' ' LEU . 11.4 tp -56.87 -35.78 69.3 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.135 0.493 . . . . 0.0 109.816 178.988 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -77.05 -42.39 19.83 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.276 178.74 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -84.13 103.02 13.0 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.829 0.347 . . . . 0.0 110.656 179.232 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 182' ' ' MET . . . . . 0.85 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.9 mtm 178.85 159.76 0.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.123 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -118.36 -54.53 2.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.814 0.34 . . . . 0.0 111.122 -179.743 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -162.66 142.63 9.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.999 -179.834 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.912 HG12 HG12 ' A' ' 199' ' ' VAL . 17.7 mt -105.23 115.04 46.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.422 179.4 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 23.2 m170 -105.69 129.37 53.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.164 -179.499 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -82.2 104.54 12.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.521 179.663 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.65 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.529 0.149 0 CA-C-O 120.861 0.362 . . . . 0.0 111.101 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 195' ' ' ASP . . . . . 0.592 ' OD1' HG22 ' A' ' 210' ' ' THR . 1.8 p30 -99.86 34.03 2.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.612 179.787 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.48 111.64 22.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.422 -179.491 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.869 ' O ' HD13 ' A' ' 198' ' ' ILE . 33.3 m -107.78 169.46 2.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.495 179.384 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.869 HD13 ' O ' ' A' ' 197' ' ' VAL . 15.1 mm -136.03 109.67 9.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.785 0.326 . . . . 0.0 111.2 179.888 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.912 HG12 HG12 ' A' ' 185' ' ' ILE . 9.9 m -97.85 120.9 47.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.081 179.727 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -81.76 152.65 26.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.788 -179.984 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 4.6 mmt -109.44 146.93 33.7 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.604 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -58.13 -29.07 65.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.073 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -78.21 -2.17 36.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.836 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 95.3 14.49 47.91 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 120.478 -0.867 . . . . 0.0 113.142 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -89.51 157.14 18.21 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.972 0.386 . . . . 0.0 111.04 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -125.84 111.54 14.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.724 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 22.8 t -110.77 139.59 33.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.139 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 208' ' ' SER . . . . . 0.587 ' OG ' HD12 ' A' ' 198' ' ' ILE . 14.5 m -110.36 118.33 36.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.737 179.869 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.51 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -128.42 164.57 22.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.888 0.375 . . . . 0.0 111.067 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.592 HG22 ' OD1' ' A' ' 195' ' ' ASP . 0.6 OUTLIER -103.67 155.38 18.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.507 179.842 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 25.7 mt -62.91 -27.48 43.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.008 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 212' ' ' ARG . . . . . 0.405 ' CZ ' ' HB3' ' A' ' 212' ' ' ARG . 0.0 OUTLIER -82.48 -41.9 19.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.742 0.306 . . . . 0.0 111.009 179.877 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -108.78 32.12 5.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.121 -179.931 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.558 ' CE1' HD11 ' A' ' 171' ' ' LEU . 11.3 t80 -64.25 -54.59 30.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.94 0.4 . . . . 0.0 110.284 179.737 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.71 -38.36 90.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.611 179.685 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -68.32 -51.95 39.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.436 179.53 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 1.8 mmmm -54.33 -43.02 70.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.951 179.819 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.851 ' HB3' HG11 ' A' ' 178' ' ' VAL . 4.1 mm? -82.32 -24.96 34.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.769 179.3 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 10.2 t -61.75 -31.74 71.94 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.851 0.357 . . . . 0.0 110.191 179.26 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.068 179.596 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 121.176 0.512 . . . . 0.0 111.103 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.762 ' HB2' HD13 ' A' ' 134' ' ' LEU . 78.8 m95 -72.21 168.2 18.75 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.955 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -102.75 136.1 43.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.542 179.559 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 73.4 mtt180 -71.69 105.87 3.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.833 0.349 . . . . 0.0 110.669 -179.875 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.898 HD11 HG22 ' A' ' 168' ' ' THR . 45.9 pt -94.06 -8.82 9.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.472 179.31 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -158.62 176.36 12.49 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 120.629 0.252 . . . . 0.0 110.76 179.926 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.457 ' O ' ' HA ' ' A' ' 154' ' ' VAL . 32.2 m-85 -143.07 127.0 17.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.378 179.771 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.618 HG21 HD11 ' A' ' 139' ' ' LEU . 5.3 t -93.51 122.79 45.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.32 -179.464 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.432 ' CD1' ' CE1' ' A' ' 130' ' ' PHE . 42.4 t80 -80.67 107.1 13.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.844 -179.943 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -163.47 154.24 16.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.521 -179.866 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.54 30.59 19.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.865 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 61.82 32.28 18.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.15 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 73.3 m -154.98 155.29 33.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.036 179.841 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.432 ' CE1' ' CD1' ' A' ' 125' ' ' TYR . 7.0 m-85 -96.26 91.11 5.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.463 179.567 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.496 ' HB2' HD21 ' A' ' 139' ' ' LEU . 24.2 m-85 -65.52 123.98 85.98 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.964 -179.626 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.407 ' HB3' ' CE2' ' A' ' 123' ' ' TYR . 55.4 Cg_endo -71.53 114.62 4.0 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 122.171 1.914 . . . . 0.0 112.743 -179.552 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.704 HD21 ' OG1' ' A' ' 168' ' ' THR . 29.0 tp -93.36 123.83 36.93 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.632 179.453 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.762 HD13 ' HB2' ' A' ' 118' ' ' TRP . 45.0 mt -69.51 173.66 5.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.47 -179.851 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.401 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 2.1 pt-20 -64.71 -28.35 69.53 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.118 179.751 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 42.7 p-10 -90.33 12.58 17.85 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.301 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.598 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 74.08 22.74 77.48 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.987 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.682 ' HB3' HD12 ' A' ' 134' ' ' LEU . 15.1 tpp85 -82.14 93.42 7.04 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.539 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.618 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -69.51 108.76 3.92 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.155 -179.212 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 15.8 mt -85.53 72.03 10.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.821 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.445 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 19.7 mttt -57.96 -20.85 40.97 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.45 179.873 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -94.09 19.74 8.82 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.42 179.578 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -144.49 25.32 1.51 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.655 0.264 . . . . 0.0 111.151 179.781 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . -58.98 166.69 7.59 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.88 -179.683 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 10.2 t -132.41 150.44 52.16 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.873 0.368 . . . . 0.0 110.751 -179.878 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.02 52.1 2.08 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.436 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.72 158.47 6.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.094 0.473 . . . . 0.0 110.678 -179.399 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -91.2 136.13 27.55 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.61 -179.504 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.448 ' HD2' ' CG2' ' A' ' 154' ' ' VAL . 62.9 Cg_endo -84.09 98.57 0.76 Allowed 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.11 2.54 . . . . 0.0 112.621 179.78 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 4.9 t -67.36 -9.66 43.51 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.713 179.363 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -90.21 -21.8 21.98 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.698 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -138.78 167.09 20.7 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.019 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.698 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 60.2 Cg_endo -73.76 163.55 36.91 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 122.5 2.134 . . . . 0.0 112.382 179.986 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 25.2 t -124.09 109.89 24.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.051 0.453 . . . . 0.0 111.591 -179.798 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.858 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.6 96.18 1.94 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.836 179.228 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.427 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 57.4 t -92.33 137.31 22.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.055 -179.928 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 47.5 56.96 7.76 Favored Glycine 0 CA--C 1.52 0.393 0 CA-C-N 115.855 -0.611 . . . . 0.0 113.231 179.371 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.858 ' CE2' HD23 ' A' ' 155' ' ' LEU . 2.9 m95 -99.44 151.16 21.42 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.185 0.516 . . . . 0.0 111.756 -179.386 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.66 -172.1 0.16 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.509 179.377 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -42.58 154.29 0.06 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.68 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.533 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.15 -24.68 52.04 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.232 179.491 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.05 -40.54 89.8 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-O 120.975 0.417 . . . . 0.0 110.041 179.193 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -74.25 -40.66 62.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.935 178.88 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.533 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.1 mt -58.92 -41.06 81.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.931 178.885 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.73 -31.0 57.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.25 179.881 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.418 ' CB ' HG21 ' A' ' 211' ' ' ILE . 5.4 mm-40 -67.63 -52.97 31.95 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-O 121.434 0.635 . . . . 0.0 110.245 179.571 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.819 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -59.45 -44.28 92.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.175 179.151 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.898 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -58.85 -38.16 78.11 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.534 179.271 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.37 -37.35 91.84 Favored Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 178.493 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 40.8 mm-40 -73.4 -45.71 53.06 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.403 -0.399 . . . . 0.0 111.199 179.035 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.573 ' HA ' HD22 ' A' ' 174' ' ' LEU . 11.0 mp -65.8 -29.55 70.05 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.688 0.28 . . . . 0.0 111.295 179.836 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.4 -19.98 64.64 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.335 -179.994 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -111.61 -26.75 8.87 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.613 0.244 . . . . 0.0 111.511 -179.834 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.573 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.1 OUTLIER -56.72 166.53 1.29 Allowed Pre-proline 0 CA--C 1.538 0.516 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.06 -179.665 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -69.7 128.07 15.55 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.269 1.979 . . . . 0.0 112.692 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.97 -25.9 5.29 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.676 179.802 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.76 -50.06 74.51 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.844 0.354 . . . . 0.0 111.037 179.701 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.868 HG11 ' HB3' ' A' ' 218' ' ' LEU . 30.1 t -74.11 -35.61 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.582 179.638 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.544 HD23 ' HD3' ' A' ' 153' ' ' PRO . 0.5 OUTLIER -56.98 -34.35 68.01 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.108 0.48 . . . . 0.0 109.772 179.002 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -78.48 -38.86 23.73 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 178.578 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -88.35 103.17 15.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.947 0.403 . . . . 0.0 110.774 179.229 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 182' ' ' MET . . . . . 0.838 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.9 mtm 178.73 166.72 0.88 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.987 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.4 t -127.04 -51.48 1.43 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.706 0.289 . . . . 0.0 111.51 -179.613 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -163.06 142.83 8.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.934 0.397 . . . . 0.0 111.082 -179.668 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.93 HG12 HG12 ' A' ' 199' ' ' VAL . 19.0 mt -108.7 115.14 48.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.54 179.516 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 186' ' ' HIS . . . . . 0.427 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 22.2 m170 -106.14 123.4 47.95 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.952 -179.684 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -76.35 105.38 7.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.617 179.75 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.643 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 CA--C 1.529 0.168 0 N-CA-C 111.641 0.237 . . . . 0.0 111.641 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 195' ' ' ASP . . . . . 0.5 ' OD1' HG22 ' A' ' 210' ' ' THR . 2.4 p30 -110.3 37.45 2.72 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.624 0.249 . . . . 0.0 111.07 -179.812 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.19 117.34 28.87 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.04 0.448 . . . . 0.0 111.255 -179.795 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.878 ' O ' HD13 ' A' ' 198' ' ' ILE . 31.7 m -112.73 169.84 4.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.73 179.655 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.878 HD13 ' O ' ' A' ' 197' ' ' VAL . 22.7 mm -134.61 111.12 13.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.774 0.321 . . . . 0.0 111.356 179.898 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.93 HG12 HG12 ' A' ' 185' ' ' ILE . 10.7 m -100.23 133.58 42.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.877 179.601 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -95.11 152.51 18.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.799 179.954 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 6.5 mmt -105.12 166.74 10.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.937 0.398 . . . . 0.0 111.051 -179.904 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 19.5 p30 -69.37 -26.39 64.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.195 179.884 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -88.48 12.57 14.04 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -179.856 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 83.05 14.34 75.16 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.554 -0.831 . . . . 0.0 113.311 179.718 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -82.98 150.94 26.08 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 117.127 0.463 . . . . 0.0 110.626 179.886 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -121.75 111.43 17.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.889 -179.922 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.6 t -113.03 140.24 34.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.142 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 208' ' ' SER . . . . . 0.575 ' HB2' HD12 ' A' ' 198' ' ' ILE . 26.6 t -113.69 119.43 37.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.783 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.664 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -130.21 159.29 37.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.857 179.803 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.5 HG22 ' OD1' ' A' ' 195' ' ' ASP . 0.6 OUTLIER -92.36 156.56 17.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.68 179.747 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.418 HG21 ' CB ' ' A' ' 166' ' ' GLU . 33.9 mt -70.41 -34.82 59.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.764 0.316 . . . . 0.0 110.749 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.5 -30.89 70.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.215 -179.467 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -130.62 35.85 3.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.898 179.984 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.587 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 11.8 t80 -63.08 -52.7 61.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.801 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.43 -40.22 86.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.062 -179.918 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.21 -49.77 58.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.077 0.465 . . . . 0.0 110.439 179.589 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.23 -43.79 71.16 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.027 179.701 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.868 ' HB3' HG11 ' A' ' 178' ' ' VAL . 4.0 mm? -82.7 -26.32 32.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.97 179.517 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 12.2 t -60.81 -31.61 71.01 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.996 0.427 . . . . 0.0 110.386 179.463 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.27 179.532 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 121.101 0.477 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.741 ' HB2' HD13 ' A' ' 134' ' ' LEU . 81.0 m95 -65.71 168.35 7.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.142 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.43 HH11 HG22 ' A' ' 121' ' ' ILE . 3.6 tmt_? -102.25 135.23 44.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.53 179.536 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 6.6 mtm-85 -71.29 105.28 3.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.673 -179.923 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.86 HD11 HG22 ' A' ' 168' ' ' THR . 46.7 pt -94.19 -6.7 10.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.654 179.518 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -161.14 176.71 11.0 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 121.002 -0.279 . . . . 0.0 111.065 179.823 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.465 ' O ' ' HA ' ' A' ' 154' ' ' VAL . 32.5 m-85 -143.35 127.19 17.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.19 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.58 HG21 HD11 ' A' ' 139' ' ' LEU . 5.1 t -93.26 122.81 45.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.041 0.448 . . . . 0.0 111.344 -179.386 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.43 ' HD2' HG13 ' A' ' 156' ' ' VAL . 33.2 t80 -80.43 109.48 14.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.712 -179.945 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.401 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 4.9 t70 -164.77 148.93 9.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.538 -179.788 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.68 31.69 18.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.895 -179.659 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 61.43 30.27 18.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.972 -179.991 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.529 HG23 ' O ' ' A' ' 145' ' ' THR . 84.7 m -151.09 149.73 29.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.801 179.861 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -94.2 91.75 6.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.53 179.65 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.549 ' HB2' HD21 ' A' ' 139' ' ' LEU . 20.6 m-85 -64.82 117.0 34.28 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.289 -179.41 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -64.12 119.03 5.96 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.172 1.915 . . . . 0.0 112.435 179.981 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.646 HD21 ' OG1' ' A' ' 168' ' ' THR . 38.3 tp -99.79 124.18 44.8 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.802 179.672 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.741 HD13 ' HB2' ' A' ' 118' ' ' TRP . 41.3 mt -70.5 173.39 7.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.647 -179.827 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.405 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.9 pt-20 -64.59 -28.46 69.65 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.03 179.604 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -90.17 12.78 16.92 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.213 179.61 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.642 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 72.5 23.8 77.32 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.755 -0.736 . . . . 0.0 113.048 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.674 ' HB3' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -81.76 96.88 7.71 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.385 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.58 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -72.48 121.26 19.31 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.664 -178.93 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -98.39 72.24 2.08 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.678 179.385 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.459 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 21.6 mttt -57.83 -20.16 33.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.69 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -88.24 -24.43 23.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.564 -180.0 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -102.07 25.61 8.58 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.846 0.314 . . . . 0.0 111.846 -179.566 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . -58.95 164.91 8.92 Favored Glycine 0 CA--C 1.509 -0.292 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.757 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.529 ' O ' HG23 ' A' ' 129' ' ' THR . 9.0 t -130.03 155.29 46.37 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.073 0.463 . . . . 0.0 110.907 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -97.1 54.24 1.23 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.433 -179.703 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.69 170.95 6.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.265 -179.294 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -103.87 138.19 19.46 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.776 -179.355 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.462 ' HD2' ' CG2' ' A' ' 154' ' ' VAL . 58.8 Cg_endo -84.9 100.27 0.73 Allowed 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.219 2.613 . . . . 0.0 112.645 179.799 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 18.1 t -65.82 -11.21 44.54 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.72 179.334 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.93 -21.77 20.4 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.783 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.678 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -136.7 166.4 27.79 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -178.943 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.678 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 70.9 Cg_endo -75.15 164.57 32.83 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.487 2.125 . . . . 0.0 112.335 179.924 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 20.1 t -122.61 108.87 22.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.95 0.405 . . . . 0.0 111.677 -179.763 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.903 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.52 95.99 1.88 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.728 179.065 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.43 HG13 ' HD2' ' A' ' 125' ' ' TYR . 50.3 t -92.78 137.65 21.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.918 0.389 . . . . 0.0 111.181 -179.952 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 47.78 57.61 7.51 Favored Glycine 0 CA--C 1.521 0.431 0 CA-C-N 115.987 -0.551 . . . . 0.0 113.27 179.363 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.903 ' CE2' HD23 ' A' ' 155' ' ' LEU . 3.1 m95 -100.11 151.27 21.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.167 0.508 . . . . 0.0 111.705 -179.452 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -66.51 -172.39 0.16 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.569 179.276 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -43.08 154.17 0.08 Allowed 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -179.75 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.543 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.0 -24.76 51.82 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.239 179.477 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.15 -39.55 86.76 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.959 0.409 . . . . 0.0 110.066 179.199 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -75.86 -40.97 53.63 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.108 178.955 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.543 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.2 mt -58.55 -42.34 84.38 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.884 179.048 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.65 -25.93 20.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.477 179.648 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.467 ' CB ' HG21 ' A' ' 211' ' ' ILE . 6.0 mm-40 -71.49 -54.38 10.76 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.056 0.455 . . . . 0.0 110.854 -179.901 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.837 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -62.31 -37.33 85.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.244 179.547 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.86 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -60.51 -38.3 83.9 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.909 179.027 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -61.3 -36.06 91.88 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 177.62 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 55.3 mm-40 -70.65 -48.94 52.32 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.118 -0.541 . . . . 0.0 110.6 178.478 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.65 ' HA ' HD22 ' A' ' 174' ' ' LEU . 10.8 mp -65.06 -27.86 69.08 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.396 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.67 -18.46 62.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.373 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -112.19 -28.66 7.87 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 120.658 0.266 . . . . 0.0 111.519 -179.706 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.65 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.1 OUTLIER -57.61 167.2 1.43 Allowed Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.041 -179.612 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -70.34 129.19 16.58 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.248 1.965 . . . . 0.0 112.893 179.946 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.33 -25.34 9.38 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.65 179.667 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.97 -48.63 79.41 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.944 0.402 . . . . 0.0 110.869 179.664 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.879 HG11 ' HB3' ' A' ' 218' ' ' LEU . 39.3 t -74.12 -35.53 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.424 179.399 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.46 ' HB2' HD21 ' A' ' 174' ' ' LEU . 8.7 tp -56.8 -36.26 69.69 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.118 0.485 . . . . 0.0 109.949 179.019 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -76.67 -39.96 28.06 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.328 178.759 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -88.09 103.14 15.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.906 0.384 . . . . 0.0 110.669 179.268 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 182' ' ' MET . . . . . 0.837 ' CE ' HG12 ' A' ' 178' ' ' VAL . 3.0 mtm 179.42 162.34 0.86 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.194 179.992 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.42 -56.22 2.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.742 0.306 . . . . 0.0 111.038 -179.838 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -163.11 142.69 8.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.832 -179.945 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.875 HG12 HG12 ' A' ' 199' ' ' VAL . 14.3 mt -103.11 115.15 44.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.539 179.484 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 24.2 m170 -104.19 127.32 51.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.03 -179.548 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -82.52 104.66 12.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.576 179.719 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.714 -179.929 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 . . . . . 0 CA--C 1.529 0.15 0 CA-C-O 120.664 0.269 . . . . 0.0 111.427 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 195' ' ' ASP . . . . . 0.572 ' HB3' HD12 ' A' ' 211' ' ' ILE . 0.4 OUTLIER -109.68 40.87 1.8 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.017 0.437 . . . . 0.0 110.295 179.748 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 2.1 tpm_? -87.68 112.86 22.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.857 -179.956 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.822 ' O ' HD13 ' A' ' 198' ' ' ILE . 31.9 m -108.23 168.23 3.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.027 179.941 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.822 HD13 ' O ' ' A' ' 197' ' ' VAL . 19.3 mm -134.4 108.45 10.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.372 179.956 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.875 HG12 HG12 ' A' ' 185' ' ' ILE . 6.8 m -98.08 122.37 49.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.903 0.382 . . . . 0.0 110.873 179.462 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -82.4 152.27 26.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.834 -179.869 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.56 144.67 31.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.554 179.887 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 44.3 m-20 -57.43 -29.28 64.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.017 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -74.78 -7.44 53.4 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.633 179.676 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 101.54 14.47 29.87 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 120.484 -0.865 . . . . 0.0 113.123 -179.929 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -92.24 166.11 12.77 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.98 0.39 . . . . 0.0 111.049 -179.844 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -132.16 111.43 11.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.827 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.5 t -109.86 138.56 36.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.103 179.994 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 52.5 p -112.08 116.78 31.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.981 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.658 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -127.75 158.14 38.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.653 179.775 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -97.62 148.43 23.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.778 0.323 . . . . 0.0 110.653 179.891 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.572 HD12 ' HB3' ' A' ' 195' ' ' ASP . 59.5 mt -59.96 -36.59 67.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.825 179.927 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.25 -33.88 74.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.289 -179.524 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -134.92 44.17 2.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.984 0.421 . . . . 0.0 111.015 -179.885 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.579 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 10.8 t80 -66.91 -52.64 40.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.779 179.801 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.35 -41.51 89.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.232 -179.724 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -67.13 -49.76 63.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.102 0.477 . . . . 0.0 110.476 179.655 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.95 -44.56 74.43 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.015 179.782 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.879 ' HB3' HG11 ' A' ' 178' ' ' VAL . 4.1 mm? -81.22 -26.86 35.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.061 179.635 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 13.6 t -61.14 -31.7 71.41 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.93 0.395 . . . . 0.0 110.28 179.346 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.232 179.556 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 121.094 0.473 . . . . 0.0 110.944 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.748 ' HB2' HD13 ' A' ' 134' ' ' LEU . 82.7 m95 -70.42 168.29 16.42 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.967 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.94 135.02 44.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.503 179.594 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 12.8 mtt180 -71.39 106.45 3.91 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.915 -179.815 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.896 HD11 HG22 ' A' ' 168' ' ' THR . 46.0 pt -95.8 -7.81 9.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.496 179.278 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.541 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -157.94 176.1 12.99 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 120.619 0.247 . . . . 0.0 110.713 179.768 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.468 ' CD1' ' CG ' ' A' ' 149' ' ' PRO . 39.1 m-85 -145.58 126.0 14.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.348 -179.895 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.672 HG21 HD11 ' A' ' 139' ' ' LEU . 4.2 t -94.05 123.21 46.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.016 0.436 . . . . 0.0 111.269 -179.458 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.465 ' CD1' ' CE1' ' A' ' 130' ' ' PHE . 7.0 t80 -82.59 101.85 11.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.892 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -156.31 155.35 32.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.704 -179.912 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 60.85 32.95 20.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.878 -179.783 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 60.28 31.26 20.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.91 179.961 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.445 HG22 ' N ' ' A' ' 130' ' ' PHE . 70.6 m -152.94 161.49 42.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.883 179.766 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.465 ' CE1' ' CD1' ' A' ' 125' ' ' TYR . 97.2 m-85 -102.54 90.41 3.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.696 179.668 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.49 ' HA ' ' HA2' ' A' ' 144' ' ' GLY . 22.8 m-85 -65.45 124.79 88.12 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.088 -179.923 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.63 119.17 5.79 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 121.986 1.791 . . . . 0.0 112.367 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.608 HD11 ' HA2' ' A' ' 137' ' ' GLY . 32.2 tp -96.1 123.81 39.86 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.657 179.793 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.748 HD13 ' HB2' ' A' ' 118' ' ' TRP . 41.6 mt -70.79 172.77 8.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.563 -179.713 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.41 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.8 pt-20 -63.27 -29.05 70.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.992 179.692 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -89.9 12.52 17.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.131 179.577 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.658 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 72.72 25.09 74.87 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.997 179.874 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.662 ' HB3' HD12 ' A' ' 134' ' ' LEU . 0.8 OUTLIER -82.61 95.11 7.68 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.433 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.672 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -72.69 107.21 5.03 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.301 -179.221 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.436 HD11 HD21 ' A' ' 134' ' ' LEU . 30.5 mt -84.48 76.8 10.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.271 179.375 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.443 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 24.6 mtpt -67.84 -8.77 38.99 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.407 -179.603 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -84.77 -28.53 26.13 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.707 0.289 . . . . 0.0 110.915 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -85.65 -79.95 0.23 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.072 -179.848 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.49 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . 57.28 160.71 0.02 OUTLIER Glycine 0 CA--C 1.507 -0.462 0 CA-C-N 116.283 -0.417 . . . . 0.0 112.837 -179.625 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 9.6 t -140.63 150.78 43.99 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.356 -0.422 . . . . 0.0 110.68 -179.647 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -89.26 50.87 2.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.96 0.41 . . . . 0.0 110.625 179.839 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -171.33 155.49 4.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.956 0.408 . . . . 0.0 110.611 -179.286 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -98.74 125.26 43.05 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.148 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.468 ' CG ' ' CD1' ' A' ' 123' ' ' TYR . 96.5 Cg_endo -84.93 109.26 1.25 Allowed 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 122.494 2.13 . . . . 0.0 112.779 -179.767 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 17.0 t -69.86 -7.86 43.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.958 179.743 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -77.28 -23.41 51.13 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 120.808 0.337 . . . . 0.0 110.451 179.006 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.651 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -139.47 166.23 25.82 Favored Pre-proline 0 N--CA 1.453 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.546 -179.493 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.651 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 72.4 Cg_endo -75.57 151.08 36.6 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.426 2.084 . . . . 0.0 112.662 -179.821 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.436 HG22 ' HB2' ' A' ' 123' ' ' TYR . 9.4 t -113.2 111.59 36.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.902 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.863 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.44 96.02 1.85 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.619 179.22 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.414 HG23 ' HB2' ' A' ' 184' ' ' GLU . 62.1 t -90.75 137.0 22.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.956 0.408 . . . . 0.0 111.18 179.966 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 47.76 60.78 5.19 Favored Glycine 0 CA--C 1.521 0.434 0 CA-C-N 115.938 -0.573 . . . . 0.0 113.147 179.377 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.863 ' CE2' HD23 ' A' ' 155' ' ' LEU . 3.0 m95 -104.35 151.27 23.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.228 0.537 . . . . 0.0 111.823 -179.344 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.25 -172.17 0.2 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.393 179.386 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -42.15 153.66 0.06 Allowed 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.733 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.503 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -56.94 -24.85 51.74 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.215 179.446 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -59.87 -40.49 88.84 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.916 0.388 . . . . 0.0 109.987 179.213 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -75.17 -38.95 60.67 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.988 178.907 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.503 HD12 ' HA2' ' A' ' 161' ' ' GLY . 5.4 mt -59.88 -43.69 92.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.808 178.866 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.413 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . . . -53.54 -26.11 19.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.717 179.962 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.401 ' CB ' HG21 ' A' ' 211' ' ' ILE . 3.5 mm-40 -70.34 -54.57 12.01 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.1 0.476 . . . . 0.0 110.781 -179.9 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.823 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -61.75 -35.85 79.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.291 179.518 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.896 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -60.88 -40.88 94.69 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.938 178.89 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.94 -35.36 86.74 Favored Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 177.903 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -72.46 -46.85 53.0 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.236 -0.482 . . . . 0.0 110.66 178.656 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.647 ' HA ' HD22 ' A' ' 174' ' ' LEU . 10.8 mp -66.25 -27.57 68.05 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.773 0.321 . . . . 0.0 111.592 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.46 -17.54 62.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.257 179.868 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -114.38 -26.89 7.78 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -179.681 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.647 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER -57.77 167.63 1.37 Allowed Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.037 -179.58 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -69.1 127.74 15.57 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.138 1.892 . . . . 0.0 112.829 179.812 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.45 -25.88 11.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.611 179.713 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.81 -48.45 79.69 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.866 0.365 . . . . 0.0 110.967 179.658 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.887 HG11 ' HB3' ' A' ' 218' ' ' LEU . 22.3 t -74.06 -37.13 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.571 179.584 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.525 ' HB2' HD21 ' A' ' 174' ' ' LEU . 6.6 tp -55.59 -36.1 66.52 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.237 0.541 . . . . 0.0 110.072 179.058 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -76.54 -40.96 26.09 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.268 178.864 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -87.58 102.87 15.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.979 0.419 . . . . 0.0 110.596 179.225 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 182' ' ' MET . . . . . 0.838 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.9 mtm 177.89 162.47 0.59 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.084 -179.916 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 7.5 t -118.26 -56.9 2.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.819 0.343 . . . . 0.0 110.92 -179.859 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 184' ' ' GLU . . . . . 0.414 ' HB2' HG23 ' A' ' 156' ' ' VAL . 5.3 pt-20 -161.28 142.44 11.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.957 -179.848 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.877 HG12 HG12 ' A' ' 199' ' ' VAL . 16.8 mt -100.4 115.91 42.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.403 179.483 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 19.9 m170 -105.04 115.25 29.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.965 -179.526 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.433 ' HB2' ' CE2' ' A' ' 158' ' ' TRP . 14.5 t80 -74.79 104.62 5.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.688 179.817 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.448 179.85 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 . . . . . 0 CA--C 1.529 0.172 0 CA-C-O 120.548 0.213 . . . . 0.0 111.271 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -107.8 36.75 2.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.742 0.306 . . . . 0.0 110.591 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 3.3 ttt180 -89.42 115.87 27.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.306 -179.673 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.759 ' O ' HD13 ' A' ' 198' ' ' ILE . 34.0 m -112.78 165.27 7.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.684 179.563 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.759 HD13 ' O ' ' A' ' 197' ' ' VAL . 23.8 mm -131.32 105.76 11.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.775 0.321 . . . . 0.0 111.279 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.877 HG12 HG12 ' A' ' 185' ' ' ILE . 6.9 m -95.85 121.48 46.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.941 179.652 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -81.82 146.47 29.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.646 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -95.06 167.15 11.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.033 -179.655 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.27 -27.69 65.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.059 -179.919 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -90.43 15.31 10.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.884 -179.845 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 87.69 -7.14 82.1 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.474 -0.869 . . . . 0.0 113.315 179.947 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.09 170.2 0.93 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 117.235 0.518 . . . . 0.0 110.928 -179.966 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -141.33 111.45 6.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.694 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.4 t -112.4 125.27 69.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.262 -179.774 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 208' ' ' SER . . . . . 0.505 ' OG ' HD12 ' A' ' 198' ' ' ILE . 4.6 m -100.98 112.04 24.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.661 179.721 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.636 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -124.1 160.87 26.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.88 -179.899 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.66 155.85 17.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.499 179.841 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.401 HG21 ' CB ' ' A' ' 166' ' ' GLU . 30.8 mt -67.08 -32.07 56.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.897 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.45 -40.52 70.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.355 -179.469 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -116.86 31.8 6.53 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.796 0.331 . . . . 0.0 110.95 -179.912 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.588 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 11.6 t80 -59.4 -54.92 41.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.997 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.43 -40.12 81.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.138 -179.922 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.38 -49.73 52.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.075 0.464 . . . . 0.0 110.333 179.553 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.14 -41.99 69.03 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.012 179.654 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.887 ' HB3' HG11 ' A' ' 178' ' ' VAL . 4.1 mm? -85.97 -23.54 26.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.825 179.462 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 9.4 t -60.69 -33.87 73.5 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.006 0.431 . . . . 0.0 110.119 179.232 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 32.7 m170 . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.117 179.183 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 . . . . . 0 CA--C 1.522 -0.129 0 CA-C-O 121.133 0.492 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.755 ' HB2' HD13 ' A' ' 134' ' ' LEU . 78.9 m95 -66.89 168.21 10.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.988 179.915 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 -102.82 136.67 42.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.467 179.588 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.7 mtm-85 -71.75 105.54 3.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.874 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.883 HD11 HG22 ' A' ' 168' ' ' THR . 46.8 pt -94.34 -8.71 9.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.38 179.205 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.486 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -158.16 176.19 12.81 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 120.601 0.238 . . . . 0.0 110.609 179.749 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.464 ' CD1' ' CG ' ' A' ' 149' ' ' PRO . 34.2 m-85 -144.99 125.91 14.44 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.633 HG21 HD11 ' A' ' 139' ' ' LEU . 4.8 t -93.69 123.3 45.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.044 0.45 . . . . 0.0 111.509 -179.292 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.478 ' CD1' ' CE1' ' A' ' 130' ' ' PHE . 30.2 t80 -81.35 101.77 10.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.758 179.965 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -155.58 153.74 30.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.645 -179.887 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 60.87 31.17 20.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.952 -179.672 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 61.87 30.86 18.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.188 179.811 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.446 HG22 ' N ' ' A' ' 130' ' ' PHE . 87.1 m -151.46 161.73 42.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.768 179.773 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.541 ' CE2' ' HB2' ' A' ' 148' ' ' ALA . 9.1 m-85 -101.39 90.27 4.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.866 179.666 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.473 ' HA ' ' HA2' ' A' ' 144' ' ' GLY . 22.1 m-85 -65.79 123.99 86.31 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.766 179.809 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.3 118.34 5.47 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.114 1.876 . . . . 0.0 112.338 -179.936 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.71 HD21 ' OG1' ' A' ' 168' ' ' THR . 25.8 tp -95.96 123.54 39.6 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.521 179.684 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.755 HD13 ' HB2' ' A' ' 118' ' ' TRP . 50.7 mt -70.67 173.73 6.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.344 -0.843 . . . . 0.0 111.449 -179.748 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.405 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 2.0 pt-20 -63.89 -28.33 69.76 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.995 179.588 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -91.29 14.23 15.05 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.199 179.791 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.619 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 72.85 28.06 67.68 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.57 -179.976 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.651 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -81.65 90.1 6.29 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 178.721 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.633 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -72.31 102.01 3.01 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.802 -179.485 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 31.7 mt -83.06 79.39 9.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.824 -179.957 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.487 ' HE3' HD13 ' A' ' 139' ' ' LEU . 37.8 mttt -69.69 -8.51 48.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.207 -179.912 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -82.92 -29.63 29.02 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.83 0.348 . . . . 0.0 110.695 179.69 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -85.27 -80.4 0.21 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.957 179.98 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . 56.92 160.76 0.02 OUTLIER Glycine 0 CA--C 1.506 -0.475 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.949 -179.777 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 10.2 t -142.07 150.38 41.15 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.437 -0.382 . . . . 0.0 110.753 -179.738 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.443 ' HE2' HG23 ' A' ' 129' ' ' THR . 3.7 mmtt -89.53 51.8 2.19 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.018 0.437 . . . . 0.0 110.596 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -171.26 149.99 2.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.735 -179.34 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.541 ' HB2' ' CE2' ' A' ' 130' ' ' PHE . . . -93.94 125.01 54.65 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.201 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.464 ' CG ' ' CD1' ' A' ' 123' ' ' TYR . 89.9 Cg_endo -85.04 109.89 1.27 Allowed 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.57 2.18 . . . . 0.0 112.796 -179.861 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 21.5 t -69.93 -7.74 43.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.935 179.79 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -77.61 -23.07 49.93 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 120.809 0.338 . . . . 0.0 110.515 179.096 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.657 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -139.92 166.22 25.35 Favored Pre-proline 0 N--CA 1.453 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.628 -179.41 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.657 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 64.4 Cg_endo -74.68 152.24 42.21 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.424 2.082 . . . . 0.0 112.346 -179.926 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 9.8 t -113.99 109.46 28.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.065 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.844 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.33 96.03 1.81 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.705 179.231 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.42 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 53.5 t -93.68 136.21 26.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.91 0.386 . . . . 0.0 111.012 179.944 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 50.81 57.5 10.79 Favored Glycine 0 CA--C 1.519 0.306 0 CA-C-N 115.886 -0.597 . . . . 0.0 113.089 179.443 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.844 ' CE2' HD23 ' A' ' 155' ' ' LEU . 3.2 m95 -102.16 151.2 22.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.08 0.467 . . . . 0.0 111.634 -179.572 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.73 -172.41 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.608 179.523 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -43.59 154.26 0.1 Allowed 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.775 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.532 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.58 -25.11 54.79 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.239 179.544 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.2 -38.42 83.24 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.948 0.404 . . . . 0.0 110.112 179.278 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.34 -39.2 48.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.03 179.034 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.532 HD12 ' HA2' ' A' ' 161' ' ' GLY . 5.9 mt -59.96 -41.46 86.15 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.857 179.046 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.8 -30.51 45.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.168 179.682 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.405 ' CB ' HG21 ' A' ' 211' ' ' ILE . 10.7 mm-40 -67.19 -53.0 34.41 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-O 121.417 0.627 . . . . 0.0 110.14 179.391 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.796 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -60.78 -43.22 98.38 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.088 179.025 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.883 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -58.5 -38.66 78.11 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.51 179.214 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.09 -37.43 92.8 Favored Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 178.378 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 63.2 mm-40 -72.29 -45.85 58.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.462 -0.369 . . . . 0.0 110.892 178.972 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.561 ' O ' HD22 ' A' ' 174' ' ' LEU . 11.1 mp -65.48 -30.05 70.78 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.694 0.283 . . . . 0.0 111.202 179.685 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.0 -18.57 64.07 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.344 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -112.28 -26.71 8.63 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.632 0.254 . . . . 0.0 111.66 -179.696 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.561 HD22 ' O ' ' A' ' 171' ' ' LEU . 0.1 OUTLIER -56.86 166.67 1.28 Allowed Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.169 -179.517 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -69.29 128.66 16.79 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.163 1.908 . . . . 0.0 112.69 179.832 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.09 -25.66 5.36 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.69 179.715 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.18 -49.97 74.32 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.033 179.76 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.939 HG11 ' HB3' ' A' ' 218' ' ' LEU . 23.9 t -74.18 -39.81 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.715 179.609 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.521 ' HG ' HD21 ' A' ' 174' ' ' LEU . 0.5 OUTLIER -53.15 -33.38 52.24 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.103 0.478 . . . . 0.0 110.169 179.385 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -81.86 -38.92 12.55 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.591 178.802 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.43 ' HB1' ' SD ' ' A' ' 201' ' ' MET . . . -88.92 103.43 16.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.828 0.347 . . . . 0.0 110.852 179.528 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 182' ' ' MET . . . . . 0.829 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.6 mtm 177.87 169.08 0.71 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.304 179.817 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 7.7 t -124.24 -59.61 1.47 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.752 0.311 . . . . 0.0 111.127 -179.901 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -157.02 142.73 17.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.121 -179.784 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.907 HG12 HG12 ' A' ' 199' ' ' VAL . 14.9 mt -106.23 114.53 45.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.269 179.359 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 186' ' ' HIS . . . . . 0.42 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 22.5 m170 -104.7 121.56 43.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.153 -179.431 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -72.67 104.95 4.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.58 179.769 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.78 -179.921 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 . . . . . 0 N--CA 1.462 0.137 0 CA-C-O 120.647 0.26 . . . . 0.0 111.51 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 195' ' ' ASP . . . . . 0.599 ' HB3' HD12 ' A' ' 211' ' ' ILE . 0.4 OUTLIER -106.5 40.04 1.7 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.967 0.413 . . . . 0.0 110.373 179.785 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 31.7 ttt85 -93.0 119.94 32.78 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.969 179.974 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.847 ' O ' HD13 ' A' ' 198' ' ' ILE . 23.2 m -113.03 167.77 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.09 -179.931 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.847 HD13 ' O ' ' A' ' 197' ' ' VAL . 24.7 mm -134.09 105.9 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.139 179.783 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.907 HG12 HG12 ' A' ' 185' ' ' ILE . 15.8 m -97.63 138.81 21.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.992 0.425 . . . . 0.0 111.02 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.423 ' CE2' ' HG3' ' A' ' 206' ' ' GLU . 50.7 m-85 -102.46 152.48 21.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.587 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 201' ' ' MET . . . . . 0.43 ' SD ' ' HB1' ' A' ' 181' ' ' ALA . 21.3 tpp -104.06 158.21 16.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.833 0.349 . . . . 0.0 110.914 -179.902 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -56.27 -22.37 29.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.584 -179.825 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -90.4 15.34 10.8 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 111.825 0.305 . . . . 0.0 111.825 -179.913 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 77.05 14.58 82.48 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.583 -0.818 . . . . 0.0 113.147 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -77.55 167.7 21.19 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.99 0.395 . . . . 0.0 110.884 179.994 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 206' ' ' GLU . . . . . 0.423 ' HG3' ' CE2' ' A' ' 200' ' ' TYR . 7.2 tt0 -134.31 111.47 10.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.854 -179.964 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 17.7 t -116.56 131.14 70.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.976 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 208' ' ' SER . . . . . 0.704 ' OG ' HD12 ' A' ' 198' ' ' ILE . 59.5 m -104.03 116.9 33.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.054 -179.858 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.632 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -127.62 159.24 35.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.736 179.712 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.2 153.1 19.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.811 0.339 . . . . 0.0 110.751 -179.95 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.599 HD12 ' HB3' ' A' ' 195' ' ' ASP . 64.2 mt -63.31 -36.71 77.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.803 179.763 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.92 -35.9 79.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.548 -179.452 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -132.67 42.76 3.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.925 0.393 . . . . 0.0 111.115 -179.835 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.575 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 11.3 t80 -65.49 -52.57 51.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.525 179.815 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.89 -43.38 86.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.293 -179.716 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.38 -49.39 60.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.102 0.477 . . . . 0.0 110.205 179.461 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.73 -42.76 65.18 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.181 179.683 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.939 ' HB3' HG11 ' A' ' 178' ' ' VAL . 4.0 mm? -87.16 -23.43 24.82 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.181 179.614 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 10.9 t -60.35 -33.88 73.05 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.025 0.44 . . . . 0.0 110.299 179.542 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.534 0.347 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.109 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.187 0 N-CA-C 112.556 -0.218 . . . . 0.0 112.556 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 13.3 p -115.64 153.64 30.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.807 0.337 . . . . 0.0 110.871 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 61.07 154.79 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.052 0.453 . . . . 0.0 110.978 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.769 ' HB2' HD13 ' A' ' 134' ' ' LEU . 81.6 m95 -77.29 168.51 19.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.976 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.8 ttm-85 -102.4 134.19 46.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.607 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.9 mtm180 -70.42 106.8 3.53 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.887 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.875 HD11 HG22 ' A' ' 168' ' ' THR . 44.5 pt -96.61 -7.06 9.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.448 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.536 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -159.38 175.94 12.73 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 120.606 0.241 . . . . 0.0 110.916 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.472 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 29.0 m-85 -143.65 126.23 15.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.253 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.661 HG21 HD11 ' A' ' 139' ' ' LEU . 3.8 t -93.86 123.28 45.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.512 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.501 ' CE1' ' CZ ' ' A' ' 130' ' ' PHE . 9.4 t80 -85.0 96.21 9.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.734 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -147.84 155.98 42.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.632 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.03 31.22 21.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.846 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.67 34.69 14.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.034 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.451 HG22 ' N ' ' A' ' 130' ' ' PHE . 57.0 m -154.66 161.52 41.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.034 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.501 ' CZ ' ' CE1' ' A' ' 125' ' ' TYR . 96.2 m-85 -103.82 90.49 3.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.166 0.508 . . . . 0.0 110.712 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.565 ' HB2' HD21 ' A' ' 139' ' ' LEU . 22.9 m-85 -67.69 127.4 93.38 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.561 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.424 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 7.7 Cg_exo -71.62 118.16 5.51 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 122.37 2.047 . . . . 0.0 112.369 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.64 HD21 ' OG1' ' A' ' 168' ' ' THR . 38.0 tp -97.52 123.6 41.44 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.123 0.487 . . . . 0.0 110.595 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.769 HD13 ' HB2' ' A' ' 118' ' ' TRP . 52.4 mt -71.46 173.0 8.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.578 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.418 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.3 pt-20 -63.71 -29.27 70.52 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.114 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -89.92 11.36 20.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.16 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.64 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 75.5 18.67 79.76 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.831 -0.7 . . . . 0.0 113.162 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.701 ' HB3' HD12 ' A' ' 134' ' ' LEU . 13.4 tpp180 -76.78 95.7 4.1 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.661 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -71.44 113.58 8.62 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.494 -179.054 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 22.8 mt -88.11 71.76 9.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.292 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.463 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 30.8 mttt -56.87 -20.62 23.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.922 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -87.04 -18.73 29.91 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -104.93 30.85 5.2 Favored 'General case' 0 N--CA 1.461 0.121 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . -63.89 162.38 35.06 Favored Glycine 0 CA--C 1.51 -0.237 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.786 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 10.6 t -136.03 151.39 49.82 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.543 -0.329 . . . . 0.0 110.658 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.423 ' HE2' HG23 ' A' ' 129' ' ' THR . 4.7 mmpt? -89.32 50.37 1.92 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.953 0.406 . . . . 0.0 110.671 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -171.04 151.4 3.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.554 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -96.88 125.87 44.84 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.23 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.472 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 74.3 Cg_endo -82.82 112.75 2.12 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.396 2.064 . . . . 0.0 112.474 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 30.6 t -69.92 -7.65 42.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.121 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -76.53 -23.44 53.64 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 120.828 0.346 . . . . 0.0 110.417 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.697 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -139.83 167.89 16.9 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.723 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.697 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 67.3 Cg_endo -74.79 158.24 43.11 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.351 2.034 . . . . 0.0 112.114 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 10.7 t -118.83 110.83 31.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.051 0.453 . . . . 0.0 111.081 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.833 HD23 ' CE2' ' A' ' 158' ' ' TRP . 0.9 OUTLIER -72.83 96.01 2.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.579 179.022 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 54.3 t -93.1 136.52 24.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.961 0.41 . . . . 0.0 111.103 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 50.06 55.28 15.79 Favored Glycine 0 CA--C 1.52 0.375 0 CA-C-N 115.906 -0.588 . . . . 0.0 113.287 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.833 ' CE2' HD23 ' A' ' 155' ' ' LEU . 3.5 m95 -99.59 151.25 21.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.169 0.509 . . . . 0.0 111.649 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.89 -172.19 0.26 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.457 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -42.69 154.32 0.07 Allowed 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.541 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.18 -25.29 53.91 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.181 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -59.62 -39.43 84.27 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 120.957 0.408 . . . . 0.0 110.036 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.1 -40.06 53.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.94 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.541 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.6 mt -59.68 -42.13 87.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.898 179.087 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.63 -30.63 43.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.139 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.438 ' CB ' HG21 ' A' ' 211' ' ' ILE . 2.5 mm-40 -67.22 -53.14 32.94 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 121.528 0.68 . . . . 0.0 110.098 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.774 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -60.38 -43.46 96.58 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.06 179.019 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.875 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -58.77 -38.0 77.5 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.525 179.356 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.56 -37.65 92.51 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 178.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -72.03 -46.39 57.26 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.353 -0.423 . . . . 0.0 111.025 178.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.601 ' HA ' HD22 ' A' ' 174' ' ' LEU . 10.9 mp -66.14 -27.71 68.24 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.665 0.269 . . . . 0.0 111.417 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.69 -18.93 62.81 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.438 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -111.74 -27.37 8.54 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.6 0.238 . . . . 0.0 111.413 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.601 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.1 OUTLIER -57.93 167.3 1.55 Allowed Pre-proline 0 CA--C 1.539 0.535 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.929 -179.735 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -70.39 128.01 14.86 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.177 1.918 . . . . 0.0 112.858 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.96 -25.41 8.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.606 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.93 -49.15 77.76 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.814 0.34 . . . . 0.0 110.896 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.874 HG11 ' HB3' ' A' ' 218' ' ' LEU . 37.6 t -73.96 -35.22 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.445 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.537 HD13 ' CD2' ' A' ' 174' ' ' LEU . 5.7 tp -56.04 -35.52 66.98 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.183 0.515 . . . . 0.0 109.988 179.043 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -78.33 -40.19 20.36 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.336 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -86.06 103.01 14.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.894 0.378 . . . . 0.0 110.625 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' MET . . . . . 0.838 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.9 mtm 178.43 165.84 0.8 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.128 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.47 -54.53 1.97 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.797 0.332 . . . . 0.0 111.253 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -163.31 142.94 8.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.92 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.923 HG12 HG12 ' A' ' 199' ' ' VAL . 16.8 mt -106.26 114.71 46.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.722 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' HIS . . . . . 0.454 ' CE1' ' CE1' ' A' ' 200' ' ' TYR . 11.4 m170 -104.68 131.03 52.61 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.988 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -83.24 104.79 13.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.515 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.36 89.64 52.19 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.649 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.67 149.18 60.67 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.312 2.008 . . . . 0.0 112.578 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.509 HG21 ' HE ' ' A' ' 196' ' ' ARG . 21.9 p -121.53 161.05 23.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.548 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 9.5 ptt85 -54.7 -23.05 15.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.651 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -113.75 -10.78 13.0 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -143.49 79.95 1.65 Allowed 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.9 0.381 . . . . 0.0 111.554 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.58 -21.4 38.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.297 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ASP . . . . . 0.404 ' OD1' HG22 ' A' ' 210' ' ' THR . 1.5 p30 -102.18 35.13 2.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.774 0.321 . . . . 0.0 110.708 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.509 ' HE ' HG21 ' A' ' 190' ' ' THR . 1.0 OUTLIER -89.45 113.08 24.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.178 -179.807 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.868 ' O ' HD13 ' A' ' 198' ' ' ILE . 29.1 m -108.57 168.07 3.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.847 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.868 HD13 ' O ' ' A' ' 197' ' ' VAL . 20.7 mm -134.79 108.06 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.826 0.345 . . . . 0.0 111.383 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.923 HG12 HG12 ' A' ' 185' ' ' ILE . 8.1 m -96.42 124.06 48.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.895 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.454 ' CE1' ' CE1' ' A' ' 186' ' ' HIS . 5.2 m-85 -82.58 146.0 29.41 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.796 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.83 156.23 17.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.04 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -64.26 -23.81 67.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.532 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -90.25 15.4 10.49 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 79.59 14.29 81.41 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.079 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -84.43 167.32 16.55 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.929 0.364 . . . . 0.0 110.71 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -133.72 111.66 10.75 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.604 HG11 HD12 ' A' ' 224' ' ' ILE . 21.2 t -112.73 124.35 69.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.19 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 80.0 p -101.42 116.47 32.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.695 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.671 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -127.0 158.41 36.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.96 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.404 HG22 ' OD1' ' A' ' 195' ' ' ASP . 0.6 OUTLIER -95.13 154.38 17.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.724 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.438 HG21 ' CB ' ' A' ' 166' ' ' GLU . 36.8 mt -66.39 -35.17 74.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.999 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.49 -35.31 80.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.384 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -129.8 40.91 3.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.891 0.377 . . . . 0.0 111.055 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.563 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 11.9 t80 -65.54 -50.62 64.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.707 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.9 -41.26 91.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.093 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.06 -49.38 65.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.997 0.427 . . . . 0.0 110.46 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 2.1 mmpt? -54.65 -45.09 73.75 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.07 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.874 ' HB3' HG11 ' A' ' 178' ' ' VAL . 4.2 mm? -80.95 -27.5 36.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.978 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 14.3 t -60.76 -31.55 70.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.964 0.411 . . . . 0.0 110.372 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' HIS . . . . . 0.697 ' O ' ' HB3' ' A' ' 223' ' ' ALA . 26.5 m-70 -69.97 -16.68 63.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.245 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -67.06 130.16 93.87 Favored Pre-proline 0 CA--C 1.535 0.381 0 C-N-CA 121.289 -0.164 . . . . 0.0 110.9 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.426 ' O ' ' HB2' ' A' ' 223' ' ' ALA . 70.5 Cg_endo -86.72 108.03 1.03 Allowed 'Cis proline' 0 C--N 1.358 1.062 0 C-N-CA 124.586 -1.006 . . . . 0.0 112.663 0.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.697 ' HB3' ' O ' ' A' ' 220' ' ' HIS . . . 174.15 42.13 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.166 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.604 HD12 HG11 ' A' ' 207' ' ' VAL . 4.6 pt -121.02 -178.79 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.248 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 224' ' ' ILE . . . 76.05 93.23 0.07 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.944 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -110.0 -161.77 0.77 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.9 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -93.65 21.13 6.67 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.722 ' O ' HD23 ' A' ' 228' ' ' LEU . 1.7 tt -97.24 24.34 6.54 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.725 0.298 . . . . 0.0 110.831 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -135.68 30.86 3.11 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.813 0.34 . . . . 0.0 110.9 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 3.3 ptt85 -110.91 -33.5 6.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.859 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 25.7 p30 -98.19 36.75 1.53 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.881 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 13.6 m -150.88 33.92 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.072 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 7.8 mtpt . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.935 -179.986 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.175 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.14 93.86 9.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.717 0.294 . . . . 0.0 110.94 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 61.89 148.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.174 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.746 ' HB2' HD13 ' A' ' 134' ' ' LEU . 79.4 m95 -68.67 168.27 13.5 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.092 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -102.8 136.37 42.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.476 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 41.7 mtt85 -71.95 106.11 4.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.936 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.912 HD11 HG22 ' A' ' 168' ' ' THR . 45.9 pt -94.1 -7.84 10.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.476 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -159.47 176.44 12.08 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 121.017 -0.273 . . . . 0.0 110.89 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.449 ' O ' ' HA ' ' A' ' 154' ' ' VAL . 32.1 m-85 -142.85 126.14 16.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.322 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.621 HG21 ' CD1' ' A' ' 139' ' ' LEU . 4.1 t -93.43 122.74 45.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.963 0.411 . . . . 0.0 111.226 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.492 ' CD1' ' CE1' ' A' ' 130' ' ' PHE . 17.9 t80 -80.99 106.51 13.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.698 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -163.36 156.59 19.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.595 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.448 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 1.2 mmm180 60.18 30.22 19.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.884 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 63.12 32.24 15.31 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.366 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.452 HG22 ' N ' ' A' ' 130' ' ' PHE . 91.1 m -156.92 161.25 39.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.878 0.371 . . . . 0.0 111.026 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.492 ' CE1' ' CD1' ' A' ' 125' ' ' TYR . 58.5 m-85 -99.85 90.3 4.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.626 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.513 ' HA ' ' HA2' ' A' ' 144' ' ' GLY . 22.6 m-85 -65.48 125.5 89.7 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.787 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.456 ' HG2' HD12 ' A' ' 140' ' ' LEU . 58.3 Cg_endo -73.57 118.82 5.64 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.044 1.829 . . . . 0.0 112.411 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.666 HD21 ' OG1' ' A' ' 168' ' ' THR . 28.4 tp -96.22 123.85 40.01 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.396 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.746 HD13 ' HB2' ' A' ' 118' ' ' TRP . 39.9 mt -69.64 173.62 5.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.45 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -64.68 -28.02 69.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.948 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 48.8 p-10 -90.93 13.91 15.26 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.285 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.602 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 72.63 21.78 79.39 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.731 -0.747 . . . . 0.0 113.119 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.687 ' HB3' HD12 ' A' ' 134' ' ' LEU . 9.7 tpp180 -80.82 94.25 6.4 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.621 ' CD1' HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -72.13 113.6 9.33 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.48 -179.024 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.569 HD11 HD21 ' A' ' 134' ' ' LEU . 25.1 mt -88.39 80.43 7.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.414 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.454 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 15.4 mtpt -71.45 -5.77 35.34 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -91.11 -24.28 20.04 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 122.304 -0.248 . . . . 0.0 111.432 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -89.46 -79.12 0.34 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.779 0.323 . . . . 0.0 111.403 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.513 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . 58.11 161.1 0.04 OUTLIER Glycine 0 CA--C 1.505 -0.57 0 CA-C-N 116.279 -0.419 . . . . 0.0 112.753 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.8 t -140.01 148.61 42.11 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.872 0.368 . . . . 0.0 110.939 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.45 ' HE2' HG23 ' A' ' 129' ' ' THR . 4.2 mmtt -91.1 51.97 2.04 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.157 0.503 . . . . 0.0 110.216 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.59 148.48 3.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.773 -179.041 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -81.89 135.14 48.89 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.703 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.458 ' HD2' ' CG2' ' A' ' 154' ' ' VAL . 68.4 Cg_endo -84.08 97.96 0.75 Allowed 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.052 2.501 . . . . 0.0 112.549 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 26.2 t -67.5 -9.3 41.0 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.825 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -90.0 -21.92 22.15 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.566 0.222 . . . . 0.0 111.588 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.71 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -139.79 167.4 18.63 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.71 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 60.3 Cg_endo -73.65 162.89 38.7 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.408 2.072 . . . . 0.0 112.518 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.458 ' CG2' ' HD2' ' A' ' 149' ' ' PRO . 18.3 t -123.82 110.14 24.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.572 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.84 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.85 95.91 2.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.747 179.112 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 59.0 t -93.01 136.87 23.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.927 0.394 . . . . 0.0 111.094 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 48.85 55.42 11.47 Favored Glycine 0 CA--C 1.52 0.369 0 CA-C-N 115.966 -0.561 . . . . 0.0 113.174 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.84 ' CE2' HD23 ' A' ' 155' ' ' LEU . 3.4 m95 -99.07 151.18 21.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.156 0.503 . . . . 0.0 111.735 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.43 -172.27 0.15 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.604 179.451 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -43.21 154.39 0.08 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.332 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.515 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -56.94 -24.66 50.94 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.218 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.72 -40.09 86.85 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.967 0.413 . . . . 0.0 110.05 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.12 -39.78 54.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.009 178.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.515 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.1 mt -59.67 -41.23 84.55 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.9 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.0 -30.58 47.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.214 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.403 ' CB ' HG21 ' A' ' 211' ' ' ILE . 15.4 mm-40 -67.64 -52.9 32.73 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.385 0.612 . . . . 0.0 110.107 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.82 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -59.44 -45.27 92.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.971 178.954 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.912 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -57.65 -38.38 74.96 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.549 179.207 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.83 -36.46 90.02 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 110.701 -0.959 . . . . 0.0 110.701 178.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -74.17 -46.36 42.65 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.451 -0.374 . . . . 0.0 111.06 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.565 ' HA ' HD22 ' A' ' 174' ' ' LEU . 11.3 mp -65.43 -29.6 70.31 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.689 0.28 . . . . 0.0 111.319 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.49 -19.18 63.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.345 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -111.01 -27.85 8.58 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.635 0.255 . . . . 0.0 111.433 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.565 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.1 OUTLIER -56.89 166.58 1.32 Allowed Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.161 -179.473 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.54 127.44 14.77 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.243 1.962 . . . . 0.0 112.744 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.71 -26.01 5.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.784 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.56 -50.76 72.05 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.925 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.854 HG11 ' HB3' ' A' ' 218' ' ' LEU . 33.8 t -74.16 -32.42 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.414 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.525 HD23 ' HD3' ' A' ' 153' ' ' PRO . 0.5 OUTLIER -58.2 -34.2 70.12 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.865 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -79.48 -39.61 17.88 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -86.77 103.03 14.82 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.952 0.405 . . . . 0.0 110.6 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' MET . . . . . 0.844 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.8 mtm 178.49 160.48 0.6 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.994 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.1 m -120.56 -52.31 2.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.682 0.277 . . . . 0.0 111.379 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -163.27 142.64 8.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.926 0.394 . . . . 0.0 111.283 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.922 HG12 HG12 ' A' ' 199' ' ' VAL . 17.6 mt -106.71 114.19 45.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.344 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -104.39 119.87 39.94 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.135 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.415 ' HD1' HG12 ' A' ' 197' ' ' VAL . 13.6 t80 -75.8 104.57 6.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.544 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.33 82.0 52.6 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.572 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.73 140.5 42.95 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.35 2.033 . . . . 0.0 112.487 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 17.4 p -116.71 160.11 21.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.703 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -53.4 -25.41 15.63 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.464 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -107.69 -16.85 14.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.687 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -134.27 76.83 1.67 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.906 0.384 . . . . 0.0 111.227 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -56.57 -22.25 32.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.589 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -109.27 37.84 2.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.765 0.317 . . . . 0.0 111.082 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.83 115.59 27.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.947 0.403 . . . . 0.0 111.229 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.825 ' O ' HD13 ' A' ' 198' ' ' ILE . 28.1 m -112.51 166.14 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.808 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.825 HD13 ' O ' ' A' ' 197' ' ' VAL . 22.3 mm -133.03 107.85 12.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.81 0.338 . . . . 0.0 111.401 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.922 HG12 HG12 ' A' ' 185' ' ' ILE . 11.3 m -96.73 120.9 46.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.934 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -81.84 152.29 26.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.562 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 3.6 mmt -108.53 150.03 28.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.809 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -58.74 -25.61 63.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.261 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -88.63 12.94 13.34 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 81.98 14.36 77.42 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.378 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -86.13 153.41 22.1 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 117.103 0.451 . . . . 0.0 110.807 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -123.27 111.42 16.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.86 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.757 HG11 HD12 ' A' ' 224' ' ' ILE . 21.6 t -115.01 123.25 70.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.154 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.557 ' HB2' HD12 ' A' ' 198' ' ' ILE . 9.8 t -98.84 115.49 28.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.742 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.626 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -123.91 162.93 22.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.8 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.73 153.99 18.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.727 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.403 HG21 ' CB ' ' A' ' 166' ' ' GLU . 33.1 mt -65.98 -36.64 77.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.803 0.335 . . . . 0.0 110.763 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -64.82 -36.51 84.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.124 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -128.31 43.51 3.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.916 0.389 . . . . 0.0 110.929 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.571 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 11.4 t80 -68.46 -54.61 15.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.786 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.5 -39.15 79.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.904 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -67.24 -50.04 62.16 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.117 0.484 . . . . 0.0 110.29 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.29 -45.35 72.5 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.057 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.854 ' HB3' HG11 ' A' ' 178' ' ' VAL . 3.9 mm? -80.18 -27.52 38.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.873 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 1.1 m -61.04 -29.85 69.97 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.403 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' HIS . . . . . 0.409 ' HB2' HG22 ' A' ' 224' ' ' ILE . 7.1 m170 -68.94 -17.58 63.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.282 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -64.84 137.05 97.02 Favored Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.536 ' O ' ' HB3' ' A' ' 223' ' ' ALA . 59.6 Cg_endo -71.06 154.57 96.74 Favored 'Cis proline' 0 C--N 1.356 0.937 0 C-N-CA 124.714 -0.952 . . . . 0.0 112.822 0.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.536 ' HB3' ' O ' ' A' ' 222' ' ' PRO . . . 83.12 76.4 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.42 -179.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.757 HD12 HG11 ' A' ' 207' ' ' VAL . 7.4 pt -124.7 -178.88 2.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.2 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 67.99 139.12 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.085 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -115.91 -164.1 0.94 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.106 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -100.45 31.43 3.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.889 0.376 . . . . 0.0 110.938 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 9.9 mt -90.9 15.52 11.2 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.44 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -110.6 56.47 0.63 Allowed 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 121.046 0.451 . . . . 0.0 110.874 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 7.3 mtt85 -148.33 -55.31 0.2 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.911 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 25.0 p30 -60.84 92.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.872 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' VAL . . . . . 0.412 HG22 ' HG2' ' A' ' 233' ' ' LYS . 12.1 p -108.29 137.73 38.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.073 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 233' ' ' LYS . . . . . 0.412 ' HG2' HG22 ' A' ' 232' ' ' VAL . 16.9 mmmt . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.942 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.078 0 N-CA-C 112.522 -0.231 . . . . 0.0 112.522 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 7.5 t 68.31 -68.03 0.18 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.747 0.308 . . . . 0.0 111.001 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -63.81 148.67 48.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.047 0.451 . . . . 0.0 111.013 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.75 ' HB2' HD13 ' A' ' 134' ' ' LEU . 80.9 m95 -68.7 168.31 13.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.015 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.14 135.72 43.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.548 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.9 mtm180 -71.5 105.29 3.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.721 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.892 HD11 HG22 ' A' ' 168' ' ' THR . 47.1 pt -94.18 -8.24 9.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.406 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.443 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -158.47 176.88 11.86 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.467 0.175 . . . . 0.0 110.575 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.467 ' CD1' ' HG3' ' A' ' 149' ' ' PRO . 31.3 m-85 -144.35 125.84 14.93 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.558 HG21 HD11 ' A' ' 139' ' ' LEU . 3.7 t -93.58 122.85 45.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.058 0.456 . . . . 0.0 111.557 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -83.49 94.31 8.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.681 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -145.01 155.13 43.2 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.603 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.93 30.82 20.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.712 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 63.29 33.85 13.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.863 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.41 HG22 ' N ' ' A' ' 130' ' ' PHE . 58.6 m -155.9 159.7 39.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.057 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.41 ' N ' HG22 ' A' ' 129' ' ' THR . 92.6 m-85 -99.77 91.23 4.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.217 0.532 . . . . 0.0 110.863 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.5 ' HB2' HD21 ' A' ' 139' ' ' LEU . 26.1 m-85 -70.37 114.13 23.53 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.722 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.431 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 31.8 Cg_exo -58.72 123.35 13.35 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 122.414 2.076 . . . . 0.0 112.659 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.692 HD21 ' OG1' ' A' ' 168' ' ' THR . 28.9 tp -102.39 123.94 47.06 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.346 179.138 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.75 HD13 ' HB2' ' A' ' 118' ' ' TRP . 40.3 mt -70.32 173.21 7.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.634 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.402 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 2.1 pt-20 -64.11 -28.3 69.68 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.037 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -90.79 13.72 15.53 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.209 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.604 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 72.84 21.7 79.57 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.75 -0.738 . . . . 0.0 113.01 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.686 ' HB3' HD12 ' A' ' 134' ' ' LEU . 1.3 tpt180 -80.8 92.67 6.11 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.558 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -66.21 113.56 4.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.322 -179.125 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 43.4 mt -83.66 67.68 9.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.707 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.446 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 2.3 mttp -57.58 -21.49 39.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.451 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -95.56 21.07 8.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.433 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -147.31 28.47 0.99 Allowed 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.787 0.327 . . . . 0.0 111.238 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.431 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -60.83 162.83 21.01 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.897 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.4 ' N ' ' CG2' ' A' ' 129' ' ' THR . 9.0 t -132.96 150.86 52.13 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.814 0.34 . . . . 0.0 110.611 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.4 mmtt -90.34 50.02 1.78 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.531 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -171.09 150.24 3.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.516 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -94.55 125.76 50.46 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.219 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.467 ' HG3' ' CD1' ' A' ' 123' ' ' TYR . 73.6 Cg_endo -83.65 111.97 1.8 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.428 2.085 . . . . 0.0 112.605 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 46.6 t -69.84 -7.89 43.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.038 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -77.27 -22.55 51.94 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 120.798 0.333 . . . . 0.0 110.572 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.673 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -142.15 167.06 17.72 Favored Pre-proline 0 N--CA 1.453 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.702 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.673 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 62.5 Cg_endo -74.58 157.68 44.33 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.37 2.046 . . . . 0.0 112.315 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 12.8 t -118.28 111.0 32.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.346 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.836 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.65 96.05 1.94 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.762 179.016 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.1 t -93.56 135.44 28.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.995 0.426 . . . . 0.0 110.945 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 49.62 58.08 8.73 Favored Glycine 0 CA--C 1.521 0.42 0 CA-C-N 115.874 -0.603 . . . . 0.0 113.158 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.836 ' CE2' HD23 ' A' ' 155' ' ' LEU . 3.0 m95 -100.59 151.35 21.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.201 0.524 . . . . 0.0 111.744 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.413 ' HD3' ' CE2' ' A' ' 187' ' ' TYR . 2.6 tptt -64.76 -172.47 0.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.523 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -44.35 154.89 0.1 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.122 0.487 . . . . 0.0 112.212 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.55 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.29 -25.37 54.38 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.225 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.34 -38.25 83.21 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.979 0.419 . . . . 0.0 110.165 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.82 -40.61 47.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.116 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.55 HD12 ' HA2' ' A' ' 161' ' ' GLY . 5.9 mt -58.45 -41.38 81.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.973 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.12 -30.34 48.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.144 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.406 ' CB ' HG21 ' A' ' 211' ' ' ILE . 3.8 mm-40 -68.1 -53.04 28.34 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-O 121.368 0.604 . . . . 0.0 110.196 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.817 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -59.66 -43.6 93.89 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.03 179.064 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.892 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -59.2 -37.24 76.95 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.466 179.009 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.05 -37.01 92.11 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -73.06 -46.87 49.21 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.359 -0.421 . . . . 0.0 111.163 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.574 ' HA ' HD22 ' A' ' 174' ' ' LEU . 11.1 mp -65.3 -29.28 70.02 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.7 0.286 . . . . 0.0 111.345 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.79 -20.89 64.36 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.317 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -110.56 -26.3 9.54 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.599 0.238 . . . . 0.0 111.52 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.574 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.1 OUTLIER -57.42 166.62 1.58 Allowed Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.083 -179.697 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -68.8 127.14 14.9 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.308 2.005 . . . . 0.0 112.698 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.07 -25.96 5.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.643 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -58.23 -49.89 75.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.907 0.384 . . . . 0.0 110.986 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.852 HG11 ' HB3' ' A' ' 218' ' ' LEU . 32.0 t -74.0 -34.87 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.704 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.567 HD21 ' O ' ' A' ' 121' ' ' ILE . 0.5 OUTLIER -57.61 -33.91 68.73 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.119 0.485 . . . . 0.0 109.838 178.99 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -78.62 -39.79 20.37 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -87.74 103.18 15.37 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.884 0.373 . . . . 0.0 110.684 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' MET . . . . . 0.842 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.8 mtm 178.79 163.4 0.78 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.202 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -120.39 -57.1 1.94 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.742 0.306 . . . . 0.0 111.206 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -159.97 142.52 13.47 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.992 0.425 . . . . 0.0 111.124 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.882 HG12 HG12 ' A' ' 199' ' ' VAL . 17.8 mt -105.12 114.84 45.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.279 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 23.5 m170 -104.24 120.38 41.02 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.117 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.414 ' CD2' ' HD3' ' A' ' 189' ' ' PRO . 83.7 t80 -75.03 104.45 5.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.474 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.23 89.24 52.11 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.529 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.414 ' HD3' ' CD2' ' A' ' 187' ' ' TYR . 49.2 Cg_endo -68.42 142.12 53.34 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.258 1.972 . . . . 0.0 112.386 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 18.3 p -119.77 159.1 25.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.678 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -54.96 -24.73 25.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.51 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -104.15 -17.83 14.75 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.828 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.438 ' CD1' HG21 ' A' ' 210' ' ' THR . 49.4 m-85 -141.45 85.41 1.96 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.93 0.395 . . . . 0.0 111.498 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -55.68 -24.23 32.98 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.333 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ASP . . . . . 0.604 ' HB3' HD12 ' A' ' 211' ' ' ILE . 0.5 OUTLIER -106.55 40.39 1.63 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.036 0.446 . . . . 0.0 110.308 179.755 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.18 116.45 27.44 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.959 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.874 ' O ' HD13 ' A' ' 198' ' ' ILE . 29.2 m -109.96 168.05 4.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.082 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.874 HD13 ' O ' ' A' ' 197' ' ' VAL . 21.8 mm -135.37 108.24 8.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.196 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.882 HG12 HG12 ' A' ' 185' ' ' ILE . 15.4 m -97.61 139.72 19.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.998 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -101.51 152.72 20.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.778 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 6.0 mmt -105.28 159.7 15.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.88 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -60.13 -27.07 66.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.256 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -86.92 9.96 17.74 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 84.54 14.34 71.01 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.565 -0.826 . . . . 0.0 113.266 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -81.05 158.38 25.11 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 117.228 0.514 . . . . 0.0 110.739 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -128.15 111.25 13.25 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.814 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.624 HG11 HD12 ' A' ' 224' ' ' ILE . 21.2 t -111.21 133.58 56.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.951 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.489 ' HB3' HD12 ' A' ' 198' ' ' ILE . 0.3 OUTLIER -104.63 117.25 33.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.938 -179.919 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.661 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -129.49 156.84 43.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.681 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.438 HG21 ' CD1' ' A' ' 193' ' ' TYR . 0.4 OUTLIER -99.16 149.33 23.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.78 0.324 . . . . 0.0 110.764 179.932 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.604 HD12 ' HB3' ' A' ' 195' ' ' ASP . 64.1 mt -59.55 -38.25 74.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.955 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -61.84 -32.9 73.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.301 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -134.87 46.41 2.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.904 0.383 . . . . 0.0 111.075 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.493 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 11.4 t80 -70.26 -51.36 31.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.795 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.93 -39.65 86.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.014 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.85 -50.34 62.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.144 0.497 . . . . 0.0 110.454 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.99 -45.11 71.36 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.169 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.852 ' HB3' HG11 ' A' ' 178' ' ' VAL . 3.9 mm? -81.33 -26.33 35.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.95 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.31 -30.56 70.57 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.871 0.367 . . . . 0.0 110.301 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' HIS . . . . . 0.449 ' HB2' HG22 ' A' ' 224' ' ' ILE . 13.8 m170 -68.72 -17.51 64.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.189 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -67.78 137.3 92.66 Favored Pre-proline 0 CA--C 1.533 0.301 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.538 ' O ' ' HB3' ' A' ' 223' ' ' ALA . 59.7 Cg_endo -71.31 155.0 97.3 Favored 'Cis proline' 0 C--N 1.355 0.88 0 C-N-CA 124.728 -0.947 . . . . 0.0 112.799 0.296 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' A' ' 222' ' ' PRO . . . 85.18 74.49 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.714 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.624 HD12 HG11 ' A' ' 207' ' ' VAL . 7.5 pt -125.38 -179.42 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.027 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 64.44 164.66 0.14 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.081 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -143.64 -165.11 2.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.179 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -106.43 34.11 3.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.929 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.587 ' O ' HD23 ' A' ' 228' ' ' LEU . 5.1 tt -86.28 8.54 20.9 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.829 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.45 40.5 1.3 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.944 0.402 . . . . 0.0 110.952 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' ARG . . . . . 0.503 ' O ' HG23 ' A' ' 232' ' ' VAL . 31.3 mtp180 -94.28 -34.61 12.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.875 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -61.14 -37.05 81.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.963 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 230' ' ' ARG . 21.1 t 63.71 151.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.206 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.794 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.207 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.6 m -70.01 -32.15 70.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.821 0.343 . . . . 0.0 110.88 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -82.71 157.96 23.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.955 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.779 ' HB2' HD13 ' A' ' 134' ' ' LEU . 82.3 m95 -80.66 168.41 18.9 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.143 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -101.06 132.34 46.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.761 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 12.1 mtm-85 -69.94 106.12 3.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.667 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.891 HD11 HG22 ' A' ' 168' ' ' THR . 43.4 pt -94.5 -7.82 9.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.409 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -160.46 176.81 11.22 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 121.158 -0.217 . . . . 0.0 110.669 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.475 ' O ' ' HA ' ' A' ' 154' ' ' VAL . 30.4 m-85 -142.34 126.96 17.96 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.11 -0.329 . . . . 0.0 110.11 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.552 HG21 ' CD1' ' A' ' 139' ' ' LEU . 3.9 t -93.22 122.49 44.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.345 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -80.42 94.39 6.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.632 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -146.92 156.5 43.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.375 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.34 29.79 19.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.86 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 62.76 34.92 14.24 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.108 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.447 HG22 ' N ' ' A' ' 130' ' ' PHE . 86.7 m -158.06 161.76 38.05 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.194 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.447 ' N ' HG22 ' A' ' 129' ' ' THR . 6.3 m-85 -98.2 90.9 5.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.142 0.496 . . . . 0.0 111.041 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.479 ' HB2' HD21 ' A' ' 139' ' ' LEU . 23.9 m-85 -69.67 120.35 76.85 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.248 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.42 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 23.5 Cg_exo -64.2 117.63 4.64 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.341 2.027 . . . . 0.0 112.798 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.643 HD21 ' OG1' ' A' ' 168' ' ' THR . 35.9 tp -96.84 123.65 40.6 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.144 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.779 HD13 ' HB2' ' A' ' 118' ' ' TRP . 55.9 mt -70.75 171.39 10.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.666 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.412 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 2.1 pt-20 -62.82 -29.36 70.67 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.938 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -89.29 10.3 22.8 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.156 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.645 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 76.57 18.05 79.38 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.159 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.715 ' HB3' HD12 ' A' ' 134' ' ' LEU . 18.3 tpp85 -76.97 94.04 3.9 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.552 ' CD1' HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -68.14 110.03 3.8 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.675 -178.889 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 37.5 mt -81.74 73.62 8.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.676 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.452 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 13.1 mtpt -60.72 -17.86 50.89 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.575 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -101.32 25.01 8.75 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.535 0.207 . . . . 0.0 111.219 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -145.83 26.7 1.23 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.707 0.289 . . . . 0.0 111.353 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . -59.21 164.16 10.66 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.719 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.8 t -135.24 148.55 49.63 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.925 0.393 . . . . 0.0 110.784 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 3.6 mmtt -90.04 53.24 2.47 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.491 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.72 153.56 4.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.361 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -88.62 133.8 35.37 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.83 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.448 ' HG3' ' CD1' ' A' ' 123' ' ' TYR . 73.7 Cg_endo -81.63 98.86 1.01 Allowed 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.905 2.404 . . . . 0.0 112.505 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.0 t -67.23 -9.62 42.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.877 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -89.65 -22.23 22.39 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 111.666 0.247 . . . . 0.0 111.666 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.731 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -139.03 168.07 16.88 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.067 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.731 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 61.6 Cg_endo -74.12 165.81 31.09 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.352 2.035 . . . . 0.0 112.278 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 25.6 t -125.12 107.83 18.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.035 0.445 . . . . 0.0 111.744 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.882 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.43 96.19 1.87 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.023 179.336 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.444 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 61.9 t -94.17 138.02 21.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.085 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 48.01 56.05 9.36 Favored Glycine 0 CA--C 1.52 0.39 0 CA-C-N 115.964 -0.562 . . . . 0.0 113.261 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.882 ' CE2' HD23 ' A' ' 155' ' ' LEU . 3.4 m95 -99.16 151.16 21.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.187 0.518 . . . . 0.0 111.659 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.47 -172.37 0.16 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.519 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -43.06 154.22 0.08 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.567 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.06 -24.89 52.53 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.267 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -60.26 -39.27 86.17 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.998 0.427 . . . . 0.0 110.162 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.7 -39.51 51.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.18 179.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.567 HD12 ' HA2' ' A' ' 161' ' ' GLY . 7.1 mt -60.07 -42.13 88.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.126 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.48 -30.83 54.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.285 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.414 ' HB3' HG21 ' A' ' 211' ' ' ILE . 3.0 mm-40 -65.95 -53.27 41.19 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.409 0.623 . . . . 0.0 110.01 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.785 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -61.48 -43.05 99.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.087 179.06 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.891 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -59.19 -37.28 77.02 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.38 179.281 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.52 -38.37 94.79 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 110.456 -1.057 . . . . 0.0 110.456 178.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 33.6 mm-40 -71.31 -44.15 65.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.384 -0.408 . . . . 0.0 110.801 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.659 ' HA ' HD22 ' A' ' 174' ' ' LEU . 10.5 mp -66.92 -28.41 68.27 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.7 0.286 . . . . 0.0 111.384 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.83 -16.18 62.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.377 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -114.7 -29.25 6.84 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 111.561 0.208 . . . . 0.0 111.561 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.659 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER -56.85 167.16 1.12 Allowed Pre-proline 0 CA--C 1.538 0.5 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.121 -179.673 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -69.99 126.94 13.73 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.153 1.902 . . . . 0.0 113.043 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.35 -25.31 5.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.696 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -56.08 -50.72 70.21 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.907 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.886 HG11 ' HB3' ' A' ' 218' ' ' LEU . 42.8 t -74.74 -34.74 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.54 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.478 ' HB2' HD21 ' A' ' 174' ' ' LEU . 11.6 tp -54.92 -35.32 64.04 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.181 0.515 . . . . 0.0 110.13 179.069 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -79.99 -41.83 11.8 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 111.169 -0.773 . . . . 0.0 111.169 178.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -82.3 103.14 11.66 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.843 0.354 . . . . 0.0 110.469 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' MET . . . . . 0.844 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.9 mtm 177.81 171.6 0.64 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.129 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.3 m -127.54 -54.59 1.34 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.811 0.338 . . . . 0.0 110.877 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -163.49 142.32 8.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.029 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.925 HG12 HG12 ' A' ' 199' ' ' VAL . 18.6 mt -105.51 114.32 44.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.137 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' HIS . . . . . 0.444 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 19.2 m170 -105.88 114.92 29.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.424 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.419 ' HB2' ' CD2' ' A' ' 158' ' ' TRP . 83.8 t80 -66.09 104.43 1.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.136 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -126.78 87.65 56.09 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.939 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.25 159.61 52.47 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.432 2.088 . . . . 0.0 112.288 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 5.5 p -134.14 169.29 17.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.61 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -59.88 -26.97 66.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.096 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.428 ' HG2' ' CD2' ' A' ' 193' ' ' TYR . 0.5 OUTLIER -118.18 11.21 13.16 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.594 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.428 ' CD2' ' HG2' ' A' ' 192' ' ' GLU . 58.0 m-85 -157.73 75.25 0.77 Allowed 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 120.987 0.422 . . . . 0.0 111.131 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -56.91 -25.85 58.01 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.166 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 6.9 p30 -102.15 37.27 1.91 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.556 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 2.0 tpm_? -89.5 114.23 25.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.134 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.686 ' O ' HD13 ' A' ' 198' ' ' ILE . 28.7 m -110.48 166.0 5.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.622 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.686 HD13 ' O ' ' A' ' 197' ' ' VAL . 19.1 mm -131.43 106.14 11.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.805 0.336 . . . . 0.0 111.43 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.925 HG12 HG12 ' A' ' 185' ' ' ILE . 9.5 m -96.11 118.36 42.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.919 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -81.63 152.92 26.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.547 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.17 148.15 28.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.863 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 36.1 m-20 -58.24 -28.85 65.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.017 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -76.86 -4.68 44.93 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.765 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 97.41 14.46 41.26 Favored Glycine 0 C--N 1.335 0.517 0 C-N-CA 120.533 -0.841 . . . . 0.0 113.106 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -87.61 170.99 10.8 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.957 0.408 . . . . 0.0 111.103 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -135.04 111.12 9.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.623 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.437 ' HB ' HG23 ' A' ' 199' ' ' VAL . 28.9 t -113.94 124.82 70.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.881 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 2.8 m -102.17 115.64 30.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.781 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -123.49 171.01 9.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.82 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -107.42 155.09 20.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.474 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.414 HG21 ' HB3' ' A' ' 166' ' ' GLU . 38.5 mt -68.13 -35.95 73.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.807 0.336 . . . . 0.0 110.76 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -62.85 -36.87 84.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.258 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -130.64 40.99 3.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.953 0.406 . . . . 0.0 111.068 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.542 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 10.6 t80 -64.06 -55.04 25.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.553 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.04 -42.73 85.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.271 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -66.67 -48.21 70.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.015 0.436 . . . . 0.0 110.496 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' LYS . . . . . 0.437 ' O ' HG21 ' A' ' 224' ' ' ILE . 1.2 mmpt? -55.1 -44.4 74.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.279 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.886 ' HB3' HG11 ' A' ' 178' ' ' VAL . 3.7 mm? -83.99 -25.69 29.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.074 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 14.9 t -60.74 -32.81 72.08 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.973 0.416 . . . . 0.0 110.157 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 24.5 m170 -71.17 -16.72 62.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.181 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.42 ' CE1' ' HB3' ' A' ' 222' ' ' PRO . 3.5 t80 -56.96 135.52 79.92 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.877 -0.147 . . . . 0.0 110.986 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.42 ' HB3' ' CE1' ' A' ' 221' ' ' TYR . 57.1 Cg_endo -90.51 107.91 0.79 Allowed 'Cis proline' 0 C--N 1.357 0.983 0 C-N-CA 124.681 -0.966 . . . . 0.0 112.631 0.091 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . 178.84 42.56 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.096 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.437 HG21 ' O ' ' A' ' 217' ' ' LYS . 0.2 OUTLIER -146.01 160.51 11.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.078 179.82 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 225' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' A' ' 224' ' ' ILE . . . 176.81 40.33 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.083 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . 59.99 -176.25 0.1 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.075 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.401 ' C ' HD12 ' A' ' 228' ' ' LEU . . . -138.41 31.49 2.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.048 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.401 HD12 ' C ' ' A' ' 227' ' ' ALA . 10.8 mp -118.84 32.61 6.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.854 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -112.69 44.64 1.44 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.812 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 48.3 mtp85 -136.45 -53.39 0.72 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.983 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 43.7 m-20 -90.93 81.59 5.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.879 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 10.2 m -75.09 177.46 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.061 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 6.8 ttmm . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.188 -0.911 . . . . 0.0 110.88 179.959 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.15 0 N-CA-C 112.469 -0.252 . . . . 0.0 112.469 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.8 m -96.69 80.12 3.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.804 0.335 . . . . 0.0 110.931 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -133.69 151.39 51.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.876 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.769 ' HB2' HD13 ' A' ' 134' ' ' LEU . 81.0 m95 -73.56 168.48 19.21 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.185 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -102.88 132.24 49.22 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.808 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.31 107.03 3.11 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.777 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.887 HD11 HG22 ' A' ' 168' ' ' THR . 44.2 pt -96.21 -7.8 9.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.498 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.435 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -159.94 176.78 11.47 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.003 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.463 ' O ' ' HA ' ' A' ' 154' ' ' VAL . 33.1 m-85 -143.41 127.2 17.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.284 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.577 HG21 ' CD1' ' A' ' 139' ' ' LEU . 3.6 t -93.44 122.71 45.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.098 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -82.52 94.11 7.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.36 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -145.22 155.68 43.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.255 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 59.31 29.45 19.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.855 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 62.88 35.03 13.82 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.142 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 53.3 m -157.13 156.76 33.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.836 0.351 . . . . 0.0 111.17 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -94.75 91.39 6.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.888 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.45 ' CG ' ' HA ' ' A' ' 141' ' ' LYS . 23.3 m-85 -70.81 121.75 84.77 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.303 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.409 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 22.3 Cg_exo -64.81 121.66 9.26 Favored 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 122.414 2.076 . . . . 0.0 112.757 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.658 HD21 ' OG1' ' A' ' 168' ' ' THR . 31.1 tp -102.09 123.36 45.82 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-O 121.128 0.49 . . . . 0.0 110.087 178.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.769 HD13 ' HB2' ' A' ' 118' ' ' TRP . 51.5 mt -70.72 171.81 9.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.652 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.407 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.6 pt-20 -62.94 -28.32 69.99 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.979 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 50.8 p-10 -90.46 11.97 20.0 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.225 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.628 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 75.15 18.79 80.05 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.237 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.69 ' HB3' HD12 ' A' ' 134' ' ' LEU . 1.5 tpt180 -77.6 92.43 4.09 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.577 ' CD1' HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -66.41 113.78 4.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.418 -179.053 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.503 HD13 ' HG3' ' A' ' 143' ' ' GLU . 30.1 mt -84.01 70.07 10.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.69 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.45 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 5.4 mtpt -58.26 -20.3 41.18 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.56 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -99.38 25.24 7.15 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.739 -0.21 . . . . 0.0 111.27 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.503 ' HG3' HD13 ' A' ' 140' ' ' LEU . 54.3 mm-40 -147.16 24.83 1.14 Allowed 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.582 0.23 . . . . 0.0 111.493 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . -59.41 161.71 15.21 Favored Glycine 0 CA--C 1.509 -0.335 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.747 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 9.0 t -131.27 154.51 48.42 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.041 0.448 . . . . 0.0 110.7 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -92.95 53.92 2.08 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.766 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.74 170.81 6.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.256 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -104.26 135.85 19.27 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.537 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.449 ' HG3' ' CD1' ' A' ' 123' ' ' TYR . 68.3 Cg_endo -82.77 99.67 0.93 Allowed 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.95 2.433 . . . . 0.0 112.443 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.4 t -67.01 -10.1 46.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.844 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.92 -22.08 22.16 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.692 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -138.67 166.69 23.4 Favored Pre-proline 0 C--N 1.328 -0.356 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -178.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.692 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 61.3 Cg_endo -73.87 164.2 35.19 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 122.487 2.125 . . . . 0.0 112.3 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 24.3 t -123.4 109.68 24.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.666 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.841 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.58 96.77 2.02 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.947 179.344 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 59.5 t -94.68 136.87 24.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.983 0.421 . . . . 0.0 111.124 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 49.7 51.33 28.71 Favored Glycine 0 CA--C 1.52 0.375 0 CA-C-N 115.811 -0.631 . . . . 0.0 113.259 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.841 ' CE2' HD23 ' A' ' 155' ' ' LEU . 2.9 m95 -94.75 151.01 19.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.054 0.454 . . . . 0.0 111.574 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -66.0 -172.43 0.14 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.421 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -43.67 154.7 0.09 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.073 0.463 . . . . 0.0 112.217 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.55 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -56.45 -25.24 48.91 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.269 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.33 -39.17 86.12 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 120.912 0.387 . . . . 0.0 110.058 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.19 -40.22 52.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.102 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.55 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.1 mt -59.13 -41.58 84.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.909 179.073 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.44 -30.74 53.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.2 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.4 ' CB ' HG21 ' A' ' 211' ' ' ILE . 3.2 mm-40 -67.21 -53.17 32.67 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-O 121.439 0.638 . . . . 0.0 110.072 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.802 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -59.72 -45.53 91.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.989 178.865 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.887 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -57.28 -36.77 71.45 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.565 179.037 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.13 -38.21 94.04 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 178.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -71.24 -48.17 52.83 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.329 -0.436 . . . . 0.0 110.939 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.612 ' HA ' HD22 ' A' ' 174' ' ' LEU . 10.9 mp -64.51 -28.6 69.76 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.742 0.306 . . . . 0.0 111.275 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.87 -18.37 63.41 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.37 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -112.15 -28.32 8.02 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.645 0.26 . . . . 0.0 111.421 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.612 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.1 OUTLIER -57.55 166.9 1.51 Allowed Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.998 -179.695 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -70.04 128.78 16.26 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.263 1.975 . . . . 0.0 112.898 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.94 -25.8 9.01 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.64 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -58.05 -48.79 79.04 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.881 0.372 . . . . 0.0 110.935 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.882 HG11 ' HB3' ' A' ' 218' ' ' LEU . 24.6 t -73.66 -35.31 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.504 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 11.5 tp -55.26 -34.61 64.19 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.234 0.54 . . . . 0.0 109.987 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -78.71 -42.73 12.86 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.314 178.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -82.16 103.19 11.59 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.899 0.381 . . . . 0.0 110.404 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' MET . . . . . 0.84 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.9 mtm 177.65 173.48 0.54 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.956 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 3.2 t -133.09 -51.65 0.89 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.705 0.288 . . . . 0.0 111.229 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' GLU . . . . . 0.428 ' HG2' ' CD1' ' A' ' 200' ' ' TYR . 1.3 pm0 -163.13 142.85 8.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.035 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.898 HG12 HG12 ' A' ' 199' ' ' VAL . 19.9 mt -106.66 114.24 45.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.442 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -104.6 124.04 48.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.16 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -80.47 104.82 11.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.368 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.71 85.91 56.37 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.54 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.27 140.29 44.14 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.258 1.972 . . . . 0.0 112.419 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 17.2 p -117.9 160.54 21.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.76 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -54.7 -28.65 49.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.335 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -102.41 -15.9 16.37 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.841 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -141.05 80.21 1.73 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.924 0.392 . . . . 0.0 111.464 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -56.66 -22.01 31.47 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.43 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -107.13 38.33 2.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.772 0.32 . . . . 0.0 110.616 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -91.1 115.75 28.27 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.985 0.421 . . . . 0.0 111.379 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.727 ' O ' HD13 ' A' ' 198' ' ' ILE . 27.7 m -112.55 166.6 6.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.655 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.727 HD13 ' O ' ' A' ' 197' ' ' VAL . 21.5 mm -131.68 109.85 16.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.732 0.301 . . . . 0.0 111.29 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.898 HG12 HG12 ' A' ' 185' ' ' ILE . 8.5 m -100.08 124.92 53.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.912 0.387 . . . . 0.0 111.021 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.428 ' CD1' ' HG2' ' A' ' 184' ' ' GLU . 44.8 m-85 -86.6 152.53 22.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.571 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 5.5 mmt -104.07 165.4 11.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.937 0.399 . . . . 0.0 110.936 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -67.4 -26.15 66.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.062 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -89.94 13.87 13.59 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 80.99 14.44 79.42 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 120.556 -0.831 . . . . 0.0 113.321 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -77.0 168.09 20.69 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 117.119 0.46 . . . . 0.0 110.729 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -134.51 111.57 10.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.851 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.679 HG11 HD12 ' A' ' 224' ' ' ILE . 17.9 t -119.38 123.91 72.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.165 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.544 ' HB2' HD12 ' A' ' 198' ' ' ILE . 27.1 t -101.29 114.84 29.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.751 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.625 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -122.91 161.75 23.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.862 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.83 154.94 17.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.624 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.4 HG21 ' CB ' ' A' ' 166' ' ' GLU . 36.8 mt -67.18 -30.14 48.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.713 0.292 . . . . 0.0 110.986 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -72.07 -38.26 69.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.289 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -121.99 34.69 5.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.038 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.602 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 12.0 t80 -62.0 -56.05 23.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.926 0.393 . . . . 0.0 110.7 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.63 -40.64 83.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.138 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -67.42 -49.19 64.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.952 0.406 . . . . 0.0 110.365 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.42 -45.02 72.91 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.057 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.882 ' HB3' HG11 ' A' ' 178' ' ' VAL . 3.8 mm? -80.89 -27.67 36.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.785 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 13.5 t -60.64 -30.34 69.81 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.846 0.355 . . . . 0.0 110.529 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 65.6 m-70 -69.25 -16.9 63.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.21 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -64.66 139.46 97.76 Favored Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 121.285 -0.166 . . . . 0.0 110.844 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.496 ' O ' ' HB2' ' A' ' 223' ' ' ALA . 70.5 Cg_endo -86.64 110.47 1.64 Allowed 'Cis proline' 0 C--N 1.357 0.976 0 C-N-CA 124.532 -1.029 . . . . 0.0 112.609 0.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.496 ' HB2' ' O ' ' A' ' 222' ' ' PRO . . . 169.27 43.94 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.216 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.679 HD12 HG11 ' A' ' 207' ' ' VAL . 9.9 pt -120.76 -178.48 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.273 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 224' ' ' ILE . . . 77.19 68.61 0.05 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.043 0.449 . . . . 0.0 110.99 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -89.91 -157.0 0.44 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.576 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -92.1 20.49 5.84 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.448 ' HA ' HD22 ' A' ' 228' ' ' LEU . 0.3 OUTLIER -114.9 26.54 10.08 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.793 0.33 . . . . 0.0 110.666 179.513 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -135.12 73.87 1.5 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.047 0.451 . . . . 0.0 110.877 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -153.26 -48.74 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.87 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ASN . . . . . 0.498 ' O ' HG13 ' A' ' 232' ' ' VAL . 3.7 m-80 64.0 -79.27 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.004 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 232' ' ' VAL . . . . . 0.498 HG13 ' O ' ' A' ' 231' ' ' ASN . 5.0 m -157.84 178.53 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.833 0.349 . . . . 0.0 111.065 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 22.0 pttt . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.83 -179.958 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.185 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 59.1 p -72.27 149.23 44.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.744 0.307 . . . . 0.0 110.916 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -157.98 154.18 27.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.959 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.767 ' HB2' HD13 ' A' ' 134' ' ' LEU . 81.9 m95 -74.15 168.4 19.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.143 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 6.9 ptt180 -101.7 134.49 44.78 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.845 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -71.2 106.89 3.96 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.858 0.361 . . . . 0.0 110.75 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.918 HD11 HG22 ' A' ' 168' ' ' THR . 46.0 pt -95.93 -9.45 9.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.315 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.467 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -157.75 176.14 12.97 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 120.586 0.231 . . . . 0.0 110.691 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.47 ' CD1' ' HG3' ' A' ' 149' ' ' PRO . 29.9 m-85 -143.92 126.7 16.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.16 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.646 HG21 HD11 ' A' ' 139' ' ' LEU . 4.3 t -93.12 122.42 44.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.279 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.497 ' CE1' ' CE1' ' A' ' 130' ' ' PHE . 7.3 t80 -81.92 97.13 7.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.935 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -149.14 151.62 34.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.44 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 61.17 30.88 19.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.804 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 61.81 31.29 18.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.034 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.501 HG23 ' O ' ' A' ' 145' ' ' THR . 70.4 m -151.2 151.13 31.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.941 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.639 ' CE2' ' HB2' ' A' ' 148' ' ' ALA . 12.1 m-85 -93.07 91.05 7.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.701 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.507 ' HB2' HD21 ' A' ' 139' ' ' LEU . 23.5 m-85 -66.57 123.38 85.56 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.665 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -70.65 113.32 3.48 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 122.107 1.872 . . . . 0.0 112.727 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.647 HD21 ' OG1' ' A' ' 168' ' ' THR . 32.2 tp -92.44 124.02 36.18 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.706 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.767 HD13 ' HB2' ' A' ' 118' ' ' TRP . 48.1 mt -69.86 174.25 5.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.503 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -65.73 -28.31 68.95 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.029 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -89.74 11.84 18.82 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.156 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.625 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 74.1 22.8 77.37 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.937 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.687 ' HB3' HD12 ' A' ' 134' ' ' LEU . 18.2 tpp180 -81.92 93.62 6.95 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.646 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -68.69 109.34 3.76 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.151 -179.155 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 15.7 mt -85.14 71.64 10.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.87 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.478 ' HE3' HD13 ' A' ' 139' ' ' LEU . 12.8 mttt -57.77 -21.14 39.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.469 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -94.28 20.05 8.67 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.419 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -145.15 26.95 1.31 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.846 0.355 . . . . 0.0 111.045 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.77 163.89 39.76 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.96 -0.638 . . . . 0.0 113.199 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.501 ' O ' HG23 ' A' ' 129' ' ' THR . 6.7 t -130.69 157.01 43.94 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.328 -0.436 . . . . 0.0 110.563 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.3 mmmt -94.3 50.09 1.35 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.548 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.15 150.35 3.0 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.695 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.639 ' HB2' ' CE2' ' A' ' 130' ' ' PHE . . . -93.05 125.64 54.16 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.242 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.47 ' HG3' ' CD1' ' A' ' 123' ' ' TYR . 71.9 Cg_endo -84.1 111.32 1.62 Allowed 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.433 2.089 . . . . 0.0 112.599 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 45.5 t -69.62 -8.19 45.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.013 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -77.25 -23.51 51.24 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 120.865 0.364 . . . . 0.0 110.54 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.665 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -140.17 166.62 22.25 Favored Pre-proline 0 N--CA 1.453 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.562 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.665 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 66.7 Cg_endo -74.99 158.03 42.49 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.342 2.028 . . . . 0.0 112.331 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 14.3 t -118.24 110.67 31.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.251 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.838 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.52 96.25 1.92 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.726 179.206 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.42 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 61.7 t -93.35 137.22 23.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.007 0.432 . . . . 0.0 111.149 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 49.0 54.13 15.77 Favored Glycine 0 CA--C 1.52 0.363 0 CA-C-N 115.859 -0.609 . . . . 0.0 113.327 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.838 ' CE2' HD23 ' A' ' 155' ' ' LEU . 2.7 m95 -97.32 151.13 20.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.118 0.485 . . . . 0.0 111.55 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.22 -172.41 0.15 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.322 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -43.21 154.99 0.07 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.543 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -56.51 -24.51 46.93 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.154 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -60.33 -40.27 90.02 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.969 0.414 . . . . 0.0 109.911 179.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.51 ' HB1' ' HE2' ' A' ' 187' ' ' TYR . . . -74.39 -41.43 60.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.972 178.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.543 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.6 mt -58.28 -42.21 83.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.009 179.06 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.77 -29.89 42.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.192 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.429 ' CB ' HG21 ' A' ' 211' ' ' ILE . 4.2 mm-40 -68.19 -53.2 26.6 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.435 0.636 . . . . 0.0 110.107 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.804 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -59.08 -45.97 89.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.099 178.981 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.918 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -56.98 -37.52 71.75 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.709 179.258 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.14 -37.86 93.52 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 47.9 mm-40 -72.89 -46.32 53.43 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.419 -0.39 . . . . 0.0 111.135 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.613 ' HA ' HD22 ' A' ' 174' ' ' LEU . 11.1 mp -65.86 -28.57 69.06 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.658 0.266 . . . . 0.0 111.406 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.52 -17.67 62.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.379 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -112.51 -28.79 7.72 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 120.697 0.284 . . . . 0.0 111.453 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.613 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.1 OUTLIER -56.94 167.28 1.11 Allowed Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.188 -179.564 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -69.24 127.15 14.58 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.21 1.94 . . . . 0.0 112.861 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.11 -25.51 9.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.592 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -58.46 -48.99 78.92 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.959 0.409 . . . . 0.0 110.889 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.854 HG11 ' HB3' ' A' ' 218' ' ' LEU . 27.2 t -73.75 -33.8 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.438 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.408 ' HB2' HD21 ' A' ' 174' ' ' LEU . 13.8 tp -56.46 -35.26 67.72 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.141 0.496 . . . . 0.0 109.815 179.009 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -78.02 -40.84 19.73 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.188 178.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -84.6 102.84 13.22 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.977 0.418 . . . . 0.0 110.57 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' MET . . . . . 0.842 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.9 mtm 177.63 173.55 0.54 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.007 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 4.7 t -133.68 -50.27 0.84 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.752 0.31 . . . . 0.0 111.225 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -163.45 145.25 9.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.025 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.905 HG12 HG12 ' A' ' 199' ' ' VAL . 20.2 mt -110.87 115.99 51.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.539 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' HIS . . . . . 0.42 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 20.3 m170 -106.64 137.82 43.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.208 -179.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.51 ' HE2' ' HB1' ' A' ' 163' ' ' ALA . 0.2 OUTLIER -87.86 104.54 16.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.472 179.596 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.35 89.27 50.26 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.87 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.78 158.76 55.83 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.314 2.009 . . . . 0.0 112.486 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 6.9 p -133.59 170.0 16.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.75 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 7.4 ptt180 -60.23 -27.42 67.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.151 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.403 ' O ' ' CG ' ' A' ' 193' ' ' TYR . 1.7 mm-40 -117.3 10.6 13.76 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.403 ' CG ' ' O ' ' A' ' 192' ' ' GLU . 73.7 m-85 -156.96 75.5 0.83 Allowed 'General case' 0 C--O 1.231 0.108 0 CA-C-O 120.949 0.404 . . . . 0.0 111.208 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -57.21 -26.36 60.57 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.215 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ASP . . . . . 0.4 ' HB2' ' HB ' ' A' ' 211' ' ' ILE . 6.8 p30 -102.94 37.09 2.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.752 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -87.59 115.39 24.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.938 0.399 . . . . 0.0 111.093 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.813 ' O ' HD13 ' A' ' 198' ' ' ILE . 30.5 m -112.14 168.19 5.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.686 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.813 HD13 ' O ' ' A' ' 197' ' ' VAL . 25.7 mm -132.61 109.77 15.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.785 0.326 . . . . 0.0 111.318 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.905 HG12 HG12 ' A' ' 185' ' ' ILE . 6.9 m -99.0 121.04 49.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.901 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -81.94 152.52 26.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.835 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.04 146.44 35.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.863 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -57.32 -22.61 43.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.504 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -89.7 15.22 9.99 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 79.62 14.41 81.22 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.241 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -90.59 149.92 21.94 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 117.137 0.468 . . . . 0.0 110.801 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -119.38 111.33 18.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.765 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 20.8 t -111.68 126.23 69.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.964 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.578 ' OG ' HD12 ' A' ' 198' ' ' ILE . 11.0 m -103.08 116.36 32.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.934 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -121.84 -177.58 3.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.569 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.66 153.7 35.15 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.494 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.429 HG21 ' CB ' ' A' ' 166' ' ' GLU . 43.7 mt -66.63 -34.93 73.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.811 0.339 . . . . 0.0 110.775 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.4 -36.42 81.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.207 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -129.92 45.27 2.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.978 0.418 . . . . 0.0 110.903 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.621 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 11.6 t80 -68.53 -52.24 34.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.768 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.9 -39.7 86.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.132 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.71 -49.99 64.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.146 0.498 . . . . 0.0 110.603 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 217' ' ' LYS . . . . . 0.691 ' O ' HG21 ' A' ' 224' ' ' ILE . 1.8 mmpt? -53.99 -44.08 70.52 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.41 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.854 ' HB3' HG11 ' A' ' 178' ' ' VAL . 3.9 mm? -84.85 -23.77 28.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.266 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.31 -33.59 73.83 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.003 0.43 . . . . 0.0 109.934 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 38.2 m170 -70.06 -16.16 63.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.236 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.412 ' CE1' ' HB3' ' A' ' 222' ' ' PRO . 12.6 t80 -56.82 137.62 78.59 Favored Pre-proline 0 CA--C 1.535 0.367 0 O-C-N 122.535 -0.103 . . . . 0.0 111.134 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.416 ' O ' ' HB2' ' A' ' 223' ' ' ALA . 51.9 Cg_endo -91.81 105.43 0.45 Allowed 'Cis proline' 0 C--N 1.357 0.995 0 C-N-CA 124.702 -0.958 . . . . 0.0 112.539 0.098 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 222' ' ' PRO . . . 176.47 42.85 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.969 0.414 . . . . 0.0 111.124 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.691 HG21 ' O ' ' A' ' 217' ' ' LYS . 0.2 OUTLIER -117.65 -178.63 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.136 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 225' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 224' ' ' ILE . . . 70.34 86.49 0.12 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.971 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -76.79 -163.8 0.37 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.096 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -98.82 33.06 2.41 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.882 0.372 . . . . 0.0 110.906 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 1.3 tp -83.65 5.5 24.25 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.75 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -118.69 31.7 6.52 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.861 0.363 . . . . 0.0 110.888 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -176.79 37.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.947 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -168.97 -60.13 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.85 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 21.5 t -108.38 106.79 21.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.078 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 2.3 mttm . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.878 179.98 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.152 0 N-CA-C 112.535 -0.226 . . . . 0.0 112.535 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.51 88.75 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.852 0.358 . . . . 0.0 110.941 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -77.66 153.08 33.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.995 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.769 ' HB2' HD13 ' A' ' 134' ' ' LEU . 80.7 m95 -77.13 168.36 20.21 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.053 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.32 133.77 46.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.818 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.4 mtt85 -70.4 106.78 3.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.869 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.904 HD11 HG22 ' A' ' 168' ' ' THR . 44.6 pt -95.47 -8.44 9.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.412 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.406 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -159.38 176.28 12.32 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 120.588 0.232 . . . . 0.0 110.894 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.453 ' O ' ' HA ' ' A' ' 154' ' ' VAL . 32.2 m-85 -143.5 126.96 16.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.332 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.645 HG21 HD11 ' A' ' 139' ' ' LEU . 5.0 t -93.36 122.63 45.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.083 0.468 . . . . 0.0 111.12 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.5 ' CD1' ' CE1' ' A' ' 130' ' ' PHE . 7.9 t80 -82.52 103.84 12.35 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.857 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -158.44 154.22 26.5 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.592 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.62 30.65 19.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.803 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 62.99 31.48 16.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.274 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 88.1 m -153.79 156.77 38.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.89 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.5 ' CE1' ' CD1' ' A' ' 125' ' ' TYR . 81.2 m-85 -98.42 90.88 4.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.602 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.491 ' HB2' HD21 ' A' ' 139' ' ' LEU . 23.4 m-85 -65.35 123.79 85.26 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.117 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.402 ' HB3' ' CE2' ' A' ' 123' ' ' TYR . 56.1 Cg_endo -71.57 115.22 4.21 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.255 1.97 . . . . 0.0 112.793 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.687 HD21 ' OG1' ' A' ' 168' ' ' THR . 29.2 tp -94.09 124.06 37.86 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.665 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.769 HD13 ' HB2' ' A' ' 118' ' ' TRP . 52.8 mt -70.69 173.29 7.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.517 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.4 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.3 pt-20 -64.3 -28.66 69.87 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.969 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -89.8 11.72 19.28 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.251 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.602 ' HA2' HD11 ' A' ' 133' ' ' LEU . . . 74.38 22.72 77.11 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.726 -0.75 . . . . 0.0 113.048 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.693 ' HB3' HD12 ' A' ' 134' ' ' LEU . 1.4 tpt180 -81.43 94.53 6.84 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.645 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -70.96 107.88 4.28 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.211 -179.164 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 16.7 mt -86.17 72.85 10.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.547 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.46 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 23.8 mttp -56.86 -20.95 25.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.77 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -85.24 -14.87 45.39 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -112.03 30.82 6.7 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . -60.5 166.24 12.12 Favored Glycine 0 CA--C 1.511 -0.185 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.453 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 9.0 t -135.3 148.27 49.45 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.992 0.425 . . . . 0.0 111.029 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 3.0 mmtt -90.86 52.82 2.24 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.356 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.68 152.22 3.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.549 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -86.99 135.95 34.61 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.833 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.452 ' HD2' ' CG2' ' A' ' 154' ' ' VAL . 60.6 Cg_endo -84.46 98.42 0.72 Allowed 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.028 2.485 . . . . 0.0 112.641 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.2 t -67.46 -9.13 39.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.714 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -90.35 -22.06 21.7 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 111.533 0.197 . . . . 0.0 111.533 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.717 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -138.7 167.43 19.52 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.717 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 60.9 Cg_endo -73.36 161.85 41.7 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.533 2.156 . . . . 0.0 112.382 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 24.2 t -123.07 110.03 25.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.044 0.45 . . . . 0.0 111.712 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.827 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.62 95.92 1.91 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.74 179.156 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 59.6 t -91.37 137.06 22.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.99 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 46.72 56.59 7.33 Favored Glycine 0 CA--C 1.52 0.399 0 CA-C-N 115.882 -0.599 . . . . 0.0 113.374 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.827 ' CE2' HD23 ' A' ' 155' ' ' LEU . 2.7 m95 -98.25 151.2 20.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.26 0.552 . . . . 0.0 111.707 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 8.1 mmtm -65.23 -172.44 0.1 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.59 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -43.62 154.02 0.1 Allowed 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.54 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.21 -24.85 52.89 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.224 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.01 -38.53 82.9 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.984 0.421 . . . . 0.0 110.056 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.01 -40.24 47.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.003 178.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.54 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.2 mt -58.87 -41.46 82.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.874 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.09 -29.68 45.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.276 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.432 ' CB ' HG21 ' A' ' 211' ' ' ILE . 3.0 mm-40 -69.08 -53.03 22.47 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.31 0.576 . . . . 0.0 110.256 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.825 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -59.1 -44.52 91.97 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.041 178.965 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.904 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -58.49 -38.22 77.19 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.397 179.214 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.19 -36.16 87.49 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 178.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -73.92 -47.59 36.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.264 -0.468 . . . . 0.0 110.988 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.611 ' HA ' HD22 ' A' ' 174' ' ' LEU . 11.0 mp -65.07 -27.93 69.11 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.754 0.311 . . . . 0.0 111.477 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.74 -18.6 62.78 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.297 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -113.4 -27.01 8.08 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.596 0.236 . . . . 0.0 111.626 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.611 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER -57.09 167.5 1.12 Allowed Pre-proline 0 CA--C 1.537 0.481 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.079 -179.684 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.52 128.22 15.92 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.2 1.933 . . . . 0.0 112.84 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.22 -25.38 9.1 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.631 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.74 -48.95 78.18 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.944 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.904 HG11 ' HB3' ' A' ' 218' ' ' LEU . 38.9 t -74.16 -35.48 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.439 179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.487 ' HB2' HD21 ' A' ' 174' ' ' LEU . 13.8 tp -56.82 -39.4 74.12 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.095 0.474 . . . . 0.0 109.969 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -73.6 -40.05 47.69 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 178.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -88.14 102.87 15.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.948 0.404 . . . . 0.0 110.577 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' MET . . . . . 0.837 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.8 mtm 177.69 164.19 0.62 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.146 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.53 -59.85 1.59 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.725 0.298 . . . . 0.0 111.091 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -155.24 142.58 19.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.034 0.445 . . . . 0.0 111.29 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.907 HG12 HG12 ' A' ' 199' ' ' VAL . 20.4 mt -104.69 114.86 45.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.317 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 23.6 m170 -103.12 117.46 34.59 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.256 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.41 ' HB2' ' CD2' ' A' ' 158' ' ' TRP . 71.2 t80 -76.4 104.48 6.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.432 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.94 82.44 43.21 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.647 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.403 ' HD3' ' CD2' ' A' ' 187' ' ' TYR . 60.7 Cg_endo -71.99 147.53 49.32 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.383 2.056 . . . . 0.0 112.559 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 19.5 p -128.52 160.35 32.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.699 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 6.0 ptp85 -52.52 -24.98 9.1 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.661 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -106.62 -19.22 13.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.685 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -136.37 75.57 1.55 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.912 0.387 . . . . 0.0 111.274 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -58.37 -20.1 41.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.577 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -110.32 36.21 3.15 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.691 0.281 . . . . 0.0 111.062 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 9.4 ttt180 -89.53 115.17 26.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.121 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.86 ' O ' HD13 ' A' ' 198' ' ' ILE . 22.5 m -111.91 166.91 5.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.955 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.86 HD13 ' O ' ' A' ' 197' ' ' VAL . 19.8 mm -133.9 107.72 10.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.8 0.333 . . . . 0.0 111.314 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.907 HG12 HG12 ' A' ' 185' ' ' ILE . 13.2 m -99.05 131.26 46.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.081 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -95.37 152.44 18.39 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.534 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.52 157.97 16.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.895 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -57.81 -24.8 59.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.343 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -90.42 15.45 10.65 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 79.53 14.32 81.45 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.565 -0.826 . . . . 0.0 113.243 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -75.75 164.98 25.7 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.994 0.397 . . . . 0.0 110.791 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -134.56 111.45 10.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.86 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.687 HG11 HD12 ' A' ' 224' ' ' ILE . 21.6 t -117.87 128.92 74.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.081 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 4.2 m -103.13 115.2 30.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.768 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.686 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -127.11 158.58 36.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.893 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.06 153.27 18.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.503 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.432 HG21 ' CB ' ' A' ' 166' ' ' GLU . 36.7 mt -65.07 -37.18 79.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.882 0.372 . . . . 0.0 110.867 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.48 -33.17 72.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.198 -179.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -134.89 42.27 2.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.86 0.362 . . . . 0.0 111.104 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.584 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 11.4 t80 -64.64 -52.24 58.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.625 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.69 -42.16 87.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.192 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.65 -48.78 63.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.063 0.458 . . . . 0.0 110.338 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 1.3 mmpt? -53.84 -41.63 67.62 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.06 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.904 ' HB3' HG11 ' A' ' 178' ' ' VAL . 3.8 mm? -87.0 -24.01 24.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.97 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 12.6 t -62.63 -30.47 71.38 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.81 0.338 . . . . 0.0 110.42 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' HIS . . . . . 0.734 ' HB2' HG22 ' A' ' 224' ' ' ILE . 38.7 m170 -69.03 -16.79 63.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.265 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.414 ' HA ' HG23 ' A' ' 224' ' ' ILE . 71.5 t80 -66.11 136.49 95.43 Favored Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 110.259 -0.275 . . . . 0.0 110.259 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.524 ' O ' ' HB3' ' A' ' 223' ' ' ALA . 65.5 Cg_endo -72.77 154.92 99.41 Favored 'Cis proline' 0 C--N 1.355 0.887 0 C-N-CA 124.585 -1.006 . . . . 0.0 112.795 0.064 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.524 ' HB3' ' O ' ' A' ' 222' ' ' PRO . . . 81.99 77.57 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.921 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.734 HG22 ' HB2' ' A' ' 220' ' ' HIS . 12.3 pt -127.74 -178.51 2.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.414 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 68.01 122.47 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.046 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -107.59 -164.99 1.01 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.173 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -105.08 36.24 2.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.86 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.578 ' O ' HD23 ' A' ' 228' ' ' LEU . 6.7 tt -80.03 0.9 29.81 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.986 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -89.95 53.03 2.42 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.081 0.467 . . . . 0.0 110.744 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.9 -28.66 20.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.166 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ASN . . . . . 0.493 ' O ' HG22 ' A' ' 232' ' ' VAL . 4.7 m120 -57.81 -74.56 0.06 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.081 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 232' ' ' VAL . . . . . 0.493 HG22 ' O ' ' A' ' 231' ' ' ASN . 17.5 m 46.19 -173.52 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.295 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.883 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.104 0 N-CA-C 112.522 -0.231 . . . . 0.0 112.522 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 59.98 109.36 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.759 0.314 . . . . 0.0 110.987 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -111.68 148.51 33.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.028 0.442 . . . . 0.0 110.972 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.759 ' HB2' HD13 ' A' ' 134' ' ' LEU . 81.8 m95 -73.4 168.34 19.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.069 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.82 136.64 41.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.489 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.64 105.38 4.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.683 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.86 HD11 HG22 ' A' ' 168' ' ' THR . 47.8 pt -95.13 -7.68 9.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.574 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.519 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -159.34 177.06 11.4 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 120.481 0.181 . . . . 0.0 110.589 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.476 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 30.3 m-85 -144.69 126.0 14.79 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.566 HG21 HD11 ' A' ' 139' ' ' LEU . 4.2 t -93.27 122.27 44.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.165 0.507 . . . . 0.0 111.416 -179.379 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.49 ' CE1' ' CE1' ' A' ' 130' ' ' PHE . 11.1 t80 -84.07 94.22 8.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.79 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -142.56 152.55 42.71 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.408 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 58.77 30.31 19.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.99 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 64.11 34.31 11.26 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.357 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.464 HG23 ' O ' ' A' ' 145' ' ' THR . 52.9 m -153.92 152.87 31.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.825 0.345 . . . . 0.0 111.135 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.692 ' CE2' ' HB2' ' A' ' 148' ' ' ALA . 11.1 m-85 -94.41 90.92 6.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.836 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.529 ' HB2' HD21 ' A' ' 139' ' ' LEU . 27.2 m-85 -71.17 110.83 8.12 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.794 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.429 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 49.5 Cg_exo -55.41 121.34 9.75 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 122.39 2.06 . . . . 0.0 112.73 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.713 HD21 ' OG1' ' A' ' 168' ' ' THR . 30.3 tp -101.42 123.82 46.1 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.43 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.759 HD13 ' HB2' ' A' ' 118' ' ' TRP . 46.4 mt -70.72 174.13 6.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.577 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.414 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.3 pt-20 -64.63 -29.28 70.28 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.079 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -90.07 12.62 17.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.192 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.631 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 74.96 16.73 80.39 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.111 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.7 ' HB3' HD12 ' A' ' 134' ' ' LEU . 9.2 tpt180 -74.85 93.53 2.65 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.566 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -68.35 121.29 15.98 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.631 -178.906 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -90.97 73.48 6.44 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.696 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.476 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 7.7 mttt -61.46 -16.11 43.85 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.995 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -94.7 -24.18 17.25 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -101.32 27.62 6.07 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.429 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -61.59 159.39 30.62 Favored Glycine 0 CA--C 1.508 -0.358 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.711 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.464 ' O ' HG23 ' A' ' 129' ' ' THR . 8.0 t -130.65 157.53 42.52 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.971 0.415 . . . . 0.0 110.877 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -94.69 50.34 1.32 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.577 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.98 149.81 3.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.583 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.692 ' HB2' ' CE2' ' A' ' 130' ' ' PHE . . . -93.66 125.77 52.32 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.387 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.476 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 60.6 Cg_endo -82.12 111.78 2.2 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.243 1.962 . . . . 0.0 112.339 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 11.6 t -69.5 -7.96 42.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.12 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -78.36 -23.32 46.94 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 120.717 0.294 . . . . 0.0 110.507 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.664 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -140.23 166.84 20.66 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.765 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.664 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 65.2 Cg_endo -74.85 156.11 43.67 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.384 2.056 . . . . 0.0 112.304 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 9.3 t -116.68 110.44 31.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.192 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.868 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.41 95.93 1.83 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.577 179.0 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 46.6 t -92.58 137.15 22.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.98 0.419 . . . . 0.0 111.162 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 48.73 57.78 8.2 Favored Glycine 0 CA--C 1.52 0.382 0 CA-C-N 115.893 -0.594 . . . . 0.0 113.304 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.868 ' CE2' HD23 ' A' ' 155' ' ' LEU . 2.9 m95 -100.69 151.17 21.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.198 0.523 . . . . 0.0 111.536 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -65.34 -172.43 0.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.459 179.329 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -43.74 154.69 0.09 Allowed 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.558 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -56.79 -25.15 51.46 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.327 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.22 -38.84 84.61 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 120.951 0.405 . . . . 0.0 110.087 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.62 -40.31 49.71 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.081 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.558 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.5 mt -59.17 -41.67 84.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.035 179.189 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.34 -30.9 53.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.23 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.422 ' HB3' HG21 ' A' ' 211' ' ' ILE . 5.4 mm-40 -67.83 -53.23 28.53 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.4 0.619 . . . . 0.0 109.968 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.808 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -59.53 -45.45 91.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.936 178.939 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.86 HG22 HD11 ' A' ' 121' ' ' ILE . 0.3 OUTLIER -56.75 -37.95 71.74 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.555 179.172 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.9 -37.38 92.51 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 178.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -70.94 -48.24 54.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.41 -0.395 . . . . 0.0 110.785 178.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.629 HD11 ' CE1' ' A' ' 214' ' ' PHE . 11.2 mp -64.89 -28.76 69.76 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.797 0.332 . . . . 0.0 111.23 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.31 -18.94 63.87 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.229 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -111.49 -28.64 8.09 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.669 0.271 . . . . 0.0 111.372 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.61 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.1 OUTLIER -56.85 166.86 1.21 Allowed Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.135 -179.658 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.28 128.0 15.82 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.225 1.95 . . . . 0.0 112.918 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.34 -26.29 11.86 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.541 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -58.42 -48.63 80.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.923 0.392 . . . . 0.0 110.88 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.855 HG11 ' HB3' ' A' ' 218' ' ' LEU . 33.7 t -73.7 -33.52 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.406 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.57 HD13 ' CD2' ' A' ' 174' ' ' LEU . 6.4 tp -57.44 -36.21 71.1 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 121.122 0.487 . . . . 0.0 109.818 179.048 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -76.42 -42.04 23.79 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.296 178.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -84.36 103.12 13.26 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.977 0.418 . . . . 0.0 110.584 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' MET . . . . . 0.853 ' CE ' HG12 ' A' ' 178' ' ' VAL . 3.0 mtm 178.74 169.57 0.87 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.008 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.13 -55.32 1.47 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.733 0.301 . . . . 0.0 111.082 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -163.23 142.32 8.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.928 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.897 HG12 HG12 ' A' ' 199' ' ' VAL . 12.4 mt -104.78 114.38 44.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.229 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 23.3 m170 -103.81 126.32 50.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.191 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.43 ' CD2' ' HD3' ' A' ' 189' ' ' PRO . 46.0 t80 -79.21 104.09 9.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.2 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.75 78.41 39.3 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.764 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.43 ' HD3' ' CD2' ' A' ' 187' ' ' TYR . 50.6 Cg_endo -68.2 143.03 57.53 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.418 2.079 . . . . 0.0 112.365 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 18.6 p -122.47 160.47 25.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.786 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 57.8 mtt-85 -53.4 -26.91 21.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.403 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -105.96 -16.66 14.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.784 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -137.06 76.75 1.6 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.898 0.38 . . . . 0.0 111.367 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -56.5 -23.8 41.95 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.351 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -106.57 38.52 2.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.754 0.311 . . . . 0.0 110.71 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 4.0 tpt180 -90.26 118.7 29.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.065 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.854 ' O ' HD13 ' A' ' 198' ' ' ILE . 25.5 m -117.51 165.94 12.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.915 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.854 HD13 ' O ' ' A' ' 197' ' ' VAL . 21.1 mm -134.56 107.45 9.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.149 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.897 HG12 HG12 ' A' ' 185' ' ' ILE . 8.4 m -96.12 123.84 48.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.985 0.421 . . . . 0.0 110.997 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -83.54 152.62 24.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.748 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 4.3 mmt -108.55 152.39 24.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.895 0.379 . . . . 0.0 110.947 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 39.2 m-20 -60.11 -26.35 66.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.196 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -89.77 14.54 11.6 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.89 0.329 . . . . 0.0 111.89 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 81.13 14.41 79.18 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.373 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.42 154.59 22.7 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 117.028 0.414 . . . . 0.0 110.78 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -125.1 111.36 15.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.841 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 26.2 t -112.79 123.76 68.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.004 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.634 ' OG ' HD12 ' A' ' 198' ' ' ILE . 58.2 m -97.7 114.7 26.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.676 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.659 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -127.28 162.23 26.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.955 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.91 156.18 17.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.555 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.423 HD11 ' HE1' ' A' ' 187' ' ' TYR . 48.9 mt -63.49 -29.73 48.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.784 0.326 . . . . 0.0 110.953 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -74.63 -39.74 61.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.343 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -118.86 36.74 4.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.86 0.362 . . . . 0.0 111.016 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.629 ' CE1' HD11 ' A' ' 171' ' ' LEU . 11.6 t80 -66.69 -53.3 35.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.738 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.55 -37.22 86.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.757 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.9 -51.76 44.29 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.205 0.526 . . . . 0.0 110.463 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 217' ' ' LYS . . . . . 0.69 ' O ' HG21 ' A' ' 224' ' ' ILE . 8.4 mmmt -54.23 -43.35 70.8 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.094 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.855 ' HB3' HG11 ' A' ' 178' ' ' VAL . 4.2 mm? -83.59 -23.67 31.84 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.114 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.41 -34.14 74.87 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.056 0.455 . . . . 0.0 109.834 178.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -74.12 -16.85 61.0 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.087 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -55.58 130.64 71.04 Favored Pre-proline 0 CA--C 1.536 0.437 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.213 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -91.07 104.93 0.43 Allowed 'Cis proline' 0 C--N 1.356 0.968 0 C-N-CA 124.931 -0.862 . . . . 0.0 112.519 0.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -178.74 38.36 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.15 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.69 HG21 ' O ' ' A' ' 217' ' ' LYS . 0.1 OUTLIER -141.78 157.98 20.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.99 179.588 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -179.82 174.53 0.91 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.167 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -85.87 148.53 25.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.194 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -144.51 34.26 1.17 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.054 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 3.3 tp -97.51 38.13 1.3 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.868 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 2.9 t70 59.0 90.51 0.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.853 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.42 87.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.029 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -177.03 -39.66 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.985 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 21.7 t 66.66 98.6 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.022 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 8.2 tppt? . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.931 -179.984 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.18 0 N-CA-C 112.452 -0.259 . . . . 0.0 112.452 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.2 m -111.24 170.65 7.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.857 0.361 . . . . 0.0 110.859 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -68.19 147.53 52.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.034 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.754 ' HB2' HD13 ' A' ' 134' ' ' LEU . 79.3 m95 -70.34 168.3 16.27 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.044 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.78 138.08 40.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.517 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.33 105.71 4.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.858 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.87 HD11 HG22 ' A' ' 168' ' ' THR . 49.4 pt -95.36 -6.64 9.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.604 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.493 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -159.75 176.83 11.49 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 120.553 0.216 . . . . 0.0 110.571 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.473 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 34.6 m-85 -144.64 126.11 14.94 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.622 HG21 HD11 ' A' ' 139' ' ' LEU . 3.7 t -93.16 122.28 44.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.101 0.477 . . . . 0.0 111.41 -179.091 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.482 ' CE1' ' CE1' ' A' ' 130' ' ' PHE . 15.8 t80 -83.05 93.96 7.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.669 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -144.73 153.06 41.29 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.352 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 60.2 29.35 18.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.758 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 62.36 34.51 15.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.863 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.4 ' CG2' ' N ' ' A' ' 145' ' ' THR . 45.2 m -152.47 156.23 39.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.059 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.648 ' CE2' ' HB2' ' A' ' 148' ' ' ALA . 19.0 m-85 -97.93 91.43 5.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.225 0.536 . . . . 0.0 110.866 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.525 ' HB2' HD21 ' A' ' 139' ' ' LEU . 27.8 m-85 -72.0 115.04 34.33 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.613 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.419 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 33.3 Cg_exo -61.16 117.07 3.82 Favored 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 122.422 2.082 . . . . 0.0 112.672 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.677 HD21 ' OG1' ' A' ' 168' ' ' THR . 30.6 tp -96.77 124.01 40.63 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.414 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.754 HD13 ' HB2' ' A' ' 118' ' ' TRP . 52.1 mt -70.5 174.45 5.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.645 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.409 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 2.0 pt-20 -65.11 -29.26 70.11 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.099 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 51.3 p-10 -89.68 11.88 18.56 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.254 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.636 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 75.08 19.02 80.08 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.856 -0.688 . . . . 0.0 113.007 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.709 ' HB3' HD12 ' A' ' 134' ' ' LEU . 1.2 tpt180 -77.36 93.2 4.01 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.622 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -68.32 121.48 16.36 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.806 -178.791 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.492 HD12 ' HG2' ' A' ' 143' ' ' GLU . 3.8 mm? -90.29 73.4 7.08 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.394 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.456 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 6.0 mttp -61.58 -15.61 40.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.302 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -98.52 -21.57 16.45 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.492 ' HG2' HD12 ' A' ' 140' ' ' LEU . 39.0 mm-40 -101.06 27.7 5.88 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.419 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -62.09 160.36 31.03 Favored Glycine 0 CA--C 1.51 -0.267 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.824 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.4 ' N ' ' CG2' ' A' ' 129' ' ' THR . 9.7 t -131.28 156.36 45.58 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.987 0.422 . . . . 0.0 110.729 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -93.11 51.0 1.6 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.735 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.1 151.23 3.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.573 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.648 ' HB2' ' CE2' ' A' ' 130' ' ' PHE . . . -95.14 125.64 49.59 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.39 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.473 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 73.9 Cg_endo -83.13 111.02 1.84 Allowed 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.355 2.037 . . . . 0.0 112.299 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 22.3 t -69.28 -8.12 43.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.163 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -77.85 -23.61 48.85 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 120.861 0.362 . . . . 0.0 110.607 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.668 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -138.11 166.71 23.89 Favored Pre-proline 0 N--CA 1.453 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.845 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.668 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 65.5 Cg_endo -74.67 157.93 43.79 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.444 2.096 . . . . 0.0 112.105 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 12.5 t -118.47 110.09 29.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.0 0.428 . . . . 0.0 111.369 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.854 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.61 95.95 1.91 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.644 179.054 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.432 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 61.6 t -92.54 136.66 24.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.09 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 48.59 57.07 8.74 Favored Glycine 0 CA--C 1.521 0.41 0 CA-C-N 115.891 -0.595 . . . . 0.0 113.319 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.854 ' CE2' HD23 ' A' ' 155' ' ' LEU . 3.5 m95 -99.91 151.14 21.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.175 0.512 . . . . 0.0 111.65 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.37 -172.22 0.15 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.553 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -43.4 154.27 0.09 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.268 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.56 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.16 -24.94 53.07 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.238 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -59.98 -40.72 90.09 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.871 0.367 . . . . 0.0 110.124 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -75.12 -40.34 59.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.982 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.56 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.8 mt -58.89 -41.99 84.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.971 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.71 -31.54 48.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.087 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -67.23 -52.96 34.58 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.575 0.702 . . . . 0.0 109.885 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.802 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -60.26 -44.42 95.32 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.013 178.865 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.87 HG22 HD11 ' A' ' 121' ' ' ILE . 0.3 OUTLIER -57.02 -38.11 72.66 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.484 179.171 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.18 -37.78 93.44 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 46.9 mm-40 -69.45 -48.69 60.07 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.408 -0.396 . . . . 0.0 110.92 178.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.602 HD11 ' CE1' ' A' ' 214' ' ' PHE . 9.9 mp -64.61 -29.35 70.36 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.758 0.313 . . . . 0.0 111.191 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.44 -20.28 64.63 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.368 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -110.91 -26.58 9.23 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.601 0.238 . . . . 0.0 111.414 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.673 ' CD2' HD13 ' A' ' 179' ' ' LEU . 0.1 OUTLIER -57.85 166.32 1.99 Allowed Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.898 -179.754 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.52 128.29 16.03 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.26 1.973 . . . . 0.0 112.94 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.24 -25.95 10.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.53 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -58.63 -48.65 80.3 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.877 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.85 HG11 ' HB3' ' A' ' 218' ' ' LEU . 32.3 t -73.81 -33.31 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.417 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.673 HD13 ' CD2' ' A' ' 174' ' ' LEU . 10.2 tp -56.71 -35.29 68.35 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 121.126 0.489 . . . . 0.0 110.047 179.102 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -79.5 -40.1 16.45 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.232 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -85.65 103.14 14.19 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 120.93 0.395 . . . . 0.0 110.556 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' MET . . . . . 0.838 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.8 mtm 177.35 170.8 0.58 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.158 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.48 -56.81 1.49 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.721 0.296 . . . . 0.0 111.063 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -163.16 142.7 8.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.047 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.922 HG12 HG12 ' A' ' 199' ' ' VAL . 13.8 mt -103.03 115.11 44.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.484 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' HIS . . . . . 0.432 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 21.6 m170 -105.75 125.43 50.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.205 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -78.48 104.73 9.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.335 179.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.5 78.53 37.09 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.424 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -66.54 147.87 82.75 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.442 2.095 . . . . 0.0 112.647 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 24.9 p -126.49 158.46 36.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.624 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 25.4 mtt180 -52.64 -26.59 14.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.507 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -105.63 -18.31 14.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.691 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -137.22 77.01 1.61 Allowed 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.955 0.407 . . . . 0.0 111.414 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -57.14 -22.15 37.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.419 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -105.14 36.88 2.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.777 0.322 . . . . 0.0 110.782 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 4.6 tpt180 -90.5 115.61 27.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.108 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.871 ' O ' HD13 ' A' ' 198' ' ' ILE . 25.0 m -112.97 167.34 6.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.717 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.871 HD13 ' O ' ' A' ' 197' ' ' VAL . 20.6 mm -135.22 106.75 7.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.457 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.922 HG12 HG12 ' A' ' 185' ' ' ILE . 7.7 m -95.86 125.72 48.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.924 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -86.12 152.2 23.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.698 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.52 152.8 23.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.858 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -58.41 -23.84 58.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.418 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -89.99 15.35 10.2 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 78.16 14.41 82.28 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.508 -0.853 . . . . 0.0 113.13 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -82.83 166.47 18.95 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 117.07 0.435 . . . . 0.0 110.749 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -133.54 114.54 13.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.973 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.74 HG11 HD12 ' A' ' 224' ' ' ILE . 21.3 t -115.96 126.07 73.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.087 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 2.8 p -99.14 115.68 29.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.767 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.67 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -126.37 159.26 33.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.73 154.8 18.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.569 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 32.6 mt -64.02 -34.08 66.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.018 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -67.62 -40.51 84.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.4 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -125.28 43.53 3.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.88 0.372 . . . . 0.0 110.967 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.602 ' CE1' HD11 ' A' ' 171' ' ' LEU . 12.5 t80 -67.93 -53.34 27.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.836 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.72 -38.13 77.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.211 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.92 -48.45 65.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.99 0.424 . . . . 0.0 110.559 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.16 -43.77 70.89 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.094 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.85 ' HB3' HG11 ' A' ' 178' ' ' VAL . 4.0 mm? -84.53 -25.24 28.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.982 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 11.8 t -61.21 -31.36 71.14 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 120.822 0.344 . . . . 0.0 110.454 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' HIS . . . . . 0.416 ' CB ' HG22 ' A' ' 224' ' ' ILE . 1.5 m170 -69.12 -17.07 63.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.095 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.425 ' CD1' ' HA ' ' A' ' 222' ' ' PRO . 78.2 t80 -63.79 135.9 96.49 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.537 ' O ' ' HB3' ' A' ' 223' ' ' ALA . 60.8 Cg_endo -72.0 153.9 97.82 Favored 'Cis proline' 0 C--N 1.356 0.961 0 C-N-CA 124.512 -1.037 . . . . 0.0 112.444 0.032 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 222' ' ' PRO . . . 82.44 77.62 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.508 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.74 HD12 HG11 ' A' ' 207' ' ' VAL . 5.5 pt -123.01 -179.18 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.096 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 66.53 123.2 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.076 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -115.28 -164.55 0.95 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.099 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -98.16 30.89 2.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.041 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.597 ' O ' HD23 ' A' ' 228' ' ' LEU . 5.3 tt -86.44 8.6 21.13 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.662 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -88.75 53.87 2.84 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.047 0.451 . . . . 0.0 110.903 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 12.8 mtt180 -142.35 54.96 1.44 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.551 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 19.4 t30 64.11 132.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.773 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 11.1 p -57.26 144.23 9.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.254 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.297 -0.859 . . . . 0.0 110.887 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.168 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 79.6 p -88.39 148.25 24.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.763 0.316 . . . . 0.0 110.925 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 61.67 148.99 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.139 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.755 ' HB2' HD13 ' A' ' 134' ' ' LEU . 80.6 m95 -70.73 168.31 16.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.143 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -101.94 134.8 44.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.561 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 26.5 mtt180 -71.3 106.61 3.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.837 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.873 HD11 HG22 ' A' ' 168' ' ' THR . 47.5 pt -96.92 -6.38 9.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.494 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.565 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -160.64 176.25 11.76 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 121.08 -0.248 . . . . 0.0 110.88 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.481 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 37.5 m-85 -145.91 127.57 15.2 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.674 HG21 HD11 ' A' ' 139' ' ' LEU . 4.0 t -92.82 122.47 44.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.075 0.464 . . . . 0.0 111.445 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.492 ' CE1' ' CZ ' ' A' ' 130' ' ' PHE . 9.5 t80 -85.12 100.93 12.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.925 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -154.16 154.22 33.17 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.489 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 8.1 tpp180 60.69 31.47 20.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.721 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 62.27 32.08 17.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.945 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.452 HG22 ' N ' ' A' ' 130' ' ' PHE . 50.1 m -151.03 161.74 42.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.234 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.492 ' CZ ' ' CE1' ' A' ' 125' ' ' TYR . 87.0 m-85 -106.87 90.67 3.38 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.235 0.54 . . . . 0.0 110.841 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.563 ' HB2' HD21 ' A' ' 139' ' ' LEU . 20.7 m-85 -66.77 124.65 89.08 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.508 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.45 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 13.7 Cg_exo -68.6 123.29 10.31 Favored 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 122.327 2.018 . . . . 0.0 112.343 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.7 HD21 ' OG1' ' A' ' 168' ' ' THR . 36.9 tp -104.2 123.57 47.55 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.565 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.755 HD13 ' HB2' ' A' ' 118' ' ' TRP . 50.6 mt -72.69 173.07 9.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.733 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.414 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.5 pt-20 -63.02 -29.69 71.02 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.001 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 39.6 p-10 -89.84 11.91 18.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.143 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.648 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 74.93 19.27 80.02 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.183 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.688 ' HB3' HD12 ' A' ' 134' ' ' LEU . 13.8 tpp180 -76.69 95.68 4.04 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.674 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -70.71 122.46 19.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.913 -178.8 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -95.31 71.34 3.23 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.599 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.459 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 27.8 mttt -58.59 -19.76 41.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.78 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -89.46 -23.69 22.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.742 -0.208 . . . . 0.0 111.434 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -99.22 25.06 7.2 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.45 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -57.58 161.87 9.1 Favored Glycine 0 CA--C 1.51 -0.265 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.597 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 10.7 t -135.78 150.46 49.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.503 -0.348 . . . . 0.0 110.717 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.444 ' HE2' HG23 ' A' ' 129' ' ' THR . 3.5 mmtt -89.81 52.05 2.22 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.017 0.437 . . . . 0.0 110.62 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.92 149.05 2.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.678 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -93.91 125.52 52.75 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.153 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.481 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 72.0 Cg_endo -84.22 109.72 1.45 Allowed 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.486 2.124 . . . . 0.0 112.567 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.2 t -69.77 -7.73 42.1 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.101 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -78.16 -22.95 47.95 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.79 0.329 . . . . 0.0 110.551 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.674 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -139.59 166.9 20.91 Favored Pre-proline 0 N--CA 1.453 -0.282 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.758 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.718 ' HD3' HD23 ' A' ' 179' ' ' LEU . 61.0 Cg_endo -74.37 153.8 45.33 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.4 2.067 . . . . 0.0 112.194 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 12.2 t -115.67 109.51 28.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.222 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.861 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.55 95.74 1.86 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.534 178.881 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 55.3 t -92.33 136.99 23.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.956 0.407 . . . . 0.0 111.014 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 47.9 58.67 6.74 Favored Glycine 0 CA--C 1.521 0.416 0 CA-C-N 115.954 -0.567 . . . . 0.0 113.24 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.861 ' CE2' HD23 ' A' ' 155' ' ' LEU . 2.4 m95 -100.83 151.2 22.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.102 0.477 . . . . 0.0 111.828 -179.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -172.58 0.06 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.448 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -44.74 155.15 0.11 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.084 0.468 . . . . 0.0 112.173 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.564 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.42 -25.54 55.07 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.261 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.95 -39.42 85.52 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 120.991 0.424 . . . . 0.0 110.213 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -75.93 -40.75 53.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.184 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.564 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.2 mt -58.34 -41.48 81.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.045 179.109 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.14 -31.78 53.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.255 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -67.83 -53.08 29.74 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-O 121.517 0.675 . . . . 0.0 110.05 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.798 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -59.17 -45.74 90.22 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.002 178.919 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.873 HG22 HD11 ' A' ' 121' ' ' ILE . 0.5 OUTLIER -56.26 -38.63 71.41 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.643 179.075 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -58.77 -38.45 92.09 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 178.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 45.1 mm-40 -69.56 -48.37 60.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.315 -0.442 . . . . 0.0 110.902 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.618 HD11 ' CE1' ' A' ' 214' ' ' PHE . 10.8 mp -64.08 -29.85 70.96 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.724 0.297 . . . . 0.0 111.113 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -67.68 -19.96 65.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.259 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -111.22 -26.0 9.41 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.609 0.242 . . . . 0.0 111.424 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.557 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.1 OUTLIER -57.4 166.6 1.58 Allowed Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.079 -179.607 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.83 129.03 15.83 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.358 2.039 . . . . 0.0 112.707 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.19 -25.79 5.96 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.666 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.95 -49.82 75.48 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.953 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.925 HG11 ' HB3' ' A' ' 218' ' ' LEU . 34.8 t -74.07 -34.65 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.502 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.718 HD23 ' HD3' ' A' ' 153' ' ' PRO . 0.7 OUTLIER -56.47 -37.78 70.79 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.093 0.473 . . . . 0.0 110.063 179.276 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -78.92 -36.17 29.16 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.356 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -90.17 103.18 15.88 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.931 0.396 . . . . 0.0 110.846 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' MET . . . . . 0.836 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.7 mtm 177.66 173.99 0.53 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.034 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.97 -54.8 1.21 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.665 0.269 . . . . 0.0 111.168 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -163.14 142.83 8.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.959 0.409 . . . . 0.0 111.11 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.888 HG12 HG12 ' A' ' 199' ' ' VAL . 13.3 mt -104.8 114.98 45.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.454 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -103.32 123.66 47.2 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.155 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.437 ' HB2' ' CD2' ' A' ' 158' ' ' TRP . 65.9 t80 -81.58 104.33 11.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.375 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.37 80.87 45.79 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.667 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.406 ' HD3' ' CD2' ' A' ' 187' ' ' TYR . 48.2 Cg_endo -67.96 146.69 72.25 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.324 2.016 . . . . 0.0 112.46 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 22.3 p -127.11 158.36 37.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.771 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 7.5 ptt-85 -52.18 -26.32 11.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.571 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -106.37 -18.89 13.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.506 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -134.99 73.82 1.5 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.007 0.432 . . . . 0.0 111.106 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.62 -21.58 28.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.646 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 11.3 p30 -109.47 38.98 2.19 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.861 0.362 . . . . 0.0 110.734 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 11.8 ttt-85 -91.47 117.16 29.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.18 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.857 ' O ' HD13 ' A' ' 198' ' ' ILE . 28.9 m -113.48 167.13 6.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.676 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.857 HD13 ' O ' ' A' ' 197' ' ' VAL . 17.0 mm -134.81 107.34 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.726 0.298 . . . . 0.0 111.363 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.888 HG12 HG12 ' A' ' 185' ' ' ILE . 11.9 m -98.04 134.87 34.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.927 0.394 . . . . 0.0 110.886 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -96.46 152.64 18.42 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.803 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 24.3 tpp -107.17 152.92 23.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.556 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -54.99 -24.45 24.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.784 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -90.44 15.55 10.5 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 79.24 14.54 81.55 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.544 -0.836 . . . . 0.0 113.047 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -77.99 157.8 29.52 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.929 0.395 . . . . 0.0 110.771 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -129.59 111.2 12.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.837 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.592 HG11 HG12 ' A' ' 224' ' ' ILE . 21.8 t -114.41 136.42 51.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.161 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 50.0 m -106.15 111.92 24.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.674 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -118.86 175.58 5.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.935 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.77 154.54 32.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.389 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 35.8 mt -66.61 -30.26 49.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.724 0.297 . . . . 0.0 110.859 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.61 -31.41 63.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.322 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -132.81 42.27 3.09 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.907 0.384 . . . . 0.0 110.96 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.618 ' CE1' HD11 ' A' ' 171' ' ' LEU . 11.7 t80 -68.3 -52.64 31.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.739 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.36 -39.44 87.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.892 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.18 -51.63 43.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.218 0.533 . . . . 0.0 110.243 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.91 -41.67 67.9 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.237 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.925 ' HB3' HG11 ' A' ' 178' ' ' VAL . 4.1 mm? -85.8 -23.13 27.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.061 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.03 -33.54 74.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.976 0.417 . . . . 0.0 110.144 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' HIS . . . . . 0.593 ' CB ' HG22 ' A' ' 224' ' ' ILE . 21.1 m170 -70.7 -16.77 62.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.421 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.431 ' N ' HG21 ' A' ' 224' ' ' ILE . 48.3 t80 -54.32 139.65 56.44 Favored Pre-proline 0 CA--C 1.537 0.473 0 O-C-N 122.42 -0.175 . . . . 0.0 110.557 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.526 ' O ' ' HB3' ' A' ' 223' ' ' ALA . 69.2 Cg_endo -73.37 154.06 99.41 Favored 'Cis proline' 0 C--N 1.354 0.852 0 C-N-CA 124.307 -1.122 . . . . 0.0 112.751 0.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 222' ' ' PRO . . . 84.63 76.59 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.099 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.597 HD13 ' H ' ' A' ' 224' ' ' ILE . 0.1 OUTLIER -146.09 143.57 21.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.032 0.444 . . . . 0.0 111.498 178.953 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 179.13 -169.93 0.11 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.029 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -109.66 144.95 37.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.943 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -129.81 33.37 4.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.242 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 13.8 mt -100.94 31.69 3.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.847 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -118.79 35.56 4.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.932 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 25.4 mtt85 -147.35 -47.46 0.17 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.835 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -122.7 111.78 17.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.782 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 21.3 t -59.26 139.05 19.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.193 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.903 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.142 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 62.21 149.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.755 0.312 . . . . 0.0 111.005 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 60.97 159.38 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.076 0.465 . . . . 0.0 111.048 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.761 ' HB2' HD13 ' A' ' 134' ' ' LEU . 84.9 m95 -66.18 168.31 8.75 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.007 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -100.72 136.33 40.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.391 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 5.9 mtm180 -72.35 107.33 4.89 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.762 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.886 HD11 HG22 ' A' ' 168' ' ' THR . 47.1 pt -96.89 -8.61 9.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.339 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.564 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -158.25 175.8 13.29 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 120.572 0.225 . . . . 0.0 110.672 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.478 ' CD1' ' CG ' ' A' ' 149' ' ' PRO . 30.4 m-85 -144.59 126.37 15.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.26 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.703 HG21 HD11 ' A' ' 139' ' ' LEU . 4.2 t -93.53 123.1 45.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.986 0.422 . . . . 0.0 111.294 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.491 ' CE1' ' CE1' ' A' ' 130' ' ' PHE . 7.0 t80 -84.61 105.38 15.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.842 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -159.77 154.44 24.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.673 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 60.57 30.96 20.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.914 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 62.05 31.87 17.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.136 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.527 HG23 ' O ' ' A' ' 145' ' ' THR . 89.3 m -153.72 150.16 28.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.987 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.842 ' CE2' ' HB2' ' A' ' 148' ' ' ALA . 54.1 m-85 -93.94 90.95 6.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.103 0.478 . . . . 0.0 110.705 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.554 ' HB2' HD21 ' A' ' 139' ' ' LEU . 22.3 m-85 -65.55 126.02 90.77 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.324 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.85 117.3 5.06 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 122.189 1.926 . . . . 0.0 112.441 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.67 HD21 ' OG1' ' A' ' 168' ' ' THR . 32.0 tp -96.59 124.02 40.45 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.731 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.761 HD13 ' HB2' ' A' ' 118' ' ' TRP . 54.0 mt -71.35 174.12 6.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.632 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.413 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.3 pt-20 -64.59 -29.45 70.47 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.091 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 48.4 p-10 -88.91 11.15 18.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.215 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.637 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 74.58 22.53 77.12 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.847 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.69 ' HB3' HD12 ' A' ' 134' ' ' LEU . 15.5 tpp85 -80.49 95.95 6.62 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.703 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -73.28 106.1 4.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.232 -179.215 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 13.3 mt -85.51 72.41 10.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.335 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.448 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 33.6 mttt -56.2 -21.23 21.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.896 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -82.87 -22.62 33.96 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -103.11 28.58 6.17 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . -64.16 163.84 33.67 Favored Glycine 0 CA--C 1.511 -0.169 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.699 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.527 ' O ' HG23 ' A' ' 129' ' ' THR . 9.2 t -132.09 157.03 45.24 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.504 -0.348 . . . . 0.0 110.529 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.6 mmtp -92.21 48.55 1.42 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.091 0.472 . . . . 0.0 110.554 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -171.26 154.55 4.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.438 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.842 ' HB2' ' CE2' ' A' ' 130' ' ' PHE . . . -99.31 126.52 37.5 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.076 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.478 ' CG ' ' CD1' ' A' ' 123' ' ' TYR . 72.2 Cg_endo -82.39 112.38 2.2 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.36 2.04 . . . . 0.0 112.702 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 28.0 t -69.82 -7.71 42.22 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.518 -0.764 . . . . 0.0 112.0 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -76.1 -22.82 55.11 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 120.779 0.323 . . . . 0.0 110.447 179.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.699 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -139.77 167.7 17.59 Favored Pre-proline 0 N--CA 1.452 -0.334 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.721 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.699 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 61.5 Cg_endo -73.98 154.36 47.73 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.364 2.042 . . . . 0.0 112.332 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 10.1 t -116.66 110.44 31.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.971 0.415 . . . . 0.0 111.088 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.856 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.55 95.94 1.89 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.584 179.058 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.42 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 51.3 t -91.24 136.74 23.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.028 0.442 . . . . 0.0 111.106 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 48.56 58.59 7.29 Favored Glycine 0 CA--C 1.52 0.392 0 CA-C-N 115.816 -0.629 . . . . 0.0 113.259 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.856 ' CE2' HD23 ' A' ' 155' ' ' LEU . 3.2 m95 -102.13 151.12 22.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.186 0.517 . . . . 0.0 111.721 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.89 -172.07 0.17 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.548 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -42.71 154.22 0.07 Allowed 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.526 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.08 -24.89 52.62 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.163 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.56 -39.65 84.74 Favored 'General case' 0 C--O 1.23 0.074 0 CA-C-O 120.916 0.388 . . . . 0.0 110.007 179.219 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.05 -40.03 54.21 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.917 178.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.526 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.3 mt -59.73 -41.68 86.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.873 179.018 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.13 -30.97 50.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.228 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.406 ' CB ' HG21 ' A' ' 211' ' ' ILE . 17.5 mm-40 -66.97 -53.01 35.77 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-O 121.491 0.662 . . . . 0.0 110.05 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.822 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -59.94 -44.78 94.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.905 178.914 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.886 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -58.34 -37.17 74.63 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.454 179.223 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.88 -37.68 92.93 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 178.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 35.0 mm-40 -72.87 -46.47 52.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.401 -0.399 . . . . 0.0 111.029 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.584 ' HA ' HD22 ' A' ' 174' ' ' LEU . 10.9 mp -65.92 -28.71 69.13 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.622 0.248 . . . . 0.0 111.323 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.88 -21.07 64.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.336 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -110.45 -26.19 9.65 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.588 0.232 . . . . 0.0 111.496 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.584 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.1 OUTLIER -57.55 166.51 1.71 Allowed Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.107 -179.684 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -70.09 128.08 15.22 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.305 2.003 . . . . 0.0 112.798 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.07 -25.78 5.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.726 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.71 -50.08 74.41 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.898 0.38 . . . . 0.0 111.012 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.869 HG11 ' HB3' ' A' ' 218' ' ' LEU . 41.5 t -74.25 -34.9 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.495 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.646 HD21 ' O ' ' A' ' 121' ' ' ILE . 0.5 OUTLIER -57.19 -34.49 68.54 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.156 0.503 . . . . 0.0 109.842 179.096 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -79.47 -38.54 20.86 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 178.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -87.92 103.06 15.32 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.865 0.364 . . . . 0.0 110.75 179.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' MET . . . . . 0.836 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.8 mtm 178.25 172.04 0.7 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.055 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -130.45 -52.61 1.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.677 0.275 . . . . 0.0 111.466 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -163.17 143.69 9.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.881 0.372 . . . . 0.0 111.135 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.905 HG12 HG12 ' A' ' 199' ' ' VAL . 15.7 mt -108.29 114.78 47.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.653 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' HIS . . . . . 0.42 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 23.5 m170 -105.77 129.33 53.98 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.057 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -79.33 104.81 10.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.444 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -127.68 78.07 75.37 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.584 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -81.19 160.22 20.38 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.475 2.117 . . . . 0.0 112.709 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 19.2 p -128.17 169.62 13.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.531 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.38 -24.1 11.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.611 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -110.39 -15.2 13.99 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.941 0.348 . . . . 0.0 111.941 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -130.73 73.08 1.52 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.045 0.45 . . . . 0.0 111.255 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -58.88 -18.65 34.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.895 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' ASP . . . . . 0.448 ' OD1' HG22 ' A' ' 210' ' ' THR . 3.5 p30 -113.27 35.71 3.86 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.693 0.283 . . . . 0.0 111.13 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 2.0 ttt-85 -89.64 113.48 24.96 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.894 0.378 . . . . 0.0 111.318 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.845 ' O ' HD13 ' A' ' 198' ' ' ILE . 31.3 m -109.76 167.9 4.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.858 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.845 HD13 ' O ' ' A' ' 197' ' ' VAL . 22.4 mm -134.4 108.39 10.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.754 0.312 . . . . 0.0 111.278 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.905 HG12 HG12 ' A' ' 185' ' ' ILE . 11.2 m -97.51 137.52 24.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.989 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -98.26 152.82 19.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.79 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 27.9 tpp -110.77 153.65 25.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.831 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -55.92 -22.51 26.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.747 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -90.18 15.43 10.33 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 76.75 14.4 82.57 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.594 -0.813 . . . . 0.0 113.112 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -83.77 157.32 22.14 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 117.023 0.412 . . . . 0.0 110.729 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -127.69 111.47 13.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.689 HG11 HD12 ' A' ' 224' ' ' ILE . 20.6 t -111.44 130.54 64.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.942 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.519 ' OG ' HD12 ' A' ' 198' ' ' ILE . 16.7 m -102.62 116.66 33.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.798 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.647 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -128.19 160.25 32.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.861 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.448 HG22 ' OD1' ' A' ' 195' ' ' ASP . 0.6 OUTLIER -96.69 155.68 16.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.561 179.84 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.406 HG21 ' CB ' ' A' ' 166' ' ' GLU . 32.0 mt -67.18 -31.06 51.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.02 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.93 -32.06 65.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.357 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -126.53 33.95 4.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.06 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.578 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 11.4 t80 -62.99 -53.91 46.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.708 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.78 -39.95 86.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.832 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.29 -51.27 46.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.098 0.475 . . . . 0.0 110.236 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 217' ' ' LYS . . . . . 0.694 ' O ' HG21 ' A' ' 224' ' ' ILE . 0.7 OUTLIER -54.86 -44.03 73.63 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.859 179.605 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.869 ' HB3' HG11 ' A' ' 178' ' ' VAL . 4.1 mm? -80.69 -25.75 37.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.942 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.9 -33.15 72.67 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.045 0.45 . . . . 0.0 110.123 179.07 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 3.6 m170 -74.33 -17.19 60.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.445 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -64.33 136.28 96.69 Favored Pre-proline 0 CA--C 1.533 0.293 0 C-N-CA 121.359 -0.136 . . . . 0.0 110.978 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.478 ' O ' ' HB2' ' A' ' 223' ' ' ALA . 61.6 Cg_endo -89.89 107.34 0.75 Allowed 'Cis proline' 0 C--N 1.357 1.0 0 C-N-CA 124.595 -1.002 . . . . 0.0 112.596 0.153 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.478 ' HB2' ' O ' ' A' ' 222' ' ' PRO . . . 171.01 43.38 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.073 0.463 . . . . 0.0 110.356 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.694 HG21 ' O ' ' A' ' 217' ' ' LYS . 10.2 pt -125.25 -178.57 2.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.206 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 225' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 224' ' ' ILE . . . 76.31 96.3 0.07 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.964 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -95.46 -158.59 0.66 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.901 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -96.83 35.87 1.48 Allowed 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.786 0.327 . . . . 0.0 111.017 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.19 3.51 27.01 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.54 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -88.5 53.79 2.84 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.021 0.439 . . . . 0.0 110.929 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 31.1 mtt85 -142.85 -77.33 0.25 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.773 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 43.16 60.07 2.68 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.995 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 21.8 m -73.4 168.49 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.323 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 7.4 mtmt . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.849 -179.928 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.158 0 N-CA-C 112.563 -0.215 . . . . 0.0 112.563 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.2 m -105.54 -39.69 6.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.856 0.36 . . . . 0.0 110.939 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -89.97 150.6 22.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.134 0.492 . . . . 0.0 110.911 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.759 ' HB2' HD13 ' A' ' 134' ' ' LEU . 79.3 m95 -66.11 168.25 8.72 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.015 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -101.36 141.09 34.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.631 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.402 ' HG3' HD23 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -74.55 106.14 5.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.748 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.897 HD11 HG22 ' A' ' 168' ' ' THR . 50.9 pt -97.41 -7.04 9.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.299 179.086 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.471 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -162.42 175.29 11.68 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 120.597 0.237 . . . . 0.0 110.779 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.464 ' CD1' ' HG3' ' A' ' 149' ' ' PRO . 25.9 m-85 -144.12 127.11 16.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.097 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.709 HG21 HD11 ' A' ' 139' ' ' LEU . 4.9 t -93.14 122.36 44.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.119 0.485 . . . . 0.0 111.292 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.493 ' CE1' ' CE1' ' A' ' 130' ' ' PHE . 14.8 t80 -83.38 105.34 14.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.812 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -159.68 153.6 23.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.59 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.67 30.79 20.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.973 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 63.12 32.65 15.08 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.317 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 145' ' ' THR . 90.3 m -154.41 150.49 27.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.982 0.42 . . . . 0.0 111.087 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.711 ' CE2' ' HB2' ' A' ' 148' ' ' ALA . 22.6 m-85 -93.77 90.85 6.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.52 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.533 ' HB2' HD21 ' A' ' 139' ' ' LEU . 21.3 m-85 -65.35 121.03 72.58 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.329 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.402 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 37.5 Cg_endo -67.62 118.11 5.35 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.215 1.943 . . . . 0.0 112.544 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.645 HD11 ' HA2' ' A' ' 137' ' ' GLY . 48.6 tp -99.66 124.69 45.13 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.953 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.759 HD13 ' HB2' ' A' ' 118' ' ' TRP . 52.7 mt -72.91 177.14 5.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.727 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.416 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.4 pt-20 -67.12 -28.77 68.43 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.118 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -89.71 12.45 16.95 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.167 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.654 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 72.25 23.95 77.15 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.741 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.696 ' HB3' HD12 ' A' ' 134' ' ' LEU . 1.3 tpt180 -81.14 97.66 7.68 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 178.328 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.709 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -75.89 112.44 12.3 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.232 -179.031 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 12.7 mt -92.69 72.16 4.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.179 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.453 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 39.4 mttt -55.21 -22.25 17.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.814 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -82.34 -24.06 34.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.191 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -100.2 27.05 5.91 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.417 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . -63.68 163.62 32.15 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.752 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.49 ' O ' HG23 ' A' ' 129' ' ' THR . 10.0 t -132.34 155.3 48.64 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.83 0.348 . . . . 0.0 110.714 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.8 mmtp -92.58 49.74 1.51 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.089 0.471 . . . . 0.0 110.494 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -171.13 153.73 3.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.613 -179.373 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.711 ' HB2' ' CE2' ' A' ' 130' ' ' PHE . . . -97.06 125.75 44.88 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.328 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.464 ' HG3' ' CD1' ' A' ' 123' ' ' TYR . 74.3 Cg_endo -83.2 111.76 1.9 Allowed 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.392 2.062 . . . . 0.0 112.533 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 29.1 t -69.87 -7.77 43.0 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.958 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -77.14 -23.22 51.72 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 120.763 0.316 . . . . 0.0 110.423 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.665 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -140.07 166.82 21.02 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.682 -179.394 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.665 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 69.1 Cg_endo -75.05 154.27 42.12 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.348 2.032 . . . . 0.0 112.34 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 9.0 t -114.56 110.91 33.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.139 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.858 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.61 95.96 1.91 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.536 179.069 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 50.1 t -91.48 137.18 22.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.053 0.454 . . . . 0.0 111.194 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 48.06 57.85 7.56 Favored Glycine 0 CA--C 1.521 0.459 0 CA-C-N 115.858 -0.61 . . . . 0.0 113.325 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.858 ' CE2' HD23 ' A' ' 155' ' ' LEU . 3.0 m95 -100.58 151.15 21.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.107 0.48 . . . . 0.0 111.782 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.32 -172.36 0.1 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.596 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -43.92 153.79 0.12 Allowed 'General case' 0 C--O 1.235 0.337 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.552 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -56.73 -25.16 50.97 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.261 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -60.29 -38.35 83.33 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.884 0.374 . . . . 0.0 110.109 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.96 -40.33 47.32 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.956 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.552 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.1 mt -58.53 -42.06 83.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.983 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.71 -30.19 42.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.299 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.45 ' CB ' HG21 ' A' ' 211' ' ' ILE . 14.2 mm-40 -68.26 -52.86 29.19 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.391 0.615 . . . . 0.0 110.016 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.788 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -60.7 -43.86 97.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.998 178.999 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.897 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -58.2 -36.54 73.26 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.291 179.206 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.66 -39.4 96.52 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 110.509 -1.037 . . . . 0.0 110.509 178.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 54.6 mm-40 -69.62 -46.33 66.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.407 -0.396 . . . . 0.0 110.839 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.593 ' HA ' HD22 ' A' ' 174' ' ' LEU . 10.9 mp -66.01 -28.29 68.76 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.693 0.283 . . . . 0.0 111.363 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.1 -18.65 63.26 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.345 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -112.79 -27.29 8.2 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.622 0.249 . . . . 0.0 111.576 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.593 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER -57.13 167.01 1.25 Allowed Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.072 -179.745 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.29 127.81 15.53 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.198 1.932 . . . . 0.0 112.831 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.61 -25.77 7.6 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.652 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.97 -49.46 76.74 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.871 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.881 HG11 ' HB3' ' A' ' 218' ' ' LEU . 24.5 t -74.01 -32.98 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.469 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.445 HD12 ' HA ' ' A' ' 179' ' ' LEU . 11.7 tp -57.24 -36.35 70.82 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 121.194 0.521 . . . . 0.0 109.865 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -77.35 -40.86 22.56 Favored Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.301 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -84.94 103.07 13.66 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.877 0.37 . . . . 0.0 110.658 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' MET . . . . . 0.85 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.8 mtm 177.31 162.63 0.5 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.033 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -120.9 -54.24 2.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.752 0.311 . . . . 0.0 111.267 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -162.38 142.94 10.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.814 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.896 HG12 HG12 ' A' ' 199' ' ' VAL . 16.2 mt -106.9 114.51 46.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.55 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 21.4 m170 -103.6 119.39 38.81 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.245 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.422 ' HB2' ' CD2' ' A' ' 158' ' ' TRP . 33.1 t80 -75.97 104.49 6.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.46 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.87 79.56 24.5 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.722 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.1 145.9 62.52 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.319 2.013 . . . . 0.0 112.479 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 19.5 p -128.17 159.24 35.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.815 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 8.1 ptt180 -52.54 -25.35 10.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.615 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -105.53 -19.9 13.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.627 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -136.04 74.81 1.52 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.871 0.367 . . . . 0.0 111.198 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -56.47 -22.04 29.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.596 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -108.95 38.47 2.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.802 0.334 . . . . 0.0 110.93 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -91.27 118.47 30.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.089 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.88 ' O ' HD13 ' A' ' 198' ' ' ILE . 21.2 m -115.63 167.81 7.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.863 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.88 HD13 ' O ' ' A' ' 197' ' ' VAL . 19.1 mm -135.31 109.49 10.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.799 0.333 . . . . 0.0 111.059 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.896 HG12 HG12 ' A' ' 185' ' ' ILE . 7.0 m -97.62 120.88 47.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.038 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -82.05 152.73 26.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.769 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.99 149.81 28.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.727 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -58.86 -29.12 66.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.168 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -80.87 1.76 29.43 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.983 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 92.1 14.43 56.14 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.466 -0.873 . . . . 0.0 113.184 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -86.69 162.32 17.96 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 117.067 0.434 . . . . 0.0 110.952 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -130.75 111.52 12.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.812 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.427 ' HB ' HG23 ' A' ' 199' ' ' VAL . 21.7 t -111.32 131.42 62.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.115 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.545 ' OG ' HD12 ' A' ' 198' ' ' ILE . 35.8 m -103.34 116.29 32.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.78 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.685 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -129.69 159.53 36.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.86 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.37 157.08 17.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.572 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.45 HG21 ' CB ' ' A' ' 166' ' ' GLU . 48.9 mt -67.44 -33.47 62.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.875 0.369 . . . . 0.0 110.848 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.73 -33.99 77.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.41 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -132.92 38.73 3.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.834 0.349 . . . . 0.0 111.148 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.582 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 11.0 t80 -62.52 -49.73 74.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.926 0.393 . . . . 0.0 110.637 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.97 -38.59 91.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.187 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -68.69 -50.56 49.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.022 0.439 . . . . 0.0 110.556 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' LYS . . . . . 0.641 ' O ' HG21 ' A' ' 224' ' ' ILE . 10.9 mmmt -53.43 -42.75 67.39 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.184 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.881 ' HB3' HG11 ' A' ' 178' ' ' VAL . 4.0 mm? -85.73 -23.46 27.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.968 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 9.0 t -60.13 -34.43 73.51 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.102 0.477 . . . . 0.0 109.964 179.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -74.18 -16.23 60.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.968 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.413 ' CE1' ' HB3' ' A' ' 222' ' ' PRO . 14.6 t80 -60.76 139.78 93.28 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 116.867 -0.151 . . . . 0.0 111.104 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.485 ' O ' ' HB2' ' A' ' 223' ' ' ALA . 62.2 Cg_endo -89.84 107.57 0.79 Allowed 'Cis proline' 0 C--N 1.356 0.923 0 C-N-CA 124.543 -1.024 . . . . 0.0 112.425 0.056 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.485 ' HB2' ' O ' ' A' ' 222' ' ' PRO . . . 171.95 41.94 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.864 0.364 . . . . 0.0 110.992 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.641 HG21 ' O ' ' A' ' 217' ' ' LYS . 0.1 OUTLIER -134.51 157.88 41.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.92 0.39 . . . . 0.0 111.143 179.747 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 225' ' ' ALA . . . . . 0.418 ' HB2' ' O ' ' A' ' 224' ' ' ILE . . . 176.78 76.67 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.114 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . 60.14 158.11 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.233 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -145.2 31.43 1.11 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.732 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 19.0 mt -94.5 46.02 1.14 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.622 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 71.27 22.6 4.28 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.321 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 50.75 27.25 2.94 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.743 0.306 . . . . 0.0 111.759 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -91.49 93.37 8.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.973 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 20.3 t -143.13 67.98 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.103 0.477 . . . . 0.0 111.043 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 4.9 ptmm? . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.235 -0.888 . . . . 0.0 112.009 -179.869 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 18.9 m -65.1 81.85 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.873 0.368 . . . . 0.0 110.885 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -100.5 151.96 20.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.915 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.767 ' HB2' HD13 ' A' ' 134' ' ' LEU . 85.6 m95 -66.04 168.33 8.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.287 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.29 133.61 45.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.762 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 59.5 mtt180 -71.25 107.72 4.38 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.833 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.909 HD11 HG22 ' A' ' 168' ' ' THR . 42.9 pt -96.08 -9.15 9.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.414 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.518 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -156.33 175.97 13.3 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.659 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.479 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 37.9 m-85 -145.02 126.05 14.56 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.353 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.614 HG21 HD11 ' A' ' 139' ' ' LEU . 3.4 t -93.69 122.9 45.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.101 0.477 . . . . 0.0 111.13 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -82.4 97.46 8.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.776 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -151.09 156.01 40.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.44 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 6.3 tpp180 60.39 30.54 19.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.838 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.2 33.4 16.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.913 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 145' ' ' THR . 85.5 m -157.14 153.74 28.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.912 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -93.54 91.18 6.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.694 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.493 ' HB2' HD21 ' A' ' 139' ' ' LEU . 22.6 m-85 -66.06 125.02 89.33 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.874 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.61 115.84 4.49 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.008 1.806 . . . . 0.0 112.725 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.694 HD21 ' OG1' ' A' ' 168' ' ' THR . 25.1 tp -93.64 123.8 37.2 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.656 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.767 HD13 ' HB2' ' A' ' 118' ' ' TRP . 39.9 mt -69.55 171.86 8.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.48 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.4 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 0.9 OUTLIER -63.15 -31.76 72.98 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.987 179.893 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -84.68 3.81 35.46 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.278 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.621 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 82.71 21.24 60.07 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.766 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.644 ' HB3' HD12 ' A' ' 134' ' ' LEU . 6.2 tpt180 -79.9 94.29 5.82 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.572 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.614 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -69.79 107.41 3.5 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.95 -179.502 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 15.3 mt -83.45 72.54 10.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.979 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.451 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 9.2 mttp -57.79 -20.73 37.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.481 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -96.9 23.79 6.81 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.289 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -147.94 27.49 0.96 Allowed 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.747 0.308 . . . . 0.0 111.122 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.422 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . -63.52 166.66 25.84 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.913 -0.66 . . . . 0.0 113.183 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.416 ' O ' HG23 ' A' ' 129' ' ' THR . 9.6 t -132.58 151.72 51.84 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.867 0.365 . . . . 0.0 110.442 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.06 50.77 1.7 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.118 0.485 . . . . 0.0 110.598 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.71 147.04 2.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.644 -179.404 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -90.2 125.32 60.6 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.327 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.479 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 77.8 Cg_endo -84.83 107.27 1.1 Allowed 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.534 2.156 . . . . 0.0 112.605 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 15.0 t -69.83 -7.8 42.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.008 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -78.26 -23.64 47.19 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 120.841 0.353 . . . . 0.0 110.503 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.689 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -138.35 167.28 20.42 Favored Pre-proline 0 N--CA 1.453 -0.302 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.629 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.689 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 68.0 Cg_endo -74.62 156.36 44.75 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.452 2.101 . . . . 0.0 112.539 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 18.3 t -118.96 109.22 26.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.236 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.853 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.1 mp -72.54 96.14 1.91 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.699 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.7 t -91.37 136.23 24.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.082 0.467 . . . . 0.0 111.046 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 47.9 57.71 7.54 Favored Glycine 0 CA--C 1.522 0.471 0 CA-C-N 115.701 -0.681 . . . . 0.0 113.237 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.853 ' CE2' HD23 ' A' ' 155' ' ' LEU . 2.5 m95 -99.81 151.36 21.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.193 0.52 . . . . 0.0 111.831 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.52 -172.42 0.08 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.627 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -44.37 154.24 0.13 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.284 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.533 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.65 -24.93 54.61 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.159 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -59.56 -39.49 84.21 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.887 0.375 . . . . 0.0 110.125 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.28 -40.32 51.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.962 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.533 HD12 ' HA2' ' A' ' 161' ' ' GLY . 5.9 mt -58.72 -41.08 81.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.922 178.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.72 -29.48 39.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.138 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -70.1 -53.01 19.26 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 121.512 0.672 . . . . 0.0 110.137 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.833 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -58.95 -43.98 91.36 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.042 178.996 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.909 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -58.65 -36.43 74.12 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.395 179.08 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.26 -37.19 92.62 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 178.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 93.3 mm-40 -73.72 -45.58 51.27 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.339 -0.43 . . . . 0.0 111.083 178.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.608 ' HA ' HD22 ' A' ' 174' ' ' LEU . 11.3 mp -66.36 -28.47 68.67 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.697 0.284 . . . . 0.0 111.374 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.9 -16.18 62.66 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.34 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -115.2 -28.03 7.07 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.669 HD21 HD13 ' A' ' 179' ' ' LEU . 0.2 OUTLIER -55.88 167.29 0.86 Allowed Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 116.754 -0.203 . . . . 0.0 111.3 -179.539 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -69.92 128.15 15.47 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.269 1.979 . . . . 0.0 112.92 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.47 -25.64 6.8 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.718 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.51 -49.68 75.52 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.847 0.356 . . . . 0.0 110.947 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.871 HG11 ' HB3' ' A' ' 218' ' ' LEU . 32.4 t -74.34 -36.05 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.608 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.669 HD13 HD21 ' A' ' 174' ' ' LEU . 10.7 tp -55.1 -34.08 63.37 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.162 0.506 . . . . 0.0 110.155 179.027 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -80.29 -41.59 11.58 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.405 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -85.53 103.02 14.01 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.912 0.386 . . . . 0.0 110.665 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' MET . . . . . 0.835 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.8 mtm 178.52 166.18 0.83 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.228 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.85 -56.96 1.91 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.836 0.35 . . . . 0.0 111.001 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -162.96 142.56 8.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.771 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.894 HG12 HG12 ' A' ' 199' ' ' VAL . 11.7 mt -101.91 115.55 43.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.475 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' HIS . . . . . 0.4 ' HB3' ' CE ' ' A' ' 188' ' ' LYS . 22.9 m170 -105.21 121.62 44.21 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.98 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -78.53 104.69 9.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.509 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' LYS . . . . . 0.4 ' CE ' ' HB3' ' A' ' 186' ' ' HIS . 0.1 OUTLIER -121.93 82.55 43.18 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.547 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -67.77 147.73 75.87 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.409 2.073 . . . . 0.0 112.593 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 22.0 p -126.17 160.01 31.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.695 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 12.5 mtt180 -51.88 -28.83 17.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.608 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -107.48 -15.08 14.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.875 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -135.29 74.41 1.52 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.996 0.427 . . . . 0.0 111.293 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -56.18 -24.96 44.8 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.415 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 9.8 p30 -105.12 38.54 1.92 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.765 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -90.77 116.85 28.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.105 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.798 ' O ' HD13 ' A' ' 198' ' ' ILE . 22.1 m -114.24 164.35 10.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.725 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.798 HD13 ' O ' ' A' ' 197' ' ' VAL . 20.3 mm -133.3 105.95 8.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.785 0.326 . . . . 0.0 111.17 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.894 HG12 HG12 ' A' ' 185' ' ' ILE . 6.7 m -94.75 124.72 47.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.028 0.442 . . . . 0.0 111.011 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -84.26 152.82 23.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.809 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.8 149.02 29.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.729 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -58.77 -28.8 66.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.157 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -80.67 1.5 29.78 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.325 -0.398 . . . . 0.0 112.06 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 91.99 14.41 56.34 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.571 -0.823 . . . . 0.0 113.149 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -87.1 160.19 18.65 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.992 0.396 . . . . 0.0 110.732 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -128.67 111.47 13.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.919 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.991 HG13 ' HB2' ' A' ' 225' ' ' ALA . 23.1 t -110.88 137.46 43.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.044 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 3.8 m -110.83 112.07 23.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.755 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.41 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -121.86 170.76 9.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.938 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.92 157.56 19.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.402 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 33.0 mt -69.54 -31.48 49.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.794 0.331 . . . . 0.0 110.838 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.48 -30.15 65.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.345 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -133.12 37.31 3.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.809 0.338 . . . . 0.0 111.051 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.577 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 11.2 t80 -63.08 -55.46 25.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.837 0.351 . . . . 0.0 110.458 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.75 -42.38 79.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.146 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -68.91 -47.72 65.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.041 0.448 . . . . 0.0 110.232 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -54.95 -43.63 73.6 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.905 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.871 ' HB3' HG11 ' A' ' 178' ' ' VAL . 3.9 mm? -83.09 -26.44 31.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.779 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 13.2 t -61.19 -30.53 70.47 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.955 0.407 . . . . 0.0 110.528 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' HIS . . . . . 0.415 ' CB ' HG22 ' A' ' 224' ' ' ILE . 1.1 m-70 -69.37 -16.81 63.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.107 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.483 ' HB2' HD13 ' A' ' 224' ' ' ILE . 41.1 t80 -59.06 138.4 87.85 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 110.477 -0.194 . . . . 0.0 110.477 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.523 ' O ' ' HB3' ' A' ' 223' ' ' ALA . 12.8 Cg_exo -70.48 154.82 95.35 Favored 'Cis proline' 0 C--N 1.355 0.893 0 C-N-CA 124.875 -0.885 . . . . 0.0 112.707 0.182 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.523 ' HB3' ' O ' ' A' ' 222' ' ' PRO . . . 83.96 75.89 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.912 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.623 HD12 HG11 ' A' ' 207' ' ' VAL . 26.2 pt -136.77 -178.65 2.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.059 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 225' ' ' ALA . . . . . 0.991 ' HB2' HG13 ' A' ' 207' ' ' VAL . . . 72.57 -179.03 0.21 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.095 0.474 . . . . 0.0 111.367 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . 62.89 94.4 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.286 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -117.76 30.88 7.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.621 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 22.3 mt -123.1 30.2 6.45 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.097 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.86 36.26 2.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.903 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.88 -62.0 0.42 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.898 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -91.61 101.35 13.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.865 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 20.0 t -101.98 121.39 52.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.108 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.882 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.144 0 N-CA-C 112.534 -0.226 . . . . 0.0 112.534 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.5 p -103.38 -74.2 0.65 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.816 0.341 . . . . 0.0 110.946 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -60.82 148.53 38.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.97 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.773 ' HB2' HD13 ' A' ' 134' ' ' LEU . 81.5 m95 -73.16 167.95 20.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.057 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.7 ttm-85 -102.64 135.57 44.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.401 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 -71.74 105.92 3.92 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.491 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.87 HD11 HG22 ' A' ' 168' ' ' THR . 42.9 pt -93.54 -9.06 9.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.492 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.486 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -158.99 176.57 12.14 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 120.99 -0.284 . . . . 0.0 110.795 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.456 ' O ' ' HA ' ' A' ' 154' ' ' VAL . 30.8 m-85 -142.77 128.3 19.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.268 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.623 HG21 HD11 ' A' ' 139' ' ' LEU . 3.9 t -93.28 122.41 44.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.072 0.463 . . . . 0.0 111.239 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.479 ' CE1' ' CE1' ' A' ' 130' ' ' PHE . 7.6 t80 -82.75 94.45 7.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.735 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -144.46 153.04 41.47 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.433 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 59.44 30.66 20.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.858 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 61.81 34.71 17.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.036 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.472 HG23 ' HE2' ' A' ' 146' ' ' LYS . 65.7 m -152.2 162.21 41.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.07 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.479 ' CE1' ' CE1' ' A' ' 125' ' ' TYR . 18.5 m-85 -103.27 90.71 3.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.191 0.52 . . . . 0.0 111.194 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.514 ' HB2' HD21 ' A' ' 139' ' ' LEU . 23.8 m-85 -69.82 118.33 62.08 Favored Pre-proline 0 CA--C 1.536 0.437 0 CA-C-N 115.437 -0.802 . . . . 0.0 111.499 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.433 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 25.0 Cg_exo -63.16 119.86 7.09 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 122.423 2.082 . . . . 0.0 112.61 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.677 HD21 ' OG1' ' A' ' 168' ' ' THR . 29.6 tp -100.25 123.17 44.16 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.285 179.153 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.773 HD13 ' HB2' ' A' ' 118' ' ' TRP . 46.5 mt -70.13 171.4 9.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.701 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.415 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.5 pt-20 -61.67 -33.33 73.79 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.098 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ASN . . . . . 0.462 ' ND2' ' CD1' ' A' ' 118' ' ' TRP . 4.2 p30 -82.34 -4.36 57.13 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.107 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.663 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 91.34 15.84 54.56 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.804 -179.438 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.669 ' HB3' HD12 ' A' ' 134' ' ' LEU . 15.1 tpp85 -73.62 97.21 2.6 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.466 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.623 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -70.98 109.18 4.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.565 -178.978 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 27.6 mt -84.22 71.16 10.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.487 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.452 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 18.6 mttt -56.79 -21.5 29.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.738 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -84.54 -17.39 39.05 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -106.67 29.48 6.91 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . -60.55 161.62 21.7 Favored Glycine 0 CA--C 1.509 -0.316 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.359 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 11.1 t -136.28 148.81 48.17 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.999 0.428 . . . . 0.0 110.927 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.472 ' HE2' HG23 ' A' ' 129' ' ' THR . 6.7 mmtt -89.92 55.86 3.28 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.343 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.405 ' O ' ' CG ' ' A' ' 130' ' ' PHE . 0.0 OUTLIER -170.41 167.32 8.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.255 -179.327 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -102.67 136.62 19.29 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.928 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.455 ' HG3' ' CD1' ' A' ' 123' ' ' TYR . 59.7 Cg_endo -84.7 99.98 0.74 Allowed 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 123.174 2.582 . . . . 0.0 112.491 179.451 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 16.8 t -67.24 -9.52 41.32 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.793 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -89.58 -22.24 22.46 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 111.562 0.208 . . . . 0.0 111.562 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.692 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -139.33 166.92 21.03 Favored Pre-proline 0 C--N 1.328 -0.334 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -178.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.692 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 58.9 Cg_endo -73.46 164.24 35.56 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.495 2.13 . . . . 0.0 112.275 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 22.1 t -122.92 109.12 22.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 121.065 0.46 . . . . 0.0 111.655 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.873 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.72 95.95 1.96 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.687 179.068 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.405 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 54.9 t -92.99 137.87 21.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.164 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 47.69 56.06 8.93 Favored Glycine 0 CA--C 1.521 0.421 0 CA-C-N 115.913 -0.585 . . . . 0.0 113.227 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.873 ' CE2' HD23 ' A' ' 155' ' ' LEU . 3.2 m95 -98.9 151.26 21.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.181 0.515 . . . . 0.0 111.62 -179.464 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.98 -172.4 0.14 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.423 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -43.58 154.69 0.08 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.095 0.474 . . . . 0.0 112.184 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.552 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.29 -25.05 53.78 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.275 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.97 -38.75 83.44 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.001 0.429 . . . . 0.0 110.125 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.18 -40.23 46.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.053 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.552 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.5 mt -59.4 -42.25 86.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.081 179.257 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.38 -29.49 48.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.366 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.429 ' CB ' HG21 ' A' ' 211' ' ' ILE . 5.6 mm-40 -67.84 -53.28 28.06 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.4 0.619 . . . . 0.0 110.162 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.79 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -60.89 -43.51 98.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.995 178.92 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.87 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -58.88 -37.82 77.42 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.361 179.181 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.62 -37.54 92.42 Favored Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 178.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -72.04 -46.5 56.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.366 -0.417 . . . . 0.0 110.848 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.552 ' HA ' HD22 ' A' ' 174' ' ' LEU . 10.4 mp -64.22 -30.45 71.51 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.789 0.328 . . . . 0.0 111.219 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -67.67 -21.91 65.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.552 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -109.61 -26.49 9.88 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 120.595 0.236 . . . . 0.0 111.498 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.552 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.1 OUTLIER -56.99 166.37 1.43 Allowed Pre-proline 0 CA--C 1.538 0.491 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.096 -179.685 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -69.32 128.95 17.19 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.364 2.043 . . . . 0.0 112.702 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.89 -25.89 5.13 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.75 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.87 -50.05 74.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.971 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.905 HG11 ' HB3' ' A' ' 218' ' ' LEU . 24.4 t -74.21 -35.44 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.705 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.523 ' HG ' HD21 ' A' ' 174' ' ' LEU . 0.4 OUTLIER -56.56 -35.04 67.7 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.131 0.491 . . . . 0.0 109.956 179.29 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -79.5 -39.21 18.92 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.269 -0.733 . . . . 0.0 111.269 178.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -86.85 103.16 14.99 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.935 0.398 . . . . 0.0 110.654 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' MET . . . . . 0.841 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.9 mtm 178.35 161.18 0.61 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.027 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 6.6 t -118.93 -58.52 1.94 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.767 0.318 . . . . 0.0 110.881 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.8 pm0 -157.62 142.58 16.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.001 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.89 HG12 HG12 ' A' ' 199' ' ' VAL . 17.0 mt -107.01 115.0 47.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.341 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' HIS . . . . . 0.405 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 21.8 m170 -106.01 123.46 48.03 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.207 -179.39 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.45 ' CE2' ' HG3' ' A' ' 189' ' ' PRO . 59.1 t80 -75.67 104.55 6.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.167 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 4.3 mttm -129.7 88.79 48.48 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.908 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.45 ' HG3' ' CE2' ' A' ' 187' ' ' TYR . 13.0 Cg_exo -69.58 161.64 45.13 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.477 2.118 . . . . 0.0 112.073 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.451 HG21 ' HD3' ' A' ' 196' ' ' ARG . 9.1 p -133.6 169.48 16.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.764 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.1 -23.5 62.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.193 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -120.3 8.78 10.89 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -155.46 75.94 0.94 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.994 0.426 . . . . 0.0 111.272 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.61 -22.46 34.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.332 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' ASP . . . . . 0.442 ' OD1' HG22 ' A' ' 210' ' ' THR . 3.4 p30 -106.9 37.86 2.24 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.746 0.308 . . . . 0.0 110.802 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.451 ' HD3' HG21 ' A' ' 190' ' ' THR . 7.2 ttt180 -88.86 116.22 26.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.838 0.352 . . . . 0.0 111.439 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.74 ' O ' HD13 ' A' ' 198' ' ' ILE . 23.6 m -112.81 166.41 6.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.66 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.74 HD13 ' O ' ' A' ' 197' ' ' VAL . 19.2 mm -132.01 108.77 14.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.793 0.33 . . . . 0.0 111.287 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.89 HG12 HG12 ' A' ' 185' ' ' ILE . 10.2 m -100.98 120.78 50.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.028 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -85.81 152.62 22.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.631 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 9.7 mmt -102.67 161.24 13.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.034 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -62.56 -25.89 68.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.153 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -87.15 10.62 16.22 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 83.77 14.4 72.97 Favored Glycine 0 C--N 1.335 0.496 0 C-N-CA 120.451 -0.881 . . . . 0.0 113.282 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -80.15 170.41 16.47 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 117.014 0.407 . . . . 0.0 110.767 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -136.43 111.48 8.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.928 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.444 ' HB ' HG23 ' A' ' 199' ' ' VAL . 21.7 t -114.77 122.59 69.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.089 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -99.31 114.64 27.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.671 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.626 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -126.12 161.32 27.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.802 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.442 HG22 ' OD1' ' A' ' 195' ' ' ASP . 0.6 OUTLIER -99.76 152.73 19.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.673 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.429 HG21 ' CB ' ' A' ' 166' ' ' GLU . 48.4 mt -63.88 -36.49 76.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.838 0.351 . . . . 0.0 110.724 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.23 -34.66 76.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.158 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -132.64 44.28 2.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.919 0.39 . . . . 0.0 111.02 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.623 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 11.3 t80 -66.94 -52.58 41.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.564 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.01 -40.02 91.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.911 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.37 -51.15 55.66 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.158 0.504 . . . . 0.0 110.399 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 217' ' ' LYS . . . . . 0.876 ' O ' HG21 ' A' ' 224' ' ' ILE . 0.1 OUTLIER -54.25 -43.78 71.22 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.163 179.827 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.905 ' HB3' HG11 ' A' ' 178' ' ' VAL . 4.1 mm? -83.52 -23.15 32.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.097 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.49 -34.3 75.26 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.045 0.45 . . . . 0.0 109.799 179.069 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -70.5 -16.93 62.95 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.151 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -56.43 141.76 70.57 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 116.866 -0.152 . . . . 0.0 111.187 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.52 ' O ' ' HB2' ' A' ' 223' ' ' ALA . 56.1 Cg_endo -91.04 106.71 0.6 Allowed 'Cis proline' 0 C--N 1.356 0.972 0 C-N-CA 124.557 -1.018 . . . . 0.0 112.624 0.143 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.52 ' HB2' ' O ' ' A' ' 222' ' ' PRO . . . 168.43 42.61 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.773 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.876 HG21 ' O ' ' A' ' 217' ' ' LYS . 0.2 OUTLIER -126.2 152.7 33.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.927 0.394 . . . . 0.0 111.232 179.994 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 225' ' ' ALA . . . . . 0.452 ' HB2' ' O ' ' A' ' 224' ' ' ILE . . . 173.76 -178.15 0.08 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.887 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -63.67 157.32 24.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.187 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.419 ' H ' HD12 ' A' ' 228' ' ' LEU . . . -145.07 29.07 1.2 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.129 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.571 HD12 ' N ' ' A' ' 228' ' ' LEU . 5.5 mp -95.27 46.38 1.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.139 0.495 . . . . 0.0 110.487 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 65.51 26.8 11.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.994 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 55.71 99.26 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.224 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 -154.85 133.04 11.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.919 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' VAL . . . . . 0.57 ' O ' HG13 ' A' ' 232' ' ' VAL . 11.0 p -151.93 110.89 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.952 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.892 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.176 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.4 m -94.55 -37.5 11.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.809 0.338 . . . . 0.0 110.978 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -126.99 161.07 29.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.939 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.774 ' HB2' HD13 ' A' ' 134' ' ' LEU . 87.3 m95 -70.11 168.37 15.73 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.093 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 2.0 ptt180 -99.57 133.39 43.97 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.696 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 32.4 mtm180 -71.33 106.68 3.96 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.628 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.892 HD11 HG22 ' A' ' 168' ' ' THR . 44.1 pt -95.86 -8.25 9.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.436 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.541 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -158.41 176.53 12.33 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 120.647 0.26 . . . . 0.0 110.882 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.469 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 38.2 m-85 -144.91 126.59 15.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.188 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.643 HG21 HD11 ' A' ' 139' ' ' LEU . 4.1 t -93.45 122.65 45.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.124 0.487 . . . . 0.0 111.013 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -83.69 95.07 8.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.48 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -145.52 155.16 42.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.42 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 4.0 tpp180 59.58 30.2 19.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.787 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 62.27 34.83 15.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.997 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.445 HG22 ' N ' ' A' ' 130' ' ' PHE . 57.8 m -153.54 161.46 42.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.826 0.346 . . . . 0.0 111.278 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.659 ' CZ ' ' HB2' ' A' ' 148' ' ' ALA . 31.8 m-85 -101.75 91.12 4.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.132 0.491 . . . . 0.0 110.914 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.471 ' HB2' HD21 ' A' ' 139' ' ' LEU . 24.3 m-85 -70.19 122.96 87.9 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.336 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.422 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 15.1 Cg_exo -67.94 118.17 5.42 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 122.31 2.007 . . . . 0.0 112.636 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.655 HD21 ' OG1' ' A' ' 168' ' ' THR . 30.4 tp -98.02 123.32 41.98 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.086 0.469 . . . . 0.0 110.362 179.167 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.774 HD13 ' HB2' ' A' ' 118' ' ' TRP . 44.6 mt -70.4 171.97 9.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.511 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.406 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 0.9 OUTLIER -62.85 -32.33 73.53 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.857 179.924 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -84.07 2.45 39.22 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.161 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.666 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 83.89 20.27 59.83 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.827 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.64 ' HB3' HD12 ' A' ' 134' ' ' LEU . 13.8 tpp180 -78.4 94.08 4.82 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.416 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.643 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -68.2 105.1 1.99 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.438 -179.025 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 17.3 mt -78.58 69.34 4.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.746 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.44 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 2.3 mttt -57.2 -21.31 32.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.564 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -91.96 11.94 23.44 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -134.74 26.5 3.67 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.762 0.315 . . . . 0.0 111.17 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.422 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -61.23 163.02 22.63 Favored Glycine 0 CA--C 1.509 -0.323 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.844 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.9 t -136.3 151.84 50.05 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.526 -0.337 . . . . 0.0 110.428 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.42 ' HE2' HG23 ' A' ' 129' ' ' THR . 4.2 mmtt -89.03 51.84 2.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.014 0.435 . . . . 0.0 110.705 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.18 148.97 2.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.638 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.659 ' HB2' ' CZ ' ' A' ' 130' ' ' PHE . . . -93.73 125.81 52.0 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.474 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.469 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 89.1 Cg_endo -84.39 109.97 1.43 Allowed 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.528 2.152 . . . . 0.0 112.508 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.3 t -70.2 -6.86 37.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.081 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.73 -23.04 53.06 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 120.836 0.351 . . . . 0.0 110.507 178.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.688 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -140.72 167.2 18.42 Favored Pre-proline 0 N--CA 1.453 -0.306 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.794 -179.401 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.688 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 61.5 Cg_endo -74.04 154.44 47.48 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.412 2.074 . . . . 0.0 112.306 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 14.2 t -115.81 111.5 35.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.115 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.823 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.71 96.45 2.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.858 179.207 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.434 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 59.0 t -93.07 136.03 26.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.975 0.417 . . . . 0.0 110.981 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 48.97 56.32 10.25 Favored Glycine 0 CA--C 1.521 0.423 0 CA-C-N 115.903 -0.589 . . . . 0.0 113.17 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.823 ' CE2' HD23 ' A' ' 155' ' ' LEU . 3.2 m95 -99.52 151.31 21.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.195 0.521 . . . . 0.0 111.799 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -65.79 -172.43 0.13 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.529 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -44.33 154.43 0.12 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.118 0.485 . . . . 0.0 112.203 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.564 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.27 -25.07 53.78 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.239 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -60.12 -38.3 82.59 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 120.967 0.413 . . . . 0.0 110.113 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.79 -41.36 44.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.0 178.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.564 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.5 mt -57.73 -42.35 81.56 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.11 179.173 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.22 -29.78 34.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.166 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.416 ' CB ' HG21 ' A' ' 211' ' ' ILE . 2.0 mt-10 -68.64 -53.43 22.53 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-O 121.503 0.668 . . . . 0.0 110.054 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.797 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -59.84 -43.81 94.39 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.701 -0.682 . . . . 0.0 109.88 178.989 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.892 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -58.62 -36.35 73.92 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.329 179.018 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.84 -38.47 94.06 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 178.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -71.93 -45.45 61.1 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.269 -0.465 . . . . 0.0 110.727 178.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.563 ' HA ' HD22 ' A' ' 174' ' ' LEU . 10.7 mp -67.83 -21.32 65.21 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.72 0.295 . . . . 0.0 111.691 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -77.12 -16.69 59.09 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.114 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -114.9 -26.5 7.75 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.75 HD21 ' HB2' ' A' ' 179' ' ' LEU . 0.1 OUTLIER -57.75 166.35 1.91 Allowed Pre-proline 0 CA--C 1.536 0.412 0 CA-C-O 120.513 0.197 . . . . 0.0 111.051 -179.497 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -69.48 128.88 16.94 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.31 2.007 . . . . 0.0 112.707 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.86 -25.25 7.52 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.67 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.42 -49.39 76.36 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.904 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.906 HG11 ' HB3' ' A' ' 218' ' ' LEU . 23.5 t -74.32 -39.97 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.57 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.75 ' HB2' HD21 ' A' ' 174' ' ' LEU . 12.4 tp -54.52 -32.63 58.5 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.059 0.457 . . . . 0.0 110.22 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -82.41 -36.18 17.95 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 178.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -90.48 103.2 15.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.898 0.38 . . . . 0.0 110.614 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' MET . . . . . 0.833 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.9 mtm 178.92 179.79 0.39 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.023 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -136.72 -52.16 0.69 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.732 0.301 . . . . 0.0 111.198 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -163.43 142.69 8.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.124 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.89 HG12 HG12 ' A' ' 199' ' ' VAL . 19.2 mt -106.25 114.95 46.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.316 179.215 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' HIS . . . . . 0.434 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 20.1 m170 -106.24 123.61 48.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.25 -179.372 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.417 ' CD1' ' HD3' ' A' ' 189' ' ' PRO . 0.5 OUTLIER -75.31 104.85 6.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.474 179.558 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 9.0 mmtt -118.05 75.86 11.24 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.5 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.417 ' HD3' ' CD1' ' A' ' 187' ' ' TYR . 43.9 Cg_endo -67.4 145.17 70.44 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.392 2.061 . . . . 0.0 112.595 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 20.5 p -127.92 158.61 37.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.726 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.04 -24.82 10.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.612 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -103.3 -21.63 13.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.51 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -137.41 79.67 1.76 Allowed 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.844 0.354 . . . . 0.0 111.28 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -57.99 -24.29 57.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.282 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -104.19 36.01 2.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.795 0.331 . . . . 0.0 110.779 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 24.0 ttt85 -90.57 113.43 25.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.988 0.423 . . . . 0.0 111.182 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.854 ' O ' HD13 ' A' ' 198' ' ' ILE . 23.1 m -109.2 167.82 4.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.751 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.854 HD13 ' O ' ' A' ' 197' ' ' VAL . 22.5 mm -134.33 105.75 7.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.684 0.278 . . . . 0.0 111.34 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.89 HG12 HG12 ' A' ' 185' ' ' ILE . 12.5 m -94.53 134.87 30.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.868 0.366 . . . . 0.0 110.921 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -97.54 153.08 18.4 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.667 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 33.5 tpp -112.24 149.35 32.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.448 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 16.9 m-20 -55.27 -28.96 57.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.513 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -75.38 -5.89 47.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.817 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 94.78 14.62 49.02 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.499 -0.857 . . . . 0.0 112.988 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.439 ' CE2' HG22 ' A' ' 207' ' ' VAL . 11.2 t80 -86.28 158.2 19.75 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 117.005 0.403 . . . . 0.0 110.915 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -124.85 111.18 15.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.676 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.641 HG11 HD12 ' A' ' 224' ' ' ILE . 25.5 t -113.04 135.64 51.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.938 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 93.7 p -109.26 116.36 31.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.74 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.407 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -125.27 169.36 12.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.797 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -108.2 154.25 22.03 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.706 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.416 HG21 ' CB ' ' A' ' 166' ' ' GLU . 34.5 mt -66.08 -34.05 67.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.782 0.325 . . . . 0.0 110.832 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.46 -35.61 80.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.334 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -131.65 43.34 3.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.983 0.42 . . . . 0.0 110.961 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.568 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 11.1 t80 -66.73 -50.77 61.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.722 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.27 -42.22 90.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.347 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -67.31 -49.55 63.7 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.052 0.454 . . . . 0.0 110.458 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.93 -43.4 69.76 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.174 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.906 ' HB3' HG11 ' A' ' 178' ' ' VAL . 4.0 mm? -84.11 -25.5 29.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.004 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 12.6 t -61.15 -31.45 71.18 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.892 0.377 . . . . 0.0 110.396 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' HIS . . . . . 0.419 ' CB ' HG22 ' A' ' 224' ' ' ILE . 1.5 m-70 -69.66 -15.74 63.23 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.402 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.43 ' HB2' HD13 ' A' ' 224' ' ' ILE . 68.8 t80 -59.33 137.79 88.75 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 110.399 -0.223 . . . . 0.0 110.399 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.529 ' O ' ' HB3' ' A' ' 223' ' ' ALA . 59.6 Cg_endo -71.6 154.71 97.59 Favored 'Cis proline' 0 C--N 1.355 0.906 0 C-N-CA 124.569 -1.013 . . . . 0.0 112.743 0.206 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 222' ' ' PRO . . . 82.26 77.39 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.821 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.641 HD12 HG11 ' A' ' 207' ' ' VAL . 18.7 pt -130.11 176.59 8.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.296 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 225' ' ' ALA . . . . . 0.533 ' HB2' HG13 ' A' ' 207' ' ' VAL . . . 59.02 165.13 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.202 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -110.26 -165.04 0.97 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.93 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -100.3 24.71 8.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.24 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.14 25.31 6.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.741 0.305 . . . . 0.0 110.835 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 25.1 p30 -107.22 31.3 5.48 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.865 0.364 . . . . 0.0 110.859 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 15.9 mtp180 -105.61 -74.88 0.64 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.76 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 63.98 -78.96 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.014 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 10.6 p -113.88 128.42 70.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.814 0.34 . . . . 0.0 111.064 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 16.9 mttp . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.892 179.967 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.176 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 68.4 m -65.03 -68.66 0.34 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.81 0.338 . . . . 0.0 110.93 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 61.7 155.37 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.041 0.448 . . . . 0.0 110.977 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.762 ' HB2' HD13 ' A' ' 134' ' ' LEU . 81.3 m95 -73.89 168.55 19.22 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.204 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.2 ptt180 -101.05 135.22 42.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.841 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 8.4 mtm180 -71.87 106.68 4.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.867 0.365 . . . . 0.0 110.731 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.888 HD11 HG22 ' A' ' 168' ' ' THR . 49.3 pt -97.09 -7.65 9.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.366 179.268 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.478 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -159.39 176.17 12.44 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 121.111 -0.236 . . . . 0.0 110.71 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.47 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 29.1 m-85 -144.48 126.26 15.24 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.088 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.559 HG21 HD11 ' A' ' 139' ' ' LEU . 8.6 t -93.64 122.77 45.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.108 0.48 . . . . 0.0 111.471 -179.445 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.476 ' CD1' ' CE1' ' A' ' 130' ' ' PHE . 28.5 t80 -82.7 110.7 17.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.729 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -165.08 152.41 10.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.651 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? 60.37 31.6 20.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.015 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 62.2 31.49 17.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.264 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.521 HG23 ' O ' ' A' ' 145' ' ' THR . 84.7 m -153.43 150.13 28.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.874 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.476 ' CE1' ' CD1' ' A' ' 125' ' ' TYR . 98.7 m-85 -95.55 91.52 6.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.793 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.516 ' HB2' HD21 ' A' ' 139' ' ' LEU . 23.8 m-85 -65.19 126.15 90.77 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.313 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -72.58 116.67 4.8 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.176 1.917 . . . . 0.0 112.434 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.621 HD21 ' OG1' ' A' ' 168' ' ' THR . 42.8 tp -96.02 124.38 40.01 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.864 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.762 HD13 ' HB2' ' A' ' 118' ' ' TRP . 55.0 mt -71.65 174.73 6.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.65 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.406 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.5 pt-20 -65.46 -28.73 69.43 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.076 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 46.7 p-10 -89.82 11.68 19.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.143 179.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.666 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 73.41 23.49 77.1 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.932 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.703 ' HB3' HD12 ' A' ' 134' ' ' LEU . 18.4 tpp180 -81.11 95.95 7.02 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.559 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -72.68 107.33 5.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.326 -179.005 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 13.5 mt -85.03 72.13 10.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.321 179.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.465 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 7.5 mtpt -56.2 -21.38 22.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.993 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -85.54 -16.22 40.17 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -108.88 29.69 7.23 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . -64.52 163.08 36.42 Favored Glycine 0 CA--C 1.51 -0.228 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.88 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.521 ' O ' HG23 ' A' ' 129' ' ' THR . 9.1 t -131.31 155.95 46.31 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.41 -0.395 . . . . 0.0 110.619 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.39 48.52 1.31 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.127 0.489 . . . . 0.0 110.319 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -170.97 150.73 3.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.533 -179.314 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.455 ' HB2' ' CZ ' ' A' ' 130' ' ' PHE . . . -95.02 125.93 48.76 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.21 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.47 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 72.8 Cg_endo -83.02 111.83 1.96 Allowed 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.349 2.032 . . . . 0.0 112.619 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 33.3 t -69.81 -7.6 41.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.062 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.82 -23.44 52.76 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 120.821 0.343 . . . . 0.0 110.456 178.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.674 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -139.44 166.9 21.05 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.653 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.674 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 60.0 Cg_endo -73.81 154.54 48.7 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.348 2.032 . . . . 0.0 112.265 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 13.4 t -116.91 109.98 29.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.063 0.458 . . . . 0.0 111.207 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.891 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.2 mp -72.33 96.12 1.82 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.611 179.085 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.417 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 60.8 t -92.41 137.16 22.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.129 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 48.97 57.85 8.33 Favored Glycine 0 CA--C 1.52 0.374 0 CA-C-N 115.921 -0.581 . . . . 0.0 113.223 179.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.891 ' CE2' HD23 ' A' ' 155' ' ' LEU . 2.7 m95 -101.13 151.07 22.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.162 0.506 . . . . 0.0 111.679 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.7 tttp -66.76 -172.18 0.16 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.374 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -42.26 154.42 0.06 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.534 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -56.87 -24.96 51.63 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.267 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.04 -38.69 83.51 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.996 0.427 . . . . 0.0 109.978 179.068 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -75.91 -40.6 53.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.913 178.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.534 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.2 mt -59.11 -44.0 90.58 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.878 179.08 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -52.92 -25.9 13.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.617 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -71.39 -54.43 10.73 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 121.072 0.463 . . . . 0.0 110.923 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.813 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -62.14 -37.19 84.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.217 179.495 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.888 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -60.5 -38.11 83.26 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.911 178.881 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -61.59 -35.68 91.49 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 177.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -71.6 -49.02 44.27 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.181 -0.51 . . . . 0.0 110.669 178.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.637 ' HA ' HD22 ' A' ' 174' ' ' LEU . 10.8 mp -65.2 -27.42 68.67 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.548 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.13 -18.2 61.91 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.273 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -113.27 -27.75 7.86 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.637 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER -57.0 167.23 1.14 Allowed Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.154 -179.582 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.413 ' HG2' HG23 ' A' ' 178' ' ' VAL . 38.2 Cg_endo -67.19 127.78 17.32 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.192 1.928 . . . . 0.0 112.728 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.45 -26.43 12.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.525 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -58.93 -48.09 82.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.924 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.894 HG11 ' HB3' ' A' ' 218' ' ' LEU . 22.1 t -73.0 -35.82 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.696 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.484 ' HB2' HD21 ' A' ' 174' ' ' LEU . 13.0 tp -56.13 -36.36 68.15 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.129 0.49 . . . . 0.0 110.032 179.223 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -76.92 -40.11 26.46 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 178.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -87.7 103.09 15.27 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.879 0.371 . . . . 0.0 110.718 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' MET . . . . . 0.839 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.8 mtm 178.02 167.73 0.75 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.127 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.92 -56.75 1.55 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.63 0.252 . . . . 0.0 111.268 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 6.3 pm0 -160.39 142.79 13.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.894 0.378 . . . . 0.0 111.307 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.874 HG12 HG12 ' A' ' 199' ' ' VAL . 13.3 mt -104.33 115.96 47.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.455 179.424 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' HIS . . . . . 0.417 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 20.2 m170 -106.45 124.05 49.01 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.113 -179.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -79.46 104.7 10.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.709 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.75 86.86 55.51 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.517 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.33 146.9 57.94 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.312 2.008 . . . . 0.0 112.535 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 18.6 p -128.28 159.66 34.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.677 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 4.2 mtt180 -54.51 -26.83 34.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.459 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -100.99 -19.32 15.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.652 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -141.46 82.18 1.81 Allowed 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.767 0.318 . . . . 0.0 111.439 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.1 -24.15 52.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.245 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -106.0 38.37 2.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.608 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.08 114.72 25.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.322 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.874 ' O ' HD13 ' A' ' 198' ' ' ILE . 32.8 m -110.59 169.37 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.724 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.874 HD13 ' O ' ' A' ' 197' ' ' VAL . 22.0 mm -134.95 110.29 12.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.72 0.295 . . . . 0.0 111.285 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.874 HG12 HG12 ' A' ' 185' ' ' ILE . 12.3 m -102.81 127.18 56.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.987 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -88.64 152.56 21.75 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.675 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.11 157.62 16.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.812 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -57.78 -23.84 54.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.527 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -89.89 15.36 10.03 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 79.64 14.19 81.47 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.57 -0.824 . . . . 0.0 113.081 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -78.39 175.05 10.64 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 117.094 0.447 . . . . 0.0 110.836 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -140.53 111.46 7.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.082 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.482 HG11 HG12 ' A' ' 224' ' ' ILE . 20.1 t -114.22 135.63 53.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.911 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 1.5 m -107.64 118.36 36.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.928 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.645 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -131.12 161.94 30.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.66 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -99.28 156.75 16.82 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.737 0.303 . . . . 0.0 110.788 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 45.9 mt -68.46 -33.1 58.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.771 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 -67.38 -38.06 84.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.091 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -126.53 41.14 3.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.974 0.416 . . . . 0.0 110.866 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.597 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 11.5 t80 -65.02 -52.57 55.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.869 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.29 -37.74 81.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.048 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -69.25 -49.62 54.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.063 0.458 . . . . 0.0 110.372 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 1.2 mmpt? -53.25 -41.72 65.76 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.058 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.894 ' HB3' HG11 ' A' ' 178' ' ' VAL . 4.3 mm? -87.06 -23.16 25.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.9 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 11.0 t -60.95 -32.64 72.17 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.921 0.391 . . . . 0.0 110.157 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' HIS . . . . . 0.589 ' CB ' HG22 ' A' ' 224' ' ' ILE . 24.9 m170 -69.53 -15.84 63.32 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.195 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.42 ' CD2' ' HA ' ' A' ' 222' ' ' PRO . 48.1 t80 -55.76 139.87 68.66 Favored Pre-proline 0 CA--C 1.537 0.444 0 N-CA-C 110.492 -0.188 . . . . 0.0 110.492 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.528 ' O ' ' HB3' ' A' ' 223' ' ' ALA . 68.8 Cg_endo -73.33 154.14 99.45 Favored 'Cis proline' 0 C--N 1.354 0.86 0 C-N-CA 124.344 -1.107 . . . . 0.0 112.714 0.211 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 222' ' ' PRO . . . 85.43 75.63 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.22 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.616 HD13 ' H ' ' A' ' 224' ' ' ILE . 0.1 OUTLIER -143.97 135.95 22.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.044 0.45 . . . . 0.0 111.358 178.762 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 225' ' ' ALA . . . . . 0.411 ' HB2' ' O ' ' A' ' 224' ' ' ILE . . . 176.5 -175.5 0.12 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.045 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -105.5 -166.42 1.21 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.878 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -128.02 33.81 4.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.79 0.329 . . . . 0.0 111.102 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 60.1 mt -107.54 30.21 6.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.964 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -111.93 57.37 0.64 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.995 0.426 . . . . 0.0 110.787 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 -132.69 -47.31 0.88 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.982 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -67.31 88.9 0.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.808 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 232' ' ' VAL . . . . . 0.402 HG22 ' N ' ' A' ' 233' ' ' LYS . 11.1 p -88.25 154.48 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.04 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 233' ' ' LYS . . . . . 0.402 ' N ' HG22 ' A' ' 232' ' ' VAL . 16.7 mttm . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.922 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.216 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.98 137.03 19.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.867 0.365 . . . . 0.0 110.945 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -65.28 154.93 36.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.942 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.769 ' HB2' HD13 ' A' ' 134' ' ' LEU . 82.8 m95 -70.91 168.44 16.91 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.219 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.85 132.2 47.76 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.799 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -69.17 108.4 3.6 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.926 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.911 HD11 HG22 ' A' ' 168' ' ' THR . 44.2 pt -98.01 -7.93 9.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.323 179.151 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.471 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -159.97 174.45 14.36 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 121.134 -0.226 . . . . 0.0 110.649 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.476 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 28.0 m-85 -143.03 126.75 17.04 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.277 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.651 HG21 HD11 ' A' ' 139' ' ' LEU . 3.5 t -93.35 123.65 45.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.018 0.437 . . . . 0.0 111.643 -179.179 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.481 ' CE1' ' CE1' ' A' ' 130' ' ' PHE . 7.5 t80 -84.51 105.11 15.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.754 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -159.66 154.92 25.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.681 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 60.46 30.56 19.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.945 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 62.38 32.16 16.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.166 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.484 HG23 ' O ' ' A' ' 145' ' ' THR . 75.3 m -153.1 151.39 30.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.085 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.815 ' CE2' ' HB2' ' A' ' 148' ' ' ALA . 36.4 m-85 -94.52 90.91 6.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.537 179.573 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.564 ' HB2' HD21 ' A' ' 139' ' ' LEU . 21.4 m-85 -65.47 138.17 96.82 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.739 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -85.16 116.06 1.73 Allowed 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.311 2.008 . . . . 0.0 112.083 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.609 HD21 ' OG1' ' A' ' 168' ' ' THR . 37.9 tp -95.29 123.65 38.91 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.882 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.769 HD13 ' HB2' ' A' ' 118' ' ' TRP . 58.2 mt -72.15 172.69 9.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.485 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.41 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.5 pt-20 -63.19 -28.75 70.26 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.854 179.725 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -90.5 12.39 18.81 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.209 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.642 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 74.07 28.34 64.63 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.717 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.628 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -81.62 92.36 6.55 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.723 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.651 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -74.17 105.03 5.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.957 0.408 . . . . 0.0 110.972 -179.533 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 88.6 mt -85.84 70.87 10.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.701 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.462 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 29.5 mttt -52.87 -23.24 6.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.983 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -84.09 -20.54 32.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.596 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -102.54 27.86 6.51 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 111.703 0.26 . . . . 0.0 111.703 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . -65.22 163.88 37.74 Favored Glycine 0 CA--C 1.511 -0.215 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.144 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.484 ' O ' HG23 ' A' ' 129' ' ' THR . 7.8 t -133.07 158.3 43.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.955 0.407 . . . . 0.0 110.648 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 6.2 mmmm -93.98 48.86 1.28 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.36 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.33 151.53 3.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.593 -179.007 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.815 ' HB2' ' CE2' ' A' ' 130' ' ' PHE . . . -96.93 126.73 41.51 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.178 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.476 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 73.2 Cg_endo -82.24 111.95 2.19 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.335 2.023 . . . . 0.0 112.552 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 28.2 t -69.82 -7.47 40.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.112 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -76.47 -23.33 53.82 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 120.859 0.362 . . . . 0.0 110.451 179.021 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.697 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -139.74 167.88 17.01 Favored Pre-proline 0 N--CA 1.454 -0.265 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.697 -179.308 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.697 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 61.0 Cg_endo -74.22 158.0 45.52 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.389 2.059 . . . . 0.0 112.236 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 11.1 t -118.47 111.04 32.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.049 0.452 . . . . 0.0 111.16 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.829 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.52 95.98 1.88 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.535 179.122 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.426 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 61.2 t -93.22 136.45 25.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.977 0.418 . . . . 0.0 111.014 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 49.05 55.98 10.96 Favored Glycine 0 CA--C 1.521 0.411 0 CA-C-N 115.808 -0.633 . . . . 0.0 113.264 179.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.829 ' CE2' HD23 ' A' ' 155' ' ' LEU . 2.7 m95 -98.34 151.11 20.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.128 0.489 . . . . 0.0 111.652 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.97 -172.65 0.07 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.349 179.337 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -44.46 155.5 0.09 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.134 0.492 . . . . 0.0 112.143 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.567 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -56.54 -25.14 49.45 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.25 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -60.89 -39.03 87.71 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 120.938 0.399 . . . . 0.0 110.038 179.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.424 ' HB1' ' HE2' ' A' ' 187' ' ' TYR . . . -75.36 -40.16 58.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.128 179.045 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.567 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.3 mt -59.0 -43.1 88.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.102 179.157 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.34 -29.69 35.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.35 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -68.14 -53.12 27.51 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.424 0.63 . . . . 0.0 110.189 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.77 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -60.39 -42.3 95.6 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.027 179.064 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.911 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -59.51 -37.47 78.42 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.306 179.252 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.78 -36.67 92.3 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 178.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -72.92 -46.86 50.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.424 -0.388 . . . . 0.0 110.945 178.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.573 ' O ' HD22 ' A' ' 174' ' ' LEU . 10.6 mp -65.69 -28.49 69.11 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.75 0.31 . . . . 0.0 111.34 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.31 -17.98 63.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.335 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -112.72 -27.36 8.19 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.65 0.262 . . . . 0.0 111.529 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.573 HD22 ' O ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER -56.88 167.0 1.16 Allowed Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.183 -179.463 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -69.2 127.82 15.61 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.249 1.966 . . . . 0.0 112.721 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.02 -25.85 5.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.81 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.65 -50.0 74.61 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.007 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.855 HG11 ' HB3' ' A' ' 218' ' ' LEU . 22.3 t -74.19 -35.33 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.667 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.661 HD21 ' O ' ' A' ' 121' ' ' ILE . 0.8 OUTLIER -56.37 -34.78 66.98 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.105 0.479 . . . . 0.0 110.091 179.212 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -79.56 -40.27 15.81 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.35 178.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -87.32 103.15 15.2 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.931 0.396 . . . . 0.0 110.745 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' MET . . . . . 0.841 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.8 mtm 178.95 164.66 0.86 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.24 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.33 -60.28 1.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.755 0.312 . . . . 0.0 111.195 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -155.64 142.89 19.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.029 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.89 HG12 HG12 ' A' ' 199' ' ' VAL . 16.7 mt -107.35 115.12 47.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.434 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' HIS . . . . . 0.426 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 20.7 m170 -106.39 135.07 48.53 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.186 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.424 ' HE2' ' HB1' ' A' ' 163' ' ' ALA . 0.3 OUTLIER -86.65 104.35 15.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.269 179.417 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.12 81.66 57.27 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.8 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.3 151.91 60.69 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.44 2.094 . . . . 0.0 112.371 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.51 HG21 ' CZ ' ' A' ' 196' ' ' ARG . 18.2 p -123.46 174.11 7.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.809 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 42.4 mtt180 -57.35 -29.5 64.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.341 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.402 ' O ' ' CD1' ' A' ' 193' ' ' TYR . 6.0 pm0 -118.74 7.87 11.73 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.402 ' CD1' ' O ' ' A' ' 192' ' ' GLU . 39.5 m-85 -144.51 69.57 1.27 Allowed 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.977 0.418 . . . . 0.0 111.064 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -56.58 -22.0 30.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.61 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 9.3 p30 -110.09 38.26 2.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.743 0.306 . . . . 0.0 111.047 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.51 ' CZ ' HG21 ' A' ' 190' ' ' THR . 0.0 OUTLIER -90.34 117.04 28.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.912 0.387 . . . . 0.0 111.121 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.88 ' O ' HD13 ' A' ' 198' ' ' ILE . 22.0 m -114.45 168.47 6.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.747 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.88 HD13 ' O ' ' A' ' 197' ' ' VAL . 22.7 mm -134.64 113.58 16.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.732 0.301 . . . . 0.0 111.221 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.89 HG12 HG12 ' A' ' 185' ' ' ILE . 10.4 m -104.8 125.91 59.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.09 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -88.72 152.52 21.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.787 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.02 154.88 18.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.761 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -58.03 -27.82 63.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.249 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -82.98 4.24 26.72 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 89.98 14.4 59.32 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 120.476 -0.869 . . . . 0.0 113.244 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -80.1 173.58 12.45 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 117.059 0.429 . . . . 0.0 110.902 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -139.3 111.34 7.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.904 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.803 HG11 HD12 ' A' ' 224' ' ' ILE . 19.6 t -115.79 137.36 49.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.924 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 97.7 p -110.77 119.66 39.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.942 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.567 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -130.36 164.21 25.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.71 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.86 153.71 20.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.76 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 33.9 mt -64.3 -36.81 78.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.837 0.351 . . . . 0.0 110.693 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.14 -36.39 81.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.159 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -132.0 46.12 2.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.007 0.432 . . . . 0.0 110.889 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.574 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 11.5 t80 -67.53 -51.71 47.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.785 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.15 -41.05 87.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.146 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -68.25 -49.85 57.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.148 0.499 . . . . 0.0 110.268 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 1.5 mmpt? -52.28 -41.81 63.19 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.102 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.855 ' HB3' HG11 ' A' ' 178' ' ' VAL . 3.8 mm? -86.85 -24.66 24.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.008 179.35 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 13.5 t -60.87 -30.76 70.34 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.829 0.347 . . . . 0.0 110.531 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 220' ' ' HIS . . . . . 0.743 ' HB2' HG22 ' A' ' 224' ' ' ILE . 58.7 m170 -68.83 -16.96 63.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.25 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.406 ' N ' ' CG2' ' A' ' 224' ' ' ILE . 70.1 t80 -65.04 137.4 97.09 Favored Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 110.408 -0.219 . . . . 0.0 110.408 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.532 ' O ' ' HB3' ' A' ' 223' ' ' ALA . 8.4 Cg_exo -72.48 154.86 98.96 Favored 'Cis proline' 0 C--N 1.355 0.891 0 C-N-CA 124.845 -0.898 . . . . 0.0 112.532 0.228 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.532 ' HB3' ' O ' ' A' ' 222' ' ' PRO . . . 82.02 77.75 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.079 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.803 HD12 HG11 ' A' ' 207' ' ' VAL . 15.5 pt -129.25 -178.64 2.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.387 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 65.19 132.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.226 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -65.49 -165.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.083 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -102.03 31.42 3.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.883 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.702 ' O ' HD23 ' A' ' 228' ' ' LEU . 1.0 OUTLIER -90.56 14.98 11.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.562 179.736 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -88.39 -32.0 18.58 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.856 0.36 . . . . 0.0 110.83 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -68.19 -31.96 71.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.898 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -90.84 51.99 2.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.852 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 11.2 p -59.34 148.7 6.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.087 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 20.3 pttm . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.161 -0.923 . . . . 0.0 110.846 179.972 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.212 0 N-CA-C 112.469 -0.252 . . . . 0.0 112.469 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 26.5 t 60.38 66.25 0.97 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.069 0.461 . . . . 0.0 110.877 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -148.96 151.77 35.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.071 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.773 ' HB2' HD13 ' A' ' 134' ' ' LEU . 82.1 m95 -68.79 168.0 14.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.106 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -102.68 138.01 40.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.403 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 10.3 mtt180 -73.4 105.59 4.84 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.729 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.922 HD11 HG22 ' A' ' 168' ' ' THR . 45.6 pt -93.49 -9.26 9.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.366 179.244 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.483 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -157.36 176.44 12.68 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 120.599 0.237 . . . . 0.0 110.537 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.467 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 34.0 m-85 -143.9 126.14 15.62 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.588 HG21 ' CD1' ' A' ' 139' ' ' LEU . 3.9 t -93.67 122.91 45.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.058 0.456 . . . . 0.0 111.417 -179.222 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -80.69 94.21 6.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.556 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -145.26 154.13 42.03 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.327 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.2 mmt-85 60.0 29.94 19.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.699 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 61.51 34.75 17.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.968 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.446 HG22 ' N ' ' A' ' 130' ' ' PHE . 83.6 m -154.87 162.04 41.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.818 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.446 ' N ' HG22 ' A' ' 129' ' ' THR . 10.7 m-85 -100.47 90.71 4.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.141 0.496 . . . . 0.0 111.201 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.464 ' HA ' ' HA2' ' A' ' 144' ' ' GLY . 23.1 m-85 -68.9 118.09 57.74 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.391 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.678 ' HB2' HD12 ' A' ' 140' ' ' LEU . 23.1 Cg_exo -64.3 115.35 3.11 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 122.359 2.039 . . . . 0.0 112.594 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.655 HD21 ' OG1' ' A' ' 168' ' ' THR . 30.3 tp -94.17 123.41 37.54 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.358 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.773 HD13 ' HB2' ' A' ' 118' ' ' TRP . 45.5 mt -69.02 173.6 5.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.557 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.404 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.6 pt-20 -64.72 -29.7 70.69 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.14 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -88.14 9.84 21.38 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.19 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.635 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 77.01 20.99 75.03 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.817 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.683 ' HB3' HD12 ' A' ' 134' ' ' LEU . 17.3 tpp180 -79.85 92.39 5.48 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.317 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.588 ' CD1' HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -66.81 119.89 12.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.501 -178.893 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.678 HD12 ' HB2' ' A' ' 132' ' ' PRO . 33.1 mt -88.17 76.49 8.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.306 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.453 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 15.7 mtpt -71.49 -5.86 36.22 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.002 -0.544 . . . . 0.0 112.454 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -94.97 -25.08 16.66 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.606 0.241 . . . . 0.0 111.078 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -87.16 -82.19 0.22 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.294 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.464 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . 59.52 153.84 0.02 OUTLIER Glycine 0 CA--C 1.506 -0.506 0 C-N-CA 121.337 -0.459 . . . . 0.0 112.8 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 10.1 t -137.77 152.35 49.08 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.127 -0.536 . . . . 0.0 110.61 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.31 51.34 1.89 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.566 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.12 147.43 2.57 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.741 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -90.9 125.11 60.08 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.332 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.467 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 71.6 Cg_endo -84.74 107.88 1.17 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.613 2.209 . . . . 0.0 112.659 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 25.8 t -69.52 -8.03 43.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.017 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -77.83 -24.49 48.68 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 120.879 0.371 . . . . 0.0 110.377 179.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.68 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -138.85 167.04 20.8 Favored Pre-proline 0 N--CA 1.452 -0.339 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.616 -179.488 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.68 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 70.2 Cg_endo -75.03 157.99 42.32 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.404 2.069 . . . . 0.0 112.572 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 13.6 t -118.97 110.72 30.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.095 0.474 . . . . 0.0 111.028 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.854 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.64 96.05 1.94 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.868 179.439 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.416 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 61.3 t -94.18 137.14 23.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.989 0.423 . . . . 0.0 111.048 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 48.83 57.02 9.03 Favored Glycine 0 C--N 1.332 0.345 0 CA-C-N 115.921 -0.581 . . . . 0.0 113.175 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.854 ' CE2' HD23 ' A' ' 155' ' ' LEU . 3.2 m95 -100.04 151.14 21.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.153 0.501 . . . . 0.0 111.843 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.411 ' HB2' ' CD2' ' A' ' 187' ' ' TYR . 0.0 OUTLIER -66.56 -172.27 0.16 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.438 179.288 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -43.6 154.39 0.09 Allowed 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.566 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.07 -25.63 54.2 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.262 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -60.22 -37.66 80.99 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.984 0.421 . . . . 0.0 110.027 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.14 -40.51 45.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.039 179.008 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.566 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.2 mt -58.73 -41.42 82.4 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.051 179.106 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.24 -29.92 48.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.067 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.462 ' CB ' HG21 ' A' ' 211' ' ' ILE . 5.0 mm-40 -68.26 -53.0 27.63 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 121.387 0.613 . . . . 0.0 110.117 179.378 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.811 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -59.12 -46.3 88.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.036 178.993 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.922 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -57.01 -36.78 70.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.549 179.231 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.75 -37.37 93.47 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 178.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -73.64 -45.78 50.71 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.315 -0.443 . . . . 0.0 111.077 179.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.574 ' HA ' HD22 ' A' ' 174' ' ' LEU . 11.0 mp -65.0 -29.69 70.62 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.828 0.347 . . . . 0.0 111.338 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.6 -16.99 63.5 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.365 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -114.23 -27.28 7.68 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.658 0.266 . . . . 0.0 111.633 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.574 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER -57.05 167.17 1.18 Allowed Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.269 -179.561 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -70.68 127.79 14.32 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.226 1.95 . . . . 0.0 112.938 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.04 -25.64 5.12 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.723 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.4 -50.17 73.86 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.968 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.867 HG11 ' HB3' ' A' ' 218' ' ' LEU . 34.7 t -74.18 -33.5 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.49 179.446 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.516 HD13 HD21 ' A' ' 174' ' ' LEU . 11.4 tp -56.46 -36.88 69.55 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.096 0.474 . . . . 0.0 109.935 179.076 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -77.36 -41.65 20.49 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.284 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -84.32 103.0 13.13 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.896 0.379 . . . . 0.0 110.558 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' MET . . . . . 0.84 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.8 mtm 177.02 166.11 0.53 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.142 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 27.3 t -124.82 -53.99 1.64 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.732 0.301 . . . . 0.0 111.147 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -162.14 142.63 10.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.977 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.925 HG12 HG12 ' A' ' 199' ' ' VAL . 19.1 mt -104.89 115.44 46.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.472 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' HIS . . . . . 0.416 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 21.9 m170 -105.37 123.36 47.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.159 -179.525 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.411 ' CD2' ' HB2' ' A' ' 159' ' ' LYS . 14.0 t80 -78.82 104.35 9.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.438 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.65 81.56 40.46 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.584 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -67.26 145.8 73.5 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.311 2.007 . . . . 0.0 112.451 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 21.2 p -123.98 158.85 31.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.735 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.38 -25.16 9.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.664 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -108.61 -17.64 13.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.629 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -135.14 77.76 1.7 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.883 0.373 . . . . 0.0 111.209 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -57.09 -22.45 39.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.499 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 5.8 p30 -108.17 37.71 2.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.731 0.301 . . . . 0.0 110.819 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 9.5 ttt-85 -89.76 114.32 26.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.911 0.386 . . . . 0.0 111.2 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.852 ' O ' HD13 ' A' ' 198' ' ' ILE . 25.1 m -111.61 167.85 5.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.9 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.852 HD13 ' O ' ' A' ' 197' ' ' VAL . 22.7 mm -134.24 111.34 14.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.844 0.354 . . . . 0.0 110.974 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.925 HG12 HG12 ' A' ' 185' ' ' ILE . 6.7 m -100.31 120.15 49.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.21 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -81.88 152.46 26.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.661 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' MET . . . . . 0.462 ' HE2' ' HG3' ' A' ' 182' ' ' MET . 7.6 mmt -105.6 157.89 17.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.99 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 39.5 m-20 -59.82 -27.03 66.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.142 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.02 13.27 13.33 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 89.1 -14.07 61.64 Favored Glycine 0 CA--C 1.52 0.397 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.247 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -58.13 156.03 10.24 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 117.133 0.467 . . . . 0.0 110.96 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -131.3 111.31 11.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.919 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 20.8 t -107.03 141.92 21.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.04 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 5.6 m -112.41 116.87 31.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.883 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.607 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -128.58 162.48 27.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.804 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.7 154.91 17.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.584 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.462 HG21 ' CB ' ' A' ' 166' ' ' GLU . 40.5 mt -67.3 -35.7 74.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.804 0.335 . . . . 0.0 110.96 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -38.4 91.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.24 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -128.09 40.64 3.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.914 0.388 . . . . 0.0 110.892 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.572 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 11.1 t80 -62.56 -54.35 41.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.768 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.1 -41.38 78.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.276 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.62 -46.58 68.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.075 0.464 . . . . 0.0 110.421 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 217' ' ' LYS . . . . . 0.728 ' O ' HG21 ' A' ' 224' ' ' ILE . 0.4 OUTLIER -55.6 -44.75 77.29 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.883 179.611 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.867 ' HB3' HG11 ' A' ' 178' ' ' VAL . 3.9 mm? -83.31 -25.05 31.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.037 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 13.0 t -60.97 -33.14 72.76 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.062 0.458 . . . . 0.0 110.131 179.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 9.6 m170 -71.66 -15.84 62.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.268 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -55.05 133.47 68.1 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 116.726 -0.215 . . . . 0.0 111.165 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -91.72 105.68 0.48 Allowed 'Cis proline' 0 C--N 1.356 0.953 0 C-N-CA 124.824 -0.907 . . . . 0.0 112.677 0.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -179.02 38.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.118 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.728 HG21 ' O ' ' A' ' 217' ' ' LYS . 0.1 OUTLIER -139.84 156.83 25.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.029 179.666 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 179.6 172.05 0.97 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.098 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -123.67 154.88 38.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.165 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -143.2 42.56 1.53 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.076 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 4.5 tp -98.64 30.9 3.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.012 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -113.78 32.52 5.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.808 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 46.7 mtm180 -147.34 54.6 1.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.794 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -167.33 152.55 7.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.665 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 21.0 t 67.08 116.29 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.11 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.874 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.166 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 26.1 m -132.98 178.43 6.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.795 0.331 . . . . 0.0 110.902 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -68.53 147.18 52.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.047 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.759 ' HB2' HD13 ' A' ' 134' ' ' LEU . 80.6 m95 -68.42 168.3 12.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.237 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 11.4 ttt180 -102.49 137.66 40.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.348 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 24.8 mtt85 -72.91 106.48 4.84 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.861 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.9 HD11 HG22 ' A' ' 168' ' ' THR . 46.6 pt -95.61 -8.1 9.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.361 179.278 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.475 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -158.75 176.45 12.34 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 120.578 0.228 . . . . 0.0 110.708 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.465 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 29.8 m-85 -144.94 126.45 15.01 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.688 HG21 HD11 ' A' ' 139' ' ' LEU . 4.3 t -93.08 122.61 44.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.091 0.472 . . . . 0.0 111.267 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.472 ' CE1' ' CE1' ' A' ' 130' ' ' PHE . 9.3 t80 -83.96 100.01 10.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.842 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -151.76 151.8 31.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.601 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 60.0 30.88 20.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 63.4 32.41 14.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.2 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.573 HG23 ' O ' ' A' ' 145' ' ' THR . 87.8 m -152.89 149.02 27.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.828 0.347 . . . . 0.0 110.988 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.755 ' CE2' ' HB2' ' A' ' 148' ' ' ALA . 24.2 m-85 -93.69 91.0 6.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.713 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.565 ' HB2' HD21 ' A' ' 139' ' ' LEU . 24.7 m-85 -66.05 120.79 72.27 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.141 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -68.12 115.5 3.86 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.045 1.83 . . . . 0.0 112.539 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.661 HD21 ' OG1' ' A' ' 168' ' ' THR . 34.1 tp -95.0 124.2 38.91 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.787 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.759 HD13 ' HB2' ' A' ' 118' ' ' TRP . 42.5 mt -69.89 175.47 4.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.5 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.41 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.3 pt-20 -66.52 -28.41 68.53 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.125 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 32.7 p-10 -90.47 13.21 16.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.235 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.615 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 73.79 20.15 79.76 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.978 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.69 ' HB3' HD12 ' A' ' 134' ' ' LEU . 0.7 OUTLIER -79.04 94.14 5.25 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.326 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.688 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -70.45 116.37 10.7 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.652 -178.875 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.474 HD23 ' HG3' ' A' ' 143' ' ' GLU . 10.4 mp -90.35 76.25 6.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.343 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.478 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 4.5 mttt -61.46 -15.46 37.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.241 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -94.38 -24.11 17.5 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.474 ' HG3' HD23 ' A' ' 140' ' ' LEU . 68.7 mm-40 -99.81 26.82 5.91 Favored 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.428 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . -62.95 163.66 29.13 Favored Glycine 0 CA--C 1.51 -0.222 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.885 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.573 ' O ' HG23 ' A' ' 129' ' ' THR . 7.1 t -130.79 158.2 40.8 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.877 0.37 . . . . 0.0 110.712 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -94.42 49.32 1.27 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.513 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.3 154.64 4.0 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.609 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.755 ' HB2' ' CE2' ' A' ' 130' ' ' PHE . . . -97.64 125.53 44.43 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.24 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.465 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 73.7 Cg_endo -83.06 111.9 1.96 Allowed 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.4 2.066 . . . . 0.0 112.573 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 11.0 t -69.48 -8.14 44.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.175 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -77.11 -23.54 51.81 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 120.88 0.372 . . . . 0.0 110.507 179.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.672 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -138.97 166.92 21.43 Favored Pre-proline 0 N--CA 1.452 -0.336 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.669 -179.328 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.672 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 67.7 Cg_endo -74.83 154.33 43.32 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.401 2.067 . . . . 0.0 112.308 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 10.6 t -116.04 110.48 31.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.93 0.395 . . . . 0.0 111.293 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.849 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.36 95.94 1.81 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.552 179.025 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.415 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 60.1 t -91.98 136.12 25.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.946 0.403 . . . . 0.0 111.116 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 48.83 58.75 7.34 Favored Glycine 0 CA--C 1.521 0.468 0 CA-C-N 115.837 -0.619 . . . . 0.0 113.189 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.849 ' CE2' HD23 ' A' ' 155' ' ' LEU . 3.1 m95 -101.31 151.17 22.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.198 0.523 . . . . 0.0 111.834 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.42 -172.24 0.15 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.412 179.394 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -42.92 154.49 0.07 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.532 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.51 -25.84 55.86 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.157 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.97 -38.85 80.05 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.967 0.413 . . . . 0.0 109.943 179.191 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.64 -39.98 50.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.009 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.532 HD12 ' HA2' ' A' ' 161' ' ' GLY . 5.8 mt -59.28 -41.39 83.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.903 178.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.9 -31.06 48.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.129 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.419 ' HB3' HG21 ' A' ' 211' ' ' ILE . 2.6 mm-40 -67.8 -53.02 30.37 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.386 0.613 . . . . 0.0 110.138 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.82 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -59.24 -44.56 92.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.01 179.095 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.9 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -58.42 -37.55 75.61 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.545 179.106 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.89 -36.86 91.48 Favored Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 178.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -73.83 -46.33 45.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.342 -0.429 . . . . 0.0 111.008 178.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.592 ' HA ' HD22 ' A' ' 174' ' ' LEU . 11.3 mp -66.22 -28.01 68.41 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.683 0.278 . . . . 0.0 111.349 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.87 -17.22 62.73 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.682 -0.236 . . . . 0.0 111.291 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -112.62 -29.85 7.31 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.653 0.263 . . . . 0.0 111.345 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.592 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER -55.44 167.32 0.76 Allowed Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.216 -179.651 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.416 ' HG2' HG23 ' A' ' 178' ' ' VAL . 47.9 Cg_endo -69.63 128.78 16.63 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.208 1.939 . . . . 0.0 112.921 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.28 -25.63 9.95 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.535 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -58.82 -48.59 80.78 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.894 0.378 . . . . 0.0 110.927 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.873 HG11 ' HB3' ' A' ' 218' ' ' LEU . 23.0 t -73.51 -35.69 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.649 179.58 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.432 ' HB2' HD21 ' A' ' 174' ' ' LEU . 4.8 tp -55.85 -34.31 65.33 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.128 0.49 . . . . 0.0 110.075 179.217 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -78.77 -41.9 14.25 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.295 178.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -84.99 102.86 13.52 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.884 0.373 . . . . 0.0 110.632 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' MET . . . . . 0.844 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.8 mtm 177.22 161.81 0.47 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.146 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 12.3 t -117.18 -57.63 2.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.749 0.309 . . . . 0.0 110.908 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -160.91 142.31 11.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.001 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.904 HG12 HG12 ' A' ' 199' ' ' VAL . 16.3 mt -102.1 114.51 41.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.316 179.329 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' HIS . . . . . 0.415 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 21.6 m170 -104.34 122.58 45.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.237 -179.408 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.418 ' CD2' ' HD3' ' A' ' 189' ' ' PRO . 51.9 t80 -74.5 104.25 5.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.275 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 11.8 mmtt -119.78 76.37 20.72 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.692 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.418 ' HD3' ' CD2' ' A' ' 187' ' ' TYR . 56.0 Cg_endo -70.2 144.69 52.44 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.21 1.94 . . . . 0.0 112.443 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 18.6 p -127.18 159.77 33.27 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.671 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 37.8 mtt-85 -53.52 -24.91 14.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.45 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -103.12 -21.14 13.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.597 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -137.16 79.2 1.74 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.975 0.417 . . . . 0.0 111.282 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.68 -23.23 50.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.484 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -107.01 36.52 2.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.75 0.31 . . . . 0.0 110.976 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 6.4 ttt85 -89.58 115.03 26.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.979 0.419 . . . . 0.0 111.15 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.839 ' O ' HD13 ' A' ' 198' ' ' ILE . 27.2 m -111.67 166.68 5.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.729 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.839 HD13 ' O ' ' A' ' 197' ' ' VAL . 22.7 mm -133.52 108.9 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.821 0.343 . . . . 0.0 111.222 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.904 HG12 HG12 ' A' ' 185' ' ' ILE . 9.1 m -99.08 122.65 51.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.088 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -85.14 152.48 23.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.761 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 4.7 mmt -104.97 158.88 16.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.017 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -63.22 -26.64 68.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.13 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -87.09 11.16 14.5 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 83.65 14.51 73.06 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.539 -0.838 . . . . 0.0 113.281 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -82.14 166.83 19.33 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 117.073 0.437 . . . . 0.0 110.845 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -133.72 111.67 10.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.879 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.416 ' HB ' HG23 ' A' ' 199' ' ' VAL . 21.4 t -114.63 125.26 71.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.131 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.557 ' HB3' HD12 ' A' ' 198' ' ' ILE . 2.0 p -101.18 116.1 32.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.76 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.664 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -126.87 159.89 32.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.872 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.47 152.52 19.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.687 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.419 HG21 ' HB3' ' A' ' 166' ' ' GLU . 35.2 mt -64.37 -38.29 82.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.95 0.405 . . . . 0.0 110.642 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 2.2 ptt85 -60.01 -34.61 73.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.205 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -134.77 45.5 2.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.933 0.397 . . . . 0.0 111.034 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.6 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 10.9 t80 -67.75 -53.9 23.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.712 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.2 -39.81 76.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.264 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.99 -48.84 62.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.101 0.477 . . . . 0.0 110.284 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 217' ' ' LYS . . . . . 0.419 ' O ' HG21 ' A' ' 224' ' ' ILE . 0.6 OUTLIER -53.27 -42.51 66.59 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.14 179.642 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.873 ' HB3' HG11 ' A' ' 178' ' ' VAL . 3.9 mm? -86.95 -23.48 25.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.042 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 11.2 t -60.99 -33.15 72.79 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.901 0.381 . . . . 0.0 110.22 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -69.83 -16.44 63.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.204 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.405 ' CE1' ' HB3' ' A' ' 222' ' ' PRO . 38.0 t80 -57.79 142.58 78.3 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.734 -0.212 . . . . 0.0 111.057 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.466 ' O ' ' HB2' ' A' ' 223' ' ' ALA . 46.1 Cg_endo -92.71 105.74 0.45 Allowed 'Cis proline' 0 C--N 1.356 0.953 0 C-N-CA 124.733 -0.944 . . . . 0.0 112.698 0.187 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.466 ' HB2' ' O ' ' A' ' 222' ' ' PRO . . . 172.7 42.3 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.441 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.419 HG21 ' O ' ' A' ' 217' ' ' LYS . 0.1 OUTLIER -134.02 165.23 32.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.858 -179.642 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 179.74 -170.16 0.13 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.12 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -79.3 151.64 30.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.158 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -145.24 25.63 1.37 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.134 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.665 ' O ' HD23 ' A' ' 228' ' ' LEU . 1.4 tt -110.1 50.26 0.81 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.176 0.512 . . . . 0.0 110.381 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 76.13 -60.49 0.48 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.952 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 65.39 47.67 2.26 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.991 0.424 . . . . 0.0 110.865 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -116.6 86.18 2.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.722 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 11.5 p -73.59 127.94 35.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.065 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.993 179.995 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.183 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.8 m 64.01 -78.33 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.698 0.285 . . . . 0.0 111.138 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -105.2 144.97 31.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.066 0.46 . . . . 0.0 110.997 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.763 ' HB2' HD13 ' A' ' 134' ' ' LEU . 78.8 m95 -67.3 168.09 11.18 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.06 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? -103.05 138.77 39.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.287 179.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.26 105.73 4.79 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 120.822 0.344 . . . . 0.0 110.669 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.867 HD11 HG22 ' A' ' 168' ' ' THR . 46.6 pt -95.04 -7.55 9.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.501 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.526 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -160.15 176.36 11.86 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 120.766 0.317 . . . . 0.0 110.946 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.471 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 35.7 m-85 -144.98 126.93 15.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.821 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.516 HG21 HD11 ' A' ' 139' ' ' LEU . 6.1 t -93.21 122.91 45.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.155 0.503 . . . . 0.0 111.587 -179.044 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.437 ' CE1' ' CE1' ' A' ' 130' ' ' PHE . 34.7 t80 -83.11 94.38 7.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.916 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -144.76 152.97 41.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.437 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.86 30.32 19.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.812 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 62.13 34.25 16.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.934 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.454 HG22 ' N ' ' A' ' 130' ' ' PHE . 58.5 m -151.04 161.93 41.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.993 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.641 ' CE2' ' HB2' ' A' ' 148' ' ' ALA . 16.8 m-85 -104.61 91.14 3.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.256 0.551 . . . . 0.0 110.897 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.489 ' HB2' HD21 ' A' ' 139' ' ' LEU . 23.8 m-85 -69.62 121.55 82.81 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.547 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.436 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 21.1 Cg_exo -65.2 122.16 9.82 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 122.374 2.05 . . . . 0.0 112.549 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.697 HD21 ' OG1' ' A' ' 168' ' ' THR . 31.0 tp -104.12 123.48 47.34 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.296 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.763 HD13 ' HB2' ' A' ' 118' ' ' TRP . 53.6 mt -71.58 174.92 6.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.582 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.421 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.3 pt-20 -64.93 -29.06 69.97 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.915 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 14.9 p-10 -91.17 13.66 16.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.152 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.638 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 74.95 22.52 76.7 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.059 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.674 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -76.0 92.76 3.18 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.412 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.516 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -70.64 119.86 15.41 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.023 0.439 . . . . 0.0 111.607 -179.083 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.421 HD12 ' HG2' ' A' ' 143' ' ' GLU . 4.0 mm? -92.24 72.91 5.38 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.711 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.467 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 0.4 OUTLIER -61.05 -16.84 48.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.012 -179.753 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -95.52 -20.0 19.37 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.421 ' HG2' HD12 ' A' ' 140' ' ' LEU . 39.9 mm-40 -102.23 25.7 8.57 Favored 'General case' 0 N--CA 1.461 0.111 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.436 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -58.43 162.6 10.29 Favored Glycine 0 CA--C 1.509 -0.337 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.708 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 11.1 t -136.33 150.83 49.04 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.767 0.317 . . . . 0.0 110.67 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.438 ' HE2' HG23 ' A' ' 129' ' ' THR . 3.9 mmtt -88.99 52.19 2.35 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.005 0.431 . . . . 0.0 110.705 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.23 149.46 2.81 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.658 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.641 ' HB2' ' CE2' ' A' ' 130' ' ' PHE . . . -94.6 125.66 50.7 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.324 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.471 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 75.2 Cg_endo -84.24 111.26 1.58 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.49 2.126 . . . . 0.0 112.638 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.3 t -69.91 -7.53 41.16 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.035 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -77.09 -23.2 51.9 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 120.806 0.336 . . . . 0.0 110.58 179.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.681 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -140.47 167.11 18.96 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.944 -179.246 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.681 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 62.7 Cg_endo -74.48 154.33 45.1 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.351 2.034 . . . . 0.0 112.133 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 14.3 t -115.47 111.12 34.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.019 0.437 . . . . 0.0 111.286 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.807 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.36 96.11 1.83 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.747 179.052 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.436 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 62.6 t -92.74 135.78 26.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.901 0.382 . . . . 0.0 110.936 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 48.77 58.28 7.75 Favored Glycine 0 CA--C 1.521 0.443 0 CA-C-N 115.963 -0.562 . . . . 0.0 113.209 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.807 ' CE2' HD23 ' A' ' 155' ' ' LEU . 3.0 m95 -101.13 151.3 22.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.206 0.526 . . . . 0.0 111.787 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -65.49 -173.34 0.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.319 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -43.81 154.88 0.09 Allowed 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.552 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.26 -25.13 53.86 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.134 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -59.95 -38.52 82.69 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.921 0.391 . . . . 0.0 110.107 179.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.89 -41.02 45.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.056 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.552 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.1 mt -58.08 -41.89 81.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.016 179.222 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.87 -30.54 46.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.228 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -68.74 -53.02 24.48 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 121.548 0.689 . . . . 0.0 110.026 179.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.766 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -60.11 -42.94 95.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.947 178.958 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.867 HG22 HD11 ' A' ' 121' ' ' ILE . 0.3 OUTLIER -59.51 -37.01 77.16 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.296 179.22 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.17 -39.52 94.59 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 110.556 -1.017 . . . . 0.0 110.556 178.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 48.1 mm-40 -69.72 -45.73 67.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.427 -0.387 . . . . 0.0 110.782 178.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.611 ' HA ' HD22 ' A' ' 174' ' ' LEU . 11.0 mp -66.58 -26.94 67.35 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.695 0.284 . . . . 0.0 111.462 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.98 -19.12 62.57 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.223 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -112.63 -26.67 8.52 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.573 0.225 . . . . 0.0 111.505 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.611 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER -57.55 167.4 1.34 Allowed Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.089 -179.754 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -70.66 127.9 14.48 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.201 1.934 . . . . 0.0 112.943 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.08 -25.28 8.34 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.597 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.44 -49.33 76.6 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.856 0.36 . . . . 0.0 110.944 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.866 HG11 ' HB3' ' A' ' 218' ' ' LEU . 39.9 t -74.24 -36.11 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.451 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.493 ' HB2' HD21 ' A' ' 174' ' ' LEU . 12.7 tp -55.13 -37.01 66.37 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.09 0.472 . . . . 0.0 110.11 179.209 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -78.39 -39.09 23.44 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.393 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -87.29 103.04 15.08 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.9 0.381 . . . . 0.0 110.73 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' MET . . . . . 0.834 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.8 mtm 178.05 176.61 0.44 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.053 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 9.1 t -132.07 -54.77 0.98 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.783 0.325 . . . . 0.0 111.129 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -162.17 142.52 10.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.021 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.89 HG12 HG12 ' A' ' 199' ' ' VAL . 19.7 mt -104.76 114.69 45.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.34 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' HIS . . . . . 0.436 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 20.0 m170 -106.21 126.28 52.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.079 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.413 ' CD1' ' HD3' ' A' ' 189' ' ' PRO . 0.4 OUTLIER -77.39 104.83 8.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.517 179.57 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 11.8 mmtp -117.24 76.03 8.73 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.351 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.413 ' HD3' ' CD1' ' A' ' 187' ' ' TYR . 39.7 Cg_endo -66.67 145.43 75.73 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.374 2.05 . . . . 0.0 112.631 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 20.8 p -127.06 157.23 40.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.699 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 3.9 ptp85 -54.14 -24.2 16.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.4 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -101.41 -22.81 14.47 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.353 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -139.67 81.61 1.83 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.936 0.398 . . . . 0.0 111.216 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -57.54 -22.45 44.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.376 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -104.11 35.88 2.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.749 0.309 . . . . 0.0 110.881 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -89.95 113.15 24.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.044 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.875 ' O ' HD13 ' A' ' 198' ' ' ILE . 19.7 m -109.8 168.31 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.88 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.875 HD13 ' O ' ' A' ' 197' ' ' VAL . 22.8 mm -135.14 110.54 12.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.708 0.29 . . . . 0.0 111.242 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.89 HG12 HG12 ' A' ' 185' ' ' ILE . 10.6 m -99.09 133.97 39.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.963 0.411 . . . . 0.0 110.878 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -95.98 152.5 18.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.765 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 25.2 tpp -112.28 150.61 30.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.745 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 21.1 p30 -57.47 -28.93 63.81 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.28 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -72.69 -8.78 57.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.768 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 96.73 14.55 43.07 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 120.473 -0.87 . . . . 0.0 113.1 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -90.82 162.55 14.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 117.026 0.413 . . . . 0.0 111.018 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -126.85 111.26 13.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.809 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.745 HG11 HD12 ' A' ' 224' ' ' ILE . 20.6 t -109.36 137.52 41.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.067 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 10.7 p -109.58 118.66 37.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.967 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -127.07 172.54 10.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.679 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.33 154.5 27.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.609 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 31.9 mt -66.01 -35.45 75.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.812 0.339 . . . . 0.0 110.938 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.7 -35.63 81.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.194 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -134.83 47.53 2.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.016 0.436 . . . . 0.0 111.005 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.583 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 10.5 t80 -69.35 -50.81 42.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.613 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.97 -42.22 84.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.256 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -67.37 -47.68 69.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.986 0.422 . . . . 0.0 110.397 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.9 -45.34 74.69 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.09 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.866 ' HB3' HG11 ' A' ' 178' ' ' VAL . 4.4 mm? -82.12 -26.25 33.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.979 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 13.5 t -60.38 -32.46 71.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.002 0.429 . . . . 0.0 110.217 179.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.9 m170 -70.14 -17.11 63.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.118 179.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -71.26 139.6 84.72 Favored Pre-proline 0 CA--C 1.533 0.316 0 C-N-CA 121.359 -0.136 . . . . 0.0 110.939 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.503 ' O ' ' HB2' ' A' ' 223' ' ' ALA . 67.0 Cg_endo -87.26 109.97 1.44 Allowed 'Cis proline' 0 C--N 1.357 0.981 0 C-N-CA 124.505 -1.04 . . . . 0.0 112.56 0.169 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.503 ' HB2' ' O ' ' A' ' 222' ' ' PRO . . . 168.09 44.63 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.007 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.745 HD12 HG11 ' A' ' 207' ' ' VAL . 4.3 pt -115.81 -178.8 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.249 -179.415 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 225' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 224' ' ' ILE . . . 74.78 75.68 0.11 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.042 0.448 . . . . 0.0 110.842 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -112.21 -158.78 0.66 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.809 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -97.09 35.91 1.51 Allowed 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 120.845 0.355 . . . . 0.0 110.933 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.608 ' O ' HD23 ' A' ' 228' ' ' LEU . 7.5 tt -76.26 -3.08 34.61 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.794 179.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -98.32 32.47 2.47 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.765 0.317 . . . . 0.0 110.933 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 2.3 mtt85 -105.09 -52.26 2.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.88 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -63.53 89.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.885 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 19.6 t -127.25 143.29 41.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.117 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.278 -0.867 . . . . 0.0 110.874 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.113 0 N-CA-C 112.534 -0.226 . . . . 0.0 112.534 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 51.9 p -105.84 -176.97 3.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.857 0.36 . . . . 0.0 110.936 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -112.95 146.48 38.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.107 0.479 . . . . 0.0 110.935 179.991 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.731 ' HB2' HD13 ' A' ' 134' ' ' LEU . 79.5 m95 -67.11 168.27 10.5 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.068 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -102.79 135.41 44.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.466 179.449 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 15.0 mtt180 -71.42 105.49 3.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.743 -179.906 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.91 HD11 HG22 ' A' ' 168' ' ' THR . 45.3 pt -93.53 -8.31 10.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.503 179.455 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -159.16 176.53 12.12 Favored 'General case' 0 C--O 1.226 -0.178 0 C-N-CA 121.037 -0.265 . . . . 0.0 111.0 179.885 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.464 ' O ' ' HA ' ' A' ' 154' ' ' VAL . 32.3 m-85 -143.28 126.8 16.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.455 179.78 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.638 HG21 HD11 ' A' ' 139' ' ' LEU . 4.5 t -93.47 123.01 45.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.05 0.453 . . . . 0.0 111.133 -179.607 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.428 ' CD1' ' CE1' ' A' ' 130' ' ' PHE . 37.3 t80 -80.19 103.02 9.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.748 -179.889 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -159.18 155.44 27.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.559 -179.808 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.19 31.61 19.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.849 -179.851 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 60.41 31.38 20.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.0 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.45 HG23 ' HE2' ' A' ' 146' ' ' LYS . 86.3 m -154.05 161.87 41.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.846 179.929 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.446 ' N ' HG22 ' A' ' 129' ' ' THR . 8.9 m-85 -100.65 90.4 4.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.669 179.625 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.502 ' HA ' ' HA2' ' A' ' 144' ' ' GLY . 22.3 m-85 -65.41 125.44 89.52 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.811 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.4 ' HB3' ' CE2' ' A' ' 123' ' ' TYR . 60.9 Cg_endo -73.66 120.17 6.3 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.219 1.946 . . . . 0.0 112.372 -179.773 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.676 HD21 ' OG1' ' A' ' 168' ' ' THR . 27.4 tp -98.04 123.58 42.13 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.489 179.636 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.731 HD13 ' HB2' ' A' ' 118' ' ' TRP . 37.0 mt -69.63 172.68 7.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.464 -179.747 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -63.81 -28.32 69.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.998 179.706 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 50.5 p-10 -90.59 13.43 15.93 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.281 179.781 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.599 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 73.1 22.36 79.07 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.227 179.797 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.66 ' HB3' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -81.01 94.44 6.56 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.519 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.638 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -73.42 112.49 9.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.362 -179.04 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 34.3 mt -88.84 81.25 6.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.405 179.418 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.456 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 9.6 mtpt -71.13 -5.61 33.03 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -179.388 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -90.41 -27.14 19.51 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.635 0.255 . . . . 0.0 111.183 179.885 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -85.81 -79.98 0.23 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.76 0.314 . . . . 0.0 111.322 -179.707 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.502 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . 57.83 161.13 0.04 OUTLIER Glycine 0 CA--C 1.506 -0.514 0 CA-C-N 116.29 -0.413 . . . . 0.0 112.708 -179.572 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.9 t -140.07 148.67 42.11 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.357 -0.422 . . . . 0.0 110.842 -179.548 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.45 ' HE2' HG23 ' A' ' 129' ' ' THR . 4.0 mmtt -89.85 52.56 2.32 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.381 179.807 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.98 154.48 4.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.093 0.473 . . . . 0.0 110.613 -179.358 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.33 135.41 34.63 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.597 -179.493 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.45 ' HD2' ' CG2' ' A' ' 154' ' ' VAL . 67.1 Cg_endo -83.81 98.73 0.79 Allowed 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 122.993 2.462 . . . . 0.0 112.535 179.689 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 43.9 t -67.23 -9.57 41.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.786 179.468 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -90.15 -22.2 21.85 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 120.615 0.245 . . . . 0.0 111.572 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.723 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -138.9 167.75 18.16 Favored Pre-proline 0 C--N 1.329 -0.287 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -178.997 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.723 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 64.7 Cg_endo -74.22 163.97 35.29 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 122.469 2.113 . . . . 0.0 112.511 -179.863 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 20.1 t -123.73 109.05 22.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.517 -179.755 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.826 HD21 ' SD ' ' A' ' 167' ' ' MET . 1.1 mp -72.8 95.97 1.99 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.694 179.107 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 53.5 t -92.57 136.46 24.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.983 0.421 . . . . 0.0 111.231 -179.904 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 49.21 49.17 31.55 Favored Glycine 0 CA--C 1.519 0.299 0 CA-C-N 115.783 -0.644 . . . . 0.0 113.381 179.16 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.823 ' CE2' HD23 ' A' ' 155' ' ' LEU . 2.7 m95 -92.2 151.1 20.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.102 0.477 . . . . 0.0 111.371 -179.622 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -172.55 0.08 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.539 179.542 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -43.99 154.34 0.11 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.088 -0.506 . . . . 0.0 112.21 -179.846 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.534 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.41 -24.75 53.19 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.147 179.448 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.8 -39.23 84.31 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-O 120.959 0.409 . . . . 0.0 110.137 179.219 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.65 -40.84 47.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.054 178.996 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.534 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.2 mt -58.13 -41.68 81.28 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.093 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.991 179.104 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.21 -28.69 28.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.151 179.494 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -69.15 -53.23 21.19 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-O 121.474 0.654 . . . . 0.0 110.172 179.348 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.826 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -59.84 -45.11 93.45 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.11 179.051 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.91 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -56.84 -38.82 73.19 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.592 179.344 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.14 -37.73 92.12 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 178.26 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -72.03 -46.47 56.97 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.375 -0.412 . . . . 0.0 111.073 178.822 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.595 ' HA ' HD22 ' A' ' 174' ' ' LEU . 10.9 mp -65.88 -28.73 69.17 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.724 0.297 . . . . 0.0 111.414 179.785 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.82 -18.12 63.43 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.363 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -113.8 -26.79 8.03 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 111.661 0.245 . . . . 0.0 111.661 -179.73 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.595 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER -57.32 167.27 1.28 Allowed Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 116.682 -0.236 . . . . 0.0 111.22 -179.561 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -67.68 126.32 14.56 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.215 1.943 . . . . 0.0 112.796 179.74 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.92 -26.07 9.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.676 179.805 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -58.5 -48.83 79.52 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.873 0.368 . . . . 0.0 110.891 179.683 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.851 HG11 ' HB3' ' A' ' 218' ' ' LEU . 25.3 t -73.7 -33.7 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.531 179.515 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.401 ' HB2' HD21 ' A' ' 174' ' ' LEU . 11.4 tp -56.87 -35.78 69.3 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.135 0.493 . . . . 0.0 109.816 178.988 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -77.05 -42.39 19.83 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.276 178.74 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -84.13 103.02 13.0 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.829 0.347 . . . . 0.0 110.656 179.232 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 182' ' ' MET . . . . . 0.85 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.9 mtm 178.85 159.76 0.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.123 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -118.36 -54.53 2.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.814 0.34 . . . . 0.0 111.122 -179.743 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -162.66 142.63 9.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.999 -179.834 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.912 HG12 HG12 ' A' ' 199' ' ' VAL . 17.7 mt -105.23 115.04 46.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.422 179.4 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 23.2 m170 -105.69 129.37 53.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.164 -179.499 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -82.2 104.54 12.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.521 179.663 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.19 90.01 51.05 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.65 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.21 149.65 58.04 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.309 2.006 . . . . 0.0 112.49 -179.721 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.457 HG21 ' HD3' ' A' ' 196' ' ' ARG . 6.9 p -122.09 169.94 10.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.557 179.728 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -60.2 -28.4 67.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.942 179.886 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.406 ' O ' ' CG ' ' A' ' 193' ' ' TYR . 3.0 mm-40 -115.61 9.78 15.4 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -179.54 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.406 ' CG ' ' O ' ' A' ' 192' ' ' GLU . 53.1 m-85 -157.96 76.29 0.78 Allowed 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.919 0.39 . . . . 0.0 111.327 179.872 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.54 -24.3 60.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.101 179.481 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 195' ' ' ASP . . . . . 0.592 ' OD1' HG22 ' A' ' 210' ' ' THR . 1.8 p30 -99.86 34.03 2.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.612 179.787 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.457 ' HD3' HG21 ' A' ' 190' ' ' THR . 0.2 OUTLIER -88.48 111.64 22.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.422 -179.491 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.869 ' O ' HD13 ' A' ' 198' ' ' ILE . 33.3 m -107.78 169.46 2.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.495 179.384 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.869 HD13 ' O ' ' A' ' 197' ' ' VAL . 15.1 mm -136.03 109.67 9.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.785 0.326 . . . . 0.0 111.2 179.888 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.912 HG12 HG12 ' A' ' 185' ' ' ILE . 9.9 m -97.85 120.9 47.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.081 179.727 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -81.76 152.65 26.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.788 -179.984 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 4.6 mmt -109.44 146.93 33.7 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.604 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -58.13 -29.07 65.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.073 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -78.21 -2.17 36.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.836 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 95.3 14.49 47.91 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 120.478 -0.867 . . . . 0.0 113.142 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -89.51 157.14 18.21 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.972 0.386 . . . . 0.0 111.04 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -125.84 111.54 14.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.724 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.838 HG11 HD12 ' A' ' 224' ' ' ILE . 22.8 t -110.77 139.59 33.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.139 -179.848 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.587 ' OG ' HD12 ' A' ' 198' ' ' ILE . 14.5 m -110.36 118.33 36.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.737 179.869 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.51 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -128.42 164.57 22.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.888 0.375 . . . . 0.0 111.067 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.592 HG22 ' OD1' ' A' ' 195' ' ' ASP . 0.6 OUTLIER -103.67 155.38 18.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.507 179.842 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 25.7 mt -62.91 -27.48 43.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.008 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 0.405 ' CZ ' ' HB3' ' A' ' 212' ' ' ARG . 0.0 OUTLIER -82.48 -41.9 19.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.742 0.306 . . . . 0.0 111.009 179.877 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -108.78 32.12 5.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.121 -179.931 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.558 ' CE1' HD11 ' A' ' 171' ' ' LEU . 11.3 t80 -64.25 -54.59 30.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.94 0.4 . . . . 0.0 110.284 179.737 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.71 -38.36 90.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.611 179.685 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -68.32 -51.95 39.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.436 179.53 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 1.8 mmmm -54.33 -43.02 70.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.951 179.819 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.851 ' HB3' HG11 ' A' ' 178' ' ' VAL . 4.1 mm? -82.32 -24.96 34.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.769 179.3 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 10.2 t -61.75 -31.74 71.94 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.851 0.357 . . . . 0.0 110.191 179.26 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -69.3 -17.1 63.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.068 179.596 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.442 ' CD1' ' HA ' ' A' ' 222' ' ' PRO . 60.1 t80 -63.74 136.41 96.71 Favored Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.469 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.538 ' O ' ' HB3' ' A' ' 223' ' ' ALA . 59.6 Cg_endo -71.38 154.42 97.14 Favored 'Cis proline' 0 C--N 1.355 0.878 0 C-N-CA 124.619 -0.992 . . . . 0.0 112.711 0.277 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' A' ' 222' ' ' PRO . . . 83.43 76.54 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.736 -179.479 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.838 HD12 HG11 ' A' ' 207' ' ' VAL . 8.3 pt -125.9 -179.95 2.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.065 -179.84 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 61.56 154.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.034 -179.808 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -115.34 -164.82 0.97 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.076 -179.841 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -106.83 31.19 5.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.898 0.38 . . . . 0.0 110.838 179.84 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -95.23 23.3 5.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.167 179.783 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -128.51 31.73 4.95 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.793 0.33 . . . . 0.0 110.929 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -95.46 -33.38 12.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.042 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -82.34 -63.05 1.46 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.937 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 33.8 m 43.15 34.37 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 179.92 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.807 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.155 0 N-CA-C 112.451 -0.26 . . . . 0.0 112.451 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.3 t 60.71 -172.0 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.781 0.324 . . . . 0.0 110.855 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 61.57 150.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.176 0.512 . . . . 0.0 111.103 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.762 ' HB2' HD13 ' A' ' 134' ' ' LEU . 78.8 m95 -72.21 168.2 18.75 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.955 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -102.75 136.1 43.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.542 179.559 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 73.4 mtt180 -71.69 105.87 3.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.833 0.349 . . . . 0.0 110.669 -179.875 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.898 HD11 HG22 ' A' ' 168' ' ' THR . 45.9 pt -94.06 -8.82 9.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.472 179.31 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -158.62 176.36 12.49 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 120.629 0.252 . . . . 0.0 110.76 179.926 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.457 ' O ' ' HA ' ' A' ' 154' ' ' VAL . 32.2 m-85 -143.07 127.0 17.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.378 179.771 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.618 HG21 HD11 ' A' ' 139' ' ' LEU . 5.3 t -93.51 122.79 45.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.32 -179.464 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.432 ' CD1' ' CE1' ' A' ' 130' ' ' PHE . 42.4 t80 -80.67 107.1 13.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.844 -179.943 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -163.47 154.24 16.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.521 -179.866 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.54 30.59 19.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.865 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 61.82 32.28 18.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.15 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 73.3 m -154.98 155.29 33.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.036 179.841 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.432 ' CE1' ' CD1' ' A' ' 125' ' ' TYR . 7.0 m-85 -96.26 91.11 5.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.463 179.567 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.496 ' HB2' HD21 ' A' ' 139' ' ' LEU . 24.2 m-85 -65.52 123.98 85.98 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.964 -179.626 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.407 ' HB3' ' CE2' ' A' ' 123' ' ' TYR . 55.4 Cg_endo -71.53 114.62 4.0 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 122.171 1.914 . . . . 0.0 112.743 -179.552 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.704 HD21 ' OG1' ' A' ' 168' ' ' THR . 29.0 tp -93.36 123.83 36.93 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.632 179.453 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.762 HD13 ' HB2' ' A' ' 118' ' ' TRP . 45.0 mt -69.51 173.66 5.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.47 -179.851 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.401 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 2.1 pt-20 -64.71 -28.35 69.53 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.118 179.751 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 42.7 p-10 -90.33 12.58 17.85 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.301 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.598 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 74.08 22.74 77.48 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.987 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.682 ' HB3' HD12 ' A' ' 134' ' ' LEU . 15.1 tpp85 -82.14 93.42 7.04 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.539 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.618 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -69.51 108.76 3.92 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.155 -179.212 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 15.8 mt -85.53 72.03 10.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.821 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.445 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 19.7 mttt -57.96 -20.85 40.97 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.45 179.873 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -94.09 19.74 8.82 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.42 179.578 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -144.49 25.32 1.51 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.655 0.264 . . . . 0.0 111.151 179.781 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . -58.98 166.69 7.59 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.88 -179.683 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 10.2 t -132.41 150.44 52.16 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.873 0.368 . . . . 0.0 110.751 -179.878 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.02 52.1 2.08 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.436 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.72 158.47 6.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.094 0.473 . . . . 0.0 110.678 -179.399 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -91.2 136.13 27.55 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.61 -179.504 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.448 ' HD2' ' CG2' ' A' ' 154' ' ' VAL . 62.9 Cg_endo -84.09 98.57 0.76 Allowed 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.11 2.54 . . . . 0.0 112.621 179.78 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 4.9 t -67.36 -9.66 43.51 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.713 179.363 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -90.21 -21.8 21.98 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.698 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -138.78 167.09 20.7 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.019 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.698 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 60.2 Cg_endo -73.76 163.55 36.91 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 122.5 2.134 . . . . 0.0 112.382 179.986 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 25.2 t -124.09 109.89 24.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.051 0.453 . . . . 0.0 111.591 -179.798 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.858 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.6 96.18 1.94 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.836 179.228 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.427 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 57.4 t -92.33 137.31 22.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.055 -179.928 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 47.5 56.96 7.76 Favored Glycine 0 CA--C 1.52 0.393 0 CA-C-N 115.855 -0.611 . . . . 0.0 113.231 179.371 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.858 ' CE2' HD23 ' A' ' 155' ' ' LEU . 2.9 m95 -99.44 151.16 21.42 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.185 0.516 . . . . 0.0 111.756 -179.386 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.66 -172.1 0.16 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.509 179.377 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -42.58 154.29 0.06 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.68 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.533 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.15 -24.68 52.04 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.232 179.491 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.05 -40.54 89.8 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-O 120.975 0.417 . . . . 0.0 110.041 179.193 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -74.25 -40.66 62.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.935 178.88 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.533 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.1 mt -58.92 -41.06 81.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.931 178.885 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.73 -31.0 57.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.25 179.881 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.418 ' CB ' HG21 ' A' ' 211' ' ' ILE . 5.4 mm-40 -67.63 -52.97 31.95 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-O 121.434 0.635 . . . . 0.0 110.245 179.571 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.819 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -59.45 -44.28 92.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.175 179.151 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.898 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -58.85 -38.16 78.11 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.534 179.271 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.37 -37.35 91.84 Favored Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 178.493 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 40.8 mm-40 -73.4 -45.71 53.06 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.403 -0.399 . . . . 0.0 111.199 179.035 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.573 ' HA ' HD22 ' A' ' 174' ' ' LEU . 11.0 mp -65.8 -29.55 70.05 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.688 0.28 . . . . 0.0 111.295 179.836 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.4 -19.98 64.64 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.335 -179.994 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -111.61 -26.75 8.87 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.613 0.244 . . . . 0.0 111.511 -179.834 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.573 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.1 OUTLIER -56.72 166.53 1.29 Allowed Pre-proline 0 CA--C 1.538 0.516 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.06 -179.665 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -69.7 128.07 15.55 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.269 1.979 . . . . 0.0 112.692 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.97 -25.9 5.29 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.676 179.802 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.76 -50.06 74.51 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.844 0.354 . . . . 0.0 111.037 179.701 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.868 HG11 ' HB3' ' A' ' 218' ' ' LEU . 30.1 t -74.11 -35.61 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.582 179.638 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.544 HD23 ' HD3' ' A' ' 153' ' ' PRO . 0.5 OUTLIER -56.98 -34.35 68.01 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.108 0.48 . . . . 0.0 109.772 179.002 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -78.48 -38.86 23.73 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 178.578 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -88.35 103.17 15.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.947 0.403 . . . . 0.0 110.774 179.229 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 182' ' ' MET . . . . . 0.838 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.9 mtm 178.73 166.72 0.88 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.987 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.4 t -127.04 -51.48 1.43 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.706 0.289 . . . . 0.0 111.51 -179.613 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -163.06 142.83 8.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.934 0.397 . . . . 0.0 111.082 -179.668 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.93 HG12 HG12 ' A' ' 199' ' ' VAL . 19.0 mt -108.7 115.14 48.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.54 179.516 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 186' ' ' HIS . . . . . 0.427 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 22.2 m170 -106.14 123.4 47.95 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.952 -179.684 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -76.35 105.38 7.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.617 179.75 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.04 83.2 60.65 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.643 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.78 151.58 63.36 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.406 2.071 . . . . 0.0 112.653 -179.699 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 22.8 p -127.85 159.8 33.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.637 179.721 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -52.4 -24.96 8.67 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.727 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -107.32 -18.77 13.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.646 -179.954 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -133.67 77.7 1.73 Allowed 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.922 0.392 . . . . 0.0 111.159 -179.694 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -57.18 -21.11 30.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.641 179.819 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 195' ' ' ASP . . . . . 0.5 ' OD1' HG22 ' A' ' 210' ' ' THR . 2.4 p30 -110.3 37.45 2.72 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.624 0.249 . . . . 0.0 111.07 -179.812 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.19 117.34 28.87 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.04 0.448 . . . . 0.0 111.255 -179.795 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.878 ' O ' HD13 ' A' ' 198' ' ' ILE . 31.7 m -112.73 169.84 4.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.73 179.655 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.878 HD13 ' O ' ' A' ' 197' ' ' VAL . 22.7 mm -134.61 111.12 13.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.774 0.321 . . . . 0.0 111.356 179.898 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.93 HG12 HG12 ' A' ' 185' ' ' ILE . 10.7 m -100.23 133.58 42.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.877 179.601 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -95.11 152.51 18.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.799 179.954 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 6.5 mmt -105.12 166.74 10.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.937 0.398 . . . . 0.0 111.051 -179.904 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 19.5 p30 -69.37 -26.39 64.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.195 179.884 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -88.48 12.57 14.04 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -179.856 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 83.05 14.34 75.16 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.554 -0.831 . . . . 0.0 113.311 179.718 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -82.98 150.94 26.08 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 117.127 0.463 . . . . 0.0 110.626 179.886 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -121.75 111.43 17.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.889 -179.922 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.742 HG11 HD12 ' A' ' 224' ' ' ILE . 21.6 t -113.03 140.24 34.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.142 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.575 ' HB2' HD12 ' A' ' 198' ' ' ILE . 26.6 t -113.69 119.43 37.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.783 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.664 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -130.21 159.29 37.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.857 179.803 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.5 HG22 ' OD1' ' A' ' 195' ' ' ASP . 0.6 OUTLIER -92.36 156.56 17.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.68 179.747 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.418 HG21 ' CB ' ' A' ' 166' ' ' GLU . 33.9 mt -70.41 -34.82 59.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.764 0.316 . . . . 0.0 110.749 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.5 -30.89 70.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.215 -179.467 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -130.62 35.85 3.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.898 179.984 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.587 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 11.8 t80 -63.08 -52.7 61.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.801 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.43 -40.22 86.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.062 -179.918 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.21 -49.77 58.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.077 0.465 . . . . 0.0 110.439 179.589 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 217' ' ' LYS . . . . . 0.421 ' O ' HG21 ' A' ' 224' ' ' ILE . 1.0 OUTLIER -54.23 -43.79 71.16 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.027 179.701 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.868 ' HB3' HG11 ' A' ' 178' ' ' VAL . 4.0 mm? -82.7 -26.32 32.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.97 179.517 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 12.2 t -60.81 -31.61 71.01 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.996 0.427 . . . . 0.0 110.386 179.463 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -69.78 -16.47 63.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.27 179.532 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -65.83 137.79 96.24 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 121.328 -0.149 . . . . 0.0 110.901 180.0 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.52 ' O ' ' HB2' ' A' ' 223' ' ' ALA . 69.0 Cg_endo -86.51 109.9 1.47 Allowed 'Cis proline' 0 C--N 1.358 1.053 0 C-N-CA 124.513 -1.036 . . . . 0.0 112.601 0.145 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.52 ' HB2' ' O ' ' A' ' 222' ' ' PRO . . . 166.85 44.74 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.034 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.742 HD12 HG11 ' A' ' 207' ' ' VAL . 4.3 pt -115.16 -178.92 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.077 -179.433 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 225' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 224' ' ' ILE . . . 69.87 73.85 0.23 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.113 0.482 . . . . 0.0 110.655 -179.485 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -90.74 -166.3 1.55 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.416 -179.659 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -110.04 46.31 1.04 Allowed 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.746 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.667 ' O ' HD23 ' A' ' 228' ' ' LEU . 1.7 tt -64.76 52.72 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.671 -178.766 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 56.22 -178.01 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.849 0.357 . . . . 0.0 111.438 179.674 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.43 33.45 3.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.662 179.935 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -61.52 87.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.806 -179.864 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 232' ' ' VAL . . . . . 0.552 HG22 ' O ' ' A' ' 232' ' ' VAL . 12.3 p -154.27 47.44 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.133 0.492 . . . . 0.0 110.962 179.921 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 25.0 tttt . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.893 -179.951 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 112.543 -0.223 . . . . 0.0 112.543 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 8.5 t 61.03 112.05 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.725 0.297 . . . . 0.0 110.864 -179.9 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 62.34 146.46 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.101 0.477 . . . . 0.0 110.885 -179.853 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.741 ' HB2' HD13 ' A' ' 134' ' ' LEU . 81.0 m95 -65.71 168.35 7.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.142 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.43 HH11 HG22 ' A' ' 121' ' ' ILE . 3.6 tmt_? -102.25 135.23 44.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.53 179.536 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 6.6 mtm-85 -71.29 105.28 3.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.673 -179.923 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.86 HD11 HG22 ' A' ' 168' ' ' THR . 46.7 pt -94.19 -6.7 10.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.654 179.518 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -161.14 176.71 11.0 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 121.002 -0.279 . . . . 0.0 111.065 179.823 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.465 ' O ' ' HA ' ' A' ' 154' ' ' VAL . 32.5 m-85 -143.35 127.19 17.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.19 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.58 HG21 HD11 ' A' ' 139' ' ' LEU . 5.1 t -93.26 122.81 45.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.041 0.448 . . . . 0.0 111.344 -179.386 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.43 ' HD2' HG13 ' A' ' 156' ' ' VAL . 33.2 t80 -80.43 109.48 14.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.712 -179.945 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.401 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 4.9 t70 -164.77 148.93 9.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.538 -179.788 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.68 31.69 18.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.895 -179.659 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 61.43 30.27 18.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.972 -179.991 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.529 HG23 ' O ' ' A' ' 145' ' ' THR . 84.7 m -151.09 149.73 29.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.801 179.861 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -94.2 91.75 6.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.53 179.65 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.549 ' HB2' HD21 ' A' ' 139' ' ' LEU . 20.6 m-85 -64.82 117.0 34.28 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.289 -179.41 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -64.12 119.03 5.96 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.172 1.915 . . . . 0.0 112.435 179.981 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.646 HD21 ' OG1' ' A' ' 168' ' ' THR . 38.3 tp -99.79 124.18 44.8 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.802 179.672 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.741 HD13 ' HB2' ' A' ' 118' ' ' TRP . 41.3 mt -70.5 173.39 7.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.647 -179.827 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.405 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.9 pt-20 -64.59 -28.46 69.65 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.03 179.604 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -90.17 12.78 16.92 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.213 179.61 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.642 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 72.5 23.8 77.32 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.755 -0.736 . . . . 0.0 113.048 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.674 ' HB3' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -81.76 96.88 7.71 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.385 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.58 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -72.48 121.26 19.31 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.664 -178.93 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -98.39 72.24 2.08 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.678 179.385 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.459 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 21.6 mttt -57.83 -20.16 33.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.69 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -88.24 -24.43 23.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.564 -180.0 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -102.07 25.61 8.58 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.846 0.314 . . . . 0.0 111.846 -179.566 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . -58.95 164.91 8.92 Favored Glycine 0 CA--C 1.509 -0.292 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.757 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.529 ' O ' HG23 ' A' ' 129' ' ' THR . 9.0 t -130.03 155.29 46.37 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.073 0.463 . . . . 0.0 110.907 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -97.1 54.24 1.23 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.433 -179.703 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.69 170.95 6.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.265 -179.294 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -103.87 138.19 19.46 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.776 -179.355 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.462 ' HD2' ' CG2' ' A' ' 154' ' ' VAL . 58.8 Cg_endo -84.9 100.27 0.73 Allowed 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.219 2.613 . . . . 0.0 112.645 179.799 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 18.1 t -65.82 -11.21 44.54 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.72 179.334 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.93 -21.77 20.4 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.783 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.678 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -136.7 166.4 27.79 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -178.943 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.678 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 70.9 Cg_endo -75.15 164.57 32.83 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.487 2.125 . . . . 0.0 112.335 179.924 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 20.1 t -122.61 108.87 22.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.95 0.405 . . . . 0.0 111.677 -179.763 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.903 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.52 95.99 1.88 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.728 179.065 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.43 HG13 ' HD2' ' A' ' 125' ' ' TYR . 50.3 t -92.78 137.65 21.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.918 0.389 . . . . 0.0 111.181 -179.952 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 47.78 57.61 7.51 Favored Glycine 0 CA--C 1.521 0.431 0 CA-C-N 115.987 -0.551 . . . . 0.0 113.27 179.363 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.903 ' CE2' HD23 ' A' ' 155' ' ' LEU . 3.1 m95 -100.11 151.27 21.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.167 0.508 . . . . 0.0 111.705 -179.452 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -66.51 -172.39 0.16 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.569 179.276 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -43.08 154.17 0.08 Allowed 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -179.75 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.543 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.0 -24.76 51.82 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.239 179.477 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.15 -39.55 86.76 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.959 0.409 . . . . 0.0 110.066 179.199 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -75.86 -40.97 53.63 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.108 178.955 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.543 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.2 mt -58.55 -42.34 84.38 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.884 179.048 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.65 -25.93 20.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.477 179.648 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.467 ' CB ' HG21 ' A' ' 211' ' ' ILE . 6.0 mm-40 -71.49 -54.38 10.76 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.056 0.455 . . . . 0.0 110.854 -179.901 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.837 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -62.31 -37.33 85.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.244 179.547 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.86 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -60.51 -38.3 83.9 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.909 179.027 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -61.3 -36.06 91.88 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 177.62 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 55.3 mm-40 -70.65 -48.94 52.32 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.118 -0.541 . . . . 0.0 110.6 178.478 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.65 ' HA ' HD22 ' A' ' 174' ' ' LEU . 10.8 mp -65.06 -27.86 69.08 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.396 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.67 -18.46 62.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.373 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -112.19 -28.66 7.87 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 120.658 0.266 . . . . 0.0 111.519 -179.706 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.65 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.1 OUTLIER -57.61 167.2 1.43 Allowed Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.041 -179.612 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -70.34 129.19 16.58 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.248 1.965 . . . . 0.0 112.893 179.946 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.33 -25.34 9.38 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.65 179.667 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.97 -48.63 79.41 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.944 0.402 . . . . 0.0 110.869 179.664 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.879 HG11 ' HB3' ' A' ' 218' ' ' LEU . 39.3 t -74.12 -35.53 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.424 179.399 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.46 ' HB2' HD21 ' A' ' 174' ' ' LEU . 8.7 tp -56.8 -36.26 69.69 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.118 0.485 . . . . 0.0 109.949 179.019 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -76.67 -39.96 28.06 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.328 178.759 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -88.09 103.14 15.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.906 0.384 . . . . 0.0 110.669 179.268 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 182' ' ' MET . . . . . 0.837 ' CE ' HG12 ' A' ' 178' ' ' VAL . 3.0 mtm 179.42 162.34 0.86 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.194 179.992 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.42 -56.22 2.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.742 0.306 . . . . 0.0 111.038 -179.838 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -163.11 142.69 8.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.832 -179.945 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.875 HG12 HG12 ' A' ' 199' ' ' VAL . 14.3 mt -103.11 115.15 44.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.539 179.484 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 24.2 m170 -104.19 127.32 51.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.03 -179.548 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -82.52 104.66 12.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.576 179.719 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -127.93 89.22 51.08 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.714 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -66.93 149.2 83.02 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.283 1.989 . . . . 0.0 112.532 -179.862 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 25.8 p -126.21 157.78 37.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.828 179.891 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -53.12 -25.31 12.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.595 -179.98 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -106.73 -17.92 14.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.785 -179.893 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -137.86 83.66 1.99 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.886 0.374 . . . . 0.0 111.315 -179.676 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -55.92 -22.7 27.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.427 179.623 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 195' ' ' ASP . . . . . 0.572 ' HB3' HD12 ' A' ' 211' ' ' ILE . 0.4 OUTLIER -109.68 40.87 1.8 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.017 0.437 . . . . 0.0 110.295 179.748 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 2.1 tpm_? -87.68 112.86 22.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.857 -179.956 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.822 ' O ' HD13 ' A' ' 198' ' ' ILE . 31.9 m -108.23 168.23 3.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.027 179.941 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.822 HD13 ' O ' ' A' ' 197' ' ' VAL . 19.3 mm -134.4 108.45 10.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.372 179.956 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.875 HG12 HG12 ' A' ' 185' ' ' ILE . 6.8 m -98.08 122.37 49.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.903 0.382 . . . . 0.0 110.873 179.462 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -82.4 152.27 26.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.834 -179.869 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.56 144.67 31.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.554 179.887 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 44.3 m-20 -57.43 -29.28 64.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.017 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -74.78 -7.44 53.4 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.633 179.676 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 101.54 14.47 29.87 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 120.484 -0.865 . . . . 0.0 113.123 -179.929 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -92.24 166.11 12.77 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.98 0.39 . . . . 0.0 111.049 -179.844 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -132.16 111.43 11.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.827 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.774 HG11 HD12 ' A' ' 224' ' ' ILE . 21.5 t -109.86 138.56 36.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.103 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 52.5 p -112.08 116.78 31.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.981 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.658 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -127.75 158.14 38.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.653 179.775 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -97.62 148.43 23.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.778 0.323 . . . . 0.0 110.653 179.891 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.572 HD12 ' HB3' ' A' ' 195' ' ' ASP . 59.5 mt -59.96 -36.59 67.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.825 179.927 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.25 -33.88 74.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.289 -179.524 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -134.92 44.17 2.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.984 0.421 . . . . 0.0 111.015 -179.885 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.579 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 10.8 t80 -66.91 -52.64 40.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.779 179.801 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.35 -41.51 89.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.232 -179.724 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -67.13 -49.76 63.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.102 0.477 . . . . 0.0 110.476 179.655 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.95 -44.56 74.43 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.015 179.782 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.879 ' HB3' HG11 ' A' ' 178' ' ' VAL . 4.1 mm? -81.22 -26.86 35.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.061 179.635 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 13.6 t -61.14 -31.7 71.41 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.93 0.395 . . . . 0.0 110.28 179.346 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 -69.77 -16.78 63.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.232 179.556 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -66.27 138.17 95.85 Favored Pre-proline 0 CA--C 1.534 0.33 0 C-N-CA 121.445 -0.102 . . . . 0.0 110.963 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.512 ' O ' ' HB2' ' A' ' 223' ' ' ALA . 68.9 Cg_endo -86.62 110.44 1.63 Allowed 'Cis proline' 0 C--N 1.356 0.961 0 C-N-CA 124.499 -1.042 . . . . 0.0 112.614 0.184 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.512 ' HB2' ' O ' ' A' ' 222' ' ' PRO . . . 167.72 44.27 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.147 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.774 HD12 HG11 ' A' ' 207' ' ' VAL . 5.5 pt -117.13 -178.71 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.22 -179.44 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 225' ' ' ALA . . . . . 0.492 ' HB3' ' O ' ' A' ' 224' ' ' ILE . . . 75.87 88.55 0.08 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.909 -179.589 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -85.35 -162.82 0.76 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.079 -179.92 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -98.22 30.11 3.27 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.807 0.337 . . . . 0.0 110.995 179.862 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.794 HD13 ' O ' ' A' ' 228' ' ' LEU . 1.1 tm? -58.96 -20.32 51.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.436 179.643 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -82.98 63.88 7.3 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.046 0.451 . . . . 0.0 110.871 179.821 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 10.9 ttp180 -98.25 -27.93 13.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.08 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -58.07 -51.34 70.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.826 0.346 . . . . 0.0 111.116 -179.952 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 232' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 232' ' ' VAL . 27.7 m -69.94 108.22 2.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.122 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.848 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.151 0 N-CA-C 112.575 -0.21 . . . . 0.0 112.575 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.25 177.8 4.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.838 0.351 . . . . 0.0 110.813 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 61.72 152.54 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.094 0.473 . . . . 0.0 110.944 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.748 ' HB2' HD13 ' A' ' 134' ' ' LEU . 82.7 m95 -70.42 168.29 16.42 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.967 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.94 135.02 44.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.503 179.594 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 12.8 mtt180 -71.39 106.45 3.91 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.915 -179.815 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.896 HD11 HG22 ' A' ' 168' ' ' THR . 46.0 pt -95.8 -7.81 9.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.496 179.278 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.541 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -157.94 176.1 12.99 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 120.619 0.247 . . . . 0.0 110.713 179.768 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.468 ' CD1' ' CG ' ' A' ' 149' ' ' PRO . 39.1 m-85 -145.58 126.0 14.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.348 -179.895 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.672 HG21 HD11 ' A' ' 139' ' ' LEU . 4.2 t -94.05 123.21 46.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.016 0.436 . . . . 0.0 111.269 -179.458 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.465 ' CD1' ' CE1' ' A' ' 130' ' ' PHE . 7.0 t80 -82.59 101.85 11.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.892 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -156.31 155.35 32.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.704 -179.912 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 60.85 32.95 20.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.878 -179.783 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 60.28 31.26 20.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.91 179.961 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.445 HG22 ' N ' ' A' ' 130' ' ' PHE . 70.6 m -152.94 161.49 42.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.883 179.766 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.465 ' CE1' ' CD1' ' A' ' 125' ' ' TYR . 97.2 m-85 -102.54 90.41 3.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.696 179.668 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.49 ' HA ' ' HA2' ' A' ' 144' ' ' GLY . 22.8 m-85 -65.45 124.79 88.12 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.088 -179.923 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.63 119.17 5.79 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 121.986 1.791 . . . . 0.0 112.367 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.608 HD11 ' HA2' ' A' ' 137' ' ' GLY . 32.2 tp -96.1 123.81 39.86 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.657 179.793 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.748 HD13 ' HB2' ' A' ' 118' ' ' TRP . 41.6 mt -70.79 172.77 8.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.563 -179.713 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.41 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.8 pt-20 -63.27 -29.05 70.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.992 179.692 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -89.9 12.52 17.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.131 179.577 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.658 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 72.72 25.09 74.87 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.997 179.874 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.662 ' HB3' HD12 ' A' ' 134' ' ' LEU . 0.8 OUTLIER -82.61 95.11 7.68 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.433 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.672 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -72.69 107.21 5.03 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.301 -179.221 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.436 HD11 HD21 ' A' ' 134' ' ' LEU . 30.5 mt -84.48 76.8 10.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.271 179.375 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.443 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 24.6 mtpt -67.84 -8.77 38.99 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.407 -179.603 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -84.77 -28.53 26.13 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.707 0.289 . . . . 0.0 110.915 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -85.65 -79.95 0.23 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.072 -179.848 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.49 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . 57.28 160.71 0.02 OUTLIER Glycine 0 CA--C 1.507 -0.462 0 CA-C-N 116.283 -0.417 . . . . 0.0 112.837 -179.625 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 9.6 t -140.63 150.78 43.99 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.356 -0.422 . . . . 0.0 110.68 -179.647 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -89.26 50.87 2.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.96 0.41 . . . . 0.0 110.625 179.839 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -171.33 155.49 4.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.956 0.408 . . . . 0.0 110.611 -179.286 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -98.74 125.26 43.05 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.148 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.468 ' CG ' ' CD1' ' A' ' 123' ' ' TYR . 96.5 Cg_endo -84.93 109.26 1.25 Allowed 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 122.494 2.13 . . . . 0.0 112.779 -179.767 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 17.0 t -69.86 -7.86 43.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.958 179.743 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -77.28 -23.41 51.13 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 120.808 0.337 . . . . 0.0 110.451 179.006 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.651 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -139.47 166.23 25.82 Favored Pre-proline 0 N--CA 1.453 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.546 -179.493 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.651 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 72.4 Cg_endo -75.57 151.08 36.6 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.426 2.084 . . . . 0.0 112.662 -179.821 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.436 HG22 ' HB2' ' A' ' 123' ' ' TYR . 9.4 t -113.2 111.59 36.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.902 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.863 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.44 96.02 1.85 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.619 179.22 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.414 HG23 ' HB2' ' A' ' 184' ' ' GLU . 62.1 t -90.75 137.0 22.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.956 0.408 . . . . 0.0 111.18 179.966 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 47.76 60.78 5.19 Favored Glycine 0 CA--C 1.521 0.434 0 CA-C-N 115.938 -0.573 . . . . 0.0 113.147 179.377 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.863 ' CE2' HD23 ' A' ' 155' ' ' LEU . 3.0 m95 -104.35 151.27 23.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.228 0.537 . . . . 0.0 111.823 -179.344 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.25 -172.17 0.2 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.393 179.386 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -42.15 153.66 0.06 Allowed 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.733 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.503 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -56.94 -24.85 51.74 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.215 179.446 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -59.87 -40.49 88.84 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.916 0.388 . . . . 0.0 109.987 179.213 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -75.17 -38.95 60.67 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.988 178.907 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.503 HD12 ' HA2' ' A' ' 161' ' ' GLY . 5.4 mt -59.88 -43.69 92.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.808 178.866 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.413 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . . . -53.54 -26.11 19.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.717 179.962 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.401 ' CB ' HG21 ' A' ' 211' ' ' ILE . 3.5 mm-40 -70.34 -54.57 12.01 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.1 0.476 . . . . 0.0 110.781 -179.9 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.823 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -61.75 -35.85 79.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.291 179.518 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.896 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -60.88 -40.88 94.69 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.938 178.89 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.94 -35.36 86.74 Favored Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 177.903 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -72.46 -46.85 53.0 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.236 -0.482 . . . . 0.0 110.66 178.656 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.647 ' HA ' HD22 ' A' ' 174' ' ' LEU . 10.8 mp -66.25 -27.57 68.05 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.773 0.321 . . . . 0.0 111.592 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.46 -17.54 62.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.257 179.868 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -114.38 -26.89 7.78 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -179.681 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.647 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER -57.77 167.63 1.37 Allowed Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.037 -179.58 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -69.1 127.74 15.57 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.138 1.892 . . . . 0.0 112.829 179.812 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.45 -25.88 11.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.611 179.713 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.81 -48.45 79.69 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.866 0.365 . . . . 0.0 110.967 179.658 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.887 HG11 ' HB3' ' A' ' 218' ' ' LEU . 22.3 t -74.06 -37.13 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.571 179.584 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.525 ' HB2' HD21 ' A' ' 174' ' ' LEU . 6.6 tp -55.59 -36.1 66.52 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.237 0.541 . . . . 0.0 110.072 179.058 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -76.54 -40.96 26.09 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.268 178.864 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -87.58 102.87 15.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.979 0.419 . . . . 0.0 110.596 179.225 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 182' ' ' MET . . . . . 0.838 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.9 mtm 177.89 162.47 0.59 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.084 -179.916 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 7.5 t -118.26 -56.9 2.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.819 0.343 . . . . 0.0 110.92 -179.859 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 184' ' ' GLU . . . . . 0.414 ' HB2' HG23 ' A' ' 156' ' ' VAL . 5.3 pt-20 -161.28 142.44 11.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.957 -179.848 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.877 HG12 HG12 ' A' ' 199' ' ' VAL . 16.8 mt -100.4 115.91 42.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.403 179.483 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 19.9 m170 -105.04 115.25 29.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.965 -179.526 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.433 ' HB2' ' CE2' ' A' ' 158' ' ' TRP . 14.5 t80 -74.79 104.62 5.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.688 179.817 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.91 84.8 44.79 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.448 179.85 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.83 148.78 58.9 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.395 2.063 . . . . 0.0 112.62 -179.668 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 8.3 p -133.74 162.11 32.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.58 179.681 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 17.7 mtt-85 -57.04 -26.38 60.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.149 179.721 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -97.48 -19.25 18.53 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.583 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -146.91 82.16 1.56 Allowed 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 120.87 0.367 . . . . 0.0 111.388 -179.881 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -58.29 -21.65 49.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.271 179.737 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -107.8 36.75 2.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.742 0.306 . . . . 0.0 110.591 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 3.3 ttt180 -89.42 115.87 27.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.306 -179.673 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.759 ' O ' HD13 ' A' ' 198' ' ' ILE . 34.0 m -112.78 165.27 7.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.684 179.563 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.759 HD13 ' O ' ' A' ' 197' ' ' VAL . 23.8 mm -131.32 105.76 11.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.775 0.321 . . . . 0.0 111.279 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.877 HG12 HG12 ' A' ' 185' ' ' ILE . 6.9 m -95.85 121.48 46.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.941 179.652 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -81.82 146.47 29.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.646 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -95.06 167.15 11.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.033 -179.655 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.27 -27.69 65.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.059 -179.919 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -90.43 15.31 10.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.884 -179.845 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 87.69 -7.14 82.1 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.474 -0.869 . . . . 0.0 113.315 179.947 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.09 170.2 0.93 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 117.235 0.518 . . . . 0.0 110.928 -179.966 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -141.33 111.45 6.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.694 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.4 t -112.4 125.27 69.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.262 -179.774 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.505 ' OG ' HD12 ' A' ' 198' ' ' ILE . 4.6 m -100.98 112.04 24.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.661 179.721 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.636 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -124.1 160.87 26.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.88 -179.899 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.66 155.85 17.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.499 179.841 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.401 HG21 ' CB ' ' A' ' 166' ' ' GLU . 30.8 mt -67.08 -32.07 56.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.897 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.45 -40.52 70.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.355 -179.469 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -116.86 31.8 6.53 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.796 0.331 . . . . 0.0 110.95 -179.912 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.588 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 11.6 t80 -59.4 -54.92 41.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.997 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.43 -40.12 81.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.138 -179.922 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.38 -49.73 52.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.075 0.464 . . . . 0.0 110.333 179.553 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 217' ' ' LYS . . . . . 0.589 ' O ' HG21 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -54.14 -41.99 69.03 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.012 179.654 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.887 ' HB3' HG11 ' A' ' 178' ' ' VAL . 4.1 mm? -85.97 -23.54 26.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.825 179.462 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 9.4 t -60.69 -33.87 73.5 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.006 0.431 . . . . 0.0 110.119 179.232 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -70.08 -16.95 63.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.117 179.183 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.418 ' CE1' ' HB3' ' A' ' 222' ' ' PRO . 22.5 t80 -58.16 141.06 82.5 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 116.772 -0.194 . . . . 0.0 111.132 -179.902 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.477 ' O ' ' HB2' ' A' ' 223' ' ' ALA . 60.2 Cg_endo -90.42 107.4 0.72 Allowed 'Cis proline' 0 C--N 1.357 1.011 0 C-N-CA 124.597 -1.001 . . . . 0.0 112.654 0.191 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.477 ' HB2' ' O ' ' A' ' 222' ' ' PRO . . . 172.77 41.58 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.913 179.822 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.589 HG21 ' O ' ' A' ' 217' ' ' LYS . 0.1 OUTLIER -134.2 158.75 42.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.165 179.885 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 225' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 224' ' ' ILE . . . 177.13 -179.68 0.21 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.982 179.718 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -79.58 118.23 21.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.023 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -130.86 35.45 3.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.148 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 4.9 tp -98.73 30.83 3.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.878 179.935 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -139.44 34.03 2.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.87 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 20.7 mtp85 -125.75 -45.49 1.76 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.75 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 24.5 m-20 60.82 102.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.933 -179.957 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 21.6 t -84.89 90.76 2.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.09 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 15.3 tttm . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.957 179.904 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.16 0 N-CA-C 112.549 -0.221 . . . . 0.0 112.549 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.13 76.82 9.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.92 0.39 . . . . 0.0 110.924 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -101.6 151.95 21.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.133 0.492 . . . . 0.0 110.968 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.755 ' HB2' HD13 ' A' ' 134' ' ' LEU . 78.9 m95 -66.89 168.21 10.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.988 179.915 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 -102.82 136.67 42.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.467 179.588 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.7 mtm-85 -71.75 105.54 3.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.874 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.883 HD11 HG22 ' A' ' 168' ' ' THR . 46.8 pt -94.34 -8.71 9.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.38 179.205 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.486 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -158.16 176.19 12.81 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 120.601 0.238 . . . . 0.0 110.609 179.749 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.464 ' CD1' ' CG ' ' A' ' 149' ' ' PRO . 34.2 m-85 -144.99 125.91 14.44 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.633 HG21 HD11 ' A' ' 139' ' ' LEU . 4.8 t -93.69 123.3 45.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.044 0.45 . . . . 0.0 111.509 -179.292 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.478 ' CD1' ' CE1' ' A' ' 130' ' ' PHE . 30.2 t80 -81.35 101.77 10.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.758 179.965 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -155.58 153.74 30.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.645 -179.887 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 60.87 31.17 20.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.952 -179.672 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 61.87 30.86 18.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.188 179.811 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.446 HG22 ' N ' ' A' ' 130' ' ' PHE . 87.1 m -151.46 161.73 42.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.768 179.773 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.541 ' CE2' ' HB2' ' A' ' 148' ' ' ALA . 9.1 m-85 -101.39 90.27 4.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.866 179.666 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.473 ' HA ' ' HA2' ' A' ' 144' ' ' GLY . 22.1 m-85 -65.79 123.99 86.31 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.766 179.809 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.3 118.34 5.47 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.114 1.876 . . . . 0.0 112.338 -179.936 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.71 HD21 ' OG1' ' A' ' 168' ' ' THR . 25.8 tp -95.96 123.54 39.6 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.521 179.684 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.755 HD13 ' HB2' ' A' ' 118' ' ' TRP . 50.7 mt -70.67 173.73 6.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.344 -0.843 . . . . 0.0 111.449 -179.748 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.405 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 2.0 pt-20 -63.89 -28.33 69.76 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.995 179.588 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -91.29 14.23 15.05 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.199 179.791 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.619 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 72.85 28.06 67.68 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.57 -179.976 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.651 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -81.65 90.1 6.29 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 178.721 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.633 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -72.31 102.01 3.01 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.802 -179.485 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 31.7 mt -83.06 79.39 9.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.824 -179.957 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.487 ' HE3' HD13 ' A' ' 139' ' ' LEU . 37.8 mttt -69.69 -8.51 48.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.207 -179.912 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -82.92 -29.63 29.02 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.83 0.348 . . . . 0.0 110.695 179.69 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -85.27 -80.4 0.21 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.957 179.98 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . 56.92 160.76 0.02 OUTLIER Glycine 0 CA--C 1.506 -0.475 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.949 -179.777 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 10.2 t -142.07 150.38 41.15 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.437 -0.382 . . . . 0.0 110.753 -179.738 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.443 ' HE2' HG23 ' A' ' 129' ' ' THR . 3.7 mmtt -89.53 51.8 2.19 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.018 0.437 . . . . 0.0 110.596 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -171.26 149.99 2.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.735 -179.34 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.541 ' HB2' ' CE2' ' A' ' 130' ' ' PHE . . . -93.94 125.01 54.65 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.201 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.464 ' CG ' ' CD1' ' A' ' 123' ' ' TYR . 89.9 Cg_endo -85.04 109.89 1.27 Allowed 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.57 2.18 . . . . 0.0 112.796 -179.861 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 21.5 t -69.93 -7.74 43.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.935 179.79 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -77.61 -23.07 49.93 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 120.809 0.338 . . . . 0.0 110.515 179.096 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.657 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -139.92 166.22 25.35 Favored Pre-proline 0 N--CA 1.453 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.628 -179.41 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.657 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 64.4 Cg_endo -74.68 152.24 42.21 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.424 2.082 . . . . 0.0 112.346 -179.926 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 9.8 t -113.99 109.46 28.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.065 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.844 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.33 96.03 1.81 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.705 179.231 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.42 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 53.5 t -93.68 136.21 26.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.91 0.386 . . . . 0.0 111.012 179.944 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 50.81 57.5 10.79 Favored Glycine 0 CA--C 1.519 0.306 0 CA-C-N 115.886 -0.597 . . . . 0.0 113.089 179.443 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.844 ' CE2' HD23 ' A' ' 155' ' ' LEU . 3.2 m95 -102.16 151.2 22.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.08 0.467 . . . . 0.0 111.634 -179.572 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.73 -172.41 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.608 179.523 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -43.59 154.26 0.1 Allowed 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.775 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.532 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.58 -25.11 54.79 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.239 179.544 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.2 -38.42 83.24 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.948 0.404 . . . . 0.0 110.112 179.278 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.34 -39.2 48.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.03 179.034 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.532 HD12 ' HA2' ' A' ' 161' ' ' GLY . 5.9 mt -59.96 -41.46 86.15 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.857 179.046 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.8 -30.51 45.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.168 179.682 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.405 ' CB ' HG21 ' A' ' 211' ' ' ILE . 10.7 mm-40 -67.19 -53.0 34.41 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-O 121.417 0.627 . . . . 0.0 110.14 179.391 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.796 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -60.78 -43.22 98.38 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.088 179.025 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.883 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -58.5 -38.66 78.11 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.51 179.214 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.09 -37.43 92.8 Favored Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 178.378 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 63.2 mm-40 -72.29 -45.85 58.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.462 -0.369 . . . . 0.0 110.892 178.972 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.561 ' O ' HD22 ' A' ' 174' ' ' LEU . 11.1 mp -65.48 -30.05 70.78 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.694 0.283 . . . . 0.0 111.202 179.685 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.0 -18.57 64.07 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.344 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -112.28 -26.71 8.63 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.632 0.254 . . . . 0.0 111.66 -179.696 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.561 HD22 ' O ' ' A' ' 171' ' ' LEU . 0.1 OUTLIER -56.86 166.67 1.28 Allowed Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.169 -179.517 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -69.29 128.66 16.79 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.163 1.908 . . . . 0.0 112.69 179.832 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.09 -25.66 5.36 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.69 179.715 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.18 -49.97 74.32 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.033 179.76 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.939 HG11 ' HB3' ' A' ' 218' ' ' LEU . 23.9 t -74.18 -39.81 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.715 179.609 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.521 ' HG ' HD21 ' A' ' 174' ' ' LEU . 0.5 OUTLIER -53.15 -33.38 52.24 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.103 0.478 . . . . 0.0 110.169 179.385 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -81.86 -38.92 12.55 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.591 178.802 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.43 ' HB1' ' SD ' ' A' ' 201' ' ' MET . . . -88.92 103.43 16.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.828 0.347 . . . . 0.0 110.852 179.528 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 182' ' ' MET . . . . . 0.829 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.6 mtm 177.87 169.08 0.71 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.304 179.817 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 7.7 t -124.24 -59.61 1.47 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.752 0.311 . . . . 0.0 111.127 -179.901 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -157.02 142.73 17.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.121 -179.784 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.907 HG12 HG12 ' A' ' 199' ' ' VAL . 14.9 mt -106.23 114.53 45.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.269 179.359 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 186' ' ' HIS . . . . . 0.42 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 22.5 m170 -104.7 121.56 43.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.153 -179.431 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -72.67 104.95 4.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.58 179.769 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp -119.51 80.43 22.5 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.78 -179.921 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.27 145.21 59.26 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.259 1.973 . . . . 0.0 112.296 -179.903 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 18.2 p -128.3 159.31 35.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.733 179.944 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.41 -23.51 16.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.518 179.87 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -104.19 -20.39 13.82 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.569 -179.921 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -140.19 78.5 1.66 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.901 0.381 . . . . 0.0 111.287 -179.656 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -55.71 -24.06 32.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.51 179.835 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 195' ' ' ASP . . . . . 0.599 ' HB3' HD12 ' A' ' 211' ' ' ILE . 0.4 OUTLIER -106.5 40.04 1.7 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.967 0.413 . . . . 0.0 110.373 179.785 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 31.7 ttt85 -93.0 119.94 32.78 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.969 179.974 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.847 ' O ' HD13 ' A' ' 198' ' ' ILE . 23.2 m -113.03 167.77 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.09 -179.931 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.847 HD13 ' O ' ' A' ' 197' ' ' VAL . 24.7 mm -134.09 105.9 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.139 179.783 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.907 HG12 HG12 ' A' ' 185' ' ' ILE . 15.8 m -97.63 138.81 21.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.992 0.425 . . . . 0.0 111.02 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.423 ' CE2' ' HG3' ' A' ' 206' ' ' GLU . 50.7 m-85 -102.46 152.48 21.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.587 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 201' ' ' MET . . . . . 0.43 ' SD ' ' HB1' ' A' ' 181' ' ' ALA . 21.3 tpp -104.06 158.21 16.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.833 0.349 . . . . 0.0 110.914 -179.902 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -56.27 -22.37 29.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.584 -179.825 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -90.4 15.34 10.8 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 111.825 0.305 . . . . 0.0 111.825 -179.913 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 77.05 14.58 82.48 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.583 -0.818 . . . . 0.0 113.147 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -77.55 167.7 21.19 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.99 0.395 . . . . 0.0 110.884 179.994 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 206' ' ' GLU . . . . . 0.423 ' HG3' ' CE2' ' A' ' 200' ' ' TYR . 7.2 tt0 -134.31 111.47 10.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.854 -179.964 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 17.7 t -116.56 131.14 70.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.976 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.704 ' OG ' HD12 ' A' ' 198' ' ' ILE . 59.5 m -104.03 116.9 33.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.054 -179.858 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.632 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -127.62 159.24 35.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.736 179.712 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.2 153.1 19.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.811 0.339 . . . . 0.0 110.751 -179.95 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.599 HD12 ' HB3' ' A' ' 195' ' ' ASP . 64.2 mt -63.31 -36.71 77.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.803 179.763 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.92 -35.9 79.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.548 -179.452 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -132.67 42.76 3.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.925 0.393 . . . . 0.0 111.115 -179.835 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.575 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 11.3 t80 -65.49 -52.57 51.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.525 179.815 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.89 -43.38 86.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.293 -179.716 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.38 -49.39 60.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.102 0.477 . . . . 0.0 110.205 179.461 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 217' ' ' LYS . . . . . 0.404 ' O ' HG21 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -52.73 -42.76 65.18 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.181 179.683 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.939 ' HB3' HG11 ' A' ' 178' ' ' VAL . 4.0 mm? -87.16 -23.43 24.82 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.181 179.614 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 10.9 t -60.35 -33.88 73.05 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.025 0.44 . . . . 0.0 110.299 179.542 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -70.86 -16.88 62.73 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.109 179.3 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.418 ' CE1' ' HB3' ' A' ' 222' ' ' PRO . 21.9 t80 -58.13 142.16 80.78 Favored Pre-proline 0 CA--C 1.534 0.342 0 CA-C-N 116.798 -0.183 . . . . 0.0 110.901 179.925 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.494 ' O ' ' HB2' ' A' ' 223' ' ' ALA . 58.9 Cg_endo -89.98 108.66 0.93 Allowed 'Cis proline' 0 C--N 1.357 0.988 0 C-N-CA 124.649 -0.98 . . . . 0.0 112.705 0.264 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.494 ' HB2' ' O ' ' A' ' 222' ' ' PRO . . . 171.08 45.51 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.707 179.726 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.404 HG21 ' O ' ' A' ' 217' ' ' LYS . 0.1 OUTLIER -140.55 162.86 23.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.923 0.392 . . . . 0.0 111.366 -179.719 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 178.94 -169.16 0.09 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.798 179.724 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -60.05 113.0 2.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.139 179.939 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.579 ' O ' HG11 ' A' ' 232' ' ' VAL . . . -127.94 40.96 3.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.031 -179.998 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.577 ' O ' HD23 ' A' ' 228' ' ' LEU . 4.4 tt -88.84 11.72 17.11 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.749 179.885 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -108.59 172.45 6.83 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.887 0.375 . . . . 0.0 110.922 179.964 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 1.3 mtp180 62.57 20.77 12.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.452 -179.985 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 61.44 116.13 0.02 OUTLIER 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.898 0.38 . . . . 0.0 111.154 179.86 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 232' ' ' VAL . . . . . 0.579 HG11 ' O ' ' A' ' 227' ' ' ALA . 5.5 m -118.14 141.94 35.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.167 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 12.1 mttm . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.844 -179.988 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 121.052 0.453 . . . . 0.0 110.978 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.769 ' HB2' HD13 ' A' ' 134' ' ' LEU . 81.6 m95 -77.29 168.51 19.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.976 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.8 ttm-85 -102.4 134.19 46.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.607 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.9 mtm180 -70.42 106.8 3.53 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.887 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.875 HD11 HG22 ' A' ' 168' ' ' THR . 44.5 pt -96.61 -7.06 9.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.448 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.536 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -159.38 175.94 12.73 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 120.606 0.241 . . . . 0.0 110.916 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.472 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 29.0 m-85 -143.65 126.23 15.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.253 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.661 HG21 HD11 ' A' ' 139' ' ' LEU . 3.8 t -93.86 123.28 45.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.512 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.501 ' CE1' ' CZ ' ' A' ' 130' ' ' PHE . 9.4 t80 -85.0 96.21 9.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.734 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -147.84 155.98 42.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.632 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.03 31.22 21.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.846 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.67 34.69 14.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.034 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.451 HG22 ' N ' ' A' ' 130' ' ' PHE . 57.0 m -154.66 161.52 41.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.034 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.501 ' CZ ' ' CE1' ' A' ' 125' ' ' TYR . 96.2 m-85 -103.82 90.49 3.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.166 0.508 . . . . 0.0 110.712 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.565 ' HB2' HD21 ' A' ' 139' ' ' LEU . 22.9 m-85 -67.69 127.4 93.38 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.561 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.424 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 7.7 Cg_exo -71.62 118.16 5.51 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 122.37 2.047 . . . . 0.0 112.369 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.64 HD21 ' OG1' ' A' ' 168' ' ' THR . 38.0 tp -97.52 123.6 41.44 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.123 0.487 . . . . 0.0 110.595 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.769 HD13 ' HB2' ' A' ' 118' ' ' TRP . 52.4 mt -71.46 173.0 8.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.578 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.418 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.3 pt-20 -63.71 -29.27 70.52 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.114 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -89.92 11.36 20.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.16 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.64 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 75.5 18.67 79.76 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.831 -0.7 . . . . 0.0 113.162 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.701 ' HB3' HD12 ' A' ' 134' ' ' LEU . 13.4 tpp180 -76.78 95.7 4.1 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.661 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -71.44 113.58 8.62 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.494 -179.054 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 22.8 mt -88.11 71.76 9.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.292 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.463 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 30.8 mttt -56.87 -20.62 23.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.922 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -87.04 -18.73 29.91 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -104.93 30.85 5.2 Favored 'General case' 0 N--CA 1.461 0.121 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . -63.89 162.38 35.06 Favored Glycine 0 CA--C 1.51 -0.237 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.786 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 10.6 t -136.03 151.39 49.82 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.543 -0.329 . . . . 0.0 110.658 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.423 ' HE2' HG23 ' A' ' 129' ' ' THR . 4.7 mmpt? -89.32 50.37 1.92 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.953 0.406 . . . . 0.0 110.671 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -171.04 151.4 3.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.554 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -96.88 125.87 44.84 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.23 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.472 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 74.3 Cg_endo -82.82 112.75 2.12 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.396 2.064 . . . . 0.0 112.474 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 30.6 t -69.92 -7.65 42.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.121 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -76.53 -23.44 53.64 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 120.828 0.346 . . . . 0.0 110.417 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.697 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -139.83 167.89 16.9 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.723 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.697 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 67.3 Cg_endo -74.79 158.24 43.11 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.351 2.034 . . . . 0.0 112.114 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 10.7 t -118.83 110.83 31.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.051 0.453 . . . . 0.0 111.081 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.833 HD23 ' CE2' ' A' ' 158' ' ' TRP . 0.9 OUTLIER -72.83 96.01 2.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.579 179.022 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 54.3 t -93.1 136.52 24.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.961 0.41 . . . . 0.0 111.103 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 50.06 55.28 15.79 Favored Glycine 0 CA--C 1.52 0.375 0 CA-C-N 115.906 -0.588 . . . . 0.0 113.287 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.833 ' CE2' HD23 ' A' ' 155' ' ' LEU . 3.5 m95 -99.59 151.25 21.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.169 0.509 . . . . 0.0 111.649 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.89 -172.19 0.26 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.457 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -42.69 154.32 0.07 Allowed 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.541 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.18 -25.29 53.91 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.181 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -59.62 -39.43 84.27 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 120.957 0.408 . . . . 0.0 110.036 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.1 -40.06 53.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.94 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.541 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.6 mt -59.68 -42.13 87.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.898 179.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.63 -30.63 43.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.139 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.438 ' CB ' HG21 ' A' ' 211' ' ' ILE . 2.5 mm-40 -67.22 -53.14 32.94 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 121.528 0.68 . . . . 0.0 110.098 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.774 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -60.38 -43.46 96.58 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.06 179.019 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.875 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -58.77 -38.0 77.5 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.525 179.356 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.56 -37.65 92.51 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 178.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -72.03 -46.39 57.26 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.353 -0.423 . . . . 0.0 111.025 178.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.601 ' HA ' HD22 ' A' ' 174' ' ' LEU . 10.9 mp -66.14 -27.71 68.24 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.665 0.269 . . . . 0.0 111.417 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.69 -18.93 62.81 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.438 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -111.74 -27.37 8.54 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.6 0.238 . . . . 0.0 111.413 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.601 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.1 OUTLIER -57.93 167.3 1.55 Allowed Pre-proline 0 CA--C 1.539 0.535 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.929 -179.735 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -70.39 128.01 14.86 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.177 1.918 . . . . 0.0 112.858 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.96 -25.41 8.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.606 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.93 -49.15 77.76 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.814 0.34 . . . . 0.0 110.896 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.874 HG11 ' HB3' ' A' ' 218' ' ' LEU . 37.6 t -73.96 -35.22 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.445 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.537 HD13 ' CD2' ' A' ' 174' ' ' LEU . 5.7 tp -56.04 -35.52 66.98 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.183 0.515 . . . . 0.0 109.988 179.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -78.33 -40.19 20.36 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.336 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -86.06 103.01 14.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.894 0.378 . . . . 0.0 110.625 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . 0.838 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.9 mtm 178.43 165.84 0.8 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.128 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.47 -54.53 1.97 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.797 0.332 . . . . 0.0 111.253 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -163.31 142.94 8.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.92 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.923 HG12 HG12 ' A' ' 199' ' ' VAL . 16.8 mt -106.26 114.71 46.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.722 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . 0.454 ' CE1' ' CE1' ' A' ' 200' ' ' TYR . 11.4 m170 -104.68 131.03 52.61 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.988 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -83.24 104.79 13.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.515 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.649 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.53 0.191 0 CA-C-O 120.684 0.278 . . . . 0.0 111.297 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . 0.404 ' OD1' HG22 ' A' ' 210' ' ' THR . 1.5 p30 -102.18 35.13 2.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.774 0.321 . . . . 0.0 110.708 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -89.45 113.08 24.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.178 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.868 ' O ' HD13 ' A' ' 198' ' ' ILE . 29.1 m -108.57 168.07 3.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.847 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.868 HD13 ' O ' ' A' ' 197' ' ' VAL . 20.7 mm -134.79 108.06 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.826 0.345 . . . . 0.0 111.383 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.923 HG12 HG12 ' A' ' 185' ' ' ILE . 8.1 m -96.42 124.06 48.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.895 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.454 ' CE1' ' CE1' ' A' ' 186' ' ' HIS . 5.2 m-85 -82.58 146.0 29.41 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.796 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.83 156.23 17.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.04 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -64.26 -23.81 67.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.532 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -90.25 15.4 10.49 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 79.59 14.29 81.41 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.079 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -84.43 167.32 16.55 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.929 0.364 . . . . 0.0 110.71 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -133.72 111.66 10.75 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.405 ' HB ' HG23 ' A' ' 199' ' ' VAL . 21.2 t -112.73 124.35 69.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.19 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 80.0 p -101.42 116.47 32.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.695 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.671 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -127.0 158.41 36.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.96 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.404 HG22 ' OD1' ' A' ' 195' ' ' ASP . 0.6 OUTLIER -95.13 154.38 17.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.724 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.438 HG21 ' CB ' ' A' ' 166' ' ' GLU . 36.8 mt -66.39 -35.17 74.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.999 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.49 -35.31 80.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.384 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -129.8 40.91 3.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.891 0.377 . . . . 0.0 111.055 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.563 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 11.9 t80 -65.54 -50.62 64.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.707 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.9 -41.26 91.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.093 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.06 -49.38 65.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.997 0.427 . . . . 0.0 110.46 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 2.1 mmpt? -54.65 -45.09 73.75 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.07 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.874 ' HB3' HG11 ' A' ' 178' ' ' VAL . 4.2 mm? -80.95 -27.5 36.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.978 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 14.3 t -60.76 -31.55 70.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.964 0.411 . . . . 0.0 110.372 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.245 179.471 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 121.146 0.498 . . . . 0.0 111.174 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.746 ' HB2' HD13 ' A' ' 134' ' ' LEU . 79.4 m95 -68.67 168.27 13.5 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.092 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -102.8 136.37 42.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.476 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 41.7 mtt85 -71.95 106.11 4.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.936 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.912 HD11 HG22 ' A' ' 168' ' ' THR . 45.9 pt -94.1 -7.84 10.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.476 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -159.47 176.44 12.08 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 121.017 -0.273 . . . . 0.0 110.89 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.449 ' O ' ' HA ' ' A' ' 154' ' ' VAL . 32.1 m-85 -142.85 126.14 16.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.322 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.621 HG21 ' CD1' ' A' ' 139' ' ' LEU . 4.1 t -93.43 122.74 45.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.963 0.411 . . . . 0.0 111.226 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.492 ' CD1' ' CE1' ' A' ' 130' ' ' PHE . 17.9 t80 -80.99 106.51 13.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.698 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -163.36 156.59 19.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.595 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.448 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 1.2 mmm180 60.18 30.22 19.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.884 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 63.12 32.24 15.31 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.366 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.452 HG22 ' N ' ' A' ' 130' ' ' PHE . 91.1 m -156.92 161.25 39.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.878 0.371 . . . . 0.0 111.026 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.492 ' CE1' ' CD1' ' A' ' 125' ' ' TYR . 58.5 m-85 -99.85 90.3 4.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.626 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.513 ' HA ' ' HA2' ' A' ' 144' ' ' GLY . 22.6 m-85 -65.48 125.5 89.7 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.787 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.456 ' HG2' HD12 ' A' ' 140' ' ' LEU . 58.3 Cg_endo -73.57 118.82 5.64 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.044 1.829 . . . . 0.0 112.411 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.666 HD21 ' OG1' ' A' ' 168' ' ' THR . 28.4 tp -96.22 123.85 40.01 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.396 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.746 HD13 ' HB2' ' A' ' 118' ' ' TRP . 39.9 mt -69.64 173.62 5.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.45 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -64.68 -28.02 69.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.948 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 48.8 p-10 -90.93 13.91 15.26 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.285 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.602 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 72.63 21.78 79.39 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.731 -0.747 . . . . 0.0 113.119 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.687 ' HB3' HD12 ' A' ' 134' ' ' LEU . 9.7 tpp180 -80.82 94.25 6.4 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.621 ' CD1' HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -72.13 113.6 9.33 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.48 -179.024 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.569 HD11 HD21 ' A' ' 134' ' ' LEU . 25.1 mt -88.39 80.43 7.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.414 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.454 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 15.4 mtpt -71.45 -5.77 35.34 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -91.11 -24.28 20.04 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 122.304 -0.248 . . . . 0.0 111.432 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -89.46 -79.12 0.34 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.779 0.323 . . . . 0.0 111.403 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.513 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . 58.11 161.1 0.04 OUTLIER Glycine 0 CA--C 1.505 -0.57 0 CA-C-N 116.279 -0.419 . . . . 0.0 112.753 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.8 t -140.01 148.61 42.11 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.872 0.368 . . . . 0.0 110.939 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.45 ' HE2' HG23 ' A' ' 129' ' ' THR . 4.2 mmtt -91.1 51.97 2.04 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.157 0.503 . . . . 0.0 110.216 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.59 148.48 3.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.773 -179.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -81.89 135.14 48.89 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.703 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.458 ' HD2' ' CG2' ' A' ' 154' ' ' VAL . 68.4 Cg_endo -84.08 97.96 0.75 Allowed 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.052 2.501 . . . . 0.0 112.549 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 26.2 t -67.5 -9.3 41.0 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.825 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -90.0 -21.92 22.15 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.566 0.222 . . . . 0.0 111.588 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.71 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -139.79 167.4 18.63 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.71 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 60.3 Cg_endo -73.65 162.89 38.7 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.408 2.072 . . . . 0.0 112.518 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.458 ' CG2' ' HD2' ' A' ' 149' ' ' PRO . 18.3 t -123.82 110.14 24.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.572 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.84 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.85 95.91 2.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.747 179.112 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 59.0 t -93.01 136.87 23.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.927 0.394 . . . . 0.0 111.094 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 48.85 55.42 11.47 Favored Glycine 0 CA--C 1.52 0.369 0 CA-C-N 115.966 -0.561 . . . . 0.0 113.174 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.84 ' CE2' HD23 ' A' ' 155' ' ' LEU . 3.4 m95 -99.07 151.18 21.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.156 0.503 . . . . 0.0 111.735 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.43 -172.27 0.15 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.604 179.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -43.21 154.39 0.08 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.332 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.515 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -56.94 -24.66 50.94 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.218 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.72 -40.09 86.85 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.967 0.413 . . . . 0.0 110.05 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.12 -39.78 54.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.009 178.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.515 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.1 mt -59.67 -41.23 84.55 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.9 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.0 -30.58 47.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.214 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.403 ' CB ' HG21 ' A' ' 211' ' ' ILE . 15.4 mm-40 -67.64 -52.9 32.73 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.385 0.612 . . . . 0.0 110.107 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.82 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -59.44 -45.27 92.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.971 178.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.912 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -57.65 -38.38 74.96 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.549 179.207 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.83 -36.46 90.02 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 110.701 -0.959 . . . . 0.0 110.701 178.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -74.17 -46.36 42.65 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.451 -0.374 . . . . 0.0 111.06 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.565 ' HA ' HD22 ' A' ' 174' ' ' LEU . 11.3 mp -65.43 -29.6 70.31 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.689 0.28 . . . . 0.0 111.319 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.49 -19.18 63.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.345 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -111.01 -27.85 8.58 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.635 0.255 . . . . 0.0 111.433 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.565 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.1 OUTLIER -56.89 166.58 1.32 Allowed Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.161 -179.473 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.54 127.44 14.77 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.243 1.962 . . . . 0.0 112.744 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.71 -26.01 5.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.784 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.56 -50.76 72.05 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.925 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.854 HG11 ' HB3' ' A' ' 218' ' ' LEU . 33.8 t -74.16 -32.42 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.414 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.525 HD23 ' HD3' ' A' ' 153' ' ' PRO . 0.5 OUTLIER -58.2 -34.2 70.12 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.865 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -79.48 -39.61 17.88 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -86.77 103.03 14.82 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.952 0.405 . . . . 0.0 110.6 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . 0.844 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.8 mtm 178.49 160.48 0.6 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.994 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.1 m -120.56 -52.31 2.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.682 0.277 . . . . 0.0 111.379 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -163.27 142.64 8.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.926 0.394 . . . . 0.0 111.283 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.922 HG12 HG12 ' A' ' 199' ' ' VAL . 17.6 mt -106.71 114.19 45.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.344 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -104.39 119.87 39.94 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.135 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.415 ' HD1' HG12 ' A' ' 197' ' ' VAL . 13.6 t80 -75.8 104.57 6.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.544 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.572 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 . . . . . 0 CA--C 1.529 0.153 0 CA-C-O 120.599 0.238 . . . . 0.0 111.589 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -109.27 37.84 2.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.765 0.317 . . . . 0.0 111.082 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.83 115.59 27.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.947 0.403 . . . . 0.0 111.229 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.825 ' O ' HD13 ' A' ' 198' ' ' ILE . 28.1 m -112.51 166.14 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.808 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.825 HD13 ' O ' ' A' ' 197' ' ' VAL . 22.3 mm -133.03 107.85 12.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.81 0.338 . . . . 0.0 111.401 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.922 HG12 HG12 ' A' ' 185' ' ' ILE . 11.3 m -96.73 120.9 46.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.934 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -81.84 152.29 26.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.562 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 3.6 mmt -108.53 150.03 28.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.809 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -58.74 -25.61 63.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.261 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -88.63 12.94 13.34 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 81.98 14.36 77.42 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.378 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -86.13 153.41 22.1 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 117.103 0.451 . . . . 0.0 110.807 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -123.27 111.42 16.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.86 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.6 t -115.01 123.25 70.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.154 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . 0.557 ' HB2' HD12 ' A' ' 198' ' ' ILE . 9.8 t -98.84 115.49 28.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.742 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.626 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -123.91 162.93 22.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.8 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.73 153.99 18.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.727 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.403 HG21 ' CB ' ' A' ' 166' ' ' GLU . 33.1 mt -65.98 -36.64 77.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.803 0.335 . . . . 0.0 110.763 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -64.82 -36.51 84.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.124 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -128.31 43.51 3.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.916 0.389 . . . . 0.0 110.929 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.571 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 11.4 t80 -68.46 -54.61 15.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.786 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.5 -39.15 79.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.904 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -67.24 -50.04 62.16 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.117 0.484 . . . . 0.0 110.29 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.29 -45.35 72.5 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.057 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.854 ' HB3' HG11 ' A' ' 178' ' ' VAL . 3.9 mm? -80.18 -27.52 38.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.873 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 1.1 m -61.04 -29.85 69.97 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.403 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 7.1 m170 . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.282 179.831 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 121.047 0.451 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.75 ' HB2' HD13 ' A' ' 134' ' ' LEU . 80.9 m95 -68.7 168.31 13.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.015 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.14 135.72 43.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.548 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.9 mtm180 -71.5 105.29 3.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.721 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.892 HD11 HG22 ' A' ' 168' ' ' THR . 47.1 pt -94.18 -8.24 9.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.406 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.443 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -158.47 176.88 11.86 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.467 0.175 . . . . 0.0 110.575 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.467 ' CD1' ' HG3' ' A' ' 149' ' ' PRO . 31.3 m-85 -144.35 125.84 14.93 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.558 HG21 HD11 ' A' ' 139' ' ' LEU . 3.7 t -93.58 122.85 45.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.058 0.456 . . . . 0.0 111.557 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -83.49 94.31 8.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.681 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -145.01 155.13 43.2 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.603 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.93 30.82 20.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.712 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 63.29 33.85 13.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.863 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.41 HG22 ' N ' ' A' ' 130' ' ' PHE . 58.6 m -155.9 159.7 39.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.057 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.41 ' N ' HG22 ' A' ' 129' ' ' THR . 92.6 m-85 -99.77 91.23 4.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.217 0.532 . . . . 0.0 110.863 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.5 ' HB2' HD21 ' A' ' 139' ' ' LEU . 26.1 m-85 -70.37 114.13 23.53 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.722 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.431 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 31.8 Cg_exo -58.72 123.35 13.35 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 122.414 2.076 . . . . 0.0 112.659 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.692 HD21 ' OG1' ' A' ' 168' ' ' THR . 28.9 tp -102.39 123.94 47.06 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.346 179.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.75 HD13 ' HB2' ' A' ' 118' ' ' TRP . 40.3 mt -70.32 173.21 7.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.634 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.402 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 2.1 pt-20 -64.11 -28.3 69.68 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.037 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -90.79 13.72 15.53 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.209 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.604 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 72.84 21.7 79.57 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.75 -0.738 . . . . 0.0 113.01 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.686 ' HB3' HD12 ' A' ' 134' ' ' LEU . 1.3 tpt180 -80.8 92.67 6.11 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.558 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -66.21 113.56 4.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.322 -179.125 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 43.4 mt -83.66 67.68 9.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.707 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.446 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 2.3 mttp -57.58 -21.49 39.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.451 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -95.56 21.07 8.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.433 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -147.31 28.47 0.99 Allowed 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.787 0.327 . . . . 0.0 111.238 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.431 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -60.83 162.83 21.01 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.897 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.4 ' N ' ' CG2' ' A' ' 129' ' ' THR . 9.0 t -132.96 150.86 52.13 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.814 0.34 . . . . 0.0 110.611 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.4 mmtt -90.34 50.02 1.78 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.531 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -171.09 150.24 3.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.516 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -94.55 125.76 50.46 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.219 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.467 ' HG3' ' CD1' ' A' ' 123' ' ' TYR . 73.6 Cg_endo -83.65 111.97 1.8 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.428 2.085 . . . . 0.0 112.605 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 46.6 t -69.84 -7.89 43.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.038 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -77.27 -22.55 51.94 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 120.798 0.333 . . . . 0.0 110.572 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.673 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -142.15 167.06 17.72 Favored Pre-proline 0 N--CA 1.453 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.702 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.673 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 62.5 Cg_endo -74.58 157.68 44.33 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.37 2.046 . . . . 0.0 112.315 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 12.8 t -118.28 111.0 32.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.346 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.836 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.65 96.05 1.94 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.762 179.016 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.1 t -93.56 135.44 28.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.995 0.426 . . . . 0.0 110.945 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 49.62 58.08 8.73 Favored Glycine 0 CA--C 1.521 0.42 0 CA-C-N 115.874 -0.603 . . . . 0.0 113.158 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.836 ' CE2' HD23 ' A' ' 155' ' ' LEU . 3.0 m95 -100.59 151.35 21.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.201 0.524 . . . . 0.0 111.744 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.413 ' HD3' ' CE2' ' A' ' 187' ' ' TYR . 2.6 tptt -64.76 -172.47 0.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.523 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -44.35 154.89 0.1 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.122 0.487 . . . . 0.0 112.212 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.55 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.29 -25.37 54.38 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.225 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.34 -38.25 83.21 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.979 0.419 . . . . 0.0 110.165 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.82 -40.61 47.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.116 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.55 HD12 ' HA2' ' A' ' 161' ' ' GLY . 5.9 mt -58.45 -41.38 81.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.973 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.12 -30.34 48.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.144 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.406 ' CB ' HG21 ' A' ' 211' ' ' ILE . 3.8 mm-40 -68.1 -53.04 28.34 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-O 121.368 0.604 . . . . 0.0 110.196 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.817 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -59.66 -43.6 93.89 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.03 179.064 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.892 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -59.2 -37.24 76.95 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.466 179.009 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.05 -37.01 92.11 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -73.06 -46.87 49.21 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.359 -0.421 . . . . 0.0 111.163 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.574 ' HA ' HD22 ' A' ' 174' ' ' LEU . 11.1 mp -65.3 -29.28 70.02 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.7 0.286 . . . . 0.0 111.345 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.79 -20.89 64.36 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.317 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -110.56 -26.3 9.54 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.599 0.238 . . . . 0.0 111.52 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.574 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.1 OUTLIER -57.42 166.62 1.58 Allowed Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.083 -179.697 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -68.8 127.14 14.9 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.308 2.005 . . . . 0.0 112.698 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.07 -25.96 5.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.643 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -58.23 -49.89 75.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.907 0.384 . . . . 0.0 110.986 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.852 HG11 ' HB3' ' A' ' 218' ' ' LEU . 32.0 t -74.0 -34.87 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.704 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.567 HD21 ' O ' ' A' ' 121' ' ' ILE . 0.5 OUTLIER -57.61 -33.91 68.73 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.119 0.485 . . . . 0.0 109.838 178.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -78.62 -39.79 20.37 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -87.74 103.18 15.37 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.884 0.373 . . . . 0.0 110.684 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . 0.842 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.8 mtm 178.79 163.4 0.78 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.202 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -120.39 -57.1 1.94 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.742 0.306 . . . . 0.0 111.206 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -159.97 142.52 13.47 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.992 0.425 . . . . 0.0 111.124 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.882 HG12 HG12 ' A' ' 199' ' ' VAL . 17.8 mt -105.12 114.84 45.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.279 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 23.5 m170 -104.24 120.38 41.02 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.117 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.413 ' CE2' ' HD3' ' A' ' 159' ' ' LYS . 83.7 t80 -75.03 104.45 5.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.474 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.529 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 . . . . . 0 CA--C 1.529 0.167 0 CA-C-O 120.729 0.3 . . . . 0.0 111.333 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . 0.604 ' HB3' HD12 ' A' ' 211' ' ' ILE . 0.5 OUTLIER -106.55 40.39 1.63 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.036 0.446 . . . . 0.0 110.308 179.755 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.18 116.45 27.44 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.959 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.874 ' O ' HD13 ' A' ' 198' ' ' ILE . 29.2 m -109.96 168.05 4.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.082 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.874 HD13 ' O ' ' A' ' 197' ' ' VAL . 21.8 mm -135.37 108.24 8.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.196 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.882 HG12 HG12 ' A' ' 185' ' ' ILE . 15.4 m -97.61 139.72 19.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.998 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -101.51 152.72 20.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.778 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 6.0 mmt -105.28 159.7 15.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.88 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -60.13 -27.07 66.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.256 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -86.92 9.96 17.74 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 84.54 14.34 71.01 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.565 -0.826 . . . . 0.0 113.266 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -81.05 158.38 25.11 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 117.228 0.514 . . . . 0.0 110.739 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -128.15 111.25 13.25 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.814 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.2 t -111.21 133.58 56.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.951 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . 0.489 ' HB3' HD12 ' A' ' 198' ' ' ILE . 0.3 OUTLIER -104.63 117.25 33.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.938 -179.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.661 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -129.49 156.84 43.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.681 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -99.16 149.33 23.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.78 0.324 . . . . 0.0 110.764 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.604 HD12 ' HB3' ' A' ' 195' ' ' ASP . 64.1 mt -59.55 -38.25 74.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.955 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -61.84 -32.9 73.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.301 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -134.87 46.41 2.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.904 0.383 . . . . 0.0 111.075 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.493 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 11.4 t80 -70.26 -51.36 31.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.795 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.93 -39.65 86.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.014 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.85 -50.34 62.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.144 0.497 . . . . 0.0 110.454 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.99 -45.11 71.36 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.169 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.852 ' HB3' HG11 ' A' ' 178' ' ' VAL . 3.9 mm? -81.33 -26.33 35.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.95 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.31 -30.56 70.57 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.871 0.367 . . . . 0.0 110.301 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 13.8 m170 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.189 179.767 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.898 0.38 . . . . 0.0 110.955 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.779 ' HB2' HD13 ' A' ' 134' ' ' LEU . 82.3 m95 -80.66 168.41 18.9 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.143 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -101.06 132.34 46.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.761 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 12.1 mtm-85 -69.94 106.12 3.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.667 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.891 HD11 HG22 ' A' ' 168' ' ' THR . 43.4 pt -94.5 -7.82 9.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.409 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -160.46 176.81 11.22 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 121.158 -0.217 . . . . 0.0 110.669 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.475 ' O ' ' HA ' ' A' ' 154' ' ' VAL . 30.4 m-85 -142.34 126.96 17.96 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.11 -0.329 . . . . 0.0 110.11 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.552 HG21 ' CD1' ' A' ' 139' ' ' LEU . 3.9 t -93.22 122.49 44.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.345 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -80.42 94.39 6.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.632 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -146.92 156.5 43.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.375 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.34 29.79 19.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.86 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 62.76 34.92 14.24 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.108 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.447 HG22 ' N ' ' A' ' 130' ' ' PHE . 86.7 m -158.06 161.76 38.05 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.194 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.447 ' N ' HG22 ' A' ' 129' ' ' THR . 6.3 m-85 -98.2 90.9 5.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.142 0.496 . . . . 0.0 111.041 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.479 ' HB2' HD21 ' A' ' 139' ' ' LEU . 23.9 m-85 -69.67 120.35 76.85 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.248 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.42 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 23.5 Cg_exo -64.2 117.63 4.64 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.341 2.027 . . . . 0.0 112.798 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.643 HD21 ' OG1' ' A' ' 168' ' ' THR . 35.9 tp -96.84 123.65 40.6 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.144 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.779 HD13 ' HB2' ' A' ' 118' ' ' TRP . 55.9 mt -70.75 171.39 10.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.666 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.412 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 2.1 pt-20 -62.82 -29.36 70.67 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.938 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -89.29 10.3 22.8 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.156 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.645 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 76.57 18.05 79.38 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.159 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.715 ' HB3' HD12 ' A' ' 134' ' ' LEU . 18.3 tpp85 -76.97 94.04 3.9 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.552 ' CD1' HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -68.14 110.03 3.8 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.675 -178.889 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 37.5 mt -81.74 73.62 8.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.676 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.452 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 13.1 mtpt -60.72 -17.86 50.89 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.575 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -101.32 25.01 8.75 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.535 0.207 . . . . 0.0 111.219 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -145.83 26.7 1.23 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.707 0.289 . . . . 0.0 111.353 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . -59.21 164.16 10.66 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.719 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.8 t -135.24 148.55 49.63 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.925 0.393 . . . . 0.0 110.784 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 3.6 mmtt -90.04 53.24 2.47 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.491 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.72 153.56 4.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.361 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -88.62 133.8 35.37 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.83 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.448 ' HG3' ' CD1' ' A' ' 123' ' ' TYR . 73.7 Cg_endo -81.63 98.86 1.01 Allowed 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.905 2.404 . . . . 0.0 112.505 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.0 t -67.23 -9.62 42.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.877 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -89.65 -22.23 22.39 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 111.666 0.247 . . . . 0.0 111.666 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.731 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -139.03 168.07 16.88 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.731 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 61.6 Cg_endo -74.12 165.81 31.09 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.352 2.035 . . . . 0.0 112.278 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 25.6 t -125.12 107.83 18.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.035 0.445 . . . . 0.0 111.744 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.882 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.43 96.19 1.87 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.023 179.336 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.444 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 61.9 t -94.17 138.02 21.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.085 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 48.01 56.05 9.36 Favored Glycine 0 CA--C 1.52 0.39 0 CA-C-N 115.964 -0.562 . . . . 0.0 113.261 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.882 ' CE2' HD23 ' A' ' 155' ' ' LEU . 3.4 m95 -99.16 151.16 21.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.187 0.518 . . . . 0.0 111.659 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.47 -172.37 0.16 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.519 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -43.06 154.22 0.08 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.567 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.06 -24.89 52.53 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.267 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -60.26 -39.27 86.17 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.998 0.427 . . . . 0.0 110.162 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.7 -39.51 51.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.18 179.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.567 HD12 ' HA2' ' A' ' 161' ' ' GLY . 7.1 mt -60.07 -42.13 88.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.126 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.48 -30.83 54.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.285 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.414 ' HB3' HG21 ' A' ' 211' ' ' ILE . 3.0 mm-40 -65.95 -53.27 41.19 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.409 0.623 . . . . 0.0 110.01 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.785 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -61.48 -43.05 99.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.087 179.06 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.891 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -59.19 -37.28 77.02 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.38 179.281 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.52 -38.37 94.79 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 110.456 -1.057 . . . . 0.0 110.456 178.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 33.6 mm-40 -71.31 -44.15 65.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.384 -0.408 . . . . 0.0 110.801 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.659 ' HA ' HD22 ' A' ' 174' ' ' LEU . 10.5 mp -66.92 -28.41 68.27 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.7 0.286 . . . . 0.0 111.384 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.83 -16.18 62.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.377 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -114.7 -29.25 6.84 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 111.561 0.208 . . . . 0.0 111.561 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.659 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER -56.85 167.16 1.12 Allowed Pre-proline 0 CA--C 1.538 0.5 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.121 -179.673 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -69.99 126.94 13.73 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.153 1.902 . . . . 0.0 113.043 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.35 -25.31 5.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.696 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -56.08 -50.72 70.21 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.907 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.886 HG11 ' HB3' ' A' ' 218' ' ' LEU . 42.8 t -74.74 -34.74 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.54 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.478 ' HB2' HD21 ' A' ' 174' ' ' LEU . 11.6 tp -54.92 -35.32 64.04 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.181 0.515 . . . . 0.0 110.13 179.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -79.99 -41.83 11.8 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 111.169 -0.773 . . . . 0.0 111.169 178.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -82.3 103.14 11.66 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.843 0.354 . . . . 0.0 110.469 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . 0.844 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.9 mtm 177.81 171.6 0.64 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.129 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.3 m -127.54 -54.59 1.34 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.811 0.338 . . . . 0.0 110.877 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -163.49 142.32 8.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.029 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.925 HG12 HG12 ' A' ' 199' ' ' VAL . 18.6 mt -105.51 114.32 44.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.137 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . 0.444 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 19.2 m170 -105.88 114.92 29.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.424 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.419 ' HB2' ' CD2' ' A' ' 158' ' ' TRP . 83.8 t80 -66.09 104.43 1.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 12.2 mttt . . . . . 0 C--N 1.327 -0.396 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.939 -179.314 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 . . . . . 0 CA--C 1.529 0.139 0 CA-C-O 120.815 0.341 . . . . 0.0 111.166 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 6.9 p30 -102.15 37.27 1.91 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.556 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 2.0 tpm_? -89.5 114.23 25.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.134 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.686 ' O ' HD13 ' A' ' 198' ' ' ILE . 28.7 m -110.48 166.0 5.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.622 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.686 HD13 ' O ' ' A' ' 197' ' ' VAL . 19.1 mm -131.43 106.14 11.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.805 0.336 . . . . 0.0 111.43 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.925 HG12 HG12 ' A' ' 185' ' ' ILE . 9.5 m -96.11 118.36 42.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.919 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -81.63 152.92 26.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.547 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.17 148.15 28.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.863 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 36.1 m-20 -58.24 -28.85 65.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.017 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -76.86 -4.68 44.93 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.765 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 97.41 14.46 41.26 Favored Glycine 0 C--N 1.335 0.517 0 C-N-CA 120.533 -0.841 . . . . 0.0 113.106 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -87.61 170.99 10.8 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.957 0.408 . . . . 0.0 111.103 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -135.04 111.12 9.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.623 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.437 ' HB ' HG23 ' A' ' 199' ' ' VAL . 28.9 t -113.94 124.82 70.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.881 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 2.8 m -102.17 115.64 30.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.781 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -123.49 171.01 9.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.82 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -107.42 155.09 20.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.474 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.414 HG21 ' HB3' ' A' ' 166' ' ' GLU . 38.5 mt -68.13 -35.95 73.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.807 0.336 . . . . 0.0 110.76 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -62.85 -36.87 84.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.258 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -130.64 40.99 3.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.953 0.406 . . . . 0.0 111.068 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.542 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 10.6 t80 -64.06 -55.04 25.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.553 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.04 -42.73 85.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.271 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -66.67 -48.21 70.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.015 0.436 . . . . 0.0 110.496 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 1.2 mmpt? -55.1 -44.4 74.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.279 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.886 ' HB3' HG11 ' A' ' 178' ' ' VAL . 3.7 mm? -83.99 -25.69 29.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.074 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 14.9 t -60.74 -32.81 72.08 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.973 0.416 . . . . 0.0 110.157 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 24.5 m170 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.181 179.293 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.991 0.424 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.769 ' HB2' HD13 ' A' ' 134' ' ' LEU . 81.0 m95 -73.56 168.48 19.21 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.185 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -102.88 132.24 49.22 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.808 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.31 107.03 3.11 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.777 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.887 HD11 HG22 ' A' ' 168' ' ' THR . 44.2 pt -96.21 -7.8 9.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.498 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.435 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -159.94 176.78 11.47 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.003 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.463 ' O ' ' HA ' ' A' ' 154' ' ' VAL . 33.1 m-85 -143.41 127.2 17.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.284 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.577 HG21 ' CD1' ' A' ' 139' ' ' LEU . 3.6 t -93.44 122.71 45.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.098 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -82.52 94.11 7.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.36 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -145.22 155.68 43.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.255 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 59.31 29.45 19.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.855 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 62.88 35.03 13.82 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.142 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 53.3 m -157.13 156.76 33.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.836 0.351 . . . . 0.0 111.17 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -94.75 91.39 6.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.888 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.45 ' CG ' ' HA ' ' A' ' 141' ' ' LYS . 23.3 m-85 -70.81 121.75 84.77 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.303 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.409 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 22.3 Cg_exo -64.81 121.66 9.26 Favored 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 122.414 2.076 . . . . 0.0 112.757 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.658 HD21 ' OG1' ' A' ' 168' ' ' THR . 31.1 tp -102.09 123.36 45.82 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-O 121.128 0.49 . . . . 0.0 110.087 178.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.769 HD13 ' HB2' ' A' ' 118' ' ' TRP . 51.5 mt -70.72 171.81 9.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.652 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.407 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.6 pt-20 -62.94 -28.32 69.99 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.979 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 50.8 p-10 -90.46 11.97 20.0 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.225 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.628 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 75.15 18.79 80.05 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.237 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.69 ' HB3' HD12 ' A' ' 134' ' ' LEU . 1.5 tpt180 -77.6 92.43 4.09 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.577 ' CD1' HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -66.41 113.78 4.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.418 -179.053 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.503 HD13 ' HG3' ' A' ' 143' ' ' GLU . 30.1 mt -84.01 70.07 10.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.69 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.45 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 5.4 mtpt -58.26 -20.3 41.18 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.56 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -99.38 25.24 7.15 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.739 -0.21 . . . . 0.0 111.27 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.503 ' HG3' HD13 ' A' ' 140' ' ' LEU . 54.3 mm-40 -147.16 24.83 1.14 Allowed 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.582 0.23 . . . . 0.0 111.493 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . -59.41 161.71 15.21 Favored Glycine 0 CA--C 1.509 -0.335 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.747 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 9.0 t -131.27 154.51 48.42 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.041 0.448 . . . . 0.0 110.7 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -92.95 53.92 2.08 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.766 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.74 170.81 6.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.256 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -104.26 135.85 19.27 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.537 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.449 ' HG3' ' CD1' ' A' ' 123' ' ' TYR . 68.3 Cg_endo -82.77 99.67 0.93 Allowed 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.95 2.433 . . . . 0.0 112.443 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.4 t -67.01 -10.1 46.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.844 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.92 -22.08 22.16 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.692 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -138.67 166.69 23.4 Favored Pre-proline 0 C--N 1.328 -0.356 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -178.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.692 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 61.3 Cg_endo -73.87 164.2 35.19 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 122.487 2.125 . . . . 0.0 112.3 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 24.3 t -123.4 109.68 24.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.666 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.841 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.58 96.77 2.02 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.947 179.344 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 59.5 t -94.68 136.87 24.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.983 0.421 . . . . 0.0 111.124 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 49.7 51.33 28.71 Favored Glycine 0 CA--C 1.52 0.375 0 CA-C-N 115.811 -0.631 . . . . 0.0 113.259 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.841 ' CE2' HD23 ' A' ' 155' ' ' LEU . 2.9 m95 -94.75 151.01 19.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.054 0.454 . . . . 0.0 111.574 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -66.0 -172.43 0.14 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.421 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -43.67 154.7 0.09 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.073 0.463 . . . . 0.0 112.217 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.55 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -56.45 -25.24 48.91 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.269 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.33 -39.17 86.12 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 120.912 0.387 . . . . 0.0 110.058 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.19 -40.22 52.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.102 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.55 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.1 mt -59.13 -41.58 84.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.909 179.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.44 -30.74 53.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.2 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.4 ' CB ' HG21 ' A' ' 211' ' ' ILE . 3.2 mm-40 -67.21 -53.17 32.67 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-O 121.439 0.638 . . . . 0.0 110.072 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.802 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -59.72 -45.53 91.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.989 178.865 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.887 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -57.28 -36.77 71.45 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.565 179.037 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.13 -38.21 94.04 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 178.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -71.24 -48.17 52.83 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.329 -0.436 . . . . 0.0 110.939 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.612 ' HA ' HD22 ' A' ' 174' ' ' LEU . 10.9 mp -64.51 -28.6 69.76 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.742 0.306 . . . . 0.0 111.275 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.87 -18.37 63.41 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.37 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -112.15 -28.32 8.02 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.645 0.26 . . . . 0.0 111.421 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.612 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.1 OUTLIER -57.55 166.9 1.51 Allowed Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.998 -179.695 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -70.04 128.78 16.26 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.263 1.975 . . . . 0.0 112.898 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.94 -25.8 9.01 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.64 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -58.05 -48.79 79.04 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.881 0.372 . . . . 0.0 110.935 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.882 HG11 ' HB3' ' A' ' 218' ' ' LEU . 24.6 t -73.66 -35.31 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.504 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 11.5 tp -55.26 -34.61 64.19 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.234 0.54 . . . . 0.0 109.987 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -78.71 -42.73 12.86 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.314 178.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -82.16 103.19 11.59 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.899 0.381 . . . . 0.0 110.404 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . 0.84 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.9 mtm 177.65 173.48 0.54 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.956 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 3.2 t -133.09 -51.65 0.89 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.705 0.288 . . . . 0.0 111.229 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . 0.428 ' HG2' ' CD1' ' A' ' 200' ' ' TYR . 1.3 pm0 -163.13 142.85 8.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.035 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.898 HG12 HG12 ' A' ' 199' ' ' VAL . 19.9 mt -106.66 114.24 45.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.442 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -104.6 124.04 48.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.16 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -80.47 104.82 11.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.368 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.54 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 . . . . . 0 CA--C 1.53 0.211 0 CA-C-O 120.658 0.266 . . . . 0.0 111.43 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -107.13 38.33 2.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.772 0.32 . . . . 0.0 110.616 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -91.1 115.75 28.27 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.985 0.421 . . . . 0.0 111.379 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.727 ' O ' HD13 ' A' ' 198' ' ' ILE . 27.7 m -112.55 166.6 6.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.655 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.727 HD13 ' O ' ' A' ' 197' ' ' VAL . 21.5 mm -131.68 109.85 16.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.732 0.301 . . . . 0.0 111.29 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.898 HG12 HG12 ' A' ' 185' ' ' ILE . 8.5 m -100.08 124.92 53.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.912 0.387 . . . . 0.0 111.021 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.428 ' CD1' ' HG2' ' A' ' 184' ' ' GLU . 44.8 m-85 -86.6 152.53 22.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.571 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 5.5 mmt -104.07 165.4 11.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.937 0.399 . . . . 0.0 110.936 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -67.4 -26.15 66.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.062 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -89.94 13.87 13.59 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 80.99 14.44 79.42 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 120.556 -0.831 . . . . 0.0 113.321 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -77.0 168.09 20.69 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 117.119 0.46 . . . . 0.0 110.729 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -134.51 111.57 10.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.851 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 17.9 t -119.38 123.91 72.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.165 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . 0.544 ' HB2' HD12 ' A' ' 198' ' ' ILE . 27.1 t -101.29 114.84 29.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.751 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.625 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -122.91 161.75 23.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.862 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.83 154.94 17.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.624 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.4 HG21 ' CB ' ' A' ' 166' ' ' GLU . 36.8 mt -67.18 -30.14 48.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.713 0.292 . . . . 0.0 110.986 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -72.07 -38.26 69.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.289 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -121.99 34.69 5.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.038 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.602 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 12.0 t80 -62.0 -56.05 23.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.926 0.393 . . . . 0.0 110.7 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.63 -40.64 83.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.138 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -67.42 -49.19 64.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.952 0.406 . . . . 0.0 110.365 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.42 -45.02 72.91 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.057 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.882 ' HB3' HG11 ' A' ' 178' ' ' VAL . 3.8 mm? -80.89 -27.67 36.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.785 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 13.5 t -60.64 -30.34 69.81 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.846 0.355 . . . . 0.0 110.529 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 65.6 m-70 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.21 179.646 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 . . . . . 0 C--O 1.231 0.088 0 CA-C-O 121.031 0.443 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.767 ' HB2' HD13 ' A' ' 134' ' ' LEU . 81.9 m95 -74.15 168.4 19.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.143 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 6.9 ptt180 -101.7 134.49 44.78 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.845 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -71.2 106.89 3.96 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.858 0.361 . . . . 0.0 110.75 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.918 HD11 HG22 ' A' ' 168' ' ' THR . 46.0 pt -95.93 -9.45 9.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.315 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.467 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -157.75 176.14 12.97 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 120.586 0.231 . . . . 0.0 110.691 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.47 ' CD1' ' HG3' ' A' ' 149' ' ' PRO . 29.9 m-85 -143.92 126.7 16.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.16 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.646 HG21 HD11 ' A' ' 139' ' ' LEU . 4.3 t -93.12 122.42 44.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.279 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.497 ' CE1' ' CE1' ' A' ' 130' ' ' PHE . 7.3 t80 -81.92 97.13 7.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.935 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -149.14 151.62 34.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.44 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 61.17 30.88 19.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.804 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 61.81 31.29 18.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.034 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.501 HG23 ' O ' ' A' ' 145' ' ' THR . 70.4 m -151.2 151.13 31.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.941 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.639 ' CE2' ' HB2' ' A' ' 148' ' ' ALA . 12.1 m-85 -93.07 91.05 7.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.701 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.507 ' HB2' HD21 ' A' ' 139' ' ' LEU . 23.5 m-85 -66.57 123.38 85.56 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.665 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -70.65 113.32 3.48 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 122.107 1.872 . . . . 0.0 112.727 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.647 HD21 ' OG1' ' A' ' 168' ' ' THR . 32.2 tp -92.44 124.02 36.18 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.706 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.767 HD13 ' HB2' ' A' ' 118' ' ' TRP . 48.1 mt -69.86 174.25 5.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.503 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -65.73 -28.31 68.95 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.029 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -89.74 11.84 18.82 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.156 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.625 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 74.1 22.8 77.37 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.937 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.687 ' HB3' HD12 ' A' ' 134' ' ' LEU . 18.2 tpp180 -81.92 93.62 6.95 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.646 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -68.69 109.34 3.76 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.151 -179.155 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 15.7 mt -85.14 71.64 10.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.87 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.478 ' HE3' HD13 ' A' ' 139' ' ' LEU . 12.8 mttt -57.77 -21.14 39.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.469 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -94.28 20.05 8.67 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.419 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -145.15 26.95 1.31 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.846 0.355 . . . . 0.0 111.045 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.77 163.89 39.76 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.96 -0.638 . . . . 0.0 113.199 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.501 ' O ' HG23 ' A' ' 129' ' ' THR . 6.7 t -130.69 157.01 43.94 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.328 -0.436 . . . . 0.0 110.563 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.3 mmmt -94.3 50.09 1.35 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.548 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.15 150.35 3.0 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.695 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.639 ' HB2' ' CE2' ' A' ' 130' ' ' PHE . . . -93.05 125.64 54.16 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.242 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.47 ' HG3' ' CD1' ' A' ' 123' ' ' TYR . 71.9 Cg_endo -84.1 111.32 1.62 Allowed 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.433 2.089 . . . . 0.0 112.599 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 45.5 t -69.62 -8.19 45.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.013 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -77.25 -23.51 51.24 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 120.865 0.364 . . . . 0.0 110.54 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.665 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -140.17 166.62 22.25 Favored Pre-proline 0 N--CA 1.453 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.562 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.665 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 66.7 Cg_endo -74.99 158.03 42.49 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.342 2.028 . . . . 0.0 112.331 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 14.3 t -118.24 110.67 31.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.251 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.838 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.52 96.25 1.92 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.726 179.206 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.42 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 61.7 t -93.35 137.22 23.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.007 0.432 . . . . 0.0 111.149 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 49.0 54.13 15.77 Favored Glycine 0 CA--C 1.52 0.363 0 CA-C-N 115.859 -0.609 . . . . 0.0 113.327 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.838 ' CE2' HD23 ' A' ' 155' ' ' LEU . 2.7 m95 -97.32 151.13 20.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.118 0.485 . . . . 0.0 111.55 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.22 -172.41 0.15 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.322 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -43.21 154.99 0.07 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.543 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -56.51 -24.51 46.93 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.154 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -60.33 -40.27 90.02 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.969 0.414 . . . . 0.0 109.911 179.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.51 ' HB1' ' HE2' ' A' ' 187' ' ' TYR . . . -74.39 -41.43 60.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.972 178.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.543 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.6 mt -58.28 -42.21 83.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.009 179.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.77 -29.89 42.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.192 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.429 ' CB ' HG21 ' A' ' 211' ' ' ILE . 4.2 mm-40 -68.19 -53.2 26.6 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.435 0.636 . . . . 0.0 110.107 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.804 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -59.08 -45.97 89.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.099 178.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.918 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -56.98 -37.52 71.75 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.709 179.258 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.14 -37.86 93.52 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 47.9 mm-40 -72.89 -46.32 53.43 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.419 -0.39 . . . . 0.0 111.135 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.613 ' HA ' HD22 ' A' ' 174' ' ' LEU . 11.1 mp -65.86 -28.57 69.06 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.658 0.266 . . . . 0.0 111.406 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.52 -17.67 62.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.379 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -112.51 -28.79 7.72 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 120.697 0.284 . . . . 0.0 111.453 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.613 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.1 OUTLIER -56.94 167.28 1.11 Allowed Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.188 -179.564 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -69.24 127.15 14.58 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.21 1.94 . . . . 0.0 112.861 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.11 -25.51 9.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.592 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -58.46 -48.99 78.92 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.959 0.409 . . . . 0.0 110.889 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.854 HG11 ' HB3' ' A' ' 218' ' ' LEU . 27.2 t -73.75 -33.8 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.438 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.408 ' HB2' HD21 ' A' ' 174' ' ' LEU . 13.8 tp -56.46 -35.26 67.72 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.141 0.496 . . . . 0.0 109.815 179.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -78.02 -40.84 19.73 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.188 178.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -84.6 102.84 13.22 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.977 0.418 . . . . 0.0 110.57 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . 0.842 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.9 mtm 177.63 173.55 0.54 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.007 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 4.7 t -133.68 -50.27 0.84 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.752 0.31 . . . . 0.0 111.225 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -163.45 145.25 9.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.025 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.905 HG12 HG12 ' A' ' 199' ' ' VAL . 20.2 mt -110.87 115.99 51.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.539 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . 0.42 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 20.3 m170 -106.64 137.82 43.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.208 -179.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.51 ' HE2' ' HB1' ' A' ' 163' ' ' ALA . 0.2 OUTLIER -87.86 104.54 16.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.472 179.596 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.87 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.857 0.36 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . 0.4 ' HB2' ' HB ' ' A' ' 211' ' ' ILE . 6.8 p30 -102.94 37.09 2.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.752 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -87.59 115.39 24.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.938 0.399 . . . . 0.0 111.093 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.813 ' O ' HD13 ' A' ' 198' ' ' ILE . 30.5 m -112.14 168.19 5.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.686 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.813 HD13 ' O ' ' A' ' 197' ' ' VAL . 25.7 mm -132.61 109.77 15.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.785 0.326 . . . . 0.0 111.318 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.905 HG12 HG12 ' A' ' 185' ' ' ILE . 6.9 m -99.0 121.04 49.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.901 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -81.94 152.52 26.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.835 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.04 146.44 35.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.863 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -57.32 -22.61 43.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.504 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -89.7 15.22 9.99 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 79.62 14.41 81.22 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.241 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -90.59 149.92 21.94 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 117.137 0.468 . . . . 0.0 110.801 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -119.38 111.33 18.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.765 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 20.8 t -111.68 126.23 69.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.964 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . 0.578 ' OG ' HD12 ' A' ' 198' ' ' ILE . 11.0 m -103.08 116.36 32.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.934 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -121.84 -177.58 3.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.569 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.66 153.7 35.15 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.494 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.429 HG21 ' CB ' ' A' ' 166' ' ' GLU . 43.7 mt -66.63 -34.93 73.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.811 0.339 . . . . 0.0 110.775 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.4 -36.42 81.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.207 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -129.92 45.27 2.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.978 0.418 . . . . 0.0 110.903 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.621 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 11.6 t80 -68.53 -52.24 34.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.768 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.9 -39.7 86.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.132 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.71 -49.99 64.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.146 0.498 . . . . 0.0 110.603 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -53.99 -44.08 70.52 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.41 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.854 ' HB3' HG11 ' A' ' 178' ' ' VAL . 3.9 mm? -84.85 -23.77 28.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.266 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.31 -33.59 73.83 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.003 0.43 . . . . 0.0 109.934 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 38.2 m170 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.236 179.306 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.936 0.398 . . . . 0.0 110.995 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.769 ' HB2' HD13 ' A' ' 134' ' ' LEU . 80.7 m95 -77.13 168.36 20.21 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.053 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.32 133.77 46.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.818 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.4 mtt85 -70.4 106.78 3.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.869 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.904 HD11 HG22 ' A' ' 168' ' ' THR . 44.6 pt -95.47 -8.44 9.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.412 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.406 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -159.38 176.28 12.32 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 120.588 0.232 . . . . 0.0 110.894 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.453 ' O ' ' HA ' ' A' ' 154' ' ' VAL . 32.2 m-85 -143.5 126.96 16.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.332 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.645 HG21 HD11 ' A' ' 139' ' ' LEU . 5.0 t -93.36 122.63 45.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.083 0.468 . . . . 0.0 111.12 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.5 ' CD1' ' CE1' ' A' ' 130' ' ' PHE . 7.9 t80 -82.52 103.84 12.35 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.857 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -158.44 154.22 26.5 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.592 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.62 30.65 19.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.803 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 62.99 31.48 16.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.274 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 88.1 m -153.79 156.77 38.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.89 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.5 ' CE1' ' CD1' ' A' ' 125' ' ' TYR . 81.2 m-85 -98.42 90.88 4.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.602 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.491 ' HB2' HD21 ' A' ' 139' ' ' LEU . 23.4 m-85 -65.35 123.79 85.26 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.117 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.402 ' HB3' ' CE2' ' A' ' 123' ' ' TYR . 56.1 Cg_endo -71.57 115.22 4.21 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.255 1.97 . . . . 0.0 112.793 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.687 HD21 ' OG1' ' A' ' 168' ' ' THR . 29.2 tp -94.09 124.06 37.86 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.665 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.769 HD13 ' HB2' ' A' ' 118' ' ' TRP . 52.8 mt -70.69 173.29 7.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.517 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.4 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.3 pt-20 -64.3 -28.66 69.87 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.969 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -89.8 11.72 19.28 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.251 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.602 ' HA2' HD11 ' A' ' 133' ' ' LEU . . . 74.38 22.72 77.11 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.726 -0.75 . . . . 0.0 113.048 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.693 ' HB3' HD12 ' A' ' 134' ' ' LEU . 1.4 tpt180 -81.43 94.53 6.84 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.645 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -70.96 107.88 4.28 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.211 -179.164 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 16.7 mt -86.17 72.85 10.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.547 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.46 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 23.8 mttp -56.86 -20.95 25.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.77 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -85.24 -14.87 45.39 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -112.03 30.82 6.7 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . -60.5 166.24 12.12 Favored Glycine 0 CA--C 1.511 -0.185 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.453 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 9.0 t -135.3 148.27 49.45 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.992 0.425 . . . . 0.0 111.029 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 3.0 mmtt -90.86 52.82 2.24 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.356 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.68 152.22 3.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.549 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -86.99 135.95 34.61 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.833 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.452 ' HD2' ' CG2' ' A' ' 154' ' ' VAL . 60.6 Cg_endo -84.46 98.42 0.72 Allowed 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.028 2.485 . . . . 0.0 112.641 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.2 t -67.46 -9.13 39.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.714 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -90.35 -22.06 21.7 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 111.533 0.197 . . . . 0.0 111.533 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.717 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -138.7 167.43 19.52 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.717 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 60.9 Cg_endo -73.36 161.85 41.7 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.533 2.156 . . . . 0.0 112.382 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 24.2 t -123.07 110.03 25.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.044 0.45 . . . . 0.0 111.712 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.827 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.62 95.92 1.91 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.74 179.156 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 59.6 t -91.37 137.06 22.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.99 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 46.72 56.59 7.33 Favored Glycine 0 CA--C 1.52 0.399 0 CA-C-N 115.882 -0.599 . . . . 0.0 113.374 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.827 ' CE2' HD23 ' A' ' 155' ' ' LEU . 2.7 m95 -98.25 151.2 20.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.26 0.552 . . . . 0.0 111.707 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 8.1 mmtm -65.23 -172.44 0.1 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.59 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -43.62 154.02 0.1 Allowed 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.54 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.21 -24.85 52.89 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.224 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.01 -38.53 82.9 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.984 0.421 . . . . 0.0 110.056 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.01 -40.24 47.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.003 178.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.54 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.2 mt -58.87 -41.46 82.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.874 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.09 -29.68 45.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.276 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.432 ' CB ' HG21 ' A' ' 211' ' ' ILE . 3.0 mm-40 -69.08 -53.03 22.47 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.31 0.576 . . . . 0.0 110.256 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.825 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -59.1 -44.52 91.97 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.041 178.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.904 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -58.49 -38.22 77.19 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.397 179.214 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.19 -36.16 87.49 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 178.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -73.92 -47.59 36.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.264 -0.468 . . . . 0.0 110.988 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.611 ' HA ' HD22 ' A' ' 174' ' ' LEU . 11.0 mp -65.07 -27.93 69.11 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.754 0.311 . . . . 0.0 111.477 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.74 -18.6 62.78 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.297 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -113.4 -27.01 8.08 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.596 0.236 . . . . 0.0 111.626 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.611 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER -57.09 167.5 1.12 Allowed Pre-proline 0 CA--C 1.537 0.481 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.079 -179.684 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.52 128.22 15.92 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.2 1.933 . . . . 0.0 112.84 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.22 -25.38 9.1 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.631 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.74 -48.95 78.18 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.944 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.904 HG11 ' HB3' ' A' ' 218' ' ' LEU . 38.9 t -74.16 -35.48 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.439 179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.487 ' HB2' HD21 ' A' ' 174' ' ' LEU . 13.8 tp -56.82 -39.4 74.12 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.095 0.474 . . . . 0.0 109.969 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -73.6 -40.05 47.69 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 178.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -88.14 102.87 15.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.948 0.404 . . . . 0.0 110.577 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . 0.837 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.8 mtm 177.69 164.19 0.62 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.146 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.53 -59.85 1.59 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.725 0.298 . . . . 0.0 111.091 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -155.24 142.58 19.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.034 0.445 . . . . 0.0 111.29 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.907 HG12 HG12 ' A' ' 199' ' ' VAL . 20.4 mt -104.69 114.86 45.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.317 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 23.6 m170 -103.12 117.46 34.59 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.256 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.41 ' HB2' ' CD2' ' A' ' 158' ' ' TRP . 71.2 t80 -76.4 104.48 6.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.432 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.647 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 . . . . . 0 CA--C 1.53 0.175 0 N-CA-C 111.577 0.214 . . . . 0.0 111.577 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -110.32 36.21 3.15 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.691 0.281 . . . . 0.0 111.062 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 9.4 ttt180 -89.53 115.17 26.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.121 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.86 ' O ' HD13 ' A' ' 198' ' ' ILE . 22.5 m -111.91 166.91 5.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.955 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.86 HD13 ' O ' ' A' ' 197' ' ' VAL . 19.8 mm -133.9 107.72 10.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.8 0.333 . . . . 0.0 111.314 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.907 HG12 HG12 ' A' ' 185' ' ' ILE . 13.2 m -99.05 131.26 46.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.081 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -95.37 152.44 18.39 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.534 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.52 157.97 16.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.895 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -57.81 -24.8 59.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.343 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -90.42 15.45 10.65 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 79.53 14.32 81.45 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.565 -0.826 . . . . 0.0 113.243 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -75.75 164.98 25.7 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.994 0.397 . . . . 0.0 110.791 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -134.56 111.45 10.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.86 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.6 t -117.87 128.92 74.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.081 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 4.2 m -103.13 115.2 30.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.768 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.686 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -127.11 158.58 36.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.893 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.06 153.27 18.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.503 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.432 HG21 ' CB ' ' A' ' 166' ' ' GLU . 36.7 mt -65.07 -37.18 79.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.882 0.372 . . . . 0.0 110.867 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.48 -33.17 72.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.198 -179.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -134.89 42.27 2.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.86 0.362 . . . . 0.0 111.104 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.584 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 11.4 t80 -64.64 -52.24 58.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.625 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.69 -42.16 87.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.192 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.65 -48.78 63.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.063 0.458 . . . . 0.0 110.338 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 1.3 mmpt? -53.84 -41.63 67.62 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.06 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.904 ' HB3' HG11 ' A' ' 178' ' ' VAL . 3.8 mm? -87.0 -24.01 24.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.97 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 12.6 t -62.63 -30.47 71.38 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.81 0.338 . . . . 0.0 110.42 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 38.7 m170 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.265 179.784 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 121.028 0.442 . . . . 0.0 110.972 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.759 ' HB2' HD13 ' A' ' 134' ' ' LEU . 81.8 m95 -73.4 168.34 19.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.069 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.82 136.64 41.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.489 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.64 105.38 4.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.683 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.86 HD11 HG22 ' A' ' 168' ' ' THR . 47.8 pt -95.13 -7.68 9.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.574 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.519 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -159.34 177.06 11.4 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 120.481 0.181 . . . . 0.0 110.589 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.476 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 30.3 m-85 -144.69 126.0 14.79 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.566 HG21 HD11 ' A' ' 139' ' ' LEU . 4.2 t -93.27 122.27 44.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.165 0.507 . . . . 0.0 111.416 -179.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.49 ' CE1' ' CE1' ' A' ' 130' ' ' PHE . 11.1 t80 -84.07 94.22 8.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.79 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -142.56 152.55 42.71 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.408 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 58.77 30.31 19.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.99 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 64.11 34.31 11.26 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.357 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.464 HG23 ' O ' ' A' ' 145' ' ' THR . 52.9 m -153.92 152.87 31.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.825 0.345 . . . . 0.0 111.135 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.692 ' CE2' ' HB2' ' A' ' 148' ' ' ALA . 11.1 m-85 -94.41 90.92 6.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.836 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.529 ' HB2' HD21 ' A' ' 139' ' ' LEU . 27.2 m-85 -71.17 110.83 8.12 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.794 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.429 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 49.5 Cg_exo -55.41 121.34 9.75 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 122.39 2.06 . . . . 0.0 112.73 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.713 HD21 ' OG1' ' A' ' 168' ' ' THR . 30.3 tp -101.42 123.82 46.1 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.43 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.759 HD13 ' HB2' ' A' ' 118' ' ' TRP . 46.4 mt -70.72 174.13 6.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.577 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.414 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.3 pt-20 -64.63 -29.28 70.28 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.079 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -90.07 12.62 17.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.192 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.631 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 74.96 16.73 80.39 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.111 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.7 ' HB3' HD12 ' A' ' 134' ' ' LEU . 9.2 tpt180 -74.85 93.53 2.65 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.566 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -68.35 121.29 15.98 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.631 -178.906 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -90.97 73.48 6.44 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.696 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.476 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 7.7 mttt -61.46 -16.11 43.85 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.995 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -94.7 -24.18 17.25 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -101.32 27.62 6.07 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.429 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -61.59 159.39 30.62 Favored Glycine 0 CA--C 1.508 -0.358 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.711 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.464 ' O ' HG23 ' A' ' 129' ' ' THR . 8.0 t -130.65 157.53 42.52 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.971 0.415 . . . . 0.0 110.877 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -94.69 50.34 1.32 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.577 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.98 149.81 3.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.583 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.692 ' HB2' ' CE2' ' A' ' 130' ' ' PHE . . . -93.66 125.77 52.32 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.387 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.476 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 60.6 Cg_endo -82.12 111.78 2.2 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.243 1.962 . . . . 0.0 112.339 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 11.6 t -69.5 -7.96 42.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.12 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -78.36 -23.32 46.94 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 120.717 0.294 . . . . 0.0 110.507 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.664 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -140.23 166.84 20.66 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.765 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.664 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 65.2 Cg_endo -74.85 156.11 43.67 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.384 2.056 . . . . 0.0 112.304 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 9.3 t -116.68 110.44 31.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.192 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.868 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.41 95.93 1.83 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.577 179.0 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 46.6 t -92.58 137.15 22.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.98 0.419 . . . . 0.0 111.162 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 48.73 57.78 8.2 Favored Glycine 0 CA--C 1.52 0.382 0 CA-C-N 115.893 -0.594 . . . . 0.0 113.304 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.868 ' CE2' HD23 ' A' ' 155' ' ' LEU . 2.9 m95 -100.69 151.17 21.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.198 0.523 . . . . 0.0 111.536 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -65.34 -172.43 0.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.459 179.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -43.74 154.69 0.09 Allowed 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.558 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -56.79 -25.15 51.46 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.327 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.22 -38.84 84.61 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 120.951 0.405 . . . . 0.0 110.087 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.62 -40.31 49.71 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.081 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.558 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.5 mt -59.17 -41.67 84.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.035 179.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.34 -30.9 53.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.23 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.422 ' HB3' HG21 ' A' ' 211' ' ' ILE . 5.4 mm-40 -67.83 -53.23 28.53 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.4 0.619 . . . . 0.0 109.968 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.808 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -59.53 -45.45 91.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.936 178.939 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.86 HG22 HD11 ' A' ' 121' ' ' ILE . 0.3 OUTLIER -56.75 -37.95 71.74 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.555 179.172 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.9 -37.38 92.51 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 178.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -70.94 -48.24 54.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.41 -0.395 . . . . 0.0 110.785 178.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.629 HD11 ' CE1' ' A' ' 214' ' ' PHE . 11.2 mp -64.89 -28.76 69.76 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.797 0.332 . . . . 0.0 111.23 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.31 -18.94 63.87 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.229 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -111.49 -28.64 8.09 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.669 0.271 . . . . 0.0 111.372 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.61 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.1 OUTLIER -56.85 166.86 1.21 Allowed Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.135 -179.658 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.28 128.0 15.82 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.225 1.95 . . . . 0.0 112.918 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.34 -26.29 11.86 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.541 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -58.42 -48.63 80.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.923 0.392 . . . . 0.0 110.88 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.855 HG11 ' HB3' ' A' ' 218' ' ' LEU . 33.7 t -73.7 -33.52 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.406 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.57 HD13 ' CD2' ' A' ' 174' ' ' LEU . 6.4 tp -57.44 -36.21 71.1 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 121.122 0.487 . . . . 0.0 109.818 179.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -76.42 -42.04 23.79 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.296 178.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -84.36 103.12 13.26 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.977 0.418 . . . . 0.0 110.584 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . 0.853 ' CE ' HG12 ' A' ' 178' ' ' VAL . 3.0 mtm 178.74 169.57 0.87 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.008 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.13 -55.32 1.47 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.733 0.301 . . . . 0.0 111.082 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -163.23 142.32 8.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.928 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.897 HG12 HG12 ' A' ' 199' ' ' VAL . 12.4 mt -104.78 114.38 44.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.229 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 23.3 m170 -103.81 126.32 50.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.191 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.423 ' HE1' HD11 ' A' ' 211' ' ' ILE . 46.0 t80 -79.21 104.09 9.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.2 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.764 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 . . . . . 0 N--CA 1.462 0.171 0 CA-C-O 120.669 0.271 . . . . 0.0 111.351 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -106.57 38.52 2.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.754 0.311 . . . . 0.0 110.71 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 4.0 tpt180 -90.26 118.7 29.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.065 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.854 ' O ' HD13 ' A' ' 198' ' ' ILE . 25.5 m -117.51 165.94 12.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.915 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.854 HD13 ' O ' ' A' ' 197' ' ' VAL . 21.1 mm -134.56 107.45 9.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.149 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.897 HG12 HG12 ' A' ' 185' ' ' ILE . 8.4 m -96.12 123.84 48.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.985 0.421 . . . . 0.0 110.997 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -83.54 152.62 24.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.748 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 4.3 mmt -108.55 152.39 24.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.895 0.379 . . . . 0.0 110.947 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 39.2 m-20 -60.11 -26.35 66.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.196 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -89.77 14.54 11.6 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.89 0.329 . . . . 0.0 111.89 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 81.13 14.41 79.18 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.373 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.42 154.59 22.7 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 117.028 0.414 . . . . 0.0 110.78 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -125.1 111.36 15.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.841 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 26.2 t -112.79 123.76 68.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.004 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . 0.634 ' OG ' HD12 ' A' ' 198' ' ' ILE . 58.2 m -97.7 114.7 26.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.676 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.659 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -127.28 162.23 26.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.955 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.91 156.18 17.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.555 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.423 HD11 ' HE1' ' A' ' 187' ' ' TYR . 48.9 mt -63.49 -29.73 48.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.784 0.326 . . . . 0.0 110.953 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -74.63 -39.74 61.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.343 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -118.86 36.74 4.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.86 0.362 . . . . 0.0 111.016 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.629 ' CE1' HD11 ' A' ' 171' ' ' LEU . 11.6 t80 -66.69 -53.3 35.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.738 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.55 -37.22 86.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.757 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.9 -51.76 44.29 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.205 0.526 . . . . 0.0 110.463 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 8.4 mmmt -54.23 -43.35 70.8 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.094 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.855 ' HB3' HG11 ' A' ' 178' ' ' VAL . 4.2 mm? -83.59 -23.67 31.84 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.114 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.41 -34.14 74.87 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.056 0.455 . . . . 0.0 109.834 178.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 . . . . . 0 CA--C 1.533 0.299 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.087 179.139 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.995 0.426 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.754 ' HB2' HD13 ' A' ' 134' ' ' LEU . 79.3 m95 -70.34 168.3 16.27 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.044 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.78 138.08 40.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.517 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.33 105.71 4.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.858 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.87 HD11 HG22 ' A' ' 168' ' ' THR . 49.4 pt -95.36 -6.64 9.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.604 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.493 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -159.75 176.83 11.49 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 120.553 0.216 . . . . 0.0 110.571 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.473 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 34.6 m-85 -144.64 126.11 14.94 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.622 HG21 HD11 ' A' ' 139' ' ' LEU . 3.7 t -93.16 122.28 44.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.101 0.477 . . . . 0.0 111.41 -179.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.482 ' CE1' ' CE1' ' A' ' 130' ' ' PHE . 15.8 t80 -83.05 93.96 7.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.669 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -144.73 153.06 41.29 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.352 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 60.2 29.35 18.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.758 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 62.36 34.51 15.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.863 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.4 ' CG2' ' N ' ' A' ' 145' ' ' THR . 45.2 m -152.47 156.23 39.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.059 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.648 ' CE2' ' HB2' ' A' ' 148' ' ' ALA . 19.0 m-85 -97.93 91.43 5.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.225 0.536 . . . . 0.0 110.866 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.525 ' HB2' HD21 ' A' ' 139' ' ' LEU . 27.8 m-85 -72.0 115.04 34.33 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.613 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.419 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 33.3 Cg_exo -61.16 117.07 3.82 Favored 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 122.422 2.082 . . . . 0.0 112.672 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.677 HD21 ' OG1' ' A' ' 168' ' ' THR . 30.6 tp -96.77 124.01 40.63 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.414 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.754 HD13 ' HB2' ' A' ' 118' ' ' TRP . 52.1 mt -70.5 174.45 5.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.645 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.409 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 2.0 pt-20 -65.11 -29.26 70.11 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.099 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 51.3 p-10 -89.68 11.88 18.56 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.254 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.636 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 75.08 19.02 80.08 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.856 -0.688 . . . . 0.0 113.007 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.709 ' HB3' HD12 ' A' ' 134' ' ' LEU . 1.2 tpt180 -77.36 93.2 4.01 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.622 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -68.32 121.48 16.36 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.806 -178.791 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.492 HD12 ' HG2' ' A' ' 143' ' ' GLU . 3.8 mm? -90.29 73.4 7.08 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.394 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.456 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 6.0 mttp -61.58 -15.61 40.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.302 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -98.52 -21.57 16.45 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.492 ' HG2' HD12 ' A' ' 140' ' ' LEU . 39.0 mm-40 -101.06 27.7 5.88 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.419 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -62.09 160.36 31.03 Favored Glycine 0 CA--C 1.51 -0.267 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.824 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.4 ' N ' ' CG2' ' A' ' 129' ' ' THR . 9.7 t -131.28 156.36 45.58 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.987 0.422 . . . . 0.0 110.729 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -93.11 51.0 1.6 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.735 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.1 151.23 3.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.573 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.648 ' HB2' ' CE2' ' A' ' 130' ' ' PHE . . . -95.14 125.64 49.59 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.39 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.473 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 73.9 Cg_endo -83.13 111.02 1.84 Allowed 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.355 2.037 . . . . 0.0 112.299 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 22.3 t -69.28 -8.12 43.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.163 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -77.85 -23.61 48.85 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 120.861 0.362 . . . . 0.0 110.607 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.668 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -138.11 166.71 23.89 Favored Pre-proline 0 N--CA 1.453 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.845 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.668 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 65.5 Cg_endo -74.67 157.93 43.79 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.444 2.096 . . . . 0.0 112.105 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 12.5 t -118.47 110.09 29.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.0 0.428 . . . . 0.0 111.369 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.854 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.61 95.95 1.91 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.644 179.054 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.432 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 61.6 t -92.54 136.66 24.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.09 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 48.59 57.07 8.74 Favored Glycine 0 CA--C 1.521 0.41 0 CA-C-N 115.891 -0.595 . . . . 0.0 113.319 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.854 ' CE2' HD23 ' A' ' 155' ' ' LEU . 3.5 m95 -99.91 151.14 21.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.175 0.512 . . . . 0.0 111.65 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.37 -172.22 0.15 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.553 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -43.4 154.27 0.09 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.268 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.56 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.16 -24.94 53.07 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.238 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -59.98 -40.72 90.09 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.871 0.367 . . . . 0.0 110.124 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -75.12 -40.34 59.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.982 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.56 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.8 mt -58.89 -41.99 84.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.971 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.71 -31.54 48.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.087 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -67.23 -52.96 34.58 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.575 0.702 . . . . 0.0 109.885 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.802 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -60.26 -44.42 95.32 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.013 178.865 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.87 HG22 HD11 ' A' ' 121' ' ' ILE . 0.3 OUTLIER -57.02 -38.11 72.66 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.484 179.171 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.18 -37.78 93.44 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 46.9 mm-40 -69.45 -48.69 60.07 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.408 -0.396 . . . . 0.0 110.92 178.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.602 HD11 ' CE1' ' A' ' 214' ' ' PHE . 9.9 mp -64.61 -29.35 70.36 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.758 0.313 . . . . 0.0 111.191 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.44 -20.28 64.63 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.368 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -110.91 -26.58 9.23 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.601 0.238 . . . . 0.0 111.414 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.673 ' CD2' HD13 ' A' ' 179' ' ' LEU . 0.1 OUTLIER -57.85 166.32 1.99 Allowed Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.898 -179.754 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.52 128.29 16.03 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.26 1.973 . . . . 0.0 112.94 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.24 -25.95 10.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.53 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -58.63 -48.65 80.3 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.877 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.85 HG11 ' HB3' ' A' ' 218' ' ' LEU . 32.3 t -73.81 -33.31 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.417 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.673 HD13 ' CD2' ' A' ' 174' ' ' LEU . 10.2 tp -56.71 -35.29 68.35 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 121.126 0.489 . . . . 0.0 110.047 179.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -79.5 -40.1 16.45 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.232 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -85.65 103.14 14.19 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 120.93 0.395 . . . . 0.0 110.556 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . 0.838 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.8 mtm 177.35 170.8 0.58 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.158 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.48 -56.81 1.49 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.721 0.296 . . . . 0.0 111.063 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -163.16 142.7 8.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.047 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.922 HG12 HG12 ' A' ' 199' ' ' VAL . 13.8 mt -103.03 115.11 44.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.484 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . 0.432 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 21.6 m170 -105.75 125.43 50.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.205 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -78.48 104.73 9.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.335 179.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.424 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.722 0.296 . . . . 0.0 111.419 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -105.14 36.88 2.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.777 0.322 . . . . 0.0 110.782 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 4.6 tpt180 -90.5 115.61 27.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.108 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.871 ' O ' HD13 ' A' ' 198' ' ' ILE . 25.0 m -112.97 167.34 6.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.717 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.871 HD13 ' O ' ' A' ' 197' ' ' VAL . 20.6 mm -135.22 106.75 7.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.457 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.922 HG12 HG12 ' A' ' 185' ' ' ILE . 7.7 m -95.86 125.72 48.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.924 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -86.12 152.2 23.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.698 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.52 152.8 23.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.858 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -58.41 -23.84 58.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.418 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -89.99 15.35 10.2 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 78.16 14.41 82.28 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.508 -0.853 . . . . 0.0 113.13 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -82.83 166.47 18.95 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 117.07 0.435 . . . . 0.0 110.749 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -133.54 114.54 13.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.973 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.3 t -115.96 126.07 73.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.087 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 2.8 p -99.14 115.68 29.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.767 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.67 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -126.37 159.26 33.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.73 154.8 18.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.569 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 32.6 mt -64.02 -34.08 66.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.018 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -67.62 -40.51 84.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.4 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -125.28 43.53 3.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.88 0.372 . . . . 0.0 110.967 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.602 ' CE1' HD11 ' A' ' 171' ' ' LEU . 12.5 t80 -67.93 -53.34 27.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.836 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.72 -38.13 77.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.211 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.92 -48.45 65.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.99 0.424 . . . . 0.0 110.559 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.16 -43.77 70.89 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.094 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.85 ' HB3' HG11 ' A' ' 178' ' ' VAL . 4.0 mm? -84.53 -25.24 28.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.982 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 11.8 t -61.21 -31.36 71.14 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 120.822 0.344 . . . . 0.0 110.454 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 1.5 m170 . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.095 179.674 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 121.076 0.465 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.755 ' HB2' HD13 ' A' ' 134' ' ' LEU . 80.6 m95 -70.73 168.31 16.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.143 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -101.94 134.8 44.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.561 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 26.5 mtt180 -71.3 106.61 3.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.837 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.873 HD11 HG22 ' A' ' 168' ' ' THR . 47.5 pt -96.92 -6.38 9.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.494 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.565 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -160.64 176.25 11.76 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 121.08 -0.248 . . . . 0.0 110.88 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.481 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 37.5 m-85 -145.91 127.57 15.2 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.674 HG21 HD11 ' A' ' 139' ' ' LEU . 4.0 t -92.82 122.47 44.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.075 0.464 . . . . 0.0 111.445 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.492 ' CE1' ' CZ ' ' A' ' 130' ' ' PHE . 9.5 t80 -85.12 100.93 12.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.925 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -154.16 154.22 33.17 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.489 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 8.1 tpp180 60.69 31.47 20.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.721 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 62.27 32.08 17.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.945 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.452 HG22 ' N ' ' A' ' 130' ' ' PHE . 50.1 m -151.03 161.74 42.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.234 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.492 ' CZ ' ' CE1' ' A' ' 125' ' ' TYR . 87.0 m-85 -106.87 90.67 3.38 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.235 0.54 . . . . 0.0 110.841 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.563 ' HB2' HD21 ' A' ' 139' ' ' LEU . 20.7 m-85 -66.77 124.65 89.08 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.508 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.45 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 13.7 Cg_exo -68.6 123.29 10.31 Favored 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 122.327 2.018 . . . . 0.0 112.343 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.7 HD21 ' OG1' ' A' ' 168' ' ' THR . 36.9 tp -104.2 123.57 47.55 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.565 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.755 HD13 ' HB2' ' A' ' 118' ' ' TRP . 50.6 mt -72.69 173.07 9.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.733 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.414 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.5 pt-20 -63.02 -29.69 71.02 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.001 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 39.6 p-10 -89.84 11.91 18.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.143 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.648 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 74.93 19.27 80.02 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.183 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.688 ' HB3' HD12 ' A' ' 134' ' ' LEU . 13.8 tpp180 -76.69 95.68 4.04 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.674 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -70.71 122.46 19.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.913 -178.8 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -95.31 71.34 3.23 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.599 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.459 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 27.8 mttt -58.59 -19.76 41.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.78 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -89.46 -23.69 22.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.742 -0.208 . . . . 0.0 111.434 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -99.22 25.06 7.2 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.45 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -57.58 161.87 9.1 Favored Glycine 0 CA--C 1.51 -0.265 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.597 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 10.7 t -135.78 150.46 49.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.503 -0.348 . . . . 0.0 110.717 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.444 ' HE2' HG23 ' A' ' 129' ' ' THR . 3.5 mmtt -89.81 52.05 2.22 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.017 0.437 . . . . 0.0 110.62 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.92 149.05 2.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.678 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -93.91 125.52 52.75 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.153 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.481 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 72.0 Cg_endo -84.22 109.72 1.45 Allowed 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.486 2.124 . . . . 0.0 112.567 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.2 t -69.77 -7.73 42.1 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.101 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -78.16 -22.95 47.95 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.79 0.329 . . . . 0.0 110.551 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.674 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -139.59 166.9 20.91 Favored Pre-proline 0 N--CA 1.453 -0.282 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.758 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.718 ' HD3' HD23 ' A' ' 179' ' ' LEU . 61.0 Cg_endo -74.37 153.8 45.33 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.4 2.067 . . . . 0.0 112.194 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 12.2 t -115.67 109.51 28.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.222 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.861 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.55 95.74 1.86 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.534 178.881 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 55.3 t -92.33 136.99 23.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.956 0.407 . . . . 0.0 111.014 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 47.9 58.67 6.74 Favored Glycine 0 CA--C 1.521 0.416 0 CA-C-N 115.954 -0.567 . . . . 0.0 113.24 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.861 ' CE2' HD23 ' A' ' 155' ' ' LEU . 2.4 m95 -100.83 151.2 22.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.102 0.477 . . . . 0.0 111.828 -179.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -172.58 0.06 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.448 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -44.74 155.15 0.11 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.084 0.468 . . . . 0.0 112.173 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.564 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.42 -25.54 55.07 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.261 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.95 -39.42 85.52 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 120.991 0.424 . . . . 0.0 110.213 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -75.93 -40.75 53.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.184 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.564 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.2 mt -58.34 -41.48 81.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.045 179.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.14 -31.78 53.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.255 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -67.83 -53.08 29.74 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-O 121.517 0.675 . . . . 0.0 110.05 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.798 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -59.17 -45.74 90.22 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.002 178.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.873 HG22 HD11 ' A' ' 121' ' ' ILE . 0.5 OUTLIER -56.26 -38.63 71.41 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.643 179.075 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -58.77 -38.45 92.09 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 178.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 45.1 mm-40 -69.56 -48.37 60.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.315 -0.442 . . . . 0.0 110.902 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.618 HD11 ' CE1' ' A' ' 214' ' ' PHE . 10.8 mp -64.08 -29.85 70.96 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.724 0.297 . . . . 0.0 111.113 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -67.68 -19.96 65.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.259 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -111.22 -26.0 9.41 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.609 0.242 . . . . 0.0 111.424 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.557 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.1 OUTLIER -57.4 166.6 1.58 Allowed Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.079 -179.607 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.83 129.03 15.83 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.358 2.039 . . . . 0.0 112.707 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.19 -25.79 5.96 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.666 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.95 -49.82 75.48 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.953 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.925 HG11 ' HB3' ' A' ' 218' ' ' LEU . 34.8 t -74.07 -34.65 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.502 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.718 HD23 ' HD3' ' A' ' 153' ' ' PRO . 0.7 OUTLIER -56.47 -37.78 70.79 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.093 0.473 . . . . 0.0 110.063 179.276 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -78.92 -36.17 29.16 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.356 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -90.17 103.18 15.88 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.931 0.396 . . . . 0.0 110.846 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . 0.836 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.7 mtm 177.66 173.99 0.53 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.034 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.97 -54.8 1.21 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.665 0.269 . . . . 0.0 111.168 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -163.14 142.83 8.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.959 0.409 . . . . 0.0 111.11 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.888 HG12 HG12 ' A' ' 199' ' ' VAL . 13.3 mt -104.8 114.98 45.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.454 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -103.32 123.66 47.2 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.155 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.437 ' HB2' ' CD2' ' A' ' 158' ' ' TRP . 65.9 t80 -81.58 104.33 11.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.375 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.667 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.165 0 CA-C-O 120.654 0.264 . . . . 0.0 111.646 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 11.3 p30 -109.47 38.98 2.19 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.861 0.362 . . . . 0.0 110.734 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 11.8 ttt-85 -91.47 117.16 29.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.18 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.857 ' O ' HD13 ' A' ' 198' ' ' ILE . 28.9 m -113.48 167.13 6.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.676 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.857 HD13 ' O ' ' A' ' 197' ' ' VAL . 17.0 mm -134.81 107.34 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.726 0.298 . . . . 0.0 111.363 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.888 HG12 HG12 ' A' ' 185' ' ' ILE . 11.9 m -98.04 134.87 34.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.927 0.394 . . . . 0.0 110.886 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -96.46 152.64 18.42 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.803 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 24.3 tpp -107.17 152.92 23.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.556 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -54.99 -24.45 24.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.784 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -90.44 15.55 10.5 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 79.24 14.54 81.55 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.544 -0.836 . . . . 0.0 113.047 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -77.99 157.8 29.52 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.929 0.395 . . . . 0.0 110.771 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -129.59 111.2 12.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.837 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.41 136.42 51.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.161 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 50.0 m -106.15 111.92 24.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.674 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -118.86 175.58 5.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.935 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.77 154.54 32.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.389 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 35.8 mt -66.61 -30.26 49.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.724 0.297 . . . . 0.0 110.859 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.61 -31.41 63.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.322 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -132.81 42.27 3.09 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.907 0.384 . . . . 0.0 110.96 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.618 ' CE1' HD11 ' A' ' 171' ' ' LEU . 11.7 t80 -68.3 -52.64 31.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.739 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.36 -39.44 87.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.892 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.18 -51.63 43.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.218 0.533 . . . . 0.0 110.243 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.91 -41.67 67.9 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.237 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.925 ' HB3' HG11 ' A' ' 178' ' ' VAL . 4.1 mm? -85.8 -23.13 27.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.061 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.03 -33.54 74.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.976 0.417 . . . . 0.0 110.144 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 21.1 m170 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.421 179.823 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 121.076 0.465 . . . . 0.0 111.048 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.761 ' HB2' HD13 ' A' ' 134' ' ' LEU . 84.9 m95 -66.18 168.31 8.75 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.007 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -100.72 136.33 40.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.391 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 5.9 mtm180 -72.35 107.33 4.89 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.762 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.886 HD11 HG22 ' A' ' 168' ' ' THR . 47.1 pt -96.89 -8.61 9.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.339 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.564 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -158.25 175.8 13.29 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 120.572 0.225 . . . . 0.0 110.672 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.478 ' CD1' ' CG ' ' A' ' 149' ' ' PRO . 30.4 m-85 -144.59 126.37 15.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.26 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.703 HG21 HD11 ' A' ' 139' ' ' LEU . 4.2 t -93.53 123.1 45.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.986 0.422 . . . . 0.0 111.294 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.491 ' CE1' ' CE1' ' A' ' 130' ' ' PHE . 7.0 t80 -84.61 105.38 15.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.842 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -159.77 154.44 24.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.673 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 60.57 30.96 20.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.914 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 62.05 31.87 17.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.136 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.527 HG23 ' O ' ' A' ' 145' ' ' THR . 89.3 m -153.72 150.16 28.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.987 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.842 ' CE2' ' HB2' ' A' ' 148' ' ' ALA . 54.1 m-85 -93.94 90.95 6.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.103 0.478 . . . . 0.0 110.705 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.554 ' HB2' HD21 ' A' ' 139' ' ' LEU . 22.3 m-85 -65.55 126.02 90.77 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.324 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.85 117.3 5.06 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 122.189 1.926 . . . . 0.0 112.441 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.67 HD21 ' OG1' ' A' ' 168' ' ' THR . 32.0 tp -96.59 124.02 40.45 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.731 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.761 HD13 ' HB2' ' A' ' 118' ' ' TRP . 54.0 mt -71.35 174.12 6.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.632 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.413 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.3 pt-20 -64.59 -29.45 70.47 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.091 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 48.4 p-10 -88.91 11.15 18.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.215 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.637 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 74.58 22.53 77.12 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.847 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.69 ' HB3' HD12 ' A' ' 134' ' ' LEU . 15.5 tpp85 -80.49 95.95 6.62 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.703 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -73.28 106.1 4.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.232 -179.215 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 13.3 mt -85.51 72.41 10.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.335 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.448 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 33.6 mttt -56.2 -21.23 21.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.896 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -82.87 -22.62 33.96 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -103.11 28.58 6.17 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . -64.16 163.84 33.67 Favored Glycine 0 CA--C 1.511 -0.169 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.699 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.527 ' O ' HG23 ' A' ' 129' ' ' THR . 9.2 t -132.09 157.03 45.24 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.504 -0.348 . . . . 0.0 110.529 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.6 mmtp -92.21 48.55 1.42 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.091 0.472 . . . . 0.0 110.554 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -171.26 154.55 4.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.438 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.842 ' HB2' ' CE2' ' A' ' 130' ' ' PHE . . . -99.31 126.52 37.5 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.076 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.478 ' CG ' ' CD1' ' A' ' 123' ' ' TYR . 72.2 Cg_endo -82.39 112.38 2.2 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.36 2.04 . . . . 0.0 112.702 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 28.0 t -69.82 -7.71 42.22 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.518 -0.764 . . . . 0.0 112.0 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -76.1 -22.82 55.11 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 120.779 0.323 . . . . 0.0 110.447 179.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.699 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -139.77 167.7 17.59 Favored Pre-proline 0 N--CA 1.452 -0.334 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.721 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.699 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 61.5 Cg_endo -73.98 154.36 47.73 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.364 2.042 . . . . 0.0 112.332 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 10.1 t -116.66 110.44 31.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.971 0.415 . . . . 0.0 111.088 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.856 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.55 95.94 1.89 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.584 179.058 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.42 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 51.3 t -91.24 136.74 23.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.028 0.442 . . . . 0.0 111.106 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 48.56 58.59 7.29 Favored Glycine 0 CA--C 1.52 0.392 0 CA-C-N 115.816 -0.629 . . . . 0.0 113.259 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.856 ' CE2' HD23 ' A' ' 155' ' ' LEU . 3.2 m95 -102.13 151.12 22.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.186 0.517 . . . . 0.0 111.721 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.89 -172.07 0.17 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.548 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -42.71 154.22 0.07 Allowed 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.526 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.08 -24.89 52.62 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.163 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.56 -39.65 84.74 Favored 'General case' 0 C--O 1.23 0.074 0 CA-C-O 120.916 0.388 . . . . 0.0 110.007 179.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.05 -40.03 54.21 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.917 178.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.526 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.3 mt -59.73 -41.68 86.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.873 179.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.13 -30.97 50.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.228 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.406 ' CB ' HG21 ' A' ' 211' ' ' ILE . 17.5 mm-40 -66.97 -53.01 35.77 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-O 121.491 0.662 . . . . 0.0 110.05 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.822 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -59.94 -44.78 94.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.905 178.914 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.886 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -58.34 -37.17 74.63 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.454 179.223 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.88 -37.68 92.93 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 178.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 35.0 mm-40 -72.87 -46.47 52.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.401 -0.399 . . . . 0.0 111.029 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.584 ' HA ' HD22 ' A' ' 174' ' ' LEU . 10.9 mp -65.92 -28.71 69.13 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.622 0.248 . . . . 0.0 111.323 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.88 -21.07 64.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.336 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -110.45 -26.19 9.65 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.588 0.232 . . . . 0.0 111.496 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.584 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.1 OUTLIER -57.55 166.51 1.71 Allowed Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.107 -179.684 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -70.09 128.08 15.22 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.305 2.003 . . . . 0.0 112.798 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.07 -25.78 5.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.726 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.71 -50.08 74.41 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.898 0.38 . . . . 0.0 111.012 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.869 HG11 ' HB3' ' A' ' 218' ' ' LEU . 41.5 t -74.25 -34.9 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.495 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.646 HD21 ' O ' ' A' ' 121' ' ' ILE . 0.5 OUTLIER -57.19 -34.49 68.54 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.156 0.503 . . . . 0.0 109.842 179.096 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -79.47 -38.54 20.86 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 178.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -87.92 103.06 15.32 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.865 0.364 . . . . 0.0 110.75 179.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . 0.836 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.8 mtm 178.25 172.04 0.7 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.055 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -130.45 -52.61 1.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.677 0.275 . . . . 0.0 111.466 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -163.17 143.69 9.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.881 0.372 . . . . 0.0 111.135 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.905 HG12 HG12 ' A' ' 199' ' ' VAL . 15.7 mt -108.29 114.78 47.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.653 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . 0.42 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 23.5 m170 -105.77 129.33 53.98 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.057 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -79.33 104.81 10.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.444 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.584 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 . . . . . 0 CA--C 1.53 0.202 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . 0.448 ' OD1' HG22 ' A' ' 210' ' ' THR . 3.5 p30 -113.27 35.71 3.86 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.693 0.283 . . . . 0.0 111.13 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 2.0 ttt-85 -89.64 113.48 24.96 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.894 0.378 . . . . 0.0 111.318 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.845 ' O ' HD13 ' A' ' 198' ' ' ILE . 31.3 m -109.76 167.9 4.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.858 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.845 HD13 ' O ' ' A' ' 197' ' ' VAL . 22.4 mm -134.4 108.39 10.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.754 0.312 . . . . 0.0 111.278 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.905 HG12 HG12 ' A' ' 185' ' ' ILE . 11.2 m -97.51 137.52 24.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.989 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -98.26 152.82 19.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.79 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 27.9 tpp -110.77 153.65 25.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.831 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -55.92 -22.51 26.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.747 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -90.18 15.43 10.33 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 76.75 14.4 82.57 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.594 -0.813 . . . . 0.0 113.112 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -83.77 157.32 22.14 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 117.023 0.412 . . . . 0.0 110.729 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -127.69 111.47 13.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 20.6 t -111.44 130.54 64.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.942 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . 0.519 ' OG ' HD12 ' A' ' 198' ' ' ILE . 16.7 m -102.62 116.66 33.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.798 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.647 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -128.19 160.25 32.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.861 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.448 HG22 ' OD1' ' A' ' 195' ' ' ASP . 0.6 OUTLIER -96.69 155.68 16.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.561 179.84 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.406 HG21 ' CB ' ' A' ' 166' ' ' GLU . 32.0 mt -67.18 -31.06 51.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.02 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.93 -32.06 65.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.357 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -126.53 33.95 4.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.06 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.578 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 11.4 t80 -62.99 -53.91 46.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.708 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.78 -39.95 86.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.832 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.29 -51.27 46.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.098 0.475 . . . . 0.0 110.236 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.86 -44.03 73.63 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.859 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.869 ' HB3' HG11 ' A' ' 178' ' ' VAL . 4.1 mm? -80.69 -25.75 37.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.942 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.9 -33.15 72.67 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.045 0.45 . . . . 0.0 110.123 179.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 3.6 m170 . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.445 179.675 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 121.134 0.492 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.759 ' HB2' HD13 ' A' ' 134' ' ' LEU . 79.3 m95 -66.11 168.25 8.72 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.015 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -101.36 141.09 34.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.631 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.402 ' HG3' HD23 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -74.55 106.14 5.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.748 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.897 HD11 HG22 ' A' ' 168' ' ' THR . 50.9 pt -97.41 -7.04 9.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.299 179.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.471 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -162.42 175.29 11.68 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 120.597 0.237 . . . . 0.0 110.779 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.464 ' CD1' ' HG3' ' A' ' 149' ' ' PRO . 25.9 m-85 -144.12 127.11 16.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.097 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.709 HG21 HD11 ' A' ' 139' ' ' LEU . 4.9 t -93.14 122.36 44.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.119 0.485 . . . . 0.0 111.292 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.493 ' CE1' ' CE1' ' A' ' 130' ' ' PHE . 14.8 t80 -83.38 105.34 14.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.812 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -159.68 153.6 23.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.59 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.67 30.79 20.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.973 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 63.12 32.65 15.08 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.317 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 145' ' ' THR . 90.3 m -154.41 150.49 27.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.982 0.42 . . . . 0.0 111.087 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.711 ' CE2' ' HB2' ' A' ' 148' ' ' ALA . 22.6 m-85 -93.77 90.85 6.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.52 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.533 ' HB2' HD21 ' A' ' 139' ' ' LEU . 21.3 m-85 -65.35 121.03 72.58 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.329 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.402 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 37.5 Cg_endo -67.62 118.11 5.35 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.215 1.943 . . . . 0.0 112.544 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.645 HD11 ' HA2' ' A' ' 137' ' ' GLY . 48.6 tp -99.66 124.69 45.13 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.953 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.759 HD13 ' HB2' ' A' ' 118' ' ' TRP . 52.7 mt -72.91 177.14 5.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.727 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.416 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.4 pt-20 -67.12 -28.77 68.43 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.118 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -89.71 12.45 16.95 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.167 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.654 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 72.25 23.95 77.15 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.741 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.696 ' HB3' HD12 ' A' ' 134' ' ' LEU . 1.3 tpt180 -81.14 97.66 7.68 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 178.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.709 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -75.89 112.44 12.3 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.232 -179.031 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 12.7 mt -92.69 72.16 4.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.179 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.453 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 39.4 mttt -55.21 -22.25 17.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.814 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -82.34 -24.06 34.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.191 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -100.2 27.05 5.91 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.417 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . -63.68 163.62 32.15 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.752 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.49 ' O ' HG23 ' A' ' 129' ' ' THR . 10.0 t -132.34 155.3 48.64 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.83 0.348 . . . . 0.0 110.714 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.8 mmtp -92.58 49.74 1.51 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.089 0.471 . . . . 0.0 110.494 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -171.13 153.73 3.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.613 -179.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.711 ' HB2' ' CE2' ' A' ' 130' ' ' PHE . . . -97.06 125.75 44.88 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.328 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.464 ' HG3' ' CD1' ' A' ' 123' ' ' TYR . 74.3 Cg_endo -83.2 111.76 1.9 Allowed 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.392 2.062 . . . . 0.0 112.533 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 29.1 t -69.87 -7.77 43.0 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.958 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -77.14 -23.22 51.72 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 120.763 0.316 . . . . 0.0 110.423 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.665 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -140.07 166.82 21.02 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.682 -179.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.665 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 69.1 Cg_endo -75.05 154.27 42.12 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.348 2.032 . . . . 0.0 112.34 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 9.0 t -114.56 110.91 33.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.139 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.858 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.61 95.96 1.91 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.536 179.069 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 50.1 t -91.48 137.18 22.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.053 0.454 . . . . 0.0 111.194 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 48.06 57.85 7.56 Favored Glycine 0 CA--C 1.521 0.459 0 CA-C-N 115.858 -0.61 . . . . 0.0 113.325 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.858 ' CE2' HD23 ' A' ' 155' ' ' LEU . 3.0 m95 -100.58 151.15 21.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.107 0.48 . . . . 0.0 111.782 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.32 -172.36 0.1 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.596 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -43.92 153.79 0.12 Allowed 'General case' 0 C--O 1.235 0.337 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.552 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -56.73 -25.16 50.97 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.261 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -60.29 -38.35 83.33 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.884 0.374 . . . . 0.0 110.109 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.96 -40.33 47.32 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.956 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.552 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.1 mt -58.53 -42.06 83.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.983 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.71 -30.19 42.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.299 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.45 ' CB ' HG21 ' A' ' 211' ' ' ILE . 14.2 mm-40 -68.26 -52.86 29.19 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.391 0.615 . . . . 0.0 110.016 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.788 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -60.7 -43.86 97.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.998 178.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.897 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -58.2 -36.54 73.26 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.291 179.206 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.66 -39.4 96.52 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 110.509 -1.037 . . . . 0.0 110.509 178.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 54.6 mm-40 -69.62 -46.33 66.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.407 -0.396 . . . . 0.0 110.839 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.593 ' HA ' HD22 ' A' ' 174' ' ' LEU . 10.9 mp -66.01 -28.29 68.76 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.693 0.283 . . . . 0.0 111.363 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.1 -18.65 63.26 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.345 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -112.79 -27.29 8.2 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.622 0.249 . . . . 0.0 111.576 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.593 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER -57.13 167.01 1.25 Allowed Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.072 -179.745 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.29 127.81 15.53 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.198 1.932 . . . . 0.0 112.831 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.61 -25.77 7.6 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.652 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.97 -49.46 76.74 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.871 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.881 HG11 ' HB3' ' A' ' 218' ' ' LEU . 24.5 t -74.01 -32.98 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.469 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.445 HD12 ' HA ' ' A' ' 179' ' ' LEU . 11.7 tp -57.24 -36.35 70.82 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 121.194 0.521 . . . . 0.0 109.865 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -77.35 -40.86 22.56 Favored Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.301 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -84.94 103.07 13.66 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.877 0.37 . . . . 0.0 110.658 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . 0.85 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.8 mtm 177.31 162.63 0.5 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.033 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -120.9 -54.24 2.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.752 0.311 . . . . 0.0 111.267 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -162.38 142.94 10.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.814 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.896 HG12 HG12 ' A' ' 199' ' ' VAL . 16.2 mt -106.9 114.51 46.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.55 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 21.4 m170 -103.6 119.39 38.81 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.245 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.422 ' HB2' ' CD2' ' A' ' 158' ' ' TRP . 33.1 t80 -75.97 104.49 6.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.46 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.722 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 . . . . . 0 CA--C 1.529 0.163 0 CA-C-O 120.606 0.241 . . . . 0.0 111.596 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -108.95 38.47 2.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.802 0.334 . . . . 0.0 110.93 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -91.27 118.47 30.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.089 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.88 ' O ' HD13 ' A' ' 198' ' ' ILE . 21.2 m -115.63 167.81 7.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.863 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.88 HD13 ' O ' ' A' ' 197' ' ' VAL . 19.1 mm -135.31 109.49 10.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.799 0.333 . . . . 0.0 111.059 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.896 HG12 HG12 ' A' ' 185' ' ' ILE . 7.0 m -97.62 120.88 47.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.038 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -82.05 152.73 26.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.769 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.99 149.81 28.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.727 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -58.86 -29.12 66.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.168 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -80.87 1.76 29.43 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.983 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 92.1 14.43 56.14 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.466 -0.873 . . . . 0.0 113.184 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -86.69 162.32 17.96 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 117.067 0.434 . . . . 0.0 110.952 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -130.75 111.52 12.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.812 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.427 ' HB ' HG23 ' A' ' 199' ' ' VAL . 21.7 t -111.32 131.42 62.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.115 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . 0.545 ' OG ' HD12 ' A' ' 198' ' ' ILE . 35.8 m -103.34 116.29 32.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.78 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.685 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -129.69 159.53 36.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.86 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.37 157.08 17.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.572 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.45 HG21 ' CB ' ' A' ' 166' ' ' GLU . 48.9 mt -67.44 -33.47 62.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.875 0.369 . . . . 0.0 110.848 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.73 -33.99 77.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.41 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -132.92 38.73 3.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.834 0.349 . . . . 0.0 111.148 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.582 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 11.0 t80 -62.52 -49.73 74.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.926 0.393 . . . . 0.0 110.637 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.97 -38.59 91.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.187 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -68.69 -50.56 49.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.022 0.439 . . . . 0.0 110.556 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 10.9 mmmt -53.43 -42.75 67.39 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.184 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.881 ' HB3' HG11 ' A' ' 178' ' ' VAL . 4.0 mm? -85.73 -23.46 27.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.968 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 9.0 t -60.13 -34.43 73.51 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.102 0.477 . . . . 0.0 109.964 179.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.968 179.015 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 . . . . . 0 C--O 1.23 0.058 0 CA-C-O 121.051 0.453 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.767 ' HB2' HD13 ' A' ' 134' ' ' LEU . 85.6 m95 -66.04 168.33 8.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.287 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.29 133.61 45.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.762 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 59.5 mtt180 -71.25 107.72 4.38 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.833 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.909 HD11 HG22 ' A' ' 168' ' ' THR . 42.9 pt -96.08 -9.15 9.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.414 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.518 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -156.33 175.97 13.3 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.659 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.479 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 37.9 m-85 -145.02 126.05 14.56 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.353 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.614 HG21 HD11 ' A' ' 139' ' ' LEU . 3.4 t -93.69 122.9 45.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.101 0.477 . . . . 0.0 111.13 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -82.4 97.46 8.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.776 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -151.09 156.01 40.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.44 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 6.3 tpp180 60.39 30.54 19.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.838 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.2 33.4 16.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.913 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 145' ' ' THR . 85.5 m -157.14 153.74 28.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.912 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -93.54 91.18 6.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.694 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.493 ' HB2' HD21 ' A' ' 139' ' ' LEU . 22.6 m-85 -66.06 125.02 89.33 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.874 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.61 115.84 4.49 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.008 1.806 . . . . 0.0 112.725 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.694 HD21 ' OG1' ' A' ' 168' ' ' THR . 25.1 tp -93.64 123.8 37.2 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.656 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.767 HD13 ' HB2' ' A' ' 118' ' ' TRP . 39.9 mt -69.55 171.86 8.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.48 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.4 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 0.9 OUTLIER -63.15 -31.76 72.98 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.987 179.893 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . 0.457 ' ND2' ' CD1' ' A' ' 118' ' ' TRP . 2.9 p30 -84.68 3.81 35.46 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.278 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.621 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 82.71 21.24 60.07 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.766 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.644 ' HB3' HD12 ' A' ' 134' ' ' LEU . 6.2 tpt180 -79.9 94.29 5.82 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.614 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -69.79 107.41 3.5 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.95 -179.502 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 15.3 mt -83.45 72.54 10.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.979 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.451 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 9.2 mttp -57.79 -20.73 37.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.481 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -96.9 23.79 6.81 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.289 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -147.94 27.49 0.96 Allowed 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.747 0.308 . . . . 0.0 111.122 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.422 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . -63.52 166.66 25.84 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.913 -0.66 . . . . 0.0 113.183 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.416 ' O ' HG23 ' A' ' 129' ' ' THR . 9.6 t -132.58 151.72 51.84 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.867 0.365 . . . . 0.0 110.442 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.06 50.77 1.7 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.118 0.485 . . . . 0.0 110.598 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.71 147.04 2.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.644 -179.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -90.2 125.32 60.6 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.327 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.479 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 77.8 Cg_endo -84.83 107.27 1.1 Allowed 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.534 2.156 . . . . 0.0 112.605 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 15.0 t -69.83 -7.8 42.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.008 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -78.26 -23.64 47.19 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 120.841 0.353 . . . . 0.0 110.503 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.689 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -138.35 167.28 20.42 Favored Pre-proline 0 N--CA 1.453 -0.302 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.629 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.689 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 68.0 Cg_endo -74.62 156.36 44.75 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.452 2.101 . . . . 0.0 112.539 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 18.3 t -118.96 109.22 26.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.236 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.853 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.1 mp -72.54 96.14 1.91 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.699 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.7 t -91.37 136.23 24.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.082 0.467 . . . . 0.0 111.046 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 47.9 57.71 7.54 Favored Glycine 0 CA--C 1.522 0.471 0 CA-C-N 115.701 -0.681 . . . . 0.0 113.237 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.853 ' CE2' HD23 ' A' ' 155' ' ' LEU . 2.5 m95 -99.81 151.36 21.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.193 0.52 . . . . 0.0 111.831 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.52 -172.42 0.08 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.627 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -44.37 154.24 0.13 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.284 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.533 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.65 -24.93 54.61 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.159 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -59.56 -39.49 84.21 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.887 0.375 . . . . 0.0 110.125 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.28 -40.32 51.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.962 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.533 HD12 ' HA2' ' A' ' 161' ' ' GLY . 5.9 mt -58.72 -41.08 81.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.922 178.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.72 -29.48 39.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.138 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -70.1 -53.01 19.26 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 121.512 0.672 . . . . 0.0 110.137 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.833 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -58.95 -43.98 91.36 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.042 178.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.909 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -58.65 -36.43 74.12 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.395 179.08 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.26 -37.19 92.62 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 178.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 93.3 mm-40 -73.72 -45.58 51.27 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.339 -0.43 . . . . 0.0 111.083 178.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.608 ' HA ' HD22 ' A' ' 174' ' ' LEU . 11.3 mp -66.36 -28.47 68.67 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.697 0.284 . . . . 0.0 111.374 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.9 -16.18 62.66 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.34 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -115.2 -28.03 7.07 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.669 HD21 HD13 ' A' ' 179' ' ' LEU . 0.2 OUTLIER -55.88 167.29 0.86 Allowed Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 116.754 -0.203 . . . . 0.0 111.3 -179.539 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -69.92 128.15 15.47 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.269 1.979 . . . . 0.0 112.92 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.47 -25.64 6.8 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.718 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.51 -49.68 75.52 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.847 0.356 . . . . 0.0 110.947 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.871 HG11 ' HB3' ' A' ' 218' ' ' LEU . 32.4 t -74.34 -36.05 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.608 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.669 HD13 HD21 ' A' ' 174' ' ' LEU . 10.7 tp -55.1 -34.08 63.37 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.162 0.506 . . . . 0.0 110.155 179.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -80.29 -41.59 11.58 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.405 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -85.53 103.02 14.01 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.912 0.386 . . . . 0.0 110.665 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . 0.835 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.8 mtm 178.52 166.18 0.83 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.228 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.85 -56.96 1.91 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.836 0.35 . . . . 0.0 111.001 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -162.96 142.56 8.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.771 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.894 HG12 HG12 ' A' ' 199' ' ' VAL . 11.7 mt -101.91 115.55 43.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.475 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . 0.4 ' HB3' ' CE ' ' A' ' 188' ' ' LYS . 22.9 m170 -105.21 121.62 44.21 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.98 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -78.53 104.69 9.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.509 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . 0.4 ' CE ' ' HB3' ' A' ' 186' ' ' HIS . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.547 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 . . . . . 0 CA--C 1.529 0.146 0 CA-C-O 120.754 0.311 . . . . 0.0 111.415 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 9.8 p30 -105.12 38.54 1.92 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.765 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -90.77 116.85 28.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.105 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.798 ' O ' HD13 ' A' ' 198' ' ' ILE . 22.1 m -114.24 164.35 10.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.725 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.798 HD13 ' O ' ' A' ' 197' ' ' VAL . 20.3 mm -133.3 105.95 8.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.785 0.326 . . . . 0.0 111.17 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.894 HG12 HG12 ' A' ' 185' ' ' ILE . 6.7 m -94.75 124.72 47.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.028 0.442 . . . . 0.0 111.011 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -84.26 152.82 23.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.809 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.8 149.02 29.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.729 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -58.77 -28.8 66.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.157 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -80.67 1.5 29.78 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.325 -0.398 . . . . 0.0 112.06 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 91.99 14.41 56.34 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.571 -0.823 . . . . 0.0 113.149 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -87.1 160.19 18.65 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.992 0.396 . . . . 0.0 110.732 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -128.67 111.47 13.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.919 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 23.1 t -110.88 137.46 43.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.044 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 3.8 m -110.83 112.07 23.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.755 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.41 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -121.86 170.76 9.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.938 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.92 157.56 19.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.402 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 33.0 mt -69.54 -31.48 49.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.794 0.331 . . . . 0.0 110.838 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.48 -30.15 65.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.345 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -133.12 37.31 3.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.809 0.338 . . . . 0.0 111.051 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.577 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 11.2 t80 -63.08 -55.46 25.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.837 0.351 . . . . 0.0 110.458 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.75 -42.38 79.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.146 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -68.91 -47.72 65.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.041 0.448 . . . . 0.0 110.232 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -54.95 -43.63 73.6 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.905 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.871 ' HB3' HG11 ' A' ' 178' ' ' VAL . 3.9 mm? -83.09 -26.44 31.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.779 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 13.2 t -61.19 -30.53 70.47 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.955 0.407 . . . . 0.0 110.528 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.107 179.612 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.993 0.425 . . . . 0.0 110.97 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.773 ' HB2' HD13 ' A' ' 134' ' ' LEU . 81.5 m95 -73.16 167.95 20.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.057 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.7 ttm-85 -102.64 135.57 44.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.401 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 -71.74 105.92 3.92 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.491 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.87 HD11 HG22 ' A' ' 168' ' ' THR . 42.9 pt -93.54 -9.06 9.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.492 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.486 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -158.99 176.57 12.14 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 120.99 -0.284 . . . . 0.0 110.795 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.456 ' O ' ' HA ' ' A' ' 154' ' ' VAL . 30.8 m-85 -142.77 128.3 19.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.268 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.623 HG21 HD11 ' A' ' 139' ' ' LEU . 3.9 t -93.28 122.41 44.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.072 0.463 . . . . 0.0 111.239 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.479 ' CE1' ' CE1' ' A' ' 130' ' ' PHE . 7.6 t80 -82.75 94.45 7.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.735 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -144.46 153.04 41.47 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.433 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 59.44 30.66 20.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.858 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 61.81 34.71 17.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.036 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.472 HG23 ' HE2' ' A' ' 146' ' ' LYS . 65.7 m -152.2 162.21 41.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.07 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.479 ' CE1' ' CE1' ' A' ' 125' ' ' TYR . 18.5 m-85 -103.27 90.71 3.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.191 0.52 . . . . 0.0 111.194 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.514 ' HB2' HD21 ' A' ' 139' ' ' LEU . 23.8 m-85 -69.82 118.33 62.08 Favored Pre-proline 0 CA--C 1.536 0.437 0 CA-C-N 115.437 -0.802 . . . . 0.0 111.499 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.433 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 25.0 Cg_exo -63.16 119.86 7.09 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 122.423 2.082 . . . . 0.0 112.61 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.677 HD21 ' OG1' ' A' ' 168' ' ' THR . 29.6 tp -100.25 123.17 44.16 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.285 179.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.773 HD13 ' HB2' ' A' ' 118' ' ' TRP . 46.5 mt -70.13 171.4 9.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.701 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.415 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.5 pt-20 -61.67 -33.33 73.79 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.098 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . 0.462 ' ND2' ' CD1' ' A' ' 118' ' ' TRP . 4.2 p30 -82.34 -4.36 57.13 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.107 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.663 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 91.34 15.84 54.56 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.804 -179.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.669 ' HB3' HD12 ' A' ' 134' ' ' LEU . 15.1 tpp85 -73.62 97.21 2.6 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.623 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -70.98 109.18 4.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.565 -178.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 27.6 mt -84.22 71.16 10.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.487 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.452 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 18.6 mttt -56.79 -21.5 29.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.738 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -84.54 -17.39 39.05 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -106.67 29.48 6.91 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . -60.55 161.62 21.7 Favored Glycine 0 CA--C 1.509 -0.316 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.359 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 11.1 t -136.28 148.81 48.17 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.999 0.428 . . . . 0.0 110.927 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.472 ' HE2' HG23 ' A' ' 129' ' ' THR . 6.7 mmtt -89.92 55.86 3.28 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.343 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.405 ' O ' ' CG ' ' A' ' 130' ' ' PHE . 0.0 OUTLIER -170.41 167.32 8.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.255 -179.327 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -102.67 136.62 19.29 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.928 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.455 ' HG3' ' CD1' ' A' ' 123' ' ' TYR . 59.7 Cg_endo -84.7 99.98 0.74 Allowed 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 123.174 2.582 . . . . 0.0 112.491 179.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 16.8 t -67.24 -9.52 41.32 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.793 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -89.58 -22.24 22.46 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 111.562 0.208 . . . . 0.0 111.562 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.692 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -139.33 166.92 21.03 Favored Pre-proline 0 C--N 1.328 -0.334 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -178.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.692 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 58.9 Cg_endo -73.46 164.24 35.56 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.495 2.13 . . . . 0.0 112.275 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 22.1 t -122.92 109.12 22.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 121.065 0.46 . . . . 0.0 111.655 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.873 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.72 95.95 1.96 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.687 179.068 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.405 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 54.9 t -92.99 137.87 21.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.164 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 47.69 56.06 8.93 Favored Glycine 0 CA--C 1.521 0.421 0 CA-C-N 115.913 -0.585 . . . . 0.0 113.227 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.873 ' CE2' HD23 ' A' ' 155' ' ' LEU . 3.2 m95 -98.9 151.26 21.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.181 0.515 . . . . 0.0 111.62 -179.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.98 -172.4 0.14 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.423 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -43.58 154.69 0.08 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.095 0.474 . . . . 0.0 112.184 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.552 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.29 -25.05 53.78 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.275 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.97 -38.75 83.44 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.001 0.429 . . . . 0.0 110.125 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.18 -40.23 46.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.053 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.552 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.5 mt -59.4 -42.25 86.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.081 179.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.38 -29.49 48.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.366 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.429 ' CB ' HG21 ' A' ' 211' ' ' ILE . 5.6 mm-40 -67.84 -53.28 28.06 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.4 0.619 . . . . 0.0 110.162 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.79 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -60.89 -43.51 98.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.995 178.92 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.87 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -58.88 -37.82 77.42 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.361 179.181 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.62 -37.54 92.42 Favored Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 178.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -72.04 -46.5 56.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.366 -0.417 . . . . 0.0 110.848 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.552 ' HA ' HD22 ' A' ' 174' ' ' LEU . 10.4 mp -64.22 -30.45 71.51 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.789 0.328 . . . . 0.0 111.219 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -67.67 -21.91 65.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.552 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -109.61 -26.49 9.88 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 120.595 0.236 . . . . 0.0 111.498 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.552 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.1 OUTLIER -56.99 166.37 1.43 Allowed Pre-proline 0 CA--C 1.538 0.491 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.096 -179.685 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -69.32 128.95 17.19 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.364 2.043 . . . . 0.0 112.702 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.89 -25.89 5.13 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.75 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.87 -50.05 74.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.971 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.905 HG11 ' HB3' ' A' ' 218' ' ' LEU . 24.4 t -74.21 -35.44 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.705 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.523 ' HG ' HD21 ' A' ' 174' ' ' LEU . 0.4 OUTLIER -56.56 -35.04 67.7 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.131 0.491 . . . . 0.0 109.956 179.29 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -79.5 -39.21 18.92 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.269 -0.733 . . . . 0.0 111.269 178.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -86.85 103.16 14.99 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.935 0.398 . . . . 0.0 110.654 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . 0.841 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.9 mtm 178.35 161.18 0.61 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.027 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 6.6 t -118.93 -58.52 1.94 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.767 0.318 . . . . 0.0 110.881 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.8 pm0 -157.62 142.58 16.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.001 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.89 HG12 HG12 ' A' ' 199' ' ' VAL . 17.0 mt -107.01 115.0 47.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.341 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . 0.405 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 21.8 m170 -106.01 123.46 48.03 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.207 -179.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -75.67 104.55 6.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.167 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 4.3 mttm . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.908 -179.629 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.257 0 CA-C-O 120.719 0.295 . . . . 0.0 111.332 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . 0.442 ' OD1' HG22 ' A' ' 210' ' ' THR . 3.4 p30 -106.9 37.86 2.24 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.746 0.308 . . . . 0.0 110.802 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 7.2 ttt180 -88.86 116.22 26.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.838 0.352 . . . . 0.0 111.439 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.74 ' O ' HD13 ' A' ' 198' ' ' ILE . 23.6 m -112.81 166.41 6.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.66 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.74 HD13 ' O ' ' A' ' 197' ' ' VAL . 19.2 mm -132.01 108.77 14.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.793 0.33 . . . . 0.0 111.287 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.89 HG12 HG12 ' A' ' 185' ' ' ILE . 10.2 m -100.98 120.78 50.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.028 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -85.81 152.62 22.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.631 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 9.7 mmt -102.67 161.24 13.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.034 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -62.56 -25.89 68.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.153 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -87.15 10.62 16.22 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 83.77 14.4 72.97 Favored Glycine 0 C--N 1.335 0.496 0 C-N-CA 120.451 -0.881 . . . . 0.0 113.282 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -80.15 170.41 16.47 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 117.014 0.407 . . . . 0.0 110.767 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -136.43 111.48 8.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.928 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.444 ' HB ' HG23 ' A' ' 199' ' ' VAL . 21.7 t -114.77 122.59 69.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.089 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -99.31 114.64 27.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.671 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.626 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -126.12 161.32 27.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.802 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.442 HG22 ' OD1' ' A' ' 195' ' ' ASP . 0.6 OUTLIER -99.76 152.73 19.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.673 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.429 HG21 ' CB ' ' A' ' 166' ' ' GLU . 48.4 mt -63.88 -36.49 76.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.838 0.351 . . . . 0.0 110.724 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.23 -34.66 76.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.158 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -132.64 44.28 2.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.919 0.39 . . . . 0.0 111.02 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.623 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 11.3 t80 -66.94 -52.58 41.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.564 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.01 -40.02 91.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.911 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.37 -51.15 55.66 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.158 0.504 . . . . 0.0 110.399 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.25 -43.78 71.22 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.163 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.905 ' HB3' HG11 ' A' ' 178' ' ' VAL . 4.1 mm? -83.52 -23.15 32.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.097 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.49 -34.3 75.26 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.045 0.45 . . . . 0.0 109.799 179.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 . . . . . 0 CA--C 1.533 0.298 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.151 179.446 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 121.025 0.44 . . . . 0.0 110.939 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.774 ' HB2' HD13 ' A' ' 134' ' ' LEU . 87.3 m95 -70.11 168.37 15.73 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.093 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 2.0 ptt180 -99.57 133.39 43.97 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.696 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 32.4 mtm180 -71.33 106.68 3.96 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.628 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.892 HD11 HG22 ' A' ' 168' ' ' THR . 44.1 pt -95.86 -8.25 9.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.436 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.541 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -158.41 176.53 12.33 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 120.647 0.26 . . . . 0.0 110.882 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.469 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 38.2 m-85 -144.91 126.59 15.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.188 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.643 HG21 HD11 ' A' ' 139' ' ' LEU . 4.1 t -93.45 122.65 45.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.124 0.487 . . . . 0.0 111.013 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -83.69 95.07 8.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.48 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -145.52 155.16 42.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.42 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 4.0 tpp180 59.58 30.2 19.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.787 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 62.27 34.83 15.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.997 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.445 HG22 ' N ' ' A' ' 130' ' ' PHE . 57.8 m -153.54 161.46 42.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.826 0.346 . . . . 0.0 111.278 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.659 ' CZ ' ' HB2' ' A' ' 148' ' ' ALA . 31.8 m-85 -101.75 91.12 4.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.132 0.491 . . . . 0.0 110.914 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.471 ' HB2' HD21 ' A' ' 139' ' ' LEU . 24.3 m-85 -70.19 122.96 87.9 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.336 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.422 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 15.1 Cg_exo -67.94 118.17 5.42 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 122.31 2.007 . . . . 0.0 112.636 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.655 HD21 ' OG1' ' A' ' 168' ' ' THR . 30.4 tp -98.02 123.32 41.98 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.086 0.469 . . . . 0.0 110.362 179.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.774 HD13 ' HB2' ' A' ' 118' ' ' TRP . 44.6 mt -70.4 171.97 9.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.511 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.406 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 0.9 OUTLIER -62.85 -32.33 73.53 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.857 179.924 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . 0.461 ' ND2' ' CD1' ' A' ' 118' ' ' TRP . 3.1 p30 -84.07 2.45 39.22 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.161 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.666 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 83.89 20.27 59.83 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.827 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.64 ' HB3' HD12 ' A' ' 134' ' ' LEU . 13.8 tpp180 -78.4 94.08 4.82 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.643 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -68.2 105.1 1.99 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.438 -179.025 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 17.3 mt -78.58 69.34 4.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.746 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.44 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 2.3 mttt -57.2 -21.31 32.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.564 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -91.96 11.94 23.44 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -134.74 26.5 3.67 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.762 0.315 . . . . 0.0 111.17 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.422 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -61.23 163.02 22.63 Favored Glycine 0 CA--C 1.509 -0.323 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.844 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.9 t -136.3 151.84 50.05 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.526 -0.337 . . . . 0.0 110.428 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.42 ' HE2' HG23 ' A' ' 129' ' ' THR . 4.2 mmtt -89.03 51.84 2.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.014 0.435 . . . . 0.0 110.705 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.18 148.97 2.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.638 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.659 ' HB2' ' CZ ' ' A' ' 130' ' ' PHE . . . -93.73 125.81 52.0 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.474 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.469 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 89.1 Cg_endo -84.39 109.97 1.43 Allowed 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.528 2.152 . . . . 0.0 112.508 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.3 t -70.2 -6.86 37.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.081 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.73 -23.04 53.06 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 120.836 0.351 . . . . 0.0 110.507 178.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.688 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -140.72 167.2 18.42 Favored Pre-proline 0 N--CA 1.453 -0.306 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.794 -179.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.688 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 61.5 Cg_endo -74.04 154.44 47.48 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.412 2.074 . . . . 0.0 112.306 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 14.2 t -115.81 111.5 35.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.115 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.823 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.71 96.45 2.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.858 179.207 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.434 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 59.0 t -93.07 136.03 26.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.975 0.417 . . . . 0.0 110.981 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 48.97 56.32 10.25 Favored Glycine 0 CA--C 1.521 0.423 0 CA-C-N 115.903 -0.589 . . . . 0.0 113.17 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.823 ' CE2' HD23 ' A' ' 155' ' ' LEU . 3.2 m95 -99.52 151.31 21.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.195 0.521 . . . . 0.0 111.799 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -65.79 -172.43 0.13 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.529 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -44.33 154.43 0.12 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.118 0.485 . . . . 0.0 112.203 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.564 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.27 -25.07 53.78 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.239 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -60.12 -38.3 82.59 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 120.967 0.413 . . . . 0.0 110.113 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.79 -41.36 44.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.0 178.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.564 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.5 mt -57.73 -42.35 81.56 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.11 179.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.22 -29.78 34.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.166 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.416 ' CB ' HG21 ' A' ' 211' ' ' ILE . 2.0 mt-10 -68.64 -53.43 22.53 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-O 121.503 0.668 . . . . 0.0 110.054 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.797 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -59.84 -43.81 94.39 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.701 -0.682 . . . . 0.0 109.88 178.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.892 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -58.62 -36.35 73.92 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.329 179.018 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.84 -38.47 94.06 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 178.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -71.93 -45.45 61.1 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.269 -0.465 . . . . 0.0 110.727 178.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.563 ' HA ' HD22 ' A' ' 174' ' ' LEU . 10.7 mp -67.83 -21.32 65.21 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.72 0.295 . . . . 0.0 111.691 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -77.12 -16.69 59.09 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.114 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -114.9 -26.5 7.75 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.75 HD21 ' HB2' ' A' ' 179' ' ' LEU . 0.1 OUTLIER -57.75 166.35 1.91 Allowed Pre-proline 0 CA--C 1.536 0.412 0 CA-C-O 120.513 0.197 . . . . 0.0 111.051 -179.497 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -69.48 128.88 16.94 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.31 2.007 . . . . 0.0 112.707 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.86 -25.25 7.52 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.67 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.42 -49.39 76.36 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.904 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.906 HG11 ' HB3' ' A' ' 218' ' ' LEU . 23.5 t -74.32 -39.97 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.57 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.75 ' HB2' HD21 ' A' ' 174' ' ' LEU . 12.4 tp -54.52 -32.63 58.5 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.059 0.457 . . . . 0.0 110.22 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -82.41 -36.18 17.95 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 178.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -90.48 103.2 15.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.898 0.38 . . . . 0.0 110.614 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . 0.833 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.9 mtm 178.92 179.79 0.39 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.023 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -136.72 -52.16 0.69 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.732 0.301 . . . . 0.0 111.198 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -163.43 142.69 8.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.124 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.89 HG12 HG12 ' A' ' 199' ' ' VAL . 19.2 mt -106.25 114.95 46.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.316 179.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . 0.434 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 20.1 m170 -106.24 123.61 48.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.25 -179.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -75.31 104.85 6.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.474 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 9.0 mmtt . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.5 179.867 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 . . . . . 0 CA--C 1.528 0.121 0 CA-C-O 120.695 0.283 . . . . 0.0 111.282 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -104.19 36.01 2.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.795 0.331 . . . . 0.0 110.779 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 24.0 ttt85 -90.57 113.43 25.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.988 0.423 . . . . 0.0 111.182 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.854 ' O ' HD13 ' A' ' 198' ' ' ILE . 23.1 m -109.2 167.82 4.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.751 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.854 HD13 ' O ' ' A' ' 197' ' ' VAL . 22.5 mm -134.33 105.75 7.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.684 0.278 . . . . 0.0 111.34 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.89 HG12 HG12 ' A' ' 185' ' ' ILE . 12.5 m -94.53 134.87 30.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.868 0.366 . . . . 0.0 110.921 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -97.54 153.08 18.4 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.667 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 33.5 tpp -112.24 149.35 32.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.448 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 16.9 m-20 -55.27 -28.96 57.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.513 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -75.38 -5.89 47.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.817 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 94.78 14.62 49.02 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.499 -0.857 . . . . 0.0 112.988 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.439 ' CE2' HG22 ' A' ' 207' ' ' VAL . 11.2 t80 -86.28 158.2 19.75 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 117.005 0.403 . . . . 0.0 110.915 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -124.85 111.18 15.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.676 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.439 HG22 ' CE2' ' A' ' 205' ' ' TYR . 25.5 t -113.04 135.64 51.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.938 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 93.7 p -109.26 116.36 31.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.74 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.407 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -125.27 169.36 12.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.797 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -108.2 154.25 22.03 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.706 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.416 HG21 ' CB ' ' A' ' 166' ' ' GLU . 34.5 mt -66.08 -34.05 67.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.782 0.325 . . . . 0.0 110.832 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.46 -35.61 80.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.334 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -131.65 43.34 3.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.983 0.42 . . . . 0.0 110.961 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.568 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 11.1 t80 -66.73 -50.77 61.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.722 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.27 -42.22 90.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.347 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -67.31 -49.55 63.7 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.052 0.454 . . . . 0.0 110.458 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.93 -43.4 69.76 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.174 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.906 ' HB3' HG11 ' A' ' 178' ' ' VAL . 4.0 mm? -84.11 -25.5 29.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.004 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 12.6 t -61.15 -31.45 71.18 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.892 0.377 . . . . 0.0 110.396 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 . . . . . 0 CA--C 1.531 0.248 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.402 179.665 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 121.041 0.448 . . . . 0.0 110.977 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.762 ' HB2' HD13 ' A' ' 134' ' ' LEU . 81.3 m95 -73.89 168.55 19.22 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.204 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.2 ptt180 -101.05 135.22 42.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.841 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 8.4 mtm180 -71.87 106.68 4.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.867 0.365 . . . . 0.0 110.731 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.888 HD11 HG22 ' A' ' 168' ' ' THR . 49.3 pt -97.09 -7.65 9.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.366 179.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.478 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -159.39 176.17 12.44 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 121.111 -0.236 . . . . 0.0 110.71 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.47 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 29.1 m-85 -144.48 126.26 15.24 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.088 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.559 HG21 HD11 ' A' ' 139' ' ' LEU . 8.6 t -93.64 122.77 45.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.108 0.48 . . . . 0.0 111.471 -179.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.476 ' CD1' ' CE1' ' A' ' 130' ' ' PHE . 28.5 t80 -82.7 110.7 17.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.729 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -165.08 152.41 10.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.651 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? 60.37 31.6 20.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.015 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 62.2 31.49 17.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.264 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.521 HG23 ' O ' ' A' ' 145' ' ' THR . 84.7 m -153.43 150.13 28.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.874 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.476 ' CE1' ' CD1' ' A' ' 125' ' ' TYR . 98.7 m-85 -95.55 91.52 6.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.793 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.516 ' HB2' HD21 ' A' ' 139' ' ' LEU . 23.8 m-85 -65.19 126.15 90.77 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.313 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -72.58 116.67 4.8 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.176 1.917 . . . . 0.0 112.434 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.621 HD21 ' OG1' ' A' ' 168' ' ' THR . 42.8 tp -96.02 124.38 40.01 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.864 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.762 HD13 ' HB2' ' A' ' 118' ' ' TRP . 55.0 mt -71.65 174.73 6.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.65 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.406 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.5 pt-20 -65.46 -28.73 69.43 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.076 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 46.7 p-10 -89.82 11.68 19.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.143 179.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.666 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 73.41 23.49 77.1 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.932 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.703 ' HB3' HD12 ' A' ' 134' ' ' LEU . 18.4 tpp180 -81.11 95.95 7.02 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.559 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -72.68 107.33 5.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.326 -179.005 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 13.5 mt -85.03 72.13 10.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.321 179.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.465 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 7.5 mtpt -56.2 -21.38 22.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.993 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -85.54 -16.22 40.17 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -108.88 29.69 7.23 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . -64.52 163.08 36.42 Favored Glycine 0 CA--C 1.51 -0.228 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.88 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.521 ' O ' HG23 ' A' ' 129' ' ' THR . 9.1 t -131.31 155.95 46.31 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.41 -0.395 . . . . 0.0 110.619 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.39 48.52 1.31 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.127 0.489 . . . . 0.0 110.319 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -170.97 150.73 3.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.533 -179.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.455 ' HB2' ' CZ ' ' A' ' 130' ' ' PHE . . . -95.02 125.93 48.76 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.21 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.47 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 72.8 Cg_endo -83.02 111.83 1.96 Allowed 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.349 2.032 . . . . 0.0 112.619 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 33.3 t -69.81 -7.6 41.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.062 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.82 -23.44 52.76 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 120.821 0.343 . . . . 0.0 110.456 178.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.674 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -139.44 166.9 21.05 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.653 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.674 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 60.0 Cg_endo -73.81 154.54 48.7 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.348 2.032 . . . . 0.0 112.265 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 13.4 t -116.91 109.98 29.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.063 0.458 . . . . 0.0 111.207 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.891 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.2 mp -72.33 96.12 1.82 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.611 179.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.417 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 60.8 t -92.41 137.16 22.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.129 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 48.97 57.85 8.33 Favored Glycine 0 CA--C 1.52 0.374 0 CA-C-N 115.921 -0.581 . . . . 0.0 113.223 179.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.891 ' CE2' HD23 ' A' ' 155' ' ' LEU . 2.7 m95 -101.13 151.07 22.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.162 0.506 . . . . 0.0 111.679 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.7 tttp -66.76 -172.18 0.16 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.374 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -42.26 154.42 0.06 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.534 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -56.87 -24.96 51.63 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.267 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.04 -38.69 83.51 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.996 0.427 . . . . 0.0 109.978 179.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -75.91 -40.6 53.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.913 178.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.534 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.2 mt -59.11 -44.0 90.58 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.878 179.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -52.92 -25.9 13.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.617 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -71.39 -54.43 10.73 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 121.072 0.463 . . . . 0.0 110.923 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.813 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -62.14 -37.19 84.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.217 179.495 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.888 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -60.5 -38.11 83.26 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.911 178.881 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -61.59 -35.68 91.49 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 177.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -71.6 -49.02 44.27 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.181 -0.51 . . . . 0.0 110.669 178.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.637 ' HA ' HD22 ' A' ' 174' ' ' LEU . 10.8 mp -65.2 -27.42 68.67 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.548 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.13 -18.2 61.91 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.273 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -113.27 -27.75 7.86 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.637 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER -57.0 167.23 1.14 Allowed Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.154 -179.582 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.413 ' HG2' HG23 ' A' ' 178' ' ' VAL . 38.2 Cg_endo -67.19 127.78 17.32 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.192 1.928 . . . . 0.0 112.728 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.45 -26.43 12.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.525 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -58.93 -48.09 82.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.924 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.894 HG11 ' HB3' ' A' ' 218' ' ' LEU . 22.1 t -73.0 -35.82 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.696 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.484 ' HB2' HD21 ' A' ' 174' ' ' LEU . 13.0 tp -56.13 -36.36 68.15 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.129 0.49 . . . . 0.0 110.032 179.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -76.92 -40.11 26.46 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 178.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -87.7 103.09 15.27 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.879 0.371 . . . . 0.0 110.718 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . 0.839 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.8 mtm 178.02 167.73 0.75 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.127 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.92 -56.75 1.55 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.63 0.252 . . . . 0.0 111.268 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 6.3 pm0 -160.39 142.79 13.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.894 0.378 . . . . 0.0 111.307 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.874 HG12 HG12 ' A' ' 199' ' ' VAL . 13.3 mt -104.33 115.96 47.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.455 179.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . 0.417 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 20.2 m170 -106.45 124.05 49.01 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.113 -179.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -79.46 104.7 10.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.709 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.517 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.53 0.209 0 CA-C-O 120.748 0.308 . . . . 0.0 111.245 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -106.0 38.37 2.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.608 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.08 114.72 25.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.322 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.874 ' O ' HD13 ' A' ' 198' ' ' ILE . 32.8 m -110.59 169.37 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.724 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.874 HD13 ' O ' ' A' ' 197' ' ' VAL . 22.0 mm -134.95 110.29 12.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.72 0.295 . . . . 0.0 111.285 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.874 HG12 HG12 ' A' ' 185' ' ' ILE . 12.3 m -102.81 127.18 56.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.987 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -88.64 152.56 21.75 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.675 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.11 157.62 16.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.812 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -57.78 -23.84 54.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.527 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -89.89 15.36 10.03 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 79.64 14.19 81.47 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.57 -0.824 . . . . 0.0 113.081 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -78.39 175.05 10.64 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 117.094 0.447 . . . . 0.0 110.836 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -140.53 111.46 7.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.082 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 20.1 t -114.22 135.63 53.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.911 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 1.5 m -107.64 118.36 36.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.928 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.645 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -131.12 161.94 30.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.66 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -99.28 156.75 16.82 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.737 0.303 . . . . 0.0 110.788 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 45.9 mt -68.46 -33.1 58.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.771 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 -67.38 -38.06 84.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.091 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -126.53 41.14 3.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.974 0.416 . . . . 0.0 110.866 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.597 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 11.5 t80 -65.02 -52.57 55.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.869 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.29 -37.74 81.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.048 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -69.25 -49.62 54.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.063 0.458 . . . . 0.0 110.372 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 1.2 mmpt? -53.25 -41.72 65.76 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.058 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.894 ' HB3' HG11 ' A' ' 178' ' ' VAL . 4.3 mm? -87.06 -23.16 25.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.9 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 11.0 t -60.95 -32.64 72.17 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.921 0.391 . . . . 0.0 110.157 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 24.9 m170 . . . . . 0 CA--C 1.533 0.29 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.195 179.398 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 121.011 0.434 . . . . 0.0 110.942 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.769 ' HB2' HD13 ' A' ' 134' ' ' LEU . 82.8 m95 -70.91 168.44 16.91 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.219 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.85 132.2 47.76 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.799 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -69.17 108.4 3.6 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.926 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.911 HD11 HG22 ' A' ' 168' ' ' THR . 44.2 pt -98.01 -7.93 9.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.323 179.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.471 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -159.97 174.45 14.36 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 121.134 -0.226 . . . . 0.0 110.649 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.476 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 28.0 m-85 -143.03 126.75 17.04 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.277 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.651 HG21 HD11 ' A' ' 139' ' ' LEU . 3.5 t -93.35 123.65 45.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.018 0.437 . . . . 0.0 111.643 -179.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.481 ' CE1' ' CE1' ' A' ' 130' ' ' PHE . 7.5 t80 -84.51 105.11 15.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.754 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -159.66 154.92 25.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.681 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 60.46 30.56 19.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.945 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 62.38 32.16 16.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.166 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.484 HG23 ' O ' ' A' ' 145' ' ' THR . 75.3 m -153.1 151.39 30.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.085 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.815 ' CE2' ' HB2' ' A' ' 148' ' ' ALA . 36.4 m-85 -94.52 90.91 6.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.537 179.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.564 ' HB2' HD21 ' A' ' 139' ' ' LEU . 21.4 m-85 -65.47 138.17 96.82 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.739 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -85.16 116.06 1.73 Allowed 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.311 2.008 . . . . 0.0 112.083 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.609 HD21 ' OG1' ' A' ' 168' ' ' THR . 37.9 tp -95.29 123.65 38.91 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.882 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.769 HD13 ' HB2' ' A' ' 118' ' ' TRP . 58.2 mt -72.15 172.69 9.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.485 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.41 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.5 pt-20 -63.19 -28.75 70.26 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.854 179.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -90.5 12.39 18.81 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.209 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.642 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 74.07 28.34 64.63 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.717 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.628 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -81.62 92.36 6.55 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.723 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.651 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -74.17 105.03 5.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.957 0.408 . . . . 0.0 110.972 -179.533 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 88.6 mt -85.84 70.87 10.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.701 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.462 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 29.5 mttt -52.87 -23.24 6.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.983 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -84.09 -20.54 32.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.596 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -102.54 27.86 6.51 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 111.703 0.26 . . . . 0.0 111.703 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . -65.22 163.88 37.74 Favored Glycine 0 CA--C 1.511 -0.215 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.144 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.484 ' O ' HG23 ' A' ' 129' ' ' THR . 7.8 t -133.07 158.3 43.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.955 0.407 . . . . 0.0 110.648 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 6.2 mmmm -93.98 48.86 1.28 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.36 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.33 151.53 3.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.593 -179.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.815 ' HB2' ' CE2' ' A' ' 130' ' ' PHE . . . -96.93 126.73 41.51 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.178 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.476 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 73.2 Cg_endo -82.24 111.95 2.19 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.335 2.023 . . . . 0.0 112.552 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 28.2 t -69.82 -7.47 40.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.112 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -76.47 -23.33 53.82 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 120.859 0.362 . . . . 0.0 110.451 179.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.697 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -139.74 167.88 17.01 Favored Pre-proline 0 N--CA 1.454 -0.265 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.697 -179.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.697 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 61.0 Cg_endo -74.22 158.0 45.52 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.389 2.059 . . . . 0.0 112.236 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 11.1 t -118.47 111.04 32.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.049 0.452 . . . . 0.0 111.16 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.829 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.52 95.98 1.88 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.535 179.122 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.426 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 61.2 t -93.22 136.45 25.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.977 0.418 . . . . 0.0 111.014 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 49.05 55.98 10.96 Favored Glycine 0 CA--C 1.521 0.411 0 CA-C-N 115.808 -0.633 . . . . 0.0 113.264 179.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.829 ' CE2' HD23 ' A' ' 155' ' ' LEU . 2.7 m95 -98.34 151.11 20.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.128 0.489 . . . . 0.0 111.652 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.97 -172.65 0.07 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.349 179.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -44.46 155.5 0.09 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.134 0.492 . . . . 0.0 112.143 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.567 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -56.54 -25.14 49.45 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.25 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -60.89 -39.03 87.71 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 120.938 0.399 . . . . 0.0 110.038 179.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.424 ' HB1' ' HE2' ' A' ' 187' ' ' TYR . . . -75.36 -40.16 58.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.128 179.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.567 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.3 mt -59.0 -43.1 88.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.102 179.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.34 -29.69 35.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.35 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -68.14 -53.12 27.51 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.424 0.63 . . . . 0.0 110.189 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.77 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -60.39 -42.3 95.6 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.027 179.064 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.911 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -59.51 -37.47 78.42 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.306 179.252 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.78 -36.67 92.3 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 178.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -72.92 -46.86 50.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.424 -0.388 . . . . 0.0 110.945 178.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.573 ' O ' HD22 ' A' ' 174' ' ' LEU . 10.6 mp -65.69 -28.49 69.11 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.75 0.31 . . . . 0.0 111.34 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.31 -17.98 63.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.335 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -112.72 -27.36 8.19 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.65 0.262 . . . . 0.0 111.529 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.573 HD22 ' O ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER -56.88 167.0 1.16 Allowed Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.183 -179.463 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -69.2 127.82 15.61 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.249 1.966 . . . . 0.0 112.721 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.02 -25.85 5.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.81 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.65 -50.0 74.61 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.007 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.855 HG11 ' HB3' ' A' ' 218' ' ' LEU . 22.3 t -74.19 -35.33 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.667 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.661 HD21 ' O ' ' A' ' 121' ' ' ILE . 0.8 OUTLIER -56.37 -34.78 66.98 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.105 0.479 . . . . 0.0 110.091 179.212 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -79.56 -40.27 15.81 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.35 178.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -87.32 103.15 15.2 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.931 0.396 . . . . 0.0 110.745 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . 0.841 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.8 mtm 178.95 164.66 0.86 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.24 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.33 -60.28 1.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.755 0.312 . . . . 0.0 111.195 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -155.64 142.89 19.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.029 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.89 HG12 HG12 ' A' ' 199' ' ' VAL . 16.7 mt -107.35 115.12 47.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.434 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . 0.426 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 20.7 m170 -106.39 135.07 48.53 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.186 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.424 ' HE2' ' HB1' ' A' ' 163' ' ' ALA . 0.3 OUTLIER -86.65 104.35 15.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.269 179.417 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.8 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 . . . . . 0 CA--C 1.53 0.208 0 CA-C-O 120.598 0.237 . . . . 0.0 111.61 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 9.3 p30 -110.09 38.26 2.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.743 0.306 . . . . 0.0 111.047 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.34 117.04 28.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.912 0.387 . . . . 0.0 111.121 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.88 ' O ' HD13 ' A' ' 198' ' ' ILE . 22.0 m -114.45 168.47 6.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.747 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.88 HD13 ' O ' ' A' ' 197' ' ' VAL . 22.7 mm -134.64 113.58 16.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.732 0.301 . . . . 0.0 111.221 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.89 HG12 HG12 ' A' ' 185' ' ' ILE . 10.4 m -104.8 125.91 59.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.09 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -88.72 152.52 21.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.787 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.02 154.88 18.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.761 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -58.03 -27.82 63.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.249 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -82.98 4.24 26.72 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 89.98 14.4 59.32 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 120.476 -0.869 . . . . 0.0 113.244 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -80.1 173.58 12.45 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 117.059 0.429 . . . . 0.0 110.902 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -139.3 111.34 7.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.904 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 19.6 t -115.79 137.36 49.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.924 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 97.7 p -110.77 119.66 39.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.942 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.567 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -130.36 164.21 25.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.71 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.86 153.71 20.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.76 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 33.9 mt -64.3 -36.81 78.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.837 0.351 . . . . 0.0 110.693 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.14 -36.39 81.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.159 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -132.0 46.12 2.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.007 0.432 . . . . 0.0 110.889 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.574 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 11.5 t80 -67.53 -51.71 47.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.785 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.15 -41.05 87.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.146 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -68.25 -49.85 57.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.148 0.499 . . . . 0.0 110.268 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 1.5 mmpt? -52.28 -41.81 63.19 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.102 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.855 ' HB3' HG11 ' A' ' 178' ' ' VAL . 3.8 mm? -86.85 -24.66 24.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.008 179.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 13.5 t -60.87 -30.76 70.34 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.829 0.347 . . . . 0.0 110.531 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 58.7 m170 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.25 179.777 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 121.049 0.452 . . . . 0.0 111.071 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.773 ' HB2' HD13 ' A' ' 134' ' ' LEU . 82.1 m95 -68.79 168.0 14.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.106 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -102.68 138.01 40.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.403 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 10.3 mtt180 -73.4 105.59 4.84 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.729 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.922 HD11 HG22 ' A' ' 168' ' ' THR . 45.6 pt -93.49 -9.26 9.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.366 179.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.483 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -157.36 176.44 12.68 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 120.599 0.237 . . . . 0.0 110.537 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.467 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 34.0 m-85 -143.9 126.14 15.62 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.588 HG21 ' CD1' ' A' ' 139' ' ' LEU . 3.9 t -93.67 122.91 45.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.058 0.456 . . . . 0.0 111.417 -179.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -80.69 94.21 6.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.556 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -145.26 154.13 42.03 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.327 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.2 mmt-85 60.0 29.94 19.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.699 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 61.51 34.75 17.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.968 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.446 HG22 ' N ' ' A' ' 130' ' ' PHE . 83.6 m -154.87 162.04 41.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.818 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.446 ' N ' HG22 ' A' ' 129' ' ' THR . 10.7 m-85 -100.47 90.71 4.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.141 0.496 . . . . 0.0 111.201 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.464 ' HA ' ' HA2' ' A' ' 144' ' ' GLY . 23.1 m-85 -68.9 118.09 57.74 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.391 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.678 ' HB2' HD12 ' A' ' 140' ' ' LEU . 23.1 Cg_exo -64.3 115.35 3.11 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 122.359 2.039 . . . . 0.0 112.594 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.655 HD21 ' OG1' ' A' ' 168' ' ' THR . 30.3 tp -94.17 123.41 37.54 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.358 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.773 HD13 ' HB2' ' A' ' 118' ' ' TRP . 45.5 mt -69.02 173.6 5.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.557 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.404 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.6 pt-20 -64.72 -29.7 70.69 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.14 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . 0.459 ' ND2' ' CD1' ' A' ' 118' ' ' TRP . 2.7 p30 -88.14 9.84 21.38 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.19 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.635 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 77.01 20.99 75.03 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.817 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.683 ' HB3' HD12 ' A' ' 134' ' ' LEU . 17.3 tpp180 -79.85 92.39 5.48 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.588 ' CD1' HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -66.81 119.89 12.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.501 -178.893 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.678 HD12 ' HB2' ' A' ' 132' ' ' PRO . 33.1 mt -88.17 76.49 8.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.306 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.453 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 15.7 mtpt -71.49 -5.86 36.22 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.002 -0.544 . . . . 0.0 112.454 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -94.97 -25.08 16.66 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.606 0.241 . . . . 0.0 111.078 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -87.16 -82.19 0.22 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.294 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.464 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . 59.52 153.84 0.02 OUTLIER Glycine 0 CA--C 1.506 -0.506 0 C-N-CA 121.337 -0.459 . . . . 0.0 112.8 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 10.1 t -137.77 152.35 49.08 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.127 -0.536 . . . . 0.0 110.61 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.31 51.34 1.89 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.566 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.12 147.43 2.57 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.741 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -90.9 125.11 60.08 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.332 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.467 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 71.6 Cg_endo -84.74 107.88 1.17 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.613 2.209 . . . . 0.0 112.659 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 25.8 t -69.52 -8.03 43.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.017 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -77.83 -24.49 48.68 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 120.879 0.371 . . . . 0.0 110.377 179.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.68 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -138.85 167.04 20.8 Favored Pre-proline 0 N--CA 1.452 -0.339 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.616 -179.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.68 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 70.2 Cg_endo -75.03 157.99 42.32 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.404 2.069 . . . . 0.0 112.572 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 13.6 t -118.97 110.72 30.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.095 0.474 . . . . 0.0 111.028 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.854 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.64 96.05 1.94 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.868 179.439 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.416 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 61.3 t -94.18 137.14 23.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.989 0.423 . . . . 0.0 111.048 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 48.83 57.02 9.03 Favored Glycine 0 C--N 1.332 0.345 0 CA-C-N 115.921 -0.581 . . . . 0.0 113.175 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.854 ' CE2' HD23 ' A' ' 155' ' ' LEU . 3.2 m95 -100.04 151.14 21.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.153 0.501 . . . . 0.0 111.843 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.411 ' HB2' ' CD2' ' A' ' 187' ' ' TYR . 0.0 OUTLIER -66.56 -172.27 0.16 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.438 179.288 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -43.6 154.39 0.09 Allowed 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.566 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.07 -25.63 54.2 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.262 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -60.22 -37.66 80.99 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.984 0.421 . . . . 0.0 110.027 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.14 -40.51 45.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.039 179.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.566 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.2 mt -58.73 -41.42 82.4 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.051 179.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.24 -29.92 48.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.067 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.462 ' CB ' HG21 ' A' ' 211' ' ' ILE . 5.0 mm-40 -68.26 -53.0 27.63 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 121.387 0.613 . . . . 0.0 110.117 179.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.811 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -59.12 -46.3 88.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.036 178.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.922 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -57.01 -36.78 70.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.549 179.231 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.75 -37.37 93.47 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 178.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -73.64 -45.78 50.71 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.315 -0.443 . . . . 0.0 111.077 179.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.574 ' HA ' HD22 ' A' ' 174' ' ' LEU . 11.0 mp -65.0 -29.69 70.62 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.828 0.347 . . . . 0.0 111.338 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.6 -16.99 63.5 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.365 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -114.23 -27.28 7.68 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.658 0.266 . . . . 0.0 111.633 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.574 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER -57.05 167.17 1.18 Allowed Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.269 -179.561 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -70.68 127.79 14.32 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.226 1.95 . . . . 0.0 112.938 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.04 -25.64 5.12 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.723 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.4 -50.17 73.86 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.968 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.867 HG11 ' HB3' ' A' ' 218' ' ' LEU . 34.7 t -74.18 -33.5 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.49 179.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.516 HD13 HD21 ' A' ' 174' ' ' LEU . 11.4 tp -56.46 -36.88 69.55 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.096 0.474 . . . . 0.0 109.935 179.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -77.36 -41.65 20.49 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.284 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -84.32 103.0 13.13 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.896 0.379 . . . . 0.0 110.558 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . 0.84 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.8 mtm 177.02 166.11 0.53 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.142 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 27.3 t -124.82 -53.99 1.64 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.732 0.301 . . . . 0.0 111.147 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -162.14 142.63 10.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.977 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.925 HG12 HG12 ' A' ' 199' ' ' VAL . 19.1 mt -104.89 115.44 46.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.472 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . 0.416 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 21.9 m170 -105.37 123.36 47.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.159 -179.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.411 ' CD2' ' HB2' ' A' ' 159' ' ' LYS . 14.0 t80 -78.82 104.35 9.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.438 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.406 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.584 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 . . . . . 0 CA--C 1.529 0.153 0 CA-C-O 120.617 0.246 . . . . 0.0 111.499 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 5.8 p30 -108.17 37.71 2.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.731 0.301 . . . . 0.0 110.819 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 9.5 ttt-85 -89.76 114.32 26.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.911 0.386 . . . . 0.0 111.2 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.852 ' O ' HD13 ' A' ' 198' ' ' ILE . 25.1 m -111.61 167.85 5.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.9 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.852 HD13 ' O ' ' A' ' 197' ' ' VAL . 22.7 mm -134.24 111.34 14.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.844 0.354 . . . . 0.0 110.974 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.925 HG12 HG12 ' A' ' 185' ' ' ILE . 6.7 m -100.31 120.15 49.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.21 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -81.88 152.46 26.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.661 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 7.6 mmt -105.6 157.89 17.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.99 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 39.5 m-20 -59.82 -27.03 66.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.142 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.02 13.27 13.33 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 89.1 -14.07 61.64 Favored Glycine 0 CA--C 1.52 0.397 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.247 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -58.13 156.03 10.24 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 117.133 0.467 . . . . 0.0 110.96 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -131.3 111.31 11.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.919 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 20.8 t -107.03 141.92 21.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.04 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 5.6 m -112.41 116.87 31.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.883 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.607 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -128.58 162.48 27.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.804 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.7 154.91 17.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.584 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.462 HG21 ' CB ' ' A' ' 166' ' ' GLU . 40.5 mt -67.3 -35.7 74.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.804 0.335 . . . . 0.0 110.96 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -38.4 91.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.24 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -128.09 40.64 3.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.914 0.388 . . . . 0.0 110.892 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.572 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 11.1 t80 -62.56 -54.35 41.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.768 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.1 -41.38 78.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.276 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.62 -46.58 68.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.075 0.464 . . . . 0.0 110.421 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.6 -44.75 77.29 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.883 179.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.867 ' HB3' HG11 ' A' ' 178' ' ' VAL . 3.9 mm? -83.31 -25.05 31.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.037 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 13.0 t -60.97 -33.14 72.76 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.062 0.458 . . . . 0.0 110.131 179.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 9.6 m170 . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.268 179.181 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 121.005 0.431 . . . . 0.0 111.047 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.759 ' HB2' HD13 ' A' ' 134' ' ' LEU . 80.6 m95 -68.42 168.3 12.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.237 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 11.4 ttt180 -102.49 137.66 40.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.348 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 24.8 mtt85 -72.91 106.48 4.84 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.861 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.9 HD11 HG22 ' A' ' 168' ' ' THR . 46.6 pt -95.61 -8.1 9.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.361 179.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.475 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -158.75 176.45 12.34 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 120.578 0.228 . . . . 0.0 110.708 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.465 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 29.8 m-85 -144.94 126.45 15.01 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.688 HG21 HD11 ' A' ' 139' ' ' LEU . 4.3 t -93.08 122.61 44.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.091 0.472 . . . . 0.0 111.267 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.472 ' CE1' ' CE1' ' A' ' 130' ' ' PHE . 9.3 t80 -83.96 100.01 10.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.842 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -151.76 151.8 31.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.601 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 60.0 30.88 20.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 63.4 32.41 14.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.2 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.573 HG23 ' O ' ' A' ' 145' ' ' THR . 87.8 m -152.89 149.02 27.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.828 0.347 . . . . 0.0 110.988 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.755 ' CE2' ' HB2' ' A' ' 148' ' ' ALA . 24.2 m-85 -93.69 91.0 6.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.713 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.565 ' HB2' HD21 ' A' ' 139' ' ' LEU . 24.7 m-85 -66.05 120.79 72.27 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.141 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -68.12 115.5 3.86 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.045 1.83 . . . . 0.0 112.539 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.661 HD21 ' OG1' ' A' ' 168' ' ' THR . 34.1 tp -95.0 124.2 38.91 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.787 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.759 HD13 ' HB2' ' A' ' 118' ' ' TRP . 42.5 mt -69.89 175.47 4.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.5 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.41 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.3 pt-20 -66.52 -28.41 68.53 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.125 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 32.7 p-10 -90.47 13.21 16.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.235 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.615 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 73.79 20.15 79.76 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.978 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.69 ' HB3' HD12 ' A' ' 134' ' ' LEU . 0.7 OUTLIER -79.04 94.14 5.25 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.326 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.688 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -70.45 116.37 10.7 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.652 -178.875 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.474 HD23 ' HG3' ' A' ' 143' ' ' GLU . 10.4 mp -90.35 76.25 6.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.343 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.478 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 4.5 mttt -61.46 -15.46 37.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.241 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -94.38 -24.11 17.5 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.474 ' HG3' HD23 ' A' ' 140' ' ' LEU . 68.7 mm-40 -99.81 26.82 5.91 Favored 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . -62.95 163.66 29.13 Favored Glycine 0 CA--C 1.51 -0.222 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.885 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.573 ' O ' HG23 ' A' ' 129' ' ' THR . 7.1 t -130.79 158.2 40.8 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.877 0.37 . . . . 0.0 110.712 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -94.42 49.32 1.27 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.513 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.3 154.64 4.0 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.609 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.755 ' HB2' ' CE2' ' A' ' 130' ' ' PHE . . . -97.64 125.53 44.43 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.24 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.465 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 73.7 Cg_endo -83.06 111.9 1.96 Allowed 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.4 2.066 . . . . 0.0 112.573 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 11.0 t -69.48 -8.14 44.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.175 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -77.11 -23.54 51.81 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 120.88 0.372 . . . . 0.0 110.507 179.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.672 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -138.97 166.92 21.43 Favored Pre-proline 0 N--CA 1.452 -0.336 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.669 -179.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.672 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 67.7 Cg_endo -74.83 154.33 43.32 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.401 2.067 . . . . 0.0 112.308 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 10.6 t -116.04 110.48 31.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.93 0.395 . . . . 0.0 111.293 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.849 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.36 95.94 1.81 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.552 179.025 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.415 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 60.1 t -91.98 136.12 25.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.946 0.403 . . . . 0.0 111.116 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 48.83 58.75 7.34 Favored Glycine 0 CA--C 1.521 0.468 0 CA-C-N 115.837 -0.619 . . . . 0.0 113.189 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.849 ' CE2' HD23 ' A' ' 155' ' ' LEU . 3.1 m95 -101.31 151.17 22.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.198 0.523 . . . . 0.0 111.834 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.42 -172.24 0.15 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.412 179.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -42.92 154.49 0.07 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.532 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.51 -25.84 55.86 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.157 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.97 -38.85 80.05 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.967 0.413 . . . . 0.0 109.943 179.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.64 -39.98 50.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.009 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.532 HD12 ' HA2' ' A' ' 161' ' ' GLY . 5.8 mt -59.28 -41.39 83.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.903 178.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.9 -31.06 48.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.129 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.419 ' HB3' HG21 ' A' ' 211' ' ' ILE . 2.6 mm-40 -67.8 -53.02 30.37 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.386 0.613 . . . . 0.0 110.138 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.82 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -59.24 -44.56 92.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.01 179.095 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.9 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -58.42 -37.55 75.61 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.545 179.106 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.89 -36.86 91.48 Favored Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 178.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -73.83 -46.33 45.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.342 -0.429 . . . . 0.0 111.008 178.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.592 ' HA ' HD22 ' A' ' 174' ' ' LEU . 11.3 mp -66.22 -28.01 68.41 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.683 0.278 . . . . 0.0 111.349 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.87 -17.22 62.73 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.682 -0.236 . . . . 0.0 111.291 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -112.62 -29.85 7.31 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.653 0.263 . . . . 0.0 111.345 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.592 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER -55.44 167.32 0.76 Allowed Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.216 -179.651 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.416 ' HG2' HG23 ' A' ' 178' ' ' VAL . 47.9 Cg_endo -69.63 128.78 16.63 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.208 1.939 . . . . 0.0 112.921 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.28 -25.63 9.95 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.535 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -58.82 -48.59 80.78 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.894 0.378 . . . . 0.0 110.927 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.873 HG11 ' HB3' ' A' ' 218' ' ' LEU . 23.0 t -73.51 -35.69 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.649 179.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.432 ' HB2' HD21 ' A' ' 174' ' ' LEU . 4.8 tp -55.85 -34.31 65.33 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.128 0.49 . . . . 0.0 110.075 179.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -78.77 -41.9 14.25 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.295 178.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -84.99 102.86 13.52 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.884 0.373 . . . . 0.0 110.632 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . 0.844 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.8 mtm 177.22 161.81 0.47 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.146 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 12.3 t -117.18 -57.63 2.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.749 0.309 . . . . 0.0 110.908 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -160.91 142.31 11.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.001 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.904 HG12 HG12 ' A' ' 199' ' ' VAL . 16.3 mt -102.1 114.51 41.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.316 179.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . 0.415 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 21.6 m170 -104.34 122.58 45.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.237 -179.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -74.5 104.25 5.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.275 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 11.8 mmtt . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.692 -179.748 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.623 0.249 . . . . 0.0 111.484 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -107.01 36.52 2.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.75 0.31 . . . . 0.0 110.976 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 6.4 ttt85 -89.58 115.03 26.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.979 0.419 . . . . 0.0 111.15 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.839 ' O ' HD13 ' A' ' 198' ' ' ILE . 27.2 m -111.67 166.68 5.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.729 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.839 HD13 ' O ' ' A' ' 197' ' ' VAL . 22.7 mm -133.52 108.9 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.821 0.343 . . . . 0.0 111.222 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.904 HG12 HG12 ' A' ' 185' ' ' ILE . 9.1 m -99.08 122.65 51.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.088 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -85.14 152.48 23.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.761 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 4.7 mmt -104.97 158.88 16.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.017 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -63.22 -26.64 68.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.13 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -87.09 11.16 14.5 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 83.65 14.51 73.06 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.539 -0.838 . . . . 0.0 113.281 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -82.14 166.83 19.33 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 117.073 0.437 . . . . 0.0 110.845 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -133.72 111.67 10.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.879 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.416 ' HB ' HG23 ' A' ' 199' ' ' VAL . 21.4 t -114.63 125.26 71.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.131 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . 0.557 ' HB3' HD12 ' A' ' 198' ' ' ILE . 2.0 p -101.18 116.1 32.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.76 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.664 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -126.87 159.89 32.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.872 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.47 152.52 19.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.687 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.419 HG21 ' HB3' ' A' ' 166' ' ' GLU . 35.2 mt -64.37 -38.29 82.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.95 0.405 . . . . 0.0 110.642 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 2.2 ptt85 -60.01 -34.61 73.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.205 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -134.77 45.5 2.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.933 0.397 . . . . 0.0 111.034 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.6 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 10.9 t80 -67.75 -53.9 23.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.712 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.2 -39.81 76.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.264 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.99 -48.84 62.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.101 0.477 . . . . 0.0 110.284 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.27 -42.51 66.59 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.14 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.873 ' HB3' HG11 ' A' ' 178' ' ' VAL . 3.9 mm? -86.95 -23.48 25.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.042 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 11.2 t -60.99 -33.15 72.79 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.901 0.381 . . . . 0.0 110.22 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 30.2 m170 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.204 179.394 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 121.066 0.46 . . . . 0.0 110.997 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.763 ' HB2' HD13 ' A' ' 134' ' ' LEU . 78.8 m95 -67.3 168.09 11.18 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.06 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? -103.05 138.77 39.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.287 179.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.26 105.73 4.79 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 120.822 0.344 . . . . 0.0 110.669 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.867 HD11 HG22 ' A' ' 168' ' ' THR . 46.6 pt -95.04 -7.55 9.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.501 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.526 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -160.15 176.36 11.86 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 120.766 0.317 . . . . 0.0 110.946 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.471 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 35.7 m-85 -144.98 126.93 15.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.821 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.516 HG21 HD11 ' A' ' 139' ' ' LEU . 6.1 t -93.21 122.91 45.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.155 0.503 . . . . 0.0 111.587 -179.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.437 ' CE1' ' CE1' ' A' ' 130' ' ' PHE . 34.7 t80 -83.11 94.38 7.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.916 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -144.76 152.97 41.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.437 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.86 30.32 19.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.812 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 62.13 34.25 16.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.934 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.454 HG22 ' N ' ' A' ' 130' ' ' PHE . 58.5 m -151.04 161.93 41.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.993 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.641 ' CE2' ' HB2' ' A' ' 148' ' ' ALA . 16.8 m-85 -104.61 91.14 3.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.256 0.551 . . . . 0.0 110.897 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.489 ' HB2' HD21 ' A' ' 139' ' ' LEU . 23.8 m-85 -69.62 121.55 82.81 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.547 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.436 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 21.1 Cg_exo -65.2 122.16 9.82 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 122.374 2.05 . . . . 0.0 112.549 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.697 HD21 ' OG1' ' A' ' 168' ' ' THR . 31.0 tp -104.12 123.48 47.34 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.296 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.763 HD13 ' HB2' ' A' ' 118' ' ' TRP . 53.6 mt -71.58 174.92 6.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.582 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.421 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.3 pt-20 -64.93 -29.06 69.97 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.915 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 14.9 p-10 -91.17 13.66 16.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.152 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.638 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 74.95 22.52 76.7 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.059 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.674 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -76.0 92.76 3.18 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.412 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.516 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -70.64 119.86 15.41 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.023 0.439 . . . . 0.0 111.607 -179.083 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.421 HD12 ' HG2' ' A' ' 143' ' ' GLU . 4.0 mm? -92.24 72.91 5.38 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.711 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.467 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 0.4 OUTLIER -61.05 -16.84 48.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.012 -179.753 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -95.52 -20.0 19.37 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.421 ' HG2' HD12 ' A' ' 140' ' ' LEU . 39.9 mm-40 -102.23 25.7 8.57 Favored 'General case' 0 N--CA 1.461 0.111 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.436 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -58.43 162.6 10.29 Favored Glycine 0 CA--C 1.509 -0.337 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.708 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 11.1 t -136.33 150.83 49.04 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.767 0.317 . . . . 0.0 110.67 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.438 ' HE2' HG23 ' A' ' 129' ' ' THR . 3.9 mmtt -88.99 52.19 2.35 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.005 0.431 . . . . 0.0 110.705 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.23 149.46 2.81 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.658 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.641 ' HB2' ' CE2' ' A' ' 130' ' ' PHE . . . -94.6 125.66 50.7 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.324 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.471 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 75.2 Cg_endo -84.24 111.26 1.58 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.49 2.126 . . . . 0.0 112.638 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.3 t -69.91 -7.53 41.16 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.035 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -77.09 -23.2 51.9 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 120.806 0.336 . . . . 0.0 110.58 179.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.681 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -140.47 167.11 18.96 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.944 -179.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.681 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 62.7 Cg_endo -74.48 154.33 45.1 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.351 2.034 . . . . 0.0 112.133 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 14.3 t -115.47 111.12 34.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.019 0.437 . . . . 0.0 111.286 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.807 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.36 96.11 1.83 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.747 179.052 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.436 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 62.6 t -92.74 135.78 26.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.901 0.382 . . . . 0.0 110.936 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 48.77 58.28 7.75 Favored Glycine 0 CA--C 1.521 0.443 0 CA-C-N 115.963 -0.562 . . . . 0.0 113.209 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.807 ' CE2' HD23 ' A' ' 155' ' ' LEU . 3.0 m95 -101.13 151.3 22.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.206 0.526 . . . . 0.0 111.787 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -65.49 -173.34 0.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.319 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -43.81 154.88 0.09 Allowed 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.552 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.26 -25.13 53.86 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.134 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -59.95 -38.52 82.69 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.921 0.391 . . . . 0.0 110.107 179.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.89 -41.02 45.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.056 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.552 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.1 mt -58.08 -41.89 81.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.016 179.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.87 -30.54 46.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.228 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -68.74 -53.02 24.48 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 121.548 0.689 . . . . 0.0 110.026 179.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.766 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -60.11 -42.94 95.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.947 178.958 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.867 HG22 HD11 ' A' ' 121' ' ' ILE . 0.3 OUTLIER -59.51 -37.01 77.16 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.296 179.22 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.17 -39.52 94.59 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 110.556 -1.017 . . . . 0.0 110.556 178.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 48.1 mm-40 -69.72 -45.73 67.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.427 -0.387 . . . . 0.0 110.782 178.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.611 ' HA ' HD22 ' A' ' 174' ' ' LEU . 11.0 mp -66.58 -26.94 67.35 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.695 0.284 . . . . 0.0 111.462 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.98 -19.12 62.57 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.223 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -112.63 -26.67 8.52 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.573 0.225 . . . . 0.0 111.505 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.611 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER -57.55 167.4 1.34 Allowed Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.089 -179.754 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -70.66 127.9 14.48 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.201 1.934 . . . . 0.0 112.943 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.08 -25.28 8.34 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.597 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.44 -49.33 76.6 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.856 0.36 . . . . 0.0 110.944 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.866 HG11 ' HB3' ' A' ' 218' ' ' LEU . 39.9 t -74.24 -36.11 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.451 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.493 ' HB2' HD21 ' A' ' 174' ' ' LEU . 12.7 tp -55.13 -37.01 66.37 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.09 0.472 . . . . 0.0 110.11 179.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -78.39 -39.09 23.44 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.393 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -87.29 103.04 15.08 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.9 0.381 . . . . 0.0 110.73 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . 0.834 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.8 mtm 178.05 176.61 0.44 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.053 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 9.1 t -132.07 -54.77 0.98 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.783 0.325 . . . . 0.0 111.129 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -162.17 142.52 10.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.021 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.89 HG12 HG12 ' A' ' 199' ' ' VAL . 19.7 mt -104.76 114.69 45.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.34 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . 0.436 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 20.0 m170 -106.21 126.28 52.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.079 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -77.39 104.83 8.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.517 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 11.8 mmtp . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.351 179.733 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 . . . . . 0 CA--C 1.53 0.197 0 CA-C-O 120.571 0.224 . . . . 0.0 111.376 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -104.11 35.88 2.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.749 0.309 . . . . 0.0 110.881 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -89.95 113.15 24.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.044 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.875 ' O ' HD13 ' A' ' 198' ' ' ILE . 19.7 m -109.8 168.31 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.88 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.875 HD13 ' O ' ' A' ' 197' ' ' VAL . 22.8 mm -135.14 110.54 12.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.708 0.29 . . . . 0.0 111.242 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.89 HG12 HG12 ' A' ' 185' ' ' ILE . 10.6 m -99.09 133.97 39.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.963 0.411 . . . . 0.0 110.878 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -95.98 152.5 18.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.765 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 25.2 tpp -112.28 150.61 30.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.745 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 21.1 p30 -57.47 -28.93 63.81 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.28 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -72.69 -8.78 57.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.768 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 96.73 14.55 43.07 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 120.473 -0.87 . . . . 0.0 113.1 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -90.82 162.55 14.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 117.026 0.413 . . . . 0.0 111.018 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -126.85 111.26 13.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.809 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 20.6 t -109.36 137.52 41.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.067 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 10.7 p -109.58 118.66 37.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.967 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -127.07 172.54 10.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.679 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.33 154.5 27.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.609 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 31.9 mt -66.01 -35.45 75.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.812 0.339 . . . . 0.0 110.938 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.7 -35.63 81.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.194 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -134.83 47.53 2.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.016 0.436 . . . . 0.0 111.005 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.583 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 10.5 t80 -69.35 -50.81 42.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.613 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.97 -42.22 84.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.256 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -67.37 -47.68 69.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.986 0.422 . . . . 0.0 110.397 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.9 -45.34 74.69 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.09 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.866 ' HB3' HG11 ' A' ' 178' ' ' VAL . 4.4 mm? -82.12 -26.25 33.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.979 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 13.5 t -60.38 -32.46 71.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.002 0.429 . . . . 0.0 110.217 179.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.9 m170 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.118 179.255 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 121.107 0.479 . . . . 0.0 110.935 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.731 ' HB2' HD13 ' A' ' 134' ' ' LEU . 79.5 m95 -67.11 168.27 10.5 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.068 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -102.79 135.41 44.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.466 179.449 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 15.0 mtt180 -71.42 105.49 3.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.743 -179.906 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.91 HD11 HG22 ' A' ' 168' ' ' THR . 45.3 pt -93.53 -8.31 10.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.503 179.455 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -159.16 176.53 12.12 Favored 'General case' 0 C--O 1.226 -0.178 0 C-N-CA 121.037 -0.265 . . . . 0.0 111.0 179.885 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.464 ' O ' ' HA ' ' A' ' 154' ' ' VAL . 32.3 m-85 -143.28 126.8 16.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.455 179.78 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.638 HG21 HD11 ' A' ' 139' ' ' LEU . 4.5 t -93.47 123.01 45.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.05 0.453 . . . . 0.0 111.133 -179.607 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.428 ' CD1' ' CE1' ' A' ' 130' ' ' PHE . 37.3 t80 -80.19 103.02 9.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.748 -179.889 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -159.18 155.44 27.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.559 -179.808 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.19 31.61 19.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.849 -179.851 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 60.41 31.38 20.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.0 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.45 HG23 ' HE2' ' A' ' 146' ' ' LYS . 86.3 m -154.05 161.87 41.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.846 179.929 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.446 ' N ' HG22 ' A' ' 129' ' ' THR . 8.9 m-85 -100.65 90.4 4.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.669 179.625 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.502 ' HA ' ' HA2' ' A' ' 144' ' ' GLY . 22.3 m-85 -65.41 125.44 89.52 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.811 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.4 ' HB3' ' CE2' ' A' ' 123' ' ' TYR . 60.9 Cg_endo -73.66 120.17 6.3 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.219 1.946 . . . . 0.0 112.372 -179.773 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.676 HD21 ' OG1' ' A' ' 168' ' ' THR . 27.4 tp -98.04 123.58 42.13 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.489 179.636 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.731 HD13 ' HB2' ' A' ' 118' ' ' TRP . 37.0 mt -69.63 172.68 7.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.464 -179.747 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -63.81 -28.32 69.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.998 179.706 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 50.5 p-10 -90.59 13.43 15.93 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.281 179.781 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.599 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 73.1 22.36 79.07 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.227 179.797 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.66 ' HB3' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -81.01 94.44 6.56 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.519 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.638 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -73.42 112.49 9.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.362 -179.04 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 34.3 mt -88.84 81.25 6.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.405 179.418 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.456 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 9.6 mtpt -71.13 -5.61 33.03 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -179.388 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -90.41 -27.14 19.51 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.635 0.255 . . . . 0.0 111.183 179.885 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -85.81 -79.98 0.23 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.76 0.314 . . . . 0.0 111.322 -179.707 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.502 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . 57.83 161.13 0.04 OUTLIER Glycine 0 CA--C 1.506 -0.514 0 CA-C-N 116.29 -0.413 . . . . 0.0 112.708 -179.572 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.9 t -140.07 148.67 42.11 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.357 -0.422 . . . . 0.0 110.842 -179.548 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.45 ' HE2' HG23 ' A' ' 129' ' ' THR . 4.0 mmtt -89.85 52.56 2.32 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.381 179.807 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.98 154.48 4.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.093 0.473 . . . . 0.0 110.613 -179.358 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.33 135.41 34.63 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.597 -179.493 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.45 ' HD2' ' CG2' ' A' ' 154' ' ' VAL . 67.1 Cg_endo -83.81 98.73 0.79 Allowed 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 122.993 2.462 . . . . 0.0 112.535 179.689 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 43.9 t -67.23 -9.57 41.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.786 179.468 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -90.15 -22.2 21.85 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 120.615 0.245 . . . . 0.0 111.572 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.723 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -138.9 167.75 18.16 Favored Pre-proline 0 C--N 1.329 -0.287 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -178.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.723 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 64.7 Cg_endo -74.22 163.97 35.29 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 122.469 2.113 . . . . 0.0 112.511 -179.863 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 20.1 t -123.73 109.05 22.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.517 -179.755 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.826 HD21 ' SD ' ' A' ' 167' ' ' MET . 1.1 mp -72.8 95.97 1.99 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.694 179.107 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 53.5 t -92.57 136.46 24.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.983 0.421 . . . . 0.0 111.231 -179.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 49.21 49.17 31.55 Favored Glycine 0 CA--C 1.519 0.299 0 CA-C-N 115.783 -0.644 . . . . 0.0 113.381 179.16 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.823 ' CE2' HD23 ' A' ' 155' ' ' LEU . 2.7 m95 -92.2 151.1 20.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.102 0.477 . . . . 0.0 111.371 -179.622 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -172.55 0.08 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.539 179.542 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -43.99 154.34 0.11 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.088 -0.506 . . . . 0.0 112.21 -179.846 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.534 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.41 -24.75 53.19 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.147 179.448 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.8 -39.23 84.31 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-O 120.959 0.409 . . . . 0.0 110.137 179.219 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.65 -40.84 47.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.054 178.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.534 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.2 mt -58.13 -41.68 81.28 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.093 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.991 179.104 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.21 -28.69 28.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.151 179.494 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -69.15 -53.23 21.19 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-O 121.474 0.654 . . . . 0.0 110.172 179.348 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.826 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -59.84 -45.11 93.45 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.11 179.051 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.91 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -56.84 -38.82 73.19 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.592 179.344 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.14 -37.73 92.12 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 178.26 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -72.03 -46.47 56.97 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.375 -0.412 . . . . 0.0 111.073 178.822 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.595 ' HA ' HD22 ' A' ' 174' ' ' LEU . 10.9 mp -65.88 -28.73 69.17 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.724 0.297 . . . . 0.0 111.414 179.785 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.82 -18.12 63.43 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.363 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -113.8 -26.79 8.03 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 111.661 0.245 . . . . 0.0 111.661 -179.73 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.595 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER -57.32 167.27 1.28 Allowed Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 116.682 -0.236 . . . . 0.0 111.22 -179.561 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -67.68 126.32 14.56 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.215 1.943 . . . . 0.0 112.796 179.74 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.92 -26.07 9.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.676 179.805 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -58.5 -48.83 79.52 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.873 0.368 . . . . 0.0 110.891 179.683 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.851 HG11 ' HB3' ' A' ' 218' ' ' LEU . 25.3 t -73.7 -33.7 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.531 179.515 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.401 ' HB2' HD21 ' A' ' 174' ' ' LEU . 11.4 tp -56.87 -35.78 69.3 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.135 0.493 . . . . 0.0 109.816 178.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -77.05 -42.39 19.83 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.276 178.74 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -84.13 103.02 13.0 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.829 0.347 . . . . 0.0 110.656 179.232 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . 0.85 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.9 mtm 178.85 159.76 0.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.123 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -118.36 -54.53 2.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.814 0.34 . . . . 0.0 111.122 -179.743 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -162.66 142.63 9.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.999 -179.834 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.912 HG12 HG12 ' A' ' 199' ' ' VAL . 17.7 mt -105.23 115.04 46.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.422 179.4 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 23.2 m170 -105.69 129.37 53.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.164 -179.499 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -82.2 104.54 12.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.521 179.663 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.65 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.529 0.149 0 CA-C-O 120.861 0.362 . . . . 0.0 111.101 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . 0.592 ' OD1' HG22 ' A' ' 210' ' ' THR . 1.8 p30 -99.86 34.03 2.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.612 179.787 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.48 111.64 22.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.422 -179.491 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.869 ' O ' HD13 ' A' ' 198' ' ' ILE . 33.3 m -107.78 169.46 2.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.495 179.384 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.869 HD13 ' O ' ' A' ' 197' ' ' VAL . 15.1 mm -136.03 109.67 9.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.785 0.326 . . . . 0.0 111.2 179.888 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.912 HG12 HG12 ' A' ' 185' ' ' ILE . 9.9 m -97.85 120.9 47.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.081 179.727 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -81.76 152.65 26.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.788 -179.984 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 4.6 mmt -109.44 146.93 33.7 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.604 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -58.13 -29.07 65.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.073 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -78.21 -2.17 36.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.836 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 95.3 14.49 47.91 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 120.478 -0.867 . . . . 0.0 113.142 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -89.51 157.14 18.21 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.972 0.386 . . . . 0.0 111.04 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -125.84 111.54 14.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.724 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 22.8 t -110.77 139.59 33.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.139 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . 0.587 ' OG ' HD12 ' A' ' 198' ' ' ILE . 14.5 m -110.36 118.33 36.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.737 179.869 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.51 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -128.42 164.57 22.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.888 0.375 . . . . 0.0 111.067 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.592 HG22 ' OD1' ' A' ' 195' ' ' ASP . 0.6 OUTLIER -103.67 155.38 18.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.507 179.842 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 25.7 mt -62.91 -27.48 43.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.008 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . 0.405 ' CZ ' ' HB3' ' A' ' 212' ' ' ARG . 0.0 OUTLIER -82.48 -41.9 19.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.742 0.306 . . . . 0.0 111.009 179.877 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -108.78 32.12 5.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.121 -179.931 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.558 ' CE1' HD11 ' A' ' 171' ' ' LEU . 11.3 t80 -64.25 -54.59 30.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.94 0.4 . . . . 0.0 110.284 179.737 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.71 -38.36 90.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.611 179.685 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -68.32 -51.95 39.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.436 179.53 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 1.8 mmmm -54.33 -43.02 70.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.951 179.819 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.851 ' HB3' HG11 ' A' ' 178' ' ' VAL . 4.1 mm? -82.32 -24.96 34.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.769 179.3 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 10.2 t -61.75 -31.74 71.94 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.851 0.357 . . . . 0.0 110.191 179.26 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.068 179.596 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 121.176 0.512 . . . . 0.0 111.103 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.762 ' HB2' HD13 ' A' ' 134' ' ' LEU . 78.8 m95 -72.21 168.2 18.75 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.955 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -102.75 136.1 43.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.542 179.559 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 73.4 mtt180 -71.69 105.87 3.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.833 0.349 . . . . 0.0 110.669 -179.875 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.898 HD11 HG22 ' A' ' 168' ' ' THR . 45.9 pt -94.06 -8.82 9.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.472 179.31 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -158.62 176.36 12.49 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 120.629 0.252 . . . . 0.0 110.76 179.926 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.457 ' O ' ' HA ' ' A' ' 154' ' ' VAL . 32.2 m-85 -143.07 127.0 17.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.378 179.771 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.618 HG21 HD11 ' A' ' 139' ' ' LEU . 5.3 t -93.51 122.79 45.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.32 -179.464 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.432 ' CD1' ' CE1' ' A' ' 130' ' ' PHE . 42.4 t80 -80.67 107.1 13.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.844 -179.943 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -163.47 154.24 16.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.521 -179.866 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.54 30.59 19.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.865 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 61.82 32.28 18.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.15 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 73.3 m -154.98 155.29 33.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.036 179.841 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.432 ' CE1' ' CD1' ' A' ' 125' ' ' TYR . 7.0 m-85 -96.26 91.11 5.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.463 179.567 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.496 ' HB2' HD21 ' A' ' 139' ' ' LEU . 24.2 m-85 -65.52 123.98 85.98 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.964 -179.626 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.407 ' HB3' ' CE2' ' A' ' 123' ' ' TYR . 55.4 Cg_endo -71.53 114.62 4.0 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 122.171 1.914 . . . . 0.0 112.743 -179.552 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.704 HD21 ' OG1' ' A' ' 168' ' ' THR . 29.0 tp -93.36 123.83 36.93 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.632 179.453 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.762 HD13 ' HB2' ' A' ' 118' ' ' TRP . 45.0 mt -69.51 173.66 5.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.47 -179.851 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.401 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 2.1 pt-20 -64.71 -28.35 69.53 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.118 179.751 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 42.7 p-10 -90.33 12.58 17.85 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.301 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.598 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 74.08 22.74 77.48 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.987 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.682 ' HB3' HD12 ' A' ' 134' ' ' LEU . 15.1 tpp85 -82.14 93.42 7.04 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.539 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.618 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -69.51 108.76 3.92 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.155 -179.212 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 15.8 mt -85.53 72.03 10.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.821 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.445 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 19.7 mttt -57.96 -20.85 40.97 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.45 179.873 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -94.09 19.74 8.82 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.42 179.578 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -144.49 25.32 1.51 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.655 0.264 . . . . 0.0 111.151 179.781 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . -58.98 166.69 7.59 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.88 -179.683 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 10.2 t -132.41 150.44 52.16 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.873 0.368 . . . . 0.0 110.751 -179.878 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.02 52.1 2.08 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.436 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.72 158.47 6.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.094 0.473 . . . . 0.0 110.678 -179.399 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -91.2 136.13 27.55 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.61 -179.504 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.448 ' HD2' ' CG2' ' A' ' 154' ' ' VAL . 62.9 Cg_endo -84.09 98.57 0.76 Allowed 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.11 2.54 . . . . 0.0 112.621 179.78 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 4.9 t -67.36 -9.66 43.51 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.713 179.363 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -90.21 -21.8 21.98 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.698 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -138.78 167.09 20.7 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.019 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.698 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 60.2 Cg_endo -73.76 163.55 36.91 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 122.5 2.134 . . . . 0.0 112.382 179.986 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 25.2 t -124.09 109.89 24.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.051 0.453 . . . . 0.0 111.591 -179.798 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.858 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.6 96.18 1.94 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.836 179.228 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.427 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 57.4 t -92.33 137.31 22.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.055 -179.928 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 47.5 56.96 7.76 Favored Glycine 0 CA--C 1.52 0.393 0 CA-C-N 115.855 -0.611 . . . . 0.0 113.231 179.371 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.858 ' CE2' HD23 ' A' ' 155' ' ' LEU . 2.9 m95 -99.44 151.16 21.42 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.185 0.516 . . . . 0.0 111.756 -179.386 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.66 -172.1 0.16 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.509 179.377 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -42.58 154.29 0.06 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.68 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.533 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.15 -24.68 52.04 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.232 179.491 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.05 -40.54 89.8 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-O 120.975 0.417 . . . . 0.0 110.041 179.193 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -74.25 -40.66 62.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.935 178.88 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.533 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.1 mt -58.92 -41.06 81.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.931 178.885 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.73 -31.0 57.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.25 179.881 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.418 ' CB ' HG21 ' A' ' 211' ' ' ILE . 5.4 mm-40 -67.63 -52.97 31.95 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-O 121.434 0.635 . . . . 0.0 110.245 179.571 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.819 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -59.45 -44.28 92.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.175 179.151 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.898 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -58.85 -38.16 78.11 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.534 179.271 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.37 -37.35 91.84 Favored Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 178.493 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 40.8 mm-40 -73.4 -45.71 53.06 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.403 -0.399 . . . . 0.0 111.199 179.035 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.573 ' HA ' HD22 ' A' ' 174' ' ' LEU . 11.0 mp -65.8 -29.55 70.05 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.688 0.28 . . . . 0.0 111.295 179.836 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.4 -19.98 64.64 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.335 -179.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -111.61 -26.75 8.87 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.613 0.244 . . . . 0.0 111.511 -179.834 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.573 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.1 OUTLIER -56.72 166.53 1.29 Allowed Pre-proline 0 CA--C 1.538 0.516 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.06 -179.665 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -69.7 128.07 15.55 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.269 1.979 . . . . 0.0 112.692 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.97 -25.9 5.29 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.676 179.802 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.76 -50.06 74.51 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.844 0.354 . . . . 0.0 111.037 179.701 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.868 HG11 ' HB3' ' A' ' 218' ' ' LEU . 30.1 t -74.11 -35.61 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.582 179.638 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.544 HD23 ' HD3' ' A' ' 153' ' ' PRO . 0.5 OUTLIER -56.98 -34.35 68.01 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.108 0.48 . . . . 0.0 109.772 179.002 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -78.48 -38.86 23.73 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 178.578 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -88.35 103.17 15.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.947 0.403 . . . . 0.0 110.774 179.229 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . 0.838 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.9 mtm 178.73 166.72 0.88 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.987 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.4 t -127.04 -51.48 1.43 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.706 0.289 . . . . 0.0 111.51 -179.613 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -163.06 142.83 8.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.934 0.397 . . . . 0.0 111.082 -179.668 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.93 HG12 HG12 ' A' ' 199' ' ' VAL . 19.0 mt -108.7 115.14 48.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.54 179.516 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . 0.427 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 22.2 m170 -106.14 123.4 47.95 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.952 -179.684 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -76.35 105.38 7.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.617 179.75 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.643 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 CA--C 1.529 0.168 0 N-CA-C 111.641 0.237 . . . . 0.0 111.641 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . 0.5 ' OD1' HG22 ' A' ' 210' ' ' THR . 2.4 p30 -110.3 37.45 2.72 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.624 0.249 . . . . 0.0 111.07 -179.812 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.19 117.34 28.87 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.04 0.448 . . . . 0.0 111.255 -179.795 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.878 ' O ' HD13 ' A' ' 198' ' ' ILE . 31.7 m -112.73 169.84 4.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.73 179.655 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.878 HD13 ' O ' ' A' ' 197' ' ' VAL . 22.7 mm -134.61 111.12 13.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.774 0.321 . . . . 0.0 111.356 179.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.93 HG12 HG12 ' A' ' 185' ' ' ILE . 10.7 m -100.23 133.58 42.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.877 179.601 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -95.11 152.51 18.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.799 179.954 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 6.5 mmt -105.12 166.74 10.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.937 0.398 . . . . 0.0 111.051 -179.904 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 19.5 p30 -69.37 -26.39 64.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.195 179.884 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -88.48 12.57 14.04 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -179.856 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 83.05 14.34 75.16 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.554 -0.831 . . . . 0.0 113.311 179.718 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -82.98 150.94 26.08 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 117.127 0.463 . . . . 0.0 110.626 179.886 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -121.75 111.43 17.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.889 -179.922 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.6 t -113.03 140.24 34.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.142 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . 0.575 ' HB2' HD12 ' A' ' 198' ' ' ILE . 26.6 t -113.69 119.43 37.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.783 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.664 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -130.21 159.29 37.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.857 179.803 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.5 HG22 ' OD1' ' A' ' 195' ' ' ASP . 0.6 OUTLIER -92.36 156.56 17.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.68 179.747 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.418 HG21 ' CB ' ' A' ' 166' ' ' GLU . 33.9 mt -70.41 -34.82 59.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.764 0.316 . . . . 0.0 110.749 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.5 -30.89 70.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.215 -179.467 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -130.62 35.85 3.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.898 179.984 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.587 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 11.8 t80 -63.08 -52.7 61.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.801 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.43 -40.22 86.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.062 -179.918 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.21 -49.77 58.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.077 0.465 . . . . 0.0 110.439 179.589 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.23 -43.79 71.16 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.027 179.701 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.868 ' HB3' HG11 ' A' ' 178' ' ' VAL . 4.0 mm? -82.7 -26.32 32.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.97 179.517 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 12.2 t -60.81 -31.61 71.01 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.996 0.427 . . . . 0.0 110.386 179.463 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.27 179.532 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 121.101 0.477 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.741 ' HB2' HD13 ' A' ' 134' ' ' LEU . 81.0 m95 -65.71 168.35 7.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.142 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.43 HH11 HG22 ' A' ' 121' ' ' ILE . 3.6 tmt_? -102.25 135.23 44.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.53 179.536 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 6.6 mtm-85 -71.29 105.28 3.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.673 -179.923 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.86 HD11 HG22 ' A' ' 168' ' ' THR . 46.7 pt -94.19 -6.7 10.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.654 179.518 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -161.14 176.71 11.0 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 121.002 -0.279 . . . . 0.0 111.065 179.823 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.465 ' O ' ' HA ' ' A' ' 154' ' ' VAL . 32.5 m-85 -143.35 127.19 17.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.19 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.58 HG21 HD11 ' A' ' 139' ' ' LEU . 5.1 t -93.26 122.81 45.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.041 0.448 . . . . 0.0 111.344 -179.386 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.43 ' HD2' HG13 ' A' ' 156' ' ' VAL . 33.2 t80 -80.43 109.48 14.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.712 -179.945 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.401 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 4.9 t70 -164.77 148.93 9.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.538 -179.788 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.68 31.69 18.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.895 -179.659 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 61.43 30.27 18.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.972 -179.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.529 HG23 ' O ' ' A' ' 145' ' ' THR . 84.7 m -151.09 149.73 29.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.801 179.861 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -94.2 91.75 6.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.53 179.65 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.549 ' HB2' HD21 ' A' ' 139' ' ' LEU . 20.6 m-85 -64.82 117.0 34.28 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.289 -179.41 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -64.12 119.03 5.96 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.172 1.915 . . . . 0.0 112.435 179.981 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.646 HD21 ' OG1' ' A' ' 168' ' ' THR . 38.3 tp -99.79 124.18 44.8 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.802 179.672 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.741 HD13 ' HB2' ' A' ' 118' ' ' TRP . 41.3 mt -70.5 173.39 7.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.647 -179.827 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.405 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.9 pt-20 -64.59 -28.46 69.65 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.03 179.604 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -90.17 12.78 16.92 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.213 179.61 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.642 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 72.5 23.8 77.32 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.755 -0.736 . . . . 0.0 113.048 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.674 ' HB3' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -81.76 96.88 7.71 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.385 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.58 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -72.48 121.26 19.31 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.664 -178.93 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -98.39 72.24 2.08 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.678 179.385 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.459 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 21.6 mttt -57.83 -20.16 33.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.69 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -88.24 -24.43 23.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.564 -180.0 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -102.07 25.61 8.58 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.846 0.314 . . . . 0.0 111.846 -179.566 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . -58.95 164.91 8.92 Favored Glycine 0 CA--C 1.509 -0.292 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.757 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.529 ' O ' HG23 ' A' ' 129' ' ' THR . 9.0 t -130.03 155.29 46.37 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.073 0.463 . . . . 0.0 110.907 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -97.1 54.24 1.23 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.433 -179.703 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.69 170.95 6.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.265 -179.294 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -103.87 138.19 19.46 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.776 -179.355 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.462 ' HD2' ' CG2' ' A' ' 154' ' ' VAL . 58.8 Cg_endo -84.9 100.27 0.73 Allowed 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.219 2.613 . . . . 0.0 112.645 179.799 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 18.1 t -65.82 -11.21 44.54 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.72 179.334 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.93 -21.77 20.4 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.783 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.678 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -136.7 166.4 27.79 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -178.943 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.678 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 70.9 Cg_endo -75.15 164.57 32.83 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.487 2.125 . . . . 0.0 112.335 179.924 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 20.1 t -122.61 108.87 22.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.95 0.405 . . . . 0.0 111.677 -179.763 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.903 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.52 95.99 1.88 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.728 179.065 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.43 HG13 ' HD2' ' A' ' 125' ' ' TYR . 50.3 t -92.78 137.65 21.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.918 0.389 . . . . 0.0 111.181 -179.952 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 47.78 57.61 7.51 Favored Glycine 0 CA--C 1.521 0.431 0 CA-C-N 115.987 -0.551 . . . . 0.0 113.27 179.363 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.903 ' CE2' HD23 ' A' ' 155' ' ' LEU . 3.1 m95 -100.11 151.27 21.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.167 0.508 . . . . 0.0 111.705 -179.452 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -66.51 -172.39 0.16 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.569 179.276 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -43.08 154.17 0.08 Allowed 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -179.75 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.543 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.0 -24.76 51.82 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.239 179.477 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.15 -39.55 86.76 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.959 0.409 . . . . 0.0 110.066 179.199 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -75.86 -40.97 53.63 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.108 178.955 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.543 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.2 mt -58.55 -42.34 84.38 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.884 179.048 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.65 -25.93 20.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.477 179.648 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.467 ' CB ' HG21 ' A' ' 211' ' ' ILE . 6.0 mm-40 -71.49 -54.38 10.76 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.056 0.455 . . . . 0.0 110.854 -179.901 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.837 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -62.31 -37.33 85.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.244 179.547 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.86 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -60.51 -38.3 83.9 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.909 179.027 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -61.3 -36.06 91.88 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 177.62 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 55.3 mm-40 -70.65 -48.94 52.32 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.118 -0.541 . . . . 0.0 110.6 178.478 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.65 ' HA ' HD22 ' A' ' 174' ' ' LEU . 10.8 mp -65.06 -27.86 69.08 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.396 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.67 -18.46 62.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.373 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -112.19 -28.66 7.87 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 120.658 0.266 . . . . 0.0 111.519 -179.706 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.65 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.1 OUTLIER -57.61 167.2 1.43 Allowed Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.041 -179.612 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -70.34 129.19 16.58 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.248 1.965 . . . . 0.0 112.893 179.946 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.33 -25.34 9.38 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.65 179.667 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.97 -48.63 79.41 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.944 0.402 . . . . 0.0 110.869 179.664 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.879 HG11 ' HB3' ' A' ' 218' ' ' LEU . 39.3 t -74.12 -35.53 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.424 179.399 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.46 ' HB2' HD21 ' A' ' 174' ' ' LEU . 8.7 tp -56.8 -36.26 69.69 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.118 0.485 . . . . 0.0 109.949 179.019 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -76.67 -39.96 28.06 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.328 178.759 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -88.09 103.14 15.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.906 0.384 . . . . 0.0 110.669 179.268 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . 0.837 ' CE ' HG12 ' A' ' 178' ' ' VAL . 3.0 mtm 179.42 162.34 0.86 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.194 179.992 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.42 -56.22 2.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.742 0.306 . . . . 0.0 111.038 -179.838 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -163.11 142.69 8.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.832 -179.945 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.875 HG12 HG12 ' A' ' 199' ' ' VAL . 14.3 mt -103.11 115.15 44.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.539 179.484 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 24.2 m170 -104.19 127.32 51.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.03 -179.548 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -82.52 104.66 12.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.576 179.719 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.714 -179.929 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 . . . . . 0 CA--C 1.529 0.15 0 CA-C-O 120.664 0.269 . . . . 0.0 111.427 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . 0.572 ' HB3' HD12 ' A' ' 211' ' ' ILE . 0.4 OUTLIER -109.68 40.87 1.8 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.017 0.437 . . . . 0.0 110.295 179.748 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 2.1 tpm_? -87.68 112.86 22.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.857 -179.956 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.822 ' O ' HD13 ' A' ' 198' ' ' ILE . 31.9 m -108.23 168.23 3.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.027 179.941 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.822 HD13 ' O ' ' A' ' 197' ' ' VAL . 19.3 mm -134.4 108.45 10.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.372 179.956 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.875 HG12 HG12 ' A' ' 185' ' ' ILE . 6.8 m -98.08 122.37 49.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.903 0.382 . . . . 0.0 110.873 179.462 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -82.4 152.27 26.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.834 -179.869 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.56 144.67 31.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.554 179.887 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 44.3 m-20 -57.43 -29.28 64.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.017 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -74.78 -7.44 53.4 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.633 179.676 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 101.54 14.47 29.87 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 120.484 -0.865 . . . . 0.0 113.123 -179.929 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -92.24 166.11 12.77 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.98 0.39 . . . . 0.0 111.049 -179.844 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -132.16 111.43 11.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.827 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.5 t -109.86 138.56 36.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.103 179.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 52.5 p -112.08 116.78 31.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.981 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.658 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -127.75 158.14 38.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.653 179.775 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -97.62 148.43 23.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.778 0.323 . . . . 0.0 110.653 179.891 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.572 HD12 ' HB3' ' A' ' 195' ' ' ASP . 59.5 mt -59.96 -36.59 67.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.825 179.927 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.25 -33.88 74.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.289 -179.524 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -134.92 44.17 2.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.984 0.421 . . . . 0.0 111.015 -179.885 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.579 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 10.8 t80 -66.91 -52.64 40.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.779 179.801 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.35 -41.51 89.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.232 -179.724 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -67.13 -49.76 63.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.102 0.477 . . . . 0.0 110.476 179.655 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.95 -44.56 74.43 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.015 179.782 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.879 ' HB3' HG11 ' A' ' 178' ' ' VAL . 4.1 mm? -81.22 -26.86 35.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.061 179.635 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 13.6 t -61.14 -31.7 71.41 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.93 0.395 . . . . 0.0 110.28 179.346 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.232 179.556 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 121.094 0.473 . . . . 0.0 110.944 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.748 ' HB2' HD13 ' A' ' 134' ' ' LEU . 82.7 m95 -70.42 168.29 16.42 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.967 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.94 135.02 44.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.503 179.594 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 12.8 mtt180 -71.39 106.45 3.91 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.915 -179.815 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.896 HD11 HG22 ' A' ' 168' ' ' THR . 46.0 pt -95.8 -7.81 9.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.496 179.278 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.541 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -157.94 176.1 12.99 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 120.619 0.247 . . . . 0.0 110.713 179.768 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.468 ' CD1' ' CG ' ' A' ' 149' ' ' PRO . 39.1 m-85 -145.58 126.0 14.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.348 -179.895 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.672 HG21 HD11 ' A' ' 139' ' ' LEU . 4.2 t -94.05 123.21 46.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.016 0.436 . . . . 0.0 111.269 -179.458 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.465 ' CD1' ' CE1' ' A' ' 130' ' ' PHE . 7.0 t80 -82.59 101.85 11.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.892 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -156.31 155.35 32.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.704 -179.912 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 60.85 32.95 20.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.878 -179.783 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 60.28 31.26 20.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.91 179.961 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.445 HG22 ' N ' ' A' ' 130' ' ' PHE . 70.6 m -152.94 161.49 42.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.883 179.766 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.465 ' CE1' ' CD1' ' A' ' 125' ' ' TYR . 97.2 m-85 -102.54 90.41 3.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.696 179.668 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.49 ' HA ' ' HA2' ' A' ' 144' ' ' GLY . 22.8 m-85 -65.45 124.79 88.12 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.088 -179.923 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.63 119.17 5.79 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 121.986 1.791 . . . . 0.0 112.367 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.608 HD11 ' HA2' ' A' ' 137' ' ' GLY . 32.2 tp -96.1 123.81 39.86 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.657 179.793 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.748 HD13 ' HB2' ' A' ' 118' ' ' TRP . 41.6 mt -70.79 172.77 8.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.563 -179.713 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.41 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.8 pt-20 -63.27 -29.05 70.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.992 179.692 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -89.9 12.52 17.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.131 179.577 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.658 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 72.72 25.09 74.87 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.997 179.874 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.662 ' HB3' HD12 ' A' ' 134' ' ' LEU . 0.8 OUTLIER -82.61 95.11 7.68 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.433 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.672 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -72.69 107.21 5.03 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.301 -179.221 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.436 HD11 HD21 ' A' ' 134' ' ' LEU . 30.5 mt -84.48 76.8 10.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.271 179.375 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.443 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 24.6 mtpt -67.84 -8.77 38.99 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.407 -179.603 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -84.77 -28.53 26.13 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.707 0.289 . . . . 0.0 110.915 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -85.65 -79.95 0.23 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.072 -179.848 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.49 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . 57.28 160.71 0.02 OUTLIER Glycine 0 CA--C 1.507 -0.462 0 CA-C-N 116.283 -0.417 . . . . 0.0 112.837 -179.625 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 9.6 t -140.63 150.78 43.99 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.356 -0.422 . . . . 0.0 110.68 -179.647 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -89.26 50.87 2.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.96 0.41 . . . . 0.0 110.625 179.839 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -171.33 155.49 4.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.956 0.408 . . . . 0.0 110.611 -179.286 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -98.74 125.26 43.05 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.148 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.468 ' CG ' ' CD1' ' A' ' 123' ' ' TYR . 96.5 Cg_endo -84.93 109.26 1.25 Allowed 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 122.494 2.13 . . . . 0.0 112.779 -179.767 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 17.0 t -69.86 -7.86 43.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.958 179.743 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -77.28 -23.41 51.13 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 120.808 0.337 . . . . 0.0 110.451 179.006 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.651 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -139.47 166.23 25.82 Favored Pre-proline 0 N--CA 1.453 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.546 -179.493 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.651 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 72.4 Cg_endo -75.57 151.08 36.6 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.426 2.084 . . . . 0.0 112.662 -179.821 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.436 HG22 ' HB2' ' A' ' 123' ' ' TYR . 9.4 t -113.2 111.59 36.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.902 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.863 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.44 96.02 1.85 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.619 179.22 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.414 HG23 ' HB2' ' A' ' 184' ' ' GLU . 62.1 t -90.75 137.0 22.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.956 0.408 . . . . 0.0 111.18 179.966 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 47.76 60.78 5.19 Favored Glycine 0 CA--C 1.521 0.434 0 CA-C-N 115.938 -0.573 . . . . 0.0 113.147 179.377 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.863 ' CE2' HD23 ' A' ' 155' ' ' LEU . 3.0 m95 -104.35 151.27 23.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.228 0.537 . . . . 0.0 111.823 -179.344 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.25 -172.17 0.2 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.393 179.386 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -42.15 153.66 0.06 Allowed 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.733 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.503 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -56.94 -24.85 51.74 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.215 179.446 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -59.87 -40.49 88.84 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.916 0.388 . . . . 0.0 109.987 179.213 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -75.17 -38.95 60.67 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.988 178.907 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.503 HD12 ' HA2' ' A' ' 161' ' ' GLY . 5.4 mt -59.88 -43.69 92.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.808 178.866 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.413 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . . . -53.54 -26.11 19.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.717 179.962 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.401 ' CB ' HG21 ' A' ' 211' ' ' ILE . 3.5 mm-40 -70.34 -54.57 12.01 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.1 0.476 . . . . 0.0 110.781 -179.9 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.823 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -61.75 -35.85 79.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.291 179.518 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.896 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -60.88 -40.88 94.69 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.938 178.89 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.94 -35.36 86.74 Favored Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 177.903 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -72.46 -46.85 53.0 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.236 -0.482 . . . . 0.0 110.66 178.656 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.647 ' HA ' HD22 ' A' ' 174' ' ' LEU . 10.8 mp -66.25 -27.57 68.05 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.773 0.321 . . . . 0.0 111.592 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.46 -17.54 62.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.257 179.868 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -114.38 -26.89 7.78 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -179.681 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.647 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER -57.77 167.63 1.37 Allowed Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.037 -179.58 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -69.1 127.74 15.57 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.138 1.892 . . . . 0.0 112.829 179.812 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.45 -25.88 11.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.611 179.713 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.81 -48.45 79.69 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.866 0.365 . . . . 0.0 110.967 179.658 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.887 HG11 ' HB3' ' A' ' 218' ' ' LEU . 22.3 t -74.06 -37.13 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.571 179.584 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.525 ' HB2' HD21 ' A' ' 174' ' ' LEU . 6.6 tp -55.59 -36.1 66.52 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.237 0.541 . . . . 0.0 110.072 179.058 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -76.54 -40.96 26.09 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.268 178.864 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -87.58 102.87 15.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.979 0.419 . . . . 0.0 110.596 179.225 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . 0.838 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.9 mtm 177.89 162.47 0.59 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.084 -179.916 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 7.5 t -118.26 -56.9 2.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.819 0.343 . . . . 0.0 110.92 -179.859 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . 0.414 ' HB2' HG23 ' A' ' 156' ' ' VAL . 5.3 pt-20 -161.28 142.44 11.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.957 -179.848 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.877 HG12 HG12 ' A' ' 199' ' ' VAL . 16.8 mt -100.4 115.91 42.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.403 179.483 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 19.9 m170 -105.04 115.25 29.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.965 -179.526 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.433 ' HB2' ' CE2' ' A' ' 158' ' ' TRP . 14.5 t80 -74.79 104.62 5.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.688 179.817 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.448 179.85 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 . . . . . 0 CA--C 1.529 0.172 0 CA-C-O 120.548 0.213 . . . . 0.0 111.271 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -107.8 36.75 2.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.742 0.306 . . . . 0.0 110.591 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 3.3 ttt180 -89.42 115.87 27.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.306 -179.673 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.759 ' O ' HD13 ' A' ' 198' ' ' ILE . 34.0 m -112.78 165.27 7.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.684 179.563 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.759 HD13 ' O ' ' A' ' 197' ' ' VAL . 23.8 mm -131.32 105.76 11.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.775 0.321 . . . . 0.0 111.279 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.877 HG12 HG12 ' A' ' 185' ' ' ILE . 6.9 m -95.85 121.48 46.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.941 179.652 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -81.82 146.47 29.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.646 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -95.06 167.15 11.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.033 -179.655 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.27 -27.69 65.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.059 -179.919 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -90.43 15.31 10.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.884 -179.845 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 87.69 -7.14 82.1 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.474 -0.869 . . . . 0.0 113.315 179.947 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.09 170.2 0.93 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 117.235 0.518 . . . . 0.0 110.928 -179.966 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -141.33 111.45 6.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.694 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.4 t -112.4 125.27 69.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.262 -179.774 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . 0.505 ' OG ' HD12 ' A' ' 198' ' ' ILE . 4.6 m -100.98 112.04 24.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.661 179.721 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.636 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -124.1 160.87 26.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.88 -179.899 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.66 155.85 17.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.499 179.841 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.401 HG21 ' CB ' ' A' ' 166' ' ' GLU . 30.8 mt -67.08 -32.07 56.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.897 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.45 -40.52 70.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.355 -179.469 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -116.86 31.8 6.53 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.796 0.331 . . . . 0.0 110.95 -179.912 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.588 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 11.6 t80 -59.4 -54.92 41.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.997 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.43 -40.12 81.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.138 -179.922 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.38 -49.73 52.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.075 0.464 . . . . 0.0 110.333 179.553 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.14 -41.99 69.03 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.012 179.654 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.887 ' HB3' HG11 ' A' ' 178' ' ' VAL . 4.1 mm? -85.97 -23.54 26.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.825 179.462 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 9.4 t -60.69 -33.87 73.5 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.006 0.431 . . . . 0.0 110.119 179.232 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 32.7 m170 . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.117 179.183 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 . . . . . 0 CA--C 1.522 -0.129 0 CA-C-O 121.133 0.492 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.755 ' HB2' HD13 ' A' ' 134' ' ' LEU . 78.9 m95 -66.89 168.21 10.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.988 179.915 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 -102.82 136.67 42.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.467 179.588 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.7 mtm-85 -71.75 105.54 3.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.874 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.883 HD11 HG22 ' A' ' 168' ' ' THR . 46.8 pt -94.34 -8.71 9.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.38 179.205 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.486 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -158.16 176.19 12.81 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 120.601 0.238 . . . . 0.0 110.609 179.749 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.464 ' CD1' ' CG ' ' A' ' 149' ' ' PRO . 34.2 m-85 -144.99 125.91 14.44 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.633 HG21 HD11 ' A' ' 139' ' ' LEU . 4.8 t -93.69 123.3 45.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.044 0.45 . . . . 0.0 111.509 -179.292 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.478 ' CD1' ' CE1' ' A' ' 130' ' ' PHE . 30.2 t80 -81.35 101.77 10.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.758 179.965 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -155.58 153.74 30.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.645 -179.887 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 60.87 31.17 20.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.952 -179.672 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 61.87 30.86 18.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.188 179.811 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.446 HG22 ' N ' ' A' ' 130' ' ' PHE . 87.1 m -151.46 161.73 42.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.768 179.773 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.541 ' CE2' ' HB2' ' A' ' 148' ' ' ALA . 9.1 m-85 -101.39 90.27 4.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.866 179.666 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.473 ' HA ' ' HA2' ' A' ' 144' ' ' GLY . 22.1 m-85 -65.79 123.99 86.31 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.766 179.809 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.3 118.34 5.47 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.114 1.876 . . . . 0.0 112.338 -179.936 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.71 HD21 ' OG1' ' A' ' 168' ' ' THR . 25.8 tp -95.96 123.54 39.6 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.521 179.684 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.755 HD13 ' HB2' ' A' ' 118' ' ' TRP . 50.7 mt -70.67 173.73 6.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.344 -0.843 . . . . 0.0 111.449 -179.748 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.405 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 2.0 pt-20 -63.89 -28.33 69.76 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.995 179.588 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -91.29 14.23 15.05 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.199 179.791 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.619 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 72.85 28.06 67.68 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.57 -179.976 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.651 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -81.65 90.1 6.29 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 178.721 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.633 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -72.31 102.01 3.01 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.802 -179.485 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 31.7 mt -83.06 79.39 9.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.824 -179.957 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.487 ' HE3' HD13 ' A' ' 139' ' ' LEU . 37.8 mttt -69.69 -8.51 48.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.207 -179.912 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -82.92 -29.63 29.02 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.83 0.348 . . . . 0.0 110.695 179.69 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -85.27 -80.4 0.21 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.957 179.98 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . 56.92 160.76 0.02 OUTLIER Glycine 0 CA--C 1.506 -0.475 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.949 -179.777 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 10.2 t -142.07 150.38 41.15 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.437 -0.382 . . . . 0.0 110.753 -179.738 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.443 ' HE2' HG23 ' A' ' 129' ' ' THR . 3.7 mmtt -89.53 51.8 2.19 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.018 0.437 . . . . 0.0 110.596 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -171.26 149.99 2.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.735 -179.34 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.541 ' HB2' ' CE2' ' A' ' 130' ' ' PHE . . . -93.94 125.01 54.65 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.201 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.464 ' CG ' ' CD1' ' A' ' 123' ' ' TYR . 89.9 Cg_endo -85.04 109.89 1.27 Allowed 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.57 2.18 . . . . 0.0 112.796 -179.861 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 21.5 t -69.93 -7.74 43.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.935 179.79 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -77.61 -23.07 49.93 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 120.809 0.338 . . . . 0.0 110.515 179.096 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.657 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -139.92 166.22 25.35 Favored Pre-proline 0 N--CA 1.453 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.628 -179.41 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.657 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 64.4 Cg_endo -74.68 152.24 42.21 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.424 2.082 . . . . 0.0 112.346 -179.926 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 9.8 t -113.99 109.46 28.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.065 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.844 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.33 96.03 1.81 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.705 179.231 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.42 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 53.5 t -93.68 136.21 26.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.91 0.386 . . . . 0.0 111.012 179.944 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 50.81 57.5 10.79 Favored Glycine 0 CA--C 1.519 0.306 0 CA-C-N 115.886 -0.597 . . . . 0.0 113.089 179.443 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.844 ' CE2' HD23 ' A' ' 155' ' ' LEU . 3.2 m95 -102.16 151.2 22.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.08 0.467 . . . . 0.0 111.634 -179.572 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.73 -172.41 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.608 179.523 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -43.59 154.26 0.1 Allowed 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.775 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.532 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.58 -25.11 54.79 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.239 179.544 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.2 -38.42 83.24 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.948 0.404 . . . . 0.0 110.112 179.278 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.34 -39.2 48.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.03 179.034 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.532 HD12 ' HA2' ' A' ' 161' ' ' GLY . 5.9 mt -59.96 -41.46 86.15 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.857 179.046 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.8 -30.51 45.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.168 179.682 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.405 ' CB ' HG21 ' A' ' 211' ' ' ILE . 10.7 mm-40 -67.19 -53.0 34.41 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-O 121.417 0.627 . . . . 0.0 110.14 179.391 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.796 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -60.78 -43.22 98.38 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.088 179.025 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.883 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -58.5 -38.66 78.11 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.51 179.214 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.09 -37.43 92.8 Favored Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 178.378 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 63.2 mm-40 -72.29 -45.85 58.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.462 -0.369 . . . . 0.0 110.892 178.972 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.561 ' O ' HD22 ' A' ' 174' ' ' LEU . 11.1 mp -65.48 -30.05 70.78 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.694 0.283 . . . . 0.0 111.202 179.685 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.0 -18.57 64.07 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.344 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -112.28 -26.71 8.63 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.632 0.254 . . . . 0.0 111.66 -179.696 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.561 HD22 ' O ' ' A' ' 171' ' ' LEU . 0.1 OUTLIER -56.86 166.67 1.28 Allowed Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.169 -179.517 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -69.29 128.66 16.79 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.163 1.908 . . . . 0.0 112.69 179.832 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.09 -25.66 5.36 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.69 179.715 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.18 -49.97 74.32 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.033 179.76 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.939 HG11 ' HB3' ' A' ' 218' ' ' LEU . 23.9 t -74.18 -39.81 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.715 179.609 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.521 ' HG ' HD21 ' A' ' 174' ' ' LEU . 0.5 OUTLIER -53.15 -33.38 52.24 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.103 0.478 . . . . 0.0 110.169 179.385 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -81.86 -38.92 12.55 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.591 178.802 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.43 ' HB1' ' SD ' ' A' ' 201' ' ' MET . . . -88.92 103.43 16.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.828 0.347 . . . . 0.0 110.852 179.528 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . 0.829 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.6 mtm 177.87 169.08 0.71 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.304 179.817 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 7.7 t -124.24 -59.61 1.47 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.752 0.311 . . . . 0.0 111.127 -179.901 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -157.02 142.73 17.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.121 -179.784 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.907 HG12 HG12 ' A' ' 199' ' ' VAL . 14.9 mt -106.23 114.53 45.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.269 179.359 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . 0.42 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 22.5 m170 -104.7 121.56 43.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.153 -179.431 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -72.67 104.95 4.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.58 179.769 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.78 -179.921 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 . . . . . 0 N--CA 1.462 0.137 0 CA-C-O 120.647 0.26 . . . . 0.0 111.51 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . 0.599 ' HB3' HD12 ' A' ' 211' ' ' ILE . 0.4 OUTLIER -106.5 40.04 1.7 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.967 0.413 . . . . 0.0 110.373 179.785 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 31.7 ttt85 -93.0 119.94 32.78 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.969 179.974 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.847 ' O ' HD13 ' A' ' 198' ' ' ILE . 23.2 m -113.03 167.77 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.09 -179.931 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.847 HD13 ' O ' ' A' ' 197' ' ' VAL . 24.7 mm -134.09 105.9 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.139 179.783 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.907 HG12 HG12 ' A' ' 185' ' ' ILE . 15.8 m -97.63 138.81 21.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.992 0.425 . . . . 0.0 111.02 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.423 ' CE2' ' HG3' ' A' ' 206' ' ' GLU . 50.7 m-85 -102.46 152.48 21.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.587 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . 0.43 ' SD ' ' HB1' ' A' ' 181' ' ' ALA . 21.3 tpp -104.06 158.21 16.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.833 0.349 . . . . 0.0 110.914 -179.902 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -56.27 -22.37 29.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.584 -179.825 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -90.4 15.34 10.8 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 111.825 0.305 . . . . 0.0 111.825 -179.913 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 77.05 14.58 82.48 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.583 -0.818 . . . . 0.0 113.147 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -77.55 167.7 21.19 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.99 0.395 . . . . 0.0 110.884 179.994 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . 0.423 ' HG3' ' CE2' ' A' ' 200' ' ' TYR . 7.2 tt0 -134.31 111.47 10.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.854 -179.964 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 17.7 t -116.56 131.14 70.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.976 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . 0.704 ' OG ' HD12 ' A' ' 198' ' ' ILE . 59.5 m -104.03 116.9 33.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.054 -179.858 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.632 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -127.62 159.24 35.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.736 179.712 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.2 153.1 19.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.811 0.339 . . . . 0.0 110.751 -179.95 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.599 HD12 ' HB3' ' A' ' 195' ' ' ASP . 64.2 mt -63.31 -36.71 77.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.803 179.763 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.92 -35.9 79.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.548 -179.452 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -132.67 42.76 3.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.925 0.393 . . . . 0.0 111.115 -179.835 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.575 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 11.3 t80 -65.49 -52.57 51.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.525 179.815 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.89 -43.38 86.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.293 -179.716 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.38 -49.39 60.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.102 0.477 . . . . 0.0 110.205 179.461 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.73 -42.76 65.18 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.181 179.683 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.939 ' HB3' HG11 ' A' ' 178' ' ' VAL . 4.0 mm? -87.16 -23.43 24.82 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.181 179.614 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 10.9 t -60.35 -33.88 73.05 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.025 0.44 . . . . 0.0 110.299 179.542 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.534 0.347 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.109 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.187 0 N-CA-C 112.556 -0.218 . . . . 0.0 112.556 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 13.3 p -115.64 153.64 30.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.807 0.337 . . . . 0.0 110.871 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 61.07 154.79 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.052 0.453 . . . . 0.0 110.978 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.769 ' HB2' HD13 ' A' ' 134' ' ' LEU . 81.6 m95 -77.29 168.51 19.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.976 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.8 ttm-85 -102.4 134.19 46.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.607 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.9 mtm180 -70.42 106.8 3.53 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.887 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.875 HD11 HG22 ' A' ' 168' ' ' THR . 44.5 pt -96.61 -7.06 9.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.448 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.536 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -159.38 175.94 12.73 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 120.606 0.241 . . . . 0.0 110.916 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.472 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 29.0 m-85 -143.65 126.23 15.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.253 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.661 HG21 HD11 ' A' ' 139' ' ' LEU . 3.8 t -93.86 123.28 45.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.512 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.501 ' CE1' ' CZ ' ' A' ' 130' ' ' PHE . 9.4 t80 -85.0 96.21 9.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.734 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -147.84 155.98 42.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.632 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.03 31.22 21.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.846 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.67 34.69 14.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.034 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.451 HG22 ' N ' ' A' ' 130' ' ' PHE . 57.0 m -154.66 161.52 41.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.034 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.501 ' CZ ' ' CE1' ' A' ' 125' ' ' TYR . 96.2 m-85 -103.82 90.49 3.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.166 0.508 . . . . 0.0 110.712 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.565 ' HB2' HD21 ' A' ' 139' ' ' LEU . 22.9 m-85 -67.69 127.4 93.38 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.561 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.424 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 7.7 Cg_exo -71.62 118.16 5.51 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 122.37 2.047 . . . . 0.0 112.369 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.64 HD21 ' OG1' ' A' ' 168' ' ' THR . 38.0 tp -97.52 123.6 41.44 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.123 0.487 . . . . 0.0 110.595 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.769 HD13 ' HB2' ' A' ' 118' ' ' TRP . 52.4 mt -71.46 173.0 8.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.578 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.418 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.3 pt-20 -63.71 -29.27 70.52 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.114 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -89.92 11.36 20.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.16 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.64 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 75.5 18.67 79.76 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.831 -0.7 . . . . 0.0 113.162 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.701 ' HB3' HD12 ' A' ' 134' ' ' LEU . 13.4 tpp180 -76.78 95.7 4.1 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.661 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -71.44 113.58 8.62 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.494 -179.054 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 22.8 mt -88.11 71.76 9.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.292 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.463 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 30.8 mttt -56.87 -20.62 23.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.922 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -87.04 -18.73 29.91 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -104.93 30.85 5.2 Favored 'General case' 0 N--CA 1.461 0.121 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . -63.89 162.38 35.06 Favored Glycine 0 CA--C 1.51 -0.237 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.786 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 10.6 t -136.03 151.39 49.82 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.543 -0.329 . . . . 0.0 110.658 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.423 ' HE2' HG23 ' A' ' 129' ' ' THR . 4.7 mmpt? -89.32 50.37 1.92 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.953 0.406 . . . . 0.0 110.671 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -171.04 151.4 3.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.554 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -96.88 125.87 44.84 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.23 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.472 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 74.3 Cg_endo -82.82 112.75 2.12 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.396 2.064 . . . . 0.0 112.474 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 30.6 t -69.92 -7.65 42.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.121 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -76.53 -23.44 53.64 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 120.828 0.346 . . . . 0.0 110.417 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.697 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -139.83 167.89 16.9 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.723 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.697 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 67.3 Cg_endo -74.79 158.24 43.11 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.351 2.034 . . . . 0.0 112.114 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 10.7 t -118.83 110.83 31.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.051 0.453 . . . . 0.0 111.081 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.833 HD23 ' CE2' ' A' ' 158' ' ' TRP . 0.9 OUTLIER -72.83 96.01 2.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.579 179.022 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 54.3 t -93.1 136.52 24.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.961 0.41 . . . . 0.0 111.103 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 50.06 55.28 15.79 Favored Glycine 0 CA--C 1.52 0.375 0 CA-C-N 115.906 -0.588 . . . . 0.0 113.287 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.833 ' CE2' HD23 ' A' ' 155' ' ' LEU . 3.5 m95 -99.59 151.25 21.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.169 0.509 . . . . 0.0 111.649 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.89 -172.19 0.26 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.457 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -42.69 154.32 0.07 Allowed 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.541 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.18 -25.29 53.91 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.181 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -59.62 -39.43 84.27 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 120.957 0.408 . . . . 0.0 110.036 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.1 -40.06 53.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.94 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.541 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.6 mt -59.68 -42.13 87.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.898 179.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.63 -30.63 43.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.139 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.438 ' CB ' HG21 ' A' ' 211' ' ' ILE . 2.5 mm-40 -67.22 -53.14 32.94 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-O 121.528 0.68 . . . . 0.0 110.098 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.774 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -60.38 -43.46 96.58 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.06 179.019 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.875 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -58.77 -38.0 77.5 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.525 179.356 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.56 -37.65 92.51 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 178.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -72.03 -46.39 57.26 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.353 -0.423 . . . . 0.0 111.025 178.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.601 ' HA ' HD22 ' A' ' 174' ' ' LEU . 10.9 mp -66.14 -27.71 68.24 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.665 0.269 . . . . 0.0 111.417 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.69 -18.93 62.81 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.438 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -111.74 -27.37 8.54 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.6 0.238 . . . . 0.0 111.413 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.601 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.1 OUTLIER -57.93 167.3 1.55 Allowed Pre-proline 0 CA--C 1.539 0.535 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.929 -179.735 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -70.39 128.01 14.86 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.177 1.918 . . . . 0.0 112.858 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.96 -25.41 8.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.606 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.93 -49.15 77.76 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.814 0.34 . . . . 0.0 110.896 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.874 HG11 ' HB3' ' A' ' 218' ' ' LEU . 37.6 t -73.96 -35.22 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.445 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.537 HD13 ' CD2' ' A' ' 174' ' ' LEU . 5.7 tp -56.04 -35.52 66.98 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.183 0.515 . . . . 0.0 109.988 179.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -78.33 -40.19 20.36 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.336 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -86.06 103.01 14.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.894 0.378 . . . . 0.0 110.625 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . 0.838 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.9 mtm 178.43 165.84 0.8 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.128 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.47 -54.53 1.97 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.797 0.332 . . . . 0.0 111.253 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -163.31 142.94 8.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.92 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.923 HG12 HG12 ' A' ' 199' ' ' VAL . 16.8 mt -106.26 114.71 46.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.722 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . 0.454 ' CE1' ' CE1' ' A' ' 200' ' ' TYR . 11.4 m170 -104.68 131.03 52.61 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.988 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -83.24 104.79 13.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.515 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.36 89.64 52.19 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.649 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.67 149.18 60.67 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.312 2.008 . . . . 0.0 112.578 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.509 HG21 ' HE ' ' A' ' 196' ' ' ARG . 21.9 p -121.53 161.05 23.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.548 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 9.5 ptt85 -54.7 -23.05 15.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.651 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -113.75 -10.78 13.0 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -143.49 79.95 1.65 Allowed 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.9 0.381 . . . . 0.0 111.554 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.58 -21.4 38.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.297 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . 0.404 ' OD1' HG22 ' A' ' 210' ' ' THR . 1.5 p30 -102.18 35.13 2.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.774 0.321 . . . . 0.0 110.708 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.509 ' HE ' HG21 ' A' ' 190' ' ' THR . 1.0 OUTLIER -89.45 113.08 24.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.178 -179.807 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.868 ' O ' HD13 ' A' ' 198' ' ' ILE . 29.1 m -108.57 168.07 3.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.847 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.868 HD13 ' O ' ' A' ' 197' ' ' VAL . 20.7 mm -134.79 108.06 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.826 0.345 . . . . 0.0 111.383 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.923 HG12 HG12 ' A' ' 185' ' ' ILE . 8.1 m -96.42 124.06 48.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.895 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.454 ' CE1' ' CE1' ' A' ' 186' ' ' HIS . 5.2 m-85 -82.58 146.0 29.41 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.796 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.83 156.23 17.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.04 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -64.26 -23.81 67.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.532 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -90.25 15.4 10.49 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 79.59 14.29 81.41 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.079 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -84.43 167.32 16.55 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.929 0.364 . . . . 0.0 110.71 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -133.72 111.66 10.75 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.604 HG11 HD12 ' A' ' 224' ' ' ILE . 21.2 t -112.73 124.35 69.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.19 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 80.0 p -101.42 116.47 32.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.695 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.671 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -127.0 158.41 36.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.96 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.404 HG22 ' OD1' ' A' ' 195' ' ' ASP . 0.6 OUTLIER -95.13 154.38 17.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.724 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.438 HG21 ' CB ' ' A' ' 166' ' ' GLU . 36.8 mt -66.39 -35.17 74.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.999 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.49 -35.31 80.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.384 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -129.8 40.91 3.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.891 0.377 . . . . 0.0 111.055 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.563 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 11.9 t80 -65.54 -50.62 64.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.707 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.9 -41.26 91.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.093 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.06 -49.38 65.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.997 0.427 . . . . 0.0 110.46 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 2.1 mmpt? -54.65 -45.09 73.75 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.07 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.874 ' HB3' HG11 ' A' ' 178' ' ' VAL . 4.2 mm? -80.95 -27.5 36.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.978 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 14.3 t -60.76 -31.55 70.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.964 0.411 . . . . 0.0 110.372 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . 0.697 ' O ' ' HB3' ' A' ' 223' ' ' ALA . 26.5 m-70 -69.97 -16.68 63.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.245 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -67.06 130.16 93.87 Favored Pre-proline 0 CA--C 1.535 0.381 0 C-N-CA 121.289 -0.164 . . . . 0.0 110.9 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.426 ' O ' ' HB2' ' A' ' 223' ' ' ALA . 70.5 Cg_endo -86.72 108.03 1.03 Allowed 'Cis proline' 0 C--N 1.358 1.062 0 C-N-CA 124.586 -1.006 . . . . 0.0 112.663 0.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.697 ' HB3' ' O ' ' A' ' 220' ' ' HIS . . . 174.15 42.13 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.166 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.604 HD12 HG11 ' A' ' 207' ' ' VAL . 4.6 pt -121.02 -178.79 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.248 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 224' ' ' ILE . . . 76.05 93.23 0.07 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.944 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -110.0 -161.77 0.77 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.9 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -93.65 21.13 6.67 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.722 ' O ' HD23 ' A' ' 228' ' ' LEU . 1.7 tt -97.24 24.34 6.54 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.725 0.298 . . . . 0.0 110.831 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -135.68 30.86 3.11 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.813 0.34 . . . . 0.0 110.9 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 3.3 ptt85 -110.91 -33.5 6.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.859 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 25.7 p30 -98.19 36.75 1.53 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.881 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 13.6 m -150.88 33.92 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.072 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 7.8 mtpt . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.935 -179.986 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.175 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.14 93.86 9.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.717 0.294 . . . . 0.0 110.94 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 61.89 148.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.174 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.746 ' HB2' HD13 ' A' ' 134' ' ' LEU . 79.4 m95 -68.67 168.27 13.5 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.092 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -102.8 136.37 42.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.476 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 41.7 mtt85 -71.95 106.11 4.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.936 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.912 HD11 HG22 ' A' ' 168' ' ' THR . 45.9 pt -94.1 -7.84 10.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.476 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -159.47 176.44 12.08 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 121.017 -0.273 . . . . 0.0 110.89 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.449 ' O ' ' HA ' ' A' ' 154' ' ' VAL . 32.1 m-85 -142.85 126.14 16.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.322 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.621 HG21 ' CD1' ' A' ' 139' ' ' LEU . 4.1 t -93.43 122.74 45.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.963 0.411 . . . . 0.0 111.226 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.492 ' CD1' ' CE1' ' A' ' 130' ' ' PHE . 17.9 t80 -80.99 106.51 13.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.698 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -163.36 156.59 19.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.595 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.448 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 1.2 mmm180 60.18 30.22 19.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.884 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 63.12 32.24 15.31 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.366 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.452 HG22 ' N ' ' A' ' 130' ' ' PHE . 91.1 m -156.92 161.25 39.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.878 0.371 . . . . 0.0 111.026 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.492 ' CE1' ' CD1' ' A' ' 125' ' ' TYR . 58.5 m-85 -99.85 90.3 4.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.626 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.513 ' HA ' ' HA2' ' A' ' 144' ' ' GLY . 22.6 m-85 -65.48 125.5 89.7 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.787 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.456 ' HG2' HD12 ' A' ' 140' ' ' LEU . 58.3 Cg_endo -73.57 118.82 5.64 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.044 1.829 . . . . 0.0 112.411 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.666 HD21 ' OG1' ' A' ' 168' ' ' THR . 28.4 tp -96.22 123.85 40.01 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.396 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.746 HD13 ' HB2' ' A' ' 118' ' ' TRP . 39.9 mt -69.64 173.62 5.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.45 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -64.68 -28.02 69.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.948 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 48.8 p-10 -90.93 13.91 15.26 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.285 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.602 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 72.63 21.78 79.39 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.731 -0.747 . . . . 0.0 113.119 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.687 ' HB3' HD12 ' A' ' 134' ' ' LEU . 9.7 tpp180 -80.82 94.25 6.4 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.621 ' CD1' HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -72.13 113.6 9.33 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.48 -179.024 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.569 HD11 HD21 ' A' ' 134' ' ' LEU . 25.1 mt -88.39 80.43 7.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.414 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.454 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 15.4 mtpt -71.45 -5.77 35.34 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -91.11 -24.28 20.04 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 122.304 -0.248 . . . . 0.0 111.432 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -89.46 -79.12 0.34 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.779 0.323 . . . . 0.0 111.403 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.513 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . 58.11 161.1 0.04 OUTLIER Glycine 0 CA--C 1.505 -0.57 0 CA-C-N 116.279 -0.419 . . . . 0.0 112.753 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.8 t -140.01 148.61 42.11 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.872 0.368 . . . . 0.0 110.939 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.45 ' HE2' HG23 ' A' ' 129' ' ' THR . 4.2 mmtt -91.1 51.97 2.04 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.157 0.503 . . . . 0.0 110.216 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.59 148.48 3.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.773 -179.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -81.89 135.14 48.89 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.703 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.458 ' HD2' ' CG2' ' A' ' 154' ' ' VAL . 68.4 Cg_endo -84.08 97.96 0.75 Allowed 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.052 2.501 . . . . 0.0 112.549 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 26.2 t -67.5 -9.3 41.0 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.825 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -90.0 -21.92 22.15 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.566 0.222 . . . . 0.0 111.588 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.71 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -139.79 167.4 18.63 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.71 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 60.3 Cg_endo -73.65 162.89 38.7 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.408 2.072 . . . . 0.0 112.518 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.458 ' CG2' ' HD2' ' A' ' 149' ' ' PRO . 18.3 t -123.82 110.14 24.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.572 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.84 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.85 95.91 2.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.747 179.112 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 59.0 t -93.01 136.87 23.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.927 0.394 . . . . 0.0 111.094 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 48.85 55.42 11.47 Favored Glycine 0 CA--C 1.52 0.369 0 CA-C-N 115.966 -0.561 . . . . 0.0 113.174 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.84 ' CE2' HD23 ' A' ' 155' ' ' LEU . 3.4 m95 -99.07 151.18 21.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.156 0.503 . . . . 0.0 111.735 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.43 -172.27 0.15 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.604 179.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -43.21 154.39 0.08 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.332 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.515 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -56.94 -24.66 50.94 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.218 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.72 -40.09 86.85 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.967 0.413 . . . . 0.0 110.05 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.12 -39.78 54.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.009 178.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.515 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.1 mt -59.67 -41.23 84.55 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.9 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.0 -30.58 47.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.214 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.403 ' CB ' HG21 ' A' ' 211' ' ' ILE . 15.4 mm-40 -67.64 -52.9 32.73 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.385 0.612 . . . . 0.0 110.107 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.82 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -59.44 -45.27 92.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.971 178.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.912 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -57.65 -38.38 74.96 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.549 179.207 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.83 -36.46 90.02 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 110.701 -0.959 . . . . 0.0 110.701 178.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -74.17 -46.36 42.65 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.451 -0.374 . . . . 0.0 111.06 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.565 ' HA ' HD22 ' A' ' 174' ' ' LEU . 11.3 mp -65.43 -29.6 70.31 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.689 0.28 . . . . 0.0 111.319 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.49 -19.18 63.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.345 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -111.01 -27.85 8.58 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.635 0.255 . . . . 0.0 111.433 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.565 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.1 OUTLIER -56.89 166.58 1.32 Allowed Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.161 -179.473 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.54 127.44 14.77 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.243 1.962 . . . . 0.0 112.744 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.71 -26.01 5.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.784 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.56 -50.76 72.05 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.925 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.854 HG11 ' HB3' ' A' ' 218' ' ' LEU . 33.8 t -74.16 -32.42 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.414 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.525 HD23 ' HD3' ' A' ' 153' ' ' PRO . 0.5 OUTLIER -58.2 -34.2 70.12 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.865 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -79.48 -39.61 17.88 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -86.77 103.03 14.82 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.952 0.405 . . . . 0.0 110.6 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . 0.844 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.8 mtm 178.49 160.48 0.6 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.994 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.1 m -120.56 -52.31 2.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.682 0.277 . . . . 0.0 111.379 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -163.27 142.64 8.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.926 0.394 . . . . 0.0 111.283 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.922 HG12 HG12 ' A' ' 199' ' ' VAL . 17.6 mt -106.71 114.19 45.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.344 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -104.39 119.87 39.94 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.135 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.415 ' HD1' HG12 ' A' ' 197' ' ' VAL . 13.6 t80 -75.8 104.57 6.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.544 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.33 82.0 52.6 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.572 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.73 140.5 42.95 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.35 2.033 . . . . 0.0 112.487 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 17.4 p -116.71 160.11 21.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.703 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -53.4 -25.41 15.63 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.464 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -107.69 -16.85 14.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.687 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -134.27 76.83 1.67 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.906 0.384 . . . . 0.0 111.227 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -56.57 -22.25 32.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.589 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -109.27 37.84 2.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.765 0.317 . . . . 0.0 111.082 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.83 115.59 27.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.947 0.403 . . . . 0.0 111.229 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.825 ' O ' HD13 ' A' ' 198' ' ' ILE . 28.1 m -112.51 166.14 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.808 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.825 HD13 ' O ' ' A' ' 197' ' ' VAL . 22.3 mm -133.03 107.85 12.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.81 0.338 . . . . 0.0 111.401 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.922 HG12 HG12 ' A' ' 185' ' ' ILE . 11.3 m -96.73 120.9 46.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.934 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -81.84 152.29 26.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.562 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 3.6 mmt -108.53 150.03 28.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.809 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -58.74 -25.61 63.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.261 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -88.63 12.94 13.34 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 81.98 14.36 77.42 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.378 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -86.13 153.41 22.1 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 117.103 0.451 . . . . 0.0 110.807 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -123.27 111.42 16.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.86 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.757 HG11 HD12 ' A' ' 224' ' ' ILE . 21.6 t -115.01 123.25 70.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.154 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.557 ' HB2' HD12 ' A' ' 198' ' ' ILE . 9.8 t -98.84 115.49 28.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.742 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.626 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -123.91 162.93 22.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.8 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.73 153.99 18.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.727 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.403 HG21 ' CB ' ' A' ' 166' ' ' GLU . 33.1 mt -65.98 -36.64 77.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.803 0.335 . . . . 0.0 110.763 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -64.82 -36.51 84.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.124 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -128.31 43.51 3.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.916 0.389 . . . . 0.0 110.929 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.571 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 11.4 t80 -68.46 -54.61 15.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.786 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.5 -39.15 79.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.904 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -67.24 -50.04 62.16 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.117 0.484 . . . . 0.0 110.29 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.29 -45.35 72.5 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.057 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.854 ' HB3' HG11 ' A' ' 178' ' ' VAL . 3.9 mm? -80.18 -27.52 38.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.873 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 1.1 m -61.04 -29.85 69.97 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.403 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . 0.409 ' HB2' HG22 ' A' ' 224' ' ' ILE . 7.1 m170 -68.94 -17.58 63.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.282 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -64.84 137.05 97.02 Favored Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.536 ' O ' ' HB3' ' A' ' 223' ' ' ALA . 59.6 Cg_endo -71.06 154.57 96.74 Favored 'Cis proline' 0 C--N 1.356 0.937 0 C-N-CA 124.714 -0.952 . . . . 0.0 112.822 0.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.536 ' HB3' ' O ' ' A' ' 222' ' ' PRO . . . 83.12 76.4 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.42 -179.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.757 HD12 HG11 ' A' ' 207' ' ' VAL . 7.4 pt -124.7 -178.88 2.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.2 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 67.99 139.12 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.085 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -115.91 -164.1 0.94 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.106 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -100.45 31.43 3.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.889 0.376 . . . . 0.0 110.938 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 9.9 mt -90.9 15.52 11.2 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.44 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -110.6 56.47 0.63 Allowed 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 121.046 0.451 . . . . 0.0 110.874 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 7.3 mtt85 -148.33 -55.31 0.2 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.911 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 25.0 p30 -60.84 92.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.872 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . 0.412 HG22 ' HG2' ' A' ' 233' ' ' LYS . 12.1 p -108.29 137.73 38.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.073 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . 0.412 ' HG2' HG22 ' A' ' 232' ' ' VAL . 16.9 mmmt . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.942 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.078 0 N-CA-C 112.522 -0.231 . . . . 0.0 112.522 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 7.5 t 68.31 -68.03 0.18 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.747 0.308 . . . . 0.0 111.001 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -63.81 148.67 48.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.047 0.451 . . . . 0.0 111.013 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.75 ' HB2' HD13 ' A' ' 134' ' ' LEU . 80.9 m95 -68.7 168.31 13.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.015 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.14 135.72 43.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.548 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.9 mtm180 -71.5 105.29 3.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.721 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.892 HD11 HG22 ' A' ' 168' ' ' THR . 47.1 pt -94.18 -8.24 9.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.406 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.443 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -158.47 176.88 11.86 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.467 0.175 . . . . 0.0 110.575 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.467 ' CD1' ' HG3' ' A' ' 149' ' ' PRO . 31.3 m-85 -144.35 125.84 14.93 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.558 HG21 HD11 ' A' ' 139' ' ' LEU . 3.7 t -93.58 122.85 45.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.058 0.456 . . . . 0.0 111.557 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -83.49 94.31 8.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.681 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -145.01 155.13 43.2 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.603 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.93 30.82 20.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.712 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 63.29 33.85 13.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.863 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.41 HG22 ' N ' ' A' ' 130' ' ' PHE . 58.6 m -155.9 159.7 39.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.057 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.41 ' N ' HG22 ' A' ' 129' ' ' THR . 92.6 m-85 -99.77 91.23 4.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.217 0.532 . . . . 0.0 110.863 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.5 ' HB2' HD21 ' A' ' 139' ' ' LEU . 26.1 m-85 -70.37 114.13 23.53 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.722 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.431 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 31.8 Cg_exo -58.72 123.35 13.35 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 122.414 2.076 . . . . 0.0 112.659 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.692 HD21 ' OG1' ' A' ' 168' ' ' THR . 28.9 tp -102.39 123.94 47.06 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.346 179.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.75 HD13 ' HB2' ' A' ' 118' ' ' TRP . 40.3 mt -70.32 173.21 7.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.634 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.402 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 2.1 pt-20 -64.11 -28.3 69.68 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.037 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -90.79 13.72 15.53 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.209 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.604 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 72.84 21.7 79.57 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.75 -0.738 . . . . 0.0 113.01 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.686 ' HB3' HD12 ' A' ' 134' ' ' LEU . 1.3 tpt180 -80.8 92.67 6.11 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.558 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -66.21 113.56 4.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.322 -179.125 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 43.4 mt -83.66 67.68 9.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.707 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.446 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 2.3 mttp -57.58 -21.49 39.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.451 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -95.56 21.07 8.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.433 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -147.31 28.47 0.99 Allowed 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.787 0.327 . . . . 0.0 111.238 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.431 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -60.83 162.83 21.01 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.897 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.4 ' N ' ' CG2' ' A' ' 129' ' ' THR . 9.0 t -132.96 150.86 52.13 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.814 0.34 . . . . 0.0 110.611 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.4 mmtt -90.34 50.02 1.78 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.531 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -171.09 150.24 3.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.516 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -94.55 125.76 50.46 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.219 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.467 ' HG3' ' CD1' ' A' ' 123' ' ' TYR . 73.6 Cg_endo -83.65 111.97 1.8 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.428 2.085 . . . . 0.0 112.605 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 46.6 t -69.84 -7.89 43.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.038 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -77.27 -22.55 51.94 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 120.798 0.333 . . . . 0.0 110.572 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.673 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -142.15 167.06 17.72 Favored Pre-proline 0 N--CA 1.453 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.702 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.673 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 62.5 Cg_endo -74.58 157.68 44.33 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.37 2.046 . . . . 0.0 112.315 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 12.8 t -118.28 111.0 32.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.346 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.836 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.65 96.05 1.94 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.762 179.016 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.1 t -93.56 135.44 28.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.995 0.426 . . . . 0.0 110.945 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 49.62 58.08 8.73 Favored Glycine 0 CA--C 1.521 0.42 0 CA-C-N 115.874 -0.603 . . . . 0.0 113.158 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.836 ' CE2' HD23 ' A' ' 155' ' ' LEU . 3.0 m95 -100.59 151.35 21.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.201 0.524 . . . . 0.0 111.744 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.413 ' HD3' ' CE2' ' A' ' 187' ' ' TYR . 2.6 tptt -64.76 -172.47 0.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.523 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -44.35 154.89 0.1 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.122 0.487 . . . . 0.0 112.212 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.55 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.29 -25.37 54.38 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.225 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.34 -38.25 83.21 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.979 0.419 . . . . 0.0 110.165 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.82 -40.61 47.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.116 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.55 HD12 ' HA2' ' A' ' 161' ' ' GLY . 5.9 mt -58.45 -41.38 81.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.973 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.12 -30.34 48.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.144 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.406 ' CB ' HG21 ' A' ' 211' ' ' ILE . 3.8 mm-40 -68.1 -53.04 28.34 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-O 121.368 0.604 . . . . 0.0 110.196 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.817 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -59.66 -43.6 93.89 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.03 179.064 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.892 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -59.2 -37.24 76.95 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.466 179.009 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.05 -37.01 92.11 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -73.06 -46.87 49.21 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.359 -0.421 . . . . 0.0 111.163 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.574 ' HA ' HD22 ' A' ' 174' ' ' LEU . 11.1 mp -65.3 -29.28 70.02 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.7 0.286 . . . . 0.0 111.345 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.79 -20.89 64.36 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.317 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -110.56 -26.3 9.54 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.599 0.238 . . . . 0.0 111.52 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.574 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.1 OUTLIER -57.42 166.62 1.58 Allowed Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.083 -179.697 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -68.8 127.14 14.9 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.308 2.005 . . . . 0.0 112.698 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.07 -25.96 5.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.643 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -58.23 -49.89 75.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.907 0.384 . . . . 0.0 110.986 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.852 HG11 ' HB3' ' A' ' 218' ' ' LEU . 32.0 t -74.0 -34.87 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.704 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.567 HD21 ' O ' ' A' ' 121' ' ' ILE . 0.5 OUTLIER -57.61 -33.91 68.73 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.119 0.485 . . . . 0.0 109.838 178.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -78.62 -39.79 20.37 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -87.74 103.18 15.37 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.884 0.373 . . . . 0.0 110.684 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . 0.842 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.8 mtm 178.79 163.4 0.78 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.202 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -120.39 -57.1 1.94 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.742 0.306 . . . . 0.0 111.206 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -159.97 142.52 13.47 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.992 0.425 . . . . 0.0 111.124 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.882 HG12 HG12 ' A' ' 199' ' ' VAL . 17.8 mt -105.12 114.84 45.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.279 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 23.5 m170 -104.24 120.38 41.02 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.117 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.414 ' CD2' ' HD3' ' A' ' 189' ' ' PRO . 83.7 t80 -75.03 104.45 5.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.474 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.23 89.24 52.11 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.529 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.414 ' HD3' ' CD2' ' A' ' 187' ' ' TYR . 49.2 Cg_endo -68.42 142.12 53.34 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.258 1.972 . . . . 0.0 112.386 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 18.3 p -119.77 159.1 25.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.678 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -54.96 -24.73 25.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.51 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -104.15 -17.83 14.75 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.828 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.438 ' CD1' HG21 ' A' ' 210' ' ' THR . 49.4 m-85 -141.45 85.41 1.96 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.93 0.395 . . . . 0.0 111.498 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -55.68 -24.23 32.98 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.333 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . 0.604 ' HB3' HD12 ' A' ' 211' ' ' ILE . 0.5 OUTLIER -106.55 40.39 1.63 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.036 0.446 . . . . 0.0 110.308 179.755 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.18 116.45 27.44 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.959 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.874 ' O ' HD13 ' A' ' 198' ' ' ILE . 29.2 m -109.96 168.05 4.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.082 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.874 HD13 ' O ' ' A' ' 197' ' ' VAL . 21.8 mm -135.37 108.24 8.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.196 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.882 HG12 HG12 ' A' ' 185' ' ' ILE . 15.4 m -97.61 139.72 19.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.998 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -101.51 152.72 20.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.778 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 6.0 mmt -105.28 159.7 15.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.88 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -60.13 -27.07 66.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.256 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -86.92 9.96 17.74 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 84.54 14.34 71.01 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.565 -0.826 . . . . 0.0 113.266 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -81.05 158.38 25.11 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 117.228 0.514 . . . . 0.0 110.739 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -128.15 111.25 13.25 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.814 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.624 HG11 HD12 ' A' ' 224' ' ' ILE . 21.2 t -111.21 133.58 56.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.951 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.489 ' HB3' HD12 ' A' ' 198' ' ' ILE . 0.3 OUTLIER -104.63 117.25 33.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.938 -179.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.661 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -129.49 156.84 43.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.681 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.438 HG21 ' CD1' ' A' ' 193' ' ' TYR . 0.4 OUTLIER -99.16 149.33 23.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.78 0.324 . . . . 0.0 110.764 179.932 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.604 HD12 ' HB3' ' A' ' 195' ' ' ASP . 64.1 mt -59.55 -38.25 74.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.955 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -61.84 -32.9 73.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.301 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -134.87 46.41 2.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.904 0.383 . . . . 0.0 111.075 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.493 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 11.4 t80 -70.26 -51.36 31.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.795 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.93 -39.65 86.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.014 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.85 -50.34 62.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.144 0.497 . . . . 0.0 110.454 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.99 -45.11 71.36 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.169 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.852 ' HB3' HG11 ' A' ' 178' ' ' VAL . 3.9 mm? -81.33 -26.33 35.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.95 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.31 -30.56 70.57 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.871 0.367 . . . . 0.0 110.301 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . 0.449 ' HB2' HG22 ' A' ' 224' ' ' ILE . 13.8 m170 -68.72 -17.51 64.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.189 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -67.78 137.3 92.66 Favored Pre-proline 0 CA--C 1.533 0.301 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.538 ' O ' ' HB3' ' A' ' 223' ' ' ALA . 59.7 Cg_endo -71.31 155.0 97.3 Favored 'Cis proline' 0 C--N 1.355 0.88 0 C-N-CA 124.728 -0.947 . . . . 0.0 112.799 0.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' A' ' 222' ' ' PRO . . . 85.18 74.49 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.714 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.624 HD12 HG11 ' A' ' 207' ' ' VAL . 7.5 pt -125.38 -179.42 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.027 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 64.44 164.66 0.14 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.081 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -143.64 -165.11 2.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.179 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -106.43 34.11 3.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.929 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.587 ' O ' HD23 ' A' ' 228' ' ' LEU . 5.1 tt -86.28 8.54 20.9 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.829 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.45 40.5 1.3 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.944 0.402 . . . . 0.0 110.952 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . 0.503 ' O ' HG23 ' A' ' 232' ' ' VAL . 31.3 mtp180 -94.28 -34.61 12.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.875 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -61.14 -37.05 81.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.963 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 230' ' ' ARG . 21.1 t 63.71 151.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.206 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.794 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.207 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.6 m -70.01 -32.15 70.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.821 0.343 . . . . 0.0 110.88 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -82.71 157.96 23.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.955 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.779 ' HB2' HD13 ' A' ' 134' ' ' LEU . 82.3 m95 -80.66 168.41 18.9 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.143 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -101.06 132.34 46.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.761 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 12.1 mtm-85 -69.94 106.12 3.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.667 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.891 HD11 HG22 ' A' ' 168' ' ' THR . 43.4 pt -94.5 -7.82 9.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.409 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -160.46 176.81 11.22 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 121.158 -0.217 . . . . 0.0 110.669 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.475 ' O ' ' HA ' ' A' ' 154' ' ' VAL . 30.4 m-85 -142.34 126.96 17.96 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.11 -0.329 . . . . 0.0 110.11 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.552 HG21 ' CD1' ' A' ' 139' ' ' LEU . 3.9 t -93.22 122.49 44.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.345 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -80.42 94.39 6.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.632 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -146.92 156.5 43.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.375 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.34 29.79 19.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.86 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 62.76 34.92 14.24 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.108 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.447 HG22 ' N ' ' A' ' 130' ' ' PHE . 86.7 m -158.06 161.76 38.05 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.194 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.447 ' N ' HG22 ' A' ' 129' ' ' THR . 6.3 m-85 -98.2 90.9 5.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.142 0.496 . . . . 0.0 111.041 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.479 ' HB2' HD21 ' A' ' 139' ' ' LEU . 23.9 m-85 -69.67 120.35 76.85 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.248 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.42 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 23.5 Cg_exo -64.2 117.63 4.64 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.341 2.027 . . . . 0.0 112.798 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.643 HD21 ' OG1' ' A' ' 168' ' ' THR . 35.9 tp -96.84 123.65 40.6 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.144 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.779 HD13 ' HB2' ' A' ' 118' ' ' TRP . 55.9 mt -70.75 171.39 10.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.666 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.412 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 2.1 pt-20 -62.82 -29.36 70.67 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.938 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -89.29 10.3 22.8 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.156 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.645 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 76.57 18.05 79.38 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.159 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.715 ' HB3' HD12 ' A' ' 134' ' ' LEU . 18.3 tpp85 -76.97 94.04 3.9 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.552 ' CD1' HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -68.14 110.03 3.8 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.675 -178.889 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 37.5 mt -81.74 73.62 8.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.676 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.452 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 13.1 mtpt -60.72 -17.86 50.89 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.575 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -101.32 25.01 8.75 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.535 0.207 . . . . 0.0 111.219 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -145.83 26.7 1.23 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.707 0.289 . . . . 0.0 111.353 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . -59.21 164.16 10.66 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.719 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.8 t -135.24 148.55 49.63 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.925 0.393 . . . . 0.0 110.784 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 3.6 mmtt -90.04 53.24 2.47 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.491 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.72 153.56 4.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.361 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -88.62 133.8 35.37 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.83 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.448 ' HG3' ' CD1' ' A' ' 123' ' ' TYR . 73.7 Cg_endo -81.63 98.86 1.01 Allowed 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.905 2.404 . . . . 0.0 112.505 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.0 t -67.23 -9.62 42.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.877 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -89.65 -22.23 22.39 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 111.666 0.247 . . . . 0.0 111.666 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.731 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -139.03 168.07 16.88 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.731 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 61.6 Cg_endo -74.12 165.81 31.09 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.352 2.035 . . . . 0.0 112.278 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 25.6 t -125.12 107.83 18.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.035 0.445 . . . . 0.0 111.744 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.882 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.43 96.19 1.87 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.023 179.336 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.444 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 61.9 t -94.17 138.02 21.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.085 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 48.01 56.05 9.36 Favored Glycine 0 CA--C 1.52 0.39 0 CA-C-N 115.964 -0.562 . . . . 0.0 113.261 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.882 ' CE2' HD23 ' A' ' 155' ' ' LEU . 3.4 m95 -99.16 151.16 21.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.187 0.518 . . . . 0.0 111.659 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.47 -172.37 0.16 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.519 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -43.06 154.22 0.08 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.567 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.06 -24.89 52.53 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.267 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -60.26 -39.27 86.17 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.998 0.427 . . . . 0.0 110.162 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.7 -39.51 51.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.18 179.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.567 HD12 ' HA2' ' A' ' 161' ' ' GLY . 7.1 mt -60.07 -42.13 88.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.126 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.48 -30.83 54.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.285 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.414 ' HB3' HG21 ' A' ' 211' ' ' ILE . 3.0 mm-40 -65.95 -53.27 41.19 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.409 0.623 . . . . 0.0 110.01 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.785 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -61.48 -43.05 99.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.087 179.06 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.891 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -59.19 -37.28 77.02 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.38 179.281 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.52 -38.37 94.79 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 110.456 -1.057 . . . . 0.0 110.456 178.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 33.6 mm-40 -71.31 -44.15 65.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.384 -0.408 . . . . 0.0 110.801 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.659 ' HA ' HD22 ' A' ' 174' ' ' LEU . 10.5 mp -66.92 -28.41 68.27 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.7 0.286 . . . . 0.0 111.384 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.83 -16.18 62.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.377 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -114.7 -29.25 6.84 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 111.561 0.208 . . . . 0.0 111.561 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.659 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER -56.85 167.16 1.12 Allowed Pre-proline 0 CA--C 1.538 0.5 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.121 -179.673 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -69.99 126.94 13.73 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.153 1.902 . . . . 0.0 113.043 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.35 -25.31 5.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.696 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -56.08 -50.72 70.21 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.907 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.886 HG11 ' HB3' ' A' ' 218' ' ' LEU . 42.8 t -74.74 -34.74 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.54 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.478 ' HB2' HD21 ' A' ' 174' ' ' LEU . 11.6 tp -54.92 -35.32 64.04 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.181 0.515 . . . . 0.0 110.13 179.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -79.99 -41.83 11.8 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 111.169 -0.773 . . . . 0.0 111.169 178.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -82.3 103.14 11.66 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.843 0.354 . . . . 0.0 110.469 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . 0.844 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.9 mtm 177.81 171.6 0.64 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.129 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.3 m -127.54 -54.59 1.34 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.811 0.338 . . . . 0.0 110.877 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -163.49 142.32 8.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.029 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.925 HG12 HG12 ' A' ' 199' ' ' VAL . 18.6 mt -105.51 114.32 44.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.137 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . 0.444 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 19.2 m170 -105.88 114.92 29.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.424 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.419 ' HB2' ' CD2' ' A' ' 158' ' ' TRP . 83.8 t80 -66.09 104.43 1.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -126.78 87.65 56.09 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.939 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.25 159.61 52.47 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.432 2.088 . . . . 0.0 112.288 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 5.5 p -134.14 169.29 17.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.61 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -59.88 -26.97 66.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.096 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.428 ' HG2' ' CD2' ' A' ' 193' ' ' TYR . 0.5 OUTLIER -118.18 11.21 13.16 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.594 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.428 ' CD2' ' HG2' ' A' ' 192' ' ' GLU . 58.0 m-85 -157.73 75.25 0.77 Allowed 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 120.987 0.422 . . . . 0.0 111.131 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -56.91 -25.85 58.01 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.166 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 6.9 p30 -102.15 37.27 1.91 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.556 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 2.0 tpm_? -89.5 114.23 25.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.134 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.686 ' O ' HD13 ' A' ' 198' ' ' ILE . 28.7 m -110.48 166.0 5.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.622 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.686 HD13 ' O ' ' A' ' 197' ' ' VAL . 19.1 mm -131.43 106.14 11.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.805 0.336 . . . . 0.0 111.43 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.925 HG12 HG12 ' A' ' 185' ' ' ILE . 9.5 m -96.11 118.36 42.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.919 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -81.63 152.92 26.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.547 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.17 148.15 28.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.863 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 36.1 m-20 -58.24 -28.85 65.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.017 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -76.86 -4.68 44.93 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.765 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 97.41 14.46 41.26 Favored Glycine 0 C--N 1.335 0.517 0 C-N-CA 120.533 -0.841 . . . . 0.0 113.106 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -87.61 170.99 10.8 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.957 0.408 . . . . 0.0 111.103 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -135.04 111.12 9.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.623 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.437 ' HB ' HG23 ' A' ' 199' ' ' VAL . 28.9 t -113.94 124.82 70.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.881 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 2.8 m -102.17 115.64 30.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.781 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -123.49 171.01 9.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.82 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -107.42 155.09 20.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.474 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.414 HG21 ' HB3' ' A' ' 166' ' ' GLU . 38.5 mt -68.13 -35.95 73.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.807 0.336 . . . . 0.0 110.76 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -62.85 -36.87 84.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.258 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -130.64 40.99 3.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.953 0.406 . . . . 0.0 111.068 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.542 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 10.6 t80 -64.06 -55.04 25.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.553 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.04 -42.73 85.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.271 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -66.67 -48.21 70.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.015 0.436 . . . . 0.0 110.496 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . 0.437 ' O ' HG21 ' A' ' 224' ' ' ILE . 1.2 mmpt? -55.1 -44.4 74.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.279 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.886 ' HB3' HG11 ' A' ' 178' ' ' VAL . 3.7 mm? -83.99 -25.69 29.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.074 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 14.9 t -60.74 -32.81 72.08 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.973 0.416 . . . . 0.0 110.157 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 24.5 m170 -71.17 -16.72 62.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.181 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.42 ' CE1' ' HB3' ' A' ' 222' ' ' PRO . 3.5 t80 -56.96 135.52 79.92 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.877 -0.147 . . . . 0.0 110.986 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.42 ' HB3' ' CE1' ' A' ' 221' ' ' TYR . 57.1 Cg_endo -90.51 107.91 0.79 Allowed 'Cis proline' 0 C--N 1.357 0.983 0 C-N-CA 124.681 -0.966 . . . . 0.0 112.631 0.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . 178.84 42.56 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.096 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.437 HG21 ' O ' ' A' ' 217' ' ' LYS . 0.2 OUTLIER -146.01 160.51 11.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.078 179.82 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' A' ' 224' ' ' ILE . . . 176.81 40.33 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.083 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . 59.99 -176.25 0.1 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.075 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.401 ' C ' HD12 ' A' ' 228' ' ' LEU . . . -138.41 31.49 2.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.048 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.401 HD12 ' C ' ' A' ' 227' ' ' ALA . 10.8 mp -118.84 32.61 6.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.854 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -112.69 44.64 1.44 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.812 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 48.3 mtp85 -136.45 -53.39 0.72 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.983 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 43.7 m-20 -90.93 81.59 5.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.879 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 10.2 m -75.09 177.46 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.061 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 6.8 ttmm . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.188 -0.911 . . . . 0.0 110.88 179.959 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.15 0 N-CA-C 112.469 -0.252 . . . . 0.0 112.469 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.8 m -96.69 80.12 3.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.804 0.335 . . . . 0.0 110.931 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -133.69 151.39 51.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.876 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.769 ' HB2' HD13 ' A' ' 134' ' ' LEU . 81.0 m95 -73.56 168.48 19.21 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.185 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -102.88 132.24 49.22 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.808 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.31 107.03 3.11 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.777 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.887 HD11 HG22 ' A' ' 168' ' ' THR . 44.2 pt -96.21 -7.8 9.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.498 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.435 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -159.94 176.78 11.47 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.003 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.463 ' O ' ' HA ' ' A' ' 154' ' ' VAL . 33.1 m-85 -143.41 127.2 17.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.284 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.577 HG21 ' CD1' ' A' ' 139' ' ' LEU . 3.6 t -93.44 122.71 45.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.098 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -82.52 94.11 7.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.36 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -145.22 155.68 43.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.255 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 59.31 29.45 19.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.855 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 62.88 35.03 13.82 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.142 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 53.3 m -157.13 156.76 33.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.836 0.351 . . . . 0.0 111.17 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -94.75 91.39 6.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.888 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.45 ' CG ' ' HA ' ' A' ' 141' ' ' LYS . 23.3 m-85 -70.81 121.75 84.77 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.303 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.409 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 22.3 Cg_exo -64.81 121.66 9.26 Favored 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 122.414 2.076 . . . . 0.0 112.757 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.658 HD21 ' OG1' ' A' ' 168' ' ' THR . 31.1 tp -102.09 123.36 45.82 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-O 121.128 0.49 . . . . 0.0 110.087 178.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.769 HD13 ' HB2' ' A' ' 118' ' ' TRP . 51.5 mt -70.72 171.81 9.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.652 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.407 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.6 pt-20 -62.94 -28.32 69.99 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.979 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 50.8 p-10 -90.46 11.97 20.0 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.225 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.628 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 75.15 18.79 80.05 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.237 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.69 ' HB3' HD12 ' A' ' 134' ' ' LEU . 1.5 tpt180 -77.6 92.43 4.09 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.577 ' CD1' HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -66.41 113.78 4.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.418 -179.053 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.503 HD13 ' HG3' ' A' ' 143' ' ' GLU . 30.1 mt -84.01 70.07 10.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.69 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.45 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 5.4 mtpt -58.26 -20.3 41.18 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.56 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -99.38 25.24 7.15 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.739 -0.21 . . . . 0.0 111.27 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.503 ' HG3' HD13 ' A' ' 140' ' ' LEU . 54.3 mm-40 -147.16 24.83 1.14 Allowed 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.582 0.23 . . . . 0.0 111.493 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . -59.41 161.71 15.21 Favored Glycine 0 CA--C 1.509 -0.335 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.747 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 9.0 t -131.27 154.51 48.42 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.041 0.448 . . . . 0.0 110.7 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -92.95 53.92 2.08 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.766 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.74 170.81 6.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.256 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -104.26 135.85 19.27 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.537 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.449 ' HG3' ' CD1' ' A' ' 123' ' ' TYR . 68.3 Cg_endo -82.77 99.67 0.93 Allowed 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.95 2.433 . . . . 0.0 112.443 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.4 t -67.01 -10.1 46.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.844 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.92 -22.08 22.16 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.692 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -138.67 166.69 23.4 Favored Pre-proline 0 C--N 1.328 -0.356 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -178.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.692 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 61.3 Cg_endo -73.87 164.2 35.19 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 122.487 2.125 . . . . 0.0 112.3 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 24.3 t -123.4 109.68 24.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.666 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.841 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.58 96.77 2.02 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.947 179.344 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 59.5 t -94.68 136.87 24.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.983 0.421 . . . . 0.0 111.124 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 49.7 51.33 28.71 Favored Glycine 0 CA--C 1.52 0.375 0 CA-C-N 115.811 -0.631 . . . . 0.0 113.259 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.841 ' CE2' HD23 ' A' ' 155' ' ' LEU . 2.9 m95 -94.75 151.01 19.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.054 0.454 . . . . 0.0 111.574 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -66.0 -172.43 0.14 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.421 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -43.67 154.7 0.09 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.073 0.463 . . . . 0.0 112.217 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.55 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -56.45 -25.24 48.91 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.269 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.33 -39.17 86.12 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 120.912 0.387 . . . . 0.0 110.058 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.19 -40.22 52.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.102 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.55 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.1 mt -59.13 -41.58 84.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.909 179.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.44 -30.74 53.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.2 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.4 ' CB ' HG21 ' A' ' 211' ' ' ILE . 3.2 mm-40 -67.21 -53.17 32.67 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-O 121.439 0.638 . . . . 0.0 110.072 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.802 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -59.72 -45.53 91.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.989 178.865 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.887 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -57.28 -36.77 71.45 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.565 179.037 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.13 -38.21 94.04 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 178.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -71.24 -48.17 52.83 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.329 -0.436 . . . . 0.0 110.939 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.612 ' HA ' HD22 ' A' ' 174' ' ' LEU . 10.9 mp -64.51 -28.6 69.76 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.742 0.306 . . . . 0.0 111.275 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.87 -18.37 63.41 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.37 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -112.15 -28.32 8.02 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.645 0.26 . . . . 0.0 111.421 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.612 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.1 OUTLIER -57.55 166.9 1.51 Allowed Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.998 -179.695 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -70.04 128.78 16.26 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.263 1.975 . . . . 0.0 112.898 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.94 -25.8 9.01 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.64 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -58.05 -48.79 79.04 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.881 0.372 . . . . 0.0 110.935 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.882 HG11 ' HB3' ' A' ' 218' ' ' LEU . 24.6 t -73.66 -35.31 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.504 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 11.5 tp -55.26 -34.61 64.19 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.234 0.54 . . . . 0.0 109.987 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -78.71 -42.73 12.86 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.314 178.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -82.16 103.19 11.59 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.899 0.381 . . . . 0.0 110.404 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . 0.84 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.9 mtm 177.65 173.48 0.54 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.956 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 3.2 t -133.09 -51.65 0.89 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.705 0.288 . . . . 0.0 111.229 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . 0.428 ' HG2' ' CD1' ' A' ' 200' ' ' TYR . 1.3 pm0 -163.13 142.85 8.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.035 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.898 HG12 HG12 ' A' ' 199' ' ' VAL . 19.9 mt -106.66 114.24 45.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.442 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -104.6 124.04 48.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.16 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -80.47 104.82 11.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.368 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.71 85.91 56.37 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.54 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.27 140.29 44.14 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.258 1.972 . . . . 0.0 112.419 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 17.2 p -117.9 160.54 21.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.76 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -54.7 -28.65 49.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.335 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -102.41 -15.9 16.37 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.841 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -141.05 80.21 1.73 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.924 0.392 . . . . 0.0 111.464 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -56.66 -22.01 31.47 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.43 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -107.13 38.33 2.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.772 0.32 . . . . 0.0 110.616 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -91.1 115.75 28.27 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.985 0.421 . . . . 0.0 111.379 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.727 ' O ' HD13 ' A' ' 198' ' ' ILE . 27.7 m -112.55 166.6 6.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.655 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.727 HD13 ' O ' ' A' ' 197' ' ' VAL . 21.5 mm -131.68 109.85 16.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.732 0.301 . . . . 0.0 111.29 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.898 HG12 HG12 ' A' ' 185' ' ' ILE . 8.5 m -100.08 124.92 53.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.912 0.387 . . . . 0.0 111.021 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.428 ' CD1' ' HG2' ' A' ' 184' ' ' GLU . 44.8 m-85 -86.6 152.53 22.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.571 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 5.5 mmt -104.07 165.4 11.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.937 0.399 . . . . 0.0 110.936 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -67.4 -26.15 66.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.062 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -89.94 13.87 13.59 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 80.99 14.44 79.42 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 120.556 -0.831 . . . . 0.0 113.321 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -77.0 168.09 20.69 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 117.119 0.46 . . . . 0.0 110.729 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -134.51 111.57 10.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.851 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.679 HG11 HD12 ' A' ' 224' ' ' ILE . 17.9 t -119.38 123.91 72.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.165 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.544 ' HB2' HD12 ' A' ' 198' ' ' ILE . 27.1 t -101.29 114.84 29.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.751 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.625 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -122.91 161.75 23.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.862 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.83 154.94 17.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.624 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.4 HG21 ' CB ' ' A' ' 166' ' ' GLU . 36.8 mt -67.18 -30.14 48.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.713 0.292 . . . . 0.0 110.986 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -72.07 -38.26 69.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.289 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -121.99 34.69 5.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.038 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.602 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 12.0 t80 -62.0 -56.05 23.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.926 0.393 . . . . 0.0 110.7 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.63 -40.64 83.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.138 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -67.42 -49.19 64.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.952 0.406 . . . . 0.0 110.365 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.42 -45.02 72.91 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.057 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.882 ' HB3' HG11 ' A' ' 178' ' ' VAL . 3.8 mm? -80.89 -27.67 36.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.785 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 13.5 t -60.64 -30.34 69.81 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.846 0.355 . . . . 0.0 110.529 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 65.6 m-70 -69.25 -16.9 63.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.21 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -64.66 139.46 97.76 Favored Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 121.285 -0.166 . . . . 0.0 110.844 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.496 ' O ' ' HB2' ' A' ' 223' ' ' ALA . 70.5 Cg_endo -86.64 110.47 1.64 Allowed 'Cis proline' 0 C--N 1.357 0.976 0 C-N-CA 124.532 -1.029 . . . . 0.0 112.609 0.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.496 ' HB2' ' O ' ' A' ' 222' ' ' PRO . . . 169.27 43.94 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.216 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.679 HD12 HG11 ' A' ' 207' ' ' VAL . 9.9 pt -120.76 -178.48 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.273 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 224' ' ' ILE . . . 77.19 68.61 0.05 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.043 0.449 . . . . 0.0 110.99 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -89.91 -157.0 0.44 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.576 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -92.1 20.49 5.84 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.448 ' HA ' HD22 ' A' ' 228' ' ' LEU . 0.3 OUTLIER -114.9 26.54 10.08 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.793 0.33 . . . . 0.0 110.666 179.513 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -135.12 73.87 1.5 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.047 0.451 . . . . 0.0 110.877 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -153.26 -48.74 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.87 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . 0.498 ' O ' HG13 ' A' ' 232' ' ' VAL . 3.7 m-80 64.0 -79.27 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.004 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . 0.498 HG13 ' O ' ' A' ' 231' ' ' ASN . 5.0 m -157.84 178.53 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.833 0.349 . . . . 0.0 111.065 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 22.0 pttt . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.83 -179.958 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.185 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 59.1 p -72.27 149.23 44.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.744 0.307 . . . . 0.0 110.916 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -157.98 154.18 27.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.959 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.767 ' HB2' HD13 ' A' ' 134' ' ' LEU . 81.9 m95 -74.15 168.4 19.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.143 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 6.9 ptt180 -101.7 134.49 44.78 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.845 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -71.2 106.89 3.96 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.858 0.361 . . . . 0.0 110.75 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.918 HD11 HG22 ' A' ' 168' ' ' THR . 46.0 pt -95.93 -9.45 9.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.315 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.467 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -157.75 176.14 12.97 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 120.586 0.231 . . . . 0.0 110.691 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.47 ' CD1' ' HG3' ' A' ' 149' ' ' PRO . 29.9 m-85 -143.92 126.7 16.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.16 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.646 HG21 HD11 ' A' ' 139' ' ' LEU . 4.3 t -93.12 122.42 44.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.279 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.497 ' CE1' ' CE1' ' A' ' 130' ' ' PHE . 7.3 t80 -81.92 97.13 7.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.935 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -149.14 151.62 34.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.44 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 61.17 30.88 19.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.804 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 61.81 31.29 18.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.034 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.501 HG23 ' O ' ' A' ' 145' ' ' THR . 70.4 m -151.2 151.13 31.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.941 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.639 ' CE2' ' HB2' ' A' ' 148' ' ' ALA . 12.1 m-85 -93.07 91.05 7.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.701 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.507 ' HB2' HD21 ' A' ' 139' ' ' LEU . 23.5 m-85 -66.57 123.38 85.56 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.665 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -70.65 113.32 3.48 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 122.107 1.872 . . . . 0.0 112.727 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.647 HD21 ' OG1' ' A' ' 168' ' ' THR . 32.2 tp -92.44 124.02 36.18 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.706 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.767 HD13 ' HB2' ' A' ' 118' ' ' TRP . 48.1 mt -69.86 174.25 5.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.503 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -65.73 -28.31 68.95 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.029 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -89.74 11.84 18.82 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.156 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.625 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 74.1 22.8 77.37 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.937 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.687 ' HB3' HD12 ' A' ' 134' ' ' LEU . 18.2 tpp180 -81.92 93.62 6.95 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.646 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -68.69 109.34 3.76 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.151 -179.155 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 15.7 mt -85.14 71.64 10.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.87 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.478 ' HE3' HD13 ' A' ' 139' ' ' LEU . 12.8 mttt -57.77 -21.14 39.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.469 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -94.28 20.05 8.67 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.419 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -145.15 26.95 1.31 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.846 0.355 . . . . 0.0 111.045 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.77 163.89 39.76 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.96 -0.638 . . . . 0.0 113.199 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.501 ' O ' HG23 ' A' ' 129' ' ' THR . 6.7 t -130.69 157.01 43.94 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.328 -0.436 . . . . 0.0 110.563 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.3 mmmt -94.3 50.09 1.35 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.548 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.15 150.35 3.0 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.695 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.639 ' HB2' ' CE2' ' A' ' 130' ' ' PHE . . . -93.05 125.64 54.16 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.242 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.47 ' HG3' ' CD1' ' A' ' 123' ' ' TYR . 71.9 Cg_endo -84.1 111.32 1.62 Allowed 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.433 2.089 . . . . 0.0 112.599 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 45.5 t -69.62 -8.19 45.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.013 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -77.25 -23.51 51.24 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 120.865 0.364 . . . . 0.0 110.54 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.665 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -140.17 166.62 22.25 Favored Pre-proline 0 N--CA 1.453 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.562 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.665 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 66.7 Cg_endo -74.99 158.03 42.49 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.342 2.028 . . . . 0.0 112.331 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 14.3 t -118.24 110.67 31.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.251 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.838 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.52 96.25 1.92 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.726 179.206 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.42 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 61.7 t -93.35 137.22 23.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.007 0.432 . . . . 0.0 111.149 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 49.0 54.13 15.77 Favored Glycine 0 CA--C 1.52 0.363 0 CA-C-N 115.859 -0.609 . . . . 0.0 113.327 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.838 ' CE2' HD23 ' A' ' 155' ' ' LEU . 2.7 m95 -97.32 151.13 20.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.118 0.485 . . . . 0.0 111.55 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.22 -172.41 0.15 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.322 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -43.21 154.99 0.07 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.543 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -56.51 -24.51 46.93 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.154 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -60.33 -40.27 90.02 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.969 0.414 . . . . 0.0 109.911 179.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.51 ' HB1' ' HE2' ' A' ' 187' ' ' TYR . . . -74.39 -41.43 60.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.972 178.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.543 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.6 mt -58.28 -42.21 83.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.009 179.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.77 -29.89 42.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.192 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.429 ' CB ' HG21 ' A' ' 211' ' ' ILE . 4.2 mm-40 -68.19 -53.2 26.6 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.435 0.636 . . . . 0.0 110.107 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.804 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -59.08 -45.97 89.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.099 178.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.918 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -56.98 -37.52 71.75 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.709 179.258 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.14 -37.86 93.52 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 47.9 mm-40 -72.89 -46.32 53.43 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.419 -0.39 . . . . 0.0 111.135 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.613 ' HA ' HD22 ' A' ' 174' ' ' LEU . 11.1 mp -65.86 -28.57 69.06 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.658 0.266 . . . . 0.0 111.406 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.52 -17.67 62.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.379 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -112.51 -28.79 7.72 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 120.697 0.284 . . . . 0.0 111.453 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.613 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.1 OUTLIER -56.94 167.28 1.11 Allowed Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.188 -179.564 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -69.24 127.15 14.58 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.21 1.94 . . . . 0.0 112.861 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.11 -25.51 9.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.592 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -58.46 -48.99 78.92 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.959 0.409 . . . . 0.0 110.889 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.854 HG11 ' HB3' ' A' ' 218' ' ' LEU . 27.2 t -73.75 -33.8 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.438 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.408 ' HB2' HD21 ' A' ' 174' ' ' LEU . 13.8 tp -56.46 -35.26 67.72 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.141 0.496 . . . . 0.0 109.815 179.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -78.02 -40.84 19.73 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.188 178.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -84.6 102.84 13.22 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.977 0.418 . . . . 0.0 110.57 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . 0.842 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.9 mtm 177.63 173.55 0.54 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.007 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 4.7 t -133.68 -50.27 0.84 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.752 0.31 . . . . 0.0 111.225 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -163.45 145.25 9.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.025 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.905 HG12 HG12 ' A' ' 199' ' ' VAL . 20.2 mt -110.87 115.99 51.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.539 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . 0.42 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 20.3 m170 -106.64 137.82 43.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.208 -179.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.51 ' HE2' ' HB1' ' A' ' 163' ' ' ALA . 0.2 OUTLIER -87.86 104.54 16.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.472 179.596 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.35 89.27 50.26 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.87 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.78 158.76 55.83 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.314 2.009 . . . . 0.0 112.486 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 6.9 p -133.59 170.0 16.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.75 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 7.4 ptt180 -60.23 -27.42 67.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.151 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.403 ' O ' ' CG ' ' A' ' 193' ' ' TYR . 1.7 mm-40 -117.3 10.6 13.76 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.403 ' CG ' ' O ' ' A' ' 192' ' ' GLU . 73.7 m-85 -156.96 75.5 0.83 Allowed 'General case' 0 C--O 1.231 0.108 0 CA-C-O 120.949 0.404 . . . . 0.0 111.208 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -57.21 -26.36 60.57 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.215 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . 0.4 ' HB2' ' HB ' ' A' ' 211' ' ' ILE . 6.8 p30 -102.94 37.09 2.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.752 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -87.59 115.39 24.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.938 0.399 . . . . 0.0 111.093 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.813 ' O ' HD13 ' A' ' 198' ' ' ILE . 30.5 m -112.14 168.19 5.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.686 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.813 HD13 ' O ' ' A' ' 197' ' ' VAL . 25.7 mm -132.61 109.77 15.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.785 0.326 . . . . 0.0 111.318 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.905 HG12 HG12 ' A' ' 185' ' ' ILE . 6.9 m -99.0 121.04 49.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.901 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -81.94 152.52 26.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.835 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.04 146.44 35.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.863 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -57.32 -22.61 43.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.504 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -89.7 15.22 9.99 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 79.62 14.41 81.22 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.241 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -90.59 149.92 21.94 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 117.137 0.468 . . . . 0.0 110.801 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -119.38 111.33 18.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.765 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 20.8 t -111.68 126.23 69.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.964 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.578 ' OG ' HD12 ' A' ' 198' ' ' ILE . 11.0 m -103.08 116.36 32.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.934 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -121.84 -177.58 3.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.569 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.66 153.7 35.15 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.494 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.429 HG21 ' CB ' ' A' ' 166' ' ' GLU . 43.7 mt -66.63 -34.93 73.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.811 0.339 . . . . 0.0 110.775 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.4 -36.42 81.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.207 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -129.92 45.27 2.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.978 0.418 . . . . 0.0 110.903 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.621 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 11.6 t80 -68.53 -52.24 34.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.768 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.9 -39.7 86.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.132 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.71 -49.99 64.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.146 0.498 . . . . 0.0 110.603 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . 0.691 ' O ' HG21 ' A' ' 224' ' ' ILE . 1.8 mmpt? -53.99 -44.08 70.52 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.41 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.854 ' HB3' HG11 ' A' ' 178' ' ' VAL . 3.9 mm? -84.85 -23.77 28.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.266 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.31 -33.59 73.83 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.003 0.43 . . . . 0.0 109.934 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 38.2 m170 -70.06 -16.16 63.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.236 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.412 ' CE1' ' HB3' ' A' ' 222' ' ' PRO . 12.6 t80 -56.82 137.62 78.59 Favored Pre-proline 0 CA--C 1.535 0.367 0 O-C-N 122.535 -0.103 . . . . 0.0 111.134 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.416 ' O ' ' HB2' ' A' ' 223' ' ' ALA . 51.9 Cg_endo -91.81 105.43 0.45 Allowed 'Cis proline' 0 C--N 1.357 0.995 0 C-N-CA 124.702 -0.958 . . . . 0.0 112.539 0.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 222' ' ' PRO . . . 176.47 42.85 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.969 0.414 . . . . 0.0 111.124 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.691 HG21 ' O ' ' A' ' 217' ' ' LYS . 0.2 OUTLIER -117.65 -178.63 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.136 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 224' ' ' ILE . . . 70.34 86.49 0.12 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.971 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -76.79 -163.8 0.37 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.096 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -98.82 33.06 2.41 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.882 0.372 . . . . 0.0 110.906 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 1.3 tp -83.65 5.5 24.25 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.75 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -118.69 31.7 6.52 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.861 0.363 . . . . 0.0 110.888 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -176.79 37.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.947 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -168.97 -60.13 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.85 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 21.5 t -108.38 106.79 21.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.078 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 2.3 mttm . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.878 179.98 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.152 0 N-CA-C 112.535 -0.226 . . . . 0.0 112.535 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.51 88.75 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.852 0.358 . . . . 0.0 110.941 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -77.66 153.08 33.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.995 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.769 ' HB2' HD13 ' A' ' 134' ' ' LEU . 80.7 m95 -77.13 168.36 20.21 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.053 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.32 133.77 46.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.818 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.4 mtt85 -70.4 106.78 3.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.869 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.904 HD11 HG22 ' A' ' 168' ' ' THR . 44.6 pt -95.47 -8.44 9.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.412 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.406 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -159.38 176.28 12.32 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 120.588 0.232 . . . . 0.0 110.894 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.453 ' O ' ' HA ' ' A' ' 154' ' ' VAL . 32.2 m-85 -143.5 126.96 16.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.332 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.645 HG21 HD11 ' A' ' 139' ' ' LEU . 5.0 t -93.36 122.63 45.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.083 0.468 . . . . 0.0 111.12 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.5 ' CD1' ' CE1' ' A' ' 130' ' ' PHE . 7.9 t80 -82.52 103.84 12.35 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.857 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -158.44 154.22 26.5 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.592 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.62 30.65 19.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.803 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 62.99 31.48 16.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.274 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 88.1 m -153.79 156.77 38.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.89 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.5 ' CE1' ' CD1' ' A' ' 125' ' ' TYR . 81.2 m-85 -98.42 90.88 4.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.602 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.491 ' HB2' HD21 ' A' ' 139' ' ' LEU . 23.4 m-85 -65.35 123.79 85.26 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.117 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.402 ' HB3' ' CE2' ' A' ' 123' ' ' TYR . 56.1 Cg_endo -71.57 115.22 4.21 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.255 1.97 . . . . 0.0 112.793 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.687 HD21 ' OG1' ' A' ' 168' ' ' THR . 29.2 tp -94.09 124.06 37.86 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.665 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.769 HD13 ' HB2' ' A' ' 118' ' ' TRP . 52.8 mt -70.69 173.29 7.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.517 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.4 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.3 pt-20 -64.3 -28.66 69.87 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.969 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -89.8 11.72 19.28 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.251 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.602 ' HA2' HD11 ' A' ' 133' ' ' LEU . . . 74.38 22.72 77.11 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.726 -0.75 . . . . 0.0 113.048 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.693 ' HB3' HD12 ' A' ' 134' ' ' LEU . 1.4 tpt180 -81.43 94.53 6.84 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.645 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -70.96 107.88 4.28 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.211 -179.164 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 16.7 mt -86.17 72.85 10.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.547 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.46 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 23.8 mttp -56.86 -20.95 25.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.77 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -85.24 -14.87 45.39 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -112.03 30.82 6.7 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . -60.5 166.24 12.12 Favored Glycine 0 CA--C 1.511 -0.185 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.453 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 9.0 t -135.3 148.27 49.45 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.992 0.425 . . . . 0.0 111.029 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 3.0 mmtt -90.86 52.82 2.24 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.356 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.68 152.22 3.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.549 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -86.99 135.95 34.61 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.833 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.452 ' HD2' ' CG2' ' A' ' 154' ' ' VAL . 60.6 Cg_endo -84.46 98.42 0.72 Allowed 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.028 2.485 . . . . 0.0 112.641 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.2 t -67.46 -9.13 39.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.714 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -90.35 -22.06 21.7 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 111.533 0.197 . . . . 0.0 111.533 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.717 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -138.7 167.43 19.52 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.717 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 60.9 Cg_endo -73.36 161.85 41.7 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.533 2.156 . . . . 0.0 112.382 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 24.2 t -123.07 110.03 25.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.044 0.45 . . . . 0.0 111.712 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.827 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.62 95.92 1.91 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.74 179.156 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 59.6 t -91.37 137.06 22.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.99 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 46.72 56.59 7.33 Favored Glycine 0 CA--C 1.52 0.399 0 CA-C-N 115.882 -0.599 . . . . 0.0 113.374 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.827 ' CE2' HD23 ' A' ' 155' ' ' LEU . 2.7 m95 -98.25 151.2 20.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.26 0.552 . . . . 0.0 111.707 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 8.1 mmtm -65.23 -172.44 0.1 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.59 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -43.62 154.02 0.1 Allowed 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.54 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.21 -24.85 52.89 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.224 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.01 -38.53 82.9 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.984 0.421 . . . . 0.0 110.056 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.01 -40.24 47.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.003 178.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.54 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.2 mt -58.87 -41.46 82.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.874 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.09 -29.68 45.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.276 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.432 ' CB ' HG21 ' A' ' 211' ' ' ILE . 3.0 mm-40 -69.08 -53.03 22.47 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.31 0.576 . . . . 0.0 110.256 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.825 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -59.1 -44.52 91.97 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.041 178.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.904 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -58.49 -38.22 77.19 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.397 179.214 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.19 -36.16 87.49 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 178.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -73.92 -47.59 36.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.264 -0.468 . . . . 0.0 110.988 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.611 ' HA ' HD22 ' A' ' 174' ' ' LEU . 11.0 mp -65.07 -27.93 69.11 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.754 0.311 . . . . 0.0 111.477 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.74 -18.6 62.78 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.297 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -113.4 -27.01 8.08 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.596 0.236 . . . . 0.0 111.626 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.611 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER -57.09 167.5 1.12 Allowed Pre-proline 0 CA--C 1.537 0.481 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.079 -179.684 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.52 128.22 15.92 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.2 1.933 . . . . 0.0 112.84 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.22 -25.38 9.1 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.631 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.74 -48.95 78.18 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.944 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.904 HG11 ' HB3' ' A' ' 218' ' ' LEU . 38.9 t -74.16 -35.48 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.439 179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.487 ' HB2' HD21 ' A' ' 174' ' ' LEU . 13.8 tp -56.82 -39.4 74.12 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.095 0.474 . . . . 0.0 109.969 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -73.6 -40.05 47.69 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 178.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -88.14 102.87 15.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.948 0.404 . . . . 0.0 110.577 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . 0.837 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.8 mtm 177.69 164.19 0.62 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.146 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.53 -59.85 1.59 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.725 0.298 . . . . 0.0 111.091 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -155.24 142.58 19.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.034 0.445 . . . . 0.0 111.29 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.907 HG12 HG12 ' A' ' 199' ' ' VAL . 20.4 mt -104.69 114.86 45.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.317 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 23.6 m170 -103.12 117.46 34.59 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.256 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.41 ' HB2' ' CD2' ' A' ' 158' ' ' TRP . 71.2 t80 -76.4 104.48 6.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.432 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.94 82.44 43.21 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.647 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.403 ' HD3' ' CD2' ' A' ' 187' ' ' TYR . 60.7 Cg_endo -71.99 147.53 49.32 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.383 2.056 . . . . 0.0 112.559 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 19.5 p -128.52 160.35 32.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.699 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 6.0 ptp85 -52.52 -24.98 9.1 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.661 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -106.62 -19.22 13.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.685 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -136.37 75.57 1.55 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.912 0.387 . . . . 0.0 111.274 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -58.37 -20.1 41.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.577 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -110.32 36.21 3.15 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.691 0.281 . . . . 0.0 111.062 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 9.4 ttt180 -89.53 115.17 26.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.121 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.86 ' O ' HD13 ' A' ' 198' ' ' ILE . 22.5 m -111.91 166.91 5.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.955 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.86 HD13 ' O ' ' A' ' 197' ' ' VAL . 19.8 mm -133.9 107.72 10.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.8 0.333 . . . . 0.0 111.314 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.907 HG12 HG12 ' A' ' 185' ' ' ILE . 13.2 m -99.05 131.26 46.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.081 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -95.37 152.44 18.39 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.534 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.52 157.97 16.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.895 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -57.81 -24.8 59.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.343 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -90.42 15.45 10.65 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 79.53 14.32 81.45 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.565 -0.826 . . . . 0.0 113.243 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -75.75 164.98 25.7 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.994 0.397 . . . . 0.0 110.791 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -134.56 111.45 10.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.86 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.687 HG11 HD12 ' A' ' 224' ' ' ILE . 21.6 t -117.87 128.92 74.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.081 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 4.2 m -103.13 115.2 30.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.768 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.686 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -127.11 158.58 36.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.893 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.06 153.27 18.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.503 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.432 HG21 ' CB ' ' A' ' 166' ' ' GLU . 36.7 mt -65.07 -37.18 79.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.882 0.372 . . . . 0.0 110.867 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.48 -33.17 72.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.198 -179.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -134.89 42.27 2.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.86 0.362 . . . . 0.0 111.104 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.584 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 11.4 t80 -64.64 -52.24 58.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.625 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.69 -42.16 87.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.192 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.65 -48.78 63.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.063 0.458 . . . . 0.0 110.338 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 1.3 mmpt? -53.84 -41.63 67.62 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.06 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.904 ' HB3' HG11 ' A' ' 178' ' ' VAL . 3.8 mm? -87.0 -24.01 24.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.97 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 12.6 t -62.63 -30.47 71.38 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.81 0.338 . . . . 0.0 110.42 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . 0.734 ' HB2' HG22 ' A' ' 224' ' ' ILE . 38.7 m170 -69.03 -16.79 63.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.265 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.414 ' HA ' HG23 ' A' ' 224' ' ' ILE . 71.5 t80 -66.11 136.49 95.43 Favored Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 110.259 -0.275 . . . . 0.0 110.259 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.524 ' O ' ' HB3' ' A' ' 223' ' ' ALA . 65.5 Cg_endo -72.77 154.92 99.41 Favored 'Cis proline' 0 C--N 1.355 0.887 0 C-N-CA 124.585 -1.006 . . . . 0.0 112.795 0.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.524 ' HB3' ' O ' ' A' ' 222' ' ' PRO . . . 81.99 77.57 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.921 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.734 HG22 ' HB2' ' A' ' 220' ' ' HIS . 12.3 pt -127.74 -178.51 2.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.414 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 68.01 122.47 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.046 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -107.59 -164.99 1.01 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.173 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -105.08 36.24 2.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.86 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.578 ' O ' HD23 ' A' ' 228' ' ' LEU . 6.7 tt -80.03 0.9 29.81 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.986 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -89.95 53.03 2.42 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.081 0.467 . . . . 0.0 110.744 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.9 -28.66 20.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.166 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . 0.493 ' O ' HG22 ' A' ' 232' ' ' VAL . 4.7 m120 -57.81 -74.56 0.06 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.081 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . 0.493 HG22 ' O ' ' A' ' 231' ' ' ASN . 17.5 m 46.19 -173.52 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.295 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.883 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.104 0 N-CA-C 112.522 -0.231 . . . . 0.0 112.522 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 59.98 109.36 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.759 0.314 . . . . 0.0 110.987 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -111.68 148.51 33.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.028 0.442 . . . . 0.0 110.972 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.759 ' HB2' HD13 ' A' ' 134' ' ' LEU . 81.8 m95 -73.4 168.34 19.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.069 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.82 136.64 41.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.489 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.64 105.38 4.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.683 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.86 HD11 HG22 ' A' ' 168' ' ' THR . 47.8 pt -95.13 -7.68 9.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.574 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.519 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -159.34 177.06 11.4 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 120.481 0.181 . . . . 0.0 110.589 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.476 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 30.3 m-85 -144.69 126.0 14.79 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.566 HG21 HD11 ' A' ' 139' ' ' LEU . 4.2 t -93.27 122.27 44.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.165 0.507 . . . . 0.0 111.416 -179.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.49 ' CE1' ' CE1' ' A' ' 130' ' ' PHE . 11.1 t80 -84.07 94.22 8.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.79 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -142.56 152.55 42.71 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.408 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 58.77 30.31 19.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.99 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 64.11 34.31 11.26 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.357 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.464 HG23 ' O ' ' A' ' 145' ' ' THR . 52.9 m -153.92 152.87 31.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.825 0.345 . . . . 0.0 111.135 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.692 ' CE2' ' HB2' ' A' ' 148' ' ' ALA . 11.1 m-85 -94.41 90.92 6.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.836 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.529 ' HB2' HD21 ' A' ' 139' ' ' LEU . 27.2 m-85 -71.17 110.83 8.12 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.794 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.429 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 49.5 Cg_exo -55.41 121.34 9.75 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 122.39 2.06 . . . . 0.0 112.73 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.713 HD21 ' OG1' ' A' ' 168' ' ' THR . 30.3 tp -101.42 123.82 46.1 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.43 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.759 HD13 ' HB2' ' A' ' 118' ' ' TRP . 46.4 mt -70.72 174.13 6.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.577 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.414 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.3 pt-20 -64.63 -29.28 70.28 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.079 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -90.07 12.62 17.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.192 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.631 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 74.96 16.73 80.39 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.111 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.7 ' HB3' HD12 ' A' ' 134' ' ' LEU . 9.2 tpt180 -74.85 93.53 2.65 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.566 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -68.35 121.29 15.98 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.631 -178.906 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -90.97 73.48 6.44 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.696 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.476 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 7.7 mttt -61.46 -16.11 43.85 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.995 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -94.7 -24.18 17.25 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -101.32 27.62 6.07 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.429 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -61.59 159.39 30.62 Favored Glycine 0 CA--C 1.508 -0.358 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.711 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.464 ' O ' HG23 ' A' ' 129' ' ' THR . 8.0 t -130.65 157.53 42.52 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.971 0.415 . . . . 0.0 110.877 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -94.69 50.34 1.32 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.577 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.98 149.81 3.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.583 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.692 ' HB2' ' CE2' ' A' ' 130' ' ' PHE . . . -93.66 125.77 52.32 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.387 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.476 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 60.6 Cg_endo -82.12 111.78 2.2 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.243 1.962 . . . . 0.0 112.339 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 11.6 t -69.5 -7.96 42.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.12 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -78.36 -23.32 46.94 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 120.717 0.294 . . . . 0.0 110.507 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.664 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -140.23 166.84 20.66 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.765 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.664 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 65.2 Cg_endo -74.85 156.11 43.67 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.384 2.056 . . . . 0.0 112.304 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 9.3 t -116.68 110.44 31.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.192 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.868 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.41 95.93 1.83 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.577 179.0 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 46.6 t -92.58 137.15 22.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.98 0.419 . . . . 0.0 111.162 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 48.73 57.78 8.2 Favored Glycine 0 CA--C 1.52 0.382 0 CA-C-N 115.893 -0.594 . . . . 0.0 113.304 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.868 ' CE2' HD23 ' A' ' 155' ' ' LEU . 2.9 m95 -100.69 151.17 21.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.198 0.523 . . . . 0.0 111.536 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -65.34 -172.43 0.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.459 179.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -43.74 154.69 0.09 Allowed 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.558 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -56.79 -25.15 51.46 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.327 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.22 -38.84 84.61 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 120.951 0.405 . . . . 0.0 110.087 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.62 -40.31 49.71 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.081 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.558 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.5 mt -59.17 -41.67 84.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.035 179.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.34 -30.9 53.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.23 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.422 ' HB3' HG21 ' A' ' 211' ' ' ILE . 5.4 mm-40 -67.83 -53.23 28.53 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.4 0.619 . . . . 0.0 109.968 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.808 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -59.53 -45.45 91.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.936 178.939 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.86 HG22 HD11 ' A' ' 121' ' ' ILE . 0.3 OUTLIER -56.75 -37.95 71.74 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.555 179.172 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.9 -37.38 92.51 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 178.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -70.94 -48.24 54.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.41 -0.395 . . . . 0.0 110.785 178.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.629 HD11 ' CE1' ' A' ' 214' ' ' PHE . 11.2 mp -64.89 -28.76 69.76 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.797 0.332 . . . . 0.0 111.23 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.31 -18.94 63.87 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.229 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -111.49 -28.64 8.09 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.669 0.271 . . . . 0.0 111.372 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.61 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.1 OUTLIER -56.85 166.86 1.21 Allowed Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.135 -179.658 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.28 128.0 15.82 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.225 1.95 . . . . 0.0 112.918 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.34 -26.29 11.86 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.541 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -58.42 -48.63 80.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.923 0.392 . . . . 0.0 110.88 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.855 HG11 ' HB3' ' A' ' 218' ' ' LEU . 33.7 t -73.7 -33.52 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.406 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.57 HD13 ' CD2' ' A' ' 174' ' ' LEU . 6.4 tp -57.44 -36.21 71.1 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 121.122 0.487 . . . . 0.0 109.818 179.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -76.42 -42.04 23.79 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.296 178.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -84.36 103.12 13.26 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.977 0.418 . . . . 0.0 110.584 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . 0.853 ' CE ' HG12 ' A' ' 178' ' ' VAL . 3.0 mtm 178.74 169.57 0.87 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.008 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.13 -55.32 1.47 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.733 0.301 . . . . 0.0 111.082 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -163.23 142.32 8.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.928 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.897 HG12 HG12 ' A' ' 199' ' ' VAL . 12.4 mt -104.78 114.38 44.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.229 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 23.3 m170 -103.81 126.32 50.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.191 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.43 ' CD2' ' HD3' ' A' ' 189' ' ' PRO . 46.0 t80 -79.21 104.09 9.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.2 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.75 78.41 39.3 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.764 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.43 ' HD3' ' CD2' ' A' ' 187' ' ' TYR . 50.6 Cg_endo -68.2 143.03 57.53 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.418 2.079 . . . . 0.0 112.365 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 18.6 p -122.47 160.47 25.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.786 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 57.8 mtt-85 -53.4 -26.91 21.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.403 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -105.96 -16.66 14.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.784 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -137.06 76.75 1.6 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.898 0.38 . . . . 0.0 111.367 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -56.5 -23.8 41.95 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.351 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -106.57 38.52 2.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.754 0.311 . . . . 0.0 110.71 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 4.0 tpt180 -90.26 118.7 29.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.065 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.854 ' O ' HD13 ' A' ' 198' ' ' ILE . 25.5 m -117.51 165.94 12.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.915 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.854 HD13 ' O ' ' A' ' 197' ' ' VAL . 21.1 mm -134.56 107.45 9.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.149 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.897 HG12 HG12 ' A' ' 185' ' ' ILE . 8.4 m -96.12 123.84 48.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.985 0.421 . . . . 0.0 110.997 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -83.54 152.62 24.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.748 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 4.3 mmt -108.55 152.39 24.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.895 0.379 . . . . 0.0 110.947 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 39.2 m-20 -60.11 -26.35 66.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.196 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -89.77 14.54 11.6 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.89 0.329 . . . . 0.0 111.89 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 81.13 14.41 79.18 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.373 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.42 154.59 22.7 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 117.028 0.414 . . . . 0.0 110.78 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -125.1 111.36 15.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.841 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 26.2 t -112.79 123.76 68.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.004 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.634 ' OG ' HD12 ' A' ' 198' ' ' ILE . 58.2 m -97.7 114.7 26.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.676 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.659 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -127.28 162.23 26.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.955 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.91 156.18 17.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.555 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.423 HD11 ' HE1' ' A' ' 187' ' ' TYR . 48.9 mt -63.49 -29.73 48.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.784 0.326 . . . . 0.0 110.953 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -74.63 -39.74 61.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.343 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -118.86 36.74 4.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.86 0.362 . . . . 0.0 111.016 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.629 ' CE1' HD11 ' A' ' 171' ' ' LEU . 11.6 t80 -66.69 -53.3 35.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.738 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.55 -37.22 86.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.757 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.9 -51.76 44.29 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.205 0.526 . . . . 0.0 110.463 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . 0.69 ' O ' HG21 ' A' ' 224' ' ' ILE . 8.4 mmmt -54.23 -43.35 70.8 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.094 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.855 ' HB3' HG11 ' A' ' 178' ' ' VAL . 4.2 mm? -83.59 -23.67 31.84 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.114 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.41 -34.14 74.87 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.056 0.455 . . . . 0.0 109.834 178.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -74.12 -16.85 61.0 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.087 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -55.58 130.64 71.04 Favored Pre-proline 0 CA--C 1.536 0.437 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.213 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -91.07 104.93 0.43 Allowed 'Cis proline' 0 C--N 1.356 0.968 0 C-N-CA 124.931 -0.862 . . . . 0.0 112.519 0.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -178.74 38.36 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.15 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.69 HG21 ' O ' ' A' ' 217' ' ' LYS . 0.1 OUTLIER -141.78 157.98 20.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.99 179.588 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -179.82 174.53 0.91 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.167 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -85.87 148.53 25.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.194 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -144.51 34.26 1.17 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.054 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 3.3 tp -97.51 38.13 1.3 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.868 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 2.9 t70 59.0 90.51 0.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.853 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.42 87.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.029 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -177.03 -39.66 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.985 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 21.7 t 66.66 98.6 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.022 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 8.2 tppt? . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.931 -179.984 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.18 0 N-CA-C 112.452 -0.259 . . . . 0.0 112.452 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.2 m -111.24 170.65 7.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.857 0.361 . . . . 0.0 110.859 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -68.19 147.53 52.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.034 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.754 ' HB2' HD13 ' A' ' 134' ' ' LEU . 79.3 m95 -70.34 168.3 16.27 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.044 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.78 138.08 40.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.517 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.33 105.71 4.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.858 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.87 HD11 HG22 ' A' ' 168' ' ' THR . 49.4 pt -95.36 -6.64 9.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.604 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.493 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -159.75 176.83 11.49 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 120.553 0.216 . . . . 0.0 110.571 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.473 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 34.6 m-85 -144.64 126.11 14.94 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.622 HG21 HD11 ' A' ' 139' ' ' LEU . 3.7 t -93.16 122.28 44.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.101 0.477 . . . . 0.0 111.41 -179.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.482 ' CE1' ' CE1' ' A' ' 130' ' ' PHE . 15.8 t80 -83.05 93.96 7.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.669 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -144.73 153.06 41.29 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.352 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 60.2 29.35 18.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.758 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 62.36 34.51 15.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.863 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.4 ' CG2' ' N ' ' A' ' 145' ' ' THR . 45.2 m -152.47 156.23 39.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.059 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.648 ' CE2' ' HB2' ' A' ' 148' ' ' ALA . 19.0 m-85 -97.93 91.43 5.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.225 0.536 . . . . 0.0 110.866 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.525 ' HB2' HD21 ' A' ' 139' ' ' LEU . 27.8 m-85 -72.0 115.04 34.33 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.613 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.419 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 33.3 Cg_exo -61.16 117.07 3.82 Favored 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 122.422 2.082 . . . . 0.0 112.672 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.677 HD21 ' OG1' ' A' ' 168' ' ' THR . 30.6 tp -96.77 124.01 40.63 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.414 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.754 HD13 ' HB2' ' A' ' 118' ' ' TRP . 52.1 mt -70.5 174.45 5.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.645 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.409 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 2.0 pt-20 -65.11 -29.26 70.11 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.099 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 51.3 p-10 -89.68 11.88 18.56 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.254 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.636 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 75.08 19.02 80.08 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.856 -0.688 . . . . 0.0 113.007 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.709 ' HB3' HD12 ' A' ' 134' ' ' LEU . 1.2 tpt180 -77.36 93.2 4.01 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.622 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -68.32 121.48 16.36 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.806 -178.791 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.492 HD12 ' HG2' ' A' ' 143' ' ' GLU . 3.8 mm? -90.29 73.4 7.08 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.394 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.456 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 6.0 mttp -61.58 -15.61 40.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.302 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -98.52 -21.57 16.45 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.492 ' HG2' HD12 ' A' ' 140' ' ' LEU . 39.0 mm-40 -101.06 27.7 5.88 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.419 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -62.09 160.36 31.03 Favored Glycine 0 CA--C 1.51 -0.267 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.824 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.4 ' N ' ' CG2' ' A' ' 129' ' ' THR . 9.7 t -131.28 156.36 45.58 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.987 0.422 . . . . 0.0 110.729 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -93.11 51.0 1.6 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.735 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.1 151.23 3.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.573 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.648 ' HB2' ' CE2' ' A' ' 130' ' ' PHE . . . -95.14 125.64 49.59 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.39 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.473 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 73.9 Cg_endo -83.13 111.02 1.84 Allowed 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.355 2.037 . . . . 0.0 112.299 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 22.3 t -69.28 -8.12 43.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.163 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -77.85 -23.61 48.85 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 120.861 0.362 . . . . 0.0 110.607 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.668 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -138.11 166.71 23.89 Favored Pre-proline 0 N--CA 1.453 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.845 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.668 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 65.5 Cg_endo -74.67 157.93 43.79 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.444 2.096 . . . . 0.0 112.105 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 12.5 t -118.47 110.09 29.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.0 0.428 . . . . 0.0 111.369 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.854 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.61 95.95 1.91 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.644 179.054 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.432 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 61.6 t -92.54 136.66 24.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.09 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 48.59 57.07 8.74 Favored Glycine 0 CA--C 1.521 0.41 0 CA-C-N 115.891 -0.595 . . . . 0.0 113.319 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.854 ' CE2' HD23 ' A' ' 155' ' ' LEU . 3.5 m95 -99.91 151.14 21.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.175 0.512 . . . . 0.0 111.65 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.37 -172.22 0.15 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.553 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -43.4 154.27 0.09 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.268 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.56 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.16 -24.94 53.07 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.238 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -59.98 -40.72 90.09 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.871 0.367 . . . . 0.0 110.124 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -75.12 -40.34 59.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.982 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.56 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.8 mt -58.89 -41.99 84.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.971 179.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.71 -31.54 48.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.087 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -67.23 -52.96 34.58 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.575 0.702 . . . . 0.0 109.885 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.802 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -60.26 -44.42 95.32 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.013 178.865 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.87 HG22 HD11 ' A' ' 121' ' ' ILE . 0.3 OUTLIER -57.02 -38.11 72.66 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.484 179.171 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.18 -37.78 93.44 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 46.9 mm-40 -69.45 -48.69 60.07 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.408 -0.396 . . . . 0.0 110.92 178.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.602 HD11 ' CE1' ' A' ' 214' ' ' PHE . 9.9 mp -64.61 -29.35 70.36 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.758 0.313 . . . . 0.0 111.191 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.44 -20.28 64.63 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.368 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -110.91 -26.58 9.23 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.601 0.238 . . . . 0.0 111.414 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.673 ' CD2' HD13 ' A' ' 179' ' ' LEU . 0.1 OUTLIER -57.85 166.32 1.99 Allowed Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.898 -179.754 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.52 128.29 16.03 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.26 1.973 . . . . 0.0 112.94 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.24 -25.95 10.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.53 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -58.63 -48.65 80.3 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.877 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.85 HG11 ' HB3' ' A' ' 218' ' ' LEU . 32.3 t -73.81 -33.31 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.417 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.673 HD13 ' CD2' ' A' ' 174' ' ' LEU . 10.2 tp -56.71 -35.29 68.35 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 121.126 0.489 . . . . 0.0 110.047 179.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -79.5 -40.1 16.45 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.232 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -85.65 103.14 14.19 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 120.93 0.395 . . . . 0.0 110.556 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . 0.838 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.8 mtm 177.35 170.8 0.58 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.158 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.48 -56.81 1.49 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.721 0.296 . . . . 0.0 111.063 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -163.16 142.7 8.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.047 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.922 HG12 HG12 ' A' ' 199' ' ' VAL . 13.8 mt -103.03 115.11 44.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.484 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . 0.432 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 21.6 m170 -105.75 125.43 50.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.205 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -78.48 104.73 9.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.335 179.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.5 78.53 37.09 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.424 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -66.54 147.87 82.75 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.442 2.095 . . . . 0.0 112.647 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 24.9 p -126.49 158.46 36.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.624 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 25.4 mtt180 -52.64 -26.59 14.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.507 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -105.63 -18.31 14.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.691 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -137.22 77.01 1.61 Allowed 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.955 0.407 . . . . 0.0 111.414 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -57.14 -22.15 37.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.419 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -105.14 36.88 2.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.777 0.322 . . . . 0.0 110.782 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 4.6 tpt180 -90.5 115.61 27.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.108 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.871 ' O ' HD13 ' A' ' 198' ' ' ILE . 25.0 m -112.97 167.34 6.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.717 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.871 HD13 ' O ' ' A' ' 197' ' ' VAL . 20.6 mm -135.22 106.75 7.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.457 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.922 HG12 HG12 ' A' ' 185' ' ' ILE . 7.7 m -95.86 125.72 48.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.924 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -86.12 152.2 23.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.698 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.52 152.8 23.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.858 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -58.41 -23.84 58.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.418 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -89.99 15.35 10.2 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 78.16 14.41 82.28 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.508 -0.853 . . . . 0.0 113.13 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -82.83 166.47 18.95 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 117.07 0.435 . . . . 0.0 110.749 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -133.54 114.54 13.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.973 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.74 HG11 HD12 ' A' ' 224' ' ' ILE . 21.3 t -115.96 126.07 73.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.087 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 2.8 p -99.14 115.68 29.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.767 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.67 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -126.37 159.26 33.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.73 154.8 18.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.569 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 32.6 mt -64.02 -34.08 66.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.018 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -67.62 -40.51 84.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.4 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -125.28 43.53 3.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.88 0.372 . . . . 0.0 110.967 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.602 ' CE1' HD11 ' A' ' 171' ' ' LEU . 12.5 t80 -67.93 -53.34 27.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.836 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.72 -38.13 77.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.211 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.92 -48.45 65.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.99 0.424 . . . . 0.0 110.559 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.16 -43.77 70.89 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.094 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.85 ' HB3' HG11 ' A' ' 178' ' ' VAL . 4.0 mm? -84.53 -25.24 28.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.982 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 11.8 t -61.21 -31.36 71.14 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 120.822 0.344 . . . . 0.0 110.454 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . 0.416 ' CB ' HG22 ' A' ' 224' ' ' ILE . 1.5 m170 -69.12 -17.07 63.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.095 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.425 ' CD1' ' HA ' ' A' ' 222' ' ' PRO . 78.2 t80 -63.79 135.9 96.49 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.537 ' O ' ' HB3' ' A' ' 223' ' ' ALA . 60.8 Cg_endo -72.0 153.9 97.82 Favored 'Cis proline' 0 C--N 1.356 0.961 0 C-N-CA 124.512 -1.037 . . . . 0.0 112.444 0.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 222' ' ' PRO . . . 82.44 77.62 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.508 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.74 HD12 HG11 ' A' ' 207' ' ' VAL . 5.5 pt -123.01 -179.18 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.096 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 66.53 123.2 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.076 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -115.28 -164.55 0.95 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.099 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -98.16 30.89 2.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.041 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.597 ' O ' HD23 ' A' ' 228' ' ' LEU . 5.3 tt -86.44 8.6 21.13 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.662 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -88.75 53.87 2.84 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.047 0.451 . . . . 0.0 110.903 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 12.8 mtt180 -142.35 54.96 1.44 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.551 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 19.4 t30 64.11 132.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.773 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 11.1 p -57.26 144.23 9.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.254 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.297 -0.859 . . . . 0.0 110.887 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.168 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 79.6 p -88.39 148.25 24.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.763 0.316 . . . . 0.0 110.925 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 61.67 148.99 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.139 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.755 ' HB2' HD13 ' A' ' 134' ' ' LEU . 80.6 m95 -70.73 168.31 16.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.143 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -101.94 134.8 44.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.561 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 26.5 mtt180 -71.3 106.61 3.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.837 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.873 HD11 HG22 ' A' ' 168' ' ' THR . 47.5 pt -96.92 -6.38 9.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.494 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.565 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -160.64 176.25 11.76 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 121.08 -0.248 . . . . 0.0 110.88 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.481 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 37.5 m-85 -145.91 127.57 15.2 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.674 HG21 HD11 ' A' ' 139' ' ' LEU . 4.0 t -92.82 122.47 44.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.075 0.464 . . . . 0.0 111.445 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.492 ' CE1' ' CZ ' ' A' ' 130' ' ' PHE . 9.5 t80 -85.12 100.93 12.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.925 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -154.16 154.22 33.17 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.489 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 8.1 tpp180 60.69 31.47 20.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.721 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 62.27 32.08 17.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.945 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.452 HG22 ' N ' ' A' ' 130' ' ' PHE . 50.1 m -151.03 161.74 42.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.234 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.492 ' CZ ' ' CE1' ' A' ' 125' ' ' TYR . 87.0 m-85 -106.87 90.67 3.38 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.235 0.54 . . . . 0.0 110.841 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.563 ' HB2' HD21 ' A' ' 139' ' ' LEU . 20.7 m-85 -66.77 124.65 89.08 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.508 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.45 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 13.7 Cg_exo -68.6 123.29 10.31 Favored 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 122.327 2.018 . . . . 0.0 112.343 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.7 HD21 ' OG1' ' A' ' 168' ' ' THR . 36.9 tp -104.2 123.57 47.55 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.565 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.755 HD13 ' HB2' ' A' ' 118' ' ' TRP . 50.6 mt -72.69 173.07 9.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.733 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.414 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.5 pt-20 -63.02 -29.69 71.02 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.001 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 39.6 p-10 -89.84 11.91 18.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.143 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.648 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 74.93 19.27 80.02 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.183 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.688 ' HB3' HD12 ' A' ' 134' ' ' LEU . 13.8 tpp180 -76.69 95.68 4.04 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.674 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -70.71 122.46 19.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.913 -178.8 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -95.31 71.34 3.23 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.599 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.459 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 27.8 mttt -58.59 -19.76 41.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.78 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -89.46 -23.69 22.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.742 -0.208 . . . . 0.0 111.434 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -99.22 25.06 7.2 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.45 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -57.58 161.87 9.1 Favored Glycine 0 CA--C 1.51 -0.265 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.597 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 10.7 t -135.78 150.46 49.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.503 -0.348 . . . . 0.0 110.717 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.444 ' HE2' HG23 ' A' ' 129' ' ' THR . 3.5 mmtt -89.81 52.05 2.22 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.017 0.437 . . . . 0.0 110.62 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.92 149.05 2.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.678 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -93.91 125.52 52.75 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.153 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.481 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 72.0 Cg_endo -84.22 109.72 1.45 Allowed 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.486 2.124 . . . . 0.0 112.567 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.2 t -69.77 -7.73 42.1 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.101 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -78.16 -22.95 47.95 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.79 0.329 . . . . 0.0 110.551 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.674 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -139.59 166.9 20.91 Favored Pre-proline 0 N--CA 1.453 -0.282 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.758 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.718 ' HD3' HD23 ' A' ' 179' ' ' LEU . 61.0 Cg_endo -74.37 153.8 45.33 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.4 2.067 . . . . 0.0 112.194 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 12.2 t -115.67 109.51 28.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.222 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.861 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.55 95.74 1.86 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.534 178.881 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 55.3 t -92.33 136.99 23.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.956 0.407 . . . . 0.0 111.014 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 47.9 58.67 6.74 Favored Glycine 0 CA--C 1.521 0.416 0 CA-C-N 115.954 -0.567 . . . . 0.0 113.24 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.861 ' CE2' HD23 ' A' ' 155' ' ' LEU . 2.4 m95 -100.83 151.2 22.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.102 0.477 . . . . 0.0 111.828 -179.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -172.58 0.06 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.448 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -44.74 155.15 0.11 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.084 0.468 . . . . 0.0 112.173 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.564 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.42 -25.54 55.07 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.261 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.95 -39.42 85.52 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 120.991 0.424 . . . . 0.0 110.213 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -75.93 -40.75 53.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.184 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.564 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.2 mt -58.34 -41.48 81.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.045 179.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.14 -31.78 53.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.255 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -67.83 -53.08 29.74 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-O 121.517 0.675 . . . . 0.0 110.05 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.798 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -59.17 -45.74 90.22 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.002 178.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.873 HG22 HD11 ' A' ' 121' ' ' ILE . 0.5 OUTLIER -56.26 -38.63 71.41 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.643 179.075 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -58.77 -38.45 92.09 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 178.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 45.1 mm-40 -69.56 -48.37 60.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.315 -0.442 . . . . 0.0 110.902 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.618 HD11 ' CE1' ' A' ' 214' ' ' PHE . 10.8 mp -64.08 -29.85 70.96 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.724 0.297 . . . . 0.0 111.113 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -67.68 -19.96 65.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.259 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -111.22 -26.0 9.41 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.609 0.242 . . . . 0.0 111.424 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.557 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.1 OUTLIER -57.4 166.6 1.58 Allowed Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.079 -179.607 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.83 129.03 15.83 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.358 2.039 . . . . 0.0 112.707 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.19 -25.79 5.96 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.666 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.95 -49.82 75.48 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.953 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.925 HG11 ' HB3' ' A' ' 218' ' ' LEU . 34.8 t -74.07 -34.65 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.502 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.718 HD23 ' HD3' ' A' ' 153' ' ' PRO . 0.7 OUTLIER -56.47 -37.78 70.79 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.093 0.473 . . . . 0.0 110.063 179.276 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -78.92 -36.17 29.16 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.356 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -90.17 103.18 15.88 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.931 0.396 . . . . 0.0 110.846 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . 0.836 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.7 mtm 177.66 173.99 0.53 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.034 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.97 -54.8 1.21 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.665 0.269 . . . . 0.0 111.168 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -163.14 142.83 8.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.959 0.409 . . . . 0.0 111.11 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.888 HG12 HG12 ' A' ' 199' ' ' VAL . 13.3 mt -104.8 114.98 45.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.454 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -103.32 123.66 47.2 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.155 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.437 ' HB2' ' CD2' ' A' ' 158' ' ' TRP . 65.9 t80 -81.58 104.33 11.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.375 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.37 80.87 45.79 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.667 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.406 ' HD3' ' CD2' ' A' ' 187' ' ' TYR . 48.2 Cg_endo -67.96 146.69 72.25 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.324 2.016 . . . . 0.0 112.46 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 22.3 p -127.11 158.36 37.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.771 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 7.5 ptt-85 -52.18 -26.32 11.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.571 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -106.37 -18.89 13.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.506 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -134.99 73.82 1.5 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.007 0.432 . . . . 0.0 111.106 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.62 -21.58 28.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.646 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 11.3 p30 -109.47 38.98 2.19 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.861 0.362 . . . . 0.0 110.734 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 11.8 ttt-85 -91.47 117.16 29.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.18 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.857 ' O ' HD13 ' A' ' 198' ' ' ILE . 28.9 m -113.48 167.13 6.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.676 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.857 HD13 ' O ' ' A' ' 197' ' ' VAL . 17.0 mm -134.81 107.34 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.726 0.298 . . . . 0.0 111.363 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.888 HG12 HG12 ' A' ' 185' ' ' ILE . 11.9 m -98.04 134.87 34.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.927 0.394 . . . . 0.0 110.886 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -96.46 152.64 18.42 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.803 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 24.3 tpp -107.17 152.92 23.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.556 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -54.99 -24.45 24.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.784 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -90.44 15.55 10.5 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 79.24 14.54 81.55 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.544 -0.836 . . . . 0.0 113.047 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -77.99 157.8 29.52 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.929 0.395 . . . . 0.0 110.771 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -129.59 111.2 12.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.837 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.592 HG11 HG12 ' A' ' 224' ' ' ILE . 21.8 t -114.41 136.42 51.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.161 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 50.0 m -106.15 111.92 24.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.674 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -118.86 175.58 5.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.935 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.77 154.54 32.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.389 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 35.8 mt -66.61 -30.26 49.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.724 0.297 . . . . 0.0 110.859 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.61 -31.41 63.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.322 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -132.81 42.27 3.09 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.907 0.384 . . . . 0.0 110.96 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.618 ' CE1' HD11 ' A' ' 171' ' ' LEU . 11.7 t80 -68.3 -52.64 31.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.739 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.36 -39.44 87.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.892 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.18 -51.63 43.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.218 0.533 . . . . 0.0 110.243 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.91 -41.67 67.9 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.237 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.925 ' HB3' HG11 ' A' ' 178' ' ' VAL . 4.1 mm? -85.8 -23.13 27.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.061 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.03 -33.54 74.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.976 0.417 . . . . 0.0 110.144 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . 0.593 ' CB ' HG22 ' A' ' 224' ' ' ILE . 21.1 m170 -70.7 -16.77 62.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.421 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.431 ' N ' HG21 ' A' ' 224' ' ' ILE . 48.3 t80 -54.32 139.65 56.44 Favored Pre-proline 0 CA--C 1.537 0.473 0 O-C-N 122.42 -0.175 . . . . 0.0 110.557 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.526 ' O ' ' HB3' ' A' ' 223' ' ' ALA . 69.2 Cg_endo -73.37 154.06 99.41 Favored 'Cis proline' 0 C--N 1.354 0.852 0 C-N-CA 124.307 -1.122 . . . . 0.0 112.751 0.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 222' ' ' PRO . . . 84.63 76.59 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.099 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.597 HD13 ' H ' ' A' ' 224' ' ' ILE . 0.1 OUTLIER -146.09 143.57 21.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.032 0.444 . . . . 0.0 111.498 178.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 179.13 -169.93 0.11 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.029 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -109.66 144.95 37.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.943 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -129.81 33.37 4.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.242 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 13.8 mt -100.94 31.69 3.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.847 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -118.79 35.56 4.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.932 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 25.4 mtt85 -147.35 -47.46 0.17 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.835 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -122.7 111.78 17.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.782 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 21.3 t -59.26 139.05 19.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.193 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.903 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.142 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 62.21 149.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.755 0.312 . . . . 0.0 111.005 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 60.97 159.38 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.076 0.465 . . . . 0.0 111.048 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.761 ' HB2' HD13 ' A' ' 134' ' ' LEU . 84.9 m95 -66.18 168.31 8.75 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.007 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -100.72 136.33 40.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.391 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 5.9 mtm180 -72.35 107.33 4.89 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.762 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.886 HD11 HG22 ' A' ' 168' ' ' THR . 47.1 pt -96.89 -8.61 9.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.339 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.564 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -158.25 175.8 13.29 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 120.572 0.225 . . . . 0.0 110.672 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.478 ' CD1' ' CG ' ' A' ' 149' ' ' PRO . 30.4 m-85 -144.59 126.37 15.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.26 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.703 HG21 HD11 ' A' ' 139' ' ' LEU . 4.2 t -93.53 123.1 45.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.986 0.422 . . . . 0.0 111.294 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.491 ' CE1' ' CE1' ' A' ' 130' ' ' PHE . 7.0 t80 -84.61 105.38 15.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.842 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -159.77 154.44 24.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.673 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 60.57 30.96 20.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.914 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 62.05 31.87 17.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.136 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.527 HG23 ' O ' ' A' ' 145' ' ' THR . 89.3 m -153.72 150.16 28.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.987 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.842 ' CE2' ' HB2' ' A' ' 148' ' ' ALA . 54.1 m-85 -93.94 90.95 6.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.103 0.478 . . . . 0.0 110.705 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.554 ' HB2' HD21 ' A' ' 139' ' ' LEU . 22.3 m-85 -65.55 126.02 90.77 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.324 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.85 117.3 5.06 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 122.189 1.926 . . . . 0.0 112.441 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.67 HD21 ' OG1' ' A' ' 168' ' ' THR . 32.0 tp -96.59 124.02 40.45 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.731 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.761 HD13 ' HB2' ' A' ' 118' ' ' TRP . 54.0 mt -71.35 174.12 6.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.632 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.413 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.3 pt-20 -64.59 -29.45 70.47 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.091 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 48.4 p-10 -88.91 11.15 18.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.215 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.637 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 74.58 22.53 77.12 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.847 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.69 ' HB3' HD12 ' A' ' 134' ' ' LEU . 15.5 tpp85 -80.49 95.95 6.62 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.703 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -73.28 106.1 4.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.232 -179.215 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 13.3 mt -85.51 72.41 10.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.335 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.448 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 33.6 mttt -56.2 -21.23 21.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.896 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -82.87 -22.62 33.96 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -103.11 28.58 6.17 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . -64.16 163.84 33.67 Favored Glycine 0 CA--C 1.511 -0.169 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.699 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.527 ' O ' HG23 ' A' ' 129' ' ' THR . 9.2 t -132.09 157.03 45.24 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.504 -0.348 . . . . 0.0 110.529 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.6 mmtp -92.21 48.55 1.42 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.091 0.472 . . . . 0.0 110.554 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -171.26 154.55 4.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.438 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.842 ' HB2' ' CE2' ' A' ' 130' ' ' PHE . . . -99.31 126.52 37.5 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.076 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.478 ' CG ' ' CD1' ' A' ' 123' ' ' TYR . 72.2 Cg_endo -82.39 112.38 2.2 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.36 2.04 . . . . 0.0 112.702 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 28.0 t -69.82 -7.71 42.22 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.518 -0.764 . . . . 0.0 112.0 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -76.1 -22.82 55.11 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 120.779 0.323 . . . . 0.0 110.447 179.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.699 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -139.77 167.7 17.59 Favored Pre-proline 0 N--CA 1.452 -0.334 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.721 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.699 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 61.5 Cg_endo -73.98 154.36 47.73 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.364 2.042 . . . . 0.0 112.332 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 10.1 t -116.66 110.44 31.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.971 0.415 . . . . 0.0 111.088 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.856 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.55 95.94 1.89 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.584 179.058 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.42 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 51.3 t -91.24 136.74 23.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.028 0.442 . . . . 0.0 111.106 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 48.56 58.59 7.29 Favored Glycine 0 CA--C 1.52 0.392 0 CA-C-N 115.816 -0.629 . . . . 0.0 113.259 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.856 ' CE2' HD23 ' A' ' 155' ' ' LEU . 3.2 m95 -102.13 151.12 22.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.186 0.517 . . . . 0.0 111.721 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.89 -172.07 0.17 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.548 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -42.71 154.22 0.07 Allowed 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.526 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.08 -24.89 52.62 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.163 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.56 -39.65 84.74 Favored 'General case' 0 C--O 1.23 0.074 0 CA-C-O 120.916 0.388 . . . . 0.0 110.007 179.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.05 -40.03 54.21 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.917 178.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.526 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.3 mt -59.73 -41.68 86.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.873 179.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.13 -30.97 50.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.228 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.406 ' CB ' HG21 ' A' ' 211' ' ' ILE . 17.5 mm-40 -66.97 -53.01 35.77 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-O 121.491 0.662 . . . . 0.0 110.05 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.822 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -59.94 -44.78 94.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.905 178.914 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.886 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -58.34 -37.17 74.63 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.454 179.223 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.88 -37.68 92.93 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 178.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 35.0 mm-40 -72.87 -46.47 52.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.401 -0.399 . . . . 0.0 111.029 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.584 ' HA ' HD22 ' A' ' 174' ' ' LEU . 10.9 mp -65.92 -28.71 69.13 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.622 0.248 . . . . 0.0 111.323 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.88 -21.07 64.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.336 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -110.45 -26.19 9.65 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.588 0.232 . . . . 0.0 111.496 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.584 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.1 OUTLIER -57.55 166.51 1.71 Allowed Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.107 -179.684 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -70.09 128.08 15.22 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.305 2.003 . . . . 0.0 112.798 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.07 -25.78 5.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.726 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.71 -50.08 74.41 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.898 0.38 . . . . 0.0 111.012 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.869 HG11 ' HB3' ' A' ' 218' ' ' LEU . 41.5 t -74.25 -34.9 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.495 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.646 HD21 ' O ' ' A' ' 121' ' ' ILE . 0.5 OUTLIER -57.19 -34.49 68.54 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.156 0.503 . . . . 0.0 109.842 179.096 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -79.47 -38.54 20.86 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 178.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -87.92 103.06 15.32 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.865 0.364 . . . . 0.0 110.75 179.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . 0.836 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.8 mtm 178.25 172.04 0.7 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.055 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -130.45 -52.61 1.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.677 0.275 . . . . 0.0 111.466 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -163.17 143.69 9.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.881 0.372 . . . . 0.0 111.135 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.905 HG12 HG12 ' A' ' 199' ' ' VAL . 15.7 mt -108.29 114.78 47.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.653 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . 0.42 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 23.5 m170 -105.77 129.33 53.98 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.057 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -79.33 104.81 10.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.444 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -127.68 78.07 75.37 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.584 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -81.19 160.22 20.38 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.475 2.117 . . . . 0.0 112.709 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 19.2 p -128.17 169.62 13.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.531 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.38 -24.1 11.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.611 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -110.39 -15.2 13.99 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.941 0.348 . . . . 0.0 111.941 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -130.73 73.08 1.52 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.045 0.45 . . . . 0.0 111.255 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -58.88 -18.65 34.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.895 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . 0.448 ' OD1' HG22 ' A' ' 210' ' ' THR . 3.5 p30 -113.27 35.71 3.86 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.693 0.283 . . . . 0.0 111.13 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 2.0 ttt-85 -89.64 113.48 24.96 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.894 0.378 . . . . 0.0 111.318 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.845 ' O ' HD13 ' A' ' 198' ' ' ILE . 31.3 m -109.76 167.9 4.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.858 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.845 HD13 ' O ' ' A' ' 197' ' ' VAL . 22.4 mm -134.4 108.39 10.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.754 0.312 . . . . 0.0 111.278 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.905 HG12 HG12 ' A' ' 185' ' ' ILE . 11.2 m -97.51 137.52 24.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.989 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -98.26 152.82 19.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.79 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 27.9 tpp -110.77 153.65 25.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.831 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -55.92 -22.51 26.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.747 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -90.18 15.43 10.33 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 76.75 14.4 82.57 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.594 -0.813 . . . . 0.0 113.112 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -83.77 157.32 22.14 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 117.023 0.412 . . . . 0.0 110.729 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -127.69 111.47 13.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.689 HG11 HD12 ' A' ' 224' ' ' ILE . 20.6 t -111.44 130.54 64.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.942 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.519 ' OG ' HD12 ' A' ' 198' ' ' ILE . 16.7 m -102.62 116.66 33.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.798 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.647 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -128.19 160.25 32.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.861 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.448 HG22 ' OD1' ' A' ' 195' ' ' ASP . 0.6 OUTLIER -96.69 155.68 16.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.561 179.84 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.406 HG21 ' CB ' ' A' ' 166' ' ' GLU . 32.0 mt -67.18 -31.06 51.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.02 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.93 -32.06 65.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.357 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -126.53 33.95 4.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.06 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.578 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 11.4 t80 -62.99 -53.91 46.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.708 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.78 -39.95 86.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.832 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.29 -51.27 46.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.098 0.475 . . . . 0.0 110.236 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . 0.694 ' O ' HG21 ' A' ' 224' ' ' ILE . 0.7 OUTLIER -54.86 -44.03 73.63 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.859 179.605 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.869 ' HB3' HG11 ' A' ' 178' ' ' VAL . 4.1 mm? -80.69 -25.75 37.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.942 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.9 -33.15 72.67 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.045 0.45 . . . . 0.0 110.123 179.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 3.6 m170 -74.33 -17.19 60.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.445 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -64.33 136.28 96.69 Favored Pre-proline 0 CA--C 1.533 0.293 0 C-N-CA 121.359 -0.136 . . . . 0.0 110.978 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.478 ' O ' ' HB2' ' A' ' 223' ' ' ALA . 61.6 Cg_endo -89.89 107.34 0.75 Allowed 'Cis proline' 0 C--N 1.357 1.0 0 C-N-CA 124.595 -1.002 . . . . 0.0 112.596 0.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.478 ' HB2' ' O ' ' A' ' 222' ' ' PRO . . . 171.01 43.38 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.073 0.463 . . . . 0.0 110.356 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.694 HG21 ' O ' ' A' ' 217' ' ' LYS . 10.2 pt -125.25 -178.57 2.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.206 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 224' ' ' ILE . . . 76.31 96.3 0.07 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.964 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -95.46 -158.59 0.66 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.901 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -96.83 35.87 1.48 Allowed 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.786 0.327 . . . . 0.0 111.017 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.19 3.51 27.01 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.54 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -88.5 53.79 2.84 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.021 0.439 . . . . 0.0 110.929 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 31.1 mtt85 -142.85 -77.33 0.25 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.773 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 43.16 60.07 2.68 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.995 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 21.8 m -73.4 168.49 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.323 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 7.4 mtmt . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.849 -179.928 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.158 0 N-CA-C 112.563 -0.215 . . . . 0.0 112.563 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.2 m -105.54 -39.69 6.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.856 0.36 . . . . 0.0 110.939 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -89.97 150.6 22.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.134 0.492 . . . . 0.0 110.911 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.759 ' HB2' HD13 ' A' ' 134' ' ' LEU . 79.3 m95 -66.11 168.25 8.72 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.015 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -101.36 141.09 34.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.631 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.402 ' HG3' HD23 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -74.55 106.14 5.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.748 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.897 HD11 HG22 ' A' ' 168' ' ' THR . 50.9 pt -97.41 -7.04 9.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.299 179.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.471 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -162.42 175.29 11.68 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 120.597 0.237 . . . . 0.0 110.779 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.464 ' CD1' ' HG3' ' A' ' 149' ' ' PRO . 25.9 m-85 -144.12 127.11 16.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.097 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.709 HG21 HD11 ' A' ' 139' ' ' LEU . 4.9 t -93.14 122.36 44.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.119 0.485 . . . . 0.0 111.292 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.493 ' CE1' ' CE1' ' A' ' 130' ' ' PHE . 14.8 t80 -83.38 105.34 14.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.812 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -159.68 153.6 23.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.59 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.67 30.79 20.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.973 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 63.12 32.65 15.08 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.317 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 145' ' ' THR . 90.3 m -154.41 150.49 27.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.982 0.42 . . . . 0.0 111.087 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.711 ' CE2' ' HB2' ' A' ' 148' ' ' ALA . 22.6 m-85 -93.77 90.85 6.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.52 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.533 ' HB2' HD21 ' A' ' 139' ' ' LEU . 21.3 m-85 -65.35 121.03 72.58 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.329 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.402 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 37.5 Cg_endo -67.62 118.11 5.35 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.215 1.943 . . . . 0.0 112.544 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.645 HD11 ' HA2' ' A' ' 137' ' ' GLY . 48.6 tp -99.66 124.69 45.13 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.953 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.759 HD13 ' HB2' ' A' ' 118' ' ' TRP . 52.7 mt -72.91 177.14 5.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.727 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.416 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.4 pt-20 -67.12 -28.77 68.43 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.118 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -89.71 12.45 16.95 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.167 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.654 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 72.25 23.95 77.15 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.741 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.696 ' HB3' HD12 ' A' ' 134' ' ' LEU . 1.3 tpt180 -81.14 97.66 7.68 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 178.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.709 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -75.89 112.44 12.3 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.232 -179.031 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 12.7 mt -92.69 72.16 4.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.179 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.453 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 39.4 mttt -55.21 -22.25 17.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.814 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -82.34 -24.06 34.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.191 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -100.2 27.05 5.91 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.417 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . -63.68 163.62 32.15 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.752 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.49 ' O ' HG23 ' A' ' 129' ' ' THR . 10.0 t -132.34 155.3 48.64 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.83 0.348 . . . . 0.0 110.714 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.8 mmtp -92.58 49.74 1.51 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.089 0.471 . . . . 0.0 110.494 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -171.13 153.73 3.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.613 -179.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.711 ' HB2' ' CE2' ' A' ' 130' ' ' PHE . . . -97.06 125.75 44.88 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.328 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.464 ' HG3' ' CD1' ' A' ' 123' ' ' TYR . 74.3 Cg_endo -83.2 111.76 1.9 Allowed 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.392 2.062 . . . . 0.0 112.533 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 29.1 t -69.87 -7.77 43.0 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.958 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -77.14 -23.22 51.72 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 120.763 0.316 . . . . 0.0 110.423 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.665 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -140.07 166.82 21.02 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.682 -179.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.665 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 69.1 Cg_endo -75.05 154.27 42.12 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.348 2.032 . . . . 0.0 112.34 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 9.0 t -114.56 110.91 33.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.139 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.858 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.61 95.96 1.91 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.536 179.069 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 50.1 t -91.48 137.18 22.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.053 0.454 . . . . 0.0 111.194 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 48.06 57.85 7.56 Favored Glycine 0 CA--C 1.521 0.459 0 CA-C-N 115.858 -0.61 . . . . 0.0 113.325 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.858 ' CE2' HD23 ' A' ' 155' ' ' LEU . 3.0 m95 -100.58 151.15 21.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.107 0.48 . . . . 0.0 111.782 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.32 -172.36 0.1 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.596 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -43.92 153.79 0.12 Allowed 'General case' 0 C--O 1.235 0.337 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.552 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -56.73 -25.16 50.97 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.261 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -60.29 -38.35 83.33 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.884 0.374 . . . . 0.0 110.109 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.96 -40.33 47.32 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.956 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.552 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.1 mt -58.53 -42.06 83.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.983 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.71 -30.19 42.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.299 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.45 ' CB ' HG21 ' A' ' 211' ' ' ILE . 14.2 mm-40 -68.26 -52.86 29.19 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.391 0.615 . . . . 0.0 110.016 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.788 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -60.7 -43.86 97.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.998 178.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.897 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -58.2 -36.54 73.26 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.291 179.206 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.66 -39.4 96.52 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 110.509 -1.037 . . . . 0.0 110.509 178.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 54.6 mm-40 -69.62 -46.33 66.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.407 -0.396 . . . . 0.0 110.839 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.593 ' HA ' HD22 ' A' ' 174' ' ' LEU . 10.9 mp -66.01 -28.29 68.76 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.693 0.283 . . . . 0.0 111.363 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.1 -18.65 63.26 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.345 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -112.79 -27.29 8.2 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.622 0.249 . . . . 0.0 111.576 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.593 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER -57.13 167.01 1.25 Allowed Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.072 -179.745 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.29 127.81 15.53 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.198 1.932 . . . . 0.0 112.831 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.61 -25.77 7.6 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.652 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.97 -49.46 76.74 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.871 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.881 HG11 ' HB3' ' A' ' 218' ' ' LEU . 24.5 t -74.01 -32.98 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.469 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.445 HD12 ' HA ' ' A' ' 179' ' ' LEU . 11.7 tp -57.24 -36.35 70.82 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 121.194 0.521 . . . . 0.0 109.865 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -77.35 -40.86 22.56 Favored Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.301 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -84.94 103.07 13.66 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.877 0.37 . . . . 0.0 110.658 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . 0.85 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.8 mtm 177.31 162.63 0.5 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.033 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -120.9 -54.24 2.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.752 0.311 . . . . 0.0 111.267 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -162.38 142.94 10.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.814 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.896 HG12 HG12 ' A' ' 199' ' ' VAL . 16.2 mt -106.9 114.51 46.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.55 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 21.4 m170 -103.6 119.39 38.81 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.245 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.422 ' HB2' ' CD2' ' A' ' 158' ' ' TRP . 33.1 t80 -75.97 104.49 6.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.46 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.87 79.56 24.5 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.722 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.1 145.9 62.52 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.319 2.013 . . . . 0.0 112.479 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 19.5 p -128.17 159.24 35.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.815 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 8.1 ptt180 -52.54 -25.35 10.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.615 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -105.53 -19.9 13.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.627 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -136.04 74.81 1.52 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.871 0.367 . . . . 0.0 111.198 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -56.47 -22.04 29.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.596 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -108.95 38.47 2.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.802 0.334 . . . . 0.0 110.93 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -91.27 118.47 30.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.089 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.88 ' O ' HD13 ' A' ' 198' ' ' ILE . 21.2 m -115.63 167.81 7.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.863 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.88 HD13 ' O ' ' A' ' 197' ' ' VAL . 19.1 mm -135.31 109.49 10.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.799 0.333 . . . . 0.0 111.059 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.896 HG12 HG12 ' A' ' 185' ' ' ILE . 7.0 m -97.62 120.88 47.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.038 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -82.05 152.73 26.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.769 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.99 149.81 28.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.727 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -58.86 -29.12 66.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.168 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -80.87 1.76 29.43 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.983 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 92.1 14.43 56.14 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.466 -0.873 . . . . 0.0 113.184 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -86.69 162.32 17.96 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 117.067 0.434 . . . . 0.0 110.952 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -130.75 111.52 12.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.812 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.427 ' HB ' HG23 ' A' ' 199' ' ' VAL . 21.7 t -111.32 131.42 62.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.115 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.545 ' OG ' HD12 ' A' ' 198' ' ' ILE . 35.8 m -103.34 116.29 32.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.78 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.685 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -129.69 159.53 36.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.86 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.37 157.08 17.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.572 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.45 HG21 ' CB ' ' A' ' 166' ' ' GLU . 48.9 mt -67.44 -33.47 62.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.875 0.369 . . . . 0.0 110.848 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.73 -33.99 77.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.41 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -132.92 38.73 3.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.834 0.349 . . . . 0.0 111.148 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.582 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 11.0 t80 -62.52 -49.73 74.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.926 0.393 . . . . 0.0 110.637 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.97 -38.59 91.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.187 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -68.69 -50.56 49.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.022 0.439 . . . . 0.0 110.556 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . 0.641 ' O ' HG21 ' A' ' 224' ' ' ILE . 10.9 mmmt -53.43 -42.75 67.39 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.184 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.881 ' HB3' HG11 ' A' ' 178' ' ' VAL . 4.0 mm? -85.73 -23.46 27.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.968 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 9.0 t -60.13 -34.43 73.51 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.102 0.477 . . . . 0.0 109.964 179.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -74.18 -16.23 60.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.968 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.413 ' CE1' ' HB3' ' A' ' 222' ' ' PRO . 14.6 t80 -60.76 139.78 93.28 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 116.867 -0.151 . . . . 0.0 111.104 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.485 ' O ' ' HB2' ' A' ' 223' ' ' ALA . 62.2 Cg_endo -89.84 107.57 0.79 Allowed 'Cis proline' 0 C--N 1.356 0.923 0 C-N-CA 124.543 -1.024 . . . . 0.0 112.425 0.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.485 ' HB2' ' O ' ' A' ' 222' ' ' PRO . . . 171.95 41.94 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.864 0.364 . . . . 0.0 110.992 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.641 HG21 ' O ' ' A' ' 217' ' ' LYS . 0.1 OUTLIER -134.51 157.88 41.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.92 0.39 . . . . 0.0 111.143 179.747 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . 0.418 ' HB2' ' O ' ' A' ' 224' ' ' ILE . . . 176.78 76.67 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.114 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . 60.14 158.11 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.233 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -145.2 31.43 1.11 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.732 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 19.0 mt -94.5 46.02 1.14 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.622 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 71.27 22.6 4.28 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.321 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 50.75 27.25 2.94 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.743 0.306 . . . . 0.0 111.759 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -91.49 93.37 8.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.973 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 20.3 t -143.13 67.98 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.103 0.477 . . . . 0.0 111.043 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 4.9 ptmm? . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.235 -0.888 . . . . 0.0 112.009 -179.869 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 18.9 m -65.1 81.85 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.873 0.368 . . . . 0.0 110.885 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -100.5 151.96 20.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.915 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.767 ' HB2' HD13 ' A' ' 134' ' ' LEU . 85.6 m95 -66.04 168.33 8.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.287 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.29 133.61 45.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.762 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 59.5 mtt180 -71.25 107.72 4.38 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.833 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.909 HD11 HG22 ' A' ' 168' ' ' THR . 42.9 pt -96.08 -9.15 9.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.414 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.518 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -156.33 175.97 13.3 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.659 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.479 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 37.9 m-85 -145.02 126.05 14.56 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.353 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.614 HG21 HD11 ' A' ' 139' ' ' LEU . 3.4 t -93.69 122.9 45.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.101 0.477 . . . . 0.0 111.13 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -82.4 97.46 8.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.776 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -151.09 156.01 40.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.44 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 6.3 tpp180 60.39 30.54 19.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.838 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.2 33.4 16.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.913 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 145' ' ' THR . 85.5 m -157.14 153.74 28.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.912 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -93.54 91.18 6.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.694 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.493 ' HB2' HD21 ' A' ' 139' ' ' LEU . 22.6 m-85 -66.06 125.02 89.33 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.874 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.61 115.84 4.49 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.008 1.806 . . . . 0.0 112.725 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.694 HD21 ' OG1' ' A' ' 168' ' ' THR . 25.1 tp -93.64 123.8 37.2 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.656 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.767 HD13 ' HB2' ' A' ' 118' ' ' TRP . 39.9 mt -69.55 171.86 8.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.48 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.4 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 0.9 OUTLIER -63.15 -31.76 72.98 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.987 179.893 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . 0.457 ' ND2' ' CD1' ' A' ' 118' ' ' TRP . 2.9 p30 -84.68 3.81 35.46 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.278 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.621 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 82.71 21.24 60.07 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.766 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.644 ' HB3' HD12 ' A' ' 134' ' ' LEU . 6.2 tpt180 -79.9 94.29 5.82 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.614 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -69.79 107.41 3.5 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.95 -179.502 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 15.3 mt -83.45 72.54 10.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.979 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.451 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 9.2 mttp -57.79 -20.73 37.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.481 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -96.9 23.79 6.81 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.289 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -147.94 27.49 0.96 Allowed 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.747 0.308 . . . . 0.0 111.122 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.422 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . -63.52 166.66 25.84 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.913 -0.66 . . . . 0.0 113.183 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.416 ' O ' HG23 ' A' ' 129' ' ' THR . 9.6 t -132.58 151.72 51.84 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.867 0.365 . . . . 0.0 110.442 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.06 50.77 1.7 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.118 0.485 . . . . 0.0 110.598 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.71 147.04 2.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.644 -179.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -90.2 125.32 60.6 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.327 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.479 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 77.8 Cg_endo -84.83 107.27 1.1 Allowed 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.534 2.156 . . . . 0.0 112.605 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 15.0 t -69.83 -7.8 42.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.008 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -78.26 -23.64 47.19 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 120.841 0.353 . . . . 0.0 110.503 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.689 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -138.35 167.28 20.42 Favored Pre-proline 0 N--CA 1.453 -0.302 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.629 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.689 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 68.0 Cg_endo -74.62 156.36 44.75 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.452 2.101 . . . . 0.0 112.539 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 18.3 t -118.96 109.22 26.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.236 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.853 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.1 mp -72.54 96.14 1.91 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.699 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.7 t -91.37 136.23 24.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.082 0.467 . . . . 0.0 111.046 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 47.9 57.71 7.54 Favored Glycine 0 CA--C 1.522 0.471 0 CA-C-N 115.701 -0.681 . . . . 0.0 113.237 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.853 ' CE2' HD23 ' A' ' 155' ' ' LEU . 2.5 m95 -99.81 151.36 21.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.193 0.52 . . . . 0.0 111.831 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.52 -172.42 0.08 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.627 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -44.37 154.24 0.13 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.284 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.533 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.65 -24.93 54.61 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.159 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -59.56 -39.49 84.21 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.887 0.375 . . . . 0.0 110.125 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.28 -40.32 51.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.962 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.533 HD12 ' HA2' ' A' ' 161' ' ' GLY . 5.9 mt -58.72 -41.08 81.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.922 178.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.72 -29.48 39.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.138 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -70.1 -53.01 19.26 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 121.512 0.672 . . . . 0.0 110.137 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.833 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -58.95 -43.98 91.36 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.042 178.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.909 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -58.65 -36.43 74.12 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.395 179.08 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.26 -37.19 92.62 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 178.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 93.3 mm-40 -73.72 -45.58 51.27 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.339 -0.43 . . . . 0.0 111.083 178.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.608 ' HA ' HD22 ' A' ' 174' ' ' LEU . 11.3 mp -66.36 -28.47 68.67 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.697 0.284 . . . . 0.0 111.374 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.9 -16.18 62.66 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.34 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -115.2 -28.03 7.07 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.669 HD21 HD13 ' A' ' 179' ' ' LEU . 0.2 OUTLIER -55.88 167.29 0.86 Allowed Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 116.754 -0.203 . . . . 0.0 111.3 -179.539 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -69.92 128.15 15.47 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.269 1.979 . . . . 0.0 112.92 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.47 -25.64 6.8 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.718 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.51 -49.68 75.52 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.847 0.356 . . . . 0.0 110.947 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.871 HG11 ' HB3' ' A' ' 218' ' ' LEU . 32.4 t -74.34 -36.05 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.608 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.669 HD13 HD21 ' A' ' 174' ' ' LEU . 10.7 tp -55.1 -34.08 63.37 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.162 0.506 . . . . 0.0 110.155 179.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -80.29 -41.59 11.58 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.405 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -85.53 103.02 14.01 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.912 0.386 . . . . 0.0 110.665 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . 0.835 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.8 mtm 178.52 166.18 0.83 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.228 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.85 -56.96 1.91 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.836 0.35 . . . . 0.0 111.001 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -162.96 142.56 8.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.771 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.894 HG12 HG12 ' A' ' 199' ' ' VAL . 11.7 mt -101.91 115.55 43.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.475 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . 0.4 ' HB3' ' CE ' ' A' ' 188' ' ' LYS . 22.9 m170 -105.21 121.62 44.21 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.98 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -78.53 104.69 9.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.509 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . 0.4 ' CE ' ' HB3' ' A' ' 186' ' ' HIS . 0.1 OUTLIER -121.93 82.55 43.18 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.547 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -67.77 147.73 75.87 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.409 2.073 . . . . 0.0 112.593 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 22.0 p -126.17 160.01 31.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.695 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 12.5 mtt180 -51.88 -28.83 17.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.608 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -107.48 -15.08 14.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.875 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -135.29 74.41 1.52 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.996 0.427 . . . . 0.0 111.293 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -56.18 -24.96 44.8 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.415 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 9.8 p30 -105.12 38.54 1.92 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.765 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -90.77 116.85 28.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.105 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.798 ' O ' HD13 ' A' ' 198' ' ' ILE . 22.1 m -114.24 164.35 10.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.725 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.798 HD13 ' O ' ' A' ' 197' ' ' VAL . 20.3 mm -133.3 105.95 8.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.785 0.326 . . . . 0.0 111.17 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.894 HG12 HG12 ' A' ' 185' ' ' ILE . 6.7 m -94.75 124.72 47.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.028 0.442 . . . . 0.0 111.011 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -84.26 152.82 23.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.809 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.8 149.02 29.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.729 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -58.77 -28.8 66.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.157 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -80.67 1.5 29.78 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.325 -0.398 . . . . 0.0 112.06 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 91.99 14.41 56.34 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.571 -0.823 . . . . 0.0 113.149 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -87.1 160.19 18.65 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.992 0.396 . . . . 0.0 110.732 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -128.67 111.47 13.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.919 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.991 HG13 ' HB2' ' A' ' 225' ' ' ALA . 23.1 t -110.88 137.46 43.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.044 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 3.8 m -110.83 112.07 23.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.755 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.41 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -121.86 170.76 9.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.938 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.92 157.56 19.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.402 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 33.0 mt -69.54 -31.48 49.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.794 0.331 . . . . 0.0 110.838 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.48 -30.15 65.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.345 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -133.12 37.31 3.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.809 0.338 . . . . 0.0 111.051 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.577 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 11.2 t80 -63.08 -55.46 25.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.837 0.351 . . . . 0.0 110.458 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.75 -42.38 79.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.146 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -68.91 -47.72 65.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.041 0.448 . . . . 0.0 110.232 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -54.95 -43.63 73.6 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.905 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.871 ' HB3' HG11 ' A' ' 178' ' ' VAL . 3.9 mm? -83.09 -26.44 31.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.779 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 13.2 t -61.19 -30.53 70.47 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.955 0.407 . . . . 0.0 110.528 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . 0.415 ' CB ' HG22 ' A' ' 224' ' ' ILE . 1.1 m-70 -69.37 -16.81 63.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.107 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.483 ' HB2' HD13 ' A' ' 224' ' ' ILE . 41.1 t80 -59.06 138.4 87.85 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 110.477 -0.194 . . . . 0.0 110.477 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.523 ' O ' ' HB3' ' A' ' 223' ' ' ALA . 12.8 Cg_exo -70.48 154.82 95.35 Favored 'Cis proline' 0 C--N 1.355 0.893 0 C-N-CA 124.875 -0.885 . . . . 0.0 112.707 0.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.523 ' HB3' ' O ' ' A' ' 222' ' ' PRO . . . 83.96 75.89 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.912 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.623 HD12 HG11 ' A' ' 207' ' ' VAL . 26.2 pt -136.77 -178.65 2.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.059 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . 0.991 ' HB2' HG13 ' A' ' 207' ' ' VAL . . . 72.57 -179.03 0.21 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.095 0.474 . . . . 0.0 111.367 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . 62.89 94.4 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.286 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -117.76 30.88 7.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.621 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 22.3 mt -123.1 30.2 6.45 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.097 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.86 36.26 2.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.903 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.88 -62.0 0.42 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.898 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -91.61 101.35 13.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.865 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 20.0 t -101.98 121.39 52.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.108 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.882 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.144 0 N-CA-C 112.534 -0.226 . . . . 0.0 112.534 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.5 p -103.38 -74.2 0.65 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.816 0.341 . . . . 0.0 110.946 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -60.82 148.53 38.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.97 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.773 ' HB2' HD13 ' A' ' 134' ' ' LEU . 81.5 m95 -73.16 167.95 20.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.057 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.7 ttm-85 -102.64 135.57 44.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.401 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 -71.74 105.92 3.92 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.491 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.87 HD11 HG22 ' A' ' 168' ' ' THR . 42.9 pt -93.54 -9.06 9.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.492 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.486 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -158.99 176.57 12.14 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 120.99 -0.284 . . . . 0.0 110.795 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.456 ' O ' ' HA ' ' A' ' 154' ' ' VAL . 30.8 m-85 -142.77 128.3 19.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.268 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.623 HG21 HD11 ' A' ' 139' ' ' LEU . 3.9 t -93.28 122.41 44.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.072 0.463 . . . . 0.0 111.239 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.479 ' CE1' ' CE1' ' A' ' 130' ' ' PHE . 7.6 t80 -82.75 94.45 7.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.735 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -144.46 153.04 41.47 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.433 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 59.44 30.66 20.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.858 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 61.81 34.71 17.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.036 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.472 HG23 ' HE2' ' A' ' 146' ' ' LYS . 65.7 m -152.2 162.21 41.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.07 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.479 ' CE1' ' CE1' ' A' ' 125' ' ' TYR . 18.5 m-85 -103.27 90.71 3.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.191 0.52 . . . . 0.0 111.194 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.514 ' HB2' HD21 ' A' ' 139' ' ' LEU . 23.8 m-85 -69.82 118.33 62.08 Favored Pre-proline 0 CA--C 1.536 0.437 0 CA-C-N 115.437 -0.802 . . . . 0.0 111.499 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.433 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 25.0 Cg_exo -63.16 119.86 7.09 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 122.423 2.082 . . . . 0.0 112.61 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.677 HD21 ' OG1' ' A' ' 168' ' ' THR . 29.6 tp -100.25 123.17 44.16 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.285 179.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.773 HD13 ' HB2' ' A' ' 118' ' ' TRP . 46.5 mt -70.13 171.4 9.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.701 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.415 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.5 pt-20 -61.67 -33.33 73.79 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.098 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . 0.462 ' ND2' ' CD1' ' A' ' 118' ' ' TRP . 4.2 p30 -82.34 -4.36 57.13 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.107 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.663 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 91.34 15.84 54.56 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.804 -179.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.669 ' HB3' HD12 ' A' ' 134' ' ' LEU . 15.1 tpp85 -73.62 97.21 2.6 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.623 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -70.98 109.18 4.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.565 -178.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 27.6 mt -84.22 71.16 10.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.487 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.452 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 18.6 mttt -56.79 -21.5 29.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.738 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -84.54 -17.39 39.05 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -106.67 29.48 6.91 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . -60.55 161.62 21.7 Favored Glycine 0 CA--C 1.509 -0.316 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.359 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 11.1 t -136.28 148.81 48.17 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.999 0.428 . . . . 0.0 110.927 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.472 ' HE2' HG23 ' A' ' 129' ' ' THR . 6.7 mmtt -89.92 55.86 3.28 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.343 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.405 ' O ' ' CG ' ' A' ' 130' ' ' PHE . 0.0 OUTLIER -170.41 167.32 8.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.255 -179.327 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -102.67 136.62 19.29 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.928 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.455 ' HG3' ' CD1' ' A' ' 123' ' ' TYR . 59.7 Cg_endo -84.7 99.98 0.74 Allowed 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 123.174 2.582 . . . . 0.0 112.491 179.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 16.8 t -67.24 -9.52 41.32 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.793 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -89.58 -22.24 22.46 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 111.562 0.208 . . . . 0.0 111.562 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.692 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -139.33 166.92 21.03 Favored Pre-proline 0 C--N 1.328 -0.334 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -178.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.692 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 58.9 Cg_endo -73.46 164.24 35.56 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.495 2.13 . . . . 0.0 112.275 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 22.1 t -122.92 109.12 22.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 121.065 0.46 . . . . 0.0 111.655 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.873 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.72 95.95 1.96 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.687 179.068 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.405 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 54.9 t -92.99 137.87 21.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.164 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 47.69 56.06 8.93 Favored Glycine 0 CA--C 1.521 0.421 0 CA-C-N 115.913 -0.585 . . . . 0.0 113.227 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.873 ' CE2' HD23 ' A' ' 155' ' ' LEU . 3.2 m95 -98.9 151.26 21.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.181 0.515 . . . . 0.0 111.62 -179.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.98 -172.4 0.14 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.423 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -43.58 154.69 0.08 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.095 0.474 . . . . 0.0 112.184 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.552 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.29 -25.05 53.78 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.275 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.97 -38.75 83.44 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.001 0.429 . . . . 0.0 110.125 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.18 -40.23 46.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.053 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.552 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.5 mt -59.4 -42.25 86.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.081 179.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.38 -29.49 48.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.366 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.429 ' CB ' HG21 ' A' ' 211' ' ' ILE . 5.6 mm-40 -67.84 -53.28 28.06 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.4 0.619 . . . . 0.0 110.162 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.79 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -60.89 -43.51 98.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.995 178.92 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.87 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -58.88 -37.82 77.42 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.361 179.181 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.62 -37.54 92.42 Favored Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 178.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -72.04 -46.5 56.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.366 -0.417 . . . . 0.0 110.848 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.552 ' HA ' HD22 ' A' ' 174' ' ' LEU . 10.4 mp -64.22 -30.45 71.51 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.789 0.328 . . . . 0.0 111.219 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -67.67 -21.91 65.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.552 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -109.61 -26.49 9.88 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 120.595 0.236 . . . . 0.0 111.498 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.552 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.1 OUTLIER -56.99 166.37 1.43 Allowed Pre-proline 0 CA--C 1.538 0.491 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.096 -179.685 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -69.32 128.95 17.19 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.364 2.043 . . . . 0.0 112.702 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.89 -25.89 5.13 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.75 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.87 -50.05 74.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.971 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.905 HG11 ' HB3' ' A' ' 218' ' ' LEU . 24.4 t -74.21 -35.44 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.705 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.523 ' HG ' HD21 ' A' ' 174' ' ' LEU . 0.4 OUTLIER -56.56 -35.04 67.7 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.131 0.491 . . . . 0.0 109.956 179.29 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -79.5 -39.21 18.92 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.269 -0.733 . . . . 0.0 111.269 178.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -86.85 103.16 14.99 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.935 0.398 . . . . 0.0 110.654 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . 0.841 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.9 mtm 178.35 161.18 0.61 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.027 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 6.6 t -118.93 -58.52 1.94 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.767 0.318 . . . . 0.0 110.881 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.8 pm0 -157.62 142.58 16.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.001 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.89 HG12 HG12 ' A' ' 199' ' ' VAL . 17.0 mt -107.01 115.0 47.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.341 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . 0.405 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 21.8 m170 -106.01 123.46 48.03 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.207 -179.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.45 ' CE2' ' HG3' ' A' ' 189' ' ' PRO . 59.1 t80 -75.67 104.55 6.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.167 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 4.3 mttm -129.7 88.79 48.48 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.908 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.45 ' HG3' ' CE2' ' A' ' 187' ' ' TYR . 13.0 Cg_exo -69.58 161.64 45.13 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.477 2.118 . . . . 0.0 112.073 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.451 HG21 ' HD3' ' A' ' 196' ' ' ARG . 9.1 p -133.6 169.48 16.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.764 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.1 -23.5 62.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.193 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -120.3 8.78 10.89 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -155.46 75.94 0.94 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.994 0.426 . . . . 0.0 111.272 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.61 -22.46 34.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.332 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . 0.442 ' OD1' HG22 ' A' ' 210' ' ' THR . 3.4 p30 -106.9 37.86 2.24 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.746 0.308 . . . . 0.0 110.802 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.451 ' HD3' HG21 ' A' ' 190' ' ' THR . 7.2 ttt180 -88.86 116.22 26.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.838 0.352 . . . . 0.0 111.439 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.74 ' O ' HD13 ' A' ' 198' ' ' ILE . 23.6 m -112.81 166.41 6.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.66 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.74 HD13 ' O ' ' A' ' 197' ' ' VAL . 19.2 mm -132.01 108.77 14.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.793 0.33 . . . . 0.0 111.287 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.89 HG12 HG12 ' A' ' 185' ' ' ILE . 10.2 m -100.98 120.78 50.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.028 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -85.81 152.62 22.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.631 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 9.7 mmt -102.67 161.24 13.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.034 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -62.56 -25.89 68.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.153 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -87.15 10.62 16.22 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 83.77 14.4 72.97 Favored Glycine 0 C--N 1.335 0.496 0 C-N-CA 120.451 -0.881 . . . . 0.0 113.282 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -80.15 170.41 16.47 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 117.014 0.407 . . . . 0.0 110.767 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -136.43 111.48 8.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.928 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.444 ' HB ' HG23 ' A' ' 199' ' ' VAL . 21.7 t -114.77 122.59 69.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.089 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -99.31 114.64 27.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.671 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.626 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -126.12 161.32 27.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.802 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.442 HG22 ' OD1' ' A' ' 195' ' ' ASP . 0.6 OUTLIER -99.76 152.73 19.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.673 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.429 HG21 ' CB ' ' A' ' 166' ' ' GLU . 48.4 mt -63.88 -36.49 76.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.838 0.351 . . . . 0.0 110.724 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.23 -34.66 76.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.158 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -132.64 44.28 2.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.919 0.39 . . . . 0.0 111.02 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.623 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 11.3 t80 -66.94 -52.58 41.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.564 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.01 -40.02 91.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.911 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.37 -51.15 55.66 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.158 0.504 . . . . 0.0 110.399 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . 0.876 ' O ' HG21 ' A' ' 224' ' ' ILE . 0.1 OUTLIER -54.25 -43.78 71.22 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.163 179.827 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.905 ' HB3' HG11 ' A' ' 178' ' ' VAL . 4.1 mm? -83.52 -23.15 32.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.097 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.49 -34.3 75.26 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.045 0.45 . . . . 0.0 109.799 179.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -70.5 -16.93 62.95 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.151 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -56.43 141.76 70.57 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 116.866 -0.152 . . . . 0.0 111.187 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.52 ' O ' ' HB2' ' A' ' 223' ' ' ALA . 56.1 Cg_endo -91.04 106.71 0.6 Allowed 'Cis proline' 0 C--N 1.356 0.972 0 C-N-CA 124.557 -1.018 . . . . 0.0 112.624 0.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.52 ' HB2' ' O ' ' A' ' 222' ' ' PRO . . . 168.43 42.61 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.773 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.876 HG21 ' O ' ' A' ' 217' ' ' LYS . 0.2 OUTLIER -126.2 152.7 33.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.927 0.394 . . . . 0.0 111.232 179.994 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . 0.452 ' HB2' ' O ' ' A' ' 224' ' ' ILE . . . 173.76 -178.15 0.08 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.887 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -63.67 157.32 24.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.187 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.419 ' H ' HD12 ' A' ' 228' ' ' LEU . . . -145.07 29.07 1.2 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.129 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.571 HD12 ' N ' ' A' ' 228' ' ' LEU . 5.5 mp -95.27 46.38 1.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.139 0.495 . . . . 0.0 110.487 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 65.51 26.8 11.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.994 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 55.71 99.26 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.224 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 -154.85 133.04 11.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.919 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . 0.57 ' O ' HG13 ' A' ' 232' ' ' VAL . 11.0 p -151.93 110.89 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.952 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.892 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.176 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.4 m -94.55 -37.5 11.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.809 0.338 . . . . 0.0 110.978 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -126.99 161.07 29.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.939 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.774 ' HB2' HD13 ' A' ' 134' ' ' LEU . 87.3 m95 -70.11 168.37 15.73 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.093 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 2.0 ptt180 -99.57 133.39 43.97 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.696 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 32.4 mtm180 -71.33 106.68 3.96 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.628 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.892 HD11 HG22 ' A' ' 168' ' ' THR . 44.1 pt -95.86 -8.25 9.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.436 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.541 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -158.41 176.53 12.33 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 120.647 0.26 . . . . 0.0 110.882 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.469 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 38.2 m-85 -144.91 126.59 15.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.188 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.643 HG21 HD11 ' A' ' 139' ' ' LEU . 4.1 t -93.45 122.65 45.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.124 0.487 . . . . 0.0 111.013 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -83.69 95.07 8.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.48 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -145.52 155.16 42.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.42 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 4.0 tpp180 59.58 30.2 19.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.787 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 62.27 34.83 15.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.997 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.445 HG22 ' N ' ' A' ' 130' ' ' PHE . 57.8 m -153.54 161.46 42.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.826 0.346 . . . . 0.0 111.278 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.659 ' CZ ' ' HB2' ' A' ' 148' ' ' ALA . 31.8 m-85 -101.75 91.12 4.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.132 0.491 . . . . 0.0 110.914 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.471 ' HB2' HD21 ' A' ' 139' ' ' LEU . 24.3 m-85 -70.19 122.96 87.9 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.336 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.422 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 15.1 Cg_exo -67.94 118.17 5.42 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 122.31 2.007 . . . . 0.0 112.636 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.655 HD21 ' OG1' ' A' ' 168' ' ' THR . 30.4 tp -98.02 123.32 41.98 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.086 0.469 . . . . 0.0 110.362 179.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.774 HD13 ' HB2' ' A' ' 118' ' ' TRP . 44.6 mt -70.4 171.97 9.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.511 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.406 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 0.9 OUTLIER -62.85 -32.33 73.53 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.857 179.924 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . 0.461 ' ND2' ' CD1' ' A' ' 118' ' ' TRP . 3.1 p30 -84.07 2.45 39.22 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.161 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.666 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 83.89 20.27 59.83 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.827 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.64 ' HB3' HD12 ' A' ' 134' ' ' LEU . 13.8 tpp180 -78.4 94.08 4.82 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.643 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -68.2 105.1 1.99 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.438 -179.025 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 17.3 mt -78.58 69.34 4.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.746 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.44 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 2.3 mttt -57.2 -21.31 32.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.564 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -91.96 11.94 23.44 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -134.74 26.5 3.67 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.762 0.315 . . . . 0.0 111.17 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.422 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -61.23 163.02 22.63 Favored Glycine 0 CA--C 1.509 -0.323 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.844 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.9 t -136.3 151.84 50.05 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.526 -0.337 . . . . 0.0 110.428 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.42 ' HE2' HG23 ' A' ' 129' ' ' THR . 4.2 mmtt -89.03 51.84 2.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.014 0.435 . . . . 0.0 110.705 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.18 148.97 2.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.638 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.659 ' HB2' ' CZ ' ' A' ' 130' ' ' PHE . . . -93.73 125.81 52.0 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.474 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.469 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 89.1 Cg_endo -84.39 109.97 1.43 Allowed 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.528 2.152 . . . . 0.0 112.508 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.3 t -70.2 -6.86 37.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.081 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.73 -23.04 53.06 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 120.836 0.351 . . . . 0.0 110.507 178.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.688 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -140.72 167.2 18.42 Favored Pre-proline 0 N--CA 1.453 -0.306 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.794 -179.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.688 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 61.5 Cg_endo -74.04 154.44 47.48 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.412 2.074 . . . . 0.0 112.306 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 14.2 t -115.81 111.5 35.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.115 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.823 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.71 96.45 2.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.858 179.207 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.434 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 59.0 t -93.07 136.03 26.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.975 0.417 . . . . 0.0 110.981 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 48.97 56.32 10.25 Favored Glycine 0 CA--C 1.521 0.423 0 CA-C-N 115.903 -0.589 . . . . 0.0 113.17 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.823 ' CE2' HD23 ' A' ' 155' ' ' LEU . 3.2 m95 -99.52 151.31 21.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.195 0.521 . . . . 0.0 111.799 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -65.79 -172.43 0.13 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.529 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -44.33 154.43 0.12 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.118 0.485 . . . . 0.0 112.203 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.564 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.27 -25.07 53.78 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.239 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -60.12 -38.3 82.59 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 120.967 0.413 . . . . 0.0 110.113 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.79 -41.36 44.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.0 178.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.564 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.5 mt -57.73 -42.35 81.56 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.11 179.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.22 -29.78 34.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.166 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.416 ' CB ' HG21 ' A' ' 211' ' ' ILE . 2.0 mt-10 -68.64 -53.43 22.53 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-O 121.503 0.668 . . . . 0.0 110.054 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.797 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -59.84 -43.81 94.39 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.701 -0.682 . . . . 0.0 109.88 178.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.892 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -58.62 -36.35 73.92 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.329 179.018 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.84 -38.47 94.06 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 178.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -71.93 -45.45 61.1 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.269 -0.465 . . . . 0.0 110.727 178.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.563 ' HA ' HD22 ' A' ' 174' ' ' LEU . 10.7 mp -67.83 -21.32 65.21 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.72 0.295 . . . . 0.0 111.691 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -77.12 -16.69 59.09 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.114 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -114.9 -26.5 7.75 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.75 HD21 ' HB2' ' A' ' 179' ' ' LEU . 0.1 OUTLIER -57.75 166.35 1.91 Allowed Pre-proline 0 CA--C 1.536 0.412 0 CA-C-O 120.513 0.197 . . . . 0.0 111.051 -179.497 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -69.48 128.88 16.94 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.31 2.007 . . . . 0.0 112.707 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.86 -25.25 7.52 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.67 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.42 -49.39 76.36 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.904 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.906 HG11 ' HB3' ' A' ' 218' ' ' LEU . 23.5 t -74.32 -39.97 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.57 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.75 ' HB2' HD21 ' A' ' 174' ' ' LEU . 12.4 tp -54.52 -32.63 58.5 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.059 0.457 . . . . 0.0 110.22 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -82.41 -36.18 17.95 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 178.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -90.48 103.2 15.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.898 0.38 . . . . 0.0 110.614 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . 0.833 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.9 mtm 178.92 179.79 0.39 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.023 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -136.72 -52.16 0.69 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.732 0.301 . . . . 0.0 111.198 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -163.43 142.69 8.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.124 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.89 HG12 HG12 ' A' ' 199' ' ' VAL . 19.2 mt -106.25 114.95 46.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.316 179.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . 0.434 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 20.1 m170 -106.24 123.61 48.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.25 -179.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.417 ' CD1' ' HD3' ' A' ' 189' ' ' PRO . 0.5 OUTLIER -75.31 104.85 6.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.474 179.558 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 9.0 mmtt -118.05 75.86 11.24 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.5 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.417 ' HD3' ' CD1' ' A' ' 187' ' ' TYR . 43.9 Cg_endo -67.4 145.17 70.44 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.392 2.061 . . . . 0.0 112.595 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 20.5 p -127.92 158.61 37.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.726 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.04 -24.82 10.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.612 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -103.3 -21.63 13.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.51 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -137.41 79.67 1.76 Allowed 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.844 0.354 . . . . 0.0 111.28 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -57.99 -24.29 57.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.282 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -104.19 36.01 2.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.795 0.331 . . . . 0.0 110.779 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 24.0 ttt85 -90.57 113.43 25.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.988 0.423 . . . . 0.0 111.182 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.854 ' O ' HD13 ' A' ' 198' ' ' ILE . 23.1 m -109.2 167.82 4.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.751 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.854 HD13 ' O ' ' A' ' 197' ' ' VAL . 22.5 mm -134.33 105.75 7.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.684 0.278 . . . . 0.0 111.34 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.89 HG12 HG12 ' A' ' 185' ' ' ILE . 12.5 m -94.53 134.87 30.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.868 0.366 . . . . 0.0 110.921 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -97.54 153.08 18.4 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.667 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 33.5 tpp -112.24 149.35 32.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.448 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 16.9 m-20 -55.27 -28.96 57.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.513 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -75.38 -5.89 47.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.817 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 94.78 14.62 49.02 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.499 -0.857 . . . . 0.0 112.988 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.439 ' CE2' HG22 ' A' ' 207' ' ' VAL . 11.2 t80 -86.28 158.2 19.75 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 117.005 0.403 . . . . 0.0 110.915 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -124.85 111.18 15.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.676 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.641 HG11 HD12 ' A' ' 224' ' ' ILE . 25.5 t -113.04 135.64 51.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.938 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 93.7 p -109.26 116.36 31.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.74 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.407 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -125.27 169.36 12.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.797 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -108.2 154.25 22.03 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.706 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.416 HG21 ' CB ' ' A' ' 166' ' ' GLU . 34.5 mt -66.08 -34.05 67.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.782 0.325 . . . . 0.0 110.832 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.46 -35.61 80.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.334 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -131.65 43.34 3.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.983 0.42 . . . . 0.0 110.961 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.568 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 11.1 t80 -66.73 -50.77 61.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.722 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.27 -42.22 90.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.347 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -67.31 -49.55 63.7 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.052 0.454 . . . . 0.0 110.458 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.93 -43.4 69.76 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.174 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.906 ' HB3' HG11 ' A' ' 178' ' ' VAL . 4.0 mm? -84.11 -25.5 29.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.004 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 12.6 t -61.15 -31.45 71.18 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.892 0.377 . . . . 0.0 110.396 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . 0.419 ' CB ' HG22 ' A' ' 224' ' ' ILE . 1.5 m-70 -69.66 -15.74 63.23 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.402 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.43 ' HB2' HD13 ' A' ' 224' ' ' ILE . 68.8 t80 -59.33 137.79 88.75 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 110.399 -0.223 . . . . 0.0 110.399 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.529 ' O ' ' HB3' ' A' ' 223' ' ' ALA . 59.6 Cg_endo -71.6 154.71 97.59 Favored 'Cis proline' 0 C--N 1.355 0.906 0 C-N-CA 124.569 -1.013 . . . . 0.0 112.743 0.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 222' ' ' PRO . . . 82.26 77.39 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.821 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.641 HD12 HG11 ' A' ' 207' ' ' VAL . 18.7 pt -130.11 176.59 8.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.296 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . 0.533 ' HB2' HG13 ' A' ' 207' ' ' VAL . . . 59.02 165.13 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.202 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -110.26 -165.04 0.97 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.93 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -100.3 24.71 8.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.24 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.14 25.31 6.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.741 0.305 . . . . 0.0 110.835 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 25.1 p30 -107.22 31.3 5.48 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.865 0.364 . . . . 0.0 110.859 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 15.9 mtp180 -105.61 -74.88 0.64 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.76 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 63.98 -78.96 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.014 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 10.6 p -113.88 128.42 70.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.814 0.34 . . . . 0.0 111.064 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 16.9 mttp . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.892 179.967 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.176 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 68.4 m -65.03 -68.66 0.34 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.81 0.338 . . . . 0.0 110.93 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 61.7 155.37 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.041 0.448 . . . . 0.0 110.977 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.762 ' HB2' HD13 ' A' ' 134' ' ' LEU . 81.3 m95 -73.89 168.55 19.22 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.204 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.2 ptt180 -101.05 135.22 42.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.841 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 8.4 mtm180 -71.87 106.68 4.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.867 0.365 . . . . 0.0 110.731 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.888 HD11 HG22 ' A' ' 168' ' ' THR . 49.3 pt -97.09 -7.65 9.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.366 179.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.478 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -159.39 176.17 12.44 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 121.111 -0.236 . . . . 0.0 110.71 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.47 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 29.1 m-85 -144.48 126.26 15.24 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.088 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.559 HG21 HD11 ' A' ' 139' ' ' LEU . 8.6 t -93.64 122.77 45.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.108 0.48 . . . . 0.0 111.471 -179.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.476 ' CD1' ' CE1' ' A' ' 130' ' ' PHE . 28.5 t80 -82.7 110.7 17.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.729 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -165.08 152.41 10.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.651 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? 60.37 31.6 20.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.015 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 62.2 31.49 17.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.264 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.521 HG23 ' O ' ' A' ' 145' ' ' THR . 84.7 m -153.43 150.13 28.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.874 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.476 ' CE1' ' CD1' ' A' ' 125' ' ' TYR . 98.7 m-85 -95.55 91.52 6.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.793 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.516 ' HB2' HD21 ' A' ' 139' ' ' LEU . 23.8 m-85 -65.19 126.15 90.77 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.313 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -72.58 116.67 4.8 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.176 1.917 . . . . 0.0 112.434 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.621 HD21 ' OG1' ' A' ' 168' ' ' THR . 42.8 tp -96.02 124.38 40.01 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.864 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.762 HD13 ' HB2' ' A' ' 118' ' ' TRP . 55.0 mt -71.65 174.73 6.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.65 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.406 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.5 pt-20 -65.46 -28.73 69.43 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.076 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 46.7 p-10 -89.82 11.68 19.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.143 179.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.666 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 73.41 23.49 77.1 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.932 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.703 ' HB3' HD12 ' A' ' 134' ' ' LEU . 18.4 tpp180 -81.11 95.95 7.02 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.559 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -72.68 107.33 5.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.326 -179.005 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 13.5 mt -85.03 72.13 10.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.321 179.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.465 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 7.5 mtpt -56.2 -21.38 22.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.993 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -85.54 -16.22 40.17 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -108.88 29.69 7.23 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . -64.52 163.08 36.42 Favored Glycine 0 CA--C 1.51 -0.228 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.88 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.521 ' O ' HG23 ' A' ' 129' ' ' THR . 9.1 t -131.31 155.95 46.31 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.41 -0.395 . . . . 0.0 110.619 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.39 48.52 1.31 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.127 0.489 . . . . 0.0 110.319 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -170.97 150.73 3.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.533 -179.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.455 ' HB2' ' CZ ' ' A' ' 130' ' ' PHE . . . -95.02 125.93 48.76 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.21 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.47 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 72.8 Cg_endo -83.02 111.83 1.96 Allowed 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.349 2.032 . . . . 0.0 112.619 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 33.3 t -69.81 -7.6 41.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.062 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.82 -23.44 52.76 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 120.821 0.343 . . . . 0.0 110.456 178.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.674 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -139.44 166.9 21.05 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.653 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.674 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 60.0 Cg_endo -73.81 154.54 48.7 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.348 2.032 . . . . 0.0 112.265 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 13.4 t -116.91 109.98 29.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.063 0.458 . . . . 0.0 111.207 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.891 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.2 mp -72.33 96.12 1.82 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.611 179.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.417 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 60.8 t -92.41 137.16 22.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.129 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 48.97 57.85 8.33 Favored Glycine 0 CA--C 1.52 0.374 0 CA-C-N 115.921 -0.581 . . . . 0.0 113.223 179.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.891 ' CE2' HD23 ' A' ' 155' ' ' LEU . 2.7 m95 -101.13 151.07 22.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.162 0.506 . . . . 0.0 111.679 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.7 tttp -66.76 -172.18 0.16 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.374 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -42.26 154.42 0.06 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.534 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -56.87 -24.96 51.63 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.267 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.04 -38.69 83.51 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.996 0.427 . . . . 0.0 109.978 179.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -75.91 -40.6 53.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.913 178.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.534 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.2 mt -59.11 -44.0 90.58 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.878 179.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -52.92 -25.9 13.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.617 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -71.39 -54.43 10.73 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 121.072 0.463 . . . . 0.0 110.923 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.813 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -62.14 -37.19 84.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.217 179.495 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.888 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -60.5 -38.11 83.26 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.911 178.881 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -61.59 -35.68 91.49 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 177.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -71.6 -49.02 44.27 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.181 -0.51 . . . . 0.0 110.669 178.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.637 ' HA ' HD22 ' A' ' 174' ' ' LEU . 10.8 mp -65.2 -27.42 68.67 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.548 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.13 -18.2 61.91 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.273 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -113.27 -27.75 7.86 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.637 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER -57.0 167.23 1.14 Allowed Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.154 -179.582 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.413 ' HG2' HG23 ' A' ' 178' ' ' VAL . 38.2 Cg_endo -67.19 127.78 17.32 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.192 1.928 . . . . 0.0 112.728 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.45 -26.43 12.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.525 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -58.93 -48.09 82.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.924 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.894 HG11 ' HB3' ' A' ' 218' ' ' LEU . 22.1 t -73.0 -35.82 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.696 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.484 ' HB2' HD21 ' A' ' 174' ' ' LEU . 13.0 tp -56.13 -36.36 68.15 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.129 0.49 . . . . 0.0 110.032 179.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -76.92 -40.11 26.46 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 178.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -87.7 103.09 15.27 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.879 0.371 . . . . 0.0 110.718 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . 0.839 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.8 mtm 178.02 167.73 0.75 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.127 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.92 -56.75 1.55 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.63 0.252 . . . . 0.0 111.268 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 6.3 pm0 -160.39 142.79 13.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.894 0.378 . . . . 0.0 111.307 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.874 HG12 HG12 ' A' ' 199' ' ' VAL . 13.3 mt -104.33 115.96 47.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.455 179.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . 0.417 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 20.2 m170 -106.45 124.05 49.01 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.113 -179.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -79.46 104.7 10.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.709 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.75 86.86 55.51 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.517 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.33 146.9 57.94 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.312 2.008 . . . . 0.0 112.535 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 18.6 p -128.28 159.66 34.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.677 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 4.2 mtt180 -54.51 -26.83 34.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.459 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -100.99 -19.32 15.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.652 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -141.46 82.18 1.81 Allowed 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.767 0.318 . . . . 0.0 111.439 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.1 -24.15 52.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.245 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -106.0 38.37 2.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.608 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.08 114.72 25.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.322 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.874 ' O ' HD13 ' A' ' 198' ' ' ILE . 32.8 m -110.59 169.37 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.724 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.874 HD13 ' O ' ' A' ' 197' ' ' VAL . 22.0 mm -134.95 110.29 12.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.72 0.295 . . . . 0.0 111.285 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.874 HG12 HG12 ' A' ' 185' ' ' ILE . 12.3 m -102.81 127.18 56.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.987 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -88.64 152.56 21.75 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.675 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.11 157.62 16.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.812 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -57.78 -23.84 54.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.527 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -89.89 15.36 10.03 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 79.64 14.19 81.47 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.57 -0.824 . . . . 0.0 113.081 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -78.39 175.05 10.64 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 117.094 0.447 . . . . 0.0 110.836 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -140.53 111.46 7.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.082 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.482 HG11 HG12 ' A' ' 224' ' ' ILE . 20.1 t -114.22 135.63 53.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.911 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 1.5 m -107.64 118.36 36.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.928 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.645 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -131.12 161.94 30.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.66 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -99.28 156.75 16.82 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.737 0.303 . . . . 0.0 110.788 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 45.9 mt -68.46 -33.1 58.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.771 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 -67.38 -38.06 84.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.091 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -126.53 41.14 3.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.974 0.416 . . . . 0.0 110.866 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.597 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 11.5 t80 -65.02 -52.57 55.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.869 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.29 -37.74 81.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.048 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -69.25 -49.62 54.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.063 0.458 . . . . 0.0 110.372 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 1.2 mmpt? -53.25 -41.72 65.76 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.058 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.894 ' HB3' HG11 ' A' ' 178' ' ' VAL . 4.3 mm? -87.06 -23.16 25.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.9 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 11.0 t -60.95 -32.64 72.17 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.921 0.391 . . . . 0.0 110.157 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . 0.589 ' CB ' HG22 ' A' ' 224' ' ' ILE . 24.9 m170 -69.53 -15.84 63.32 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.195 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.42 ' CD2' ' HA ' ' A' ' 222' ' ' PRO . 48.1 t80 -55.76 139.87 68.66 Favored Pre-proline 0 CA--C 1.537 0.444 0 N-CA-C 110.492 -0.188 . . . . 0.0 110.492 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.528 ' O ' ' HB3' ' A' ' 223' ' ' ALA . 68.8 Cg_endo -73.33 154.14 99.45 Favored 'Cis proline' 0 C--N 1.354 0.86 0 C-N-CA 124.344 -1.107 . . . . 0.0 112.714 0.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 222' ' ' PRO . . . 85.43 75.63 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.22 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.616 HD13 ' H ' ' A' ' 224' ' ' ILE . 0.1 OUTLIER -143.97 135.95 22.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.044 0.45 . . . . 0.0 111.358 178.762 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . 0.411 ' HB2' ' O ' ' A' ' 224' ' ' ILE . . . 176.5 -175.5 0.12 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.045 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -105.5 -166.42 1.21 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.878 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -128.02 33.81 4.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.79 0.329 . . . . 0.0 111.102 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 60.1 mt -107.54 30.21 6.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.964 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -111.93 57.37 0.64 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.995 0.426 . . . . 0.0 110.787 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 -132.69 -47.31 0.88 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.982 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -67.31 88.9 0.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.808 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . 0.402 HG22 ' N ' ' A' ' 233' ' ' LYS . 11.1 p -88.25 154.48 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.04 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . 0.402 ' N ' HG22 ' A' ' 232' ' ' VAL . 16.7 mttm . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.922 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.216 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.98 137.03 19.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.867 0.365 . . . . 0.0 110.945 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -65.28 154.93 36.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.942 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.769 ' HB2' HD13 ' A' ' 134' ' ' LEU . 82.8 m95 -70.91 168.44 16.91 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.219 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.85 132.2 47.76 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.799 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -69.17 108.4 3.6 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.926 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.911 HD11 HG22 ' A' ' 168' ' ' THR . 44.2 pt -98.01 -7.93 9.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.323 179.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.471 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -159.97 174.45 14.36 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 121.134 -0.226 . . . . 0.0 110.649 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.476 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 28.0 m-85 -143.03 126.75 17.04 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.277 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.651 HG21 HD11 ' A' ' 139' ' ' LEU . 3.5 t -93.35 123.65 45.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.018 0.437 . . . . 0.0 111.643 -179.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.481 ' CE1' ' CE1' ' A' ' 130' ' ' PHE . 7.5 t80 -84.51 105.11 15.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.754 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -159.66 154.92 25.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.681 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 60.46 30.56 19.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.945 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 62.38 32.16 16.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.166 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.484 HG23 ' O ' ' A' ' 145' ' ' THR . 75.3 m -153.1 151.39 30.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.085 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.815 ' CE2' ' HB2' ' A' ' 148' ' ' ALA . 36.4 m-85 -94.52 90.91 6.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.537 179.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.564 ' HB2' HD21 ' A' ' 139' ' ' LEU . 21.4 m-85 -65.47 138.17 96.82 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.739 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -85.16 116.06 1.73 Allowed 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.311 2.008 . . . . 0.0 112.083 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.609 HD21 ' OG1' ' A' ' 168' ' ' THR . 37.9 tp -95.29 123.65 38.91 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.882 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.769 HD13 ' HB2' ' A' ' 118' ' ' TRP . 58.2 mt -72.15 172.69 9.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.485 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.41 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.5 pt-20 -63.19 -28.75 70.26 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.854 179.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -90.5 12.39 18.81 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.209 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.642 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 74.07 28.34 64.63 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.717 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.628 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -81.62 92.36 6.55 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.723 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.651 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -74.17 105.03 5.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.957 0.408 . . . . 0.0 110.972 -179.533 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 88.6 mt -85.84 70.87 10.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.701 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.462 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 29.5 mttt -52.87 -23.24 6.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.983 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -84.09 -20.54 32.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.596 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -102.54 27.86 6.51 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 111.703 0.26 . . . . 0.0 111.703 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . -65.22 163.88 37.74 Favored Glycine 0 CA--C 1.511 -0.215 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.144 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.484 ' O ' HG23 ' A' ' 129' ' ' THR . 7.8 t -133.07 158.3 43.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.955 0.407 . . . . 0.0 110.648 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 6.2 mmmm -93.98 48.86 1.28 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.36 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.33 151.53 3.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.593 -179.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.815 ' HB2' ' CE2' ' A' ' 130' ' ' PHE . . . -96.93 126.73 41.51 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.178 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.476 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 73.2 Cg_endo -82.24 111.95 2.19 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.335 2.023 . . . . 0.0 112.552 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 28.2 t -69.82 -7.47 40.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.112 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -76.47 -23.33 53.82 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 120.859 0.362 . . . . 0.0 110.451 179.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.697 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -139.74 167.88 17.01 Favored Pre-proline 0 N--CA 1.454 -0.265 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.697 -179.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.697 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 61.0 Cg_endo -74.22 158.0 45.52 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.389 2.059 . . . . 0.0 112.236 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 11.1 t -118.47 111.04 32.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.049 0.452 . . . . 0.0 111.16 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.829 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.52 95.98 1.88 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.535 179.122 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.426 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 61.2 t -93.22 136.45 25.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.977 0.418 . . . . 0.0 111.014 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 49.05 55.98 10.96 Favored Glycine 0 CA--C 1.521 0.411 0 CA-C-N 115.808 -0.633 . . . . 0.0 113.264 179.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.829 ' CE2' HD23 ' A' ' 155' ' ' LEU . 2.7 m95 -98.34 151.11 20.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.128 0.489 . . . . 0.0 111.652 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.97 -172.65 0.07 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.349 179.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -44.46 155.5 0.09 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.134 0.492 . . . . 0.0 112.143 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.567 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -56.54 -25.14 49.45 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.25 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -60.89 -39.03 87.71 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 120.938 0.399 . . . . 0.0 110.038 179.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.424 ' HB1' ' HE2' ' A' ' 187' ' ' TYR . . . -75.36 -40.16 58.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.128 179.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.567 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.3 mt -59.0 -43.1 88.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.102 179.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.34 -29.69 35.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.35 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -68.14 -53.12 27.51 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.424 0.63 . . . . 0.0 110.189 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.77 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -60.39 -42.3 95.6 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.027 179.064 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.911 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -59.51 -37.47 78.42 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.306 179.252 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.78 -36.67 92.3 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 178.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -72.92 -46.86 50.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.424 -0.388 . . . . 0.0 110.945 178.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.573 ' O ' HD22 ' A' ' 174' ' ' LEU . 10.6 mp -65.69 -28.49 69.11 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.75 0.31 . . . . 0.0 111.34 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.31 -17.98 63.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.335 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -112.72 -27.36 8.19 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.65 0.262 . . . . 0.0 111.529 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.573 HD22 ' O ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER -56.88 167.0 1.16 Allowed Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.183 -179.463 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -69.2 127.82 15.61 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.249 1.966 . . . . 0.0 112.721 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.02 -25.85 5.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.81 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.65 -50.0 74.61 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.007 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.855 HG11 ' HB3' ' A' ' 218' ' ' LEU . 22.3 t -74.19 -35.33 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.667 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.661 HD21 ' O ' ' A' ' 121' ' ' ILE . 0.8 OUTLIER -56.37 -34.78 66.98 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.105 0.479 . . . . 0.0 110.091 179.212 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -79.56 -40.27 15.81 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.35 178.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -87.32 103.15 15.2 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.931 0.396 . . . . 0.0 110.745 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . 0.841 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.8 mtm 178.95 164.66 0.86 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.24 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.33 -60.28 1.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.755 0.312 . . . . 0.0 111.195 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -155.64 142.89 19.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.029 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.89 HG12 HG12 ' A' ' 199' ' ' VAL . 16.7 mt -107.35 115.12 47.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.434 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . 0.426 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 20.7 m170 -106.39 135.07 48.53 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.186 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.424 ' HE2' ' HB1' ' A' ' 163' ' ' ALA . 0.3 OUTLIER -86.65 104.35 15.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.269 179.417 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.12 81.66 57.27 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.8 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.3 151.91 60.69 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.44 2.094 . . . . 0.0 112.371 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.51 HG21 ' CZ ' ' A' ' 196' ' ' ARG . 18.2 p -123.46 174.11 7.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.809 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 42.4 mtt180 -57.35 -29.5 64.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.341 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.402 ' O ' ' CD1' ' A' ' 193' ' ' TYR . 6.0 pm0 -118.74 7.87 11.73 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.402 ' CD1' ' O ' ' A' ' 192' ' ' GLU . 39.5 m-85 -144.51 69.57 1.27 Allowed 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.977 0.418 . . . . 0.0 111.064 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -56.58 -22.0 30.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.61 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 9.3 p30 -110.09 38.26 2.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.743 0.306 . . . . 0.0 111.047 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.51 ' CZ ' HG21 ' A' ' 190' ' ' THR . 0.0 OUTLIER -90.34 117.04 28.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.912 0.387 . . . . 0.0 111.121 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.88 ' O ' HD13 ' A' ' 198' ' ' ILE . 22.0 m -114.45 168.47 6.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.747 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.88 HD13 ' O ' ' A' ' 197' ' ' VAL . 22.7 mm -134.64 113.58 16.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.732 0.301 . . . . 0.0 111.221 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.89 HG12 HG12 ' A' ' 185' ' ' ILE . 10.4 m -104.8 125.91 59.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.09 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -88.72 152.52 21.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.787 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.02 154.88 18.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.761 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -58.03 -27.82 63.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.249 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -82.98 4.24 26.72 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 89.98 14.4 59.32 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 120.476 -0.869 . . . . 0.0 113.244 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -80.1 173.58 12.45 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 117.059 0.429 . . . . 0.0 110.902 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -139.3 111.34 7.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.904 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.803 HG11 HD12 ' A' ' 224' ' ' ILE . 19.6 t -115.79 137.36 49.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.924 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 97.7 p -110.77 119.66 39.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.942 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.567 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -130.36 164.21 25.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.71 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.86 153.71 20.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.76 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 33.9 mt -64.3 -36.81 78.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.837 0.351 . . . . 0.0 110.693 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.14 -36.39 81.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.159 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -132.0 46.12 2.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.007 0.432 . . . . 0.0 110.889 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.574 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 11.5 t80 -67.53 -51.71 47.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.785 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.15 -41.05 87.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.146 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -68.25 -49.85 57.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.148 0.499 . . . . 0.0 110.268 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 1.5 mmpt? -52.28 -41.81 63.19 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.102 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.855 ' HB3' HG11 ' A' ' 178' ' ' VAL . 3.8 mm? -86.85 -24.66 24.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.008 179.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 13.5 t -60.87 -30.76 70.34 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.829 0.347 . . . . 0.0 110.531 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . 0.743 ' HB2' HG22 ' A' ' 224' ' ' ILE . 58.7 m170 -68.83 -16.96 63.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.25 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.406 ' N ' ' CG2' ' A' ' 224' ' ' ILE . 70.1 t80 -65.04 137.4 97.09 Favored Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 110.408 -0.219 . . . . 0.0 110.408 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.532 ' O ' ' HB3' ' A' ' 223' ' ' ALA . 8.4 Cg_exo -72.48 154.86 98.96 Favored 'Cis proline' 0 C--N 1.355 0.891 0 C-N-CA 124.845 -0.898 . . . . 0.0 112.532 0.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.532 ' HB3' ' O ' ' A' ' 222' ' ' PRO . . . 82.02 77.75 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.079 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.803 HD12 HG11 ' A' ' 207' ' ' VAL . 15.5 pt -129.25 -178.64 2.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.387 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 65.19 132.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.226 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -65.49 -165.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.083 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -102.03 31.42 3.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.883 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.702 ' O ' HD23 ' A' ' 228' ' ' LEU . 1.0 OUTLIER -90.56 14.98 11.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.562 179.736 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -88.39 -32.0 18.58 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.856 0.36 . . . . 0.0 110.83 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -68.19 -31.96 71.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.898 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -90.84 51.99 2.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.852 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 11.2 p -59.34 148.7 6.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.087 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 20.3 pttm . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.161 -0.923 . . . . 0.0 110.846 179.972 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.212 0 N-CA-C 112.469 -0.252 . . . . 0.0 112.469 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 26.5 t 60.38 66.25 0.97 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.069 0.461 . . . . 0.0 110.877 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -148.96 151.77 35.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.071 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.773 ' HB2' HD13 ' A' ' 134' ' ' LEU . 82.1 m95 -68.79 168.0 14.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.106 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -102.68 138.01 40.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.403 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 10.3 mtt180 -73.4 105.59 4.84 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.729 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.922 HD11 HG22 ' A' ' 168' ' ' THR . 45.6 pt -93.49 -9.26 9.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.366 179.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.483 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -157.36 176.44 12.68 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 120.599 0.237 . . . . 0.0 110.537 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.467 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 34.0 m-85 -143.9 126.14 15.62 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.588 HG21 ' CD1' ' A' ' 139' ' ' LEU . 3.9 t -93.67 122.91 45.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.058 0.456 . . . . 0.0 111.417 -179.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -80.69 94.21 6.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.556 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -145.26 154.13 42.03 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.327 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.2 mmt-85 60.0 29.94 19.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.699 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 61.51 34.75 17.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.968 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.446 HG22 ' N ' ' A' ' 130' ' ' PHE . 83.6 m -154.87 162.04 41.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.818 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.446 ' N ' HG22 ' A' ' 129' ' ' THR . 10.7 m-85 -100.47 90.71 4.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.141 0.496 . . . . 0.0 111.201 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.464 ' HA ' ' HA2' ' A' ' 144' ' ' GLY . 23.1 m-85 -68.9 118.09 57.74 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.391 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.678 ' HB2' HD12 ' A' ' 140' ' ' LEU . 23.1 Cg_exo -64.3 115.35 3.11 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 122.359 2.039 . . . . 0.0 112.594 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.655 HD21 ' OG1' ' A' ' 168' ' ' THR . 30.3 tp -94.17 123.41 37.54 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.358 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.773 HD13 ' HB2' ' A' ' 118' ' ' TRP . 45.5 mt -69.02 173.6 5.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.557 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.404 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.6 pt-20 -64.72 -29.7 70.69 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.14 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . 0.459 ' ND2' ' CD1' ' A' ' 118' ' ' TRP . 2.7 p30 -88.14 9.84 21.38 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.19 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.635 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 77.01 20.99 75.03 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.817 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.683 ' HB3' HD12 ' A' ' 134' ' ' LEU . 17.3 tpp180 -79.85 92.39 5.48 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.588 ' CD1' HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -66.81 119.89 12.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.501 -178.893 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.678 HD12 ' HB2' ' A' ' 132' ' ' PRO . 33.1 mt -88.17 76.49 8.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.306 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.453 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 15.7 mtpt -71.49 -5.86 36.22 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.002 -0.544 . . . . 0.0 112.454 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -94.97 -25.08 16.66 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.606 0.241 . . . . 0.0 111.078 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -87.16 -82.19 0.22 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.294 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.464 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . 59.52 153.84 0.02 OUTLIER Glycine 0 CA--C 1.506 -0.506 0 C-N-CA 121.337 -0.459 . . . . 0.0 112.8 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 10.1 t -137.77 152.35 49.08 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.127 -0.536 . . . . 0.0 110.61 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.31 51.34 1.89 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.566 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.12 147.43 2.57 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.741 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -90.9 125.11 60.08 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.332 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.467 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 71.6 Cg_endo -84.74 107.88 1.17 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.613 2.209 . . . . 0.0 112.659 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 25.8 t -69.52 -8.03 43.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.017 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -77.83 -24.49 48.68 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 120.879 0.371 . . . . 0.0 110.377 179.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.68 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -138.85 167.04 20.8 Favored Pre-proline 0 N--CA 1.452 -0.339 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.616 -179.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.68 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 70.2 Cg_endo -75.03 157.99 42.32 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.404 2.069 . . . . 0.0 112.572 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 13.6 t -118.97 110.72 30.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.095 0.474 . . . . 0.0 111.028 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.854 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.64 96.05 1.94 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.868 179.439 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.416 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 61.3 t -94.18 137.14 23.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.989 0.423 . . . . 0.0 111.048 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 48.83 57.02 9.03 Favored Glycine 0 C--N 1.332 0.345 0 CA-C-N 115.921 -0.581 . . . . 0.0 113.175 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.854 ' CE2' HD23 ' A' ' 155' ' ' LEU . 3.2 m95 -100.04 151.14 21.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.153 0.501 . . . . 0.0 111.843 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.411 ' HB2' ' CD2' ' A' ' 187' ' ' TYR . 0.0 OUTLIER -66.56 -172.27 0.16 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.438 179.288 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -43.6 154.39 0.09 Allowed 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.566 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.07 -25.63 54.2 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.262 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -60.22 -37.66 80.99 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.984 0.421 . . . . 0.0 110.027 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.14 -40.51 45.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.039 179.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.566 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.2 mt -58.73 -41.42 82.4 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.051 179.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.24 -29.92 48.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.067 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.462 ' CB ' HG21 ' A' ' 211' ' ' ILE . 5.0 mm-40 -68.26 -53.0 27.63 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 121.387 0.613 . . . . 0.0 110.117 179.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.811 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -59.12 -46.3 88.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.036 178.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.922 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -57.01 -36.78 70.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.549 179.231 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.75 -37.37 93.47 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 178.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -73.64 -45.78 50.71 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.315 -0.443 . . . . 0.0 111.077 179.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.574 ' HA ' HD22 ' A' ' 174' ' ' LEU . 11.0 mp -65.0 -29.69 70.62 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.828 0.347 . . . . 0.0 111.338 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.6 -16.99 63.5 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.365 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -114.23 -27.28 7.68 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.658 0.266 . . . . 0.0 111.633 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.574 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER -57.05 167.17 1.18 Allowed Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.269 -179.561 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -70.68 127.79 14.32 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.226 1.95 . . . . 0.0 112.938 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.04 -25.64 5.12 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.723 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.4 -50.17 73.86 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.968 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.867 HG11 ' HB3' ' A' ' 218' ' ' LEU . 34.7 t -74.18 -33.5 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.49 179.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.516 HD13 HD21 ' A' ' 174' ' ' LEU . 11.4 tp -56.46 -36.88 69.55 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.096 0.474 . . . . 0.0 109.935 179.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -77.36 -41.65 20.49 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.284 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -84.32 103.0 13.13 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.896 0.379 . . . . 0.0 110.558 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . 0.84 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.8 mtm 177.02 166.11 0.53 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.142 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 27.3 t -124.82 -53.99 1.64 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.732 0.301 . . . . 0.0 111.147 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -162.14 142.63 10.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.977 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.925 HG12 HG12 ' A' ' 199' ' ' VAL . 19.1 mt -104.89 115.44 46.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.472 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . 0.416 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 21.9 m170 -105.37 123.36 47.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.159 -179.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.411 ' CD2' ' HB2' ' A' ' 159' ' ' LYS . 14.0 t80 -78.82 104.35 9.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.438 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.65 81.56 40.46 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.584 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -67.26 145.8 73.5 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.311 2.007 . . . . 0.0 112.451 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 21.2 p -123.98 158.85 31.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.735 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.38 -25.16 9.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.664 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -108.61 -17.64 13.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.629 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -135.14 77.76 1.7 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.883 0.373 . . . . 0.0 111.209 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -57.09 -22.45 39.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.499 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 5.8 p30 -108.17 37.71 2.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.731 0.301 . . . . 0.0 110.819 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 9.5 ttt-85 -89.76 114.32 26.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.911 0.386 . . . . 0.0 111.2 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.852 ' O ' HD13 ' A' ' 198' ' ' ILE . 25.1 m -111.61 167.85 5.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.9 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.852 HD13 ' O ' ' A' ' 197' ' ' VAL . 22.7 mm -134.24 111.34 14.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.844 0.354 . . . . 0.0 110.974 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.925 HG12 HG12 ' A' ' 185' ' ' ILE . 6.7 m -100.31 120.15 49.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.21 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -81.88 152.46 26.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.661 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . 0.462 ' HE2' ' HG3' ' A' ' 182' ' ' MET . 7.6 mmt -105.6 157.89 17.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.99 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 39.5 m-20 -59.82 -27.03 66.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.142 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.02 13.27 13.33 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 89.1 -14.07 61.64 Favored Glycine 0 CA--C 1.52 0.397 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.247 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -58.13 156.03 10.24 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 117.133 0.467 . . . . 0.0 110.96 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -131.3 111.31 11.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.919 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 20.8 t -107.03 141.92 21.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.04 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 5.6 m -112.41 116.87 31.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.883 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.607 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -128.58 162.48 27.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.804 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.7 154.91 17.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.584 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.462 HG21 ' CB ' ' A' ' 166' ' ' GLU . 40.5 mt -67.3 -35.7 74.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.804 0.335 . . . . 0.0 110.96 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -38.4 91.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.24 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -128.09 40.64 3.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.914 0.388 . . . . 0.0 110.892 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.572 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 11.1 t80 -62.56 -54.35 41.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.768 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.1 -41.38 78.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.276 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.62 -46.58 68.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.075 0.464 . . . . 0.0 110.421 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . 0.728 ' O ' HG21 ' A' ' 224' ' ' ILE . 0.4 OUTLIER -55.6 -44.75 77.29 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.883 179.611 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.867 ' HB3' HG11 ' A' ' 178' ' ' VAL . 3.9 mm? -83.31 -25.05 31.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.037 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 13.0 t -60.97 -33.14 72.76 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.062 0.458 . . . . 0.0 110.131 179.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 9.6 m170 -71.66 -15.84 62.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.268 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -55.05 133.47 68.1 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 116.726 -0.215 . . . . 0.0 111.165 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -91.72 105.68 0.48 Allowed 'Cis proline' 0 C--N 1.356 0.953 0 C-N-CA 124.824 -0.907 . . . . 0.0 112.677 0.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -179.02 38.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.118 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.728 HG21 ' O ' ' A' ' 217' ' ' LYS . 0.1 OUTLIER -139.84 156.83 25.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.029 179.666 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 179.6 172.05 0.97 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.098 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -123.67 154.88 38.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.165 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -143.2 42.56 1.53 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.076 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 4.5 tp -98.64 30.9 3.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.012 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -113.78 32.52 5.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.808 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 46.7 mtm180 -147.34 54.6 1.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.794 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -167.33 152.55 7.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.665 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 21.0 t 67.08 116.29 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.11 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.874 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.166 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 26.1 m -132.98 178.43 6.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.795 0.331 . . . . 0.0 110.902 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -68.53 147.18 52.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.047 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.759 ' HB2' HD13 ' A' ' 134' ' ' LEU . 80.6 m95 -68.42 168.3 12.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.237 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 11.4 ttt180 -102.49 137.66 40.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.348 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 24.8 mtt85 -72.91 106.48 4.84 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.861 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.9 HD11 HG22 ' A' ' 168' ' ' THR . 46.6 pt -95.61 -8.1 9.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.361 179.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.475 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -158.75 176.45 12.34 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 120.578 0.228 . . . . 0.0 110.708 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.465 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 29.8 m-85 -144.94 126.45 15.01 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.688 HG21 HD11 ' A' ' 139' ' ' LEU . 4.3 t -93.08 122.61 44.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.091 0.472 . . . . 0.0 111.267 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.472 ' CE1' ' CE1' ' A' ' 130' ' ' PHE . 9.3 t80 -83.96 100.01 10.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.842 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -151.76 151.8 31.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.601 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 60.0 30.88 20.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 63.4 32.41 14.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.2 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.573 HG23 ' O ' ' A' ' 145' ' ' THR . 87.8 m -152.89 149.02 27.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.828 0.347 . . . . 0.0 110.988 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.755 ' CE2' ' HB2' ' A' ' 148' ' ' ALA . 24.2 m-85 -93.69 91.0 6.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.713 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.565 ' HB2' HD21 ' A' ' 139' ' ' LEU . 24.7 m-85 -66.05 120.79 72.27 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.141 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -68.12 115.5 3.86 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.045 1.83 . . . . 0.0 112.539 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.661 HD21 ' OG1' ' A' ' 168' ' ' THR . 34.1 tp -95.0 124.2 38.91 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.787 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.759 HD13 ' HB2' ' A' ' 118' ' ' TRP . 42.5 mt -69.89 175.47 4.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.5 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.41 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.3 pt-20 -66.52 -28.41 68.53 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.125 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 32.7 p-10 -90.47 13.21 16.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.235 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.615 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 73.79 20.15 79.76 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.978 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.69 ' HB3' HD12 ' A' ' 134' ' ' LEU . 0.7 OUTLIER -79.04 94.14 5.25 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.326 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.688 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -70.45 116.37 10.7 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.652 -178.875 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.474 HD23 ' HG3' ' A' ' 143' ' ' GLU . 10.4 mp -90.35 76.25 6.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.343 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.478 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 4.5 mttt -61.46 -15.46 37.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.241 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -94.38 -24.11 17.5 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.474 ' HG3' HD23 ' A' ' 140' ' ' LEU . 68.7 mm-40 -99.81 26.82 5.91 Favored 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -179.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . -62.95 163.66 29.13 Favored Glycine 0 CA--C 1.51 -0.222 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.885 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.573 ' O ' HG23 ' A' ' 129' ' ' THR . 7.1 t -130.79 158.2 40.8 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.877 0.37 . . . . 0.0 110.712 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -94.42 49.32 1.27 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.513 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.3 154.64 4.0 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.609 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.755 ' HB2' ' CE2' ' A' ' 130' ' ' PHE . . . -97.64 125.53 44.43 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.24 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.465 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 73.7 Cg_endo -83.06 111.9 1.96 Allowed 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.4 2.066 . . . . 0.0 112.573 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 11.0 t -69.48 -8.14 44.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.175 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -77.11 -23.54 51.81 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 120.88 0.372 . . . . 0.0 110.507 179.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.672 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -138.97 166.92 21.43 Favored Pre-proline 0 N--CA 1.452 -0.336 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.669 -179.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.672 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 67.7 Cg_endo -74.83 154.33 43.32 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.401 2.067 . . . . 0.0 112.308 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 10.6 t -116.04 110.48 31.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.93 0.395 . . . . 0.0 111.293 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.849 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.36 95.94 1.81 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.552 179.025 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.415 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 60.1 t -91.98 136.12 25.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.946 0.403 . . . . 0.0 111.116 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 48.83 58.75 7.34 Favored Glycine 0 CA--C 1.521 0.468 0 CA-C-N 115.837 -0.619 . . . . 0.0 113.189 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.849 ' CE2' HD23 ' A' ' 155' ' ' LEU . 3.1 m95 -101.31 151.17 22.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.198 0.523 . . . . 0.0 111.834 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.42 -172.24 0.15 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.412 179.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -42.92 154.49 0.07 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.532 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.51 -25.84 55.86 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.157 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.97 -38.85 80.05 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.967 0.413 . . . . 0.0 109.943 179.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.64 -39.98 50.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.009 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.532 HD12 ' HA2' ' A' ' 161' ' ' GLY . 5.8 mt -59.28 -41.39 83.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.903 178.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.9 -31.06 48.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.129 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.419 ' HB3' HG21 ' A' ' 211' ' ' ILE . 2.6 mm-40 -67.8 -53.02 30.37 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.386 0.613 . . . . 0.0 110.138 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.82 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -59.24 -44.56 92.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.01 179.095 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.9 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -58.42 -37.55 75.61 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.545 179.106 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.89 -36.86 91.48 Favored Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 178.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -73.83 -46.33 45.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.342 -0.429 . . . . 0.0 111.008 178.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.592 ' HA ' HD22 ' A' ' 174' ' ' LEU . 11.3 mp -66.22 -28.01 68.41 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.683 0.278 . . . . 0.0 111.349 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.87 -17.22 62.73 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.682 -0.236 . . . . 0.0 111.291 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -112.62 -29.85 7.31 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.653 0.263 . . . . 0.0 111.345 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.592 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER -55.44 167.32 0.76 Allowed Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.216 -179.651 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.416 ' HG2' HG23 ' A' ' 178' ' ' VAL . 47.9 Cg_endo -69.63 128.78 16.63 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.208 1.939 . . . . 0.0 112.921 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.28 -25.63 9.95 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.535 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -58.82 -48.59 80.78 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.894 0.378 . . . . 0.0 110.927 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.873 HG11 ' HB3' ' A' ' 218' ' ' LEU . 23.0 t -73.51 -35.69 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.649 179.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.432 ' HB2' HD21 ' A' ' 174' ' ' LEU . 4.8 tp -55.85 -34.31 65.33 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.128 0.49 . . . . 0.0 110.075 179.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -78.77 -41.9 14.25 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.295 178.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -84.99 102.86 13.52 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.884 0.373 . . . . 0.0 110.632 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . 0.844 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.8 mtm 177.22 161.81 0.47 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.146 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 12.3 t -117.18 -57.63 2.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.749 0.309 . . . . 0.0 110.908 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -160.91 142.31 11.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.001 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.904 HG12 HG12 ' A' ' 199' ' ' VAL . 16.3 mt -102.1 114.51 41.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.316 179.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . 0.415 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 21.6 m170 -104.34 122.58 45.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.237 -179.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.418 ' CD2' ' HD3' ' A' ' 189' ' ' PRO . 51.9 t80 -74.5 104.25 5.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.275 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 11.8 mmtt -119.78 76.37 20.72 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.692 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.418 ' HD3' ' CD2' ' A' ' 187' ' ' TYR . 56.0 Cg_endo -70.2 144.69 52.44 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.21 1.94 . . . . 0.0 112.443 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 18.6 p -127.18 159.77 33.27 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.671 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 37.8 mtt-85 -53.52 -24.91 14.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.45 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -103.12 -21.14 13.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.597 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -137.16 79.2 1.74 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.975 0.417 . . . . 0.0 111.282 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.68 -23.23 50.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.484 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -107.01 36.52 2.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.75 0.31 . . . . 0.0 110.976 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 6.4 ttt85 -89.58 115.03 26.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.979 0.419 . . . . 0.0 111.15 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.839 ' O ' HD13 ' A' ' 198' ' ' ILE . 27.2 m -111.67 166.68 5.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.729 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.839 HD13 ' O ' ' A' ' 197' ' ' VAL . 22.7 mm -133.52 108.9 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.821 0.343 . . . . 0.0 111.222 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.904 HG12 HG12 ' A' ' 185' ' ' ILE . 9.1 m -99.08 122.65 51.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.088 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -85.14 152.48 23.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.761 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 4.7 mmt -104.97 158.88 16.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.017 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -63.22 -26.64 68.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.13 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -87.09 11.16 14.5 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 83.65 14.51 73.06 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.539 -0.838 . . . . 0.0 113.281 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -82.14 166.83 19.33 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 117.073 0.437 . . . . 0.0 110.845 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -133.72 111.67 10.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.879 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.416 ' HB ' HG23 ' A' ' 199' ' ' VAL . 21.4 t -114.63 125.26 71.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.131 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.557 ' HB3' HD12 ' A' ' 198' ' ' ILE . 2.0 p -101.18 116.1 32.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.76 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.664 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -126.87 159.89 32.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.872 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.47 152.52 19.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.687 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.419 HG21 ' HB3' ' A' ' 166' ' ' GLU . 35.2 mt -64.37 -38.29 82.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.95 0.405 . . . . 0.0 110.642 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 2.2 ptt85 -60.01 -34.61 73.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.205 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -134.77 45.5 2.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.933 0.397 . . . . 0.0 111.034 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.6 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 10.9 t80 -67.75 -53.9 23.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.712 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.2 -39.81 76.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.264 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.99 -48.84 62.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.101 0.477 . . . . 0.0 110.284 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . 0.419 ' O ' HG21 ' A' ' 224' ' ' ILE . 0.6 OUTLIER -53.27 -42.51 66.59 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.14 179.642 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.873 ' HB3' HG11 ' A' ' 178' ' ' VAL . 3.9 mm? -86.95 -23.48 25.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.042 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 11.2 t -60.99 -33.15 72.79 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.901 0.381 . . . . 0.0 110.22 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -69.83 -16.44 63.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.204 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.405 ' CE1' ' HB3' ' A' ' 222' ' ' PRO . 38.0 t80 -57.79 142.58 78.3 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.734 -0.212 . . . . 0.0 111.057 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.466 ' O ' ' HB2' ' A' ' 223' ' ' ALA . 46.1 Cg_endo -92.71 105.74 0.45 Allowed 'Cis proline' 0 C--N 1.356 0.953 0 C-N-CA 124.733 -0.944 . . . . 0.0 112.698 0.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.466 ' HB2' ' O ' ' A' ' 222' ' ' PRO . . . 172.7 42.3 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.441 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.419 HG21 ' O ' ' A' ' 217' ' ' LYS . 0.1 OUTLIER -134.02 165.23 32.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.858 -179.642 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 179.74 -170.16 0.13 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.12 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -79.3 151.64 30.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.158 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -145.24 25.63 1.37 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.134 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.665 ' O ' HD23 ' A' ' 228' ' ' LEU . 1.4 tt -110.1 50.26 0.81 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.176 0.512 . . . . 0.0 110.381 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 76.13 -60.49 0.48 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.952 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 65.39 47.67 2.26 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.991 0.424 . . . . 0.0 110.865 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -116.6 86.18 2.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.722 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 11.5 p -73.59 127.94 35.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.065 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.993 179.995 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.183 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.8 m 64.01 -78.33 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.698 0.285 . . . . 0.0 111.138 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -105.2 144.97 31.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.066 0.46 . . . . 0.0 110.997 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.763 ' HB2' HD13 ' A' ' 134' ' ' LEU . 78.8 m95 -67.3 168.09 11.18 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.06 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? -103.05 138.77 39.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.287 179.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.26 105.73 4.79 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 120.822 0.344 . . . . 0.0 110.669 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.867 HD11 HG22 ' A' ' 168' ' ' THR . 46.6 pt -95.04 -7.55 9.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.501 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.526 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -160.15 176.36 11.86 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 120.766 0.317 . . . . 0.0 110.946 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.471 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 35.7 m-85 -144.98 126.93 15.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.821 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.516 HG21 HD11 ' A' ' 139' ' ' LEU . 6.1 t -93.21 122.91 45.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.155 0.503 . . . . 0.0 111.587 -179.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.437 ' CE1' ' CE1' ' A' ' 130' ' ' PHE . 34.7 t80 -83.11 94.38 7.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.916 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -144.76 152.97 41.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.437 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.86 30.32 19.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.812 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 62.13 34.25 16.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.934 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.454 HG22 ' N ' ' A' ' 130' ' ' PHE . 58.5 m -151.04 161.93 41.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.993 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.641 ' CE2' ' HB2' ' A' ' 148' ' ' ALA . 16.8 m-85 -104.61 91.14 3.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.256 0.551 . . . . 0.0 110.897 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.489 ' HB2' HD21 ' A' ' 139' ' ' LEU . 23.8 m-85 -69.62 121.55 82.81 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.547 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.436 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 21.1 Cg_exo -65.2 122.16 9.82 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 122.374 2.05 . . . . 0.0 112.549 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.697 HD21 ' OG1' ' A' ' 168' ' ' THR . 31.0 tp -104.12 123.48 47.34 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.296 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.763 HD13 ' HB2' ' A' ' 118' ' ' TRP . 53.6 mt -71.58 174.92 6.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.582 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.421 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.3 pt-20 -64.93 -29.06 69.97 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.915 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 14.9 p-10 -91.17 13.66 16.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.152 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.638 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 74.95 22.52 76.7 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.059 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.674 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -76.0 92.76 3.18 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.412 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.516 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -70.64 119.86 15.41 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.023 0.439 . . . . 0.0 111.607 -179.083 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.421 HD12 ' HG2' ' A' ' 143' ' ' GLU . 4.0 mm? -92.24 72.91 5.38 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.711 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.467 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 0.4 OUTLIER -61.05 -16.84 48.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.012 -179.753 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -95.52 -20.0 19.37 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.421 ' HG2' HD12 ' A' ' 140' ' ' LEU . 39.9 mm-40 -102.23 25.7 8.57 Favored 'General case' 0 N--CA 1.461 0.111 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.436 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -58.43 162.6 10.29 Favored Glycine 0 CA--C 1.509 -0.337 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.708 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 11.1 t -136.33 150.83 49.04 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.767 0.317 . . . . 0.0 110.67 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.438 ' HE2' HG23 ' A' ' 129' ' ' THR . 3.9 mmtt -88.99 52.19 2.35 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.005 0.431 . . . . 0.0 110.705 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.23 149.46 2.81 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.658 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.641 ' HB2' ' CE2' ' A' ' 130' ' ' PHE . . . -94.6 125.66 50.7 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.324 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.471 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 75.2 Cg_endo -84.24 111.26 1.58 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.49 2.126 . . . . 0.0 112.638 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.3 t -69.91 -7.53 41.16 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.035 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -77.09 -23.2 51.9 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 120.806 0.336 . . . . 0.0 110.58 179.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.681 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -140.47 167.11 18.96 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.944 -179.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.681 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 62.7 Cg_endo -74.48 154.33 45.1 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.351 2.034 . . . . 0.0 112.133 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 14.3 t -115.47 111.12 34.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.019 0.437 . . . . 0.0 111.286 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.807 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.36 96.11 1.83 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.747 179.052 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.436 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 62.6 t -92.74 135.78 26.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.901 0.382 . . . . 0.0 110.936 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 48.77 58.28 7.75 Favored Glycine 0 CA--C 1.521 0.443 0 CA-C-N 115.963 -0.562 . . . . 0.0 113.209 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.807 ' CE2' HD23 ' A' ' 155' ' ' LEU . 3.0 m95 -101.13 151.3 22.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.206 0.526 . . . . 0.0 111.787 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -65.49 -173.34 0.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.319 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -43.81 154.88 0.09 Allowed 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.552 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.26 -25.13 53.86 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.134 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -59.95 -38.52 82.69 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.921 0.391 . . . . 0.0 110.107 179.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.89 -41.02 45.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.056 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.552 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.1 mt -58.08 -41.89 81.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.016 179.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.87 -30.54 46.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.228 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -68.74 -53.02 24.48 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 121.548 0.689 . . . . 0.0 110.026 179.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.766 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -60.11 -42.94 95.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.947 178.958 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.867 HG22 HD11 ' A' ' 121' ' ' ILE . 0.3 OUTLIER -59.51 -37.01 77.16 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.296 179.22 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.17 -39.52 94.59 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 110.556 -1.017 . . . . 0.0 110.556 178.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 48.1 mm-40 -69.72 -45.73 67.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.427 -0.387 . . . . 0.0 110.782 178.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.611 ' HA ' HD22 ' A' ' 174' ' ' LEU . 11.0 mp -66.58 -26.94 67.35 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.695 0.284 . . . . 0.0 111.462 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.98 -19.12 62.57 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.223 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -112.63 -26.67 8.52 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.573 0.225 . . . . 0.0 111.505 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.611 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER -57.55 167.4 1.34 Allowed Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.089 -179.754 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -70.66 127.9 14.48 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.201 1.934 . . . . 0.0 112.943 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.08 -25.28 8.34 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.597 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.44 -49.33 76.6 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.856 0.36 . . . . 0.0 110.944 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.866 HG11 ' HB3' ' A' ' 218' ' ' LEU . 39.9 t -74.24 -36.11 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.451 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.493 ' HB2' HD21 ' A' ' 174' ' ' LEU . 12.7 tp -55.13 -37.01 66.37 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.09 0.472 . . . . 0.0 110.11 179.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -78.39 -39.09 23.44 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.393 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -87.29 103.04 15.08 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.9 0.381 . . . . 0.0 110.73 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . 0.834 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.8 mtm 178.05 176.61 0.44 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.053 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 9.1 t -132.07 -54.77 0.98 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.783 0.325 . . . . 0.0 111.129 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -162.17 142.52 10.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.021 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.89 HG12 HG12 ' A' ' 199' ' ' VAL . 19.7 mt -104.76 114.69 45.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.34 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . 0.436 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 20.0 m170 -106.21 126.28 52.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.079 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.413 ' CD1' ' HD3' ' A' ' 189' ' ' PRO . 0.4 OUTLIER -77.39 104.83 8.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.517 179.57 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 11.8 mmtp -117.24 76.03 8.73 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.351 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.413 ' HD3' ' CD1' ' A' ' 187' ' ' TYR . 39.7 Cg_endo -66.67 145.43 75.73 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.374 2.05 . . . . 0.0 112.631 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 20.8 p -127.06 157.23 40.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.699 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 3.9 ptp85 -54.14 -24.2 16.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.4 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -101.41 -22.81 14.47 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.353 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -139.67 81.61 1.83 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.936 0.398 . . . . 0.0 111.216 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -57.54 -22.45 44.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.376 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -104.11 35.88 2.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.749 0.309 . . . . 0.0 110.881 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -89.95 113.15 24.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.044 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.875 ' O ' HD13 ' A' ' 198' ' ' ILE . 19.7 m -109.8 168.31 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.88 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.875 HD13 ' O ' ' A' ' 197' ' ' VAL . 22.8 mm -135.14 110.54 12.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.708 0.29 . . . . 0.0 111.242 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.89 HG12 HG12 ' A' ' 185' ' ' ILE . 10.6 m -99.09 133.97 39.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.963 0.411 . . . . 0.0 110.878 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -95.98 152.5 18.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.765 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 25.2 tpp -112.28 150.61 30.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.745 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 21.1 p30 -57.47 -28.93 63.81 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.28 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -72.69 -8.78 57.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.768 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 96.73 14.55 43.07 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 120.473 -0.87 . . . . 0.0 113.1 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -90.82 162.55 14.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 117.026 0.413 . . . . 0.0 111.018 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -126.85 111.26 13.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.809 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.745 HG11 HD12 ' A' ' 224' ' ' ILE . 20.6 t -109.36 137.52 41.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.067 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 10.7 p -109.58 118.66 37.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.967 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -127.07 172.54 10.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.679 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.33 154.5 27.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.609 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 31.9 mt -66.01 -35.45 75.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.812 0.339 . . . . 0.0 110.938 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.7 -35.63 81.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.194 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -134.83 47.53 2.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.016 0.436 . . . . 0.0 111.005 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.583 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 10.5 t80 -69.35 -50.81 42.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.613 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.97 -42.22 84.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.256 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -67.37 -47.68 69.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.986 0.422 . . . . 0.0 110.397 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.9 -45.34 74.69 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.09 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.866 ' HB3' HG11 ' A' ' 178' ' ' VAL . 4.4 mm? -82.12 -26.25 33.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.979 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 13.5 t -60.38 -32.46 71.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.002 0.429 . . . . 0.0 110.217 179.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.9 m170 -70.14 -17.11 63.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.118 179.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -71.26 139.6 84.72 Favored Pre-proline 0 CA--C 1.533 0.316 0 C-N-CA 121.359 -0.136 . . . . 0.0 110.939 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.503 ' O ' ' HB2' ' A' ' 223' ' ' ALA . 67.0 Cg_endo -87.26 109.97 1.44 Allowed 'Cis proline' 0 C--N 1.357 0.981 0 C-N-CA 124.505 -1.04 . . . . 0.0 112.56 0.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.503 ' HB2' ' O ' ' A' ' 222' ' ' PRO . . . 168.09 44.63 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.007 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.745 HD12 HG11 ' A' ' 207' ' ' VAL . 4.3 pt -115.81 -178.8 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.249 -179.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 224' ' ' ILE . . . 74.78 75.68 0.11 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.042 0.448 . . . . 0.0 110.842 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -112.21 -158.78 0.66 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.809 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -97.09 35.91 1.51 Allowed 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 120.845 0.355 . . . . 0.0 110.933 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.608 ' O ' HD23 ' A' ' 228' ' ' LEU . 7.5 tt -76.26 -3.08 34.61 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.794 179.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -98.32 32.47 2.47 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.765 0.317 . . . . 0.0 110.933 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 2.3 mtt85 -105.09 -52.26 2.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.88 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -63.53 89.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.885 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 19.6 t -127.25 143.29 41.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.117 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.278 -0.867 . . . . 0.0 110.874 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.113 0 N-CA-C 112.534 -0.226 . . . . 0.0 112.534 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 51.9 p -105.84 -176.97 3.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.857 0.36 . . . . 0.0 110.936 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -112.95 146.48 38.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.107 0.479 . . . . 0.0 110.935 179.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.731 ' HB2' HD13 ' A' ' 134' ' ' LEU . 79.5 m95 -67.11 168.27 10.5 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.068 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -102.79 135.41 44.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.466 179.449 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 15.0 mtt180 -71.42 105.49 3.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.743 -179.906 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.91 HD11 HG22 ' A' ' 168' ' ' THR . 45.3 pt -93.53 -8.31 10.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.503 179.455 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -159.16 176.53 12.12 Favored 'General case' 0 C--O 1.226 -0.178 0 C-N-CA 121.037 -0.265 . . . . 0.0 111.0 179.885 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.464 ' O ' ' HA ' ' A' ' 154' ' ' VAL . 32.3 m-85 -143.28 126.8 16.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.455 179.78 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.638 HG21 HD11 ' A' ' 139' ' ' LEU . 4.5 t -93.47 123.01 45.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.05 0.453 . . . . 0.0 111.133 -179.607 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.428 ' CD1' ' CE1' ' A' ' 130' ' ' PHE . 37.3 t80 -80.19 103.02 9.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.748 -179.889 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -159.18 155.44 27.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.559 -179.808 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.19 31.61 19.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.849 -179.851 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 60.41 31.38 20.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.0 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.45 HG23 ' HE2' ' A' ' 146' ' ' LYS . 86.3 m -154.05 161.87 41.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.846 179.929 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.446 ' N ' HG22 ' A' ' 129' ' ' THR . 8.9 m-85 -100.65 90.4 4.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.669 179.625 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.502 ' HA ' ' HA2' ' A' ' 144' ' ' GLY . 22.3 m-85 -65.41 125.44 89.52 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.811 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.4 ' HB3' ' CE2' ' A' ' 123' ' ' TYR . 60.9 Cg_endo -73.66 120.17 6.3 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.219 1.946 . . . . 0.0 112.372 -179.773 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.676 HD21 ' OG1' ' A' ' 168' ' ' THR . 27.4 tp -98.04 123.58 42.13 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.489 179.636 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.731 HD13 ' HB2' ' A' ' 118' ' ' TRP . 37.0 mt -69.63 172.68 7.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.464 -179.747 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -63.81 -28.32 69.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.998 179.706 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 50.5 p-10 -90.59 13.43 15.93 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.281 179.781 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.599 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 73.1 22.36 79.07 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.227 179.797 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.66 ' HB3' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -81.01 94.44 6.56 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.519 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.638 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -73.42 112.49 9.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.362 -179.04 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 34.3 mt -88.84 81.25 6.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.405 179.418 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.456 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 9.6 mtpt -71.13 -5.61 33.03 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -179.388 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -90.41 -27.14 19.51 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.635 0.255 . . . . 0.0 111.183 179.885 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -85.81 -79.98 0.23 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.76 0.314 . . . . 0.0 111.322 -179.707 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.502 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . 57.83 161.13 0.04 OUTLIER Glycine 0 CA--C 1.506 -0.514 0 CA-C-N 116.29 -0.413 . . . . 0.0 112.708 -179.572 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.9 t -140.07 148.67 42.11 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.357 -0.422 . . . . 0.0 110.842 -179.548 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.45 ' HE2' HG23 ' A' ' 129' ' ' THR . 4.0 mmtt -89.85 52.56 2.32 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.381 179.807 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.98 154.48 4.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.093 0.473 . . . . 0.0 110.613 -179.358 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.33 135.41 34.63 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.597 -179.493 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.45 ' HD2' ' CG2' ' A' ' 154' ' ' VAL . 67.1 Cg_endo -83.81 98.73 0.79 Allowed 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 122.993 2.462 . . . . 0.0 112.535 179.689 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 43.9 t -67.23 -9.57 41.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.786 179.468 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -90.15 -22.2 21.85 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 120.615 0.245 . . . . 0.0 111.572 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.723 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -138.9 167.75 18.16 Favored Pre-proline 0 C--N 1.329 -0.287 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -178.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.723 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 64.7 Cg_endo -74.22 163.97 35.29 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 122.469 2.113 . . . . 0.0 112.511 -179.863 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 20.1 t -123.73 109.05 22.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.517 -179.755 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.826 HD21 ' SD ' ' A' ' 167' ' ' MET . 1.1 mp -72.8 95.97 1.99 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.694 179.107 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 53.5 t -92.57 136.46 24.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.983 0.421 . . . . 0.0 111.231 -179.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 49.21 49.17 31.55 Favored Glycine 0 CA--C 1.519 0.299 0 CA-C-N 115.783 -0.644 . . . . 0.0 113.381 179.16 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.823 ' CE2' HD23 ' A' ' 155' ' ' LEU . 2.7 m95 -92.2 151.1 20.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.102 0.477 . . . . 0.0 111.371 -179.622 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -172.55 0.08 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.539 179.542 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -43.99 154.34 0.11 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.088 -0.506 . . . . 0.0 112.21 -179.846 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.534 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.41 -24.75 53.19 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.147 179.448 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.8 -39.23 84.31 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-O 120.959 0.409 . . . . 0.0 110.137 179.219 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.65 -40.84 47.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.054 178.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.534 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.2 mt -58.13 -41.68 81.28 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.093 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.991 179.104 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.21 -28.69 28.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.151 179.494 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -69.15 -53.23 21.19 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-O 121.474 0.654 . . . . 0.0 110.172 179.348 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.826 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -59.84 -45.11 93.45 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.11 179.051 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.91 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -56.84 -38.82 73.19 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.592 179.344 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.14 -37.73 92.12 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 178.26 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -72.03 -46.47 56.97 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.375 -0.412 . . . . 0.0 111.073 178.822 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.595 ' HA ' HD22 ' A' ' 174' ' ' LEU . 10.9 mp -65.88 -28.73 69.17 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.724 0.297 . . . . 0.0 111.414 179.785 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.82 -18.12 63.43 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.363 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -113.8 -26.79 8.03 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 111.661 0.245 . . . . 0.0 111.661 -179.73 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.595 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER -57.32 167.27 1.28 Allowed Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 116.682 -0.236 . . . . 0.0 111.22 -179.561 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -67.68 126.32 14.56 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.215 1.943 . . . . 0.0 112.796 179.74 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.92 -26.07 9.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.676 179.805 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -58.5 -48.83 79.52 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.873 0.368 . . . . 0.0 110.891 179.683 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.851 HG11 ' HB3' ' A' ' 218' ' ' LEU . 25.3 t -73.7 -33.7 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.531 179.515 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.401 ' HB2' HD21 ' A' ' 174' ' ' LEU . 11.4 tp -56.87 -35.78 69.3 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.135 0.493 . . . . 0.0 109.816 178.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -77.05 -42.39 19.83 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.276 178.74 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -84.13 103.02 13.0 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.829 0.347 . . . . 0.0 110.656 179.232 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . 0.85 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.9 mtm 178.85 159.76 0.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.123 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -118.36 -54.53 2.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.814 0.34 . . . . 0.0 111.122 -179.743 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -162.66 142.63 9.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.999 -179.834 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.912 HG12 HG12 ' A' ' 199' ' ' VAL . 17.7 mt -105.23 115.04 46.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.422 179.4 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 23.2 m170 -105.69 129.37 53.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.164 -179.499 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -82.2 104.54 12.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.521 179.663 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.19 90.01 51.05 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.65 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.21 149.65 58.04 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.309 2.006 . . . . 0.0 112.49 -179.721 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.457 HG21 ' HD3' ' A' ' 196' ' ' ARG . 6.9 p -122.09 169.94 10.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.557 179.728 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -60.2 -28.4 67.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.942 179.886 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.406 ' O ' ' CG ' ' A' ' 193' ' ' TYR . 3.0 mm-40 -115.61 9.78 15.4 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -179.54 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.406 ' CG ' ' O ' ' A' ' 192' ' ' GLU . 53.1 m-85 -157.96 76.29 0.78 Allowed 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.919 0.39 . . . . 0.0 111.327 179.872 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.54 -24.3 60.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.101 179.481 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . 0.592 ' OD1' HG22 ' A' ' 210' ' ' THR . 1.8 p30 -99.86 34.03 2.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.612 179.787 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.457 ' HD3' HG21 ' A' ' 190' ' ' THR . 0.2 OUTLIER -88.48 111.64 22.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.422 -179.491 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.869 ' O ' HD13 ' A' ' 198' ' ' ILE . 33.3 m -107.78 169.46 2.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.495 179.384 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.869 HD13 ' O ' ' A' ' 197' ' ' VAL . 15.1 mm -136.03 109.67 9.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.785 0.326 . . . . 0.0 111.2 179.888 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.912 HG12 HG12 ' A' ' 185' ' ' ILE . 9.9 m -97.85 120.9 47.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.081 179.727 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -81.76 152.65 26.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.788 -179.984 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 4.6 mmt -109.44 146.93 33.7 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.604 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -58.13 -29.07 65.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.073 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -78.21 -2.17 36.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.836 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 95.3 14.49 47.91 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 120.478 -0.867 . . . . 0.0 113.142 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -89.51 157.14 18.21 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.972 0.386 . . . . 0.0 111.04 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -125.84 111.54 14.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.724 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.838 HG11 HD12 ' A' ' 224' ' ' ILE . 22.8 t -110.77 139.59 33.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.139 -179.848 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.587 ' OG ' HD12 ' A' ' 198' ' ' ILE . 14.5 m -110.36 118.33 36.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.737 179.869 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.51 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -128.42 164.57 22.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.888 0.375 . . . . 0.0 111.067 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.592 HG22 ' OD1' ' A' ' 195' ' ' ASP . 0.6 OUTLIER -103.67 155.38 18.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.507 179.842 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 25.7 mt -62.91 -27.48 43.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.008 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 0.405 ' CZ ' ' HB3' ' A' ' 212' ' ' ARG . 0.0 OUTLIER -82.48 -41.9 19.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.742 0.306 . . . . 0.0 111.009 179.877 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -108.78 32.12 5.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.121 -179.931 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.558 ' CE1' HD11 ' A' ' 171' ' ' LEU . 11.3 t80 -64.25 -54.59 30.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.94 0.4 . . . . 0.0 110.284 179.737 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.71 -38.36 90.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.611 179.685 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -68.32 -51.95 39.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.436 179.53 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 1.8 mmmm -54.33 -43.02 70.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.951 179.819 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.851 ' HB3' HG11 ' A' ' 178' ' ' VAL . 4.1 mm? -82.32 -24.96 34.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.769 179.3 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 10.2 t -61.75 -31.74 71.94 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.851 0.357 . . . . 0.0 110.191 179.26 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -69.3 -17.1 63.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.068 179.596 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.442 ' CD1' ' HA ' ' A' ' 222' ' ' PRO . 60.1 t80 -63.74 136.41 96.71 Favored Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.469 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.538 ' O ' ' HB3' ' A' ' 223' ' ' ALA . 59.6 Cg_endo -71.38 154.42 97.14 Favored 'Cis proline' 0 C--N 1.355 0.878 0 C-N-CA 124.619 -0.992 . . . . 0.0 112.711 0.277 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' A' ' 222' ' ' PRO . . . 83.43 76.54 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.736 -179.479 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.838 HD12 HG11 ' A' ' 207' ' ' VAL . 8.3 pt -125.9 -179.95 2.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.065 -179.84 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 61.56 154.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.034 -179.808 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -115.34 -164.82 0.97 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.076 -179.841 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -106.83 31.19 5.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.898 0.38 . . . . 0.0 110.838 179.84 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -95.23 23.3 5.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.167 179.783 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -128.51 31.73 4.95 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.793 0.33 . . . . 0.0 110.929 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -95.46 -33.38 12.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.042 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -82.34 -63.05 1.46 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.937 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 33.8 m 43.15 34.37 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 179.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.807 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.155 0 N-CA-C 112.451 -0.26 . . . . 0.0 112.451 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.3 t 60.71 -172.0 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.781 0.324 . . . . 0.0 110.855 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 61.57 150.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.176 0.512 . . . . 0.0 111.103 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.762 ' HB2' HD13 ' A' ' 134' ' ' LEU . 78.8 m95 -72.21 168.2 18.75 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.955 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -102.75 136.1 43.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.542 179.559 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 73.4 mtt180 -71.69 105.87 3.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.833 0.349 . . . . 0.0 110.669 -179.875 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.898 HD11 HG22 ' A' ' 168' ' ' THR . 45.9 pt -94.06 -8.82 9.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.472 179.31 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -158.62 176.36 12.49 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 120.629 0.252 . . . . 0.0 110.76 179.926 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.457 ' O ' ' HA ' ' A' ' 154' ' ' VAL . 32.2 m-85 -143.07 127.0 17.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.378 179.771 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.618 HG21 HD11 ' A' ' 139' ' ' LEU . 5.3 t -93.51 122.79 45.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.32 -179.464 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.432 ' CD1' ' CE1' ' A' ' 130' ' ' PHE . 42.4 t80 -80.67 107.1 13.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.844 -179.943 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -163.47 154.24 16.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.521 -179.866 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.54 30.59 19.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.865 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 61.82 32.28 18.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.15 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 73.3 m -154.98 155.29 33.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.036 179.841 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.432 ' CE1' ' CD1' ' A' ' 125' ' ' TYR . 7.0 m-85 -96.26 91.11 5.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.463 179.567 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.496 ' HB2' HD21 ' A' ' 139' ' ' LEU . 24.2 m-85 -65.52 123.98 85.98 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.964 -179.626 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.407 ' HB3' ' CE2' ' A' ' 123' ' ' TYR . 55.4 Cg_endo -71.53 114.62 4.0 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 122.171 1.914 . . . . 0.0 112.743 -179.552 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.704 HD21 ' OG1' ' A' ' 168' ' ' THR . 29.0 tp -93.36 123.83 36.93 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.632 179.453 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.762 HD13 ' HB2' ' A' ' 118' ' ' TRP . 45.0 mt -69.51 173.66 5.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.47 -179.851 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.401 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 2.1 pt-20 -64.71 -28.35 69.53 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.118 179.751 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 42.7 p-10 -90.33 12.58 17.85 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.301 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.598 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 74.08 22.74 77.48 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.987 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.682 ' HB3' HD12 ' A' ' 134' ' ' LEU . 15.1 tpp85 -82.14 93.42 7.04 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.539 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.618 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -69.51 108.76 3.92 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.155 -179.212 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 15.8 mt -85.53 72.03 10.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.821 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.445 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 19.7 mttt -57.96 -20.85 40.97 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.45 179.873 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -94.09 19.74 8.82 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.42 179.578 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -144.49 25.32 1.51 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.655 0.264 . . . . 0.0 111.151 179.781 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . -58.98 166.69 7.59 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.88 -179.683 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 10.2 t -132.41 150.44 52.16 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.873 0.368 . . . . 0.0 110.751 -179.878 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.02 52.1 2.08 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.436 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.72 158.47 6.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.094 0.473 . . . . 0.0 110.678 -179.399 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -91.2 136.13 27.55 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.61 -179.504 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.448 ' HD2' ' CG2' ' A' ' 154' ' ' VAL . 62.9 Cg_endo -84.09 98.57 0.76 Allowed 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.11 2.54 . . . . 0.0 112.621 179.78 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 4.9 t -67.36 -9.66 43.51 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.713 179.363 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -90.21 -21.8 21.98 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.698 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -138.78 167.09 20.7 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.019 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.698 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 60.2 Cg_endo -73.76 163.55 36.91 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 122.5 2.134 . . . . 0.0 112.382 179.986 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 25.2 t -124.09 109.89 24.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.051 0.453 . . . . 0.0 111.591 -179.798 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.858 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.6 96.18 1.94 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.836 179.228 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.427 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 57.4 t -92.33 137.31 22.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.055 -179.928 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 47.5 56.96 7.76 Favored Glycine 0 CA--C 1.52 0.393 0 CA-C-N 115.855 -0.611 . . . . 0.0 113.231 179.371 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.858 ' CE2' HD23 ' A' ' 155' ' ' LEU . 2.9 m95 -99.44 151.16 21.42 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.185 0.516 . . . . 0.0 111.756 -179.386 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.66 -172.1 0.16 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.509 179.377 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -42.58 154.29 0.06 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.68 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.533 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.15 -24.68 52.04 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.232 179.491 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.05 -40.54 89.8 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-O 120.975 0.417 . . . . 0.0 110.041 179.193 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -74.25 -40.66 62.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.935 178.88 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.533 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.1 mt -58.92 -41.06 81.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.931 178.885 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.73 -31.0 57.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.25 179.881 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.418 ' CB ' HG21 ' A' ' 211' ' ' ILE . 5.4 mm-40 -67.63 -52.97 31.95 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-O 121.434 0.635 . . . . 0.0 110.245 179.571 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.819 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -59.45 -44.28 92.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.175 179.151 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.898 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -58.85 -38.16 78.11 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.534 179.271 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.37 -37.35 91.84 Favored Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 178.493 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 40.8 mm-40 -73.4 -45.71 53.06 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.403 -0.399 . . . . 0.0 111.199 179.035 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.573 ' HA ' HD22 ' A' ' 174' ' ' LEU . 11.0 mp -65.8 -29.55 70.05 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.688 0.28 . . . . 0.0 111.295 179.836 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.4 -19.98 64.64 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.335 -179.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -111.61 -26.75 8.87 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.613 0.244 . . . . 0.0 111.511 -179.834 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.573 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.1 OUTLIER -56.72 166.53 1.29 Allowed Pre-proline 0 CA--C 1.538 0.516 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.06 -179.665 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -69.7 128.07 15.55 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.269 1.979 . . . . 0.0 112.692 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.97 -25.9 5.29 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.676 179.802 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.76 -50.06 74.51 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.844 0.354 . . . . 0.0 111.037 179.701 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.868 HG11 ' HB3' ' A' ' 218' ' ' LEU . 30.1 t -74.11 -35.61 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.582 179.638 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.544 HD23 ' HD3' ' A' ' 153' ' ' PRO . 0.5 OUTLIER -56.98 -34.35 68.01 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.108 0.48 . . . . 0.0 109.772 179.002 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -78.48 -38.86 23.73 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 178.578 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -88.35 103.17 15.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.947 0.403 . . . . 0.0 110.774 179.229 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . 0.838 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.9 mtm 178.73 166.72 0.88 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.987 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.4 t -127.04 -51.48 1.43 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.706 0.289 . . . . 0.0 111.51 -179.613 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -163.06 142.83 8.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.934 0.397 . . . . 0.0 111.082 -179.668 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.93 HG12 HG12 ' A' ' 199' ' ' VAL . 19.0 mt -108.7 115.14 48.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.54 179.516 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . 0.427 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 22.2 m170 -106.14 123.4 47.95 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.952 -179.684 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -76.35 105.38 7.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.617 179.75 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.04 83.2 60.65 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.643 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.78 151.58 63.36 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.406 2.071 . . . . 0.0 112.653 -179.699 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 22.8 p -127.85 159.8 33.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.637 179.721 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -52.4 -24.96 8.67 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.727 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -107.32 -18.77 13.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.646 -179.954 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -133.67 77.7 1.73 Allowed 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.922 0.392 . . . . 0.0 111.159 -179.694 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -57.18 -21.11 30.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.641 179.819 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . 0.5 ' OD1' HG22 ' A' ' 210' ' ' THR . 2.4 p30 -110.3 37.45 2.72 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.624 0.249 . . . . 0.0 111.07 -179.812 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.19 117.34 28.87 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.04 0.448 . . . . 0.0 111.255 -179.795 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.878 ' O ' HD13 ' A' ' 198' ' ' ILE . 31.7 m -112.73 169.84 4.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.73 179.655 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.878 HD13 ' O ' ' A' ' 197' ' ' VAL . 22.7 mm -134.61 111.12 13.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.774 0.321 . . . . 0.0 111.356 179.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.93 HG12 HG12 ' A' ' 185' ' ' ILE . 10.7 m -100.23 133.58 42.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.877 179.601 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -95.11 152.51 18.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.799 179.954 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 6.5 mmt -105.12 166.74 10.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.937 0.398 . . . . 0.0 111.051 -179.904 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 19.5 p30 -69.37 -26.39 64.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.195 179.884 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -88.48 12.57 14.04 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -179.856 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 83.05 14.34 75.16 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.554 -0.831 . . . . 0.0 113.311 179.718 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -82.98 150.94 26.08 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 117.127 0.463 . . . . 0.0 110.626 179.886 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -121.75 111.43 17.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.889 -179.922 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.742 HG11 HD12 ' A' ' 224' ' ' ILE . 21.6 t -113.03 140.24 34.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.142 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.575 ' HB2' HD12 ' A' ' 198' ' ' ILE . 26.6 t -113.69 119.43 37.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.783 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.664 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -130.21 159.29 37.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.857 179.803 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.5 HG22 ' OD1' ' A' ' 195' ' ' ASP . 0.6 OUTLIER -92.36 156.56 17.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.68 179.747 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.418 HG21 ' CB ' ' A' ' 166' ' ' GLU . 33.9 mt -70.41 -34.82 59.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.764 0.316 . . . . 0.0 110.749 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.5 -30.89 70.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.215 -179.467 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -130.62 35.85 3.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.898 179.984 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.587 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 11.8 t80 -63.08 -52.7 61.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.801 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.43 -40.22 86.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.062 -179.918 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.21 -49.77 58.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.077 0.465 . . . . 0.0 110.439 179.589 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . 0.421 ' O ' HG21 ' A' ' 224' ' ' ILE . 1.0 OUTLIER -54.23 -43.79 71.16 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.027 179.701 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.868 ' HB3' HG11 ' A' ' 178' ' ' VAL . 4.0 mm? -82.7 -26.32 32.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.97 179.517 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 12.2 t -60.81 -31.61 71.01 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.996 0.427 . . . . 0.0 110.386 179.463 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -69.78 -16.47 63.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.27 179.532 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -65.83 137.79 96.24 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 121.328 -0.149 . . . . 0.0 110.901 180.0 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.52 ' O ' ' HB2' ' A' ' 223' ' ' ALA . 69.0 Cg_endo -86.51 109.9 1.47 Allowed 'Cis proline' 0 C--N 1.358 1.053 0 C-N-CA 124.513 -1.036 . . . . 0.0 112.601 0.145 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.52 ' HB2' ' O ' ' A' ' 222' ' ' PRO . . . 166.85 44.74 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.034 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.742 HD12 HG11 ' A' ' 207' ' ' VAL . 4.3 pt -115.16 -178.92 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.077 -179.433 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 224' ' ' ILE . . . 69.87 73.85 0.23 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.113 0.482 . . . . 0.0 110.655 -179.485 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -90.74 -166.3 1.55 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.416 -179.659 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -110.04 46.31 1.04 Allowed 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.746 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.667 ' O ' HD23 ' A' ' 228' ' ' LEU . 1.7 tt -64.76 52.72 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.671 -178.766 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 56.22 -178.01 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.849 0.357 . . . . 0.0 111.438 179.674 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.43 33.45 3.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.662 179.935 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -61.52 87.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.806 -179.864 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . 0.552 HG22 ' O ' ' A' ' 232' ' ' VAL . 12.3 p -154.27 47.44 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.133 0.492 . . . . 0.0 110.962 179.921 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 25.0 tttt . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.893 -179.951 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 112.543 -0.223 . . . . 0.0 112.543 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 8.5 t 61.03 112.05 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.725 0.297 . . . . 0.0 110.864 -179.9 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 62.34 146.46 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.101 0.477 . . . . 0.0 110.885 -179.853 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.741 ' HB2' HD13 ' A' ' 134' ' ' LEU . 81.0 m95 -65.71 168.35 7.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.142 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.43 HH11 HG22 ' A' ' 121' ' ' ILE . 3.6 tmt_? -102.25 135.23 44.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.53 179.536 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 6.6 mtm-85 -71.29 105.28 3.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.673 -179.923 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.86 HD11 HG22 ' A' ' 168' ' ' THR . 46.7 pt -94.19 -6.7 10.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.654 179.518 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -161.14 176.71 11.0 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 121.002 -0.279 . . . . 0.0 111.065 179.823 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.465 ' O ' ' HA ' ' A' ' 154' ' ' VAL . 32.5 m-85 -143.35 127.19 17.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.19 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.58 HG21 HD11 ' A' ' 139' ' ' LEU . 5.1 t -93.26 122.81 45.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.041 0.448 . . . . 0.0 111.344 -179.386 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.43 ' HD2' HG13 ' A' ' 156' ' ' VAL . 33.2 t80 -80.43 109.48 14.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.712 -179.945 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.401 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 4.9 t70 -164.77 148.93 9.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.538 -179.788 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.68 31.69 18.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.895 -179.659 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 61.43 30.27 18.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.972 -179.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.529 HG23 ' O ' ' A' ' 145' ' ' THR . 84.7 m -151.09 149.73 29.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.801 179.861 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -94.2 91.75 6.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.53 179.65 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.549 ' HB2' HD21 ' A' ' 139' ' ' LEU . 20.6 m-85 -64.82 117.0 34.28 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.289 -179.41 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -64.12 119.03 5.96 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.172 1.915 . . . . 0.0 112.435 179.981 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.646 HD21 ' OG1' ' A' ' 168' ' ' THR . 38.3 tp -99.79 124.18 44.8 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.802 179.672 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.741 HD13 ' HB2' ' A' ' 118' ' ' TRP . 41.3 mt -70.5 173.39 7.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.647 -179.827 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.405 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.9 pt-20 -64.59 -28.46 69.65 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.03 179.604 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -90.17 12.78 16.92 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.213 179.61 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.642 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 72.5 23.8 77.32 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.755 -0.736 . . . . 0.0 113.048 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.674 ' HB3' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -81.76 96.88 7.71 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.385 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.58 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -72.48 121.26 19.31 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.664 -178.93 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -98.39 72.24 2.08 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.678 179.385 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.459 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 21.6 mttt -57.83 -20.16 33.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.69 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -88.24 -24.43 23.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.564 -180.0 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -102.07 25.61 8.58 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.846 0.314 . . . . 0.0 111.846 -179.566 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . -58.95 164.91 8.92 Favored Glycine 0 CA--C 1.509 -0.292 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.757 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.529 ' O ' HG23 ' A' ' 129' ' ' THR . 9.0 t -130.03 155.29 46.37 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.073 0.463 . . . . 0.0 110.907 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -97.1 54.24 1.23 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.433 -179.703 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.69 170.95 6.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.265 -179.294 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -103.87 138.19 19.46 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.776 -179.355 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.462 ' HD2' ' CG2' ' A' ' 154' ' ' VAL . 58.8 Cg_endo -84.9 100.27 0.73 Allowed 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.219 2.613 . . . . 0.0 112.645 179.799 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 18.1 t -65.82 -11.21 44.54 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.72 179.334 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.93 -21.77 20.4 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.783 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.678 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -136.7 166.4 27.79 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -178.943 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.678 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 70.9 Cg_endo -75.15 164.57 32.83 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.487 2.125 . . . . 0.0 112.335 179.924 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 20.1 t -122.61 108.87 22.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.95 0.405 . . . . 0.0 111.677 -179.763 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.903 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.52 95.99 1.88 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.728 179.065 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.43 HG13 ' HD2' ' A' ' 125' ' ' TYR . 50.3 t -92.78 137.65 21.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.918 0.389 . . . . 0.0 111.181 -179.952 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 47.78 57.61 7.51 Favored Glycine 0 CA--C 1.521 0.431 0 CA-C-N 115.987 -0.551 . . . . 0.0 113.27 179.363 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.903 ' CE2' HD23 ' A' ' 155' ' ' LEU . 3.1 m95 -100.11 151.27 21.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.167 0.508 . . . . 0.0 111.705 -179.452 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -66.51 -172.39 0.16 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.569 179.276 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -43.08 154.17 0.08 Allowed 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -179.75 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.543 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.0 -24.76 51.82 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.239 179.477 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.15 -39.55 86.76 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.959 0.409 . . . . 0.0 110.066 179.199 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -75.86 -40.97 53.63 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.108 178.955 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.543 HD12 ' HA2' ' A' ' 161' ' ' GLY . 6.2 mt -58.55 -42.34 84.38 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.884 179.048 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.65 -25.93 20.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.477 179.648 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.467 ' CB ' HG21 ' A' ' 211' ' ' ILE . 6.0 mm-40 -71.49 -54.38 10.76 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.056 0.455 . . . . 0.0 110.854 -179.901 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.837 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -62.31 -37.33 85.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.244 179.547 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.86 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -60.51 -38.3 83.9 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.909 179.027 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -61.3 -36.06 91.88 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 177.62 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 55.3 mm-40 -70.65 -48.94 52.32 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.118 -0.541 . . . . 0.0 110.6 178.478 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.65 ' HA ' HD22 ' A' ' 174' ' ' LEU . 10.8 mp -65.06 -27.86 69.08 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.396 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.67 -18.46 62.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.373 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -112.19 -28.66 7.87 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 120.658 0.266 . . . . 0.0 111.519 -179.706 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.65 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.1 OUTLIER -57.61 167.2 1.43 Allowed Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.041 -179.612 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -70.34 129.19 16.58 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.248 1.965 . . . . 0.0 112.893 179.946 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.33 -25.34 9.38 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.65 179.667 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.97 -48.63 79.41 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.944 0.402 . . . . 0.0 110.869 179.664 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.879 HG11 ' HB3' ' A' ' 218' ' ' LEU . 39.3 t -74.12 -35.53 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.424 179.399 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.46 ' HB2' HD21 ' A' ' 174' ' ' LEU . 8.7 tp -56.8 -36.26 69.69 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.118 0.485 . . . . 0.0 109.949 179.019 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -76.67 -39.96 28.06 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.328 178.759 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -88.09 103.14 15.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.906 0.384 . . . . 0.0 110.669 179.268 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . 0.837 ' CE ' HG12 ' A' ' 178' ' ' VAL . 3.0 mtm 179.42 162.34 0.86 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.194 179.992 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.42 -56.22 2.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.742 0.306 . . . . 0.0 111.038 -179.838 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -163.11 142.69 8.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.832 -179.945 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.875 HG12 HG12 ' A' ' 199' ' ' VAL . 14.3 mt -103.11 115.15 44.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.539 179.484 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 24.2 m170 -104.19 127.32 51.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.03 -179.548 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -82.52 104.66 12.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.576 179.719 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -127.93 89.22 51.08 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.714 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -66.93 149.2 83.02 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.283 1.989 . . . . 0.0 112.532 -179.862 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 25.8 p -126.21 157.78 37.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.828 179.891 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -53.12 -25.31 12.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.595 -179.98 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -106.73 -17.92 14.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.785 -179.893 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -137.86 83.66 1.99 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.886 0.374 . . . . 0.0 111.315 -179.676 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -55.92 -22.7 27.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.427 179.623 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . 0.572 ' HB3' HD12 ' A' ' 211' ' ' ILE . 0.4 OUTLIER -109.68 40.87 1.8 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.017 0.437 . . . . 0.0 110.295 179.748 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 2.1 tpm_? -87.68 112.86 22.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.857 -179.956 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.822 ' O ' HD13 ' A' ' 198' ' ' ILE . 31.9 m -108.23 168.23 3.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.027 179.941 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.822 HD13 ' O ' ' A' ' 197' ' ' VAL . 19.3 mm -134.4 108.45 10.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.372 179.956 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.875 HG12 HG12 ' A' ' 185' ' ' ILE . 6.8 m -98.08 122.37 49.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.903 0.382 . . . . 0.0 110.873 179.462 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -82.4 152.27 26.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.834 -179.869 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.56 144.67 31.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.554 179.887 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 44.3 m-20 -57.43 -29.28 64.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.017 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -74.78 -7.44 53.4 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.633 179.676 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 101.54 14.47 29.87 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 120.484 -0.865 . . . . 0.0 113.123 -179.929 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -92.24 166.11 12.77 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.98 0.39 . . . . 0.0 111.049 -179.844 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -132.16 111.43 11.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.827 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.774 HG11 HD12 ' A' ' 224' ' ' ILE . 21.5 t -109.86 138.56 36.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.103 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 52.5 p -112.08 116.78 31.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.981 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.658 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -127.75 158.14 38.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.653 179.775 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -97.62 148.43 23.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.778 0.323 . . . . 0.0 110.653 179.891 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.572 HD12 ' HB3' ' A' ' 195' ' ' ASP . 59.5 mt -59.96 -36.59 67.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.825 179.927 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.25 -33.88 74.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.289 -179.524 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -134.92 44.17 2.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.984 0.421 . . . . 0.0 111.015 -179.885 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.579 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 10.8 t80 -66.91 -52.64 40.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.779 179.801 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.35 -41.51 89.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.232 -179.724 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -67.13 -49.76 63.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.102 0.477 . . . . 0.0 110.476 179.655 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.95 -44.56 74.43 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.015 179.782 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.879 ' HB3' HG11 ' A' ' 178' ' ' VAL . 4.1 mm? -81.22 -26.86 35.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.061 179.635 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 13.6 t -61.14 -31.7 71.41 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.93 0.395 . . . . 0.0 110.28 179.346 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 -69.77 -16.78 63.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.232 179.556 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -66.27 138.17 95.85 Favored Pre-proline 0 CA--C 1.534 0.33 0 C-N-CA 121.445 -0.102 . . . . 0.0 110.963 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.512 ' O ' ' HB2' ' A' ' 223' ' ' ALA . 68.9 Cg_endo -86.62 110.44 1.63 Allowed 'Cis proline' 0 C--N 1.356 0.961 0 C-N-CA 124.499 -1.042 . . . . 0.0 112.614 0.184 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.512 ' HB2' ' O ' ' A' ' 222' ' ' PRO . . . 167.72 44.27 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.147 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.774 HD12 HG11 ' A' ' 207' ' ' VAL . 5.5 pt -117.13 -178.71 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.22 -179.44 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . 0.492 ' HB3' ' O ' ' A' ' 224' ' ' ILE . . . 75.87 88.55 0.08 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.909 -179.589 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -85.35 -162.82 0.76 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.079 -179.92 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -98.22 30.11 3.27 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.807 0.337 . . . . 0.0 110.995 179.862 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.794 HD13 ' O ' ' A' ' 228' ' ' LEU . 1.1 tm? -58.96 -20.32 51.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.436 179.643 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -82.98 63.88 7.3 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.046 0.451 . . . . 0.0 110.871 179.821 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 10.9 ttp180 -98.25 -27.93 13.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.08 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -58.07 -51.34 70.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.826 0.346 . . . . 0.0 111.116 -179.952 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 232' ' ' VAL . 27.7 m -69.94 108.22 2.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.122 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.848 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.151 0 N-CA-C 112.575 -0.21 . . . . 0.0 112.575 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.25 177.8 4.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.838 0.351 . . . . 0.0 110.813 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 61.72 152.54 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.094 0.473 . . . . 0.0 110.944 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.748 ' HB2' HD13 ' A' ' 134' ' ' LEU . 82.7 m95 -70.42 168.29 16.42 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.967 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.94 135.02 44.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.503 179.594 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 12.8 mtt180 -71.39 106.45 3.91 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.915 -179.815 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.896 HD11 HG22 ' A' ' 168' ' ' THR . 46.0 pt -95.8 -7.81 9.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.496 179.278 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.541 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -157.94 176.1 12.99 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 120.619 0.247 . . . . 0.0 110.713 179.768 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.468 ' CD1' ' CG ' ' A' ' 149' ' ' PRO . 39.1 m-85 -145.58 126.0 14.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.348 -179.895 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.672 HG21 HD11 ' A' ' 139' ' ' LEU . 4.2 t -94.05 123.21 46.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.016 0.436 . . . . 0.0 111.269 -179.458 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.465 ' CD1' ' CE1' ' A' ' 130' ' ' PHE . 7.0 t80 -82.59 101.85 11.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.892 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -156.31 155.35 32.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.704 -179.912 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 60.85 32.95 20.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.878 -179.783 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 60.28 31.26 20.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.91 179.961 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.445 HG22 ' N ' ' A' ' 130' ' ' PHE . 70.6 m -152.94 161.49 42.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.883 179.766 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.465 ' CE1' ' CD1' ' A' ' 125' ' ' TYR . 97.2 m-85 -102.54 90.41 3.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.696 179.668 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.49 ' HA ' ' HA2' ' A' ' 144' ' ' GLY . 22.8 m-85 -65.45 124.79 88.12 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.088 -179.923 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.63 119.17 5.79 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 121.986 1.791 . . . . 0.0 112.367 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.608 HD11 ' HA2' ' A' ' 137' ' ' GLY . 32.2 tp -96.1 123.81 39.86 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.657 179.793 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.748 HD13 ' HB2' ' A' ' 118' ' ' TRP . 41.6 mt -70.79 172.77 8.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.563 -179.713 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.41 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 1.8 pt-20 -63.27 -29.05 70.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.992 179.692 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -89.9 12.52 17.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.131 179.577 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.658 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 72.72 25.09 74.87 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.997 179.874 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.662 ' HB3' HD12 ' A' ' 134' ' ' LEU . 0.8 OUTLIER -82.61 95.11 7.68 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.433 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.672 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -72.69 107.21 5.03 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.301 -179.221 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.436 HD11 HD21 ' A' ' 134' ' ' LEU . 30.5 mt -84.48 76.8 10.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.271 179.375 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.443 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 24.6 mtpt -67.84 -8.77 38.99 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.407 -179.603 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -84.77 -28.53 26.13 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.707 0.289 . . . . 0.0 110.915 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -85.65 -79.95 0.23 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.072 -179.848 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.49 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . 57.28 160.71 0.02 OUTLIER Glycine 0 CA--C 1.507 -0.462 0 CA-C-N 116.283 -0.417 . . . . 0.0 112.837 -179.625 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 9.6 t -140.63 150.78 43.99 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.356 -0.422 . . . . 0.0 110.68 -179.647 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -89.26 50.87 2.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.96 0.41 . . . . 0.0 110.625 179.839 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -171.33 155.49 4.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.956 0.408 . . . . 0.0 110.611 -179.286 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -98.74 125.26 43.05 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.148 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.468 ' CG ' ' CD1' ' A' ' 123' ' ' TYR . 96.5 Cg_endo -84.93 109.26 1.25 Allowed 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 122.494 2.13 . . . . 0.0 112.779 -179.767 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 17.0 t -69.86 -7.86 43.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.958 179.743 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -77.28 -23.41 51.13 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 120.808 0.337 . . . . 0.0 110.451 179.006 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.651 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -139.47 166.23 25.82 Favored Pre-proline 0 N--CA 1.453 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.546 -179.493 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.651 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 72.4 Cg_endo -75.57 151.08 36.6 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.426 2.084 . . . . 0.0 112.662 -179.821 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.436 HG22 ' HB2' ' A' ' 123' ' ' TYR . 9.4 t -113.2 111.59 36.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.902 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.863 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.44 96.02 1.85 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.619 179.22 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.414 HG23 ' HB2' ' A' ' 184' ' ' GLU . 62.1 t -90.75 137.0 22.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.956 0.408 . . . . 0.0 111.18 179.966 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 47.76 60.78 5.19 Favored Glycine 0 CA--C 1.521 0.434 0 CA-C-N 115.938 -0.573 . . . . 0.0 113.147 179.377 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.863 ' CE2' HD23 ' A' ' 155' ' ' LEU . 3.0 m95 -104.35 151.27 23.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.228 0.537 . . . . 0.0 111.823 -179.344 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.25 -172.17 0.2 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.393 179.386 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -42.15 153.66 0.06 Allowed 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.733 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.503 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -56.94 -24.85 51.74 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.215 179.446 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -59.87 -40.49 88.84 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.916 0.388 . . . . 0.0 109.987 179.213 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -75.17 -38.95 60.67 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.988 178.907 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.503 HD12 ' HA2' ' A' ' 161' ' ' GLY . 5.4 mt -59.88 -43.69 92.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.808 178.866 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.413 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . . . -53.54 -26.11 19.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.717 179.962 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.401 ' CB ' HG21 ' A' ' 211' ' ' ILE . 3.5 mm-40 -70.34 -54.57 12.01 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.1 0.476 . . . . 0.0 110.781 -179.9 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.823 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -61.75 -35.85 79.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.291 179.518 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.896 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -60.88 -40.88 94.69 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.938 178.89 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.94 -35.36 86.74 Favored Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 177.903 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -72.46 -46.85 53.0 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.236 -0.482 . . . . 0.0 110.66 178.656 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.647 ' HA ' HD22 ' A' ' 174' ' ' LEU . 10.8 mp -66.25 -27.57 68.05 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.773 0.321 . . . . 0.0 111.592 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.46 -17.54 62.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.257 179.868 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -114.38 -26.89 7.78 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -179.681 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.647 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.2 OUTLIER -57.77 167.63 1.37 Allowed Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.037 -179.58 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -69.1 127.74 15.57 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.138 1.892 . . . . 0.0 112.829 179.812 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.45 -25.88 11.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.611 179.713 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.81 -48.45 79.69 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.866 0.365 . . . . 0.0 110.967 179.658 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.887 HG11 ' HB3' ' A' ' 218' ' ' LEU . 22.3 t -74.06 -37.13 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.571 179.584 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.525 ' HB2' HD21 ' A' ' 174' ' ' LEU . 6.6 tp -55.59 -36.1 66.52 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.237 0.541 . . . . 0.0 110.072 179.058 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -76.54 -40.96 26.09 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.268 178.864 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -87.58 102.87 15.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.979 0.419 . . . . 0.0 110.596 179.225 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . 0.838 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.9 mtm 177.89 162.47 0.59 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.084 -179.916 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 7.5 t -118.26 -56.9 2.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.819 0.343 . . . . 0.0 110.92 -179.859 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . 0.414 ' HB2' HG23 ' A' ' 156' ' ' VAL . 5.3 pt-20 -161.28 142.44 11.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.957 -179.848 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.877 HG12 HG12 ' A' ' 199' ' ' VAL . 16.8 mt -100.4 115.91 42.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.403 179.483 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 19.9 m170 -105.04 115.25 29.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.965 -179.526 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.433 ' HB2' ' CE2' ' A' ' 158' ' ' TRP . 14.5 t80 -74.79 104.62 5.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.688 179.817 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.91 84.8 44.79 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.448 179.85 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.83 148.78 58.9 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.395 2.063 . . . . 0.0 112.62 -179.668 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 8.3 p -133.74 162.11 32.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.58 179.681 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 17.7 mtt-85 -57.04 -26.38 60.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.149 179.721 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -97.48 -19.25 18.53 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.583 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -146.91 82.16 1.56 Allowed 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 120.87 0.367 . . . . 0.0 111.388 -179.881 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -58.29 -21.65 49.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.271 179.737 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -107.8 36.75 2.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.742 0.306 . . . . 0.0 110.591 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 3.3 ttt180 -89.42 115.87 27.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.306 -179.673 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.759 ' O ' HD13 ' A' ' 198' ' ' ILE . 34.0 m -112.78 165.27 7.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.684 179.563 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.759 HD13 ' O ' ' A' ' 197' ' ' VAL . 23.8 mm -131.32 105.76 11.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.775 0.321 . . . . 0.0 111.279 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.877 HG12 HG12 ' A' ' 185' ' ' ILE . 6.9 m -95.85 121.48 46.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.941 179.652 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -81.82 146.47 29.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.646 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -95.06 167.15 11.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.033 -179.655 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.27 -27.69 65.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.059 -179.919 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -90.43 15.31 10.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.884 -179.845 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 87.69 -7.14 82.1 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.474 -0.869 . . . . 0.0 113.315 179.947 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.09 170.2 0.93 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 117.235 0.518 . . . . 0.0 110.928 -179.966 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -141.33 111.45 6.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.694 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.4 t -112.4 125.27 69.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.262 -179.774 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.505 ' OG ' HD12 ' A' ' 198' ' ' ILE . 4.6 m -100.98 112.04 24.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.661 179.721 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.636 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -124.1 160.87 26.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.88 -179.899 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.66 155.85 17.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.499 179.841 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.401 HG21 ' CB ' ' A' ' 166' ' ' GLU . 30.8 mt -67.08 -32.07 56.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.897 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.45 -40.52 70.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.355 -179.469 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -116.86 31.8 6.53 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.796 0.331 . . . . 0.0 110.95 -179.912 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.588 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 11.6 t80 -59.4 -54.92 41.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.997 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.43 -40.12 81.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.138 -179.922 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.38 -49.73 52.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.075 0.464 . . . . 0.0 110.333 179.553 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . 0.589 ' O ' HG21 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -54.14 -41.99 69.03 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.012 179.654 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.887 ' HB3' HG11 ' A' ' 178' ' ' VAL . 4.1 mm? -85.97 -23.54 26.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.825 179.462 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 9.4 t -60.69 -33.87 73.5 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.006 0.431 . . . . 0.0 110.119 179.232 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -70.08 -16.95 63.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.117 179.183 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.418 ' CE1' ' HB3' ' A' ' 222' ' ' PRO . 22.5 t80 -58.16 141.06 82.5 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 116.772 -0.194 . . . . 0.0 111.132 -179.902 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.477 ' O ' ' HB2' ' A' ' 223' ' ' ALA . 60.2 Cg_endo -90.42 107.4 0.72 Allowed 'Cis proline' 0 C--N 1.357 1.011 0 C-N-CA 124.597 -1.001 . . . . 0.0 112.654 0.191 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.477 ' HB2' ' O ' ' A' ' 222' ' ' PRO . . . 172.77 41.58 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.913 179.822 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.589 HG21 ' O ' ' A' ' 217' ' ' LYS . 0.1 OUTLIER -134.2 158.75 42.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.165 179.885 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 224' ' ' ILE . . . 177.13 -179.68 0.21 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.982 179.718 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -79.58 118.23 21.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.023 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -130.86 35.45 3.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.148 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 4.9 tp -98.73 30.83 3.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.878 179.935 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -139.44 34.03 2.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.87 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 20.7 mtp85 -125.75 -45.49 1.76 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.75 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 24.5 m-20 60.82 102.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.933 -179.957 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 21.6 t -84.89 90.76 2.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.09 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 15.3 tttm . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.957 179.904 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.16 0 N-CA-C 112.549 -0.221 . . . . 0.0 112.549 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.13 76.82 9.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.92 0.39 . . . . 0.0 110.924 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -101.6 151.95 21.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.133 0.492 . . . . 0.0 110.968 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.755 ' HB2' HD13 ' A' ' 134' ' ' LEU . 78.9 m95 -66.89 168.21 10.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.988 179.915 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 -102.82 136.67 42.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.467 179.588 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.7 mtm-85 -71.75 105.54 3.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.874 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.883 HD11 HG22 ' A' ' 168' ' ' THR . 46.8 pt -94.34 -8.71 9.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.38 179.205 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.486 ' HB3' HD23 ' A' ' 133' ' ' LEU . . . -158.16 176.19 12.81 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 120.601 0.238 . . . . 0.0 110.609 179.749 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.464 ' CD1' ' CG ' ' A' ' 149' ' ' PRO . 34.2 m-85 -144.99 125.91 14.44 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.633 HG21 HD11 ' A' ' 139' ' ' LEU . 4.8 t -93.69 123.3 45.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.044 0.45 . . . . 0.0 111.509 -179.292 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.478 ' CD1' ' CE1' ' A' ' 130' ' ' PHE . 30.2 t80 -81.35 101.77 10.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.758 179.965 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -155.58 153.74 30.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.645 -179.887 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 60.87 31.17 20.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.952 -179.672 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 61.87 30.86 18.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.188 179.811 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.446 HG22 ' N ' ' A' ' 130' ' ' PHE . 87.1 m -151.46 161.73 42.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.768 179.773 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.541 ' CE2' ' HB2' ' A' ' 148' ' ' ALA . 9.1 m-85 -101.39 90.27 4.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.866 179.666 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.473 ' HA ' ' HA2' ' A' ' 144' ' ' GLY . 22.1 m-85 -65.79 123.99 86.31 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.766 179.809 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.3 118.34 5.47 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.114 1.876 . . . . 0.0 112.338 -179.936 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.71 HD21 ' OG1' ' A' ' 168' ' ' THR . 25.8 tp -95.96 123.54 39.6 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.521 179.684 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.755 HD13 ' HB2' ' A' ' 118' ' ' TRP . 50.7 mt -70.67 173.73 6.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.344 -0.843 . . . . 0.0 111.449 -179.748 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.405 ' HA ' ' CD1' ' A' ' 121' ' ' ILE . 2.0 pt-20 -63.89 -28.33 69.76 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.995 179.588 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -91.29 14.23 15.05 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.199 179.791 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.619 ' HA2' HG21 ' A' ' 168' ' ' THR . . . 72.85 28.06 67.68 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.57 -179.976 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.651 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -81.65 90.1 6.29 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 178.721 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.633 HD11 HG21 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -72.31 102.01 3.01 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.802 -179.485 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 31.7 mt -83.06 79.39 9.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.824 -179.957 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.487 ' HE3' HD13 ' A' ' 139' ' ' LEU . 37.8 mttt -69.69 -8.51 48.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.207 -179.912 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -82.92 -29.63 29.02 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.83 0.348 . . . . 0.0 110.695 179.69 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -85.27 -80.4 0.21 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.957 179.98 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' A' ' 131' ' ' PHE . . . 56.92 160.76 0.02 OUTLIER Glycine 0 CA--C 1.506 -0.475 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.949 -179.777 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 10.2 t -142.07 150.38 41.15 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.437 -0.382 . . . . 0.0 110.753 -179.738 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.443 ' HE2' HG23 ' A' ' 129' ' ' THR . 3.7 mmtt -89.53 51.8 2.19 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.018 0.437 . . . . 0.0 110.596 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -171.26 149.99 2.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.735 -179.34 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.541 ' HB2' ' CE2' ' A' ' 130' ' ' PHE . . . -93.94 125.01 54.65 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.201 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.464 ' CG ' ' CD1' ' A' ' 123' ' ' TYR . 89.9 Cg_endo -85.04 109.89 1.27 Allowed 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.57 2.18 . . . . 0.0 112.796 -179.861 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 21.5 t -69.93 -7.74 43.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.935 179.79 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -77.61 -23.07 49.93 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 120.809 0.338 . . . . 0.0 110.515 179.096 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.657 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -139.92 166.22 25.35 Favored Pre-proline 0 N--CA 1.453 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.628 -179.41 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.657 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 64.4 Cg_endo -74.68 152.24 42.21 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.424 2.082 . . . . 0.0 112.346 -179.926 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 123' ' ' TYR . 9.8 t -113.99 109.46 28.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.065 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.844 HD23 ' CE2' ' A' ' 158' ' ' TRP . 1.0 OUTLIER -72.33 96.03 1.81 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.705 179.231 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.42 ' HB ' ' CD2' ' A' ' 186' ' ' HIS . 53.5 t -93.68 136.21 26.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.91 0.386 . . . . 0.0 111.012 179.944 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 50.81 57.5 10.79 Favored Glycine 0 CA--C 1.519 0.306 0 CA-C-N 115.886 -0.597 . . . . 0.0 113.089 179.443 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.844 ' CE2' HD23 ' A' ' 155' ' ' LEU . 3.2 m95 -102.16 151.2 22.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.08 0.467 . . . . 0.0 111.634 -179.572 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.73 -172.41 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.608 179.523 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -43.59 154.26 0.1 Allowed 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.775 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.532 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.58 -25.11 54.79 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.239 179.544 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.2 -38.42 83.24 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.948 0.404 . . . . 0.0 110.112 179.278 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.34 -39.2 48.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.03 179.034 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.532 HD12 ' HA2' ' A' ' 161' ' ' GLY . 5.9 mt -59.96 -41.46 86.15 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.857 179.046 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.8 -30.51 45.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.168 179.682 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.405 ' CB ' HG21 ' A' ' 211' ' ' ILE . 10.7 mm-40 -67.19 -53.0 34.41 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-O 121.417 0.627 . . . . 0.0 110.14 179.391 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.796 ' SD ' HD21 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -60.78 -43.22 98.38 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.088 179.025 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.883 HG22 HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -58.5 -38.66 78.11 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.51 179.214 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.09 -37.43 92.8 Favored Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 178.378 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 63.2 mm-40 -72.29 -45.85 58.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.462 -0.369 . . . . 0.0 110.892 178.972 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.561 ' O ' HD22 ' A' ' 174' ' ' LEU . 11.1 mp -65.48 -30.05 70.78 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.694 0.283 . . . . 0.0 111.202 179.685 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.0 -18.57 64.07 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.344 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -112.28 -26.71 8.63 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.632 0.254 . . . . 0.0 111.66 -179.696 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.561 HD22 ' O ' ' A' ' 171' ' ' LEU . 0.1 OUTLIER -56.86 166.67 1.28 Allowed Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.169 -179.517 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -69.29 128.66 16.79 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.163 1.908 . . . . 0.0 112.69 179.832 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.09 -25.66 5.36 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.69 179.715 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -57.18 -49.97 74.32 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.033 179.76 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.939 HG11 ' HB3' ' A' ' 218' ' ' LEU . 23.9 t -74.18 -39.81 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.715 179.609 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.521 ' HG ' HD21 ' A' ' 174' ' ' LEU . 0.5 OUTLIER -53.15 -33.38 52.24 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.103 0.478 . . . . 0.0 110.169 179.385 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -81.86 -38.92 12.55 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.591 178.802 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.43 ' HB1' ' SD ' ' A' ' 201' ' ' MET . . . -88.92 103.43 16.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.828 0.347 . . . . 0.0 110.852 179.528 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . 0.829 ' CE ' HG12 ' A' ' 178' ' ' VAL . 2.6 mtm 177.87 169.08 0.71 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.304 179.817 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 7.7 t -124.24 -59.61 1.47 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.752 0.311 . . . . 0.0 111.127 -179.901 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -157.02 142.73 17.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.121 -179.784 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.907 HG12 HG12 ' A' ' 199' ' ' VAL . 14.9 mt -106.23 114.53 45.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.269 179.359 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . 0.42 ' CD2' ' HB ' ' A' ' 156' ' ' VAL . 22.5 m170 -104.7 121.56 43.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.153 -179.431 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -72.67 104.95 4.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.58 179.769 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp -119.51 80.43 22.5 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.78 -179.921 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.27 145.21 59.26 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.259 1.973 . . . . 0.0 112.296 -179.903 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 18.2 p -128.3 159.31 35.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.733 179.944 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.41 -23.51 16.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.518 179.87 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -104.19 -20.39 13.82 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.569 -179.921 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -140.19 78.5 1.66 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.901 0.381 . . . . 0.0 111.287 -179.656 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -55.71 -24.06 32.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.51 179.835 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . 0.599 ' HB3' HD12 ' A' ' 211' ' ' ILE . 0.4 OUTLIER -106.5 40.04 1.7 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.967 0.413 . . . . 0.0 110.373 179.785 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 31.7 ttt85 -93.0 119.94 32.78 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.969 179.974 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.847 ' O ' HD13 ' A' ' 198' ' ' ILE . 23.2 m -113.03 167.77 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.09 -179.931 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.847 HD13 ' O ' ' A' ' 197' ' ' VAL . 24.7 mm -134.09 105.9 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.139 179.783 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.907 HG12 HG12 ' A' ' 185' ' ' ILE . 15.8 m -97.63 138.81 21.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.992 0.425 . . . . 0.0 111.02 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.423 ' CE2' ' HG3' ' A' ' 206' ' ' GLU . 50.7 m-85 -102.46 152.48 21.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.587 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . 0.43 ' SD ' ' HB1' ' A' ' 181' ' ' ALA . 21.3 tpp -104.06 158.21 16.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.833 0.349 . . . . 0.0 110.914 -179.902 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -56.27 -22.37 29.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.584 -179.825 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -90.4 15.34 10.8 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 111.825 0.305 . . . . 0.0 111.825 -179.913 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 77.05 14.58 82.48 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.583 -0.818 . . . . 0.0 113.147 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -77.55 167.7 21.19 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.99 0.395 . . . . 0.0 110.884 179.994 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . 0.423 ' HG3' ' CE2' ' A' ' 200' ' ' TYR . 7.2 tt0 -134.31 111.47 10.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.854 -179.964 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 17.7 t -116.56 131.14 70.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.976 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.704 ' OG ' HD12 ' A' ' 198' ' ' ILE . 59.5 m -104.03 116.9 33.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.054 -179.858 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.632 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -127.62 159.24 35.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.736 179.712 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.2 153.1 19.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.811 0.339 . . . . 0.0 110.751 -179.95 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.599 HD12 ' HB3' ' A' ' 195' ' ' ASP . 64.2 mt -63.31 -36.71 77.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.803 179.763 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.92 -35.9 79.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.548 -179.452 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -132.67 42.76 3.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.925 0.393 . . . . 0.0 111.115 -179.835 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.575 ' CZ ' HG11 ' A' ' 199' ' ' VAL . 11.3 t80 -65.49 -52.57 51.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.525 179.815 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.89 -43.38 86.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.293 -179.716 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.38 -49.39 60.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.102 0.477 . . . . 0.0 110.205 179.461 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . 0.404 ' O ' HG21 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -52.73 -42.76 65.18 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.181 179.683 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.939 ' HB3' HG11 ' A' ' 178' ' ' VAL . 4.0 mm? -87.16 -23.43 24.82 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.181 179.614 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 10.9 t -60.35 -33.88 73.05 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.025 0.44 . . . . 0.0 110.299 179.542 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -70.86 -16.88 62.73 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.109 179.3 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.418 ' CE1' ' HB3' ' A' ' 222' ' ' PRO . 21.9 t80 -58.13 142.16 80.78 Favored Pre-proline 0 CA--C 1.534 0.342 0 CA-C-N 116.798 -0.183 . . . . 0.0 110.901 179.925 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.494 ' O ' ' HB2' ' A' ' 223' ' ' ALA . 58.9 Cg_endo -89.98 108.66 0.93 Allowed 'Cis proline' 0 C--N 1.357 0.988 0 C-N-CA 124.649 -0.98 . . . . 0.0 112.705 0.264 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.494 ' HB2' ' O ' ' A' ' 222' ' ' PRO . . . 171.08 45.51 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.707 179.726 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.404 HG21 ' O ' ' A' ' 217' ' ' LYS . 0.1 OUTLIER -140.55 162.86 23.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.923 0.392 . . . . 0.0 111.366 -179.719 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 178.94 -169.16 0.09 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.798 179.724 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -60.05 113.0 2.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.139 179.939 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.579 ' O ' HG11 ' A' ' 232' ' ' VAL . . . -127.94 40.96 3.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.031 -179.998 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.577 ' O ' HD23 ' A' ' 228' ' ' LEU . 4.4 tt -88.84 11.72 17.11 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.749 179.885 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -108.59 172.45 6.83 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.887 0.375 . . . . 0.0 110.922 179.964 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 1.3 mtp180 62.57 20.77 12.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.452 -179.985 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 61.44 116.13 0.02 OUTLIER 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.898 0.38 . . . . 0.0 111.154 179.86 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . 0.579 HG11 ' O ' ' A' ' 227' ' ' ALA . 5.5 m -118.14 141.94 35.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.167 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 12.1 mttm . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.844 -179.988 . . . . . . . . 0 0 . 1 stop_ save_